BLASTP 2.2.26 [Sep-21-2011]
Reference: Altschul, Stephen F., Thomas L. Madden, Alejandro A. Schaffer,
Jinghui Zhang, Zheng Zhang, Webb Miller, and David J. Lipman (1997),
"Gapped BLAST and PSI-BLAST: a new generation of protein database search
programs", Nucleic Acids Res. 25:3389-3402.
Reference for compositional score matrix adjustment: Altschul, Stephen F.,
John C. Wootton, E. Michael Gertz, Richa Agarwala, Aleksandr Morgulis,
Alejandro A. Schaffer, and Yi-Kuo Yu (2005) "Protein database searches
using compositionally adjusted substitution matrices", FEBS J. 272:5101-5109.
Query= 048430
(973 letters)
Database: pdbaa
62,578 sequences; 14,973,337 total letters
Searching..................................................done
>pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1
Ectodomain
pdb|3RJ0|A Chain A, Plant Steroid Receptor Bri1 Ectodomain In Complex With
Brassinolide
Length = 772
Score = 177 bits (448), Expect = 3e-44, Method: Compositional matrix adjust.
Identities = 181/584 (30%), Positives = 253/584 (43%), Gaps = 74/584 (12%)
Query: 71 LVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLP--GDMCNSFTQLESFDVSSN 128
L L ISGN + ++ L+ +D SSN+ S +P GD + L+ D+S N
Sbjct: 177 LKHLAISGNKISGDV--DVSRCVNLEFLDVSSNNFSTGIPFLGDC----SALQHLDISGN 230
Query: 129 KITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREI 188
K++G+F AI + LK + + +N G P L SL L L N TG IP+
Sbjct: 231 KLSGDFSRAISTCTELKLLNISSNQFVGPIPP---LPLKSLQYLSLAENKFTGEIPDFLS 287
Query: 189 PNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLP--NLE 246
G L LDL GN+ G +P + S + ++ L N+ SG LP L L+
Sbjct: 288 ----GACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLK 343
Query: 247 NLFLWKNNLSGIIPDSICNASEATI-LELSSNLFSG-LVPNTFGNCRQ-LQILSLGDNQL 303
L L N SG +P+S+ N S + + L+LSSN FSG ++PN N + LQ L L +N
Sbjct: 344 VLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGF 403
Query: 304 TTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGI 363
T G+I +L+ C L L L N L G IP+S+G+LS L + + L G I
Sbjct: 404 T------GKI-PPTLSNCSELVSLHLSFNYLSGTIPSSLGSLS-KLRDLKLWLNMLEGEI 455
Query: 364 PVGFGXXXXXXXXXXXXXELAGAIPTVXXXXXXXXXXDLNSNKLKGFIPTDLCKLEKLNT 423
P +L G IP+ L++N+L G IP + +LE L
Sbjct: 456 PQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAI 515
Query: 424 LLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFXXXXXXXXX 483
L +NN+ G IP L + SL LD +N N TIP+ + +A +F
Sbjct: 516 LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYI 575
Query: 484 XXXXXXXEALGG----------------------------------------------LN 497
E G L+
Sbjct: 576 KNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLD 635
Query: 498 LTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPK 557
++ N LSGYIP IG++ L L L N G IP G L L LDLS N + G IP+
Sbjct: 636 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQ 695
Query: 558 SLEKLSRLVDFNVSFNGLEGEIPSGGPFVNFTADSFKQNYALCG 601
++ L+ L + ++S N L G IP G F F F N LCG
Sbjct: 696 AMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 739
Score = 133 bits (334), Expect = 5e-31, Method: Compositional matrix adjust.
Identities = 153/521 (29%), Positives = 221/521 (42%), Gaps = 76/521 (14%)
Query: 71 LVSLNISGNSFYD--TLPNELWHMRRLKIIDFSSNSLSGSLPGDMCN--SFTQLESFDVS 126
L SL++S NS T L LK ++ SSN+L PG + LE D+S
Sbjct: 99 LTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLD--FPGKVSGGLKLNSLEVLDLS 156
Query: 127 SNKITGEFPSAIV---NISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRI 183
+N I+G V LK + + N +SG C L L + NN + I
Sbjct: 157 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFL---DVSSNNFSTGI 213
Query: 184 PNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLP 243
P +G+ L+ LD+ GN ++G I + + + + N G +P + L
Sbjct: 214 P------FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP-LPLK 266
Query: 244 NLENLFLWKNNLSGIIPDSICNASEA-TILELSSNLFSGLVPNTFGNCRQLQILSLGDNQ 302
+L+ L L +N +G IPD + A + T L+LS N F G VP FG+C L+ L+L N
Sbjct: 267 SLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNN 326
Query: 303 LTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGG 362
+ G++ +L K R L+VL L N G +P S+ NLS SL
Sbjct: 327 FS------GELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASL------------- 367
Query: 363 IPVGFGXXXXXXXXXXXXXELAGAIPTVXXXXXXXXXXDLNSNKLKGFIPTDLCKLEK-- 420
DL+SN G I +LC+ K
Sbjct: 368 -----------------------------------LTLDLSSNNFSGPILPNLCQNPKNT 392
Query: 421 LNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFXXXXXX 480
L L NN G+IP L+N + L L N L+ TIPS+ SL + +
Sbjct: 393 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE 452
Query: 481 XXXXXXXXXXEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLIS 540
+ L L L N L+G IPS + N NL+W++L+ N G IP+ G L +
Sbjct: 453 GEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLEN 512
Query: 541 LQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPS 581
L L LS N+ SG IP L L+ +++ N G IP+
Sbjct: 513 LAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA 553
Score = 98.2 bits (243), Expect = 2e-20, Method: Compositional matrix adjust.
Identities = 124/449 (27%), Positives = 194/449 (43%), Gaps = 51/449 (11%)
Query: 142 SSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIG---NLHNL 198
+SL S+ L NSLSG P T L S L+ L N++ + P ++ L++L
Sbjct: 97 ASLTSLDLSRNSLSG--PVTTLTSLGSCSGLKFL--NVSSNT--LDFPGKVSGGLKLNSL 150
Query: 199 KILDLGGNNIAGL-IPSMIFNNS--NMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNL 255
++LDL N+I+G + + ++ + + + GN +SG + S + NLE L + NN
Sbjct: 151 EVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCV-NLEFLDVSSNNF 209
Query: 256 SGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFY 315
S IP + + S L++S N SG C +L++L++ NQ G I
Sbjct: 210 STGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFV------GPIPP 262
Query: 316 SSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGXXXXXXX 375
L +YL L N G IP+ + +L + G +P FG
Sbjct: 263 LPLKSLQYLS---LAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLES 319
Query: 376 XXXXXXELAGAIPT-VXXXXXXXXXXDLNSNKLKGFIPTDLCKLEK--LNTLLSNNNALQ 432
+G +P DL+ N+ G +P L L L LS+NN
Sbjct: 320 LALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSG 379
Query: 433 GQIPT-CLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFXXXXXXXXXXXXXXXXE 491
+P C +L+ L ++N IP T + +++
Sbjct: 380 PILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVS-------------------- 419
Query: 492 ALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNI 551
L+L+ N LSG IPSS+G+L L L L N +G IPQ + +L++L L N++
Sbjct: 420 ----LHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL 475
Query: 552 SGEIPKSLEKLSRLVDFNVSFNGLEGEIP 580
+GEIP L + L ++S N L GEIP
Sbjct: 476 TGEIPSGLSNCTNLNWISLSNNRLTGEIP 504
Score = 55.5 bits (132), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 36/102 (35%), Positives = 52/102 (50%), Gaps = 1/102 (0%)
Query: 58 GGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSF 117
GG P N ++ L++S N +P E+ M L I++ N +SGS+P D
Sbjct: 618 GGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIP-DEVGDL 676
Query: 118 TQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFP 159
L D+SSNK+ G P A+ ++ L I L NN+LSG P
Sbjct: 677 RGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 718
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 28/79 (35%), Positives = 47/79 (59%), Gaps = 1/79 (1%)
Query: 57 LGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNS 116
L G +P +G++ +L LN+ N ++P+E+ +R L I+D SSN L G +P M ++
Sbjct: 641 LSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAM-SA 699
Query: 117 FTQLESFDVSSNKITGEFP 135
T L D+S+N ++G P
Sbjct: 700 LTMLTEIDLSNNNLSGPIP 718
>pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1
pdb|3RGZ|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1
Length = 768
Score = 176 bits (446), Expect = 5e-44, Method: Compositional matrix adjust.
Identities = 181/584 (30%), Positives = 253/584 (43%), Gaps = 74/584 (12%)
Query: 71 LVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLP--GDMCNSFTQLESFDVSSN 128
L L ISGN + ++ L+ +D SSN+ S +P GD + L+ D+S N
Sbjct: 180 LKHLAISGNKISGDV--DVSRCVNLEFLDVSSNNFSTGIPFLGDC----SALQHLDISGN 233
Query: 129 KITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREI 188
K++G+F AI + LK + + +N G P L SL L L N TG IP+
Sbjct: 234 KLSGDFSRAISTCTELKLLNISSNQFVGPIPP---LPLKSLQYLSLAENKFTGEIPDFLS 290
Query: 189 PNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLP--NLE 246
G L LDL GN+ G +P + S + ++ L N+ SG LP L L+
Sbjct: 291 ----GACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLK 346
Query: 247 NLFLWKNNLSGIIPDSICNASEATI-LELSSNLFSG-LVPNTFGNCRQ-LQILSLGDNQL 303
L L N SG +P+S+ N S + + L+LSSN FSG ++PN N + LQ L L +N
Sbjct: 347 VLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGF 406
Query: 304 TTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGI 363
T G+I +L+ C L L L N L G IP+S+G+LS L + + L G I
Sbjct: 407 T------GKI-PPTLSNCSELVSLHLSFNYLSGTIPSSLGSLS-KLRDLKLWLNMLEGEI 458
Query: 364 PVGFGXXXXXXXXXXXXXELAGAIPTVXXXXXXXXXXDLNSNKLKGFIPTDLCKLEKLNT 423
P +L G IP+ L++N+L G IP + +LE L
Sbjct: 459 PQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAI 518
Query: 424 LLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFXXXXXXXXX 483
L +NN+ G IP L + SL LD +N N TIP+ + +A +F
Sbjct: 519 LKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGKIAANFIAGKRYVYI 578
Query: 484 XXXXXXXEALGG----------------------------------------------LN 497
E G L+
Sbjct: 579 KNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLD 638
Query: 498 LTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPK 557
++ N LSGYIP IG++ L L L N G IP G L L LDLS N + G IP+
Sbjct: 639 MSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQ 698
Query: 558 SLEKLSRLVDFNVSFNGLEGEIPSGGPFVNFTADSFKQNYALCG 601
++ L+ L + ++S N L G IP G F F F N LCG
Sbjct: 699 AMSALTMLTEIDLSNNNLSGPIPEMGQFETFPPAKFLNNPGLCG 742
Score = 132 bits (332), Expect = 9e-31, Method: Compositional matrix adjust.
Identities = 153/521 (29%), Positives = 221/521 (42%), Gaps = 76/521 (14%)
Query: 71 LVSLNISGNSFYD--TLPNELWHMRRLKIIDFSSNSLSGSLPGDMCN--SFTQLESFDVS 126
L SL++S NS T L LK ++ SSN+L PG + LE D+S
Sbjct: 102 LTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSSNTLD--FPGKVSGGLKLNSLEVLDLS 159
Query: 127 SNKITGEFPSAIV---NISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRI 183
+N I+G V LK + + N +SG C L L + NN + I
Sbjct: 160 ANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCVNLEFL---DVSSNNFSTGI 216
Query: 184 PNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLP 243
P +G+ L+ LD+ GN ++G I + + + + N G +P + L
Sbjct: 217 P------FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPP-LPLK 269
Query: 244 NLENLFLWKNNLSGIIPDSICNASEA-TILELSSNLFSGLVPNTFGNCRQLQILSLGDNQ 302
+L+ L L +N +G IPD + A + T L+LS N F G VP FG+C L+ L+L N
Sbjct: 270 SLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLESLALSSNN 329
Query: 303 LTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGG 362
+ G++ +L K R L+VL L N G +P S+ NLS SL
Sbjct: 330 FS------GELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASL------------- 370
Query: 363 IPVGFGXXXXXXXXXXXXXELAGAIPTVXXXXXXXXXXDLNSNKLKGFIPTDLCKLEK-- 420
DL+SN G I +LC+ K
Sbjct: 371 -----------------------------------LTLDLSSNNFSGPILPNLCQNPKNT 395
Query: 421 LNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFXXXXXX 480
L L NN G+IP L+N + L L N L+ TIPS+ SL + +
Sbjct: 396 LQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLE 455
Query: 481 XXXXXXXXXXEALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLIS 540
+ L L L N L+G IPS + N NL+W++L+ N G IP+ G L +
Sbjct: 456 GEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLEN 515
Query: 541 LQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIPS 581
L L LS N+ SG IP L L+ +++ N G IP+
Sbjct: 516 LAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPA 556
Score = 97.4 bits (241), Expect = 3e-20, Method: Compositional matrix adjust.
Identities = 124/449 (27%), Positives = 194/449 (43%), Gaps = 51/449 (11%)
Query: 142 SSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIG---NLHNL 198
+SL S+ L NSLSG P T L S L+ L N++ + P ++ L++L
Sbjct: 100 ASLTSLDLSRNSLSG--PVTTLTSLGSCSGLKFL--NVSSNT--LDFPGKVSGGLKLNSL 153
Query: 199 KILDLGGNNIAGL-IPSMIFNNS--NMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNL 255
++LDL N+I+G + + ++ + + + GN +SG + S + NLE L + NN
Sbjct: 154 EVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVDVSRCV-NLEFLDVSSNNF 212
Query: 256 SGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFY 315
S IP + + S L++S N SG C +L++L++ NQ G I
Sbjct: 213 STGIP-FLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFV------GPIPP 265
Query: 316 SSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGXXXXXXX 375
L +YL L N G IP+ + +L + G +P FG
Sbjct: 266 LPLKSLQYLS---LAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLES 322
Query: 376 XXXXXXELAGAIPT-VXXXXXXXXXXDLNSNKLKGFIPTDLCKLEK--LNTLLSNNNALQ 432
+G +P DL+ N+ G +P L L L LS+NN
Sbjct: 323 LALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSG 382
Query: 433 GQIPT-CLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFXXXXXXXXXXXXXXXXE 491
+P C +L+ L ++N IP T + +++
Sbjct: 383 PILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVS-------------------- 422
Query: 492 ALGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNI 551
L+L+ N LSG IPSS+G+L L L L N +G IPQ + +L++L L N++
Sbjct: 423 ----LHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL 478
Query: 552 SGEIPKSLEKLSRLVDFNVSFNGLEGEIP 580
+GEIP L + L ++S N L GEIP
Sbjct: 479 TGEIPSGLSNCTNLNWISLSNNRLTGEIP 507
Score = 55.5 bits (132), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 36/102 (35%), Positives = 52/102 (50%), Gaps = 1/102 (0%)
Query: 58 GGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSF 117
GG P N ++ L++S N +P E+ M L I++ N +SGS+P D
Sbjct: 621 GGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIP-DEVGDL 679
Query: 118 TQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFP 159
L D+SSNK+ G P A+ ++ L I L NN+LSG P
Sbjct: 680 RGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 28/79 (35%), Positives = 47/79 (59%), Gaps = 1/79 (1%)
Query: 57 LGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNS 116
L G +P +G++ +L LN+ N ++P+E+ +R L I+D SSN L G +P M ++
Sbjct: 644 LSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAM-SA 702
Query: 117 FTQLESFDVSSNKITGEFP 135
T L D+S+N ++G P
Sbjct: 703 LTMLTEIDLSNNNLSGPIP 721
>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|D Chain D, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|G Chain G, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
pdb|3TL8|H Chain H, The Avrptob-Bak1 Complex Reveals Two Structurally Similar
Kinaseinteracting Domains In A Single Type Iii Effector
Length = 349
Score = 149 bits (375), Expect = 9e-36, Method: Compositional matrix adjust.
Identities = 103/302 (34%), Positives = 151/302 (50%), Gaps = 22/302 (7%)
Query: 657 EENNSLNLATLSRISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQE 716
EE+ ++L L R S ELQ A++ F N+LG G F VYK LA+G VAVK L+E
Sbjct: 15 EEDPEVHLGQLKRFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVK--RLKE 72
Query: 717 DRALK---SFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS 773
+R F TE E++ HRNL+++ C P + L+ YM GS+ L S
Sbjct: 73 ERXQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPES 132
Query: 774 ---LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830
L +R I + A L YLH IIH D+K N+LLD++ A +GDFG+AKL+
Sbjct: 133 QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 192
Query: 831 DGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTG--- 887
D D TIG++APEY S G S DV+ +G++++E T ++ +
Sbjct: 193 DYKDXHVXXAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 252
Query: 888 EMSLKQWVAESLPGAVTE-VVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPE 946
++ L WV L E +VD +L +E+ + ++ +AL C+ P
Sbjct: 253 DVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEE----------VEQLIQVALLCTQSSPM 302
Query: 947 ER 948
ER
Sbjct: 303 ER 304
>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On
Plant Receptor- Like Kinase Bak1 Activation
pdb|3ULZ|A Chain A, Crystal Structure Of Apo Bak1
Length = 326
Score = 146 bits (369), Expect = 4e-35, Method: Compositional matrix adjust.
Identities = 102/302 (33%), Positives = 150/302 (49%), Gaps = 22/302 (7%)
Query: 657 EENNSLNLATLSRISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQE 716
EE+ ++L L R S ELQ A++ F N+LG G F VYK LA+G VAVK L+E
Sbjct: 7 EEDPEVHLGQLKRFSLRELQVASDNFXNKNILGRGGFGKVYKGRLADGXLVAVK--RLKE 64
Query: 717 DRALK---SFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS 773
+R F TE E++ HRNL+++ C P + L+ YM GS+ L S
Sbjct: 65 ERTQGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPES 124
Query: 774 ---LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830
L +R I + A L YLH IIH D+K N+LLD++ A +GDFG+AKL+
Sbjct: 125 QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184
Query: 831 DGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTG--- 887
D D IG++APEY S G S DV+ +G++++E T ++ +
Sbjct: 185 DYKDXHVXXAVRGXIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244
Query: 888 EMSLKQWVAESLPGAVTE-VVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPE 946
++ L WV L E +VD +L +E+ + ++ +AL C+ P
Sbjct: 245 DVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEE----------VEQLIQVALLCTQSSPM 294
Query: 947 ER 948
ER
Sbjct: 295 ER 296
>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By
Bacterial Effector Protein Avrpto
Length = 321
Score = 135 bits (339), Expect = 1e-31, Method: Compositional matrix adjust.
Identities = 95/286 (33%), Positives = 146/286 (51%), Gaps = 19/286 (6%)
Query: 669 RISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECE 728
R+ +L++ATN F L+G G F VYK L +G VA+K + + ++ F+TE E
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 729 VMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHN---YSLTIRQRLDIMID 785
+ RH +L+ ++ C LI +YM G+L++ LY + S++ QRL+I I
Sbjct: 88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 786 VASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT-QTMTLAT 844
A L YLH + IIH D+K N+LLD++ V + DFGI+K +D + T
Sbjct: 148 AARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKGT 204
Query: 845 IGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEM-SLKQWVAESL-PGA 902
+GY+ PEY +G ++ DVYSFG+++ E R + EM +L +W ES G
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQ 264
Query: 903 VTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEER 948
+ ++VD NL + E F A+KC A E+R
Sbjct: 265 LEQIVDPNLADKIRPESLRKFG----------DTAVKCLALSSEDR 300
>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|B Chain B, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|C Chain C, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
pdb|3HGK|D Chain D, Crystal Structure Of Effect Protein Avrptob Complexed With
Kinase Pto
Length = 327
Score = 133 bits (334), Expect = 5e-31, Method: Compositional matrix adjust.
Identities = 97/289 (33%), Positives = 149/289 (51%), Gaps = 25/289 (8%)
Query: 669 RISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECE 728
R+ +L++ATN F L+G G F VYK L +G VA+K + + ++ F+TE E
Sbjct: 28 RVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIE 87
Query: 729 VMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHN---YSLTIRQRLDIMID 785
+ RH +L+ ++ C LI +YM G+L++ LY + S++ QRL+I I
Sbjct: 88 TLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIG 147
Query: 786 VASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT----MT 841
A L YLH + IIH D+K N+LLD++ V + DFGI+K G + + QT +
Sbjct: 148 AARGLHYLH---TRAIIHRDVKSINILLDENFVPKITDFGISK--KGTE-LGQTHLXXVV 201
Query: 842 LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEM-SLKQWVAESL- 899
T+GY+ PEY +G ++ DVYSFG+++ E R + EM +L +W ES
Sbjct: 202 KGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHN 261
Query: 900 PGAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEER 948
G + ++VD NL + E F A+KC A E+R
Sbjct: 262 NGQLEQIVDPNLADKIRPESLRKFG----------DTAVKCLALSSEDR 300
>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4
pdb|2NRY|B Chain B, Crystal Structure Of Irak-4
pdb|2NRY|C Chain C, Crystal Structure Of Irak-4
pdb|2NRY|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 105 bits (262), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 74/234 (31%), Positives = 119/234 (50%), Gaps = 20/234 (8%)
Query: 658 ENNSLNLAT--LSRISYHELQQATNGFGES------NLLGSGSFDNVYKATLANGVSVAV 709
EN SL ++ S++EL+ TN F E N +G G F VYK + N +VAV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 710 K----VFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEK 765
K + ++ + + FD E +VM + +H NL++++ S+ L+ YMP GSL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 766 WLYSHNYS--LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGD 823
L + + L+ R I A+ + +LH + IH D+K N+LLD+ A + D
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISD 176
Query: 824 FGIAKLLDG-VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
FG+A+ + V + + T YMAPE G ++ D+YSFG++++E T
Sbjct: 177 FGLARASEKFAQTVMXSRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIIT 229
>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4
pdb|2NRU|B Chain B, Crystal Structure Of Irak-4
pdb|2NRU|C Chain C, Crystal Structure Of Irak-4
pdb|2NRU|D Chain D, Crystal Structure Of Irak-4
Length = 307
Score = 104 bits (260), Expect = 2e-22, Method: Compositional matrix adjust.
Identities = 74/234 (31%), Positives = 118/234 (50%), Gaps = 20/234 (8%)
Query: 658 ENNSLNLAT--LSRISYHELQQATNGFGES------NLLGSGSFDNVYKATLANGVSVAV 709
EN SL ++ S++EL+ TN F E N +G G F VYK + N +VAV
Sbjct: 1 ENKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAV 59
Query: 710 K----VFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEK 765
K + ++ + + FD E +VM + +H NL++++ S+ L+ YMP GSL
Sbjct: 60 KKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLD 119
Query: 766 WLYSHNYS--LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGD 823
L + + L+ R I A+ + +LH + IH D+K N+LLD+ A + D
Sbjct: 120 RLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISD 176
Query: 824 FGIAKLLDG-VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
FG+A+ + V + T YMAPE G ++ D+YSFG++++E T
Sbjct: 177 FGLARASEKFAQTVMXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIIT 229
>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
pdb|3PPZ|B Chain B, Crystal Structure Of Ctr1 Kinase Domain In Complex With
Staurosporine
Length = 309
Score = 103 bits (256), Expect = 7e-22, Method: Compositional matrix adjust.
Identities = 63/197 (31%), Positives = 108/197 (54%), Gaps = 7/197 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALK--SFDTECEVMRRIRHRNLIKIVSSC 745
+G+GSF V++A +G VAVK+ Q+ A + F E +M+R+RH N++ + +
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSH--NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
+ P +++ +Y+ +GSL + L+ L R+RL + DVA + YLH+ + PI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVH 162
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGD 863
DLK N+L+D + DFG+++ L + T +MAPE + + D
Sbjct: 163 RDLKSPNLLVDKKYTVKVCDFGLSR-LKASXFLXSKXAAGTPEWMAPEVLRDEPSNEKSD 221
Query: 864 VYSFGILMMETFTRRKP 880
VYSFG+++ E T ++P
Sbjct: 222 VYSFGVILWELATLQQP 238
>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|B Chain B, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|C Chain C, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIB|D Chain D, Crystal Structure Of Irak4 Kinase Domain Apo Form
pdb|2OIC|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OIC|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Staurosporine
pdb|2OID|A Chain A, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|B Chain B, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|C Chain C, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
pdb|2OID|D Chain D, Crystal Structure Of Irak4 Kinase Domain Complexed With
Amppnp
Length = 301
Score = 102 bits (254), Expect = 1e-21, Method: Compositional matrix adjust.
Identities = 70/220 (31%), Positives = 112/220 (50%), Gaps = 18/220 (8%)
Query: 670 ISYHELQQATNGFGES------NLLGSGSFDNVYKATLANGVSVAVK----VFNLQEDRA 719
S++EL+ TN F E N +G G F VYK + N +VAVK + ++ +
Sbjct: 9 FSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 67
Query: 720 LKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS--LTIR 777
+ FD E +VM + +H NL++++ S+ L+ YMP GSL L + + L+
Sbjct: 68 KQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWH 127
Query: 778 QRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG-VDPV 836
R I A+ + +LH + IH D+K N+LLD+ A + DFG+A+ + V
Sbjct: 128 MRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 184
Query: 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ T YMAPE G ++ D+YSFG++++E T
Sbjct: 185 MXXRIVGTTAYMAPE-ALRGEITPKSDIYSFGVVLLEIIT 223
>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
pdb|3P86|B Chain B, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In
Complex With Staurosporine
Length = 309
Score = 101 bits (251), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 62/197 (31%), Positives = 109/197 (55%), Gaps = 7/197 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALK--SFDTECEVMRRIRHRNLIKIVSSC 745
+G+GSF V++A +G VAVK+ Q+ A + F E +M+R+RH N++ + +
Sbjct: 45 IGAGSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAV 103
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSH--NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
+ P +++ +Y+ +GSL + L+ L R+RL + DVA + YLH+ + PI+H
Sbjct: 104 TQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVH 162
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGD 863
+LK N+L+D + DFG+++L ++ T +MAPE + + D
Sbjct: 163 RNLKSPNLLVDKKYTVKVCDFGLSRLKASTF-LSSKSAAGTPEWMAPEVLRDEPSNEKSD 221
Query: 864 VYSFGILMMETFTRRKP 880
VYSFG+++ E T ++P
Sbjct: 222 VYSFGVILWELATLQQP 238
>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1I|B Chain B, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 326
Score = 97.1 bits (240), Expect = 5e-20, Method: Compositional matrix adjust.
Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 688 LGSGSFDNV----YKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G+F +V Y N G VAVK + L+ F+ E E+++ ++H N++K
Sbjct: 49 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 108
Query: 743 SSCSNPGFK--ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
C + G + LIM+Y+P GSL +L H + + L + +EYL +
Sbjct: 109 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 165
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAPEYGSEGIV 858
IH DL N+L++++ +GDFG+ K+L D + + I + APE +E
Sbjct: 166 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 225
Query: 859 SISGDVYSFGILMMETFT 876
S++ DV+SFG+++ E FT
Sbjct: 226 SVASDVWSFGVVLYELFT 243
>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720
pdb|3C4C|B Chain B, B-Raf Kinase In Complex With Plx4720
Length = 280
Score = 96.3 bits (238), Expect = 7e-20, Method: Compositional matrix adjust.
Identities = 65/199 (32%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSC 745
+GSGSF VYK VAVK+ N+ + L++F E V+R+ RH N++ +
Sbjct: 20 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 77
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
+ P A++ Q+ SL L++ +++ +DI A ++YLH + IIH D
Sbjct: 78 TKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 133
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPE---YGSEGIVSIS 861
LK NN+ L +D +GDFG+A + Q L+ +I +MAPE S
Sbjct: 134 LKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 193
Query: 862 GDVYSFGILMMETFTRRKP 880
DVY+FGI++ E T + P
Sbjct: 194 SDVYAFGIVLYELMTGQLP 212
>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
pdb|4FK3|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx3203
Length = 292
Score = 95.1 bits (235), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 65/199 (32%), Positives = 100/199 (50%), Gaps = 12/199 (6%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSC 745
+GSGSF VYK VAVK+ N+ + L++F E V+R+ RH N++ +
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
+ P A++ Q+ SL L++ +++ +DI A ++YLH + IIH D
Sbjct: 90 TKPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPE---YGSEGIVSIS 861
LK NN+ L +D +GDFG+A Q L+ +I +MAPE S
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 862 GDVYSFGILMMETFTRRKP 880
DVY+FGI++ E T + P
Sbjct: 206 SDVYAFGIVLYELMTGQLP 224
>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain
pdb|2O8Y|B Chain B, Apo Irak4 Kinase Domain
Length = 298
Score = 94.7 bits (234), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 67/220 (30%), Positives = 109/220 (49%), Gaps = 18/220 (8%)
Query: 670 ISYHELQQATNGFGE------SNLLGSGSFDNVYKATLANGVSVAVK----VFNLQEDRA 719
S++EL+ TN F E N G G F VYK + N +VAVK + ++ +
Sbjct: 6 FSFYELKNVTNNFDERPISVGGNKXGEGGFGVVYKGYV-NNTTVAVKKLAAMVDITTEEL 64
Query: 720 LKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS--LTIR 777
+ FD E +V + +H NL++++ S+ L+ Y P GSL L + + L+
Sbjct: 65 KQQFDQEIKVXAKCQHENLVELLGFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWH 124
Query: 778 QRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG-VDPV 836
R I A+ + +LH + IH D+K N+LLD+ A + DFG+A+ + V
Sbjct: 125 XRCKIAQGAANGINFLHENHH---IHRDIKSANILLDEAFTAKISDFGLARASEKFAQXV 181
Query: 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ + T Y APE G ++ D+YSFG++++E T
Sbjct: 182 XXSRIVGTTAYXAPE-ALRGEITPKSDIYSFGVVLLEIIT 220
>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
pdb|3Q96|B Chain B, B-Raf Kinase Domain In Complex With A
Tetrahydronaphthalene Inhibitor
Length = 282
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 65/199 (32%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSC 745
+GSGSF VYK VAVK+ N+ + L++F E V+R+ RH N++ +
Sbjct: 18 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 75
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
+ P A++ Q+ SL L+ + + +DI A ++YLH + IIH D
Sbjct: 76 TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 131
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPE---YGSEGIVSIS 861
LK NN+ L +D+ +GDFG+A + Q L+ +I +MAPE + S
Sbjct: 132 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 191
Query: 862 GDVYSFGILMMETFTRRKP 880
DVY+FGI++ E T + P
Sbjct: 192 SDVYAFGIVLYELMTGQLP 210
>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
pdb|2FB8|B Chain B, Structure Of The B-Raf Kinase Domain Bound To Sb-590885
Length = 281
Score = 94.4 bits (233), Expect = 2e-19, Method: Compositional matrix adjust.
Identities = 65/199 (32%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSC 745
+GSGSF VYK VAVK+ N+ + L++F E V+R+ RH N++ +
Sbjct: 21 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
+ P A++ Q+ SL L+ + + +DI A ++YLH + IIH D
Sbjct: 79 TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 134
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPE---YGSEGIVSIS 861
LK NN+ L +D+ +GDFG+A + Q L+ +I +MAPE + S
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 194
Query: 862 GDVYSFGILMMETFTRRKP 880
DVY+FGI++ E T + P
Sbjct: 195 SDVYAFGIVLYELMTGQLP 213
>pdb|4H58|A Chain A, Braf In Complex With Compound 3
pdb|4H58|B Chain B, Braf In Complex With Compound 3
pdb|4H58|C Chain C, Braf In Complex With Compound 3
Length = 275
Score = 94.4 bits (233), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 65/199 (32%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSC 745
+GSGSF VYK VAVK+ N+ + L++F E V+R+ RH N++ +
Sbjct: 16 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
+ P A++ Q+ SL L+ + + +DI A ++YLH + IIH D
Sbjct: 74 TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPE---YGSEGIVSIS 861
LK NN+ L +D+ +GDFG+A + Q L+ +I +MAPE + S
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 862 GDVYSFGILMMETFTRRKP 880
DVY+FGI++ E T + P
Sbjct: 190 SDVYAFGIVLYELMTGQLP 208
>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJC|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 8
pdb|3TJD|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 19
pdb|3TJD|B Chain B, Co-Crystal Structure Of Jak2 With Thienopyridine 19
Length = 298
Score = 94.4 bits (233), Expect = 3e-19, Method: Composition-based stats.
Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 688 LGSGSFDNV----YKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G+F +V Y N G VAVK + L+ F+ E E+++ ++H N++K
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 743 SSCSNPGFK--ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
C + G + LIM+Y+P GSL +L H + + L + +EYL +
Sbjct: 81 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 137
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAPEYGSEGIV 858
IH DL N+L++++ +GDFG+ K+L D + + I + APE +E
Sbjct: 138 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 197
Query: 859 SISGDVYSFGILMMETFT 876
S++ DV+SFG+++ E FT
Sbjct: 198 SVASDVWSFGVVLYELFT 215
>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|2B7A|B Chain B, The Structural Basis Of Janus Kinase 2 Inhibition By A
Potent And Specific Pan-Janus Kinase Inhibitor
pdb|3FUP|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3FUP|B Chain B, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 293
Score = 94.4 bits (233), Expect = 3e-19, Method: Composition-based stats.
Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 688 LGSGSFDNV----YKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G+F +V Y N G VAVK + L+ F+ E E+++ ++H N++K
Sbjct: 16 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 75
Query: 743 SSCSNPGFK--ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
C + G + LIM+Y+P GSL +L H + + L + +EYL +
Sbjct: 76 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 132
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAPEYGSEGIV 858
IH DL N+L++++ +GDFG+ K+L D + + I + APE +E
Sbjct: 133 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 192
Query: 859 SISGDVYSFGILMMETFT 876
S++ DV+SFG+++ E FT
Sbjct: 193 SVASDVWSFGVVLYELFT 210
>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
pdb|4HGE|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8
Length = 300
Score = 94.4 bits (233), Expect = 3e-19, Method: Composition-based stats.
Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 688 LGSGSFDNV----YKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G+F +V Y N G VAVK + L+ F+ E E+++ ++H N++K
Sbjct: 23 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 82
Query: 743 SSCSNPGFK--ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
C + G + LIM+Y+P GSL +L H + + L + +EYL +
Sbjct: 83 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 139
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAPEYGSEGIV 858
IH DL N+L++++ +GDFG+ K+L D + + I + APE +E
Sbjct: 140 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 199
Query: 859 SISGDVYSFGILMMETFT 876
S++ DV+SFG+++ E FT
Sbjct: 200 SVASDVWSFGVVLYELFT 217
>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|B Chain B, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|D Chain D, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4M|E Chain E, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4F08|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F08|B Chain B, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
pdb|4F09|A Chain A, Discovery And Optimization Of C-2 Methyl
Imidazo-Pyrrolopyridines As Potent And Orally
Bioavailable Jak1 Inhibitors With Selectivity Over Jak2
Length = 302
Score = 94.4 bits (233), Expect = 3e-19, Method: Composition-based stats.
Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 688 LGSGSFDNV----YKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G+F +V Y N G VAVK + L+ F+ E E+++ ++H N++K
Sbjct: 25 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 84
Query: 743 SSCSNPGFK--ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
C + G + LIM+Y+P GSL +L H + + L + +EYL +
Sbjct: 85 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 141
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAPEYGSEGIV 858
IH DL N+L++++ +GDFG+ K+L D + + I + APE +E
Sbjct: 142 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 201
Query: 859 SISGDVYSFGILMMETFT 876
S++ DV+SFG+++ E FT
Sbjct: 202 SVASDVWSFGVVLYELFT 219
>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
pdb|4AQC|B Chain B, Triazolopyridine-Based Inhibitor Of Janus Kinase 2
Length = 301
Score = 94.4 bits (233), Expect = 3e-19, Method: Composition-based stats.
Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 688 LGSGSFDNV----YKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G+F +V Y N G VAVK + L+ F+ E E+++ ++H N++K
Sbjct: 24 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 83
Query: 743 SSCSNPGFK--ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
C + G + LIM+Y+P GSL +L H + + L + +EYL +
Sbjct: 84 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 140
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAPEYGSEGIV 858
IH DL N+L++++ +GDFG+ K+L D + + I + APE +E
Sbjct: 141 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 200
Query: 859 SISGDVYSFGILMMETFT 876
S++ DV+SFG+++ E FT
Sbjct: 201 SVASDVWSFGVVLYELFT 218
>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A
1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor
Length = 303
Score = 94.4 bits (233), Expect = 3e-19, Method: Composition-based stats.
Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 688 LGSGSFDNV----YKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G+F +V Y N G VAVK + L+ F+ E E+++ ++H N++K
Sbjct: 22 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 81
Query: 743 SSCSNPGFK--ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
C + G + LIM+Y+P GSL +L H + + L + +EYL +
Sbjct: 82 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 138
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAPEYGSEGIV 858
IH DL N+L++++ +GDFG+ K+L D + + I + APE +E
Sbjct: 139 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 198
Query: 859 SISGDVYSFGILMMETFT 876
S++ DV+SFG+++ E FT
Sbjct: 199 SVASDVWSFGVVLYELFT 216
>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3LPB|B Chain B, Crystal Structure Of Jak2 Complexed With A Potent
2,8-Diaryl Quinoxaline Inhibitor
pdb|3KRR|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent
Quinoxaline Atp Site Inhibitor
Length = 295
Score = 94.4 bits (233), Expect = 3e-19, Method: Composition-based stats.
Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 688 LGSGSFDNV----YKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G+F +V Y N G VAVK + L+ F+ E E+++ ++H N++K
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 743 SSCSNPGFK--ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
C + G + LIM+Y+P GSL +L H + + L + +EYL +
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAPEYGSEGIV 858
IH DL N+L++++ +GDFG+ K+L D + + I + APE +E
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 194
Query: 859 SISGDVYSFGILMMETFT 876
S++ DV+SFG+++ E FT
Sbjct: 195 SVASDVWSFGVVLYELFT 212
>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
pdb|3Q32|B Chain B, Structure Of Janus Kinase 2 With A Pyrrolotriazine
Inhibitor
Length = 301
Score = 94.4 bits (233), Expect = 3e-19, Method: Composition-based stats.
Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 688 LGSGSFDNV----YKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G+F +V Y N G VAVK + L+ F+ E E+++ ++H N++K
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 743 SSCSNPGFK--ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
C + G + LIM+Y+P GSL +L H + + L + +EYL +
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAPEYGSEGIV 858
IH DL N+L++++ +GDFG+ K+L D + + I + APE +E
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 194
Query: 859 SISGDVYSFGILMMETFT 876
S++ DV+SFG+++ E FT
Sbjct: 195 SVASDVWSFGVVLYELFT 212
>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain
pdb|2XA4|B Chain B, Inhibitors Of Jak2 Kinase Domain
Length = 298
Score = 94.4 bits (233), Expect = 3e-19, Method: Composition-based stats.
Identities = 62/198 (31%), Positives = 103/198 (52%), Gaps = 12/198 (6%)
Query: 688 LGSGSFDNV----YKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G+F +V Y N G VAVK + L+ F+ E E+++ ++H N++K
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 743 SSCSNPGFK--ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
C + G + LIM+Y+P GSL +L +H + + L + +EYL +
Sbjct: 81 GVCYSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDHIKLLQYTSQICKGMEYLG---TKR 137
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAPEYGSEGIV 858
IH DL N+L++++ +GDFG+ K+L D + + I + APE +E
Sbjct: 138 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 197
Query: 859 SISGDVYSFGILMMETFT 876
S++ DV+SFG+++ E FT
Sbjct: 198 SVASDVWSFGVVLYELFT 215
>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E63|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
pdb|3E64|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors
Length = 293
Score = 94.4 bits (233), Expect = 3e-19, Method: Composition-based stats.
Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 688 LGSGSFDNV----YKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G+F +V Y N G VAVK + L+ F+ E E+++ ++H N++K
Sbjct: 17 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 76
Query: 743 SSCSNPGFK--ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
C + G + LIM+Y+P GSL +L H + + L + +EYL +
Sbjct: 77 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 133
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAPEYGSEGIV 858
IH DL N+L++++ +GDFG+ K+L D + + I + APE +E
Sbjct: 134 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 193
Query: 859 SISGDVYSFGILMMETFT 876
S++ DV+SFG+++ E FT
Sbjct: 194 SVASDVWSFGVVLYELFT 211
>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors
Length = 311
Score = 94.4 bits (233), Expect = 3e-19, Method: Composition-based stats.
Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 688 LGSGSFDNV----YKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G+F +V Y N G VAVK + L+ F+ E E+++ ++H N++K
Sbjct: 36 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 743 SSCSNPGFK--ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
C + G + LIM+Y+P GSL +L H + + L + +EYL +
Sbjct: 96 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 152
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAPEYGSEGIV 858
IH DL N+L++++ +GDFG+ K+L D + + I + APE +E
Sbjct: 153 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 212
Query: 859 SISGDVYSFGILMMETFT 876
S++ DV+SFG+++ E FT
Sbjct: 213 SVASDVWSFGVVLYELFT 230
>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3IOK|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective
Inhibitors Of Jak2
pdb|3KCK|A Chain A, A Novel Chemotype Of Kinase Inhibitors
Length = 313
Score = 94.4 bits (233), Expect = 3e-19, Method: Composition-based stats.
Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 688 LGSGSFDNV----YKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G+F +V Y N G VAVK + L+ F+ E E+++ ++H N++K
Sbjct: 36 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 95
Query: 743 SSCSNPGFK--ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
C + G + LIM+Y+P GSL +L H + + L + +EYL +
Sbjct: 96 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 152
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAPEYGSEGIV 858
IH DL N+L++++ +GDFG+ K+L D + + I + APE +E
Sbjct: 153 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 212
Query: 859 SISGDVYSFGILMMETFT 876
S++ DV+SFG+++ E FT
Sbjct: 213 SVASDVWSFGVVLYELFT 230
>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
pdb|4DBN|B Chain B, Crystal Structure Of The Kinase Domain Of Human B-Raf With
A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 284
Score = 94.4 bits (233), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 65/199 (32%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSC 745
+GSGSF VYK VAVK+ N+ + L++F E V+R+ RH N++ +
Sbjct: 21 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 78
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
+ P A++ Q+ SL L+ + + +DI A ++YLH + IIH D
Sbjct: 79 TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 134
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPE---YGSEGIVSIS 861
LK NN+ L +D+ +GDFG+A + Q L+ +I +MAPE + S
Sbjct: 135 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 194
Query: 862 GDVYSFGILMMETFTRRKP 880
DVY+FGI++ E T + P
Sbjct: 195 SDVYAFGIVLYELMTGQLP 213
>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
pdb|3OG7|B Chain B, B-Raf Kinase V600e Oncogenic Mutant In Complex With
Plx4032
Length = 289
Score = 94.0 bits (232), Expect = 3e-19, Method: Compositional matrix adjust.
Identities = 65/199 (32%), Positives = 100/199 (50%), Gaps = 12/199 (6%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSC 745
+GSGSF VYK VAVK+ N+ + L++F E V+R+ RH N++ +
Sbjct: 32 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 89
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
+ P A++ Q+ SL L++ +++ +DI A ++YLH + IIH D
Sbjct: 90 TAPQL-AIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRD 145
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPE---YGSEGIVSIS 861
LK NN+ L +D +GDFG+A Q L+ +I +MAPE S
Sbjct: 146 LKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQ 205
Query: 862 GDVYSFGILMMETFTRRKP 880
DVY+FGI++ E T + P
Sbjct: 206 SDVYAFGIVLYELMTGQLP 224
>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3D4Q|B Chain B, Pyrazole-Based Inhibitors Of B-Raf Kinase
pdb|3PSB|A Chain A, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PSB|B Chain B, Furo[2,3-C]pyridine-Based Indanone Oximes As Potent And
Selective B- Raf Inhibitors
pdb|3PPJ|A Chain A, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPJ|B Chain B, Human B-Raf Kinase In Complex With A Furopyridine
Inhibitor
pdb|3PPK|A Chain A, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PPK|B Chain B, Human B-Raf Kinase In Complex With A Non-Oxime
Furopyridine Inhibitor
pdb|3PRF|A Chain A, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRF|B Chain B, Crystal Structure Of Human B-Raf Kinase Domain In Complex
With A Non- Oxime Furopyridine Inhibitor
pdb|3PRI|A Chain A, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3PRI|B Chain B, Crystal Structure Of Human B-Raf Kinase In Complex With A
Non-Oxime Furopyridine Inhibitor
pdb|3Q4C|A Chain A, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3Q4C|B Chain B, Crystal Structure Of Wild Type Braf Kinase Domain In
Complex With Organometallic Inhibitor Cns292
pdb|3PSD|A Chain A, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3PSD|B Chain B, Non-Oxime Pyrazole Based Inhibitors Of B-Raf Kinase
pdb|3SKC|A Chain A, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3SKC|B Chain B, Human B-Raf Kinase In Complex With An Amide Linked
Pyrazolopyridine Inhibitor
pdb|3TV4|A Chain A, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV4|B Chain B, Human B-Raf Kinase Domain In Complex With An Bromopyridine
Benzamide Inhibitor
pdb|3TV6|A Chain A, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|3TV6|B Chain B, Human B-Raf Kinase Domain In Complex With A
Methoxypyrazolopyridinyl Benzamide Inhibitor
pdb|4E26|A Chain A, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E26|B Chain B, Braf In Complex With An Organic Inhibitor 7898734
pdb|4E4X|A Chain A, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4E4X|B Chain B, Crystal Structure Of B-Raf Kinase Domain In Complex With A
Dihydropyrido[2,3-D]pyrimidinone-Based Inhibitor
pdb|4G9C|A Chain A, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
pdb|4G9C|B Chain B, Human B-Raf Kinase Domain Bound To A Type Ii
Pyrazolopyridine Inhibitor
Length = 307
Score = 94.0 bits (232), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 65/199 (32%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSC 745
+GSGSF VYK VAVK+ N+ + L++F E V+R+ RH N++ +
Sbjct: 44 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
+ P A++ Q+ SL L+ + + +DI A ++YLH + IIH D
Sbjct: 102 TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 157
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPE---YGSEGIVSIS 861
LK NN+ L +D+ +GDFG+A + Q L+ +I +MAPE + S
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 217
Query: 862 GDVYSFGILMMETFTRRKP 880
DVY+FGI++ E T + P
Sbjct: 218 SDVYAFGIVLYELMTGQLP 236
>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
pdb|3II5|B Chain B, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine
Inhibitor
Length = 306
Score = 94.0 bits (232), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 65/199 (32%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSC 745
+GSGSF VYK VAVK+ N+ + L++F E V+R+ RH N++ +
Sbjct: 43 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 100
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
+ P A++ Q+ SL L+ + + +DI A ++YLH + IIH D
Sbjct: 101 TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 156
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPE---YGSEGIVSIS 861
LK NN+ L +D+ +GDFG+A + Q L+ +I +MAPE + S
Sbjct: 157 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 216
Query: 862 GDVYSFGILMMETFTRRKP 880
DVY+FGI++ E T + P
Sbjct: 217 SDVYAFGIVLYELMTGQLP 235
>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006
pdb|1UWH|B Chain B, The Complex Of Wild Type B-Raf And Bay439006
Length = 276
Score = 93.6 bits (231), Expect = 4e-19, Method: Compositional matrix adjust.
Identities = 65/199 (32%), Positives = 101/199 (50%), Gaps = 12/199 (6%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSC 745
+GSGSF VYK VAVK+ N+ + L++F E V+R+ RH N++ +
Sbjct: 16 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
+ P A++ Q+ SL L+ + + +DI A ++YLH + IIH D
Sbjct: 74 TAPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPE---YGSEGIVSIS 861
LK NN+ L +D+ +GDFG+A + Q L+ +I +MAPE + S
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 862 GDVYSFGILMMETFTRRKP 880
DVY+FGI++ E T + P
Sbjct: 190 SDVYAFGIVLYELMTGQLP 208
>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6D|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 7
pdb|4E6Q|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
pdb|4E6Q|B Chain B, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With
Compound 12
Length = 298
Score = 93.6 bits (231), Expect = 5e-19, Method: Composition-based stats.
Identities = 61/198 (30%), Positives = 103/198 (52%), Gaps = 12/198 (6%)
Query: 688 LGSGSFDNV----YKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G+F +V Y N G VAVK + L+ F+ E E+++ ++H N++K
Sbjct: 21 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 80
Query: 743 SSCSNPGFK--ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
C + G + LIM+++P GSL ++L H + + L + +EYL +
Sbjct: 81 GVCYSAGRRNLKLIMEFLPYGSLREYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 137
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAPEYGSEGIV 858
IH DL N+L++++ +GDFG+ K+L D + + I + APE +E
Sbjct: 138 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGESPIFWYAPESLTESKF 197
Query: 859 SISGDVYSFGILMMETFT 876
S++ DV+SFG+++ E FT
Sbjct: 198 SVASDVWSFGVVLYELFT 215
>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
pdb|3VW6|B Chain B, Crystal Structure Of Human Apoptosis Signal-Regulating
Kinase 1 (Ask1) With Imidazopyridine Inhibitor
Length = 269
Score = 93.2 bits (230), Expect = 6e-19, Method: Composition-based stats.
Identities = 63/206 (30%), Positives = 108/206 (52%), Gaps = 6/206 (2%)
Query: 683 GESNLLGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKI 741
G+ +LG G++ VY L+N V +A+K ++ R + E + + ++H+N+++
Sbjct: 11 GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 70
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
+ S S GF + M+ +P GSL L S L ++ I LE L + + I
Sbjct: 71 LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQ-TIGFYTKQILEGLKYLHDNQI 129
Query: 802 IHCDLKPNNVLLDD-DMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
+H D+K +NVL++ V + DFG +K L G++P T+T T T+ YMAPE +G
Sbjct: 130 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQYMAPEIIDKGPRGY 188
Query: 861 --SGDVYSFGILMMETFTRRKPTNEM 884
+ D++S G ++E T + P E+
Sbjct: 189 GKAADIWSLGCTIIEMATGKPPFYEL 214
>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006
pdb|1UWJ|B Chain B, The Complex Of Mutant V599e B-raf And Bay439006
Length = 276
Score = 92.8 bits (229), Expect = 8e-19, Method: Compositional matrix adjust.
Identities = 65/199 (32%), Positives = 100/199 (50%), Gaps = 12/199 (6%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSC 745
+GSGSF VYK VAVK+ N+ + L++F E V+R+ RH N++ +
Sbjct: 16 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 73
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
+ P A++ Q+ SL L+ + + +DI A ++YLH + IIH D
Sbjct: 74 TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 129
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPE---YGSEGIVSIS 861
LK NN+ L +D+ +GDFG+A Q L+ +I +MAPE + S
Sbjct: 130 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 189
Query: 862 GDVYSFGILMMETFTRRKP 880
DVY+FGI++ E T + P
Sbjct: 190 SDVYAFGIVLYELMTGQLP 208
>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
pdb|3IDP|B Chain B, B-Raf V600e Kinase Domain In Complex With An
Aminoisoquinoline Inhibitor
Length = 300
Score = 92.8 bits (229), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 65/199 (32%), Positives = 100/199 (50%), Gaps = 12/199 (6%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSC 745
+GSGSF VYK VAVK+ N+ + L++F E V+R+ RH N++ +
Sbjct: 36 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 93
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
+ P A++ Q+ SL L+ + + +DI A ++YLH + IIH D
Sbjct: 94 TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 149
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPE---YGSEGIVSIS 861
LK NN+ L +D+ +GDFG+A Q L+ +I +MAPE + S
Sbjct: 150 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 209
Query: 862 GDVYSFGILMMETFTRRKP 880
DVY+FGI++ E T + P
Sbjct: 210 SDVYAFGIVLYELMTGQLP 228
>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
pdb|4G9R|B Chain B, B-Raf V600e Kinase Domain Bound To A Type Ii
Dihydroquinazoline Inhibitor
Length = 307
Score = 92.8 bits (229), Expect = 9e-19, Method: Compositional matrix adjust.
Identities = 65/199 (32%), Positives = 100/199 (50%), Gaps = 12/199 (6%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKIVSSC 745
+GSGSF VYK VAVK+ N+ + L++F E V+R+ RH N++ +
Sbjct: 44 IGSGSFGTVYKGKWHG--DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYS 101
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
+ P A++ Q+ SL L+ + + +DI A ++YLH + IIH D
Sbjct: 102 TKPQL-AIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRD 157
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPE---YGSEGIVSIS 861
LK NN+ L +D+ +GDFG+A Q L+ +I +MAPE + S
Sbjct: 158 LKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQ 217
Query: 862 GDVYSFGILMMETFTRRKP 880
DVY+FGI++ E T + P
Sbjct: 218 SDVYAFGIVLYELMTGQLP 236
>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii
Inhibtor Nvp-Bbt594
Length = 295
Score = 92.4 bits (228), Expect = 1e-18, Method: Composition-based stats.
Identities = 62/198 (31%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 688 LGSGSFDNV----YKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G+F +V Y N G VAVK + L+ F+ E E+++ ++H N++K
Sbjct: 18 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 77
Query: 743 SSCSNPGFK--ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
C + G + LIM+Y+P GSL +L H + + L + +EYL +
Sbjct: 78 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 134
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAPEYGSEGIV 858
IH DL N+L++++ +GDFG+ K+L D + + I + APE +E
Sbjct: 135 YIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKF 194
Query: 859 SISGDVYSFGILMMETFT 876
S++ DV+SFG+++ E FT
Sbjct: 195 SVASDVWSFGVVLYELFT 212
>pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase
Inhibiting Protein), A Leucine Rich Repeat Protein
Involved In Plant Defense
Length = 313
Score = 92.4 bits (228), Expect = 1e-18, Method: Compositional matrix adjust.
Identities = 72/230 (31%), Positives = 104/230 (45%), Gaps = 28/230 (12%)
Query: 405 NKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPSTFW 464
N L G IP + KL +L+ L + + G IP L+ + +L LDF N+L+ T+P +
Sbjct: 87 NNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSIS 146
Query: 465 SLKYILAVDFXXXXXXXXXXXXXXXXEAL-GGLNLTGNQLSGYIPSSIGNLKNLDWLALA 523
SL ++ + F L + ++ N+L+G IP + NL NL ++ L+
Sbjct: 147 SLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLS 205
Query: 524 RNAFQGPIPQSFGSLISLQS-----------------------LDLSGNNISGEIPKSLE 560
RN +G FGS + Q LDL N I G +P+ L
Sbjct: 206 RNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLT 265
Query: 561 KLSRLVDFNVSFNGLEGEIPSGGPFVNFTADSFKQNYALCGSSRLQVPPC 610
+L L NVSFN L GEIP GG F ++ N LCGS +P C
Sbjct: 266 QLKFLHSLNVSFNNLCGEIPQGGNLQRFDVSAYANNKCLCGSP---LPAC 312
Score = 58.9 bits (141), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 64/252 (25%), Positives = 105/252 (41%), Gaps = 32/252 (12%)
Query: 56 SLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCN 115
+L G +PP + L+ L L I+ + +P+ L ++ L +DFS N+LSG+L
Sbjct: 88 NLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTL------ 141
Query: 116 SFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLL 175
P +I ++ +L I D N +SG+ P + + +
Sbjct: 142 -------------------PPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTIS 182
Query: 176 GNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGH 235
N +TG+ IP NL NL +DL N + G + ++ N I L N L+
Sbjct: 183 RNRLTGK-----IPPTFANL-NLAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFD 236
Query: 236 LPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQI 295
L NL L L N + G +P + L +S N G +P GN ++ +
Sbjct: 237 LGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG-GNLQRFDV 295
Query: 296 LSLGDNQLTTGS 307
+ +N+ GS
Sbjct: 296 SAYANNKCLCGS 307
Score = 53.9 bits (128), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 53/197 (26%), Positives = 96/197 (48%), Gaps = 18/197 (9%)
Query: 46 RVAALSLPNLSLGGTLPPHVGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSL 105
++ L + + ++ G +P + + LV+L+ S N+ TLP + + L I F N +
Sbjct: 102 QLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRI 161
Query: 106 SGSLPGDMCNSFTQL-ESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGS----FPT 160
SG++P D SF++L S +S N++TG+ P N+ +L + L N L G F +
Sbjct: 162 SGAIP-DSYGSFSKLFTSMTISRNRLTGKIPPTFANL-NLAFVDLSRNMLEGDASVLFGS 219
Query: 161 DLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNS 220
D T+ ++ L N++ + ++G NL LDL N I G +P +
Sbjct: 220 DKNTQ-----KIHLAKNSLAFDL------GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLK 268
Query: 221 NMVAILLYGNHLSGHLP 237
+ ++ + N+L G +P
Sbjct: 269 FLHSLNVSFNNLCGEIP 285
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 63/250 (25%), Positives = 101/250 (40%), Gaps = 33/250 (13%)
Query: 188 IPNEIGNLHNLKILDLGG-NNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLE 246
IP+ + NL L L +GG NN+ G IP P+ L L
Sbjct: 68 IPSSLANLPYLNFLYIGGINNLVGPIP-----------------------PAIAKLTQLH 104
Query: 247 NLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTG 306
L++ N+SG IPD + L+ S N SG +P + + L ++ N+++
Sbjct: 105 YLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRIS-- 162
Query: 307 SSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVG 366
G I S + + + + N L G IP + NL+ + + + L G V
Sbjct: 163 ----GAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLAFVDL--SRNMLEGDASVL 216
Query: 367 FGXXXXXXXXXXXXXELAGAIPTVXXXXXXXXXXDLNSNKLKGFIPTDLCKLEKLNTLLS 426
FG LA + V DL +N++ G +P L +L+ L++L
Sbjct: 217 FGSDKNTQKIHLAKNSLAFDLGKV-GLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNV 275
Query: 427 NNNALQGQIP 436
+ N L G+IP
Sbjct: 276 SFNNLCGEIP 285
>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|B Chain B, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|C Chain C, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|D Chain D, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|E Chain E, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
pdb|4EQM|F Chain F, Structural Analysis Of Staphylococcus Aureus
SerineTHREONINE KINASE Pknb
Length = 294
Score = 91.7 bits (226), Expect = 2e-18, Method: Composition-based stats.
Identities = 63/243 (25%), Positives = 115/243 (47%), Gaps = 17/243 (6%)
Query: 688 LGSGSFDNVYKA--TLANGVSVAVKVFNL---QEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G VY A T+ N + VA+K + +++ LK F+ E ++ H+N++ ++
Sbjct: 19 LGGGGMSTVYLAEDTILN-IKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPII 802
L+M+Y+ +L +++ SH L++ ++ + L+ + H + I+
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHG-PLSVDTAINFTNQI---LDGIKHAHDMRIV 133
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISG 862
H D+KP N+L+D + + DFGIAK L L T+ Y +PE
Sbjct: 134 HRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECT 193
Query: 863 DVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVD------ANLLSRED 916
D+YS GI++ E P N +++K + +S+P T+V +N++ R
Sbjct: 194 DIYSIGIVLYEMLVGEPPFNGETAVSIAIKH-IQDSVPNVTTDVRKDIPQSLSNVILRAT 252
Query: 917 EED 919
E+D
Sbjct: 253 EKD 255
>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
pdb|2CLQ|B Chain B, Structure Of Mitogen-Activated Protein Kinase Kinase
Kinase 5
Length = 295
Score = 91.3 bits (225), Expect = 2e-18, Method: Compositional matrix adjust.
Identities = 63/206 (30%), Positives = 108/206 (52%), Gaps = 6/206 (2%)
Query: 683 GESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKI 741
G+ +LG G++ VY L+N V +A+K ++ R + E + + ++H+N+++
Sbjct: 25 GDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLKHKNIVQY 84
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
+ S S GF + M+ +P GSL L S L ++ I LE L + + I
Sbjct: 85 LGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQT-IGFYTKQILEGLKYLHDNQI 143
Query: 802 IHCDLKPNNVLLDD-DMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGI--V 858
+H D+K +NVL++ V + DFG +K L G++P T+T T T+ YMAPE +G
Sbjct: 144 VHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFT-GTLQYMAPEIIDKGPRGY 202
Query: 859 SISGDVYSFGILMMETFTRRKPTNEM 884
+ D++S G ++E T + P E+
Sbjct: 203 GKAADIWSLGCTIIEMATGKPPFYEL 228
>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBE|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|B Chain B, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|C Chain C, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
pdb|4BBF|D Chain D, Aminoalkylpyrimidine Inhibitor Complexes With Jak2
Length = 298
Score = 91.3 bits (225), Expect = 3e-18, Method: Composition-based stats.
Identities = 61/198 (30%), Positives = 102/198 (51%), Gaps = 12/198 (6%)
Query: 688 LGSGSFDNV----YKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G+F +V Y N G VAVK + L+ F+ E E+++ ++H N++K
Sbjct: 19 LGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYK 78
Query: 743 SSCSNPGFK--ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
C + G + LIM+Y+P GSL +L H + + L + +EYL +
Sbjct: 79 GVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG---TKR 135
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAPEYGSEGIV 858
IH +L N+L++++ +GDFG+ K+L D + + I + APE +E
Sbjct: 136 YIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKF 195
Query: 859 SISGDVYSFGILMMETFT 876
S++ DV+SFG+++ E FT
Sbjct: 196 SVASDVWSFGVVLYELFT 213
>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor
Length = 535
Score = 89.7 bits (221), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 71/264 (26%), Positives = 118/264 (44%), Gaps = 33/264 (12%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG G F V+ T VA+K + ++F E +VM+++RH L+++ + S
Sbjct: 275 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 333
Query: 748 PGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++ +YM +GSL +L L + Q +D+ +AS + Y+ +H DL
Sbjct: 334 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 389
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ +++V + DFG+A+L++ + + I + APE G +I DV+S
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 449
Query: 867 FGILMMETFTR-RKPTNEMFTGEMSLKQWVAESLPGAV-TEVVDANLLSREDEEDADDFA 924
FGIL+ E T+ R P PG V EV+D E
Sbjct: 450 FGILLTELTTKGRVP------------------YPGMVNREVLD-------QVERGYRMP 484
Query: 925 TKKTCISYIMSLALKCSAEIPEER 948
C + L +C + PEER
Sbjct: 485 CPPECPESLHDLMCQCWRKEPEER 508
>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1)
pdb|3OMV|B Chain B, Crystal Structure Of C-Raf (Raf-1)
Length = 307
Score = 89.7 bits (221), Expect = 7e-18, Method: Compositional matrix adjust.
Identities = 63/207 (30%), Positives = 101/207 (48%), Gaps = 14/207 (6%)
Query: 685 SNLLGSGSFDNVYKATLANGVSVAV-KVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVS 743
S +GSGSF VYK V+V + KV + ++ ++F E V+R+ RH N++ +
Sbjct: 41 STRIGSGSFGTVYKGKWHGDVAVKILKVVDPTPEQ-FQAFRNEVAVLRKTRHVNILLFMG 99
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
+ A++ Q+ SL K L+ + Q +DI A ++YLH + IIH
Sbjct: 100 YMTKDNL-AIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLH---AKNIIH 155
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKL---LDGVDPVTQTMTLATIGYMAPE---YGSEGI 857
D+K NN+ L + + +GDFG+A + G V Q ++ +MAPE
Sbjct: 156 RDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPT--GSVLWMAPEVIRMQDNNP 213
Query: 858 VSISGDVYSFGILMMETFTRRKPTNEM 884
S DVYS+GI++ E T P + +
Sbjct: 214 FSFQSDVYSYGIVLYELMTGELPYSHI 240
>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src
pdb|2SRC|A Chain A, Crystal Structure Of Human Tyrosine-protein Kinase C-src,
In Complex With Amp-pnp
Length = 452
Score = 89.4 bits (220), Expect = 8e-18, Method: Compositional matrix adjust.
Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG G F V+ T VA+K + ++F E +VM+++RH L+++ + S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 748 PGFKALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++ +YM +GSL +L L + Q +D+ +AS + Y+ +H DL
Sbjct: 251 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 306
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ +++V + DFG+A+L++ + + I + APE G +I DV+S
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 867 FGILMMETFTR-RKPTNEMFTGEM 889
FGIL+ E T+ R P M E+
Sbjct: 367 FGILLTELTTKGRVPYPGMVNREV 390
>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An
Inhibitor
Length = 452
Score = 89.4 bits (220), Expect = 9e-18, Method: Compositional matrix adjust.
Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG G F V+ T VA+K + ++F E +VM+++RH L+++ + S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 748 PGFKALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++ +YM +GSL +L L + Q +D+ +AS + Y+ +H DL
Sbjct: 251 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 306
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ +++V + DFG+A+L++ + + I + APE G +I DV+S
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 867 FGILMMETFTR-RKPTNEMFTGEM 889
FGIL+ E T+ R P M E+
Sbjct: 367 FGILLTELTTKGRVPYPGMVNREV 390
>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
pdb|1YI6|B Chain B, C-Term Tail Segment Of Human Tyrosine Kinase (258-533)
Length = 276
Score = 89.4 bits (220), Expect = 1e-17, Method: Composition-based stats.
Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG G F V+ T VA+K + ++F E +VM+++RH L+++ + S
Sbjct: 16 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 74
Query: 748 PGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++ +YM +GSL +L L + Q +D+ +AS + Y+ +H DL
Sbjct: 75 EPI-XIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 130
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ +++V + DFG+A+L++ + + I + APE G +I DV+S
Sbjct: 131 RAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 190
Query: 867 FGILMMETFTR-RKPTNEMFTGEM 889
FGIL+ E T+ R P M E+
Sbjct: 191 FGILLTELTTKGRVPYPGMVNREV 214
>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|B Chain B, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|C Chain C, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
pdb|3DQW|D Chain D, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs
Length = 286
Score = 89.4 bits (220), Expect = 1e-17, Method: Composition-based stats.
Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 7/204 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG G F V+ T VA+K + ++F E +VM+++RH L+++ + S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 748 PGFKALIMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++++YM +GSL +L L + Q +D+ +AS + Y+ +H DL
Sbjct: 85 EPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 140
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ +++V + DFG+A+L++ + + I + APE G +I DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 867 FGILMMETFTR-RKPTNEMFTGEM 889
FGIL+ E T+ R P M E+
Sbjct: 201 FGILLTELTTKGRVPYPGMVNREV 224
>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OEZ|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain Complexed With Imatinib
pdb|3OF0|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3OF0|B Chain B, Crystal Structure Of The L317i Mutant Of The Chicken C-Src
Tyrosine Kinase Domain
pdb|3QLF|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLF|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Pyrazolopyrimidine
5
pdb|3QLG|A Chain A, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
pdb|3QLG|B Chain B, Crystal Structure Of The L317i Mutant Of The C-Src
Tyrosine Kinase Domain Complexed With Dasatinib
Length = 286
Score = 89.0 bits (219), Expect = 1e-17, Method: Composition-based stats.
Identities = 60/204 (29%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG G F V+ T VA+K + ++F E +VM++IRH L+++ + S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKIRHEKLVQLYAVVSE 84
Query: 748 PGFKALIMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++ +YM +GSL +L L + Q +D+ +AS + Y+ +H DL
Sbjct: 85 EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 140
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ +++V + DFG+A+L++ + + I + APE G +I DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 867 FGILMMETFTR-RKPTNEMFTGEM 889
FGIL+ E T+ R P M E+
Sbjct: 201 FGILLTELTTKGRVPYPGMVNREV 224
>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly
Mutant) In Complex With N6-Benzyl Adp
Length = 452
Score = 88.6 bits (218), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG G F V+ T VA+K + ++F E +VM+++RH L+++ + S
Sbjct: 192 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 250
Query: 748 PGFKALIMQYMPQGSLEKWLYSHN-YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++ +YM +GSL +L L + Q +D+ +AS + Y+ +H DL
Sbjct: 251 EPI-YIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 306
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ +++V + DFG+A+L++ + + I + APE G +I DV+S
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 366
Query: 867 FGILMMETFTR-RKPTNEMFTGEM 889
FGIL+ E T+ R P M E+
Sbjct: 367 FGILLTELTTKGRVPYPGMVNREV 390
>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase
Length = 453
Score = 88.6 bits (218), Expect = 1e-17, Method: Compositional matrix adjust.
Identities = 58/204 (28%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG G F V+ T VA+K + + ++F E +VM+++RH L+++ + S
Sbjct: 193 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGNMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 251
Query: 748 PGFKALIMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++ +YM +GSL +L L + Q +D+ +AS + Y+ +H DL
Sbjct: 252 EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 307
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ +++V + DFG+ +L++ + + I + APE G +I DV+S
Sbjct: 308 RAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 367
Query: 867 FGILMMETFTR-RKPTNEMFTGEM 889
FGIL+ E T+ R P M E+
Sbjct: 368 FGILLTELTTKGRVPYPGMVNREV 391
>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
pdb|3G6H|B Chain B, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation
Length = 286
Score = 88.6 bits (218), Expect = 2e-17, Method: Composition-based stats.
Identities = 59/204 (28%), Positives = 104/204 (50%), Gaps = 7/204 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG G F V+ T VA+K + ++F E +VM+++RH L+++ + S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 748 PGFKALIMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++++YM +GSL +L L + Q +D+ +AS + Y+ +H DL
Sbjct: 85 EPI-YIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 140
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ +++V + DFG+A+L++ + + I + APE G +I DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 867 FGILMMETFTR-RKPTNEMFTGEM 889
FGIL+ E T+ R P M E+
Sbjct: 201 FGILLTELTTKGRVPYPGMVNREV 224
>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QQ7|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain With
Irreversible Inhibitor
pdb|2QI8|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|2QI8|B Chain B, Crystal Structure Of Drug Resistant Src Kinase Domain
pdb|3F3W|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3F3W|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With
Inhibitor Rl45 (Type Ii)
pdb|3LOK|A Chain A, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
pdb|3LOK|B Chain B, Drug Resistant Csrc Kinase Domain In Complex With Covalent
Inhibitor Pd168393
Length = 286
Score = 88.2 bits (217), Expect = 2e-17, Method: Composition-based stats.
Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG G F V+ T VA+K + ++F E +VM+++RH L+++ + S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 748 PGFKALIMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++M+YM +G L +L L + Q +D+ +AS + Y+ +H DL
Sbjct: 85 EPI-YIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 140
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ +++V + DFG+A+L++ + + I + APE G +I DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 867 FGILMMETFTR-RKPTNEMFTGEM 889
FGIL+ E T+ R P M E+
Sbjct: 201 FGILLTELTTKGRVPYPGMVNREV 224
>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDF|B Chain B, Src Kinase In Complex With Inhibitor Ap23451
pdb|2BDJ|A Chain A, Src Kinase In Complex With Inhibitor Ap23464
Length = 279
Score = 88.2 bits (217), Expect = 2e-17, Method: Composition-based stats.
Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG G F V+ T VA+K + ++F E +VM+++RH L+++ + S
Sbjct: 19 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 77
Query: 748 PGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++ +YM +GSL +L L + Q +D+ +AS + Y+ +H DL
Sbjct: 78 EPI-YIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 133
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ +++V + DFG+A+L++ + + I + APE G +I DV+S
Sbjct: 134 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 193
Query: 867 FGILMMETFTR-RKPTNEMFTGEM 889
FGIL+ E T+ R P M E+
Sbjct: 194 FGILLTELTTKGRVPYPGMVNREV 217
>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc4b
pdb|3U51|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
pdb|3U51|B Chain B, Src In Complex With Dna-Templated Macrocyclic Inhibitor
Mc1
Length = 275
Score = 87.8 bits (216), Expect = 3e-17, Method: Composition-based stats.
Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG G F V+ T VA+K + ++F E +VM+++RH L+++ + S
Sbjct: 15 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 73
Query: 748 PGFKALIMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++ +YM +GSL +L L + Q +D+ +AS + Y+ +H DL
Sbjct: 74 EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 129
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ +++V + DFG+A+L++ + + I + APE G +I DV+S
Sbjct: 130 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 189
Query: 867 FGILMMETFTR-RKPTNEMFTGEM 889
FGIL+ E T+ R P M E+
Sbjct: 190 FGILLTELTTKGRVPYPGMVNREV 213
>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|D Chain D, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 277
Score = 87.8 bits (216), Expect = 3e-17, Method: Composition-based stats.
Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG G F V+ T VA+K + ++F E +VM+++RH L+++ + S
Sbjct: 17 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 75
Query: 748 PGFKALIMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++ +YM +GSL +L L + Q +D+ +AS + Y+ +H DL
Sbjct: 76 EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 131
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ +++V + DFG+A+L++ + + I + APE G +I DV+S
Sbjct: 132 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 191
Query: 867 FGILMMETFTR-RKPTNEMFTGEM 889
FGIL+ E T+ R P M E+
Sbjct: 192 FGILLTELTTKGRVPYPGMVNREV 215
>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|2OIQ|B Chain B, Crystal Structure Of Chicken C-Src Kinase Domain In
Complex With The Cancer Drug Imatinib.
pdb|3D7T|B Chain B, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3DQX|A Chain A, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3DQX|B Chain B, Chicken C-Src Kinase Domain In Complex With Atpgs
pdb|3EN4|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN4|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp121, A Multitargeted
Kinase Inhibitor
pdb|3EN5|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN5|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp494, A Multitargeted
Kinase Inhibitor
pdb|3EN6|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN6|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With Pp102, A Multitargeted
Kinase Inhibitor
pdb|3EN7|A Chain A, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EN7|B Chain B, Targeted Polypharmacology: Crystal Structure Of The C-Src
Kinase Domain In Complex With S1, A Multitargeted Kinase
Inhibitor
pdb|3EL7|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 3
pdb|3EL8|A Chain A, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3EL8|B Chain B, Crystal Structure Of C-Src In Complex With
Pyrazolopyrimidine 5
pdb|3F6X|A Chain A, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|B Chain B, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|C Chain C, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3F6X|D Chain D, C-Src Kinase Domain In Complex With Small Molecule
Inhibitor
pdb|3G6G|A Chain A, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|3G6G|B Chain B, Equally Potent Inhibition Of C-Src And Abl By Compounds
That Recognize Inactive Kinase Conformations
pdb|4AGW|A Chain A, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|4AGW|B Chain B, Discovery Of A Small Molecule Type Ii Inhibitor Of Wild-
Type And Gatekeeper Mutants Of Bcr-Abl, Pdgfralpha, Kit,
And Src Kinases
pdb|3UQF|A Chain A, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQF|B Chain B, C-Src Kinase Domain In Complex With Bki Rm-1-89
pdb|3UQG|A Chain A, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|3UQG|B Chain B, C-Src Kinase Domain In Complex With Bumpless Bki Analog
Uw1243
pdb|4DGG|A Chain A, C-Src Kinase Domain In Complex With Rm-1-176
pdb|4DGG|B Chain B, C-Src Kinase Domain In Complex With Rm-1-176
Length = 286
Score = 87.8 bits (216), Expect = 3e-17, Method: Composition-based stats.
Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG G F V+ T VA+K + ++F E +VM+++RH L+++ + S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 748 PGFKALIMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++ +YM +GSL +L L + Q +D+ +AS + Y+ +H DL
Sbjct: 85 EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 140
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ +++V + DFG+A+L++ + + I + APE G +I DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 867 FGILMMETFTR-RKPTNEMFTGEM 889
FGIL+ E T+ R P M E+
Sbjct: 201 FGILLTELTTKGRVPYPGMVNREV 224
>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
Gleevec
pdb|3HMI|A Chain A, The Crystal Structure Of Human Abl2 In Complex With
5-Amino-3-{[4-
(Aminosulfonyl)phenyl]amino}-N-(2,
6-Difluorophenyl)-1h-1,2,4- Triazole-1-Carbothioamide
pdb|2XYN|A Chain A, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|B Chain B, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
pdb|2XYN|C Chain C, Human Abl2 In Complex With Aurora Kinase Inhibitor Vx-680
Length = 292
Score = 87.8 bits (216), Expect = 3e-17, Method: Composition-based stats.
Identities = 61/192 (31%), Positives = 97/192 (50%), Gaps = 8/192 (4%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G + VY S+ V V L+ED ++ F E VM+ I+H NL++++ C+
Sbjct: 40 LGGGQYGEVYVGVWKK-YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 98
Query: 747 -NPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
P F ++ +YMP G+L +L N +T L + ++SA+EYL IH
Sbjct: 99 LEPPF-YIVTEYMPYGNLLDYLRECNREEVTAVVLLYMATQISSAMEYLE---KKNFIHR 154
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDV 864
DL N L+ ++ V + DFG+++L+ G I + APE + SI DV
Sbjct: 155 DLAARNCLVGENHVVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDV 214
Query: 865 YSFGILMMETFT 876
++FG+L+ E T
Sbjct: 215 WAFGVLLWEIAT 226
>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
pdb|3SVV|B Chain B, Crystal Structure Of T338c C-Src Covalently Bound To
Vinylsulfonamide- Pyrazolopyrimidine 9
Length = 286
Score = 87.4 bits (215), Expect = 3e-17, Method: Composition-based stats.
Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG G F V+ T VA+K + ++F E +VM+++RH L+++ + S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 748 PGFKALIMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++ +YM +GSL +L L + Q +D+ +AS + Y+ +H DL
Sbjct: 85 EPI-YIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 140
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ +++V + DFG+A+L++ + + I + APE G +I DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 867 FGILMMETFTR-RKPTNEMFTGEM 889
FGIL+ E T+ R P M E+
Sbjct: 201 FGILLTELTTKGRVPYPGMVNREV 224
>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
pdb|1YOL|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Cgp77675
Length = 283
Score = 87.4 bits (215), Expect = 4e-17, Method: Composition-based stats.
Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG G F V+ T VA+K + ++F E +VM+++RH L+++ + S
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 748 PGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++ +YM +GSL +L L + Q +D+ +AS + Y+ +H DL
Sbjct: 82 EPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNYVHRDL 137
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ +++V + DFG+A+L++ + + I + APE G +I DV+S
Sbjct: 138 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 197
Query: 867 FGILMMETFTR-RKPTNEMFTGEM 889
FGIL+ E T+ R P M E+
Sbjct: 198 FGILLTELTTKGRVPYPGMVNREV 221
>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain
pdb|1YOJ|B Chain B, Crystal Structure Of Src Kinase Domain
pdb|1YOM|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
pdb|1YOM|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Purvalanol A
Length = 283
Score = 87.0 bits (214), Expect = 4e-17, Method: Composition-based stats.
Identities = 59/204 (28%), Positives = 103/204 (50%), Gaps = 7/204 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG G F V+ T VA+K + ++F E +VM+++RH L+++ + S
Sbjct: 23 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 81
Query: 748 PGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++ +YM +GSL +L L + Q +D+ +AS + Y+ +H DL
Sbjct: 82 EPI-YIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYVER---MNYVHRDL 137
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ +++V + DFG+A+L++ + + I + APE G +I DV+S
Sbjct: 138 RAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 197
Query: 867 FGILMMETFTR-RKPTNEMFTGEM 889
FGIL+ E T+ R P M E+
Sbjct: 198 FGILLTELTTKGRVPYPGMVNREV 221
>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZR|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K641r Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 87.0 bits (214), Expect = 5e-17, Method: Composition-based stats.
Identities = 64/217 (29%), Positives = 112/217 (51%), Gaps = 33/217 (15%)
Query: 688 LGSGSFDNVYKATLA--------NGVSVAVKVFNLQED---RALKSFDTECEVMRRI-RH 735
LG G+F V A V+VAVK+ L++D + L +E E+M+ I +H
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWL---------YSHNYS------LTIRQRL 780
+N+I ++ +C+ G +I++Y +G+L ++L YS++ + +T + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 781 DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840
+A +EYL S IH DL NVL+ ++ V + DFG+A+ ++ +D +T
Sbjct: 161 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTT 217
Query: 841 T-LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + + DV+SFG+LM E FT
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
pdb|3GEQ|B Chain B, Structural Basis For The Chemical Rescue Of Src Kinase
Activity
Length = 286
Score = 86.7 bits (213), Expect = 6e-17, Method: Composition-based stats.
Identities = 59/204 (28%), Positives = 102/204 (50%), Gaps = 7/204 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG G F V+ T VA+K + ++F E +VM+++RH L+++ + S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 748 PGFKALIMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++ +YM +GSL +L L + Q +D+ +AS + Y+ +H DL
Sbjct: 85 EPI-YIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 140
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
N+L+ +++V + DFG+A+L++ + + I + APE G +I DV+S
Sbjct: 141 AAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 867 FGILMMETFTR-RKPTNEMFTGEM 889
FGIL+ E T+ R P M E+
Sbjct: 201 FGILLTELTTKGRVPYPGMVNREV 224
>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
pdb|2PZ5|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549t Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 86.7 bits (213), Expect = 6e-17, Method: Composition-based stats.
Identities = 64/217 (29%), Positives = 112/217 (51%), Gaps = 33/217 (15%)
Query: 688 LGSGSFDNVYKATLA--------NGVSVAVKVFNLQED---RALKSFDTECEVMRRI-RH 735
LG G+F V A V+VAVK+ L++D + L +E E+M+ I +H
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWL---------YSHNYS------LTIRQRL 780
+N+I ++ +C+ G +I++Y +G+L ++L YS++ + +T + +
Sbjct: 101 KNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 781 DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840
+A +EYL S IH DL NVL+ ++ V + DFG+A+ ++ +D +T
Sbjct: 161 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 841 T-LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + + DV+SFG+LM E FT
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome.
pdb|2PWL|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic N549h Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 86.7 bits (213), Expect = 7e-17, Method: Composition-based stats.
Identities = 64/217 (29%), Positives = 112/217 (51%), Gaps = 33/217 (15%)
Query: 688 LGSGSFDNVYKATLA--------NGVSVAVKVFNLQED---RALKSFDTECEVMRRI-RH 735
LG G+F V A V+VAVK+ L++D + L +E E+M+ I +H
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWL---------YSHNYS------LTIRQRL 780
+N+I ++ +C+ G +I++Y +G+L ++L YS++ + +T + +
Sbjct: 101 KNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 781 DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840
+A +EYL S IH DL NVL+ ++ V + DFG+A+ ++ +D +T
Sbjct: 161 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 841 T-LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + + DV+SFG+LM E FT
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule
Inhibitor
Length = 288
Score = 86.3 bits (212), Expect = 7e-17, Method: Composition-based stats.
Identities = 55/190 (28%), Positives = 96/190 (50%), Gaps = 6/190 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG+G F V+ VAVK Q + +F E +M++++H+ L+++ + +
Sbjct: 30 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 88
Query: 748 PGFKALIMQYMPQGSLEKWLYS-HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
+I +YM GSL +L + LTI + LD+ +A + ++ IH DL
Sbjct: 89 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDL 144
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ D + + DFG+A+L++ + + I + APE + G +I DV+S
Sbjct: 145 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 204
Query: 867 FGILMMETFT 876
FGIL+ E T
Sbjct: 205 FGILLTEIVT 214
>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule
W259
Length = 287
Score = 86.3 bits (212), Expect = 7e-17, Method: Composition-based stats.
Identities = 55/190 (28%), Positives = 96/190 (50%), Gaps = 6/190 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG+G F V+ VAVK Q + +F E +M++++H+ L+++ + +
Sbjct: 29 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 87
Query: 748 PGFKALIMQYMPQGSLEKWLYS-HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
+I +YM GSL +L + LTI + LD+ +A + ++ IH DL
Sbjct: 88 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDL 143
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ D + + DFG+A+L++ + + I + APE + G +I DV+S
Sbjct: 144 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 203
Query: 867 FGILMMETFT 876
FGIL+ E T
Sbjct: 204 FGILLTEIVT 213
>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase
Domain Of Human Lck, (Auto-Phosphorylated On Tyr394)
pdb|2ZM4|A Chain A, Crystal Structure Of Imidazo Quinoxaline 1 Bound To The
Kinase Domain Of Human Lck, Activated Form (Auto-
Phosphorylated On Tyr394)
pdb|2ZYB|A Chain A, Crystal Structure Of Phenylimidazo Pyrazin 2 Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC1|A Chain A, Crystal Structure Of Pyrazin Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AC2|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC3|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC4|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC5|A Chain A, Crystal Structure Of Triazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AC8|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACJ|A Chain A, Crystal Structure Of Imidazo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3ACK|A Chain A, Crystal Structure Of Pyrrolo Pyrazine Derivative Bound To
The Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD4|A Chain A, Crystal Structure Of Methoxy Benzofuran Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
pdb|3AD5|A Chain A, Crystal Structure Of Triazolone Derivative Bound To The
Kinase Domain Of Human Lck, (Auto-Phosphorylated On
Tyr394)
pdb|3AD6|A Chain A, Crystal Structure Of Pyrazolo Pyrimidine Derivative Bound
To The Kinase Domain Of Human Lck, (Auto-Phosphorylated
On Tyr394)
Length = 285
Score = 86.3 bits (212), Expect = 7e-17, Method: Composition-based stats.
Identities = 55/190 (28%), Positives = 96/190 (50%), Gaps = 6/190 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG+G F V+ VAVK Q + +F E +M++++H+ L+++ + +
Sbjct: 27 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 748 PGFKALIMQYMPQGSLEKWLYS-HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
+I +YM GSL +L + LTI + LD+ +A + ++ IH DL
Sbjct: 86 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDL 141
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ D + + DFG+A+L++ + + I + APE + G +I DV+S
Sbjct: 142 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 201
Query: 867 FGILMMETFT 876
FGIL+ E T
Sbjct: 202 FGILLTEIVT 211
>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
pdb|1QPJ|A Chain A, Crystal Structure Of The Lymphocyte-Specific Kinase Lck In
Complex With Staurosporine.
pdb|1QPC|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck
In Complex With Non-Selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 86.3 bits (212), Expect = 7e-17, Method: Composition-based stats.
Identities = 55/190 (28%), Positives = 96/190 (50%), Gaps = 6/190 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG+G F V+ VAVK Q + +F E +M++++H+ L+++ + +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 748 PGFKALIMQYMPQGSLEKWLYS-HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
+I +YM GSL +L + LTI + LD+ +A + ++ IH DL
Sbjct: 80 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDL 135
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ D + + DFG+A+L++ + + I + APE + G +I DV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 867 FGILMMETFT 876
FGIL+ E T
Sbjct: 196 FGILLTEIVT 205
>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43
Bound To Lck
Length = 273
Score = 86.3 bits (212), Expect = 7e-17, Method: Composition-based stats.
Identities = 55/190 (28%), Positives = 96/190 (50%), Gaps = 6/190 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG+G F V+ VAVK Q + +F E +M++++H+ L+++ + +
Sbjct: 23 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 81
Query: 748 PGFKALIMQYMPQGSLEKWLYS-HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
+I +YM GSL +L + LTI + LD+ +A + ++ IH DL
Sbjct: 82 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDL 137
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ D + + DFG+A+L++ + + I + APE + G +I DV+S
Sbjct: 138 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 197
Query: 867 FGILMMETFT 876
FGIL+ E T
Sbjct: 198 FGILLTEIVT 207
>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck),
Activated Form (Auto-Phosphorylated On Tyr394)
pdb|3BYO|A Chain A, X-Ray Co-Crystal Structure Of 2-Amino-6-Phenylpyrimido[5',
4':5,6]pyrimido[1,2-A]benzimidazol-5(6h)-One 25 Bound To
Lck
Length = 271
Score = 86.3 bits (212), Expect = 7e-17, Method: Composition-based stats.
Identities = 55/190 (28%), Positives = 96/190 (50%), Gaps = 6/190 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG+G F V+ VAVK Q + +F E +M++++H+ L+++ + +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 748 PGFKALIMQYMPQGSLEKWLYS-HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
+I +YM GSL +L + LTI + LD+ +A + ++ IH DL
Sbjct: 80 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDL 135
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ D + + DFG+A+L++ + + I + APE + G +I DV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 867 FGILMMETFT 876
FGIL+ E T
Sbjct: 196 FGILLTEIVT 205
>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1
Bound To Lck
Length = 272
Score = 86.3 bits (212), Expect = 7e-17, Method: Composition-based stats.
Identities = 55/190 (28%), Positives = 96/190 (50%), Gaps = 6/190 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG+G F V+ VAVK Q + +F E +M++++H+ L+++ + +
Sbjct: 22 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 80
Query: 748 PGFKALIMQYMPQGSLEKWLYS-HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
+I +YM GSL +L + LTI + LD+ +A + ++ IH DL
Sbjct: 81 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDL 136
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ D + + DFG+A+L++ + + I + APE + G +I DV+S
Sbjct: 137 RAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 196
Query: 867 FGILMMETFT 876
FGIL+ E T
Sbjct: 197 FGILLTEIVT 206
>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains
Trapped In Trans-Phosphorylation Reaction
Length = 334
Score = 86.3 bits (212), Expect = 8e-17, Method: Compositional matrix adjust.
Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 33/217 (15%)
Query: 688 LGSGSFDNVYKATLA--------NGVSVAVKVFNLQED---RALKSFDTECEVMRRI-RH 735
LG G+F V A V+VAVK+ L++D + L +E E+M+ I +H
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWL---------YSHNY------SLTIRQRL 780
+N+I ++ +C+ G +I++Y +G+L ++L YS++ +T + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 781 DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840
+A +EYL S IH DL NVL+ ++ V + DFG+A+ ++ +D +T
Sbjct: 161 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 841 T-LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + + DV+SFG+LM E FT
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
pdb|2PZP|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K526e Mutation Responsible For
Crouzon Syndrome
Length = 324
Score = 86.3 bits (212), Expect = 8e-17, Method: Composition-based stats.
Identities = 64/217 (29%), Positives = 110/217 (50%), Gaps = 33/217 (15%)
Query: 688 LGSGSFDNVYKATLA--------NGVSVAVKVFN---LQEDRALKSFDTECEVMRRI-RH 735
LG G+F V A V+VAVK+ +ED L +E E+M+ I +H
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEED--LSDLVSEMEMMKMIGKH 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWL---------YSHNYS------LTIRQRL 780
+N+I ++ +C+ G +I++Y +G+L ++L YS++ + +T + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 781 DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840
+A +EYL S IH DL NVL+ ++ V + DFG+A+ ++ +D +T
Sbjct: 161 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 841 T-LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + + DV+SFG+LM E FT
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|C Chain C, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome.
pdb|2PVY|D Chain D, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic K659n Mutation Responsible For
An Unclassified Craniosynostosis Syndrome
Length = 324
Score = 86.3 bits (212), Expect = 8e-17, Method: Composition-based stats.
Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 33/217 (15%)
Query: 688 LGSGSFDNVYKATLA--------NGVSVAVKVFNLQED---RALKSFDTECEVMRRI-RH 735
LG G+F V A V+VAVK+ L++D + L +E E+M+ I +H
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWL---------YSHNYS------LTIRQRL 780
+N+I ++ +C+ G +I++Y +G+L ++L YS++ + +T + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 781 DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840
+A +EYL S IH DL NVL+ ++ V + DFG+A+ ++ +D T
Sbjct: 161 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTT 217
Query: 841 T-LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + + DV+SFG+LM E FT
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|3B2T|A Chain A, Structure Of Phosphotransferase
pdb|3B2T|B Chain B, Structure Of Phosphotransferase
Length = 311
Score = 85.9 bits (211), Expect = 1e-16, Method: Composition-based stats.
Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 33/217 (15%)
Query: 688 LGSGSFDNVYKATLA--------NGVSVAVKVFNLQED---RALKSFDTECEVMRRI-RH 735
LG G F V A V+VAVK+ L++D + L +E E+M+ I +H
Sbjct: 30 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 87
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWL---------YSHNYS------LTIRQRL 780
+N+I ++ +C+ G +I++Y +G+L ++L YS++ + +T + +
Sbjct: 88 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 147
Query: 781 DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840
+A +EYL S IH DL NVL+ ++ V + DFG+A+ ++ +D +T
Sbjct: 148 SCTYQLARGMEYLA---SQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTT 204
Query: 841 T-LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + + DV+SFG+LM E FT
Sbjct: 205 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 241
>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain
pdb|1OEC|A Chain A, Fgfr2 Kinase Domain
Length = 316
Score = 85.9 bits (211), Expect = 1e-16, Method: Composition-based stats.
Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 33/217 (15%)
Query: 688 LGSGSFDNVYKATLA--------NGVSVAVKVFNLQED---RALKSFDTECEVMRRI-RH 735
LG G F V A V+VAVK+ L++D + L +E E+M+ I +H
Sbjct: 35 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 92
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWL---------YSHNYS------LTIRQRL 780
+N+I ++ +C+ G +I++Y +G+L ++L YS++ + +T + +
Sbjct: 93 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 152
Query: 781 DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840
+A +EYL S IH DL NVL+ ++ V + DFG+A+ ++ +D +T
Sbjct: 153 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 209
Query: 841 T-LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + + DV+SFG+LM E FT
Sbjct: 210 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 246
>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
pdb|3RI1|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase
In Complex With Arq 069
Length = 313
Score = 85.9 bits (211), Expect = 1e-16, Method: Composition-based stats.
Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 33/217 (15%)
Query: 688 LGSGSFDNVYKATLA--------NGVSVAVKVFNLQED---RALKSFDTECEVMRRI-RH 735
LG G F V A V+VAVK+ L++D + L +E E+M+ I +H
Sbjct: 32 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 89
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWL---------YSHNYS------LTIRQRL 780
+N+I ++ +C+ G +I++Y +G+L ++L YS++ + +T + +
Sbjct: 90 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 149
Query: 781 DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840
+A +EYL S IH DL NVL+ ++ V + DFG+A+ ++ +D +T
Sbjct: 150 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 206
Query: 841 T-LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + + DV+SFG+LM E FT
Sbjct: 207 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 243
>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWO|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor
pdb|2HWP|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2HWP|B Chain B, Crystal Structure Of Src Kinase Domain In Complex With
Covalent Inhibitor Pd168393
pdb|2QLQ|A Chain A, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|2QLQ|B Chain B, Crystal Structure Of Src Kinase Domain With Covalent
Inhibitor Rl3
pdb|3F3T|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3T|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl38 (Type
Iii)
pdb|3F3U|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3U|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl37 (Type
Iii)
pdb|3F3V|A Chain A, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3F3V|B Chain B, Kinase Domain Of Csrc In Complex With Inhibitor Rl45 (Type
Ii)
pdb|3G5D|A Chain A, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3G5D|B Chain B, Kinase Domain Of Csrc In Complex With Dasatinib
pdb|3TZ7|A Chain A, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ7|B Chain B, Kinase Domain Of Csrc In Complex With Rl103
pdb|3TZ8|A Chain A, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ8|B Chain B, Kinase Domain Of Csrc In Complex With Rl104
pdb|3TZ9|A Chain A, Kinase Domain Of Csrc In Complex With Rl130
pdb|3TZ9|B Chain B, Kinase Domain Of Csrc In Complex With Rl130
Length = 286
Score = 85.9 bits (211), Expect = 1e-16, Method: Composition-based stats.
Identities = 58/204 (28%), Positives = 102/204 (50%), Gaps = 7/204 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG G F V+ T VA+K + ++F E +VM+++RH L+++ + S
Sbjct: 26 LGQGCFGEVWMGTWNGTTRVAIKTLK-PGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE 84
Query: 748 PGFKALIMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++ +YM +G L +L L + Q +D+ +AS + Y+ +H DL
Sbjct: 85 EPI-YIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDL 140
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ +++V + DFG+A+L++ + + I + APE G +I DV+S
Sbjct: 141 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 200
Query: 867 FGILMMETFTR-RKPTNEMFTGEM 889
FGIL+ E T+ R P M E+
Sbjct: 201 FGILLTELTTKGRVPYPGMVNREV 224
>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b
pdb|3BYU|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Reverse
Amide 23
Length = 277
Score = 85.9 bits (211), Expect = 1e-16, Method: Composition-based stats.
Identities = 55/190 (28%), Positives = 96/190 (50%), Gaps = 6/190 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG+G F V+ VAVK Q + +F E +M++++H+ L+++ + +
Sbjct: 27 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 85
Query: 748 PGFKALIMQYMPQGSLEKWLYS-HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
+I +YM GSL +L + LTI + LD+ +A + ++ IH DL
Sbjct: 86 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDL 141
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ D + + DFG+A+L++ + + I + APE + G +I DV+S
Sbjct: 142 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 201
Query: 867 FGILMMETFT 876
FGIL+ E T
Sbjct: 202 FGILLTEIVT 211
>pdb|2PL0|A Chain A, Lck Bound To Imatinib
Length = 289
Score = 85.9 bits (211), Expect = 1e-16, Method: Composition-based stats.
Identities = 55/190 (28%), Positives = 96/190 (50%), Gaps = 6/190 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG+G F V+ VAVK Q + +F E +M++++H+ L+++ + +
Sbjct: 31 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 89
Query: 748 PGFKALIMQYMPQGSLEKWLYS-HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
+I +YM GSL +L + LTI + LD+ +A + ++ IH DL
Sbjct: 90 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDL 145
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ D + + DFG+A+L++ + + I + APE + G +I DV+S
Sbjct: 146 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 205
Query: 867 FGILMMETFT 876
FGIL+ E T
Sbjct: 206 FGILLTEIVT 215
>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck
pdb|2OF4|A Chain A, Crystal Structure Of Furanopyrimidine 1 Bound To Lck
Length = 271
Score = 85.9 bits (211), Expect = 1e-16, Method: Composition-based stats.
Identities = 55/190 (28%), Positives = 96/190 (50%), Gaps = 6/190 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG+G F V+ VAVK Q + +F E +M++++H+ L+++ + +
Sbjct: 21 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 748 PGFKALIMQYMPQGSLEKWLYS-HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
+I +YM GSL +L + LTI + LD+ +A + ++ IH DL
Sbjct: 80 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDL 135
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ D + + DFG+A+L++ + + I + APE + G +I DV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 867 FGILMMETFT 876
FGIL+ E T
Sbjct: 196 FGILLTEIVT 205
>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
pdb|2OG8|B Chain B, Crystal Structure Of Aminoquinazoline 36 Bound To Lck
Length = 265
Score = 85.9 bits (211), Expect = 1e-16, Method: Composition-based stats.
Identities = 55/190 (28%), Positives = 96/190 (50%), Gaps = 6/190 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG+G F V+ VAVK Q + +F E +M++++H+ L+++ + +
Sbjct: 16 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 74
Query: 748 PGFKALIMQYMPQGSLEKWLYS-HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
+I +YM GSL +L + LTI + LD+ +A + ++ IH DL
Sbjct: 75 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDL 130
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ D + + DFG+A+L++ + + I + APE + G +I DV+S
Sbjct: 131 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 190
Query: 867 FGILMMETFT 876
FGIL+ E T
Sbjct: 191 FGILLTEIVT 200
>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|2OFV|B Chain B, Crystal Structure Of Aminoquinazoline 1 Bound To Lck
pdb|3B2W|A Chain A, Crystal Structure Of Pyrimidine Amide 11 Bound To Lck
Length = 277
Score = 85.9 bits (211), Expect = 1e-16, Method: Composition-based stats.
Identities = 55/190 (28%), Positives = 96/190 (50%), Gaps = 6/190 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG+G F V+ VAVK Q + +F E +M++++H+ L+++ + +
Sbjct: 26 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 84
Query: 748 PGFKALIMQYMPQGSLEKWLYS-HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
+I +YM GSL +L + LTI + LD+ +A + ++ IH DL
Sbjct: 85 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDL 140
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ D + + DFG+A+L++ + + I + APE + G +I DV+S
Sbjct: 141 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 200
Query: 867 FGILMMETFT 876
FGIL+ E T
Sbjct: 201 FGILLTEIVT 210
>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With
Staurosporine
Length = 283
Score = 85.9 bits (211), Expect = 1e-16, Method: Composition-based stats.
Identities = 53/191 (27%), Positives = 98/191 (51%), Gaps = 6/191 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG+G F V+ T VA+K + +SF E ++M++++H L+++ + S
Sbjct: 17 LGNGQFGEVWMGTWNGNTKVAIKTLK-PGTMSPESFLEEAQIMKKLKHDKLVQLYAVVSE 75
Query: 748 PGFKALIMQYMPQGSLEKWLYS-HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++ +YM +GSL +L +L + +D+ VA+ + Y+ IH DL
Sbjct: 76 EPI-YIVTEYMNKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIER---MNYIHRDL 131
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ + ++ + DFG+A+L++ + + I + APE G +I DV+S
Sbjct: 132 RSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDVWS 191
Query: 867 FGILMMETFTR 877
FGIL+ E T+
Sbjct: 192 FGILLTELVTK 202
>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
pdb|2Q0B|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565a Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 85.5 bits (210), Expect = 1e-16, Method: Composition-based stats.
Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 33/217 (15%)
Query: 688 LGSGSFDNVYKATLA--------NGVSVAVKVFNLQED---RALKSFDTECEVMRRI-RH 735
LG G+F V A V+VAVK+ L++D + L +E E+M+ I +H
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWL---------YSHNYS------LTIRQRL 780
+N+I ++ +C+ G +I+ Y +G+L ++L YS++ + +T + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 781 DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840
+A +EYL S IH DL NVL+ ++ V + DFG+A+ ++ +D +T
Sbjct: 161 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 841 T-LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + + DV+SFG+LM E FT
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 269
Score = 85.5 bits (210), Expect = 1e-16, Method: Composition-based stats.
Identities = 63/191 (32%), Positives = 93/191 (48%), Gaps = 12/191 (6%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS-CS 746
+G G F +V G VAVK ++ D ++F E VM ++RH NL++++
Sbjct: 20 IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
G ++ +YM +GSL +L S S L L +DV A+EYL +H D
Sbjct: 77 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 133
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVY 865
L NVL+ +D VA + DFG+ K TQ + + APE E S DV+
Sbjct: 134 LAARNVLVSEDNVAKVSDFGLTKEASS----TQDTGKLPVKWTAPEALREAAFSTKSDVW 189
Query: 866 SFGILMMETFT 876
SFGIL+ E ++
Sbjct: 190 SFGILLWEIYS 200
>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXR|B Chain B, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complex With Dasatinib
pdb|3SXS|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase
Complexed With Pp2
Length = 268
Score = 85.5 bits (210), Expect = 1e-16, Method: Composition-based stats.
Identities = 64/209 (30%), Positives = 96/209 (45%), Gaps = 11/209 (5%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
LGSG F V VAVK+ ++ ED F E + M ++ H L+K
Sbjct: 16 LGSGQFGVVKLGKWKGQYDVAVKMIKEGSMSEDE----FFQEAQTMMKLSHPKLVKFYGV 71
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
CS ++ +Y+ G L +L SH L Q L++ DV + +L S IH
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLE---SHQFIHR 128
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDV 864
DL N L+D D+ + DFG+ + + V+ T + + APE S DV
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDV 188
Query: 865 YSFGILMMETFTRRKPTNEMFT-GEMSLK 892
++FGILM E F+ K +++T E+ LK
Sbjct: 189 WAFGILMWEVFSLGKMPYDLYTNSEVVLK 217
>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
pdb|2PY3|B Chain B, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain
Harboring The Pathogenic E565g Mutation Responsible For
Pfeiffer Syndrome
Length = 324
Score = 85.1 bits (209), Expect = 2e-16, Method: Composition-based stats.
Identities = 64/217 (29%), Positives = 111/217 (51%), Gaps = 33/217 (15%)
Query: 688 LGSGSFDNVYKATLA--------NGVSVAVKVFNLQED---RALKSFDTECEVMRRI-RH 735
LG G+F V A V+VAVK+ L++D + L +E E+M+ I +H
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWL---------YSHNYS------LTIRQRL 780
+N+I ++ +C+ G +I+ Y +G+L ++L YS++ + +T + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 160
Query: 781 DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840
+A +EYL S IH DL NVL+ ++ V + DFG+A+ ++ +D +T
Sbjct: 161 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 217
Query: 841 T-LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + + DV+SFG+LM E FT
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
pdb|2PSQ|B Chain B, Crystal Structure Of Unphosphorylated Unactivated Wild
Type Fgf Receptor 2 (Fgfr2) Kinase Domain
Length = 370
Score = 84.7 bits (208), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 64/217 (29%), Positives = 110/217 (50%), Gaps = 33/217 (15%)
Query: 688 LGSGSFDNVYKATLA--------NGVSVAVKVFNLQED---RALKSFDTECEVMRRI-RH 735
LG G F V A V+VAVK+ L++D + L +E E+M+ I +H
Sbjct: 89 LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 146
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWL---------YSHNY------SLTIRQRL 780
+N+I ++ +C+ G +I++Y +G+L ++L YS++ +T + +
Sbjct: 147 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV 206
Query: 781 DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840
+A +EYL S IH DL NVL+ ++ V + DFG+A+ ++ +D +T
Sbjct: 207 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTT 263
Query: 841 T-LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + + DV+SFG+LM E FT
Sbjct: 264 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 300
>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf
Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp
Analog And Substrate Peptide
Length = 334
Score = 84.7 bits (208), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 108/217 (49%), Gaps = 33/217 (15%)
Query: 688 LGSGSFDNVYKATLA--------NGVSVAVKVFNLQED---RALKSFDTECEVMRRI-RH 735
LG G+F V A V+VAVK+ L++D + L +E E+M+ I +H
Sbjct: 43 LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKM--LKDDATEKDLSDLVSEMEMMKMIGKH 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSH---------------NYSLTIRQRL 780
+N+I ++ +C+ G +I++Y +G+L ++L + +T + +
Sbjct: 101 KNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMTFKDLV 160
Query: 781 DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM 840
+A +EYL S IH DL NVL+ ++ V + DFG+A+ ++ +D +T
Sbjct: 161 SCTYQLARGMEYLA---SQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTT 217
Query: 841 T-LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + + DV+SFG+LM E FT
Sbjct: 218 NGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFT 254
>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 84.7 bits (208), Expect = 2e-16, Method: Compositional matrix adjust.
Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 685 SNLLGSGSFDNVYKATL----ANGVSVAVKVFNL-QEDRALKSFDTECEVMRRIRHRNLI 739
++GSG V L V VA+K +R + F +E +M + H N+I
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH-GYS 798
++ + ++ +YM GSL+ +L +H+ TI Q + ++ V + + YL GY
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY- 172
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP---VTQTMTLATIGYMAPEYGSE 855
+H DL NVL+D ++V + DFG++++L+ DP T T I + APE +
Sbjct: 173 ---VHRDLAARNVLVDSNLVCKVSDFGLSRVLED-DPDAAXTTTGGKIPIRWTAPEAIAF 228
Query: 856 GIVSISGDVYSFGILMMETFT 876
S + DV+SFG++M E
Sbjct: 229 RTFSSASDVWSFGVVMWEVLA 249
>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F63|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 1
pdb|4F64|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F64|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 6
pdb|4F65|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
pdb|4F65|B Chain B, Crystal Structure Of Human Fibroblast Growth Factor
Receptor 1 Kinase Domain In Complex With Compound 8
Length = 309
Score = 84.7 bits (208), Expect = 2e-16, Method: Composition-based stats.
Identities = 67/215 (31%), Positives = 109/215 (50%), Gaps = 29/215 (13%)
Query: 688 LGSGSFDNVYKATL-------ANGVS-VAVKVFNLQE-DRALKSFDTECEVMRRI-RHRN 737
LG G+F V A N V+ VAVK+ ++ L +E E+M+ I +H+N
Sbjct: 28 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWL---------YSHNYS------LTIRQRLDI 782
+I ++ +C+ G +I++Y +G+L ++L YS+N S L+ + +
Sbjct: 88 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 783 MIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT- 841
VA +EYL S IH DL NVL+ +D V + DFG+A+ + +D +T
Sbjct: 148 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 204
Query: 842 LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + I + DV+SFG+L+ E FT
Sbjct: 205 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 239
>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
pdb|3RHX|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase
In Complex With Arq 069
Length = 306
Score = 84.7 bits (208), Expect = 2e-16, Method: Composition-based stats.
Identities = 67/215 (31%), Positives = 109/215 (50%), Gaps = 29/215 (13%)
Query: 688 LGSGSFDNVYKATL-------ANGVS-VAVKVFNLQE-DRALKSFDTECEVMRRI-RHRN 737
LG G+F V A N V+ VAVK+ ++ L +E E+M+ I +H+N
Sbjct: 25 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWL---------YSHNYS------LTIRQRLDI 782
+I ++ +C+ G +I++Y +G+L ++L YS+N S L+ + +
Sbjct: 85 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 783 MIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT- 841
VA +EYL S IH DL NVL+ +D V + DFG+A+ + +D +T
Sbjct: 145 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 201
Query: 842 LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + I + DV+SFG+L+ E FT
Sbjct: 202 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 236
>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|B Chain B, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|C Chain C, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
pdb|3KXX|D Chain D, Structure Of The Mutant Fibroblast Growth Factor Receptor
1
Length = 317
Score = 84.7 bits (208), Expect = 2e-16, Method: Composition-based stats.
Identities = 67/215 (31%), Positives = 109/215 (50%), Gaps = 29/215 (13%)
Query: 688 LGSGSFDNVYKATL-------ANGVS-VAVKVFNLQE-DRALKSFDTECEVMRRI-RHRN 737
LG G+F V A N V+ VAVK+ ++ L +E E+M+ I +H+N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWL---------YSHNYS------LTIRQRLDI 782
+I ++ +C+ G +I++Y +G+L ++L YS+N S L+ + +
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 783 MIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT- 841
VA +EYL S IH DL NVL+ +D V + DFG+A+ + +D +T
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 842 LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + I + DV+SFG+L+ E FT
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3JS2|B Chain B, Crystal Structure Of Minimal Kinase Domain Of Fibroblast
Growth Factor Receptor 1 In Complex With 5-(2-Thienyl)
Nicotinic Acid
pdb|3KY2|A Chain A, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
pdb|3KY2|B Chain B, Crystal Structure Of Fibroblast Growth Factor Receptor 1
Kinase Domain
Length = 317
Score = 84.7 bits (208), Expect = 2e-16, Method: Composition-based stats.
Identities = 67/215 (31%), Positives = 109/215 (50%), Gaps = 29/215 (13%)
Query: 688 LGSGSFDNVYKATL-------ANGVS-VAVKVFNLQE-DRALKSFDTECEVMRRI-RHRN 737
LG G+F V A N V+ VAVK+ ++ L +E E+M+ I +H+N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWL---------YSHNYS------LTIRQRLDI 782
+I ++ +C+ G +I++Y +G+L ++L YS+N S L+ + +
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 783 MIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT- 841
VA +EYL S IH DL NVL+ +D V + DFG+A+ + +D +T
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 842 LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + I + DV+SFG+L+ E FT
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGK|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1
pdb|1FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su5402 Inhibitor
pdb|1AGW|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|1AGW|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of
Fibroblast Growth Factor Receptor 1 In Complex With
Su4984 Inhibitor
pdb|2FGI|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
pdb|2FGI|B Chain B, Crystal Structure Of The Tyrosine Kinase Domain Of Fgf
Receptor 1 In Complex With Inhibitor Pd173074
Length = 310
Score = 84.7 bits (208), Expect = 2e-16, Method: Composition-based stats.
Identities = 67/215 (31%), Positives = 109/215 (50%), Gaps = 29/215 (13%)
Query: 688 LGSGSFDNVYKATL-------ANGVS-VAVKVFNLQE-DRALKSFDTECEVMRRI-RHRN 737
LG G+F V A N V+ VAVK+ ++ L +E E+M+ I +H+N
Sbjct: 29 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWL---------YSHNYS------LTIRQRLDI 782
+I ++ +C+ G +I++Y +G+L ++L YS+N S L+ + +
Sbjct: 89 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 783 MIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT- 841
VA +EYL S IH DL NVL+ +D V + DFG+A+ + +D +T
Sbjct: 149 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 205
Query: 842 LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + I + DV+SFG+L+ E FT
Sbjct: 206 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 240
>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8)
Length = 325
Score = 84.3 bits (207), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 59/201 (29%), Positives = 99/201 (49%), Gaps = 14/201 (6%)
Query: 685 SNLLGSGSFDNVYKATL----ANGVSVAVKVFNL-QEDRALKSFDTECEVMRRIRHRNLI 739
++GSG V L V VA+K +R + F +E +M + H N+I
Sbjct: 54 EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFDHPNII 113
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH-GYS 798
++ + ++ +YM GSL+ +L +H+ TI Q + ++ V + + YL GY
Sbjct: 114 RLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGY- 172
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP---VTQTMTLATIGYMAPEYGSE 855
+H DL NVL+D ++V + DFG++++L+ DP T T I + APE +
Sbjct: 173 ---VHRDLAARNVLVDSNLVCKVSDFGLSRVLED-DPDAAYTTTGGKIPIRWTAPEAIAF 228
Query: 856 GIVSISGDVYSFGILMMETFT 876
S + DV+SFG++M E
Sbjct: 229 RTFSSASDVWSFGVVMWEVLA 249
>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
pdb|3TT0|B Chain B, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase
Domain With
3-(2,6-Dichloro-3,
5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1-
Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398)
Length = 382
Score = 84.3 bits (207), Expect = 3e-16, Method: Compositional matrix adjust.
Identities = 67/215 (31%), Positives = 109/215 (50%), Gaps = 29/215 (13%)
Query: 688 LGSGSFDNVYKATL-------ANGVS-VAVKVFNLQE-DRALKSFDTECEVMRRI-RHRN 737
LG G+F V A N V+ VAVK+ ++ L +E E+M+ I +H+N
Sbjct: 77 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWL---------YSHNYS------LTIRQRLDI 782
+I ++ +C+ G +I++Y +G+L ++L YS+N S L+ + +
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 783 MIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT- 841
VA +EYL S IH DL NVL+ +D V + DFG+A+ + +D +T
Sbjct: 197 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 253
Query: 842 LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + I + DV+SFG+L+ E FT
Sbjct: 254 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 288
>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
pdb|3D7U|C Chain C, Structural Basis For The Recognition Of C-Src By Its
Inactivator Csk
Length = 263
Score = 84.3 bits (207), Expect = 3e-16, Method: Composition-based stats.
Identities = 63/191 (32%), Positives = 93/191 (48%), Gaps = 12/191 (6%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS-CS 746
+G G F +V G VAVK ++ D ++F E VM ++RH NL++++
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
G ++ +YM +GSL +L S S L L +DV A+EYL +H D
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 127
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVY 865
L NVL+ +D VA + DFG+ K TQ + + APE E S DV+
Sbjct: 128 LAARNVLVSEDNVAKVSDFGLTKEASS----TQDTGKLPVKWTAPEALREKKFSTKSDVW 183
Query: 866 SFGILMMETFT 876
SFGIL+ E ++
Sbjct: 184 SFGILLWEIYS 194
>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In
Complex With Inhibitor Staurosporine
Length = 278
Score = 84.3 bits (207), Expect = 3e-16, Method: Composition-based stats.
Identities = 63/191 (32%), Positives = 93/191 (48%), Gaps = 12/191 (6%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS-CS 746
+G G F +V G VAVK ++ D ++F E VM ++RH NL++++
Sbjct: 29 IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
G ++ +YM +GSL +L S S L L +DV A+EYL +H D
Sbjct: 86 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 142
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVY 865
L NVL+ +D VA + DFG+ K TQ + + APE E S DV+
Sbjct: 143 LAARNVLVSEDNVAKVSDFGLTKEASS----TQDTGKLPVKWTAPEALREKKFSTKSDVW 198
Query: 866 SFGILMMETFT 876
SFGIL+ E ++
Sbjct: 199 SFGILLWEIYS 209
>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck
In Complex With Non-selective And Src Family Selective
Kinase Inhibitors
Length = 279
Score = 84.0 bits (206), Expect = 3e-16, Method: Composition-based stats.
Identities = 54/190 (28%), Positives = 95/190 (50%), Gaps = 6/190 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG+G V+ VAVK Q + +F E +M++++H+ L+++ + +
Sbjct: 21 LGAGQAGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 748 PGFKALIMQYMPQGSLEKWLYS-HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
+I +YM GSL +L + LTI + LD+ +A + ++ IH DL
Sbjct: 80 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDL 135
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ D + + DFG+A+L++ + + I + APE + G +I DV+S
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 195
Query: 867 FGILMMETFT 876
FGIL+ E T
Sbjct: 196 FGILLTEIVT 205
>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
pdb|2V7A|B Chain B, Crystal Structure Of The T315i Abl Mutant In Complex With
The Inhibitor Pha-739358
Length = 286
Score = 84.0 bits (206), Expect = 4e-16, Method: Composition-based stats.
Identities = 57/196 (29%), Positives = 98/196 (50%), Gaps = 16/196 (8%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G + VY+ S+ V V L+ED ++ F E VM+ I+H NL++++ C+
Sbjct: 22 LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI------DVASALEYLHHGYSTP 800
+I+++M G+L +L N RQ ++ ++ ++SA+EYL
Sbjct: 81 REPPFYIIIEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 132
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
IH DL N L+ ++ + + DFG+++L+ G I + APE + SI
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 192
Query: 861 SGDVYSFGILMMETFT 876
DV++FG+L+ E T
Sbjct: 193 KSDVWAFGVLLWEIAT 208
>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK6|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 84.0 bits (206), Expect = 4e-16, Method: Composition-based stats.
Identities = 58/196 (29%), Positives = 96/196 (48%), Gaps = 16/196 (8%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G F VY+ S+ V V L+ED ++ F E VM+ I+H NL++++ C+
Sbjct: 19 LGGGQFGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI------DVASALEYLHHGYSTP 800
+I ++M G+L +L N RQ + ++ ++SA+EYL
Sbjct: 78 REPPFYIITEFMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYLE---KKN 129
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
IH DL N L+ ++ + + DFG+++L+ G I + APE + SI
Sbjct: 130 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 861 SGDVYSFGILMMETFT 876
DV++FG+L+ E T
Sbjct: 190 KSDVWAFGVLLWEIAT 205
>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine
Length = 267
Score = 84.0 bits (206), Expect = 4e-16, Method: Composition-based stats.
Identities = 54/190 (28%), Positives = 96/190 (50%), Gaps = 6/190 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG+G F V+ VAVK Q + +F E +M++++H+ L+++ + +
Sbjct: 17 LGAGQFGEVWMGYYNGHTKVAVKSLK-QGSMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ 75
Query: 748 PGFKALIMQYMPQGSLEKWLYS-HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
+I +YM GSL +L + LTI + LD+ +A + ++ IH +L
Sbjct: 76 EPI-YIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRNL 131
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ D + + DFG+A+L++ + + I + APE + G +I DV+S
Sbjct: 132 RAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWS 191
Query: 867 FGILMMETFT 876
FGIL+ E T
Sbjct: 192 FGILLTEIVT 201
>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma
Viral Oncogene Homologue (V-Fes) In Complex With
Staurosporine And A Consensus Peptide
Length = 377
Score = 84.0 bits (206), Expect = 4e-16, Method: Compositional matrix adjust.
Identities = 56/192 (29%), Positives = 97/192 (50%), Gaps = 6/192 (3%)
Query: 688 LGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKS-FDTECEVMRRIRHRNLIKIVSSC 745
+G G+F V+ L A+ VAVK LK+ F E ++++ H N+++++ C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
+ ++M+ + G +L + L ++ L ++ D A+ +EYL S IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKL-LDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDV 864
L N L+ + V + DFG+++ DGV + + + + APE + G S DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 865 YSFGILMMETFT 876
+SFGIL+ ETF+
Sbjct: 299 WSFGILLWETFS 310
>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain
pdb|4AT3|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Cpd5n
pdb|4AT4|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Ex429
pdb|4AT5|A Chain A, Crystal Structure Of Trkb Kinase Domain In Complex With
Gw2580
Length = 299
Score = 84.0 bits (206), Expect = 4e-16, Method: Composition-based stats.
Identities = 71/283 (25%), Positives = 114/283 (40%), Gaps = 45/283 (15%)
Query: 688 LGSGSFDNVYKATLAN------GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKI 741
LG G+F V+ A N + VAVK D A K F E E++ ++H +++K
Sbjct: 21 LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKF 80
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHN------------YSLTIRQRLDIMIDVASA 789
C ++ +YM G L K+L +H LT Q L I +A+
Sbjct: 81 YGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAG 140
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIGYM 848
+ YL S +H DL N L+ ++++ +GDFG+++ + D T+ I +M
Sbjct: 141 MVYLA---SQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 197
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVD 908
PE + DV+S G+++ E FT K + W S + +
Sbjct: 198 PPESIMYRKFTTESDVWSLGVVLWEIFTYGK------------QPWYQLSNNEVIECITQ 245
Query: 909 ANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINV 951
+L R +TC + L L C P R N+
Sbjct: 246 GRVLQR-----------PRTCPQEVYELMLGCWQREPHMRKNI 277
>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
pdb|3QRJ|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain T315i
Mutant In Complex With Dcc-2036
Length = 277
Score = 83.6 bits (205), Expect = 5e-16, Method: Composition-based stats.
Identities = 57/196 (29%), Positives = 98/196 (50%), Gaps = 16/196 (8%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G + VY+ S+ V V L+ED ++ F E VM+ I+H NL++++ C+
Sbjct: 26 LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI------DVASALEYLHHGYSTP 800
+I+++M G+L +L N RQ ++ ++ ++SA+EYL
Sbjct: 85 REPPFYIIIEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 136
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
IH DL N L+ ++ + + DFG+++L+ G I + APE + SI
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 861 SGDVYSFGILMMETFT 876
DV++FG+L+ E T
Sbjct: 197 KSDVWAFGVLLWEIAT 212
>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK7|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 277
Score = 83.6 bits (205), Expect = 6e-16, Method: Composition-based stats.
Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 16/196 (8%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G + VY+ S+ V V L+ED ++ F E VM+ I+H NL++++ C+
Sbjct: 19 LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI------DVASALEYLHHGYSTP 800
+I+++M G+L +L N RQ + ++ ++SA+EYL
Sbjct: 78 REPPFYIIIEFMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYLE---KKN 129
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
IH DL N L+ ++ + + DFG+++L+ G I + APE + SI
Sbjct: 130 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 861 SGDVYSFGILMMETFT 876
DV++FG+L+ E T
Sbjct: 190 KSDVWAFGVLLWEIAT 205
>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
pdb|1MQB|B Chain B, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein
Kinase
Length = 333
Score = 83.2 bits (204), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 55/201 (27%), Positives = 100/201 (49%), Gaps = 11/201 (5%)
Query: 684 ESNLLGSGSFDNVYKATLANG-----VSVAVKVFNL-QEDRALKSFDTECEVMRRIRHRN 737
++G+G F VYK L V VA+K ++ F E +M + H N
Sbjct: 48 RQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHN 107
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+I++ S +I +YM G+L+K+L + ++ Q + ++ +A+ ++YL +
Sbjct: 108 IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN-- 165
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLAT--IGYMAPEYGSE 855
+H DL N+L++ ++V + DFG++++L+ T T + I + APE S
Sbjct: 166 -MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISY 224
Query: 856 GIVSISGDVYSFGILMMETFT 876
+ + DV+SFGI+M E T
Sbjct: 225 RKFTSASDVWSFGIVMWEVMT 245
>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
pdb|2GQG|B Chain B, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To
Activated Abl Kinase Domain
Length = 278
Score = 83.2 bits (204), Expect = 6e-16, Method: Composition-based stats.
Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 16/196 (8%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G + VY+ S+ V V L+ED ++ F E VM+ I+H NL++++ C+
Sbjct: 26 LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI------DVASALEYLHHGYSTP 800
+I ++M G+L +L N RQ ++ ++ ++SA+EYL
Sbjct: 85 REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 136
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
IH DL N L+ ++ + + DFG+++L+ G I + APE + SI
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 861 SGDVYSFGILMMETFT 876
DV++FG+L+ E T
Sbjct: 197 KSDVWAFGVLLWEIAT 212
>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 83.2 bits (204), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 107/215 (49%), Gaps = 29/215 (13%)
Query: 688 LGSGSFDNVYKATL-------ANGVS-VAVKVFNLQE-DRALKSFDTECEVMRRI-RHRN 737
LG G+F V A N V+ VAVK+ ++ L +E E+M+ I +H+N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLY-------------SHN--YSLTIRQRLDI 782
+I ++ +C+ G +I++Y +G+L ++L SHN L+ + +
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 783 MIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT- 841
VA +EYL S IH DL NVL+ +D V + DFG+A+ + +D +T
Sbjct: 156 AYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNG 212
Query: 842 LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + I + DV+SFG+L+ E FT
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|B Chain B, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|C Chain C, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|D Chain D, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|E Chain E, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
pdb|1K9A|F Chain F, Crystal Structure Analysis Of Full-Length
Carboxyl-Terminal Src Kinase At 2.5 A Resolution
Length = 450
Score = 83.2 bits (204), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 63/191 (32%), Positives = 93/191 (48%), Gaps = 12/191 (6%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS-CS 746
+G G F +V G VAVK ++ D ++F E VM ++RH NL++++
Sbjct: 201 IGKGEFGDVMLGDY-RGNKVAVKC--IKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
G ++ +YM +GSL +L S S L L +DV A+EYL +H D
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRD 314
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVY 865
L NVL+ +D VA + DFG+ K TQ + + APE E S DV+
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTKEASS----TQDTGKLPVKWTAPEALREKKFSTKSDVW 370
Query: 866 SFGILMMETFT 876
SFGIL+ E ++
Sbjct: 371 SFGILLWEIYS 381
>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)
pdb|3CBL|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (v- Fes) In Complex With Staurosporine And A
Consensus Peptide
pdb|4E93|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene
Homologue (V- Fes)in Complex With Tae684
Length = 377
Score = 83.2 bits (204), Expect = 6e-16, Method: Compositional matrix adjust.
Identities = 56/192 (29%), Positives = 97/192 (50%), Gaps = 6/192 (3%)
Query: 688 LGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKS-FDTECEVMRRIRHRNLIKIVSSC 745
+G G+F V+ L A+ VAVK LK+ F E ++++ H N+++++ C
Sbjct: 122 IGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVC 181
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
+ ++M+ + G +L + L ++ L ++ D A+ +EYL S IH D
Sbjct: 182 TQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLE---SKCCIHRD 238
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKL-LDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDV 864
L N L+ + V + DFG+++ DGV + + + + APE + G S DV
Sbjct: 239 LAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDV 298
Query: 865 YSFGILMMETFT 876
+SFGIL+ ETF+
Sbjct: 299 WSFGILLWETFS 310
>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol
Length = 315
Score = 83.2 bits (204), Expect = 7e-16, Method: Composition-based stats.
Identities = 69/224 (30%), Positives = 103/224 (45%), Gaps = 21/224 (9%)
Query: 665 ATLSRISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFD 724
+L I Y E++ ++G G+F V KA VA+K + +R K+F
Sbjct: 1 GSLHMIDYKEIEV-------EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFI 50
Query: 725 TECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNY--SLTIRQRLDI 782
E + R+ H N++K+ +C NP L+M+Y GSL L+ T +
Sbjct: 51 VELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSW 108
Query: 783 MIDVASALEYLHHGYSTPIIHCDLKPNNVLL-DDDMVAHLGDFGIAKLLDGVDPVTQ-TM 840
+ + + YLH +IH DLKP N+LL V + DFG A D T T
Sbjct: 109 CLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTN 163
Query: 841 TLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEM 884
+ +MAPE S DV+S+GI++ E TRRKP +E+
Sbjct: 164 NKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 207
>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With
Its Activating Protein Tab1
pdb|2YIY|A Chain A, Crystal Structure Of Compound 8 Bound To Tak1-Tab
Length = 307
Score = 83.2 bits (204), Expect = 7e-16, Method: Composition-based stats.
Identities = 69/223 (30%), Positives = 103/223 (46%), Gaps = 21/223 (9%)
Query: 666 TLSRISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDT 725
+L I Y E++ ++G G+F V KA VA+K + +R K+F
Sbjct: 1 SLHMIDYKEIEV-------EEVVGRGAFGVVCKAKW-RAKDVAIKQIESESER--KAFIV 50
Query: 726 ECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNY--SLTIRQRLDIM 783
E + R+ H N++K+ +C NP L+M+Y GSL L+ T +
Sbjct: 51 ELRQLSRVNHPNIVKLYGACLNP--VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC 108
Query: 784 IDVASALEYLHHGYSTPIIHCDLKPNNVLL-DDDMVAHLGDFGIAKLLDGVDPVTQ-TMT 841
+ + + YLH +IH DLKP N+LL V + DFG A D T T
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTA-----CDIQTHMTNN 163
Query: 842 LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEM 884
+ +MAPE S DV+S+GI++ E TRRKP +E+
Sbjct: 164 KGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206
>pdb|2FO0|A Chain A, Organization Of The Sh3-Sh2 Unit In Active And Inactive
Forms Of The C-Abl Tyrosine Kinase
Length = 495
Score = 83.2 bits (204), Expect = 7e-16, Method: Compositional matrix adjust.
Identities = 56/196 (28%), Positives = 97/196 (49%), Gaps = 16/196 (8%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G + VY+ S+ V V L+ED ++ F E VM+ I+H NL++++ C+
Sbjct: 225 LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 283
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI------DVASALEYLHHGYSTP 800
+I ++M G+L +L N RQ ++ ++ ++SA+EYL
Sbjct: 284 REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 335
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
IH +L N L+ ++ + + DFG+++L+ G I + APE + SI
Sbjct: 336 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 395
Query: 861 SGDVYSFGILMMETFT 876
DV++FG+L+ E T
Sbjct: 396 KSDVWAFGVLLWEIAT 411
>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPL|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 537
Score = 82.8 bits (203), Expect = 8e-16, Method: Compositional matrix adjust.
Identities = 56/196 (28%), Positives = 97/196 (49%), Gaps = 16/196 (8%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G + VY+ S+ V V L+ED ++ F E VM+ I+H NL++++ C+
Sbjct: 267 LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 325
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI------DVASALEYLHHGYSTP 800
+I ++M G+L +L N RQ ++ ++ ++SA+EYL
Sbjct: 326 REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 377
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
IH +L N L+ ++ + + DFG+++L+ G I + APE + SI
Sbjct: 378 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 437
Query: 861 SGDVYSFGILMMETFT 876
DV++FG+L+ E T
Sbjct: 438 KSDVWAFGVLLWEIAT 453
>pdb|3A4O|X Chain X, Lyn Kinase Domain
Length = 286
Score = 82.8 bits (203), Expect = 8e-16, Method: Composition-based stats.
Identities = 54/193 (27%), Positives = 96/193 (49%), Gaps = 5/193 (2%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG+G F V+ N VAVK ++++F E +M+ ++H L+++ + +
Sbjct: 21 LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTR 79
Query: 748 PGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRL-DIMIDVASALEYLHHGYSTPIIHCDL 806
+I +YM +GSL +L S + +L D +A + Y+ IH DL
Sbjct: 80 EEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDL 136
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ NVL+ + ++ + DFG+A++++ + + I + APE + G +I DV+S
Sbjct: 137 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVWS 196
Query: 867 FGILMMETFTRRK 879
FGIL+ E T K
Sbjct: 197 FGILLYEIVTYGK 209
>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg-
1009247
Length = 270
Score = 82.8 bits (203), Expect = 8e-16, Method: Composition-based stats.
Identities = 58/190 (30%), Positives = 99/190 (52%), Gaps = 6/190 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG+G F V+ AT VAVK ++++F E VM+ ++H L+K+ + +
Sbjct: 23 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 81
Query: 748 PGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASAL-EYLHHGYSTPIIHCDL 806
+I ++M +GSL +L S S +Q L +ID ++ + E + IH DL
Sbjct: 82 EPI-YIITEFMAKGSLLDFLKSDEGS---KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 137
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ +V + DFG+A++++ + + I + APE + G +I DV+S
Sbjct: 138 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 197
Query: 867 FGILMMETFT 876
FGIL+ME T
Sbjct: 198 FGILLMEIVT 207
>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
pdb|3OY3|B Chain B, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound
With A Dfg- Out Inhibitor Ap24589
Length = 284
Score = 82.8 bits (203), Expect = 8e-16, Method: Composition-based stats.
Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 16/196 (8%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G + VY+ S+ V V L+ED ++ F E VM+ I+H NL++++ C+
Sbjct: 21 LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI------DVASALEYLHHGYSTP 800
+I+++M G+L +L N RQ + ++ ++SA+EYL
Sbjct: 80 REPPFYIIIEFMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYLE---KKN 131
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
IH DL N L+ ++ + + DFG+++L+ G I + APE + SI
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 861 SGDVYSFGILMMETFT 876
DV++FG+L+ E T
Sbjct: 192 KSDVWAFGVLLWEIAT 207
>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound
With Ppy-A
pdb|3IK3|A Chain A, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
pdb|3IK3|B Chain B, Ap24534, A Pan-Bcr-Abl Inhibitor For Chronic Myeloid
Leukemi Potently Inhibits The T315i Mutant And Overcomes
Mutation-B Resistance
Length = 288
Score = 82.8 bits (203), Expect = 8e-16, Method: Composition-based stats.
Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 16/196 (8%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G + VY+ S+ V V L+ED ++ F E VM+ I+H NL++++ C+
Sbjct: 21 LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI------DVASALEYLHHGYSTP 800
+I+++M G+L +L N RQ + ++ ++SA+EYL
Sbjct: 80 REPPFYIIIEFMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYLE---KKN 131
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
IH DL N L+ ++ + + DFG+++L+ G I + APE + SI
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 861 SGDVYSFGILMMETFT 876
DV++FG+L+ E T
Sbjct: 192 KSDVWAFGVLLWEIAT 207
>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRI|B Chain B, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dcc- 2036
pdb|3QRK|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In
Complex With Dp- 987
Length = 277
Score = 82.8 bits (203), Expect = 9e-16, Method: Composition-based stats.
Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 16/196 (8%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G + VY+ S+ V V L+ED ++ F E VM+ I+H NL++++ C+
Sbjct: 26 LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI------DVASALEYLHHGYSTP 800
+I ++M G+L +L N RQ ++ ++ ++SA+EYL
Sbjct: 85 REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 136
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
IH DL N L+ ++ + + DFG+++L+ G I + APE + SI
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 861 SGDVYSFGILMMETFT 876
DV++FG+L+ E T
Sbjct: 197 KSDVWAFGVLLWEIAT 212
>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
pdb|3PYY|B Chain B, Discovery And Characterization Of A Cell-Permeable,
Small-Molecule C- Abl Kinase Activator That Binds To The
Myristoyl Binding Site
Length = 298
Score = 82.8 bits (203), Expect = 9e-16, Method: Composition-based stats.
Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 16/196 (8%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G + VY+ S+ V V L+ED ++ F E VM+ I+H NL++++ C+
Sbjct: 34 LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 92
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI------DVASALEYLHHGYSTP 800
+I ++M G+L +L N RQ ++ ++ ++SA+EYL
Sbjct: 93 REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 144
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
IH DL N L+ ++ + + DFG+++L+ G I + APE + SI
Sbjct: 145 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 204
Query: 861 SGDVYSFGILMMETFT 876
DV++FG+L+ E T
Sbjct: 205 KSDVWAFGVLLWEIAT 220
>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
pdb|2E2B|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Inno-406
Length = 293
Score = 82.8 bits (203), Expect = 9e-16, Method: Composition-based stats.
Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 16/196 (8%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G + VY+ S+ V V L+ED ++ F E VM+ I+H NL++++ C+
Sbjct: 26 LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI------DVASALEYLHHGYSTP 800
+I ++M G+L +L N RQ ++ ++ ++SA+EYL
Sbjct: 85 REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 136
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
IH DL N L+ ++ + + DFG+++L+ G I + APE + SI
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 861 SGDVYSFGILMMETFT 876
DV++FG+L+ E T
Sbjct: 197 KSDVWAFGVLLWEIAT 212
>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|B Chain B, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|C Chain C, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HYY|D Chain D, Human Abl Kinase Domain In Complex With Imatinib (Sti571,
Glivec)
pdb|2HZ4|A Chain A, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|B Chain B, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
pdb|2HZ4|C Chain C, Abl Kinase Domain Unligated And In Complex With
Tetrahydrostaurosporine
Length = 273
Score = 82.8 bits (203), Expect = 9e-16, Method: Composition-based stats.
Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 16/196 (8%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G + VY+ S+ V V L+ED ++ F E VM+ I+H NL++++ C+
Sbjct: 21 LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI------DVASALEYLHHGYSTP 800
+I ++M G+L +L N RQ ++ ++ ++SA+EYL
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 131
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
IH DL N L+ ++ + + DFG+++L+ G I + APE + SI
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 861 SGDVYSFGILMMETFT 876
DV++FG+L+ E T
Sbjct: 192 KSDVWAFGVLLWEIAT 207
>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970
pdb|2HZI|B Chain B, Abl Kinase Domain In Complex With Pd180970
pdb|3CS9|A Chain A, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|B Chain B, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|C Chain C, Human Abl Kinase In Complex With Nilotinib
pdb|3CS9|D Chain D, Human Abl Kinase In Complex With Nilotinib
Length = 277
Score = 82.8 bits (203), Expect = 9e-16, Method: Composition-based stats.
Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 16/196 (8%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G + VY+ S+ V V L+ED ++ F E VM+ I+H NL++++ C+
Sbjct: 25 LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 83
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI------DVASALEYLHHGYSTP 800
+I ++M G+L +L N RQ ++ ++ ++SA+EYL
Sbjct: 84 REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 135
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
IH DL N L+ ++ + + DFG+++L+ G I + APE + SI
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 195
Query: 861 SGDVYSFGILMMETFT 876
DV++FG+L+ E T
Sbjct: 196 KSDVWAFGVLLWEIAT 211
>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082
pdb|2HZ0|B Chain B, Abl Kinase Domain In Complex With Nvp-Aeg082
Length = 270
Score = 82.8 bits (203), Expect = 9e-16, Method: Composition-based stats.
Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 16/196 (8%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G + VY+ S+ V V L+ED ++ F E VM+ I+H NL++++ C+
Sbjct: 21 LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI------DVASALEYLHHGYSTP 800
+I ++M G+L +L N RQ ++ ++ ++SA+EYL
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 131
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
IH DL N L+ ++ + + DFG+++L+ G I + APE + SI
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 861 SGDVYSFGILMMETFT 876
DV++FG+L+ E T
Sbjct: 192 KSDVWAFGVLLWEIAT 207
>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
pdb|2HIW|B Chain B, Crystal Structure Of Inactive Conformation Abl Kinase
Catalytic Domain Complexed With Type Ii Inhibitor
Length = 287
Score = 82.8 bits (203), Expect = 9e-16, Method: Composition-based stats.
Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 16/196 (8%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G + VY+ S+ V V L+ED ++ F E VM+ I+H NL++++ C+
Sbjct: 23 LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI------DVASALEYLHHGYSTP 800
+I ++M G+L +L N RQ ++ ++ ++SA+EYL
Sbjct: 82 REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 133
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
IH DL N L+ ++ + + DFG+++L+ G I + APE + SI
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 193
Query: 861 SGDVYSFGILMMETFT 876
DV++FG+L+ E T
Sbjct: 194 KSDVWAFGVLLWEIAT 209
>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|C Chain C, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G1T|D Chain D, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|3UE4|A Chain A, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
pdb|3UE4|B Chain B, Structural And Spectroscopic Analysis Of The Kinase
Inhibitor Bosutinib Binding To The Abl Tyrosine Kinase
Domain
Length = 287
Score = 82.8 bits (203), Expect = 9e-16, Method: Composition-based stats.
Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 16/196 (8%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G + VY+ S+ V V L+ED ++ F E VM+ I+H NL++++ C+
Sbjct: 23 LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI------DVASALEYLHHGYSTP 800
+I ++M G+L +L N RQ ++ ++ ++SA+EYL
Sbjct: 82 REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 133
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
IH DL N L+ ++ + + DFG+++L+ G I + APE + SI
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 193
Query: 861 SGDVYSFGILMMETFT 876
DV++FG+L+ E T
Sbjct: 194 KSDVWAFGVLLWEIAT 209
>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
pdb|3C4F|B Chain B, Fgfr Tyrosine Kinase Domain In Complex With 3-(3-
Methoxybenzyl)-7-Azaindole
Length = 302
Score = 82.8 bits (203), Expect = 1e-15, Method: Composition-based stats.
Identities = 66/215 (30%), Positives = 108/215 (50%), Gaps = 29/215 (13%)
Query: 688 LGSGSFDNVYKATL-------ANGVS-VAVKVFNLQE-DRALKSFDTECEVMRRI-RHRN 737
LG G+F V A N V+ VAVK+ ++ L +E E+M+ I +H+N
Sbjct: 21 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWL---------YSHNYS------LTIRQRLDI 782
+I ++ +C+ G +I++Y +G+L ++L Y +N S L+ + +
Sbjct: 81 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 783 MIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT- 841
VA +EYL S IH DL NVL+ +D V + DFG+A+ + +D +T
Sbjct: 141 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 197
Query: 842 LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + I + DV+SFG+L+ E FT
Sbjct: 198 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 232
>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And
Inactive Conformations Suggests A Mechanism Of
Activation For Tec Family Kinases
Length = 283
Score = 82.4 bits (202), Expect = 1e-15, Method: Composition-based stats.
Identities = 68/256 (26%), Positives = 117/256 (45%), Gaps = 16/256 (6%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
LG+G F V VA+K+ ++ ED F E +VM + H L+++
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMMNLSHEKLVQLYGV 87
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
C+ +I +YM G L +L + +Q L++ DV A+EYL S +H
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHR 144
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDV 864
DL N L++D V + DFG+++ + + + + + + PE S D+
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKSDI 204
Query: 865 YSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL----PGAVTEVVDANLLSREDEEDA 920
++FG+LM E ++ K E FT + + +A+ L P +E V + S E+ A
Sbjct: 205 WAFGVLMWEIYSLGKMPYERFTNSETAEH-IAQGLRLYRPHLASEKVYTIMYSCWHEK-A 262
Query: 921 DDFATKKTCISYIMSL 936
D+ T K +S I+ +
Sbjct: 263 DERPTFKILLSNILDV 278
>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family-
Selective Tyrosine Kinase Inhibitor
pdb|2C0I|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0I|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-420983
pdb|2C0O|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0O|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-770041
pdb|2C0T|A Chain A, Src Family Kinase Hck With Bound Inhibitor A-641359
pdb|2C0T|B Chain B, Src Family Kinase Hck With Bound Inhibitor A-641359
Length = 454
Score = 82.4 bits (202), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 58/190 (30%), Positives = 99/190 (52%), Gaps = 6/190 (3%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG+G F V+ AT VAVK ++++F E VM+ ++H L+K+ + +
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 254
Query: 748 PGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASAL-EYLHHGYSTPIIHCDL 806
+I ++M +GSL +L S S +Q L +ID ++ + E + IH DL
Sbjct: 255 EPI-YIITEFMAKGSLLDFLKSDEGS---KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 310
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ +V + DFG+A++++ + + I + APE + G +I DV+S
Sbjct: 311 RAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 370
Query: 867 FGILMMETFT 876
FGIL+ME T
Sbjct: 371 FGILLMEIVT 380
>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
Length = 495
Score = 82.4 bits (202), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 56/196 (28%), Positives = 96/196 (48%), Gaps = 16/196 (8%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G + VY+ S+ V V L+ED ++ F E VM+ I+H NL++++ C+
Sbjct: 228 LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 286
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI------DVASALEYLHHGYSTP 800
+I ++M G+L +L N RQ + ++ ++SA+EYL
Sbjct: 287 REPPFYIITEFMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYLE---KKN 338
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
IH +L N L+ ++ + + DFG+++L+ G I + APE + SI
Sbjct: 339 FIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 861 SGDVYSFGILMMETFT 876
DV++FG+L+ E T
Sbjct: 399 KSDVWAFGVLLWEIAT 414
>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:s768a Triple Mutant
Length = 373
Score = 82.4 bits (202), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 56/209 (26%), Positives = 106/209 (50%), Gaps = 15/209 (7%)
Query: 686 NLLGSGSFDNVYKATLA----NGVSVAVKVFNL-QEDRALKSFDTECEVMRRIRHRNLIK 740
++G+G F V L +SVA+K + ++ + F E +M + H N+I+
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH-GYST 799
+ + ++ +YM GSL+ +L H+ T+ Q + ++ +AS ++YL GY
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY-- 168
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA---TIGYMAPEYGSEG 856
+H DL N+L++ ++V + DFG+A++L+ DP T I + +PE +
Sbjct: 169 --VHRDLAARNILINSNLVCKVSDFGLARVLED-DPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 857 IVSISGDVYSFGILMMETFTR-RKPTNEM 884
+ + DV+S+GI++ E + +P EM
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERPYWEM 254
>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|B Chain B, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
pdb|3GQL|C Chain C, Crystal Structure Of Activated Receptor Tyrosine Kinase In
Complex With Substrates
Length = 326
Score = 82.0 bits (201), Expect = 1e-15, Method: Compositional matrix adjust.
Identities = 66/215 (30%), Positives = 108/215 (50%), Gaps = 29/215 (13%)
Query: 688 LGSGSFDNVYKATL-------ANGVS-VAVKVFNLQE-DRALKSFDTECEVMRRI-RHRN 737
LG G+F V A N V+ VAVK+ ++ L +E E+M+ I +H+N
Sbjct: 36 LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWL---------YSHNYS------LTIRQRLDI 782
+I ++ +C+ G +I++Y +G+L ++L Y +N S L+ + +
Sbjct: 96 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 783 MIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT- 841
VA +EYL S IH DL NVL+ +D V + DFG+A+ + +D +T
Sbjct: 156 AYQVARGMEYLA---SKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNG 212
Query: 842 LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + I + DV+SFG+L+ E FT
Sbjct: 213 RLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFT 247
>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A
Dfg-Out Inhibitor Ap24534
Length = 284
Score = 82.0 bits (201), Expect = 1e-15, Method: Composition-based stats.
Identities = 57/196 (29%), Positives = 96/196 (48%), Gaps = 16/196 (8%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G + VY+ S+ V V L+ED ++ F E VM+ I+H NL++++ C+
Sbjct: 21 LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI------DVASALEYLHHGYSTP 800
+I ++M G+L +L N RQ + ++ ++SA+EYL
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYLE---KKN 131
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
IH DL N L+ ++ + + DFG+++L+ G I + APE + SI
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 861 SGDVYSFGILMMETFT 876
DV++FG+L+ E T
Sbjct: 192 KSDVWAFGVLLWEIAT 207
>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|2QOH|B Chain B, Crystal Structure Of Abl Kinase Bound With Ppy-a
pdb|3KF4|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KF4|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|A Chain A, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
pdb|3KFA|B Chain B, Structural Analysis Of Dfg-In And Dfg-Out Dual Src-Abl
Inhibitors Sharing A Common Vinyl Purine Template
Length = 288
Score = 82.0 bits (201), Expect = 1e-15, Method: Composition-based stats.
Identities = 57/196 (29%), Positives = 96/196 (48%), Gaps = 16/196 (8%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G + VY+ S+ V V L+ED ++ F E VM+ I+H NL++++ C+
Sbjct: 21 LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 79
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI------DVASALEYLHHGYSTP 800
+I ++M G+L +L N RQ + ++ ++SA+EYL
Sbjct: 80 REPPFYIITEFMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYLE---KKN 131
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
IH DL N L+ ++ + + DFG+++L+ G I + APE + SI
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 861 SGDVYSFGILMMETFT 876
DV++FG+L+ E T
Sbjct: 192 KSDVWAFGVLLWEIAT 207
>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1FPU|B Chain B, Crystal Structure Of Abl Kinase Domain In Complex With A
Small Molecule Inhibitor
pdb|1IEP|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1IEP|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Sti-571.
pdb|1M52|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1M52|B Chain B, Crystal Structure Of The C-Abl Kinase Domain In Complex
With Pd173955
pdb|1OPJ|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|1OPJ|B Chain B, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine
Kinase
pdb|2HZN|A Chain A, Abl Kinase Domain In Complex With Nvp-Afg210
pdb|3K5V|A Chain A, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3K5V|B Chain B, Structure Of Abl Kinase In Complex With Imatinib And Gnf-2
pdb|3MS9|A Chain A, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MS9|B Chain B, Abl Kinase In Complex With Imatinib And A Fragment (Frag1)
I Myristate Pocket
pdb|3MSS|A Chain A, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|B Chain B, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|C Chain C, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
pdb|3MSS|D Chain D, Abl Kinase In Complex With Imatinib And Fragment (Frag2)
In The Myristate Site
Length = 293
Score = 82.0 bits (201), Expect = 1e-15, Method: Composition-based stats.
Identities = 57/196 (29%), Positives = 96/196 (48%), Gaps = 16/196 (8%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G + VY+ S+ V V L+ED ++ F E VM+ I+H NL++++ C+
Sbjct: 26 LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 84
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI------DVASALEYLHHGYSTP 800
+I ++M G+L +L N RQ + ++ ++SA+EYL
Sbjct: 85 REPPFYIITEFMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYLE---KKN 136
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
IH DL N L+ ++ + + DFG+++L+ G I + APE + SI
Sbjct: 137 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 861 SGDVYSFGILMMETFT 876
DV++FG+L+ E T
Sbjct: 197 KSDVWAFGVLLWEIAT 212
>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant
Abl Mutant In Complex With The Aurora Kinase Inhibitor
Vx-680
Length = 287
Score = 82.0 bits (201), Expect = 2e-15, Method: Composition-based stats.
Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 16/196 (8%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G + VY+ S+ V V L+ED ++ F E VM+ I+H NL++++ C+
Sbjct: 22 LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 80
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI------DVASALEYLHHGYSTP 800
+I ++M G+L +L N RQ ++ ++ ++SA+EYL
Sbjct: 81 REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 132
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
IH DL N L+ ++ + + DFG+++L+ G I + APE + SI
Sbjct: 133 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSI 192
Query: 861 SGDVYSFGILMMETFT 876
DV++FG+L+ E T
Sbjct: 193 KSDVWAFGVLLWEIAT 208
>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2F|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2H|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
pdb|2G2I|B Chain B, A Src-Like Inactive Conformation In The Abl Tyrosine
Kinase Domain
Length = 287
Score = 82.0 bits (201), Expect = 2e-15, Method: Composition-based stats.
Identities = 57/196 (29%), Positives = 97/196 (49%), Gaps = 16/196 (8%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G + VY+ S+ V V L+ED ++ F E VM+ I+H NL++++ C+
Sbjct: 23 LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 81
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI------DVASALEYLHHGYSTP 800
+I ++M G+L +L N RQ ++ ++ ++SA+EYL
Sbjct: 82 REPPFYIITEFMTYGNLLDYLRECN-----RQEVNAVVLLYMATQISSAMEYLE---KKN 133
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
IH DL N L+ ++ + + DFG+++L+ G I + APE + SI
Sbjct: 134 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSI 193
Query: 861 SGDVYSFGILMMETFT 876
DV++FG+L+ E T
Sbjct: 194 KSDVWAFGVLLWEIAT 209
>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
pdb|3DK3|B Chain B, Crystal Structure Of Mutant Abl Kinase Domain In Complex
With Small Molecule Fragment
Length = 293
Score = 81.6 bits (200), Expect = 2e-15, Method: Composition-based stats.
Identities = 57/196 (29%), Positives = 96/196 (48%), Gaps = 16/196 (8%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDR-ALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G + VY+ S+ V V L+ED ++ F E VM+ I+H NL++++ C+
Sbjct: 19 LGGGQYGEVYEGVWKK-YSLTVAVKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCT 77
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI------DVASALEYLHHGYSTP 800
+I ++M G+L +L N RQ + ++ ++SA+EYL
Sbjct: 78 REPPFYIITEFMTYGNLLDYLRECN-----RQEVSAVVLLYMATQISSAMEYLE---KKN 129
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
IH DL N L+ ++ + + DFG+++L+ G I + APE + SI
Sbjct: 130 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 861 SGDVYSFGILMMETFT 876
DV++FG+L+ E T
Sbjct: 190 KSDVWAFGVLLWEIAT 205
>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Isopropyl-7-
(4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3-
Ylamino)-2h- Phthalazin-1-One
pdb|3PIY|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With R406
pdb|3PIZ|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
(5-Amino-1-O-
Tolyl-1h-Pyrazol-4-Yl)-[3-(1-Methanesulfonyl-Piperidin-
4-Yl)-Phenyl]- Methanone
pdb|3PJ1|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
3-(2,6-Dichloro-
Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-Phenylamino]-1-
Methyl-3,4- Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3PJ2|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-[4-(2-
Diethylamino-Ethoxy)-Phenylamino]-6-(4-Fluoro-Phenoxy)-
8-Methyl-8h- Pyrido[2,3-D]pyrimidin-7-One
pdb|3PJ3|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With
2-Methyl-5-[(E)-
(3-Phenyl-Acryloyl)amino]-N-(2-Phenyl-3h-Imidazo[4,
5-B]pyridin-6-Yl)- Benzamide
Length = 274
Score = 81.6 bits (200), Expect = 2e-15, Method: Composition-based stats.
Identities = 68/256 (26%), Positives = 117/256 (45%), Gaps = 16/256 (6%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
LG+G F V VA+K+ ++ ED F E +VM + H L+++
Sbjct: 23 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMMNLSHEKLVQLYGV 78
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
C+ +I +YM G L +L + +Q L++ DV A+EYL S +H
Sbjct: 79 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHR 135
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDV 864
DL N L++D V + DFG+++ + + + + + + PE S D+
Sbjct: 136 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 195
Query: 865 YSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL----PGAVTEVVDANLLSREDEEDA 920
++FG+LM E ++ K E FT + + +A+ L P +E V + S E+ A
Sbjct: 196 WAFGVLMWEIYSLGKMPYERFTNSETAEH-IAQGLRLYRPHLASEKVYTIMYSCWHEK-A 253
Query: 921 DDFATKKTCISYIMSL 936
D+ T K +S I+ +
Sbjct: 254 DERPTFKILLSNILDV 269
>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain
pdb|3P08|B Chain B, Crystal Structure Of The Human Btk Kinase Domain
Length = 267
Score = 81.6 bits (200), Expect = 2e-15, Method: Composition-based stats.
Identities = 68/256 (26%), Positives = 117/256 (45%), Gaps = 16/256 (6%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
LG+G F V VA+K+ ++ ED F E +VM + H L+++
Sbjct: 16 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMMNLSHEKLVQLYGV 71
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
C+ +I +YM G L +L + +Q L++ DV A+EYL S +H
Sbjct: 72 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHR 128
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDV 864
DL N L++D V + DFG+++ + + + + + + PE S D+
Sbjct: 129 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 188
Query: 865 YSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL----PGAVTEVVDANLLSREDEEDA 920
++FG+LM E ++ K E FT + + +A+ L P +E V + S E+ A
Sbjct: 189 WAFGVLMWEIYSLGKMPYERFTNSETAEH-IAQGLRLYRPHLASEKVYTIMYSCWHEK-A 246
Query: 921 DDFATKKTCISYIMSL 936
D+ T K +S I+ +
Sbjct: 247 DERPTFKILLSNILDV 262
>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex
With Inhibitor Cgi1746
Length = 271
Score = 81.6 bits (200), Expect = 2e-15, Method: Composition-based stats.
Identities = 68/256 (26%), Positives = 117/256 (45%), Gaps = 16/256 (6%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
LG+G F V VA+K+ ++ ED F E +VM + H L+++
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMMNLSHEKLVQLYGV 72
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
C+ +I +YM G L +L + +Q L++ DV A+EYL S +H
Sbjct: 73 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHR 129
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDV 864
DL N L++D V + DFG+++ + + + + + + PE S D+
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 189
Query: 865 YSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL----PGAVTEVVDANLLSREDEEDA 920
++FG+LM E ++ K E FT + + +A+ L P +E V + S E+ A
Sbjct: 190 WAFGVLMWEIYSLGKMPYERFTNSETAEH-IAQGLRLYRPHLASEKVYTIMYSCWHEK-A 247
Query: 921 DDFATKKTCISYIMSL 936
D+ T K +S I+ +
Sbjct: 248 DERPTFKILLSNILDV 263
>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine
Kinase Bound To A Pyrrolopyrimidine-Containing Compound
Length = 283
Score = 81.6 bits (200), Expect = 2e-15, Method: Composition-based stats.
Identities = 68/256 (26%), Positives = 117/256 (45%), Gaps = 16/256 (6%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
LG+G F V VA+K+ ++ ED F E +VM + H L+++
Sbjct: 32 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMMNLSHEKLVQLYGV 87
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
C+ +I +YM G L +L + +Q L++ DV A+EYL S +H
Sbjct: 88 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHR 144
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDV 864
DL N L++D V + DFG+++ + + + + + + PE S D+
Sbjct: 145 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 204
Query: 865 YSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL----PGAVTEVVDANLLSREDEEDA 920
++FG+LM E ++ K E FT + + +A+ L P +E V + S E+ A
Sbjct: 205 WAFGVLMWEIYSLGKMPYERFTNSETAEH-IAQGLRLYRPHLASEKVYTIMYSCWHEK-A 262
Query: 921 DDFATKKTCISYIMSL 936
D+ T K +S I+ +
Sbjct: 263 DERPTFKILLSNILDV 278
>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain
pdb|1K2P|B Chain B, Crystal Structure Of Bruton's Tyrosine Kinase Domain
Length = 263
Score = 81.6 bits (200), Expect = 2e-15, Method: Composition-based stats.
Identities = 68/256 (26%), Positives = 117/256 (45%), Gaps = 16/256 (6%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
LG+G F V VA+K+ ++ ED F E +VM + H L+++
Sbjct: 12 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMMNLSHEKLVQLYGV 67
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
C+ +I +YM G L +L + +Q L++ DV A+EYL S +H
Sbjct: 68 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHR 124
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDV 864
DL N L++D V + DFG+++ + + + + + + PE S D+
Sbjct: 125 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDI 184
Query: 865 YSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL----PGAVTEVVDANLLSREDEEDA 920
++FG+LM E ++ K E FT + + +A+ L P +E V + S E+ A
Sbjct: 185 WAFGVLMWEIYSLGKMPYERFTNSETAEH-IAQGLRLYRPHLASEKVYTIMYSCWHEK-A 242
Query: 921 DDFATKKTCISYIMSL 936
D+ T K +S I+ +
Sbjct: 243 DERPTFKILLSNILDV 258
>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor
Awl-Ii- 38.3
pdb|4G2F|A Chain A, Human Epha3 Kinase Domain In Complex With Compound 7
pdb|4GK2|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 66
pdb|4GK3|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 87
pdb|4GK4|A Chain A, Human Epha3 Kinase Domain In Complex With Ligand 90
Length = 361
Score = 81.3 bits (199), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 106/209 (50%), Gaps = 15/209 (7%)
Query: 686 NLLGSGSFDNVYKATLA----NGVSVAVKVFNL-QEDRALKSFDTECEVMRRIRHRNLIK 740
++G+G F V L +SVA+K + ++ + F E +M + H N+I+
Sbjct: 39 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 98
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH-GYST 799
+ + ++ +YM GSL+ +L H+ T+ Q + ++ +AS ++YL GY
Sbjct: 99 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY-- 156
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA---TIGYMAPEYGSEG 856
+H DL N+L++ ++V + DFG++++L+ DP T I + +PE +
Sbjct: 157 --VHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIRWTSPEAIAYR 213
Query: 857 IVSISGDVYSFGILMMETFTR-RKPTNEM 884
+ + DV+S+GI++ E + +P EM
Sbjct: 214 KFTSASDVWSYGIVLWEVMSYGERPYWEM 242
>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound
Structure
Length = 344
Score = 81.3 bits (199), Expect = 2e-15, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 106/209 (50%), Gaps = 15/209 (7%)
Query: 686 NLLGSGSFDNVYKATLA----NGVSVAVKVFNL-QEDRALKSFDTECEVMRRIRHRNLIK 740
++G+G F V L +SVA+K + ++ + F E +M + H N+I+
Sbjct: 22 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 81
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH-GYST 799
+ + ++ +YM GSL+ +L H+ T+ Q + ++ +AS ++YL GY
Sbjct: 82 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY-- 139
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA---TIGYMAPEYGSEG 856
+H DL N+L++ ++V + DFG++++L+ DP T I + +PE +
Sbjct: 140 --VHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIRWTSPEAIAYR 196
Query: 857 IVSISGDVYSFGILMMETFTR-RKPTNEM 884
+ + DV+S+GI++ E + +P EM
Sbjct: 197 KFTSASDVWSYGIVLWEVMSYGERPYWEM 225
>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
pdb|3V5Q|B Chain B, Discovery Of A Selective Trk Inhibitor With Efficacy In
Rodent Cancer Tumor Models
Length = 297
Score = 81.3 bits (199), Expect = 2e-15, Method: Composition-based stats.
Identities = 69/286 (24%), Positives = 116/286 (40%), Gaps = 48/286 (16%)
Query: 688 LGSGSFDNVYKATLAN------GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKI 741
LG G+F V+ A N + VAVK A K F E E++ ++H +++K
Sbjct: 23 LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKF 82
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSH---------------NYSLTIRQRLDIMIDV 786
C + ++ +YM G L K+L +H L + Q L I +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 787 ASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATI 845
AS + YL S +H DL N L+ +++ +GDFG+++ + D T+ I
Sbjct: 143 ASGMVYLA---SQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPI 199
Query: 846 GYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTE 905
+M PE + DV+SFG+++ E FT K + W S +
Sbjct: 200 RWMPPESIMYRKFTTESDVWSFGVILWEIFTYGK------------QPWFQLSNTEVIEC 247
Query: 906 VVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINV 951
+ +L R + C + + L C P++R+N+
Sbjct: 248 ITQGRVLER-----------PRVCPKEVYDVMLGCWQREPQQRLNI 282
>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGW|B Chain B, Crystal Structure Of Itk Kinase Bound To An Inhibitor
pdb|3QGY|A Chain A, Crystal Structure Of Itk Inhibitor Complex
pdb|3QGY|B Chain B, Crystal Structure Of Itk Inhibitor Complex
Length = 286
Score = 81.3 bits (199), Expect = 2e-15, Method: Composition-based stats.
Identities = 55/195 (28%), Positives = 88/195 (45%), Gaps = 10/195 (5%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG F V+ N VA+K ++ ED F E EVM ++ H L+++
Sbjct: 35 IGSGQFGLVHLGYWLNKDKVAIKTIKEGSMSED----DFIEEAEVMMKLSHPKLVQLYGV 90
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
C L+ ++M G L +L + L + +DV + YL +IH
Sbjct: 91 CLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHR 147
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDV 864
DL N L+ ++ V + DFG+ + + + T T + + +PE S S DV
Sbjct: 148 DLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDV 207
Query: 865 YSFGILMMETFTRRK 879
+SFG+LM E F+ K
Sbjct: 208 WSFGVLMWEVFSEGK 222
>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r
In Complex With Dasatinib
Length = 265
Score = 81.3 bits (199), Expect = 3e-15, Method: Composition-based stats.
Identities = 68/256 (26%), Positives = 117/256 (45%), Gaps = 16/256 (6%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
LG+G F V VA+K+ ++ ED F E +VM + H L+++
Sbjct: 17 LGTGQFGVVKYGKWRGQYDVAIKMIKEGSMSEDE----FIEEAKVMMNLSHEKLVQLYGV 72
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
C+ +I +YM G L +L + +Q L++ DV A+EYL S +H
Sbjct: 73 CTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHR 129
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDV 864
DL N L++D V + DFG+++ + + + + + + PE S D+
Sbjct: 130 DLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKSDI 189
Query: 865 YSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESL----PGAVTEVVDANLLSREDEEDA 920
++FG+LM E ++ K E FT + + +A+ L P +E V + S E+ A
Sbjct: 190 WAFGVLMWEIYSLGKMPYERFTNSETAEH-IAQGLRLYRPHLASEKVYTIMYSCWHEK-A 247
Query: 921 DDFATKKTCISYIMSL 936
D+ T K +S I+ +
Sbjct: 248 DERPTFKILLSNILDV 263
>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f
Double Mutant
Length = 373
Score = 80.9 bits (198), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 106/209 (50%), Gaps = 15/209 (7%)
Query: 686 NLLGSGSFDNVYKATLA----NGVSVAVKVFNL-QEDRALKSFDTECEVMRRIRHRNLIK 740
++G+G F V L +SVA+K + ++ + F E +M + H N+I+
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH-GYST 799
+ + ++ +YM GSL+ +L H+ T+ Q + ++ +AS ++YL GY
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY-- 168
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA---TIGYMAPEYGSEG 856
+H DL N+L++ ++V + DFG++++L+ DP T I + +PE +
Sbjct: 169 --VHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 857 IVSISGDVYSFGILMMETFTR-RKPTNEM 884
+ + DV+S+GI++ E + +P EM
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERPYWEM 254
>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MIY|B Chain B, X-Ray Crystal Structure Of Itk Complexed With Sunitinib
pdb|3MJ1|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Ro5191614
pdb|3MJ2|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Inhibitor
Bms-509744
Length = 266
Score = 80.9 bits (198), Expect = 3e-15, Method: Composition-based stats.
Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 4/192 (2%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
+GSG F V+ N VA+K + + + F E EVM ++ H L+++ C
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 748 PGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLK 807
L+ ++M G L +L + L + +DV + YL +IH DL
Sbjct: 74 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEA---SVIHRDLA 130
Query: 808 PNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSF 867
N L+ ++ V + DFG+ + + + T T + + +PE S S DV+SF
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 190
Query: 868 GILMMETFTRRK 879
G+LM E F+ K
Sbjct: 191 GVLMWEVFSEGK 202
>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant
Length = 373
Score = 80.9 bits (198), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 106/209 (50%), Gaps = 15/209 (7%)
Query: 686 NLLGSGSFDNVYKATLA----NGVSVAVKVFNL-QEDRALKSFDTECEVMRRIRHRNLIK 740
++G+G F V L +SVA+K + ++ + F E +M + H N+I+
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH-GYST 799
+ + ++ +YM GSL+ +L H+ T+ Q + ++ +AS ++YL GY
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY-- 168
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA---TIGYMAPEYGSEG 856
+H DL N+L++ ++V + DFG++++L+ DP T I + +PE +
Sbjct: 169 --VHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 857 IVSISGDVYSFGILMMETFTR-RKPTNEM 884
+ + DV+S+GI++ E + +P EM
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERPYWEM 254
>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant
Length = 373
Score = 80.9 bits (198), Expect = 3e-15, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 106/209 (50%), Gaps = 15/209 (7%)
Query: 686 NLLGSGSFDNVYKATLA----NGVSVAVKVFNL-QEDRALKSFDTECEVMRRIRHRNLIK 740
++G+G F V L +SVA+K + ++ + F E +M + H N+I+
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH-GYST 799
+ + ++ +YM GSL+ +L H+ T+ Q + ++ +AS ++YL GY
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY-- 168
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA---TIGYMAPEYGSEG 856
+H DL N+L++ ++V + DFG++++L+ DP T I + +PE +
Sbjct: 169 --VHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 857 IVSISGDVYSFGILMMETFTR-RKPTNEM 884
+ + DV+S+GI++ E + +P EM
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERPYWEM 254
>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXP|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 318
Score = 80.9 bits (198), Expect = 4e-15, Method: Composition-based stats.
Identities = 66/208 (31%), Positives = 95/208 (45%), Gaps = 33/208 (15%)
Query: 688 LGSGSFDNV----YKATL-ANGVSVAVKVFNLQEDRALKS-FDTECEVMRRIRHRNLIKI 741
LG G F V Y T G VAVK +S + E +++R + H ++IK
Sbjct: 39 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHIIKY 98
Query: 742 VSSCSNPGFKAL--IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
C + G +L +M+Y+P GSL +L H S+ + Q L + + YLH +
Sbjct: 99 KGCCEDAGAASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQH-- 154
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL-----------DGVDPVTQTMTLATIGYM 848
IH DL NVLLD+D + +GDFG+AK + DG PV +
Sbjct: 155 -YIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVF---------WY 204
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFT 876
APE E + DV+SFG+ + E T
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELLT 232
>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With
Quinoline-Thiadiazole- Thiophene Inhibitor
Length = 302
Score = 80.9 bits (198), Expect = 4e-15, Method: Composition-based stats.
Identities = 66/209 (31%), Positives = 97/209 (46%), Gaps = 35/209 (16%)
Query: 688 LGSGSFDNV----YKATLANGVSVAVKVFNLQED---RALKSFDTECEVMRRIRHRNLIK 740
LG G F V Y T +G V V L+ D + + E +++R + H ++IK
Sbjct: 22 LGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIK 80
Query: 741 IVSSCSNPGFKAL--IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
C + G K+L +M+Y+P GSL +L H S+ + Q L + + YLH S
Sbjct: 81 YKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLH---S 135
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL-----------DGVDPVTQTMTLATIGY 847
IH +L NVLLD+D + +GDFG+AK + DG PV +
Sbjct: 136 QHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF---------W 186
Query: 848 MAPEYGSEGIVSISGDVYSFGILMMETFT 876
APE E + DV+SFG+ + E T
Sbjct: 187 YAPECLKEYKFYYASDVWSFGVTLYELLT 215
>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane
Region
pdb|2QO2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Apo Structure
pdb|2QO9|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Phosphorylated, Amp-pnp Bound
Length = 373
Score = 80.9 bits (198), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 106/209 (50%), Gaps = 15/209 (7%)
Query: 686 NLLGSGSFDNVYKATLA----NGVSVAVKVFNL-QEDRALKSFDTECEVMRRIRHRNLIK 740
++G+G F V L +SVA+K + ++ + F E +M + H N+I+
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH-GYST 799
+ + ++ +YM GSL+ +L H+ T+ Q + ++ +AS ++YL GY
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY-- 168
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA---TIGYMAPEYGSEG 856
+H DL N+L++ ++V + DFG++++L+ DP T I + +PE +
Sbjct: 169 --VHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 857 IVSISGDVYSFGILMMETFTR-RKPTNEM 884
+ + DV+S+GI++ E + +P EM
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERPYWEM 254
>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnye[ptyr]iw
pdb|3FY2|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To
Substrate Kqwdnyefiw
Length = 371
Score = 80.5 bits (197), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 106/209 (50%), Gaps = 15/209 (7%)
Query: 686 NLLGSGSFDNVYKATLA----NGVSVAVKVFNL-QEDRALKSFDTECEVMRRIRHRNLIK 740
++G+G F V L +SVA+K + ++ + F E +M + H N+I+
Sbjct: 49 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 108
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH-GYST 799
+ + ++ +YM GSL+ +L H+ T+ Q + ++ +AS ++YL GY
Sbjct: 109 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY-- 166
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA---TIGYMAPEYGSEG 856
+H DL N+L++ ++V + DFG++++L+ DP T I + +PE +
Sbjct: 167 --VHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIRWTSPEAIAYR 223
Query: 857 IVSISGDVYSFGILMMETFTR-RKPTNEM 884
+ + DV+S+GI++ E + +P EM
Sbjct: 224 KFTSASDVWSYGIVLWEVMSYGERPYWEM 252
>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596:y602:s768g Triple Mutant
Length = 373
Score = 80.5 bits (197), Expect = 4e-15, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 105/209 (50%), Gaps = 15/209 (7%)
Query: 686 NLLGSGSFDNVYKATLA----NGVSVAVKVFNL-QEDRALKSFDTECEVMRRIRHRNLIK 740
++G+G F V L +SVA+K + ++ + F E +M + H N+I+
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH-GYST 799
+ + ++ +YM GSL+ +L H+ T+ Q + ++ +AS ++YL GY
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY-- 168
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA---TIGYMAPEYGSEG 856
+H DL N+L++ ++V + DFG+ ++L+ DP T I + +PE +
Sbjct: 169 --VHRDLAARNILINSNLVCKVSDFGLGRVLED-DPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 857 IVSISGDVYSFGILMMETFTR-RKPTNEM 884
+ + DV+S+GI++ E + +P EM
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERPYWEM 254
>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SM2|B Chain B, Crystal Structure Of The Phosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|A Chain A, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNU|B Chain B, Crystal Structure Of The Unphosphorylated Interleukin-2
Tyrosine Kinase Catalytic Domain
pdb|1SNX|A Chain A, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
pdb|1SNX|B Chain B, Crystal Structure Of Apo Interleukin-2 Tyrosine Kinase
Catalytic Domain
Length = 264
Score = 80.1 bits (196), Expect = 5e-15, Method: Composition-based stats.
Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 4/192 (2%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
+GSG F V+ N VA+K + + + F E EVM ++ H L+++ C
Sbjct: 13 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 748 PGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLK 807
L+ ++M G L +L + L + +DV + YL +IH DL
Sbjct: 72 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLA 128
Query: 808 PNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSF 867
N L+ ++ V + DFG+ + + + T T + + +PE S S DV+SF
Sbjct: 129 ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 188
Query: 868 GILMMETFTRRK 879
G+LM E F+ K
Sbjct: 189 GVLMWEVFSEGK 200
>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52
pdb|4HCU|A Chain A, Crystal Structure Of Itk In Complext With Compound 40
pdb|4HCV|A Chain A, Crystal Structure Of Itk In Complex With Compound 53
Length = 269
Score = 80.1 bits (196), Expect = 5e-15, Method: Composition-based stats.
Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 4/192 (2%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
+GSG F V+ N VA+K + + + F E EVM ++ H L+++ C
Sbjct: 18 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 76
Query: 748 PGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLK 807
L+ ++M G L +L + L + +DV + YL +IH DL
Sbjct: 77 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLA 133
Query: 808 PNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSF 867
N L+ ++ V + DFG+ + + + T T + + +PE S S DV+SF
Sbjct: 134 ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 193
Query: 868 GILMMETFTRRK 879
G+LM E F+ K
Sbjct: 194 GVLMWEVFSEGK 205
>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5J|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 090
pdb|3V5L|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|C Chain C, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V5L|D Chain D, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 542
pdb|3V8T|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8T|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 477
pdb|3V8W|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
pdb|3V8W|B Chain B, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase
Itk Catalytic Domain With Thienopyrazolylindole
Inhibitor 469
Length = 266
Score = 80.1 bits (196), Expect = 5e-15, Method: Composition-based stats.
Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 4/192 (2%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
+GSG F V+ N VA+K + + + F E EVM ++ H L+++ C
Sbjct: 15 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 73
Query: 748 PGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLK 807
L+ ++M G L +L + L + +DV + YL +IH DL
Sbjct: 74 QAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLA 130
Query: 808 PNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSF 867
N L+ ++ V + DFG+ + + + T T + + +PE S S DV+SF
Sbjct: 131 ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 190
Query: 868 GILMMETFTRRK 879
G+LM E F+ K
Sbjct: 191 GVLMWEVFSEGK 202
>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
pdb|3LXL|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2
And Jak3 Kinase Domains In Complex With Cp-690550 And
Cmp-6
Length = 327
Score = 80.1 bits (196), Expect = 5e-15, Method: Compositional matrix adjust.
Identities = 60/198 (30%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 688 LGSGSFDNV----YKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G+F +V Y N G VAVK + F E ++++ + ++K
Sbjct: 31 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 90
Query: 743 SSCSNPGFKAL--IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
PG ++L +M+Y+P G L +L H L + L + +EYL S
Sbjct: 91 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 147
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAPEYGSEGIV 858
+H DL N+L++ + + DFG+AKLL D V + + I + APE S+ I
Sbjct: 148 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 207
Query: 859 SISGDVYSFGILMMETFT 876
S DV+SFG+++ E FT
Sbjct: 208 SRQSDVWSFGVVLYELFT 225
>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|E Chain E, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4L|D Chain D, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30
pdb|4E4N|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E4N|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 49
pdb|4E5W|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4E5W|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 26
pdb|4EHZ|A Chain A, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|B Chain B, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|C Chain C, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EHZ|D Chain D, The Jak1 Kinase Domain In Complex With Inhibitor
pdb|4EI4|A Chain A, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4EI4|B Chain B, Jak1 Kinase (jh1 Domain) In Complex With Compound 20
pdb|4FK6|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
pdb|4FK6|B Chain B, Jak1 Kinase (Jh1 Domain) In Complex With Compound 72
Length = 302
Score = 80.1 bits (196), Expect = 6e-15, Method: Composition-based stats.
Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 688 LGSGSFDNV----YKATLAN-GVSVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLIKI 741
LG G F V Y N G VAVK + + E E++R + H N++K
Sbjct: 29 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 88
Query: 742 VSSCSNPGFKA--LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
C+ G LIM+++P GSL+++L + + ++Q+L + + ++YL S
Sbjct: 89 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 145
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT---LATIGYMAPEYGSEG 856
+H DL NVL++ + +GDFG+ K ++ D T+ + + + APE +
Sbjct: 146 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE-TDKEXXTVKDDRDSPVFWYAPECLMQS 204
Query: 857 IVSISGDVYSFGILMMETFT 876
I+ DV+SFG+ + E T
Sbjct: 205 KFYIASDVWSFGVTLHELLT 224
>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
pdb|3EYH|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes
Length = 290
Score = 80.1 bits (196), Expect = 6e-15, Method: Composition-based stats.
Identities = 57/200 (28%), Positives = 97/200 (48%), Gaps = 15/200 (7%)
Query: 688 LGSGSFDNV----YKATLAN-GVSVAVKVFNLQED-RALKSFDTECEVMRRIRHRNLIKI 741
LG G F V Y N G VAVK + + E E++R + H N++K
Sbjct: 17 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKY 76
Query: 742 VSSCSNPGFKA--LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
C+ G LIM+++P GSL+++L + + ++Q+L + + ++YL S
Sbjct: 77 KGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLG---SR 133
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT---LATIGYMAPEYGSEG 856
+H DL NVL++ + +GDFG+ K ++ D T+ + + + APE +
Sbjct: 134 QYVHRDLAARNVLVESEHQVKIGDFGLTKAIE-TDKEXXTVKDDRDSPVFWYAPECLMQS 192
Query: 857 IVSISGDVYSFGILMMETFT 876
I+ DV+SFG+ + E T
Sbjct: 193 KFYIASDVWSFGVTLHELLT 212
>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed
With Imidazo[1,5-A]quinoxaline
Length = 267
Score = 80.1 bits (196), Expect = 6e-15, Method: Composition-based stats.
Identities = 53/192 (27%), Positives = 87/192 (45%), Gaps = 4/192 (2%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
+GSG F V+ N VA+K + + + F E EVM ++ H L+++ C
Sbjct: 16 IGSGQFGLVHLGYWLNKDKVAIKTIR-EGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLE 74
Query: 748 PGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLK 807
L+ ++M G L +L + L + +DV + YL +IH DL
Sbjct: 75 QAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLA 131
Query: 808 PNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSF 867
N L+ ++ V + DFG+ + + + T T + + +PE S S DV+SF
Sbjct: 132 ARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSF 191
Query: 868 GILMMETFTRRK 879
G+LM E F+ K
Sbjct: 192 GVLMWEVFSEGK 203
>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742f Triple Mutant
Length = 373
Score = 79.7 bits (195), Expect = 6e-15, Method: Compositional matrix adjust.
Identities = 53/208 (25%), Positives = 104/208 (50%), Gaps = 13/208 (6%)
Query: 686 NLLGSGSFDNVYKATLA----NGVSVAVKVFNL-QEDRALKSFDTECEVMRRIRHRNLIK 740
++G+G F V L +SVA+K + ++ + F E +M + H N+I+
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ + ++ +YM GSL+ +L H+ T+ Q + ++ +AS ++YL
Sbjct: 111 LEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMG 167
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA---TIGYMAPEYGSEGI 857
+H DL N+L++ ++V + DFG++++L+ DP T I + +PE +
Sbjct: 168 FVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 858 VSISGDVYSFGILMMETFTR-RKPTNEM 884
+ + DV+S+GI++ E + +P EM
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEM 254
>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form
pdb|2ZV8|A Chain A, Lyn Tyrosine Kinase Domain-Amp-Pnp Complex
pdb|2ZV9|A Chain A, Lyn Tyrosine Kinase Domain-Pp2 Complex
pdb|2ZVA|A Chain A, Lyn Tyrosine Kinase Domain-dasatinib Complex
Length = 279
Score = 79.7 bits (195), Expect = 8e-15, Method: Composition-based stats.
Identities = 52/193 (26%), Positives = 96/193 (49%), Gaps = 5/193 (2%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG+G F V+ N VAVK ++++F E +M+ ++H L+++ + +
Sbjct: 20 LGAGQFGEVWMGYYNNSTKVAVKTLK-PGTMSVQAFLEEANLMKTLQHDKLVRLYAVVTK 78
Query: 748 PGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRL-DIMIDVASALEYLHHGYSTPIIHCDL 806
+I ++M +GSL +L S + +L D +A + Y+ IH DL
Sbjct: 79 EEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDL 135
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ NVL+ + ++ + DFG+A++++ + + I + APE + G +I +V+S
Sbjct: 136 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNVWS 195
Query: 867 FGILMMETFTRRK 879
FGIL+ E T K
Sbjct: 196 FGILLYEIVTYGK 208
>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6
Length = 302
Score = 79.7 bits (195), Expect = 8e-15, Method: Composition-based stats.
Identities = 65/209 (31%), Positives = 97/209 (46%), Gaps = 35/209 (16%)
Query: 688 LGSGSFDNV----YKATLANGVSVAVKVFNLQED---RALKSFDTECEVMRRIRHRNLIK 740
LG G F V Y T +G V V L+ D + + E +++R + H ++IK
Sbjct: 22 LGEGHFGKVSLYCYDPT-NDGTGEMVAVKALKADCGPQHRSGWKQEIDILRTLYHEHIIK 80
Query: 741 IVSSCSNPGFKAL--IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
C + G K+L +M+Y+P GSL +L H S+ + Q L + + YLH +
Sbjct: 81 YKGCCEDQGEKSLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAYLHAQH- 137
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL-----------DGVDPVTQTMTLATIGY 847
IH +L NVLLD+D + +GDFG+AK + DG PV +
Sbjct: 138 --YIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF---------W 186
Query: 848 MAPEYGSEGIVSISGDVYSFGILMMETFT 876
APE E + DV+SFG+ + E T
Sbjct: 187 YAPECLKEYKFYYASDVWSFGVTLYELLT 215
>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 290
Score = 79.0 bits (193), Expect = 1e-14, Method: Composition-based stats.
Identities = 67/208 (32%), Positives = 94/208 (45%), Gaps = 33/208 (15%)
Query: 688 LGSGSFDNV----YKATL-ANGVSVAVKVFNLQEDRALKS-FDTECEVMRRIRHRNLIKI 741
LG G F V Y T G VAVK L+S + E E++R + H +++K
Sbjct: 16 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 75
Query: 742 VSSCSNPGFKA--LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
C + G K+ L+M+Y+P GSL +L H L Q L + + YLH +
Sbjct: 76 KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLA--QLLLFAQQICEGMAYLHAQH-- 131
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL-----------DGVDPVTQTMTLATIGYM 848
IH L NVLLD+D + +GDFG+AK + DG PV +
Sbjct: 132 -YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF---------WY 181
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFT 876
APE E + DV+SFG+ + E T
Sbjct: 182 APECLKECKFYYASDVWSFGVTLYELLT 209
>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole
Inhibitor
Length = 291
Score = 79.0 bits (193), Expect = 1e-14, Method: Composition-based stats.
Identities = 67/208 (32%), Positives = 94/208 (45%), Gaps = 33/208 (15%)
Query: 688 LGSGSFDNV----YKATL-ANGVSVAVKVFNLQEDRALKS-FDTECEVMRRIRHRNLIKI 741
LG G F V Y T G VAVK L+S + E E++R + H +++K
Sbjct: 17 LGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLYHEHIVKY 76
Query: 742 VSSCSNPGFKA--LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
C + G K+ L+M+Y+P GSL +L H L Q L + + YLH +
Sbjct: 77 KGCCEDQGEKSVQLVMEYVPLGSLRDYLPRHCVGLA--QLLLFAQQICEGMAYLHAQH-- 132
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL-----------DGVDPVTQTMTLATIGYM 848
IH L NVLLD+D + +GDFG+AK + DG PV +
Sbjct: 133 -YIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVF---------WY 182
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFT 876
APE E + DV+SFG+ + E T
Sbjct: 183 APECLKECKFYYASDVWSFGVTLYELLT 210
>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-1,2,2-trimethyl-propyl)-amide
pdb|4HVG|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((s)-2-hydroxy-1,2-dimethyl-propyl)- Amide
pdb|4HVH|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-2-hydroxy-1,2-dimethyl-propyl
pdb|4HVI|A Chain A, Jak3 Kinase Domain In Complex With
2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic
Acid ((r)-1-methyl-2-oxo-2-piperidin-1-yl- Ethyl)-amide
Length = 314
Score = 78.6 bits (192), Expect = 2e-14, Method: Composition-based stats.
Identities = 60/198 (30%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 688 LGSGSFDNV----YKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G+F +V Y N G VAVK + F E ++++ + ++K
Sbjct: 18 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 77
Query: 743 SSCSNPGFKAL--IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
PG ++L +M+Y+P G L +L H L + L + +EYL S
Sbjct: 78 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 134
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAPEYGSEGIV 858
+H DL N+L++ + + DFG+AKLL D V + + I + APE S+ I
Sbjct: 135 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 194
Query: 859 SISGDVYSFGILMMETFT 876
S DV+SFG+++ E FT
Sbjct: 195 SRQSDVWSFGVVLYELFT 212
>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site
Inhibitor Showing High Selectivity Within The Janus
Kinase Family
Length = 315
Score = 78.6 bits (192), Expect = 2e-14, Method: Composition-based stats.
Identities = 60/198 (30%), Positives = 94/198 (47%), Gaps = 12/198 (6%)
Query: 688 LGSGSFDNV----YKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G+F +V Y N G VAVK + F E ++++ + ++K
Sbjct: 19 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 78
Query: 743 SSCSNPGFKAL--IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
PG ++L +M+Y+P G L +L H L + L + +EYL S
Sbjct: 79 GVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 135
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAPEYGSEGIV 858
+H DL N+L++ + + DFG+AKLL D V + + I + APE S+ I
Sbjct: 136 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIF 195
Query: 859 SISGDVYSFGILMMETFT 876
S DV+SFG+++ E FT
Sbjct: 196 SRQSDVWSFGVVLYELFT 213
>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure
Length = 344
Score = 78.2 bits (191), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 54/209 (25%), Positives = 105/209 (50%), Gaps = 15/209 (7%)
Query: 686 NLLGSGSFDNVYKATLA----NGVSVAVKVFNL-QEDRALKSFDTECEVMRRIRHRNLIK 740
++G+G F V L +SVA+K + ++ + F E +M + H N+I+
Sbjct: 22 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 81
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH-GYST 799
+ + ++ + M GSL+ +L H+ T+ Q + ++ +AS ++YL GY
Sbjct: 82 LEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY-- 139
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA---TIGYMAPEYGSEG 856
+H DL N+L++ ++V + DFG++++L+ DP T I + +PE +
Sbjct: 140 --VHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIRWTSPEAIAYR 196
Query: 857 IVSISGDVYSFGILMMETFTR-RKPTNEM 884
+ + DV+S+GI++ E + +P EM
Sbjct: 197 KFTSASDVWSYGIVLWEVMSYGERPYWEM 225
>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex
With A Staurosporine Analogue
Length = 290
Score = 78.2 bits (191), Expect = 2e-14, Method: Composition-based stats.
Identities = 60/198 (30%), Positives = 92/198 (46%), Gaps = 12/198 (6%)
Query: 688 LGSGSFDNV----YKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G+F +V Y N G VAVK + F E ++++ + ++K
Sbjct: 15 LGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALHSDFIVKYR 74
Query: 743 SSCSNPGFKAL--IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
PG L +M+Y+P G L +L H L + L + +EYL S
Sbjct: 75 GVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLG---SRR 131
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAPEYGSEGIV 858
+H DL N+L++ + + DFG+AKLL D V + + I + APE S+ I
Sbjct: 132 CVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWYAPESLSDNIF 191
Query: 859 SISGDVYSFGILMMETFT 876
S DV+SFG+++ E FT
Sbjct: 192 SRQSDVWSFGVVLYELFT 209
>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|B Chain B, Human Trka In Complex With The Inhibitor Az-23
pdb|4AOJ|C Chain C, Human Trka In Complex With The Inhibitor Az-23
Length = 329
Score = 78.2 bits (191), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 68/285 (23%), Positives = 117/285 (41%), Gaps = 47/285 (16%)
Query: 688 LGSGSFDNVYKATLAN------GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKI 741
LG G+F V+ A N + VAVK + A + F E E++ ++H+++++
Sbjct: 49 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 108
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS--------------LTIRQRLDIMIDVA 787
C+ ++ +YM G L ++L SH L + Q L + VA
Sbjct: 109 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 168
Query: 788 SALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIG 846
+ + YL +H DL N L+ +V +GDFG+++ + D T+ I
Sbjct: 169 AGMVYL---AGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 225
Query: 847 YMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEV 906
+M PE + DV+SFG+++ E FT K + W S TE
Sbjct: 226 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGK------------QPWYQLS----NTEA 269
Query: 907 VDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEERINV 951
+D RE E + C + ++ C P++R ++
Sbjct: 270 IDCITQGRELER-------PRACPPEVYAIMRGCWQREPQQRHSI 307
>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In
Complex With An Mk-2461 Analog With Specificity For The
Activated Receptor
pdb|3R7O|A Chain A, Structure Of Dually Phosphorylated C-Met Receptor Kinase
In Complex With An Mk-2461 Analog
Length = 307
Score = 78.2 bits (191), Expect = 2e-14, Method: Compositional matrix adjust.
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 12/204 (5%)
Query: 686 NLLGSGSFDNVYKATL----ANGVSVAVKVFNLQEDRA-LKSFDTECEVMRRIRHRNLIK 740
++G G F VY TL + AVK N D + F TE +M+ H N++
Sbjct: 35 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 741 IVSSC-SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
++ C + G +++ YM G L ++ + ++ T++ + + VA ++YL S
Sbjct: 95 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASK 151
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQTMTLAT--IGYMAPEYGSEG 856
+H DL N +LD+ + DFG+A+ + D T A + +MA E
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSVHNKTGAKLPVKWMALESLQTQ 211
Query: 857 IVSISGDVYSFGILMMETFTRRKP 880
+ DV+SFG+L+ E TR P
Sbjct: 212 KFTTKSDVWSFGVLLWELMTRGAP 235
>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 77.8 bits (190), Expect = 3e-14, Method: Composition-based stats.
Identities = 80/288 (27%), Positives = 117/288 (40%), Gaps = 40/288 (13%)
Query: 675 LQQATNGFGESNL-----LGSGSFDNV----YKATLANGVSVAVKVFN---LQEDRALKS 722
LQ T GE +L LG GSF V + A VSVAVK L + A+
Sbjct: 8 LQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD 67
Query: 723 FDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDI 782
F E M + HRNLI++ P K ++ + P GSL L H +
Sbjct: 68 FIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY 126
Query: 783 MIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD--PVTQTM 840
+ VA + YL S IH DL N+LL + +GDFG+ + L D V Q
Sbjct: 127 AVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEH 183
Query: 841 TLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP 900
+ APE S + D + FG+ + E FT + + W+ L
Sbjct: 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ------------EPWIG--LN 229
Query: 901 GAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEER 948
G + +L + D+E + + C I ++ ++C A PE+R
Sbjct: 230 G-------SQILHKIDKE-GERLPRPEDCPQDIYNVMVQCWAHKPEDR 269
>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U46|B Chain B, Crystal Structure Of The Unphosphorylated Kinase Domain Of
The Tyrosine Kinase Ack1
pdb|1U4D|A Chain A, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U4D|B Chain B, Structure Of The Ack1 Kinase Domain Bound To
Debromohymenialdisine
pdb|1U54|B Chain B, Crystal Structures Of The Phosphorylated And
Unphosphorylated Kinase Domains Of The Cdc42-Associated
Tyrosine Kinase Ack1 Bound To Amp-Pcp
Length = 291
Score = 77.8 bits (190), Expect = 3e-14, Method: Composition-based stats.
Identities = 80/288 (27%), Positives = 117/288 (40%), Gaps = 40/288 (13%)
Query: 675 LQQATNGFGESNL-----LGSGSFDNV----YKATLANGVSVAVKVFN---LQEDRALKS 722
LQ T GE +L LG GSF V + A VSVAVK L + A+
Sbjct: 8 LQSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDD 67
Query: 723 FDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDI 782
F E M + HRNLI++ P K ++ + P GSL L H +
Sbjct: 68 FIREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRY 126
Query: 783 MIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP--VTQTM 840
+ VA + YL S IH DL N+LL + +GDFG+ + L D V Q
Sbjct: 127 AVQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEH 183
Query: 841 TLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP 900
+ APE S + D + FG+ + E FT + + W+ L
Sbjct: 184 RKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ------------EPWIG--LN 229
Query: 901 GAVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEER 948
G + +L + D+E + + C I ++ ++C A PE+R
Sbjct: 230 G-------SQILHKIDKE-GERLPRPEDCPQDIYNVMVQCWAHKPEDR 269
>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1
Length = 317
Score = 77.8 bits (190), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 57/204 (27%), Positives = 97/204 (47%), Gaps = 12/204 (5%)
Query: 686 NLLGSGSFDNVYKATL----ANGVSVAVKVFNLQEDRA-LKSFDTECEVMRRIRHRNLIK 740
++G G F VY TL + AVK N D + F TE +M+ H N++
Sbjct: 37 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 741 IVSSC-SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
++ C + G +++ YM G L ++ + ++ T++ + + VA +++L S
Sbjct: 97 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASK 153
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDG-VDPV-TQTMTLATIGYMAPEYGSEG 856
+H DL N +LD+ + DFG+A+ +LD D V +T + +MA E
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSVHNKTGAKLPVKWMALESLQTQ 213
Query: 857 IVSISGDVYSFGILMMETFTRRKP 880
+ DV+SFG+L+ E TR P
Sbjct: 214 KFTTKSDVWSFGVLLWELMTRGAP 237
>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Dephosphorylated, Amp-Pnp Bound
pdb|2QOQ|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Base, Amp-Pnp
Bound Structure
Length = 373
Score = 77.4 bits (189), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 54/209 (25%), Positives = 105/209 (50%), Gaps = 15/209 (7%)
Query: 686 NLLGSGSFDNVYKATLA----NGVSVAVKVFNL-QEDRALKSFDTECEVMRRIRHRNLIK 740
++G+G F V L +SVA+K + ++ + F E +M + H N+I+
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH-GYST 799
+ + ++ + M GSL+ +L H+ T+ Q + ++ +AS ++YL GY
Sbjct: 111 LEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY-- 168
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA---TIGYMAPEYGSEG 856
+H DL N+L++ ++V + DFG++++L+ DP T I + +PE +
Sbjct: 169 --VHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIRWTSPEAIAYR 225
Query: 857 IVSISGDVYSFGILMMETFTR-RKPTNEM 884
+ + DV+S+GI++ E + +P EM
Sbjct: 226 KFTSASDVWSYGIVLWEVMSYGERPYWEM 254
>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|B Chain B, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|C Chain C, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
pdb|4HZS|D Chain D, Crystal Structure Of Ack1 Kinase Domain With C-terminal
Sh3 Domain
Length = 341
Score = 77.4 bits (189), Expect = 3e-14, Method: Compositional matrix adjust.
Identities = 79/287 (27%), Positives = 115/287 (40%), Gaps = 40/287 (13%)
Query: 676 QQATNGFGESNL-----LGSGSFDNV----YKATLANGVSVAVKVFN---LQEDRALKSF 723
Q T GE +L LG GSF V + A VSVAVK L + A+ F
Sbjct: 3 QSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDF 62
Query: 724 DTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIM 783
E M + HRNLI++ P K ++ + P GSL L H +
Sbjct: 63 IREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 121
Query: 784 IDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP--VTQTMT 841
+ VA + YL S IH DL N+LL + +GDFG+ + L D V Q
Sbjct: 122 VQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 178
Query: 842 LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPG 901
+ APE S + D + FG+ + E FT + W+ L G
Sbjct: 179 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFT------------YGQEPWIG--LNG 224
Query: 902 AVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEER 948
+ +L + D+E + + C I ++ ++C A PE+R
Sbjct: 225 -------SQILHKIDKE-GERLPRPEDCPQDIYNVMVQCWAHKPEDR 263
>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156.
pdb|2X4F|B Chain B, The Crystal Structure Of The Human Myosin Light Chain
Kinase Loc340156
Length = 373
Score = 77.4 bits (189), Expect = 4e-14, Method: Compositional matrix adjust.
Identities = 54/201 (26%), Positives = 96/201 (47%), Gaps = 11/201 (5%)
Query: 676 QQATNGF---GESNLLGSGSFDNVYK-ATLANGVSVAVKVFNLQEDRALKSFDTECEVMR 731
Q A N F ++ +LG G F V+K A G+ +A K+ + + + E VM
Sbjct: 82 QGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMN 141
Query: 732 RIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALE 791
++ H NLI++ + + L+M+Y+ G L + +Y+LT + M + +
Sbjct: 142 QLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIR 201
Query: 792 YLHHGYSTPIIHCDLKPNNVLL--DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
++H Y I+H DLKP N+L D + DFG+A+ + + + T ++A
Sbjct: 202 HMHQMY---ILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKL--KVNFGTPEFLA 256
Query: 850 PEYGSEGIVSISGDVYSFGIL 870
PE + VS D++S G++
Sbjct: 257 PEVVNYDFVSFPTDMWSVGVI 277
>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7
pdb|2WQN|A Chain A, Structure Of Adp-Bound Human Nek7
Length = 310
Score = 77.4 bits (189), Expect = 4e-14, Method: Composition-based stats.
Identities = 53/200 (26%), Positives = 95/200 (47%), Gaps = 11/200 (5%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVK---VFNLQEDRALKSFDTECEVMRRIRHRNLIKIVS 743
+G G F VY+A L +GV VA+K +F+L + +A E ++++++ H N+IK +
Sbjct: 40 IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYA 99
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTI---RQRLDIMIDVASALEYLHHGYSTP 800
S ++++ G L + + + R + + SALE++H S
Sbjct: 100 SFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMH---SRR 156
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
++H D+KP NV + V LGD G+ + ++ + T YM+PE E +
Sbjct: 157 VMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL-VGTPYYMSPERIHENGYNF 215
Query: 861 SGDVYSFGILMMETFTRRKP 880
D++S G L+ E + P
Sbjct: 216 KSDIWSLGCLLYEMAALQSP 235
>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor
Length = 292
Score = 77.0 bits (188), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 12/204 (5%)
Query: 686 NLLGSGSFDNVYKATL----ANGVSVAVKVFNLQEDRA-LKSFDTECEVMRRIRHRNLIK 740
++G G F VY TL + AVK N D + F TE +M+ H N++
Sbjct: 28 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 87
Query: 741 IVSSC-SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
++ C + G +++ YM G L ++ + ++ T++ + + VA ++YL S
Sbjct: 88 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASK 144
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT---QTMTLATIGYMAPEYGSEG 856
+H DL N +LD+ + DFG+A+ + + + +T + +MA E
Sbjct: 145 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 204
Query: 857 IVSISGDVYSFGILMMETFTRRKP 880
+ DV+SFG+L+ E TR P
Sbjct: 205 KFTTKSDVWSFGVLLWELMTRGAP 228
>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase
pdb|3RHK|A Chain A, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
pdb|3RHK|B Chain B, Crystal Structure Of The Catalytic Domain Of C-Met Kinase
In Complex With Arq 197
Length = 318
Score = 77.0 bits (188), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 12/204 (5%)
Query: 686 NLLGSGSFDNVYKATL----ANGVSVAVKVFNLQEDRA-LKSFDTECEVMRRIRHRNLIK 740
++G G F VY TL + AVK N D + F TE +M+ H N++
Sbjct: 54 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 113
Query: 741 IVSSC-SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
++ C + G +++ YM G L ++ + ++ T++ + + VA ++YL S
Sbjct: 114 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASK 170
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT---QTMTLATIGYMAPEYGSEG 856
+H DL N +LD+ + DFG+A+ + + + +T + +MA E
Sbjct: 171 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 230
Query: 857 IVSISGDVYSFGILMMETFTRRKP 880
+ DV+SFG+L+ E TR P
Sbjct: 231 KFTTKSDVWSFGVLLWELMTRGAP 254
>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The
Dually-Phosphorylated, Activated State
Length = 308
Score = 77.0 bits (188), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 12/204 (5%)
Query: 686 NLLGSGSFDNVYKATL----ANGVSVAVKVFNLQEDRA-LKSFDTECEVMRRIRHRNLIK 740
++G G F VY TL + AVK N D + F TE +M+ H N++
Sbjct: 36 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 741 IVSSC-SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
++ C + G +++ YM G L ++ + ++ T++ + + VA ++YL S
Sbjct: 96 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASK 152
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT---QTMTLATIGYMAPEYGSEG 856
+H DL N +LD+ + DFG+A+ + + + +T + +MA E
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 212
Query: 857 IVSISGDVYSFGILMMETFTRRKP 880
+ DV+SFG+L+ E TR P
Sbjct: 213 KFTTKSDVWSFGVLLWELMTRGAP 236
>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
pdb|4GG7|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor
Length = 319
Score = 77.0 bits (188), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 12/204 (5%)
Query: 686 NLLGSGSFDNVYKATL----ANGVSVAVKVFNLQEDRA-LKSFDTECEVMRRIRHRNLIK 740
++G G F VY TL + AVK N D + F TE +M+ H N++
Sbjct: 55 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 114
Query: 741 IVSSC-SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
++ C + G +++ YM G L ++ + ++ T++ + + VA ++YL S
Sbjct: 115 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASK 171
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT---QTMTLATIGYMAPEYGSEG 856
+H DL N +LD+ + DFG+A+ + + + +T + +MA E
Sbjct: 172 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 231
Query: 857 IVSISGDVYSFGILMMETFTRRKP 880
+ DV+SFG+L+ E TR P
Sbjct: 232 KFTTKSDVWSFGVLLWELMTRGAP 255
>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880
(Gsk1
Length = 302
Score = 76.6 bits (187), Expect = 5e-14, Method: Compositional matrix adjust.
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 12/204 (5%)
Query: 686 NLLGSGSFDNVYKATL----ANGVSVAVKVFNLQEDRA-LKSFDTECEVMRRIRHRNLIK 740
++G G F VY TL + AVK N D + F TE +M+ H N++
Sbjct: 34 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 741 IVSSC-SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
++ C + G +++ YM G L ++ + ++ T++ + + VA ++YL S
Sbjct: 94 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASK 150
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT---QTMTLATIGYMAPEYGSEG 856
+H DL N +LD+ + DFG+A+ + + + +T + +MA E
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 210
Query: 857 IVSISGDVYSFGILMMETFTRRKP 880
+ DV+SFG+L+ E TR P
Sbjct: 211 KFTTKSDVWSFGVLLWELMTRGAP 234
>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolotriazine Based Inhibitor
Length = 373
Score = 76.6 bits (187), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 686 NLLGSGSFDNVYKATL----ANGVSVAVKVFNLQEDRA-LKSFDTECEVMRRIRHRNLIK 740
++G G F VY TL + AVK N D + F TE +M+ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 741 IVSSC-SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
++ C + G +++ YM G L ++ + ++ T++ + + VA +++L S
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASK 211
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIA-----KLLDGVDPVTQTMTLATIGYMAPEYGS 854
+H DL N +LD+ + DFG+A K D V +T + +MA E
Sbjct: 212 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKLPVKWMALESLQ 269
Query: 855 EGIVSISGDVYSFGILMMETFTRRKP 880
+ DV+SFG+L+ E TR P
Sbjct: 270 TQKFTTKSDVWSFGVLLWELMTRGAP 295
>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone
Inhibitor
pdb|2I0Y|A Chain A, Cfms Tyrosine Kinase (Fgf Kid) In Complex With An
Arylamide Inhibitor
pdb|3DPK|A Chain A, Cfms Tyrosine Kinase In Complex With A Pyridopyrimidinone
Inhibitor
pdb|3KRJ|A Chain A, Cfms Tyrosine Kinase In Complex With
4-Cyano-1h-Imidazole-2-Carboxylic Acid
(2-Cyclohex-1-Enyl-4-Piperidin-4-Yl-Phenyl)-Amide
pdb|3KRL|A Chain A, Cfms Tyrosine Kinase In Complex With
5-Cyano-Furan-2-Carboxylic Acid
[4-(4-Methyl-Piperazin-1-Yl)-2-Piperidin-1-Yl-Phenyl]-
Amide
Length = 335
Score = 76.6 bits (187), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 71/248 (28%), Positives = 121/248 (48%), Gaps = 36/248 (14%)
Query: 658 ENNSLNLATLSRISYHELQQ-ATNGFGESNLLGSGSFDNVYKATLANGV-------SVAV 709
E NS +++ Y+E + N LG+G+F V +AT A G+ VAV
Sbjct: 23 EGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEAT-AFGLGKEDAVLKVAV 81
Query: 710 KVF----NLQEDRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIMQYMPQGSLE 764
K+ + E AL S E ++M + +H N++ ++ +C++ G +I +Y G L
Sbjct: 82 KMLKSTAHADEKEALMS---ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 765 KWL---------YSHNYS------LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPN 809
+L YS+N S L+ R L VA + +L S IH D+
Sbjct: 139 NFLRRKRPPGLEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLA---SKNCIHRDVAAR 195
Query: 810 NVLLDDDMVAHLGDFGIAK-LLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFG 868
NVLL + VA +GDFG+A+ +++ + + + + +MAPE + + ++ DV+S+G
Sbjct: 196 NVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYG 255
Query: 869 ILMMETFT 876
IL+ E F+
Sbjct: 256 ILLWEIFS 263
>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine
Inhibitor 13
pdb|3U6H|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 26
pdb|3U6I|A Chain A, Crystal Structure Of C-Met In Complex With Pyrazolone
Inhibitor 58a
pdb|4DEG|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridazine Inhibitor 2
pdb|4DEH|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 3
pdb|4DEI|A Chain A, Crystal Structure Of C-Met In Complex With
Triazolopyridinone Inhibitor 24
Length = 309
Score = 76.6 bits (187), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 12/204 (5%)
Query: 686 NLLGSGSFDNVYKATL----ANGVSVAVKVFNLQEDRA-LKSFDTECEVMRRIRHRNLIK 740
++G G F VY TL + AVK N D + F TE +M+ H N++
Sbjct: 35 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 94
Query: 741 IVSSC-SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
++ C + G +++ YM G L ++ + ++ T++ + + VA ++YL S
Sbjct: 95 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASK 151
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT---QTMTLATIGYMAPEYGSEG 856
+H DL N +LD+ + DFG+A+ + + + +T + +MA E
Sbjct: 152 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 211
Query: 857 IVSISGDVYSFGILMMETFTRRKP 880
+ DV+SFG+L+ E TR P
Sbjct: 212 KFTTKSDVWSFGVLLWELMTRGAP 235
>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
pdb|3F66|B Chain B, Human C-Met Kinase In Complex With Quinoxaline Inhibitor
Length = 298
Score = 76.6 bits (187), Expect = 6e-14, Method: Compositional matrix adjust.
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 12/204 (5%)
Query: 686 NLLGSGSFDNVYKATL----ANGVSVAVKVFNLQEDRA-LKSFDTECEVMRRIRHRNLIK 740
++G G F VY TL + AVK N D + F TE +M+ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 741 IVSSC-SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
++ C + G +++ YM G L ++ + ++ T++ + + VA ++YL S
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASK 147
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT---QTMTLATIGYMAPEYGSEG 856
+H DL N +LD+ + DFG+A+ + + + +T + +MA E
Sbjct: 148 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 207
Query: 857 IVSISGDVYSFGILMMETFTRRKP 880
+ DV+SFG+L+ E TR P
Sbjct: 208 KFTTKSDVWSFGVLLWELMTRGAP 231
>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain
Of C-Met
pdb|2WKM|A Chain A, X-Ray Structure Of Pha-00665752 Bound To The Kinase Domain
Of C-Met
pdb|3ZXZ|A Chain A, X-Ray Structure Of Pf-04217903 Bound To The Kinase Domain
Of C-Met
pdb|3ZZE|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
N'-
((3z)-4-Chloro-7-Methyl-2-Oxo-1,2-Dihydro-3h-Indol-3-
Ylidene)-2-(4-Hydroxyphenyl)propanohydrazide
pdb|4AOI|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( 3-((1h-
Pyrrolo(2,3-B)pyridin-3-Yl)methyl)-(1,2,4)triazolo(
4,3-B)(1,2,4) Triazin-6-Yl)benzonitrile
pdb|4AP7|A Chain A, Crystal Structure Of C-Met Kinase Domain In Complex With
4-( (6-(4-
Fluorophenyl)-(1,2,4)triazolo(4,3-B)(1,2,
4)triazin-3-Yl)methyl) Phenol
Length = 306
Score = 76.6 bits (187), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 12/204 (5%)
Query: 686 NLLGSGSFDNVYKATL----ANGVSVAVKVFNLQEDRA-LKSFDTECEVMRRIRHRNLIK 740
++G G F VY TL + AVK N D + F TE +M+ H N++
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 92
Query: 741 IVSSC-SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
++ C + G +++ YM G L ++ + ++ T++ + + VA ++YL S
Sbjct: 93 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASK 149
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT---QTMTLATIGYMAPEYGSEG 856
+H DL N +LD+ + DFG+A+ + + + +T + +MA E
Sbjct: 150 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 209
Query: 857 IVSISGDVYSFGILMMETFTRRKP 880
+ DV+SFG+L+ E TR P
Sbjct: 210 KFTTKSDVWSFGVLLWELMTRGAP 233
>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With
6-Benzyloxyquinoline Inhibitor
Length = 319
Score = 76.6 bits (187), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 686 NLLGSGSFDNVYKATL----ANGVSVAVKVFNLQEDRA-LKSFDTECEVMRRIRHRNLIK 740
++G G F VY TL + AVK N D + F TE +M+ H N++
Sbjct: 41 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 100
Query: 741 IVSSC-SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
++ C + G +++ YM G L ++ + ++ T++ + + VA +++L S
Sbjct: 101 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASK 157
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIA-----KLLDGVDPVTQTMTLATIGYMAPEYGS 854
+H DL N +LD+ + DFG+A K D V +T + +MA E
Sbjct: 158 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKLPVKWMALESLQ 215
Query: 855 EGIVSISGDVYSFGILMMETFTRRKP 880
+ DV+SFG+L+ E TR P
Sbjct: 216 TQKFTTKSDVWSFGVLLWELMTRGAP 241
>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1
pdb|3DKF|A Chain A, Sgx Clone 5698a65kfg1h1
Length = 317
Score = 76.3 bits (186), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 686 NLLGSGSFDNVYKATL----ANGVSVAVKVFNLQEDRA-LKSFDTECEVMRRIRHRNLIK 740
++G G F VY TL + AVK N D + F TE +M+ H N++
Sbjct: 37 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 96
Query: 741 IVSSC-SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
++ C + G +++ YM G L ++ + ++ T++ + + VA +++L S
Sbjct: 97 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASK 153
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIA-----KLLDGVDPVTQTMTLATIGYMAPEYGS 854
+H DL N +LD+ + DFG+A K D V +T + +MA E
Sbjct: 154 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKLPVKWMALESLQ 211
Query: 855 EGIVSISGDVYSFGILMMETFTRRKP 880
+ DV+SFG+L+ E TR P
Sbjct: 212 TQKFTTKSDVWSFGVLLWELMTRGAP 237
>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor.
pdb|2RFN|B Chain B, X-ray Structure Of C-met With Inhibitor.
pdb|2RFS|A Chain A, X-Ray Structure Of Su11274 Bound To C-Met
pdb|3CCN|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3CD8|A Chain A, X-Ray Structure Of C-Met With Triazolopyridazine
Inhibitor.
pdb|3EFJ|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFJ|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 7
pdb|3EFK|A Chain A, Structure Of C-Met With Pyrimidone Inhibitor 50
pdb|3EFK|B Chain B, Structure Of C-Met With Pyrimidone Inhibitor 50
Length = 310
Score = 76.3 bits (186), Expect = 7e-14, Method: Compositional matrix adjust.
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 12/204 (5%)
Query: 686 NLLGSGSFDNVYKATL----ANGVSVAVKVFNLQEDRA-LKSFDTECEVMRRIRHRNLIK 740
++G G F VY TL + AVK N D + F TE +M+ H N++
Sbjct: 36 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 741 IVSSC-SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
++ C + G +++ YM G L ++ + ++ T++ + + VA ++YL S
Sbjct: 96 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYL---ASK 152
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT---QTMTLATIGYMAPEYGSEG 856
+H DL N +LD+ + DFG+A+ + + + +T + +MA E
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQ 212
Query: 857 IVSISGDVYSFGILMMETFTRRKP 880
+ DV+SFG+L+ E TR P
Sbjct: 213 KFTTKSDVWSFGVLLWELMTRGAP 236
>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972
pdb|3QTI|B Chain B, C-Met Kinase In Complex With Nvp-Bvu972
Length = 314
Score = 76.3 bits (186), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 686 NLLGSGSFDNVYKATL----ANGVSVAVKVFNLQEDRA-LKSFDTECEVMRRIRHRNLIK 740
++G G F VY TL + AVK N D + F TE +M+ H N++
Sbjct: 36 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 741 IVSSC-SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
++ C + G +++ YM G L ++ + ++ T++ + + VA +++L S
Sbjct: 96 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASK 152
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIA-----KLLDGVDPVTQTMTLATIGYMAPEYGS 854
+H DL N +LD+ + DFG+A K D V +T + +MA E
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKLPVKWMALESLQ 210
Query: 855 EGIVSISGDVYSFGILMMETFTRRKP 880
+ DV+SFG+L+ E TR P
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMTRGAP 236
>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region,
Y596f:y602f:y742a Triple Mutant
Length = 373
Score = 76.3 bits (186), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 52/208 (25%), Positives = 103/208 (49%), Gaps = 13/208 (6%)
Query: 686 NLLGSGSFDNVYKATLA----NGVSVAVKVFNL-QEDRALKSFDTECEVMRRIRHRNLIK 740
++G+G F V L +SVA+K + ++ + F E +M + H N+I+
Sbjct: 51 KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFDHPNIIR 110
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ + ++ + M GSL+ +L H+ T+ Q + ++ +AS ++YL
Sbjct: 111 LEGVVTKSKPVMIVTEXMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLS---DMG 167
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA---TIGYMAPEYGSEGI 857
+H DL N+L++ ++V + DFG++++L+ DP T I + +PE +
Sbjct: 168 AVHRDLAARNILINSNLVCKVSDFGLSRVLED-DPEAAYTTRGGKIPIRWTSPEAIAYRK 226
Query: 858 VSISGDVYSFGILMMETFTR-RKPTNEM 884
+ + DV+S+GI++ E + +P EM
Sbjct: 227 FTSASDVWSYGIVLWEVMSYGERPYWEM 254
>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CTJ|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Aminopyridine Based Inhibitor
pdb|3CE3|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
A Pyrrolopyridinepyridone Based Inhibitor
pdb|3F82|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
N-
(4-(2-Amino-3-Chloropyridin-4-Yloxy)-3-Fluorophenyl)-4-
Ethoxy-1-(4-Fluorophenyl)-2-Oxo-1,2-Dihydropyridine-3-
Carboxamide
pdb|3L8V|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepat Growth Factor Receptor C-Met In Complex With A
Biarylamine Inhibitor
Length = 314
Score = 76.3 bits (186), Expect = 8e-14, Method: Compositional matrix adjust.
Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 686 NLLGSGSFDNVYKATL----ANGVSVAVKVFNLQEDRA-LKSFDTECEVMRRIRHRNLIK 740
++G G F VY TL + AVK N D + F TE +M+ H N++
Sbjct: 36 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 95
Query: 741 IVSSC-SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
++ C + G +++ YM G L ++ + ++ T++ + + VA +++L S
Sbjct: 96 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASK 152
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIA-----KLLDGVDPVTQTMTLATIGYMAPEYGS 854
+H DL N +LD+ + DFG+A K D V +T + +MA E
Sbjct: 153 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKLPVKWMALESLQ 210
Query: 855 EGIVSISGDVYSFGILMMETFTRRKP 880
+ DV+SFG+L+ E TR P
Sbjct: 211 TQKFTTKSDVWSFGVLLWELMTRGAP 236
>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain
pdb|4HZR|B Chain B, Crystal Structure Of Ack1 Kinase Domain
Length = 277
Score = 76.3 bits (186), Expect = 8e-14, Method: Composition-based stats.
Identities = 79/287 (27%), Positives = 116/287 (40%), Gaps = 40/287 (13%)
Query: 676 QQATNGFGESNL-----LGSGSFDNV----YKATLANGVSVAVKVFN---LQEDRALKSF 723
Q T GE +L LG GSF V + A VSVAVK L + A+ F
Sbjct: 3 QSLTCLIGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDF 62
Query: 724 DTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIM 783
E M + HRNLI++ P K ++ + P GSL L H +
Sbjct: 63 IREVNAMHSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYA 121
Query: 784 IDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP--VTQTMT 841
+ VA + YL S IH DL N+LL + +GDFG+ + L D V Q
Sbjct: 122 VQVAEGMGYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHR 178
Query: 842 LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPG 901
+ APE S + D + FG+ + E FT + + W+ L G
Sbjct: 179 KVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQ------------EPWIG--LNG 224
Query: 902 AVTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEER 948
+ +L + D+E + + C I ++ ++C A PE+R
Sbjct: 225 -------SQILHKIDKE-GERLPRPEDCPQDIYNVMVQCWAHKPEDR 263
>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met In Complex With
The Microbial Alkaloid K-252a
pdb|1R1W|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Hepatocyte Growth Factor Receptor C-Met
Length = 312
Score = 76.3 bits (186), Expect = 9e-14, Method: Compositional matrix adjust.
Identities = 56/206 (27%), Positives = 94/206 (45%), Gaps = 16/206 (7%)
Query: 686 NLLGSGSFDNVYKATL----ANGVSVAVKVFNLQEDRA-LKSFDTECEVMRRIRHRNLIK 740
++G G F VY TL + AVK N D + F TE +M+ H N++
Sbjct: 34 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 93
Query: 741 IVSSC-SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
++ C + G +++ YM G L ++ + ++ T++ + + VA +++L S
Sbjct: 94 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFL---ASK 150
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIA-----KLLDGVDPVTQTMTLATIGYMAPEYGS 854
+H DL N +LD+ + DFG+A K D V +T + +MA E
Sbjct: 151 KFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH--NKTGAKLPVKWMALESLQ 208
Query: 855 EGIVSISGDVYSFGILMMETFTRRKP 880
+ DV+SFG+L+ E TR P
Sbjct: 209 TQKFTTKSDVWSFGVLLWELMTRGAP 234
>pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|2P0C|B Chain B, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein
Kina
pdb|3BRB|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BRB|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Tyrosine- Protein Kinase Mer In Complex
With Adp
pdb|3BPR|A Chain A, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|B Chain B, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|C Chain C, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3BPR|D Chain D, Crystal Structure Of Catalytic Domain Of The
Proto-Oncogene Protein Kinase Mer In Complex With
Inhibitor C52
pdb|3TCP|A Chain A, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
pdb|3TCP|B Chain B, Crystal Structure Of The Catalytic Domain Of The
Proto-Oncogene Tyrosine-Protein Kinase Mer In Complex
With Inhibitor Unc569
Length = 313
Score = 75.9 bits (185), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 104/209 (49%), Gaps = 20/209 (9%)
Query: 686 NLLGSGSFDNVYKATLA--NGVSVAVKVFNLQED----RALKSFDTECEVMRRIRHRNLI 739
+LG G F +V + L +G S+ V V ++ D R ++ F +E M+ H N+I
Sbjct: 40 KILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNVI 99
Query: 740 KIVSSC---SNPGFKA--LIMQYMPQGSLEKWL-YSHNYS----LTIRQRLDIMIDVASA 789
+++ C S+ G +I+ +M G L +L YS + + ++ L M+D+A
Sbjct: 100 RLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALG 159
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ-TMTLATIGYM 848
+EYL + +H DL N +L DDM + DFG++K + D Q + + ++
Sbjct: 160 MEYLS---NRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWI 216
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFTR 877
A E ++ + + DV++FG+ M E TR
Sbjct: 217 AIESLADRVYTSKSDVWAFGVTMWEIATR 245
>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A
Pyrimidinopyridone Inhibitor
Length = 333
Score = 75.9 bits (185), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 68/246 (27%), Positives = 118/246 (47%), Gaps = 34/246 (13%)
Query: 658 ENNSLNLATLSRISYHELQQ-ATNGFGESNLLGSGSFDNVYKATLANGV-------SVAV 709
E NS +++ Y+E + N LG+G+F V +AT A G+ VAV
Sbjct: 23 EGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEAT-AFGLGKEDAVLKVAV 81
Query: 710 KVF----NLQEDRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIMQYMPQGSLE 764
K+ + E AL S E ++M + +H N++ ++ +C++ G +I +Y G L
Sbjct: 82 KMLKSTAHADEKEALMS---ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 765 KWLYSH-------------NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNV 811
+L N +L+ R L VA + +L S IH D+ NV
Sbjct: 139 NFLRRKSRVLETDPAFAIANSTLSTRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNV 195
Query: 812 LLDDDMVAHLGDFGIAK-LLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGIL 870
LL + VA +GDFG+A+ +++ + + + + +MAPE + + ++ DV+S+GIL
Sbjct: 196 LLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGIL 255
Query: 871 MMETFT 876
+ E F+
Sbjct: 256 LWEIFS 261
>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase
Domain
Length = 317
Score = 75.5 bits (184), Expect = 1e-13, Method: Compositional matrix adjust.
Identities = 67/242 (27%), Positives = 117/242 (48%), Gaps = 30/242 (12%)
Query: 658 ENNSLNLATLSRISYHELQQ-ATNGFGESNLLGSGSFDNVYKATLANGV-------SVAV 709
E NS +++ Y+E + N LG+G+F V +AT A G+ VAV
Sbjct: 15 EGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEAT-AFGLGKEDAVLKVAV 73
Query: 710 KVF----NLQEDRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIMQYMPQGSLE 764
K+ + E AL S E ++M + +H N++ ++ +C++ G +I +Y G L
Sbjct: 74 KMLKSTAHADEKEALMS---ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 130
Query: 765 KWLYSHNYS---------LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD 815
+L + L +R L VA + +L S IH D+ NVLL +
Sbjct: 131 NFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTN 187
Query: 816 DMVAHLGDFGIAK-LLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMET 874
VA +GDFG+A+ +++ + + + + +MAPE + + ++ DV+S+GIL+ E
Sbjct: 188 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 247
Query: 875 FT 876
F+
Sbjct: 248 FS 249
>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor
pdb|4EWH|A Chain A, Co-Crystal Structure Of Ack1 With Inhibitor
Length = 275
Score = 75.5 bits (184), Expect = 1e-13, Method: Composition-based stats.
Identities = 77/280 (27%), Positives = 114/280 (40%), Gaps = 40/280 (14%)
Query: 683 GESNL-----LGSGSFDNV----YKATLANGVSVAVKVFN---LQEDRALKSFDTECEVM 730
GE +L LG GSF V + A VSVAVK L + A+ F E M
Sbjct: 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 731 RRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASAL 790
+ HRNLI++ P K ++ + P GSL L H + + VA +
Sbjct: 66 HSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD--PVTQTMTLATIGYM 848
YL S IH DL N+LL + +GDFG+ + L D V Q +
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVMQEHRKVPFAWC 181
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVD 908
APE S + D + FG+ + E FT + + W+ L G
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQ------------EPWIG--LNG------- 220
Query: 909 ANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEER 948
+ +L + D+E + + C I ++ ++C A PE+R
Sbjct: 221 SQILHKIDKE-GERLPRPEDCPQDIYNVMVQCWAHKPEDR 259
>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor
Cis-3-[8-amino-1-(4-
Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol
Length = 273
Score = 75.5 bits (184), Expect = 1e-13, Method: Composition-based stats.
Identities = 77/280 (27%), Positives = 114/280 (40%), Gaps = 40/280 (14%)
Query: 683 GESNL-----LGSGSFDNV----YKATLANGVSVAVKVFN---LQEDRALKSFDTECEVM 730
GE +L LG GSF V + A VSVAVK L + A+ F E M
Sbjct: 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 731 RRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASAL 790
+ HRNLI++ P K ++ + P GSL L H + + VA +
Sbjct: 66 HSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP--VTQTMTLATIGYM 848
YL S IH DL N+LL + +GDFG+ + L D V Q +
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVD 908
APE S + D + FG+ + E FT + + W+ L G
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQ------------EPWIG--LNG------- 220
Query: 909 ANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEER 948
+ +L + D+E + + C I ++ ++C A PE+R
Sbjct: 221 SQILHKIDKE-GERLPRPEDCPQDIYNVMVQCWAHKPEDR 259
>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95
pdb|3EQP|A Chain A, Crystal Structure Of Ack1 With Compound T95
pdb|3EQR|A Chain A, Crystal Structure Of Ack1 With Compound T74
pdb|3EQR|B Chain B, Crystal Structure Of Ack1 With Compound T74
Length = 276
Score = 75.5 bits (184), Expect = 1e-13, Method: Composition-based stats.
Identities = 77/280 (27%), Positives = 114/280 (40%), Gaps = 40/280 (14%)
Query: 683 GESNL-----LGSGSFDNV----YKATLANGVSVAVKVFN---LQEDRALKSFDTECEVM 730
GE +L LG GSF V + A VSVAVK L + A+ F E M
Sbjct: 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 731 RRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASAL 790
+ HRNLI++ P K ++ + P GSL L H + + VA +
Sbjct: 66 HSLDHRNLIRLYGVVLTPPMK-MVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP--VTQTMTLATIGYM 848
YL S IH DL N+LL + +GDFG+ + L D V Q +
Sbjct: 125 GYLE---SKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVD 908
APE S + D + FG+ + E FT + + W+ L G
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQ------------EPWIG--LNG------- 220
Query: 909 ANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEER 948
+ +L + D+E + + C I ++ ++C A PE+R
Sbjct: 221 SQILHKIDKE-GERLPRPEDCPQDIYNVMVQCWAHKPEDR 259
>pdb|1FVR|A Chain A, Tie2 Kinase Domain
pdb|1FVR|B Chain B, Tie2 Kinase Domain
Length = 327
Score = 75.5 bits (184), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 685 SNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRAL---KSFDTECEVMRRIRHR-NLI 739
+++G G+F V KA + +G+ + + ++E + + F E EV+ ++ H N+I
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLY---------------SHNYSLTIRQRLDIMI 784
++ +C + G+ L ++Y P G+L +L S +L+ +Q L
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 785 DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLAT 844
DVA ++YL IH DL N+L+ ++ VA + DFG+++ + V +TM
Sbjct: 150 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--VKKTMGRLP 204
Query: 845 IGYMAPEYGSEGIVSISGDVYSFGILMME 873
+ +MA E + + + + DV+S+G+L+ E
Sbjct: 205 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 233
>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2OSC|A Chain A, Synthesis, Structural Analysis, And Sar Studies Of
Triazine Derivatives As Potent, Selective Tie-2
Inhibitors
pdb|2P4I|A Chain A, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|2P4I|B Chain B, Evolution Of A Highly Selective And Potent
2-(Pyridin-2-Yl)- 1,3,5-Triazine Tie-2 Kinase Inhibitor
pdb|3L8P|A Chain A, Crystal Structure Of Cytoplasmic Kinase Domain Of Tie2
Complexed With Inhibitor Cep11207
Length = 317
Score = 75.1 bits (183), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 55/209 (26%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 685 SNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRAL---KSFDTECEVMRRIRHR-NLI 739
+++G G+F V KA + +G+ + + ++E + + F E EV+ ++ H N+I
Sbjct: 20 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 79
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLY---------------SHNYSLTIRQRLDIMI 784
++ +C + G+ L ++Y P G+L +L S +L+ +Q L
Sbjct: 80 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 139
Query: 785 DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLAT 844
DVA ++YL IH DL N+L+ ++ VA + DFG+++ + V +TM
Sbjct: 140 DVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY--VKKTMGRLP 194
Query: 845 IGYMAPEYGSEGIVSISGDVYSFGILMME 873
+ +MA E + + + + DV+S+G+L+ E
Sbjct: 195 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 223
>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An
Arylamide Inhibitor
Length = 333
Score = 75.1 bits (183), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 67/243 (27%), Positives = 115/243 (47%), Gaps = 28/243 (11%)
Query: 658 ENNSLNLATLSRISYHELQQ-ATNGFGESNLLGSGSFDNVYKATLANGV-------SVAV 709
E NS +++ Y+E + N LG+G+F V +AT A G+ VAV
Sbjct: 23 EGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEAT-AFGLGKEDAVLKVAV 81
Query: 710 KVF----NLQEDRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIMQYMPQGSLE 764
K+ + E AL S E ++M + +H N++ ++ +C++ G +I +Y G L
Sbjct: 82 KMLKSTAHADEKEALMS---ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 765 KWLYSHNYSLTIRQRLDIMIDVASALEYLHHG----------YSTPIIHCDLKPNNVLLD 814
+L + L I AS + LH S IH D+ NVLL
Sbjct: 139 NFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT 198
Query: 815 DDMVAHLGDFGIAK-LLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMME 873
+ VA +GDFG+A+ +++ + + + + +MAPE + + ++ DV+S+GIL+ E
Sbjct: 199 NGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWE 258
Query: 874 TFT 876
F+
Sbjct: 259 IFS 261
>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex
pdb|1AD5|B Chain B, Src Family Kinase Hck-Amp-Pnp Complex
pdb|2HCK|A Chain A, Src Family Kinase Hck-Quercetin Complex
pdb|2HCK|B Chain B, Src Family Kinase Hck-Quercetin Complex
Length = 438
Score = 75.1 bits (183), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 58/190 (30%), Positives = 95/190 (50%), Gaps = 16/190 (8%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSN 747
LG+G F V+ AT VAVK ++++F E VM+ ++H L+K+ + +
Sbjct: 190 LGAGQFGEVWMATYNKHTKVAVKTMK-PGSMSVEAFLAEANVMKTLQHDKLVKLHAVVTK 248
Query: 748 PGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASAL-EYLHHGYSTPIIHCDL 806
+I ++M +GSL +L S S +Q L +ID ++ + E + IH DL
Sbjct: 249 EPI-YIITEFMAKGSLLDFLKSDEGS---KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDL 304
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
+ N+L+ +V + DFG+A++ I + APE + G +I DV+S
Sbjct: 305 RAANILVSASLVCKIADFGLARV----------GAKFPIKWTAPEAINFGSFTIKSDVWS 354
Query: 867 FGILMMETFT 876
FGIL+ME T
Sbjct: 355 FGILLMEIVT 364
>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain
Of Csf-1r
Length = 329
Score = 74.7 bits (182), Expect = 2e-13, Method: Compositional matrix adjust.
Identities = 67/242 (27%), Positives = 117/242 (48%), Gaps = 30/242 (12%)
Query: 658 ENNSLNLATLSRISYHELQQ-ATNGFGESNLLGSGSFDNVYKATLANGV-------SVAV 709
E NS +++ Y+E + N LG+G+F V +AT A G+ VAV
Sbjct: 23 EGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEAT-AFGLGKEDAVLKVAV 81
Query: 710 KVF----NLQEDRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIMQYMPQGSLE 764
K+ + E AL S E ++M + +H N++ ++ +C++ G +I +Y G L
Sbjct: 82 KMLKSTAHADEKEALMS---ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 138
Query: 765 KWLYSHNYS---------LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD 815
+L + L +R L VA + +L S IH D+ NVLL +
Sbjct: 139 NFLRRKAEADLDKEDGRPLELRDLLHFSSQVAQGMAFLA---SKNCIHRDVAARNVLLTN 195
Query: 816 DMVAHLGDFGIAK-LLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMET 874
VA +GDFG+A+ +++ + + + + +MAPE + + ++ DV+S+GIL+ E
Sbjct: 196 GHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 255
Query: 875 FT 876
F+
Sbjct: 256 FS 257
>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain
Length = 306
Score = 74.7 bits (182), Expect = 2e-13, Method: Composition-based stats.
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 24/213 (11%)
Query: 688 LGSGSFDNVYKATLAN------GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKI 741
LG G+F V+ A N + VAVK + A + F E E++ ++H+++++
Sbjct: 26 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 85
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS--------------LTIRQRLDIMIDVA 787
C+ ++ +YM G L ++L SH L + Q L + VA
Sbjct: 86 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 145
Query: 788 SALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIG 846
+ + YL +H DL N L+ +V +GDFG+++ + D T+ I
Sbjct: 146 AGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 202
Query: 847 YMAPEYGSEGIVSISGDVYSFGILMMETFTRRK 879
+M PE + DV+SFG+++ E FT K
Sbjct: 203 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 235
>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka
pdb|4F0I|B Chain B, Crystal Structure Of Apo Trka
Length = 300
Score = 74.7 bits (182), Expect = 2e-13, Method: Composition-based stats.
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 24/213 (11%)
Query: 688 LGSGSFDNVYKATLAN------GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKI 741
LG G+F V+ A N + VAVK + A + F E E++ ++H+++++
Sbjct: 20 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQHQHIVRF 79
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS--------------LTIRQRLDIMIDVA 787
C+ ++ +YM G L ++L SH L + Q L + VA
Sbjct: 80 FGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVA 139
Query: 788 SALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV-TQTMTLATIG 846
+ + YL +H DL N L+ +V +GDFG+++ + D T+ I
Sbjct: 140 AGMVYLA---GLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIR 196
Query: 847 YMAPEYGSEGIVSISGDVYSFGILMMETFTRRK 879
+M PE + DV+SFG+++ E FT K
Sbjct: 197 WMPPESILYRKFTTESDVWSFGVVLWEIFTYGK 229
>pdb|1RJB|A Chain A, Crystal Structure Of Flt3
Length = 344
Score = 74.3 bits (181), Expect = 3e-13, Method: Compositional matrix adjust.
Identities = 64/223 (28%), Positives = 103/223 (46%), Gaps = 36/223 (16%)
Query: 686 NLLGSGSFDNVYKATLANGVS-------VAVKVFNLQEDRALK-SFDTECEVMRRI-RHR 736
+LGSG+F V AT A G+S VAVK+ + D + + + +E ++M ++ H
Sbjct: 51 KVLGSGAFGKVMNAT-AYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 737 NLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS----------------------L 774
N++ ++ +C+ G LI +Y G L +L S L
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 775 TIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDGV 833
T L VA +E+L +H DL NVL+ V + DFG+A+ ++
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDS 226
Query: 834 DPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ V + + +MAPE EGI +I DV+S+GIL+ E F+
Sbjct: 227 NYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFS 269
>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To
Appcp From D. Discoideum
pdb|4F0G|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum
pdb|4F1T|A Chain A, Crystal Structure Of The Roco4 Kinase Domain From D.
Discoideum Bound To The Rock Inhibitor H1152
Length = 287
Score = 73.9 bits (180), Expect = 4e-13, Method: Compositional matrix adjust.
Identities = 61/236 (25%), Positives = 106/236 (44%), Gaps = 22/236 (9%)
Query: 678 ATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKVFNLQEDRA-------LKSFDTECEV 729
A N +G G F V+K L SV A+K L + + F E +
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 730 MRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASA 789
M + H N++K+ NP ++M+++P G L L + + +L +M+D+A
Sbjct: 77 MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 790 LEYLHHGYSTPIIHCDLKPNNVL---LDDD--MVAHLGDFGIAKLLDGVDPVTQTMTLAT 844
+EY+ + + PI+H DL+ N+ LD++ + A + DFG+++ V V+ L
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ--QSVHSVSG--LLGN 189
Query: 845 IGYMAPEY--GSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAES 898
+MAPE E + D YSF +++ T P +E G++ + E
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE 245
>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
pdb|3S95|B Chain B, Crystal Structure Of The Human Limk1 Kinase Domain In
Complex With Staurosporine
Length = 310
Score = 73.6 bits (179), Expect = 5e-13, Method: Composition-based stats.
Identities = 59/207 (28%), Positives = 94/207 (45%), Gaps = 21/207 (10%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
+LG G F K T G + +K ++ ++F E +VMR + H N++K +
Sbjct: 17 VLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLEHPNVLKFIGVL 76
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
I +Y+ G+L + S + QR+ D+AS + YLH S IIH D
Sbjct: 77 YKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLH---SMNIIHRD 133
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG---------------YMAP 850
L +N L+ ++ + DFG+A+L+ VD TQ L ++ +MAP
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLM--VDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTR 877
E + DV+SFGI++ E R
Sbjct: 192 EMINGRSYDEKVDVFSFGIVLCEIIGR 218
>pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The
Murine Receptor Tyrosine Kinase Tyro3 (Sky)
Length = 323
Score = 73.6 bits (179), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 60/220 (27%), Positives = 103/220 (46%), Gaps = 25/220 (11%)
Query: 676 QQATNGFGESNLLGSGSFDNVYKATLA--NGVSVAVKVFNLQED----RALKSFDTECEV 729
QQ T G +LG G F +V +A L +G V V V L+ D ++ F E
Sbjct: 23 QQFTLG----RMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAAC 78
Query: 730 MRRIRHRNLIKIVSSCSNPGFKA------LIMQYMPQGSLEKWLYSHN-----YSLTIRQ 778
M+ H ++ K+V K +I+ +M G L +L + ++L ++
Sbjct: 79 MKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQT 138
Query: 779 RLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ 838
+ M+D+A +EYL S IH DL N +L +DM + DFG+++ + D Q
Sbjct: 139 LVRFMVDIACGMEYLS---SRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQ 195
Query: 839 -TMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTR 877
+ + ++A E ++ + ++ DV++FG+ M E TR
Sbjct: 196 GCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTR 235
>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWV|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWW|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWX|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWY|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VWZ|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX0|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2VX1|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2X9F|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|2XVD|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
pdb|4BB4|A Chain A, Ephb4 Kinase Domain Inhibitor Complex
Length = 302
Score = 73.6 bits (179), Expect = 5e-13, Method: Compositional matrix adjust.
Identities = 53/202 (26%), Positives = 103/202 (50%), Gaps = 14/202 (6%)
Query: 685 SNLLGSGSFDNVYKATL-ANGVS---VAVKVFNL-QEDRALKSFDTECEVMRRIRHRNLI 739
++G+G F V + L A G VA+K +R + F +E +M + H N+I
Sbjct: 21 EEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIMGQFEHPNII 80
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
++ +N ++ ++M G+L+ +L ++ T+ Q + ++ +AS + YL
Sbjct: 81 RLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFTVIQLVGMLRGIASGMRYLAE---M 137
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD--GVDPVTQTMTLA---TIGYMAPEYGS 854
+H DL N+L++ ++V + DFG+++ L+ DP T+T +L I + APE +
Sbjct: 138 SYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDP-TETSSLGGKIPIRWTAPEAIA 196
Query: 855 EGIVSISGDVYSFGILMMETFT 876
+ + D +S+GI+M E +
Sbjct: 197 FRKFTSASDAWSYGIVMWEVMS 218
>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A
Thiazolopyrimidine Inhibitor
Length = 324
Score = 73.2 bits (178), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 54/209 (25%), Positives = 106/209 (50%), Gaps = 25/209 (11%)
Query: 685 SNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRAL---KSFDTECEVMRRIRHR-NLI 739
+++G G+F V KA + +G+ + + ++E + + F E EV+ ++ H N+I
Sbjct: 27 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 86
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLY---------------SHNYSLTIRQRLDIMI 784
++ +C + G+ L ++Y P G+L +L S +L+ +Q L
Sbjct: 87 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 146
Query: 785 DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLAT 844
DVA ++YL IH +L N+L+ ++ VA + DFG+++ + V +TM
Sbjct: 147 DVARGMDYLSQ---KQFIHRNLAARNILVGENYVAKIADFGLSRGQEVY--VKKTMGRLP 201
Query: 845 IGYMAPEYGSEGIVSISGDVYSFGILMME 873
+ +MA E + + + + DV+S+G+L+ E
Sbjct: 202 VRWMAIESLNYSVYTTNSDVWSYGVLLWE 230
>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
pdb|2JC6|C Chain C, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase 1d
Length = 334
Score = 73.2 bits (178), Expect = 6e-13, Method: Compositional matrix adjust.
Identities = 67/203 (33%), Positives = 99/203 (48%), Gaps = 29/203 (14%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALK----SFDTECEVMRRIRHR 736
F LG+G+F V A A G AVK +ALK S + E V+R+I+H
Sbjct: 24 FEFKETLGTGAFSEVVLAEEKATGKLFAVKCI---PKKALKGKESSIENEIAVLRKIKHE 80
Query: 737 NLIKIVSSCSNPGFKALIMQYMPQGSL-----EKWLYSH-NYSLTIRQRLDIMIDVASAL 790
N++ + +P L+MQ + G L EK Y+ + S IRQ LD A+
Sbjct: 81 NIVALEDIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLD-------AV 133
Query: 791 EYLHHGYSTPIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
YLH I+H DLKP N+L D++ + DFG++K ++G V T T GY
Sbjct: 134 YYLHR---MGIVHRDLKPENLLYYSQDEESKIMISDFGLSK-MEGKGDVMST-ACGTPGY 188
Query: 848 MAPEYGSEGIVSISGDVYSFGIL 870
+APE ++ S + D +S G++
Sbjct: 189 VAPEVLAQKPYSKAVDCWSIGVI 211
>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7)
pdb|3DKO|A Chain A, Complex Between The Kinase Domain Of Human Ephrin Type-A
Receptor 7 (Epha7) And Inhibitor Alw-Ii-49-7
Length = 318
Score = 73.2 bits (178), Expect = 7e-13, Method: Composition-based stats.
Identities = 49/199 (24%), Positives = 101/199 (50%), Gaps = 14/199 (7%)
Query: 687 LLGSGSFDNVYKATLA----NGVSVAVKVFNL-QEDRALKSFDTECEVMRRIRHRNLIKI 741
++G+G F V L V+VA+K + ++ + F E +M + H N++ +
Sbjct: 50 VIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFDHPNVVHL 109
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYL-HHGYSTP 800
+ +++++M G+L+ +L H+ T+ Q + ++ +A+ + YL GY
Sbjct: 110 EGVVTRGKPVMIVIEFMENGALDAFLRKHDGQFTVIQLVGMLRGIAAGMRYLADMGY--- 166
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP---VTQTMTLATIGYMAPEYGSEGI 857
+H DL N+L++ ++V + DFG++++++ DP T T + + APE
Sbjct: 167 -VHRDLAARNILVNSNLVCKVSDFGLSRVIED-DPEAVYTTTGGKIPVRWTAPEAIQYRK 224
Query: 858 VSISGDVYSFGILMMETFT 876
+ + DV+S+GI+M E +
Sbjct: 225 FTSASDVWSYGIVMWEVMS 243
>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain
From D. Discoideum Bound To Appcp
Length = 287
Score = 72.8 bits (177), Expect = 8e-13, Method: Compositional matrix adjust.
Identities = 61/236 (25%), Positives = 105/236 (44%), Gaps = 22/236 (9%)
Query: 678 ATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKVFNLQEDRA-------LKSFDTECEV 729
A N +G G F V+K L SV A+K L + + F E +
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 730 MRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASA 789
M + H N++K+ NP ++M+++P G L L + + +L +M+D+A
Sbjct: 77 MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 790 LEYLHHGYSTPIIHCDLKPNNVL---LDDD--MVAHLGDFGIAKLLDGVDPVTQTMTLAT 844
+EY+ + + PI+H DL+ N+ LD++ + A + DFG ++ V V+ L
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQ--QSVHSVSG--LLGN 189
Query: 845 IGYMAPEY--GSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAES 898
+MAPE E + D YSF +++ T P +E G++ + E
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE 245
>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole
Inhibitor
Length = 291
Score = 72.8 bits (177), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 57/226 (25%), Positives = 112/226 (49%), Gaps = 23/226 (10%)
Query: 661 SLNLATLSRISYHELQQATNGFGESNLLGSGSFDNVYKATL-ANGVS---VAVKVFNL-Q 715
S+ A +SY ++++ ++G+G F V + L A G VA+K
Sbjct: 4 SMEFAKEIDVSYVKIEE---------VIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGY 54
Query: 716 EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLT 775
+R + F +E +M + H N+I++ +N ++ ++M G+L+ +L ++ T
Sbjct: 55 TERQRREFLSEASIMGQFEHPNIIRLEGVVTNSMPVMILTEFMENGALDSFLRLNDGQFT 114
Query: 776 IRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD--GV 833
+ Q + ++ +AS + YL +H DL N+L++ ++V + DFG+++ L+
Sbjct: 115 VIQLVGMLRGIASGMRYLAE---MSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSS 171
Query: 834 DPVTQTMTLA---TIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
DP T T +L I + APE + + + D +S+GI+M E +
Sbjct: 172 DP-TYTSSLGGKIPIRWTAPEAIAFRKFTSASDAWSYGIVMWEVMS 216
>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7
pdb|1UA2|B Chain B, Crystal Structure Of Human Cdk7
pdb|1UA2|C Chain C, Crystal Structure Of Human Cdk7
pdb|1UA2|D Chain D, Crystal Structure Of Human Cdk7
Length = 346
Score = 72.8 bits (177), Expect = 9e-13, Method: Compositional matrix adjust.
Identities = 59/212 (27%), Positives = 103/212 (48%), Gaps = 14/212 (6%)
Query: 674 ELQQATNGFGESNLLGSGSFDNVYKATLANGVS-VAVKVFNL-----QEDRALKSFDTEC 727
+++ + + + LG G F VYKA N VA+K L +D ++ E
Sbjct: 4 DVKSRAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREI 63
Query: 728 EVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVA 787
++++ + H N+I ++ + + +L+ +M + LE + ++ LT M+
Sbjct: 64 KLLQELSHPNIIGLLDAFGHKSNISLVFDFM-ETDLEVIIKDNSLVLTPSHIKAYMLMTL 122
Query: 788 SALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
LEYLH + I+H DLKPNN+LLD++ V L DFG+AK G + T Y
Sbjct: 123 QGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSF-GSPNRAYXHQVVTRWY 178
Query: 848 MAPE--YGSEGIVSISGDVYSFGILMMETFTR 877
APE +G+ + + D+++ G ++ E R
Sbjct: 179 RAPELLFGAR-MYGVGVDMWAVGCILAELLLR 209
>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5)
Length = 295
Score = 72.8 bits (177), Expect = 9e-13, Method: Composition-based stats.
Identities = 57/233 (24%), Positives = 112/233 (48%), Gaps = 24/233 (10%)
Query: 671 SYHELQQATNGFGES---------NLLGSGSFDNVYKATLA----NGVSVAVKVFNL-QE 716
+Y + QA + F + ++G+G F V L + VA+K +
Sbjct: 4 TYEDPNQAVHEFAKEIEASCITIERVIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYT 63
Query: 717 DRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTI 776
++ + F E +M + H N+I + + ++ +YM GSL+ +L ++ T+
Sbjct: 64 EKQRRDFLGEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDTFLKKNDGQFTV 123
Query: 777 RQRLDIMIDVASALEYLHH-GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP 835
Q + ++ +++ ++YL GY +H DL N+L++ ++V + DFG++++L+ DP
Sbjct: 124 IQLVGMLRGISAGMKYLSDMGY----VHRDLAARNILINSNLVCKVSDFGLSRVLED-DP 178
Query: 836 VTQTMTLA---TIGYMAPEYGSEGIVSISGDVYSFGILMMETFTR-RKPTNEM 884
T I + APE + + + DV+S+GI+M E + +P EM
Sbjct: 179 EAAYTTRGGKIPIRWTAPEAIAFRKFTSASDVWSYGIVMWEVVSYGERPYWEM 231
>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Vuf 12058
Length = 285
Score = 72.4 bits (176), Expect = 1e-12, Method: Composition-based stats.
Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 687 LLGSGSFDNVYKATLA----NGVSVAVKVFNL-QEDRALKSFDTECEVMRRIRHRNLIKI 741
++G G F V L + VA+K D+ + F +E +M + H N+I +
Sbjct: 15 VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 74
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
+ +I +YM GSL+ +L ++ T+ Q + ++ + S ++YL
Sbjct: 75 EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMSY 131
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA---TIGYMAPEYGSEGIV 858
+H DL N+L++ ++V + DFG++++L+ DP T I + APE +
Sbjct: 132 VHRDLAARNILVNSNLVCKVSDFGMSRVLED-DPEAAYTTRGGKIPIRWTAPEAIAYRKF 190
Query: 859 SISGDVYSFGILMMETFT 876
+ + DV+S+GI+M E +
Sbjct: 191 TSASDVWSYGIVMWEVMS 208
>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain
pdb|2Y6O|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With
Dasatinib
Length = 291
Score = 72.4 bits (176), Expect = 1e-12, Method: Composition-based stats.
Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 687 LLGSGSFDNVYKATLA----NGVSVAVKVFNL-QEDRALKSFDTECEVMRRIRHRNLIKI 741
++G G F V L + VA+K D+ + F +E +M + H N+I +
Sbjct: 21 VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 80
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
+ +I +YM GSL+ +L ++ T+ Q + ++ + S ++YL
Sbjct: 81 EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMSY 137
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA---TIGYMAPEYGSEGIV 858
+H DL N+L++ ++V + DFG++++L+ DP T I + APE +
Sbjct: 138 VHRDLAARNILVNSNLVCKVSDFGMSRVLED-DPEAAYTTRGGKIPIRWTAPEAIAYRKF 196
Query: 859 SISGDVYSFGILMMETFT 876
+ + DV+S+GI+M E +
Sbjct: 197 TSASDVWSYGIVMWEVMS 214
>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase
pdb|3COK|B Chain B, Crystal Structure Of Plk4 Kinase
Length = 278
Score = 72.4 bits (176), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 52/210 (24%), Positives = 102/210 (48%), Gaps = 12/210 (5%)
Query: 677 QATNGFGESNLLGSGSFDNVYKA-TLANGVSVAVKVFN---LQEDRALKSFDTECEVMRR 732
+ F NLLG GSF VY+A ++ G+ VA+K+ + + + ++ E ++ +
Sbjct: 8 EKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQ 67
Query: 733 IRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEY 792
++H +++++ + + + L+++ G + ++L + + + M + + + Y
Sbjct: 68 LKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLY 127
Query: 793 LH-HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAP 850
LH HG I+H DL +N+LL +M + DFG+A L P + TL T Y++P
Sbjct: 128 LHSHG----ILHRDLTLSNLLLTRNMNIKIADFGLATQLKM--PHEKHYTLCGTPNYISP 181
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKP 880
E + + DV+S G + R P
Sbjct: 182 EIATRSAHGLESDVWSLGCMFYTLLIGRPP 211
>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a)
Length = 306
Score = 72.4 bits (176), Expect = 1e-12, Method: Composition-based stats.
Identities = 51/198 (25%), Positives = 96/198 (48%), Gaps = 12/198 (6%)
Query: 687 LLGSGSFDNVYKATLA----NGVSVAVKVFNL-QEDRALKSFDTECEVMRRIRHRNLIKI 741
++G G F V L + VA+K D+ + F +E +M + H N+I +
Sbjct: 36 VIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIMGQFDHPNIIHL 95
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
+ +I +YM GSL+ +L ++ T+ Q + ++ + S ++YL
Sbjct: 96 EGVVTKCKPVMIITEYMENGSLDAFLRKNDGRFTVIQLVGMLRGIGSGMKYLS---DMSA 152
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA---TIGYMAPEYGSEGIV 858
+H DL N+L++ ++V + DFG++++L+ DP T I + APE +
Sbjct: 153 VHRDLAARNILVNSNLVCKVSDFGMSRVLED-DPEAAYTTRGGKIPIRWTAPEAIAYRKF 211
Query: 859 SISGDVYSFGILMMETFT 876
+ + DV+S+GI+M E +
Sbjct: 212 TSASDVWSYGIVMWEVMS 229
>pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
pdb|2R4B|B Chain B, Erbb4 Kinase Domain Complexed With A Thienopyrimidine
Inhibitor
Length = 321
Score = 72.4 bits (176), Expect = 1e-12, Method: Composition-based stats.
Identities = 62/222 (27%), Positives = 107/222 (48%), Gaps = 12/222 (5%)
Query: 687 LLGSGSFDNVYKAT-LANG----VSVAVKVFN-LQEDRALKSFDTECEVMRRIRHRNLIK 740
+LGSG+F VYK + G + VA+K+ N +A F E +M + H +L++
Sbjct: 45 VLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVR 104
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
++ C +P + L+ Q MP G L ++++ H ++ + L+ + +A + YL
Sbjct: 105 LLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RR 160
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQTMTLATIGYMAPEYGSEGIVS 859
++H DL NVL+ + DFG+A+LL+G + I +MA E +
Sbjct: 161 LVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFT 220
Query: 860 ISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLP 900
DV+S+G+ + E T KP + + T E+ E LP
Sbjct: 221 HQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERLP 262
>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed
With Compound 16
Length = 271
Score = 72.0 bits (175), Expect = 1e-12, Method: Compositional matrix adjust.
Identities = 53/207 (25%), Positives = 95/207 (45%), Gaps = 16/207 (7%)
Query: 685 SNLLGSGSFDNVYKA-TLANGVSVAVKVFNLQED--RALKSFDTECEVMRRIRHRNLIKI 741
++G G F VY+A + + V+V + ED + +++ E ++ ++H N+I +
Sbjct: 12 EEIIGIGGFGKVYRAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIAL 71
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
C L+M++ G L + L I ++ + +A + YLH PI
Sbjct: 72 RGVCLKEPNLCLVMEFARGGPLNRVLSGKRIPPDIL--VNWAVQIARGMNYLHDEAIVPI 129
Query: 802 IHCDLKPNNVLL-----DDDM---VAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYG 853
IH DLK +N+L+ + D+ + + DFG+A+ T+ +MAPE
Sbjct: 130 IHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHR---TTKMSAAGAYAWMAPEVI 186
Query: 854 SEGIVSISGDVYSFGILMMETFTRRKP 880
+ S DV+S+G+L+ E T P
Sbjct: 187 RASMFSKGSDVWSYGVLLWELLTGEVP 213
>pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBT|D Chain D, Crystal Structure Of The Erbb4 Kinase In Complex With
Lapatinib
pdb|3BBW|B Chain B, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BBW|A Chain A, Crystal Structure Of The Erbb4 Kinase In Its Inactive
Conformation
pdb|3BCE|A Chain A, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|B Chain B, Crystal Structure Of The Erbb4 Kinase
pdb|3BCE|C Chain C, Crystal Structure Of The Erbb4 Kinase
Length = 328
Score = 72.0 bits (175), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 54/198 (27%), Positives = 95/198 (47%), Gaps = 11/198 (5%)
Query: 686 NLLGSGSFDNVYKATLAN-----GVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLI 739
+LGSG+F VYK + VA+K+ N +A F E +M + H +L+
Sbjct: 21 KVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLV 80
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
+++ C +P + L+ Q MP G L ++++ H ++ + L+ + +A + YL
Sbjct: 81 RLLGVCLSPTIQ-LVTQLMPHGCLLEYVHEHKDNIGSQLLLNWCVQIAKGMMYLE---ER 136
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQTMTLATIGYMAPEYGSEGIV 858
++H DL NVL+ + DFG+A+LL+G + I +MA E
Sbjct: 137 RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKF 196
Query: 859 SISGDVYSFGILMMETFT 876
+ DV+S+G+ + E T
Sbjct: 197 THQSDVWSYGVTIWELMT 214
>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Adp Bound
Length = 311
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/193 (29%), Positives = 96/193 (49%), Gaps = 10/193 (5%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQ-EDRALKSFD-TECEVMRRIRHRNLIKIVSSC 745
+G G++ VYKA + G VA+K L ED + S E +++ + H N++ ++
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
+ L+ ++M + L+K L + L Q I I + L + H + I+H D
Sbjct: 89 HSERCLTLVFEFM-EKDLKKVLDENKTGLQDSQ---IKIYLYQLLRGVAHCHQHRILHRD 144
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSEGIVSISGD 863
LKP N+L++ D L DFG+A+ G+ + T + T+ Y AP+ GS+ S S D
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVVTLWYRAPDVLMGSKK-YSTSVD 202
Query: 864 VYSFGILMMETFT 876
++S G + E T
Sbjct: 203 IWSIGCIFAEMIT 215
>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 71.6 bits (174), Expect = 2e-12, Method: Composition-based stats.
Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 30/213 (14%)
Query: 688 LGSGSFDNVYKA------TLANGVSVAVKVF----NLQEDRALKSFDTECEVMRRI-RHR 736
LG G+F V +A A +VAVK+ E RAL S E +++ I H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMS---ELKILIHIGHHL 91
Query: 737 NLIKIVSSCSNPGFKAL-IMQYMPQGSLEKWLYSHNYS-----------LTIRQRLDIMI 784
N++ ++ +C+ PG + I+++ G+L +L S LT+ +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLIXYSF 151
Query: 785 DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQTMTLA 843
VA +E+L S IH DL N+LL + V + DFG+A+ + D V +
Sbjct: 152 QVAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARL 208
Query: 844 TIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + +I DV+SFG+L+ E F+
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241
>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated
Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2
Chain)
Length = 276
Score = 71.6 bits (174), Expect = 2e-12, Method: Composition-based stats.
Identities = 55/185 (29%), Positives = 88/185 (47%), Gaps = 17/185 (9%)
Query: 686 NLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALK---SFDTECEVMRRIRHRNLIKI 741
+ LG G+F V G VAVK+ N Q+ R+L E + ++ RH ++IK+
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
S P ++M+Y+ G L ++ H + R + + SA++Y H +
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRHM---V 132
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSIS 861
+H DLKP NVLLD M A + DFG++ ++ D + + Y APE IS
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRTSCGSPNYAAPEV-------IS 183
Query: 862 GDVYS 866
G +Y+
Sbjct: 184 GRLYA 188
>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510
With Indirubin 3'-Monoxime Bound
Length = 313
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 57/193 (29%), Positives = 96/193 (49%), Gaps = 10/193 (5%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNLIKIVSSC 745
+G G++ VYKA + G VA+K L ED + S E +++ + H N++ ++
Sbjct: 29 VGEGTYGVVYKAKDSQGRIVALKRIRLDAEDEGIPSTAIREISLLKELHHPNIVSLIDVI 88
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
+ L+ ++M + L+K L + L Q I I + L + H + I+H D
Sbjct: 89 HSERCLTLVFEFM-EKDLKKVLDENKTGLQDSQ---IKIYLYQLLRGVAHCHQHRILHRD 144
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSEGIVSISGD 863
LKP N+L++ D L DFG+A+ G+ + T + T+ Y AP+ GS+ S S D
Sbjct: 145 LKPQNLLINSDGALKLADFGLARAF-GIPVRSYTHEVVTLWYRAPDVLMGSKK-YSTSVD 202
Query: 864 VYSFGILMMETFT 876
++S G + E T
Sbjct: 203 IWSIGCIFAEMIT 215
>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 13/207 (6%)
Query: 673 HELQQATNGFGESNLLGSGSFDNVYKATLAN----GVSVAVKVF-NLQEDRALKSFDTEC 727
+E+Q+ G +G G F +V++ + ++VA+K N D + F E
Sbjct: 5 YEIQRERIELGRC--IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 62
Query: 728 EVMRRIRHRNLIKIVSSCS-NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDV 786
MR+ H +++K++ + NP + +IM+ G L +L YSL + + +
Sbjct: 63 LTMRQFDHPHIVKLIGVITENPVW--IIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 120
Query: 787 ASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG 846
++AL YL S +H D+ NVL+ + LGDFG+++ ++ + I
Sbjct: 121 STALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 847 YMAPEYGSEGIVSISGDVYSFGILMME 873
+MAPE + + + DV+ FG+ M E
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWE 204
>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound
To Appcp From D. Discoideum
Length = 287
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 60/236 (25%), Positives = 105/236 (44%), Gaps = 22/236 (9%)
Query: 678 ATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKVFNLQEDRA-------LKSFDTECEV 729
A N +G G F V+K L SV A+K L + + F E +
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 730 MRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASA 789
M + H N++K+ NP ++M+++P G L L + + +L +M+D+A
Sbjct: 77 MSNLNHPNIVKLYGLMHNP--PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALG 134
Query: 790 LEYLHHGYSTPIIHCDLKPNNVL---LDDD--MVAHLGDFGIAKLLDGVDPVTQTMTLAT 844
+EY+ + + PI+H DL+ N+ LD++ + A + DF +++ V V+ L
Sbjct: 135 IEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQ--QSVHSVSG--LLGN 189
Query: 845 IGYMAPEY--GSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAES 898
+MAPE E + D YSF +++ T P +E G++ + E
Sbjct: 190 FQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREE 245
>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And
Kinase Domains Of Focal Adhesion Kinase.
pdb|2JKQ|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 71.6 bits (174), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 13/207 (6%)
Query: 673 HELQQATNGFGESNLLGSGSFDNVYKATLAN----GVSVAVKVF-NLQEDRALKSFDTEC 727
+E+Q+ G +G G F +V++ + ++VA+K N D + F E
Sbjct: 5 YEIQRERIELGRC--IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 62
Query: 728 EVMRRIRHRNLIKIVSSCS-NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDV 786
MR+ H +++K++ + NP + +IM+ G L +L YSL + + +
Sbjct: 63 LTMRQFDHPHIVKLIGVITENPVW--IIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 120
Query: 787 ASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG 846
++AL YL S +H D+ NVL+ + LGDFG+++ ++ + I
Sbjct: 121 STALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 847 YMAPEYGSEGIVSISGDVYSFGILMME 873
+MAPE + + + DV+ FG+ M E
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWE 204
>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
pdb|4EBV|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With Novel Allosteric Inhibitor
Length = 304
Score = 71.2 bits (173), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 13/207 (6%)
Query: 673 HELQQATNGFGESNLLGSGSFDNVYKATLAN----GVSVAVKVF-NLQEDRALKSFDTEC 727
+E+Q+ G +G G F +V++ + ++VA+K N D + F E
Sbjct: 33 YEIQRERIELG--RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 90
Query: 728 EVMRRIRHRNLIKIVSSCS-NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDV 786
MR+ H +++K++ + NP + +IM+ G L +L YSL + + +
Sbjct: 91 LTMRQFDHPHIVKLIGVITENPVW--IIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 148
Query: 787 ASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG 846
++AL YL S +H D+ NVL+ + LGDFG+++ ++ + I
Sbjct: 149 STALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 205
Query: 847 YMAPEYGSEGIVSISGDVYSFGILMME 873
+MAPE + + + DV+ FG+ M E
Sbjct: 206 WMAPESINFRRFTSASDVWMFGVCMWE 232
>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak)
pdb|4I4F|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In
Complex With An Allosteric Binding Pyrazolobenzothiazine
Compound
Length = 281
Score = 71.2 bits (173), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 13/207 (6%)
Query: 673 HELQQATNGFGESNLLGSGSFDNVYKATLAN----GVSVAVKVF-NLQEDRALKSFDTEC 727
+E+Q+ G +G G F +V++ + ++VA+K N D + F E
Sbjct: 10 YEIQRERIELG--RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 67
Query: 728 EVMRRIRHRNLIKIVSSCS-NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDV 786
MR+ H +++K++ + NP + +IM+ G L +L YSL + + +
Sbjct: 68 LTMRQFDHPHIVKLIGVITENPVW--IIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 125
Query: 787 ASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG 846
++AL YL S +H D+ NVL+ + LGDFG+++ ++ + I
Sbjct: 126 STALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 182
Query: 847 YMAPEYGSEGIVSISGDVYSFGILMME 873
+MAPE + + + DV+ FG+ M E
Sbjct: 183 WMAPESINFRRFTSASDVWMFGVCMWE 209
>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
pdb|3PXK|B Chain B, Focal Adhesion Kinase Catalytic Domain In Complex With
Pyrrolo[2,3- D]thiazole
Length = 282
Score = 71.2 bits (173), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 13/207 (6%)
Query: 673 HELQQATNGFGESNLLGSGSFDNVYKATLAN----GVSVAVKVF-NLQEDRALKSFDTEC 727
+E+Q+ G +G G F +V++ + ++VA+K N D + F E
Sbjct: 8 YEIQRERIELG--RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 65
Query: 728 EVMRRIRHRNLIKIVSSCS-NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDV 786
MR+ H +++K++ + NP + +IM+ G L +L YSL + + +
Sbjct: 66 LTMRQFDHPHIVKLIGVITENPVW--IIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 123
Query: 787 ASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG 846
++AL YL S +H D+ NVL+ + LGDFG+++ ++ + I
Sbjct: 124 STALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 180
Query: 847 YMAPEYGSEGIVSISGDVYSFGILMME 873
+MAPE + + + DV+ FG+ M E
Sbjct: 181 WMAPESINFRRFTSASDVWMFGVCMWE 207
>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2ETM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain
Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative
pdb|2IJM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
pdb|2IJM|B Chain B, Crystal Structure Of Focal Adhesion Kinase Domain With 2
Molecules In The Asymmetric Unit Complexed With Adp And
Atp
Length = 281
Score = 71.2 bits (173), Expect = 2e-12, Method: Compositional matrix adjust.
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 13/207 (6%)
Query: 673 HELQQATNGFGESNLLGSGSFDNVYKATLAN----GVSVAVKVF-NLQEDRALKSFDTEC 727
+E+Q+ G +G G F +V++ + ++VA+K N D + F E
Sbjct: 7 YEIQRERIELG--RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 64
Query: 728 EVMRRIRHRNLIKIVSSCS-NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDV 786
MR+ H +++K++ + NP + +IM+ G L +L YSL + + +
Sbjct: 65 LTMRQFDHPHIVKLIGVITENPVW--IIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 122
Query: 787 ASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG 846
++AL YL S +H D+ NVL+ + LGDFG+++ ++ + I
Sbjct: 123 STALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 179
Query: 847 YMAPEYGSEGIVSISGDVYSFGILMME 873
+MAPE + + + DV+ FG+ M E
Sbjct: 180 WMAPESINFRRFTSASDVWMFGVCMWE 206
>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120
Length = 316
Score = 71.2 bits (173), Expect = 3e-12, Method: Composition-based stats.
Identities = 62/215 (28%), Positives = 101/215 (46%), Gaps = 32/215 (14%)
Query: 688 LGSGSFDNVYKA------TLANGVSVAVKVF----NLQEDRALKSFDTECEVMRRI-RHR 736
LG G+F V +A A +VAVK+ E RAL S E +++ I H
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMS---ELKILIHIGHHL 93
Query: 737 NLIKIVSSCSNPGFKAL-IMQYMPQGSLEKWLYSHNYS-------------LTIRQRLDI 782
N++ ++ +C+ PG + I+++ G+L +L S LT+ +
Sbjct: 94 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXY 153
Query: 783 MIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQTMT 841
VA +E+L S IH DL N+LL + V + DFG+A+ + D V +
Sbjct: 154 SFQVAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDA 210
Query: 842 LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + +I DV+SFG+L+ E F+
Sbjct: 211 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human
Pdk1 Complex 2
Length = 311
Score = 71.2 bits (173), Expect = 3e-12, Method: Composition-based stats.
Identities = 57/197 (28%), Positives = 93/197 (47%), Gaps = 9/197 (4%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRN 737
F +LG GSF V A LA A+K+ ++ ++ + E +VM R+ H
Sbjct: 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+K+ + + + Y G L K++ R ++ SALEYLH
Sbjct: 94 FVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 149
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-LATIGYMAPEYGSEG 856
IIH DLKP N+LL++DM + DFG AK+L + + + T Y++PE +E
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 209
Query: 857 IVSISGDVYSFGILMME 873
S S D+++ G ++ +
Sbjct: 210 SASKSSDLWALGCIIYQ 226
>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A
Methanesulfonamide Diaminopyrimidine Inhibitor
Length = 276
Score = 71.2 bits (173), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 54/207 (26%), Positives = 98/207 (47%), Gaps = 13/207 (6%)
Query: 673 HELQQATNGFGESNLLGSGSFDNVYKATLAN----GVSVAVKVF-NLQEDRALKSFDTEC 727
+E+Q+ G +G G F +V++ + ++VA+K N D + F E
Sbjct: 2 YEIQRERIELG--RCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEA 59
Query: 728 EVMRRIRHRNLIKIVSSCS-NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDV 786
MR+ H +++K++ + NP + +IM+ G L +L YSL + + +
Sbjct: 60 LTMRQFDHPHIVKLIGVITENPVW--IIMELCTLGELRSFLQVRKYSLDLASLILYAYQL 117
Query: 787 ASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG 846
++AL YL S +H D+ NVL+ + LGDFG+++ ++ + I
Sbjct: 118 STALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 174
Query: 847 YMAPEYGSEGIVSISGDVYSFGILMME 873
+MAPE + + + DV+ FG+ M E
Sbjct: 175 WMAPESINFRRFTSASDVWMFGVCMWE 201
>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|B Chain B, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|C Chain C, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|D Chain D, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|E Chain E, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|F Chain F, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|G Chain G, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
pdb|3QA8|H Chain H, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta
Length = 676
Score = 70.9 bits (172), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 69/256 (26%), Positives = 119/256 (46%), Gaps = 37/256 (14%)
Query: 688 LGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTEC---EVMRRIRHRNLIKIVS 743
LG+G F V + + G VA+K +++ + K+ + C ++M+++ H N +VS
Sbjct: 22 LGTGGFGYVLRWIHQDTGEQVAIK--QCRQELSPKNRERWCLEIQIMKKLNHPN---VVS 76
Query: 744 SCSNP-GFKALI--------MQYMPQGSLEKWLYSHNYSLTIRQR--LDIMIDVASALEY 792
+ P G + L M+Y G L K+L +++ ++ D++SAL Y
Sbjct: 77 AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 136
Query: 793 LHHGYSTPIIHCDLKPNNVLLD---DDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
LH IIH DLKP N++L ++ + D G AK LD + T+ + T+ Y+A
Sbjct: 137 LHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF--VGTLQYLA 191
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDA 909
PE + +++ D +SFG L E T +P L W G V E +
Sbjct: 192 PELLEQKKYTVTVDYWSFGTLAFECITGFRPF---------LPNWQPVQWHGKVREKSNE 242
Query: 910 NLLSREDEEDADDFAT 925
+++ +D A F++
Sbjct: 243 HIVVYDDLTGAVKFSS 258
>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta
(I4122)
Length = 677
Score = 70.9 bits (172), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 69/256 (26%), Positives = 119/256 (46%), Gaps = 37/256 (14%)
Query: 688 LGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTEC---EVMRRIRHRNLIKIVS 743
LG+G F V + + G VA+K +++ + K+ + C ++M+++ H N +VS
Sbjct: 23 LGTGGFGYVLRWIHQDTGEQVAIK--QCRQELSPKNRERWCLEIQIMKKLNHPN---VVS 77
Query: 744 SCSNP-GFKALI--------MQYMPQGSLEKWLYSHNYSLTIRQR--LDIMIDVASALEY 792
+ P G + L M+Y G L K+L +++ ++ D++SAL Y
Sbjct: 78 AREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRY 137
Query: 793 LHHGYSTPIIHCDLKPNNVLLD---DDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
LH IIH DLKP N++L ++ + D G AK LD + T+ + T+ Y+A
Sbjct: 138 LHENR---IIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEF--VGTLQYLA 192
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDA 909
PE + +++ D +SFG L E T +P L W G V E +
Sbjct: 193 PELLEQKKYTVTVDYWSFGTLAFECITGFRPF---------LPNWQPVQWHGKVREKSNE 243
Query: 910 NLLSREDEEDADDFAT 925
+++ +D A F++
Sbjct: 244 HIVVYDDLTGAVKFSS 259
>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase
Domain Of Csf-1r
Length = 324
Score = 70.9 bits (172), Expect = 3e-12, Method: Compositional matrix adjust.
Identities = 67/255 (26%), Positives = 117/255 (45%), Gaps = 43/255 (16%)
Query: 658 ENNSLNLATLSRISYHELQQ-ATNGFGESNLLGSGSFDNVYKATLANGV-------SVAV 709
E NS +++ Y+E + N LG+G+F V +AT A G+ VAV
Sbjct: 8 EGNSYTFIDPTQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEAT-AFGLGKEDAVLKVAV 66
Query: 710 KVF----NLQEDRALKSFDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIMQYMPQGSLE 764
K+ + E AL S E ++M + +H N++ ++ +C++ G +I +Y G L
Sbjct: 67 KMLKSTAHADEKEALMS---ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLL 123
Query: 765 KWLYSHNYS----------------------LTIRQRLDIMIDVASALEYLHHGYSTPII 802
+L + L +R L VA + +L S I
Sbjct: 124 NFLRRKAEAMLGPSLAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLA---SKNCI 180
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQTMTLATIGYMAPEYGSEGIVSIS 861
H D+ NVLL + VA +GDFG+A+ +++ + + + + +MAPE + + ++
Sbjct: 181 HRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQ 240
Query: 862 GDVYSFGILMMETFT 876
DV+S+GIL+ E F+
Sbjct: 241 SDVWSYGILLWEIFS 255
>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human
5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant
(T172d)
pdb|3AQV|A Chain A, Human Amp-Activated Protein Kinase Alpha 2 Subunit Kinase
Domain (T172d) Complexed With Compound C
Length = 276
Score = 70.9 bits (172), Expect = 4e-12, Method: Composition-based stats.
Identities = 54/185 (29%), Positives = 89/185 (48%), Gaps = 17/185 (9%)
Query: 686 NLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALK---SFDTECEVMRRIRHRNLIKI 741
+ LG G+F V G VAVK+ N Q+ R+L E + ++ RH ++IK+
Sbjct: 17 DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKL 76
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
S P ++M+Y+ G L ++ H + R + + SA++Y H +
Sbjct: 77 YQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEAR-RLFQQILSAVDYCHRHM---V 132
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSIS 861
+H DLKP NVLLD M A + DFG++ ++ + + + + Y APE IS
Sbjct: 133 VHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRD--SCGSPNYAAPEV-------IS 183
Query: 862 GDVYS 866
G +Y+
Sbjct: 184 GRLYA 188
>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor
Kinase
Length = 299
Score = 70.5 bits (171), Expect = 4e-12, Method: Composition-based stats.
Identities = 61/237 (25%), Positives = 106/237 (44%), Gaps = 22/237 (9%)
Query: 674 ELQQATNGFGESNLLGSGSFDNVYKATLANGV-------SVAVKVFNLQED-RALKSFDT 725
E + A S LG GSF VY+ +A GV VA+K N R F
Sbjct: 4 EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 62
Query: 726 ECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYS-----HNYSLTIRQRL 780
E VM+ ++++++ S +IM+ M +G L+ +L S N + L
Sbjct: 63 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 122
Query: 781 DIMI----DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836
MI ++A + YL+ + +H DL N ++ +D +GDFG+ + + D
Sbjct: 123 SKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 179
Query: 837 TQT-MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892
+ L + +M+PE +G+ + DV+SFG+++ E T + + + E L+
Sbjct: 180 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 236
>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|2ZM3|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And Isoquinolinedione Inhibitor
pdb|3F5P|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|B Chain B, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|C Chain C, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|D Chain D, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|E Chain E, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|F Chain F, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|G Chain G, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|H Chain H, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|I Chain I, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|J Chain J, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|K Chain K, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|M Chain M, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|L Chain L, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|R Chain R, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|S Chain S, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
pdb|3F5P|T Chain T, Complex Structure Of Insulin-Like Growth Factor Receptor
And 3- Cyanoquinoline Inhibitor
Length = 308
Score = 70.5 bits (171), Expect = 4e-12, Method: Composition-based stats.
Identities = 61/237 (25%), Positives = 106/237 (44%), Gaps = 22/237 (9%)
Query: 674 ELQQATNGFGESNLLGSGSFDNVYKATLANGV-------SVAVKVFNLQED-RALKSFDT 725
E + A S LG GSF VY+ +A GV VA+K N R F
Sbjct: 13 EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 71
Query: 726 ECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYS-----HNYSLTIRQRL 780
E VM+ ++++++ S +IM+ M +G L+ +L S N + L
Sbjct: 72 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 781 DIMI----DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836
MI ++A + YL+ + +H DL N ++ +D +GDFG+ + + D
Sbjct: 132 SKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXX 188
Query: 837 TQT-MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892
+ L + +M+PE +G+ + DV+SFG+++ E T + + + E L+
Sbjct: 189 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 245
>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358
pdb|2J50|B Chain B, Structure Of Aurora-2 In Complex With Pha-739358
Length = 280
Score = 70.5 bits (171), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 75/247 (30%), Positives = 113/247 (45%), Gaps = 19/247 (7%)
Query: 676 QQATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKV-FNLQEDRA--LKSFDTECEVMR 731
Q A F LG G F NVY A + A+KV F Q ++A E E+
Sbjct: 4 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 732 RIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI-DVASAL 790
+RH N++++ + LI++Y P G++ + L S QR I ++A+AL
Sbjct: 64 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 121
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMA 849
Y H S +IH D+KP N+LL + DFG + P ++ TL T+ Y+
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTTLCGTLDYLP 174
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ--WVAESLPGAVTEVV 907
PE + D++S G+L E F KP E T + + K+ V + P VTE
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 908 DANLLSR 914
+L+SR
Sbjct: 234 -RDLISR 239
>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The
Kinase Domain Of Focal Adhesion Kinase With A
Phosphorylated Activation Loop
Length = 276
Score = 70.5 bits (171), Expect = 4e-12, Method: Compositional matrix adjust.
Identities = 53/207 (25%), Positives = 98/207 (47%), Gaps = 13/207 (6%)
Query: 673 HELQQATNGFGESNLLGSGSFDNVYKATLAN----GVSVAVKVF-NLQEDRALKSFDTEC 727
+E+Q+ G +G G F +V++ + ++VA+K N D + F E
Sbjct: 5 YEIQRERIELGRC--IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 62
Query: 728 EVMRRIRHRNLIKIVSSCS-NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDV 786
MR+ H +++K++ + NP + +IM+ G L +L +SL + + +
Sbjct: 63 LTMRQFDHPHIVKLIGVITENPVW--IIMELCTLGELRSFLQVRKFSLDLASLILYAYQL 120
Query: 787 ASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG 846
++AL YL S +H D+ NVL+ + LGDFG+++ ++ + I
Sbjct: 121 STALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIK 177
Query: 847 YMAPEYGSEGIVSISGDVYSFGILMME 873
+MAPE + + + DV+ FG+ M E
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWE 204
>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
3,4,5-Trimethoxy Aniline Containing Pyrimidine
Length = 309
Score = 70.5 bits (171), Expect = 5e-12, Method: Composition-based stats.
Identities = 62/213 (29%), Positives = 101/213 (47%), Gaps = 30/213 (14%)
Query: 688 LGSGSFDNVYKA------TLANGVSVAVKVF----NLQEDRALKSFDTECEVMRRI-RHR 736
LG G+F V +A A +VAVK+ E RAL S E +++ I H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMS---ELKILIHIGHHL 91
Query: 737 NLIKIVSSCSNPGFKAL-IMQYMPQGSLEKWLYSHNYS-----------LTIRQRLDIMI 784
N++ ++ +C+ PG + I+++ G+L +L S LT+ +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKDLYKDFLTLEHLICYSF 151
Query: 785 DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQTMTLA 843
VA +E+L S IH DL N+LL + V + DFG+A+ + D V +
Sbjct: 152 QVAKGMEFLA---SRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL 208
Query: 844 TIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + +I DV+SFG+L+ E F+
Sbjct: 209 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 241
>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase
Domain From Human
Length = 314
Score = 70.1 bits (170), Expect = 6e-12, Method: Composition-based stats.
Identities = 65/213 (30%), Positives = 103/213 (48%), Gaps = 28/213 (13%)
Query: 691 GSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRR--IRHRNLIKIVSS---C 745
G F V+KA L N VAVK+F LQ+ +S+ +E E+ ++H NL++ +++
Sbjct: 26 GRFGCVWKAQLMNDF-VAVKIFPLQDK---QSWQSEREIFSTPGMKHENLLQFIAAEKRG 81
Query: 746 SNPGFKA-LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH--------G 796
SN + LI + +GSL +L + +T + + ++ L YLH G
Sbjct: 82 SNLEVELWLITAFHDKGSLTDYLKGN--IITWNELCHVAETMSRGLSYLHEDVPWCRGEG 139
Query: 797 YSTPIIHCDLKPNNVLLDDDMVAHLGDFGIA-KLLDGVDPVTQTMTLATIGYMAPEYGSE 855
+ I H D K NVLL D+ A L DFG+A + G P + T YMAPE E
Sbjct: 140 HKPSIAHRDFKSKNVLLKSDLTAVLADFGLAVRFEPGKPPGDTHGQVGTRRYMAPEV-LE 198
Query: 856 GIVSISG------DVYSFGILMMETFTRRKPTN 882
G ++ D+Y+ G+++ E +R K +
Sbjct: 199 GAINFQRDAFLRIDMYAMGLVLWELVSRCKAAD 231
>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N-
Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2
Length = 325
Score = 70.1 bits (170), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 60/199 (30%), Positives = 100/199 (50%), Gaps = 15/199 (7%)
Query: 686 NLLGSGSFDNVYKATLANGVSVAVKVFNLQ--EDRALKSFDT-----ECEVMRRIRHRNL 738
+LG GSF V+ +G S A +++ ++ + LK D E +++ + H +
Sbjct: 30 KVLGQGSFGKVFLVKKISG-SDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFI 88
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
+K+ + G LI+ ++ G L L S T + ++A AL++LH S
Sbjct: 89 VKLHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLH---S 144
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGSEGI 857
II+ DLKP N+LLD++ L DFG++K + +D + + T+ YMAPE +
Sbjct: 145 LGIIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRG 202
Query: 858 VSISGDVYSFGILMMETFT 876
+ S D +SFG+LM E T
Sbjct: 203 HTQSADWWSFGVLMFEMLT 221
>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The
Gefitinib/erlotinib Resistant Egfr Kinase Domain
L858r+t790m
pdb|4I22|A Chain A, Structure Of The Monomeric (v948r)gefitinib/erlotinib
Resistant Double Mutant (l858r+t790m) Egfr Kinase Domain
Co-crystallized With Gefitinib
Length = 329
Score = 70.1 bits (170), Expect = 6e-12, Method: Compositional matrix adjust.
Identities = 65/242 (26%), Positives = 107/242 (44%), Gaps = 12/242 (4%)
Query: 682 FGESNLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH 735
F + +LGSG+F VYK V + V + L+E +A K E VM + +
Sbjct: 19 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LIMQ MP G L ++ H ++ + L+ + +A + YL
Sbjct: 79 PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 136
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGS 854
++H DL NVL+ + DFG AKLL + I +MA E
Sbjct: 137 --DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 855 EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913
I + DV+S+G+ + E T KP + + E+S E LP +D ++
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIM 254
Query: 914 RE 915
R+
Sbjct: 255 RK 256
>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase
pdb|3COM|B Chain B, Crystal Structure Of Mst1 Kinase
Length = 314
Score = 70.1 bits (170), Expect = 6e-12, Method: Composition-based stats.
Identities = 58/195 (29%), Positives = 93/195 (47%), Gaps = 9/195 (4%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG GS+ +VYKA G VA+K ++ D L+ E +M++ +++K S
Sbjct: 37 LGEGSYGSVYKAIHKETGQIVAIKQVPVESD--LQEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++M+Y GS+ + N +LT + I+ LEYLH IH D+
Sbjct: 95 KNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK---IHRDI 151
Query: 807 KPNNVLLDDDMVAHLGDFGIA-KLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVY 865
K N+LL+ + A L DFG+A +L D + + + T +MAPE E + D++
Sbjct: 152 KAGNILLNTEGHAKLADFGVAGQLTDXM--AKRNXVIGTPFWMAPEVIQEIGYNCVADIW 209
Query: 866 SFGILMMETFTRRKP 880
S GI +E + P
Sbjct: 210 SLGITAIEMAEGKPP 224
>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
pdb|3IKA|B Chain B, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently
Binding To Wz4002
Length = 331
Score = 69.7 bits (169), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 64/239 (26%), Positives = 106/239 (44%), Gaps = 12/239 (5%)
Query: 682 FGESNLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH 735
F + +LGSG+F VYK V + V + L+E +A K E VM + +
Sbjct: 21 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LIMQ MP G L ++ H ++ + L+ + +A + YL
Sbjct: 81 PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 138
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGS 854
++H DL NVL+ + DFG+AKLL + I +MA E
Sbjct: 139 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 196
Query: 855 EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912
I + DV+S+G+ + E T KP + + E+S E LP +D ++
Sbjct: 197 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 255
>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
pdb|4I24|B Chain B, Structure Of T790m Egfr Kinase Domain Co-crystallized With
Dacomitinib
Length = 329
Score = 69.7 bits (169), Expect = 7e-12, Method: Compositional matrix adjust.
Identities = 64/239 (26%), Positives = 106/239 (44%), Gaps = 12/239 (5%)
Query: 682 FGESNLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH 735
F + +LGSG+F VYK V + V + L+E +A K E VM + +
Sbjct: 19 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LIMQ MP G L ++ H ++ + L+ + +A + YL
Sbjct: 79 PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 136
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGS 854
++H DL NVL+ + DFG+AKLL + I +MA E
Sbjct: 137 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 855 EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912
I + DV+S+G+ + E T KP + + E+S E LP +D ++
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 253
>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
pdb|2JIU|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Complex With Aee788
Length = 328
Score = 69.7 bits (169), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 64/239 (26%), Positives = 106/239 (44%), Gaps = 12/239 (5%)
Query: 682 FGESNLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH 735
F + +LGSG+F VYK V + V + L+E +A K E VM + +
Sbjct: 18 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LIMQ MP G L ++ H ++ + L+ + +A + YL
Sbjct: 78 PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 135
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGS 854
++H DL NVL+ + DFG+AKLL + I +MA E
Sbjct: 136 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 193
Query: 855 EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912
I + DV+S+G+ + E T KP + + E+S E LP +D ++
Sbjct: 194 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 252
>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
pdb|2JIV|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation In
Compex With Hki-272
Length = 328
Score = 69.7 bits (169), Expect = 8e-12, Method: Compositional matrix adjust.
Identities = 64/239 (26%), Positives = 106/239 (44%), Gaps = 12/239 (5%)
Query: 682 FGESNLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH 735
F + +LGSG+F VYK V + V + L+E +A K E VM + +
Sbjct: 18 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 77
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LIMQ MP G L ++ H ++ + L+ + +A + YL
Sbjct: 78 PHVCRLLGICLTSTVQ-LIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 135
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGS 854
++H DL NVL+ + DFG+AKLL + I +MA E
Sbjct: 136 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 193
Query: 855 EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912
I + DV+S+G+ + E T KP + + E+S E LP +D ++
Sbjct: 194 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 252
>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea
Inhibitor
Length = 316
Score = 69.7 bits (169), Expect = 8e-12, Method: Composition-based stats.
Identities = 62/216 (28%), Positives = 101/216 (46%), Gaps = 33/216 (15%)
Query: 688 LGSGSFDNVYKA------TLANGVSVAVKVF----NLQEDRALKSFDTECEVMRRI-RHR 736
LG G+F V +A A +VAVK+ E RAL S E +++ I H
Sbjct: 36 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS---ELKILIHIGHHL 92
Query: 737 NLIKIVSSCSNPGFKAL-IMQYMPQGSLEKWLYSHNYS--------------LTIRQRLD 781
N++ ++ +C+ PG + I+++ G+L +L S LT+ +
Sbjct: 93 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPEDLYKDFLTLEHLIC 152
Query: 782 IMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQTM 840
VA +E+L S IH DL N+LL + V + DFG+A+ + D V +
Sbjct: 153 YSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGD 209
Query: 841 TLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + +I DV+SFG+L+ E F+
Sbjct: 210 ARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
>pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2-
Yl]amino}phenyl)acetic Acid
Length = 303
Score = 69.3 bits (168), Expect = 9e-12, Method: Composition-based stats.
Identities = 54/224 (24%), Positives = 103/224 (45%), Gaps = 24/224 (10%)
Query: 688 LGSGSFDNVYKATLANGVS------VAVKVFNLQEDRALKS---FDTECEVMRRIRHRNL 738
LG GSF VY+ + + VAVK N E +L+ F E VM+ ++
Sbjct: 22 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 79
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSL---------TIRQRLDIMIDVASA 789
++++ S ++M+ M G L+ +L S T+++ + + ++A
Sbjct: 80 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 139
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT-MTLATIGYM 848
+ YL+ + +H DL N ++ D +GDFG+ + + D + L + +M
Sbjct: 140 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 196
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892
APE +G+ + S D++SFG+++ E + + + + E LK
Sbjct: 197 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 240
>pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex
With Peptide Substrate And Atp Analog
pdb|1GAG|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With A Bisubstrate Inhibitor
Length = 306
Score = 69.3 bits (168), Expect = 9e-12, Method: Composition-based stats.
Identities = 54/224 (24%), Positives = 103/224 (45%), Gaps = 24/224 (10%)
Query: 688 LGSGSFDNVYKATLANGVS------VAVKVFNLQEDRALKS---FDTECEVMRRIRHRNL 738
LG GSF VY+ + + VAVK N E +L+ F E VM+ ++
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 82
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSL---------TIRQRLDIMIDVASA 789
++++ S ++M+ M G L+ +L S T+++ + + ++A
Sbjct: 83 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT-MTLATIGYM 848
+ YL+ + +H DL N ++ D +GDFG+ + + D + L + +M
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892
APE +G+ + S D++SFG+++ E + + + + E LK
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243
>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a
pdb|4H1M|A Chain A, Crystal Structure Of Pyk2 With The Indole 10c
Length = 293
Score = 69.3 bits (168), Expect = 9e-12, Method: Composition-based stats.
Identities = 50/198 (25%), Positives = 95/198 (47%), Gaps = 11/198 (5%)
Query: 685 SNLLGSGSFDNVYKATLAN--GVSVAVKVFNLQEDRAL---KSFDTECEVMRRIRHRNLI 739
+ +LG G F VY+ N G + V V ++D L + F +E +M+ + H +++
Sbjct: 29 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 88
Query: 740 KIVSSCSN-PGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
K++ P + +IM+ P G L +L + SL + + + + A+ YL S
Sbjct: 89 KLIGIIEEEPTW--IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---S 143
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIV 858
+H D+ N+L+ LGDFG+++ ++ D ++T I +M+PE +
Sbjct: 144 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 203
Query: 859 SISGDVYSFGILMMETFT 876
+ + DV+ F + M E +
Sbjct: 204 TTASDVWMFAVCMWEILS 221
>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
pdb|1JPA|B Chain B, Crystal Structure Of Unphosphorylated Ephb2 Receptor
Tyrosine Kinase And Juxtamembrane Region
Length = 312
Score = 69.3 bits (168), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 52/202 (25%), Positives = 98/202 (48%), Gaps = 14/202 (6%)
Query: 685 SNLLGSGSFDNVYKATLA----NGVSVAVKVFNL-QEDRALKSFDTECEVMRRIRHRNLI 739
++G+G F V L + VA+K ++ + F +E +M + H N+I
Sbjct: 38 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 97
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
+ + +I ++M GSL+ +L ++ T+ Q + ++ +A+ ++YL
Sbjct: 98 HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DM 154
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLA---TIGYMAPEYGS 854
+H DL N+L++ ++V + DFG+++ L D DP T T L I + APE
Sbjct: 155 NYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP-TYTSALGGKIPIRWTAPEAIQ 213
Query: 855 EGIVSISGDVYSFGILMMETFT 876
+ + DV+S+GI+M E +
Sbjct: 214 YRKFTSASDVWSYGIVMWEVMS 235
>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Novel Bosutinib Isoform 1, Previously Thought
To Be Bosutinib
Length = 293
Score = 69.3 bits (168), Expect = 9e-12, Method: Composition-based stats.
Identities = 61/220 (27%), Positives = 104/220 (47%), Gaps = 14/220 (6%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G+F VYKA G A KV + + L+ + E E++ H ++K++ +
Sbjct: 19 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 78
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
+ G +++++ P G+++ + + LT Q + + AL +LH S IIH DL
Sbjct: 79 HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDL 135
Query: 807 KPNNVLLDDDMVAHLGDFGI-AKLLDGVDPVTQTMTLATIGYMAPEY-----GSEGIVSI 860
K NVL+ + L DFG+ AK L + + + T +MAPE +
Sbjct: 136 KAGNVLMTLEGDIRLADFGVSAKNLKTLQ--KRDSFIGTPYWMAPEVVMCETMKDTPYDY 193
Query: 861 SGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP 900
D++S GI ++E P +E+ + LK +A+S P
Sbjct: 194 KADIWSLGITLIEMAQIEPPHHELNPMRVLLK--IAKSDP 231
>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine
Kinase
pdb|3FZP|A Chain A, Crystal Structure Of Pyk2 Complexed With Atpgs
pdb|3FZR|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-431396
pdb|3FZS|A Chain A, Crystal Structure Of Pyk2 Complexed With Birb796
pdb|3FZT|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-4618433
pdb|3H3C|A Chain A, Crystal Structure Of Pyk2 In Complex With Sulfoximine-
Substituted Trifluoromethylpyrimidine Analog
pdb|3ET7|A Chain A, Crystal Structure Of Pyk2 Complexed With Pf-2318841
Length = 277
Score = 69.3 bits (168), Expect = 9e-12, Method: Composition-based stats.
Identities = 50/198 (25%), Positives = 95/198 (47%), Gaps = 11/198 (5%)
Query: 685 SNLLGSGSFDNVYKATLAN--GVSVAVKVFNLQEDRAL---KSFDTECEVMRRIRHRNLI 739
+ +LG G F VY+ N G + V V ++D L + F +E +M+ + H +++
Sbjct: 13 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 72
Query: 740 KIVSSCSN-PGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
K++ P + +IM+ P G L +L + SL + + + + A+ YL S
Sbjct: 73 KLIGIIEEEPTW--IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---S 127
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIV 858
+H D+ N+L+ LGDFG+++ ++ D ++T I +M+PE +
Sbjct: 128 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 187
Query: 859 SISGDVYSFGILMMETFT 876
+ + DV+ F + M E +
Sbjct: 188 TTASDVWMFAVCMWEILS 205
>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine
Kinase 2 Beta (ptk2b)
Length = 281
Score = 69.3 bits (168), Expect = 9e-12, Method: Composition-based stats.
Identities = 50/198 (25%), Positives = 95/198 (47%), Gaps = 11/198 (5%)
Query: 685 SNLLGSGSFDNVYKATLAN--GVSVAVKVFNLQEDRAL---KSFDTECEVMRRIRHRNLI 739
+ +LG G F VY+ N G + V V ++D L + F +E +M+ + H +++
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 740 KIVSSCSN-PGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
K++ P + +IM+ P G L +L + SL + + + + A+ YL S
Sbjct: 77 KLIGIIEEEPTW--IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLE---S 131
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIV 858
+H D+ N+L+ LGDFG+++ ++ D ++T I +M+PE +
Sbjct: 132 INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRF 191
Query: 859 SISGDVYSFGILMMETFT 876
+ + DV+ F + M E +
Sbjct: 192 TTASDVWMFAVCMWEILS 209
>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
Bound To Su11274
pdb|4AOT|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4AOT|B Chain B, Crystal Structure Of Human Serine Threonine Kinase-10
(Lok) Bound To Gw830263a
pdb|4EQU|A Chain A, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
pdb|4EQU|B Chain B, Human Stk-10 (Lok) Kinase Domain In Dfg-Out Conformation
With Inhibitor Dsa-7
Length = 302
Score = 69.3 bits (168), Expect = 9e-12, Method: Composition-based stats.
Identities = 61/220 (27%), Positives = 104/220 (47%), Gaps = 14/220 (6%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G+F VYKA G A KV + + L+ + E E++ H ++K++ +
Sbjct: 27 LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPYIVKLLGAYY 86
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
+ G +++++ P G+++ + + LT Q + + AL +LH S IIH DL
Sbjct: 87 HDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLH---SKRIIHRDL 143
Query: 807 KPNNVLLDDDMVAHLGDFGI-AKLLDGVDPVTQTMTLATIGYMAPEY-----GSEGIVSI 860
K NVL+ + L DFG+ AK L + + + T +MAPE +
Sbjct: 144 KAGNVLMTLEGDIRLADFGVSAKNLKTLQ--KRDSFIGTPYWMAPEVVMCETMKDTPYDY 201
Query: 861 SGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP 900
D++S GI ++E P +E+ + LK +A+S P
Sbjct: 202 KADIWSLGITLIEMAQIEPPHHELNPMRVLLK--IAKSDP 239
>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7
Length = 311
Score = 69.3 bits (168), Expect = 9e-12, Method: Composition-based stats.
Identities = 56/197 (28%), Positives = 92/197 (46%), Gaps = 9/197 (4%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRN 737
F +LG GSF V A LA A+K+ ++ ++ + E +VM R+ H
Sbjct: 31 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+K+ + + + Y G L K++ R ++ SALEYLH
Sbjct: 91 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 146
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-LATIGYMAPEYGSEG 856
IIH DLKP N+LL++DM + DFG AK+L + + + T Y++PE +E
Sbjct: 147 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 206
Query: 857 IVSISGDVYSFGILMME 873
S D+++ G ++ +
Sbjct: 207 SACKSSDLWALGCIIYQ 223
>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent
Kinase- 1 (Pdk-1)catalytic Domain Bound To A
Dibenzonaphthyridine Inhibitor
pdb|3ION|A Chain A, Pdk1 In Complex With Compound 8h
Length = 312
Score = 69.3 bits (168), Expect = 9e-12, Method: Composition-based stats.
Identities = 56/197 (28%), Positives = 92/197 (46%), Gaps = 9/197 (4%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRN 737
F +LG GSF V A LA A+K+ ++ ++ + E +VM R+ H
Sbjct: 35 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+K+ + + + Y G L K++ R ++ SALEYLH
Sbjct: 95 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 150
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-LATIGYMAPEYGSEG 856
IIH DLKP N+LL++DM + DFG AK+L + + + T Y++PE +E
Sbjct: 151 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEK 210
Query: 857 IVSISGDVYSFGILMME 873
S D+++ G ++ +
Sbjct: 211 SACKSSDLWALGCIIYQ 227
>pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
pdb|3G2F|B Chain B, Crystal Structure Of The Kinase Domain Of Bone
Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A
Resolution
Length = 336
Score = 69.3 bits (168), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 71/231 (30%), Positives = 102/231 (44%), Gaps = 38/231 (16%)
Query: 686 NLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRR--IRHRNLIKIV- 742
L+G G + VYK +L + VAVKVF+ ++F E + R + H N+ + +
Sbjct: 19 ELIGRGRYGAVYKGSL-DERPVAVKVFSFANR---QNFINEKNIYRVPLMEHDNIARFIV 74
Query: 743 --SSCSNPGFKA--LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH---- 794
+ G L+M+Y P GSL K+L H RL V L YLH
Sbjct: 75 GDERVTADGRMEYLLVMEYYPNGSLXKYLSLHTSDWVSSCRL--AHSVTRGLAYLHTELP 132
Query: 795 --HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDG---VDPVTQT----MTLATI 845
Y I H DL NVL+ +D + DFG++ L G V P + + TI
Sbjct: 133 RGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTI 192
Query: 846 GYMAPEYGSEGIVSISG--------DVYSFGILMMETFTRRKPTNEMFTGE 888
YMAPE EG V++ D+Y+ G++ E F R ++F GE
Sbjct: 193 RYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFMR---CTDLFPGE 239
>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
pdb|4G5P|B Chain B, Crystal Structure Of Egfr Kinase T790m In Complex With
Bibw2992
Length = 330
Score = 69.3 bits (168), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 64/239 (26%), Positives = 106/239 (44%), Gaps = 12/239 (5%)
Query: 682 FGESNLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH 735
F + +LGSG+F VYK V + V + L+E +A K E VM + +
Sbjct: 20 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LIMQ MP G L ++ H ++ + L+ + +A + YL
Sbjct: 80 PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 137
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGS 854
++H DL NVL+ + DFG+AKLL + I +MA E
Sbjct: 138 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 855 EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912
I + DV+S+G+ + E T KP + + E+S E LP +D ++
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 254
>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation
pdb|2JIT|B Chain B, Crystal Structure Of Egfr Kinase Domain T790m Mutation
Length = 327
Score = 69.3 bits (168), Expect = 9e-12, Method: Compositional matrix adjust.
Identities = 64/239 (26%), Positives = 106/239 (44%), Gaps = 12/239 (5%)
Query: 682 FGESNLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH 735
F + +LGSG+F VYK V + V + L+E +A K E VM + +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LIMQ MP G L ++ H ++ + L+ + +A + YL
Sbjct: 77 PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 134
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGS 854
++H DL NVL+ + DFG+AKLL + I +MA E
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 855 EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912
I + DV+S+G+ + E T KP + + E+S E LP +D ++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 251
>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626
pdb|2J4Z|B Chain B, Structure Of Aurora-2 In Complex With Pha-680626
Length = 306
Score = 69.3 bits (168), Expect = 9e-12, Method: Composition-based stats.
Identities = 81/270 (30%), Positives = 123/270 (45%), Gaps = 20/270 (7%)
Query: 654 SLPEENNSLNLATLSRISYHELQQ-ATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKV 711
S PE N LA+ + + +Q A F LG G F NVY A + A+KV
Sbjct: 7 SAPENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV 66
Query: 712 -FNLQEDRA--LKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLY 768
F Q ++A E E+ +RH N++++ + LI++Y P G++ + L
Sbjct: 67 LFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL- 125
Query: 769 SHNYSLTIRQRLDIMI-DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIA 827
S QR I ++A+AL Y H S +IH D+KP N+LL + DFG +
Sbjct: 126 -QKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 181
Query: 828 KLLDGVDPVTQTMTL-ATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFT 886
P ++ TL T+ Y+ PE + D++S G+L E F KP E T
Sbjct: 182 VHA----PSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANT 236
Query: 887 GEMSLKQW--VAESLPGAVTEVVDANLLSR 914
+ + K+ V + P VTE +L+SR
Sbjct: 237 YQETYKRISRVEFTFPDFVTEGA-RDLISR 265
>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex
pdb|3F88|B Chain B, Glycogen Synthase Kinase 3beta Inhibitor Complex
Length = 349
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 68/230 (29%), Positives = 115/230 (50%), Gaps = 34/230 (14%)
Query: 682 FGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
+ ++ ++G+GSF VY+A L + G VA+K + +D+ K + E ++MR++ H N+++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 77
Query: 741 IVSSCSNPGFKA------LIMQYMPQGSLEKWLYSHNYSLTIRQRLDI------MIDVAS 788
+ + G K L++ Y+P+ + + +YS +Q L + M +
Sbjct: 78 LRYFFYSSGEKKDVVYLNLVLDYVPETV---YRVARHYSRA-KQTLPVIYVKLYMYQLFR 133
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
+L Y+H S I H D+KP N+LLD D V L DFG AK L +P + + Y
Sbjct: 134 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYY 188
Query: 848 MAPE--YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWV 895
APE +G+ S S DV+S G ++ E +F G+ + Q V
Sbjct: 189 RAPELIFGATDYTS-SIDVWSAGCVLAELLL----GQPIFPGDSGVDQLV 233
>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
pdb|2OW3|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With Bis-
(Indole)maleimide Pyridinophane Inhibitor
Length = 352
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 68/230 (29%), Positives = 115/230 (50%), Gaps = 34/230 (14%)
Query: 682 FGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
+ ++ ++G+GSF VY+A L + G VA+K + +D+ K + E ++MR++ H N+++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 77
Query: 741 IVSSCSNPGFKA------LIMQYMPQGSLEKWLYSHNYSLTIRQRLDI------MIDVAS 788
+ + G K L++ Y+P+ + + +YS +Q L + M +
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRA-KQTLPVIYVKLYMYQLFR 133
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
+L Y+H S I H D+KP N+LLD D V L DFG AK L +P + + Y
Sbjct: 134 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYY 188
Query: 848 MAPE--YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWV 895
APE +G+ S S DV+S G ++ E +F G+ + Q V
Sbjct: 189 RAPELIFGATDYTS-SIDVWSAGCVLAELLL----GQPIFPGDSGVDQLV 233
>pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|1RQQ|B Chain B, Crystal Structure Of The Insulin Receptor Kinase In
Complex With The Sh2 Domain Of Aps
pdb|2AUH|A Chain A, Crystal Structure Of The Grb14 Bps Region In Complex With
The Insulin Receptor Tyrosine Kinase
pdb|2B4S|B Chain B, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|2B4S|D Chain D, Crystal Structure Of A Complex Between Ptp1b And The
Insulin Receptor Tyrosine Kinase
pdb|3BU3|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide
pdb|3BU5|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Peptide And Atp
pdb|3BU6|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In
Complex With Irs2 Krlb Phosphopeptide
Length = 306
Score = 69.3 bits (168), Expect = 1e-11, Method: Composition-based stats.
Identities = 54/224 (24%), Positives = 103/224 (45%), Gaps = 24/224 (10%)
Query: 688 LGSGSFDNVYKATLANGVS------VAVKVFNLQEDRALKS---FDTECEVMRRIRHRNL 738
LG GSF VY+ + + VAVK N E +L+ F E VM+ ++
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 82
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSL---------TIRQRLDIMIDVASA 789
++++ S ++M+ M G L+ +L S T+++ + + ++A
Sbjct: 83 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT-MTLATIGYM 848
+ YL+ + +H DL N ++ D +GDFG+ + + D + L + +M
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIXETDXXRKGGKGLLPVRWM 199
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892
APE +G+ + S D++SFG+++ E + + + + E LK
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243
>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
pdb|3SAY|B Chain B, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta
(Gsk3b) In Complex With Inhibitor 142
Length = 430
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 64/208 (30%), Positives = 108/208 (51%), Gaps = 30/208 (14%)
Query: 682 FGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
+ ++ ++G+GSF VY+A L + G VA+K + +D+ K + E ++MR++ H N+++
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 111
Query: 741 IVSSCSNPGFKA------LIMQYMPQGSLEKWLYSHNYSLTIRQRLDI------MIDVAS 788
+ + G K L++ Y+P+ + + +YS +Q L + M +
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRA-KQTLPVIYVKLYMYQLFR 167
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
+L Y+H S I H D+KP N+LLD D V L DFG AK L +P + + Y
Sbjct: 168 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYY 222
Query: 848 MAPE--YGSEGIVSISGDVYSFGILMME 873
APE +G+ S S DV+S G ++ E
Sbjct: 223 RAPELIFGATDYTS-SIDVWSAGCVLAE 249
>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
pdb|3F7Z|B Chain B, X-ray Co-crystal Structure Of Glycogen Synthase Kinase
3beta In Complex With An Inhibitor
Length = 350
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 68/230 (29%), Positives = 115/230 (50%), Gaps = 34/230 (14%)
Query: 682 FGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
+ ++ ++G+GSF VY+A L + G VA+K + +D+ K + E ++MR++ H N+++
Sbjct: 23 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 78
Query: 741 IVSSCSNPGFKA------LIMQYMPQGSLEKWLYSHNYSLTIRQRLDI------MIDVAS 788
+ + G K L++ Y+P+ + + +YS +Q L + M +
Sbjct: 79 LRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRA-KQTLPVIYVKLYMYQLFR 134
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
+L Y+H S I H D+KP N+LLD D V L DFG AK L +P + + Y
Sbjct: 135 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYY 189
Query: 848 MAPE--YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWV 895
APE +G+ S S DV+S G ++ E +F G+ + Q V
Sbjct: 190 RAPELIFGATDYTS-SIDVWSAGCVLAELLL----GQPIFPGDSGVDQLV 234
>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex
With An Hydantoin Inhibitor
Length = 305
Score = 69.3 bits (168), Expect = 1e-11, Method: Composition-based stats.
Identities = 61/237 (25%), Positives = 106/237 (44%), Gaps = 22/237 (9%)
Query: 674 ELQQATNGFGESNLLGSGSFDNVYKATLANGV-------SVAVKVFNLQED-RALKSFDT 725
E + A S LG GSF VY+ +A GV VA+K N R F
Sbjct: 10 EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 68
Query: 726 ECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYS-----HNYSLTIRQRL 780
E VM+ ++++++ S +IM+ M +G L+ +L S N + L
Sbjct: 69 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 128
Query: 781 DIMI----DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836
MI ++A + YL+ + +H DL N ++ +D +GDFG+ + + D
Sbjct: 129 SKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 185
Query: 837 TQT-MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892
+ L + +M+PE +G+ + DV+SFG+++ E T + + + E L+
Sbjct: 186 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 242
>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|B Chain B, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|C Chain C, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
pdb|3QQU|D Chain D, Cocrystal Structure Of Unphosphorylated Igf With
Pyrimidine 8
Length = 301
Score = 69.3 bits (168), Expect = 1e-11, Method: Composition-based stats.
Identities = 61/237 (25%), Positives = 106/237 (44%), Gaps = 22/237 (9%)
Query: 674 ELQQATNGFGESNLLGSGSFDNVYKATLANGV-------SVAVKVFNLQED-RALKSFDT 725
E + A S LG GSF VY+ +A GV VA+K N R F
Sbjct: 6 EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 726 ECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYS-----HNYSLTIRQRL 780
E VM+ ++++++ S +IM+ M +G L+ +L S N + L
Sbjct: 65 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 781 DIMI----DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836
MI ++A + YL+ + +H DL N ++ +D +GDFG+ + + D
Sbjct: 125 SKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 837 TQT-MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892
+ L + +M+PE +G+ + DV+SFG+++ E T + + + E L+
Sbjct: 182 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 238
>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With Bms-754807
[1-(4-((5-Cyclopropyl-
1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2,
4]triazin-2-Yl)-N-
(6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide]
Length = 315
Score = 69.3 bits (168), Expect = 1e-11, Method: Composition-based stats.
Identities = 61/237 (25%), Positives = 106/237 (44%), Gaps = 22/237 (9%)
Query: 674 ELQQATNGFGESNLLGSGSFDNVYKATLANGV-------SVAVKVFNLQED-RALKSFDT 725
E + A S LG GSF VY+ +A GV VA+K N R F
Sbjct: 12 EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 70
Query: 726 ECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYS-----HNYSLTIRQRL 780
E VM+ ++++++ S +IM+ M +G L+ +L S N + L
Sbjct: 71 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 781 DIMI----DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836
MI ++A + YL+ + +H DL N ++ +D +GDFG+ + + D
Sbjct: 131 SKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 187
Query: 837 TQT-MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892
+ L + +M+PE +G+ + DV+SFG+++ E T + + + E L+
Sbjct: 188 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 244
>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A
Benzimidazole Inhibitor
pdb|3NW5|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11b)
pdb|3NW6|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (11a)
pdb|3NW7|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor
(Igf-1r-Wt) Complex With A Carbon-Linked Proline
Isostere Inhibitor (34)
Length = 307
Score = 69.3 bits (168), Expect = 1e-11, Method: Composition-based stats.
Identities = 61/237 (25%), Positives = 106/237 (44%), Gaps = 22/237 (9%)
Query: 674 ELQQATNGFGESNLLGSGSFDNVYKATLANGV-------SVAVKVFNLQED-RALKSFDT 725
E + A S LG GSF VY+ +A GV VA+K N R F
Sbjct: 12 EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 70
Query: 726 ECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYS-----HNYSLTIRQRL 780
E VM+ ++++++ S +IM+ M +G L+ +L S N + L
Sbjct: 71 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 130
Query: 781 DIMI----DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836
MI ++A + YL+ + +H DL N ++ +D +GDFG+ + + D
Sbjct: 131 SKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 187
Query: 837 TQT-MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892
+ L + +M+PE +G+ + DV+SFG+++ E T + + + E L+
Sbjct: 188 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 244
>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
pdb|1M7N|B Chain B, Crystal Structure Of Unactivated Apo Insulin-Like Growth
Factor-1 Receptor Kinase Domain
Length = 322
Score = 69.3 bits (168), Expect = 1e-11, Method: Composition-based stats.
Identities = 61/237 (25%), Positives = 106/237 (44%), Gaps = 22/237 (9%)
Query: 674 ELQQATNGFGESNLLGSGSFDNVYKATLANGV-------SVAVKVFNLQED-RALKSFDT 725
E + A S LG GSF VY+ +A GV VA+K N R F
Sbjct: 19 EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 726 ECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYS-----HNYSLTIRQRL 780
E VM+ ++++++ S +IM+ M +G L+ +L S N + L
Sbjct: 78 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 137
Query: 781 DIMI----DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836
MI ++A + YL+ + +H DL N ++ +D +GDFG+ + + D
Sbjct: 138 SKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 837 TQT-MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892
+ L + +M+PE +G+ + DV+SFG+++ E T + + + E L+
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251
>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain
pdb|1JQH|B Chain B, Igf-1 Receptor Kinase Domain
pdb|1JQH|C Chain C, Igf-1 Receptor Kinase Domain
Length = 308
Score = 69.3 bits (168), Expect = 1e-11, Method: Composition-based stats.
Identities = 61/237 (25%), Positives = 106/237 (44%), Gaps = 22/237 (9%)
Query: 674 ELQQATNGFGESNLLGSGSFDNVYKATLANGV-------SVAVKVFNLQED-RALKSFDT 725
E + A S LG GSF VY+ +A GV VA+K N R F
Sbjct: 13 EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 71
Query: 726 ECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYS-----HNYSLTIRQRL 780
E VM+ ++++++ S +IM+ M +G L+ +L S N + L
Sbjct: 72 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 131
Query: 781 DIMI----DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836
MI ++A + YL+ + +H DL N ++ +D +GDFG+ + + D
Sbjct: 132 SKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 188
Query: 837 TQT-MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892
+ L + +M+PE +G+ + DV+SFG+++ E T + + + E L+
Sbjct: 189 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 245
>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr)
Kinase Domain
Length = 316
Score = 69.3 bits (168), Expect = 1e-11, Method: Composition-based stats.
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 34/217 (15%)
Query: 688 LGSGSFDNVYKA------TLANGVSVAVKVF----NLQEDRALKSFDTECEVMRRI-RHR 736
LG G+F V +A A +VAVK+ E RAL S E +++ I H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS---ELKILIHIGHHL 91
Query: 737 NLIKIVSSCSNPGFKAL-IMQYMPQGSLEKWLYSHNYS---------------LTIRQRL 780
N++ ++ +C+ PG + I+++ G+L +L S LT+ +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 781 DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQT 839
VA +E+L S IH DL N+LL + V + DFG+A+ + D V +
Sbjct: 152 CYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKG 208
Query: 840 MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + +I DV+SFG+L+ E F+
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel
4-amino-furo[2,3-d]pyrimidine
Length = 316
Score = 69.3 bits (168), Expect = 1e-11, Method: Composition-based stats.
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 34/217 (15%)
Query: 688 LGSGSFDNVYKA------TLANGVSVAVKVF----NLQEDRALKSFDTECEVMRRI-RHR 736
LG G+F V +A A +VAVK+ E RAL S E +++ I H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS---ELKILIHIGHHL 91
Query: 737 NLIKIVSSCSNPGFKAL-IMQYMPQGSLEKWLYSHNYS---------------LTIRQRL 780
N++ ++ +C+ PG + I+++ G+L +L S LT+ +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 781 DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQT 839
VA +E+L S IH DL N+LL + V + DFG+A+ + D V +
Sbjct: 152 CYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 208
Query: 840 MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + +I DV+SFG+L+ E F+
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Inhibitor 7d
Length = 350
Score = 69.3 bits (168), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 68/230 (29%), Positives = 115/230 (50%), Gaps = 34/230 (14%)
Query: 682 FGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
+ ++ ++G+GSF VY+A L + G VA+K + +D+ K + E ++MR++ H N+++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 77
Query: 741 IVSSCSNPGFKA------LIMQYMPQGSLEKWLYSHNYSLTIRQRLDI------MIDVAS 788
+ + G K L++ Y+P+ + + +YS +Q L + M +
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRA-KQTLPVIYVKLYMYQLFR 133
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
+L Y+H S I H D+KP N+LLD D V L DFG AK L +P + + Y
Sbjct: 134 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYY 188
Query: 848 MAPE--YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWV 895
APE +G+ S S DV+S G ++ E +F G+ + Q V
Sbjct: 189 RAPELIFGATDYTS-SIDVWSAGCVLAELLL----GQPIFPGDSGVDQLV 233
>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|2P2I|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Nicotinamide Inhibitor
pdb|3EFL|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
pdb|3EFL|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Motesanib
Length = 314
Score = 69.3 bits (168), Expect = 1e-11, Method: Composition-based stats.
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 34/217 (15%)
Query: 688 LGSGSFDNVYKA------TLANGVSVAVKVF----NLQEDRALKSFDTECEVMRRI-RHR 736
LG G+F V +A A +VAVK+ E RAL S E +++ I H
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS---ELKILIHIGHHL 82
Query: 737 NLIKIVSSCSNPGFKAL-IMQYMPQGSLEKWLYSHNYS---------------LTIRQRL 780
N++ ++ +C+ PG + I+++ G+L +L S LT+ +
Sbjct: 83 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 781 DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQT 839
VA +E+L S IH DL N+LL + V + DFG+A+ + D V +
Sbjct: 143 CYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 840 MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + +I DV+SFG+L+ E F+
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236
>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRK|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRL|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As
Gsk-3beta Inhibitors
pdb|3ZRM|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
pdb|3ZRM|B Chain B, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-
3beta Inhibitors
Length = 371
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 68/230 (29%), Positives = 115/230 (50%), Gaps = 34/230 (14%)
Query: 682 FGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
+ ++ ++G+GSF VY+A L + G VA+K + +D+ K + E ++MR++ H N+++
Sbjct: 34 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 89
Query: 741 IVSSCSNPGFKA------LIMQYMPQGSLEKWLYSHNYSLTIRQRLDI------MIDVAS 788
+ + G K L++ Y+P+ + + +YS +Q L + M +
Sbjct: 90 LRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRA-KQTLPVIYVKLYMYQLFR 145
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
+L Y+H S I H D+KP N+LLD D V L DFG AK L +P + + Y
Sbjct: 146 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYY 200
Query: 848 MAPE--YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWV 895
APE +G+ S S DV+S G ++ E +F G+ + Q V
Sbjct: 201 RAPELIFGATDYTS-SIDVWSAGCVLAELLL----GQPIFPGDSGVDQLV 245
>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis
Length = 394
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 64/235 (27%), Positives = 115/235 (48%), Gaps = 33/235 (14%)
Query: 676 QQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRH 735
+Q + ++G+GSF V++A L VA+K + +D+ K + E ++MR ++H
Sbjct: 36 EQREIAYTNCKVIGNGSFGVVFQAKLVESDEVAIK--KVLQDKRFK--NRELQIMRIVKH 91
Query: 736 RNLIKIVSSCSNPG------FKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDI------M 783
N++ + + + G F L+++Y+P+ + S +Y+ ++Q + + M
Sbjct: 92 PNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETV---YRASRHYA-KLKQTMPMLLIKLYM 147
Query: 784 IDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDPVTQTMTL 842
+ +L Y+H S I H D+KP N+LLD V L DFG AK+L +P +
Sbjct: 148 YQLLRSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP--NVSXI 202
Query: 843 ATIGYMAPE--YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWV 895
+ Y APE +G+ + + D++S G +M E +F GE + Q V
Sbjct: 203 CSRYYRAPELIFGATNYTT-NIDIWSTGCVMAELMQ----GQPLFPGESGIDQLV 252
>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex
Length = 353
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 68/230 (29%), Positives = 115/230 (50%), Gaps = 34/230 (14%)
Query: 682 FGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
+ ++ ++G+GSF VY+A L + G VA+K + +D+ K + E ++MR++ H N+++
Sbjct: 26 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 81
Query: 741 IVSSCSNPGFKA------LIMQYMPQGSLEKWLYSHNYSLTIRQRLDI------MIDVAS 788
+ + G K L++ Y+P+ + + +YS +Q L + M +
Sbjct: 82 LRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRA-KQTLPVIYVKLYMYQLFR 137
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
+L Y+H S I H D+KP N+LLD D V L DFG AK L +P + + Y
Sbjct: 138 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYY 192
Query: 848 MAPE--YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWV 895
APE +G+ S S DV+S G ++ E +F G+ + Q V
Sbjct: 193 RAPELIFGATDYTS-SIDVWSAGCVLAELLL----GQPIFPGDSGVDQLV 237
>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Imidazopyridine Inhibitor
Length = 382
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 68/230 (29%), Positives = 115/230 (50%), Gaps = 34/230 (14%)
Query: 682 FGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
+ ++ ++G+GSF VY+A L + G VA+K + +D+ K + E ++MR++ H N+++
Sbjct: 34 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 89
Query: 741 IVSSCSNPGFKA------LIMQYMPQGSLEKWLYSHNYSLTIRQRLDI------MIDVAS 788
+ + G K L++ Y+P+ + + +YS +Q L + M +
Sbjct: 90 LRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRA-KQTLPVIYVKLYMYQLFR 145
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
+L Y+H S I H D+KP N+LLD D V L DFG AK L +P + + Y
Sbjct: 146 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYY 200
Query: 848 MAPE--YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWV 895
APE +G+ S S DV+S G ++ E +F G+ + Q V
Sbjct: 201 RAPELIFGATDYTS-SIDVWSAGCVLAELLL----GQPIFPGDSGVDQLV 245
>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
pdb|1GNG|B Chain B, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With
Frattide Peptide
Length = 378
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 68/230 (29%), Positives = 115/230 (50%), Gaps = 34/230 (14%)
Query: 682 FGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
+ ++ ++G+GSF VY+A L + G VA+K + +D+ K + E ++MR++ H N+++
Sbjct: 41 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 96
Query: 741 IVSSCSNPGFKA------LIMQYMPQGSLEKWLYSHNYSLTIRQRLDI------MIDVAS 788
+ + G K L++ Y+P+ + + +YS +Q L + M +
Sbjct: 97 LRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRA-KQTLPVIYVKLYMYQLFR 152
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
+L Y+H S I H D+KP N+LLD D V L DFG AK L +P + + Y
Sbjct: 153 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYY 207
Query: 848 MAPE--YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWV 895
APE +G+ S S DV+S G ++ E +F G+ + Q V
Sbjct: 208 RAPELIFGATDYTS-SIDVWSAGCVLAELLL----GQPIFPGDSGVDQLV 252
>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
pdb|4AFJ|B Chain B, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective
Gsk-3 Inhibitors
Length = 367
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 68/230 (29%), Positives = 115/230 (50%), Gaps = 34/230 (14%)
Query: 682 FGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
+ ++ ++G+GSF VY+A L + G VA+K + +D+ K + E ++MR++ H N+++
Sbjct: 30 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 85
Query: 741 IVSSCSNPGFKA------LIMQYMPQGSLEKWLYSHNYSLTIRQRLDI------MIDVAS 788
+ + G K L++ Y+P+ + + +YS +Q L + M +
Sbjct: 86 LRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRA-KQTLPVIYVKLYMYQLFR 141
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
+L Y+H S I H D+KP N+LLD D V L DFG AK L +P + + Y
Sbjct: 142 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYY 196
Query: 848 MAPE--YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWV 895
APE +G+ S S DV+S G ++ E +F G+ + Q V
Sbjct: 197 RAPELIFGATDYTS-SIDVWSAGCVLAELLL----GQPIFPGDSGVDQLV 241
>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution.
pdb|1P4O|B Chain B, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a
Resolution
Length = 322
Score = 68.9 bits (167), Expect = 1e-11, Method: Composition-based stats.
Identities = 57/237 (24%), Positives = 108/237 (45%), Gaps = 22/237 (9%)
Query: 674 ELQQATNGFGESNLLGSGSFDNVYKATLANGV-------SVAVKVFNLQED-RALKSFDT 725
E + A S LG GSF VY+ +A GV VA+K N R F
Sbjct: 19 EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 77
Query: 726 ECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSL---------TI 776
E VM+ ++++++ S +IM+ M +G L+ +L S ++ ++
Sbjct: 78 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 777 RQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836
+ + + ++A + YL+ + +H DL N ++ +D +GDFG+ + + D
Sbjct: 138 SKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 194
Query: 837 TQT-MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892
+ L + +M+PE +G+ + DV+SFG+++ E T + + + E L+
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 251
>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Axitinib (Ag-013736)
(N-Methyl-2-(
3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-
Benzamide)
pdb|4AGD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sunitinib (Su11248) (N-2-
Diethylaminoethyl)-5-((Z)-(5-Fluoro-2-Oxo-1h-Indol-3-
Ylidene)methyl)-2,4-Dimethyl-1h-Pyrrole-3-Carboxamide)
pdb|4ASD|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Sorafenib (Bay 43-9006)
pdb|4ASE|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase
Domains) In Complex With Tivozanib (Av-951)
Length = 353
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 62/217 (28%), Positives = 102/217 (47%), Gaps = 34/217 (15%)
Query: 688 LGSGSFDNVYKA------TLANGVSVAVKVFN----LQEDRALKSFDTECEVMRRIRHR- 736
LG G+F V +A A +VAVK+ E RAL S E +++ I H
Sbjct: 72 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS---ELKILIHIGHHL 128
Query: 737 NLIKIVSSCSNPGFKAL-IMQYMPQGSLEKWLYS---------------HNYSLTIRQRL 780
N++ ++ +C+ PG + I+++ G+L +L S + LT+ +
Sbjct: 129 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 188
Query: 781 DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQT 839
VA +E+L S IH DL N+LL + V + DFG+A+ + D V +
Sbjct: 189 CYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 245
Query: 840 MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + +I DV+SFG+L+ E F+
Sbjct: 246 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 282
>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|B Chain B, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|C Chain C, Igf-1rk In Complex With Ligand Msc1609119a-1
pdb|3LW0|D Chain D, Igf-1rk In Complex With Ligand Msc1609119a-1
Length = 304
Score = 68.9 bits (167), Expect = 1e-11, Method: Composition-based stats.
Identities = 57/237 (24%), Positives = 108/237 (45%), Gaps = 22/237 (9%)
Query: 674 ELQQATNGFGESNLLGSGSFDNVYKATLANGV-------SVAVKVFNLQED-RALKSFDT 725
E + A S LG GSF VY+ +A GV VA+K N R F
Sbjct: 9 EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 67
Query: 726 ECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSL---------TI 776
E VM+ ++++++ S +IM+ M +G L+ +L S ++ ++
Sbjct: 68 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 127
Query: 777 RQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836
+ + + ++A + YL+ + +H DL N ++ +D +GDFG+ + + D
Sbjct: 128 SKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 184
Query: 837 TQT-MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892
+ L + +M+PE +G+ + DV+SFG+++ E T + + + E L+
Sbjct: 185 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 241
>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|B Chain B, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|C Chain C, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
pdb|3LVP|D Chain D, Crystal Structure Of Bisphosphorylated Igf1-R Kinase
Domain (2p) In Complex With A Bis-Azaindole Inhibitor
Length = 336
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 55/221 (24%), Positives = 101/221 (45%), Gaps = 22/221 (9%)
Query: 674 ELQQATNGFGESNLLGSGSFDNVYKATLANGV-------SVAVKVFNLQED-RALKSFDT 725
E + A S LG GSF VY+ +A GV VA+K N R F
Sbjct: 41 EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 99
Query: 726 ECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSL---------TI 776
E VM+ ++++++ S +IM+ M +G L+ +L S + ++
Sbjct: 100 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 159
Query: 777 RQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836
+ + + ++A + YL+ + +H DL N ++ +D +GDFG+ + + D
Sbjct: 160 SKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY 216
Query: 837 TQT-MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ L + +M+PE +G+ + DV+SFG+++ E T
Sbjct: 217 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIAT 257
>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|2GS7|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|B Chain B, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|C Chain C, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
pdb|3GT8|D Chain D, Crystal Structure Of The Inactive Egfr Kinase Domain In
Complex With Amp-Pnp
Length = 330
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 64/242 (26%), Positives = 107/242 (44%), Gaps = 12/242 (4%)
Query: 682 FGESNLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH 735
F + +LGSG+F VYK V + V + L+E +A K E VM + +
Sbjct: 20 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LI Q MP G L ++ H ++ + L+ + +A + YL
Sbjct: 80 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 137
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGS 854
++H DL NVL+ + DFG+AKLL + I +MA E
Sbjct: 138 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 855 EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913
I + DV+S+G+ + E T KP + + E+S E LP +D ++
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIM 255
Query: 914 RE 915
R+
Sbjct: 256 RK 257
>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 53/207 (25%), Positives = 98/207 (47%), Gaps = 13/207 (6%)
Query: 673 HELQQATNGFGESNLLGSGSFDNVYKATLAN----GVSVAVKVF-NLQEDRALKSFDTEC 727
+E+Q+ G +G G F +V++ + ++VA+K N D + F E
Sbjct: 385 YEIQRERIELG--RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 442
Query: 728 EVMRRIRHRNLIKIVSSCS-NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDV 786
MR+ H +++K++ + NP + +IM+ G L +L +SL + + +
Sbjct: 443 LTMRQFDHPHIVKLIGVITENPVW--IIMELCTLGELRSFLQVRKFSLDLASLILYAYQL 500
Query: 787 ASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG 846
++AL YL S +H D+ NVL+ + LGDFG+++ ++ + I
Sbjct: 501 STALAYLE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 847 YMAPEYGSEGIVSISGDVYSFGILMME 873
+MAPE + + + DV+ FG+ M E
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWE 584
>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain
Length = 310
Score = 68.9 bits (167), Expect = 1e-11, Method: Composition-based stats.
Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 9/197 (4%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRN 737
F +LG GSF V A LA A+K+ ++ ++ + E +VM R+ H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+K+ + + + Y G L K++ R ++ SALEYLH
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 147
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-LATIGYMAPEYGSEG 856
IIH DLKP N+LL++DM + DFG AK+L + + T Y++PE +E
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEK 207
Query: 857 IVSISGDVYSFGILMME 873
S D+++ G ++ +
Sbjct: 208 SACKSSDLWALGCIIYQ 224
>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|B Chain B, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|C Chain C, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|D Chain D, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|E Chain E, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|F Chain F, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|G Chain G, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
pdb|3LZB|H Chain H, Egfr Kinase Domain Complexed With An
Imidazo[2,1-B]thiazole Inhibitor
Length = 327
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 64/242 (26%), Positives = 107/242 (44%), Gaps = 12/242 (4%)
Query: 682 FGESNLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH 735
F + +LGSG+F VYK V + V + L+E +A K E VM + +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LI Q MP G L ++ H ++ + L+ + +A + YL
Sbjct: 77 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 134
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGS 854
++H DL NVL+ + DFG+AKLL + I +MA E
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 855 EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913
I + DV+S+G+ + E T KP + + E+S E LP +D ++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIM 252
Query: 914 RE 915
R+
Sbjct: 253 RK 254
>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|1Q5K|B Chain B, Crystal Structure Of Glycogen Synthase Kinase 3 In
Complexed With Inhibitor
pdb|3I4B|A Chain A, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3I4B|B Chain B, Crystal Structure Of Gsk3b In Complex With A
Pyrimidylpyrrole Inhibitor
pdb|3L1S|A Chain A, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
pdb|3L1S|B Chain B, 3-Aryl-4-(Arylhydrazono)-1h-Pyrazol-5-Ones: Highly Ligand
Efficient And Potent Inhibitors Of Gsk3
Length = 414
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 64/208 (30%), Positives = 108/208 (51%), Gaps = 30/208 (14%)
Query: 682 FGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
+ ++ ++G+GSF VY+A L + G VA+K + +D+ K + E ++MR++ H N+++
Sbjct: 50 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 105
Query: 741 IVSSCSNPGFKA------LIMQYMPQGSLEKWLYSHNYSLTIRQRLDI------MIDVAS 788
+ + G K L++ Y+P+ + + +YS +Q L + M +
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRA-KQTLPVIYVKLYMYQLFR 161
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
+L Y+H S I H D+KP N+LLD D V L DFG AK L +P + + Y
Sbjct: 162 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYY 216
Query: 848 MAPE--YGSEGIVSISGDVYSFGILMME 873
APE +G+ S S DV+S G ++ E
Sbjct: 217 RAPELIFGATDYTS-SIDVWSAGCVLAE 243
>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3D|B Chain B, Gsk-3 Beta Complexed With Staurosporine
pdb|1Q3W|A Chain A, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q3W|B Chain B, Gsk-3 Beta Complexed With Alsterpaullone
pdb|1Q41|A Chain A, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q41|B Chain B, Gsk-3 Beta Complexed With Indirubin-3'-Monoxime
pdb|1Q4L|A Chain A, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|1Q4L|B Chain B, Gsk-3 Beta Complexed With Inhibitor I-5
pdb|3Q3B|A Chain A, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
pdb|3Q3B|B Chain B, 6-Amino-4-(Pyrimidin-4-Yl)pyridones: Novel Glycogen
Synthase Kinase-3 Inhibitors
Length = 424
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 68/230 (29%), Positives = 115/230 (50%), Gaps = 34/230 (14%)
Query: 682 FGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
+ ++ ++G+GSF VY+A L + G VA+K + +D+ K + E ++MR++ H N+++
Sbjct: 60 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 115
Query: 741 IVSSCSNPGFKA------LIMQYMPQGSLEKWLYSHNYSLTIRQRLDI------MIDVAS 788
+ + G K L++ Y+P+ + + +YS +Q L + M +
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRA-KQTLPVIYVKLYMYQLFR 171
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
+L Y+H S I H D+KP N+LLD D V L DFG AK L +P + + Y
Sbjct: 172 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYY 226
Query: 848 MAPE--YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWV 895
APE +G+ S S DV+S G ++ E +F G+ + Q V
Sbjct: 227 RAPELIFGATDYTS-SIDVWSAGCVLAELLL----GQPIFPGDSGVDQLV 271
>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|3SD0|B Chain B, Identification Of A Glycogen Synthase Kinase-3b Inhibitor
That Attenuates Hyperactivity In Clock Mutant Mice
pdb|4B7T|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide And Leucettine L4
Length = 350
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 68/230 (29%), Positives = 115/230 (50%), Gaps = 34/230 (14%)
Query: 682 FGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
+ ++ ++G+GSF VY+A L + G VA+K + +D+ K + E ++MR++ H N+++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 77
Query: 741 IVSSCSNPGFKA------LIMQYMPQGSLEKWLYSHNYSLTIRQRLDI------MIDVAS 788
+ + G K L++ Y+P+ + + +YS +Q L + M +
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRA-KQTLPVIYVKLYMYQLFR 133
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
+L Y+H S I H D+KP N+LLD D V L DFG AK L +P + + Y
Sbjct: 134 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYY 188
Query: 848 MAPE--YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWV 895
APE +G+ S S DV+S G ++ E +F G+ + Q V
Sbjct: 189 RAPELIFGATDYTS-SIDVWSAGCVLAELLL----GQPIFPGDSGVDQLV 233
>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps171 Bound To The Pif-Pocket
pdb|4AW0|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps182 Bound To The Pif-Pocket
Length = 311
Score = 68.9 bits (167), Expect = 1e-11, Method: Composition-based stats.
Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 9/197 (4%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRN 737
F +LG GSF V A LA A+K+ ++ ++ + E +VM R+ H
Sbjct: 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+K+ + + + Y G L K++ R ++ SALEYLH
Sbjct: 94 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 149
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-LATIGYMAPEYGSEG 856
IIH DLKP N+LL++DM + DFG AK+L + + T Y++PE +E
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 857 IVSISGDVYSFGILMME 873
S D+++ G ++ +
Sbjct: 210 SAXKSSDLWALGCIIYQ 226
>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1I09|B Chain B, Structure Of Glycogen Synthase Kinase-3 (Gsk3b)
pdb|1J1B|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1B|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Amppnp
pdb|1J1C|A Chain A, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|1J1C|B Chain B, Binary Complex Structure Of Human Tau Protein Kinase I
With Adp
pdb|2JLD|A Chain A, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|2JLD|B Chain B, Extremely Tight Binding Of Ruthenium Complex To Glycogen
Synthase Kinase 3
pdb|3M1S|A Chain A, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3M1S|B Chain B, Structure Of Ruthenium Half-Sandwich Complex Bound To
Glycogen Synthase Kinase 3
pdb|3PUP|A Chain A, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
pdb|3PUP|B Chain B, Structure Of Glycogen Synthase Kinase 3 Beta (Gsk3b) In
Complex With A Ruthenium Octasporine Ligand (Os1)
Length = 420
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 64/208 (30%), Positives = 108/208 (51%), Gaps = 30/208 (14%)
Query: 682 FGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
+ ++ ++G+GSF VY+A L + G VA+K + +D+ K + E ++MR++ H N+++
Sbjct: 56 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 111
Query: 741 IVSSCSNPGFKA------LIMQYMPQGSLEKWLYSHNYSLTIRQRLDI------MIDVAS 788
+ + G K L++ Y+P+ + + +YS +Q L + M +
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRA-KQTLPVIYVKLYMYQLFR 167
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
+L Y+H S I H D+KP N+LLD D V L DFG AK L +P + + Y
Sbjct: 168 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYY 222
Query: 848 MAPE--YGSEGIVSISGDVYSFGILMME 873
APE +G+ S S DV+S G ++ E
Sbjct: 223 RAPELIFGATDYTS-SIDVWSAGCVLAE 249
>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase
Domain With Erlotinib
Length = 337
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 64/242 (26%), Positives = 107/242 (44%), Gaps = 12/242 (4%)
Query: 682 FGESNLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH 735
F + +LGSG+F VYK V + V + L+E +A K E VM + +
Sbjct: 27 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 86
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LI Q MP G L ++ H ++ + L+ + +A + YL
Sbjct: 87 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 144
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGS 854
++H DL NVL+ + DFG+AKLL + I +MA E
Sbjct: 145 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 202
Query: 855 EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913
I + DV+S+G+ + E T KP + + E+S E LP +D ++
Sbjct: 203 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIM 262
Query: 914 RE 915
R+
Sbjct: 263 RK 264
>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp
Length = 298
Score = 68.9 bits (167), Expect = 1e-11, Method: Composition-based stats.
Identities = 54/203 (26%), Positives = 95/203 (46%), Gaps = 12/203 (5%)
Query: 687 LLGSGSFDNVYKATL----ANGVSVAVKVFN-LQEDRALKSFDTECEVMRRIRHRNLIKI 741
++G G F VY N + A+K + + E + +++F E +MR + H N++ +
Sbjct: 28 VIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLNHPNVLAL 87
Query: 742 VSSCSNP-GFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ P G +++ YM G L +++ S + T++ + + VA +EYL
Sbjct: 88 IGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE---QK 144
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQTMTLA--TIGYMAPEYGSEGI 857
+H DL N +LD+ + DFG+A+ +LD Q A + + A E
Sbjct: 145 FVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYR 204
Query: 858 VSISGDVYSFGILMMETFTRRKP 880
+ DV+SFG+L+ E TR P
Sbjct: 205 FTTKSDVWSFGVLLWELLTRGAP 227
>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin
pdb|4GUE|A Chain A, Structure Of N-terminal Kinase Domain Of Rsk2 With
Flavonoid Glycoside Quercitrin
Length = 305
Score = 68.9 bits (167), Expect = 1e-11, Method: Composition-based stats.
Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 687 LLGSGSFDNVYKATLANGVSV----AVKVFNLQEDRALKSFDTECE--VMRRIRHRNLIK 740
+LG GSF V+ +G A+KV + T+ E ++ + H ++K
Sbjct: 32 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 91
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ + G LI+ ++ G L L S T + ++A AL++LH S
Sbjct: 92 LHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLH---SLG 147
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGSEGIVS 859
II+ DLKP N+LLD++ L DFG++K + +D + + T+ YMAPE + +
Sbjct: 148 IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 205
Query: 860 ISGDVYSFGILMMETFTRRKP 880
S D +SFG+LM E T P
Sbjct: 206 QSADWWSFGVLMFEMLTGTLP 226
>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex
With Flavonoid Glycoside Sl0101
Length = 304
Score = 68.9 bits (167), Expect = 1e-11, Method: Composition-based stats.
Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 13/201 (6%)
Query: 687 LLGSGSFDNVYKATLANGVSV----AVKVFNLQEDRALKSFDTECE--VMRRIRHRNLIK 740
+LG GSF V+ +G A+KV + T+ E ++ + H ++K
Sbjct: 31 VLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVK 90
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ + G LI+ ++ G L L S T + ++A AL++LH S
Sbjct: 91 LHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALALDHLH---SLG 146
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGSEGIVS 859
II+ DLKP N+LLD++ L DFG++K + +D + + T+ YMAPE + +
Sbjct: 147 IIYRDLKPENILLDEEGHIKLTDFGLSK--ESIDHEKKAYSFCGTVEYMAPEVVNRRGHT 204
Query: 860 ISGDVYSFGILMMETFTRRKP 880
S D +SFG+LM E T P
Sbjct: 205 QSADWWSFGVLMFEMLTGTLP 225
>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp
pdb|1PYX|B Chain B, Gsk-3 Beta Complexed With Amp-Pnp
pdb|3DU8|A Chain A, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
pdb|3DU8|B Chain B, Crystal Structure Of Gsk-3 Beta In Complex With
Nms-869553a
Length = 422
Score = 68.9 bits (167), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 68/230 (29%), Positives = 115/230 (50%), Gaps = 34/230 (14%)
Query: 682 FGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
+ ++ ++G+GSF VY+A L + G VA+K + +D+ K + E ++MR++ H N+++
Sbjct: 58 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 113
Query: 741 IVSSCSNPGFKA------LIMQYMPQGSLEKWLYSHNYSLTIRQRLDI------MIDVAS 788
+ + G K L++ Y+P+ + + +YS +Q L + M +
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRA-KQTLPVIYVKLYMYQLFR 169
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
+L Y+H S I H D+KP N+LLD D V L DFG AK L +P + + Y
Sbjct: 170 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYY 224
Query: 848 MAPE--YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWV 895
APE +G+ S S DV+S G ++ E +F G+ + Q V
Sbjct: 225 RAPELIFGATDYTS-SIDVWSAGCVLAELLL----GQPIFPGDSGVDQLV 269
>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
pdb|1R0E|B Chain B, Glycogen Synthase Kinase-3 Beta In Complex With
3-Indolyl-4- Arylmaleimide Inhibitor
Length = 391
Score = 68.6 bits (166), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 64/208 (30%), Positives = 108/208 (51%), Gaps = 30/208 (14%)
Query: 682 FGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
+ ++ ++G+GSF VY+A L + G VA+K + +D+ K + E ++MR++ H N+++
Sbjct: 27 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 82
Query: 741 IVSSCSNPGFKA------LIMQYMPQGSLEKWLYSHNYSLTIRQRLDI------MIDVAS 788
+ + G K L++ Y+P+ + + +YS +Q L + M +
Sbjct: 83 LRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRA-KQTLPVIYVKLYMYQLFR 138
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
+L Y+H S I H D+KP N+LLD D V L DFG AK L +P + + Y
Sbjct: 139 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYY 193
Query: 848 MAPE--YGSEGIVSISGDVYSFGILMME 873
APE +G+ S S DV+S G ++ E
Sbjct: 194 RAPELIFGATDYTS-SIDVWSAGCVLAE 220
>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
pdb|2JKO|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With
Bis- Anilino Pyrimidine Inhibitor
Length = 276
Score = 68.6 bits (166), Expect = 1e-11, Method: Compositional matrix adjust.
Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 13/207 (6%)
Query: 673 HELQQATNGFGESNLLGSGSFDNVYKATLAN----GVSVAVKVF-NLQEDRALKSFDTEC 727
+E+Q+ G +G G F +V++ + ++VA+K N D + F E
Sbjct: 5 YEIQRERIELG--RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 62
Query: 728 EVMRRIRHRNLIKIVSSCS-NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDV 786
MR+ H +++K++ + NP + +IM+ G L +L +SL + + +
Sbjct: 63 LTMRQFDHPHIVKLIGVITENPVW--IIMELCTLGELRSFLQVRKFSLDLASLILYAYQL 120
Query: 787 ASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG 846
++AL YL S +H D+ NVL+ LGDFG+++ ++ + I
Sbjct: 121 STALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 177
Query: 847 YMAPEYGSEGIVSISGDVYSFGILMME 873
+MAPE + + + DV+ FG+ M E
Sbjct: 178 WMAPESINFRRFTSASDVWMFGVCMWE 204
>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridinyl-Triazine Inhibitor
pdb|2QU5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzimidazole Inhibitor
pdb|2QU6|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|2QU6|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzoxazole Inhibitor
pdb|3B8Q|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8Q|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|3B8R|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Naphthamide Inhibitor
pdb|2RL5|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A 2,3-Dihydro-1,4-Benzoxazine Inhibitor
pdb|3BE2|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzamide Inhibitor
pdb|3CP9|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CP9|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPB|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPB|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Bisamide Inhibitor
pdb|3CPC|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3CPC|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridone Inhibitor
pdb|3DTW|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
pdb|3DTW|B Chain B, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Benzisoxazole Inhibitor
Length = 314
Score = 68.6 bits (166), Expect = 1e-11, Method: Composition-based stats.
Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 34/217 (15%)
Query: 688 LGSGSFDNVYKA------TLANGVSVAVKVF----NLQEDRALKSFDTECEVMRRI-RHR 736
LG G+F V +A A +VAVK+ E RAL S E +++ I H
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS---ELKILIHIGHHL 82
Query: 737 NLIKIVSSCSNPGFKALIM-QYMPQGSLEKWLYSHNYS---------------LTIRQRL 780
N++ ++ +C+ PG +++ ++ G+L +L S LT+ +
Sbjct: 83 NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 781 DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQT 839
VA +E+L S IH DL N+LL + V + DFG+A+ + D V +
Sbjct: 143 CYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKG 199
Query: 840 MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + +I DV+SFG+L+ E F+
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236
>pdb|1Z5M|A Chain A, Crystal Structure Of
N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl)
Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2-
Dimethylpropanediamide Complexed With Human Pdk1
pdb|2PE0|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
5-Hydroxy-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-1,
3-Dihydro- Indol-2-One Complex
pdb|2PE1|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
{2-Oxo-3-[1-(1h-Pyrrol-2-Yl)-Eth-(Z)-Ylidene]-2,
3-Dihydro-1h- Indol-5-Yl}-Urea {bx-517} Complex
pdb|2PE2|A Chain A, Crystal Structure Of Human Phosphoinositide-Dependent
Protein Kinase 1 (Pdk1)
3-{5-[2-Oxo-5-Ureido-1,
2-Dihydro-Indol-(3z)-Ylidenemethyl]-1h-
Pyrrol-3-Yl}-N-(2-Piperidin-1-Yl-Ethyl)-Benzamide
Complex
Length = 286
Score = 68.6 bits (166), Expect = 2e-11, Method: Composition-based stats.
Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 9/197 (4%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRN 737
F +LG GSF V A LA A+K+ ++ ++ + E +VM R+ H
Sbjct: 9 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 68
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+K+ + + + Y G L K++ R ++ SALEYLH
Sbjct: 69 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 124
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-LATIGYMAPEYGSEG 856
IIH DLKP N+LL++DM + DFG AK+L + + T Y++PE +E
Sbjct: 125 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 184
Query: 857 IVSISGDVYSFGILMME 873
S D+++ G ++ +
Sbjct: 185 SACKSSDLWALGCIIYQ 201
>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ly333531
pdb|1UU7|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-2
pdb|1UU8|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-1
pdb|1OKY|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Staurosporine
pdb|1OKZ|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Ucn-01
Length = 310
Score = 68.6 bits (166), Expect = 2e-11, Method: Composition-based stats.
Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 9/197 (4%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRN 737
F +LG GSF V A LA A+K+ ++ ++ + E +VM R+ H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+K+ + + + Y G L K++ R ++ SALEYLH
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 147
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-LATIGYMAPEYGSEG 856
IIH DLKP N+LL++DM + DFG AK+L + + T Y++PE +E
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 857 IVSISGDVYSFGILMME 873
S D+++ G ++ +
Sbjct: 208 SACKSSDLWALGCIIYQ 224
>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 68.6 bits (166), Expect = 2e-11, Method: Composition-based stats.
Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 9/197 (4%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRN 737
F +LG GSF V A LA A+K+ ++ ++ + E +VM R+ H
Sbjct: 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+K+ + + + Y G L K++ R ++ SALEYLH
Sbjct: 94 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 149
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-LATIGYMAPEYGSEG 856
IIH DLKP N+LL++DM + DFG AK+L + + T Y++PE +E
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 857 IVSISGDVYSFGILMME 873
S D+++ G ++ +
Sbjct: 210 SACKSSDLWALGCIIYQ 226
>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through
Fragment-Based Lead Discovery
pdb|3RWQ|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3-
Phosphoinositide Dependent Kinase (Pdk1)
Length = 311
Score = 68.6 bits (166), Expect = 2e-11, Method: Composition-based stats.
Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 9/197 (4%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRN 737
F +LG GSF V A LA A+K+ ++ ++ + E +VM R+ H
Sbjct: 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+K+ + + + Y G L K++ R ++ SALEYLH
Sbjct: 94 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 149
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-LATIGYMAPEYGSEG 856
IIH DLKP N+LL++DM + DFG AK+L + + T Y++PE +E
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 857 IVSISGDVYSFGILMME 873
S D+++ G ++ +
Sbjct: 210 SACKSSDLWALGCIIYQ 226
>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
pdb|3QC4|B Chain B, Pdk1 In Complex With Dfg-Out Inhibitor Xxx
Length = 314
Score = 68.6 bits (166), Expect = 2e-11, Method: Composition-based stats.
Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 9/197 (4%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRN 737
F +LG GSF V A LA A+K+ ++ ++ + E +VM R+ H
Sbjct: 37 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 96
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+K+ + + + Y G L K++ R ++ SALEYLH
Sbjct: 97 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 152
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-LATIGYMAPEYGSEG 856
IIH DLKP N+LL++DM + DFG AK+L + + T Y++PE +E
Sbjct: 153 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 212
Query: 857 IVSISGDVYSFGILMME 873
S D+++ G ++ +
Sbjct: 213 SACKSSDLWALGCIIYQ 229
>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 68.6 bits (166), Expect = 2e-11, Method: Composition-based stats.
Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 9/197 (4%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRN 737
F +LG GSF V A LA A+K+ ++ ++ + E +VM R+ H
Sbjct: 32 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+K+ + + + Y G L K++ R ++ SALEYLH
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 147
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-LATIGYMAPEYGSEG 856
IIH DLKP N+LL++DM + DFG AK+L + + T Y++PE +E
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 857 IVSISGDVYSFGILMME 873
S D+++ G ++ +
Sbjct: 208 SACKSSDLWALGCIIYQ 224
>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i
pdb|3QCQ|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-(3-
Amino-1h-Indazol-6-Yl)-N4-Ethyl-2,4-Pyrimidinediamine
pdb|3QCS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-[2-
Amino-6-(4-Morpholinyl)-4-Pyrimidinyl]-1h-Indazol-3-
Amine
pdb|3QCX|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 6-{2-
Amino-6-[(3r)-3-Methyl-4-Morpholinyl]-4-Pyrimidinyl}-1h-
Indazol-3- Amine
pdb|3QCY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 4-[2-
Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-N-
Phenyl-2- Morpholinecarboxamide
pdb|3QD0|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With (2r,5s)-
1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-Pyrimidinyl]-6-
Methyl-N- Phenyl-3-Piperidinecarboxamide
pdb|3QD3|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1- Dimethylethyl
{(3r,6s)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-6-Methyl-3-Piperidinyl}carbamate
pdb|3QD4|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) Kinase Domain
With 1,1-
Dimethylethyl{(3r,
5r)-1-[2-Amino-6-(3-Amino-1h-Indazol-6-Yl)-4-
Pyrimidinyl]-5-Methyl-3-Piperidinyl}carbamate
Length = 312
Score = 68.6 bits (166), Expect = 2e-11, Method: Composition-based stats.
Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 9/197 (4%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRN 737
F +LG GSF V A LA A+K+ ++ ++ + E +VM R+ H
Sbjct: 35 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 94
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+K+ + + + Y G L K++ R ++ SALEYLH
Sbjct: 95 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 150
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-LATIGYMAPEYGSEG 856
IIH DLKP N+LL++DM + DFG AK+L + + T Y++PE +E
Sbjct: 151 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 210
Query: 857 IVSISGDVYSFGILMME 873
S D+++ G ++ +
Sbjct: 211 SACKSSDLWALGCIIYQ 227
>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain
In Complex With Atp
pdb|3HRF|A Chain A, Crystal Structure Of Human Pdk1 Kinase Domain In Complex
With An Allosteric Activator Bound To The Pif-Pocket
pdb|3RCJ|A Chain A, Rapid Preparation Of Triazolyl Substituted Nh-Heterocyclic
Kinase Inhibitors Via One-Pot Sonogashira Coupling
Tms-Deprotection Cuaac Sequence
pdb|4A06|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Activator Ps114 Bound To The Pif-Pocket
pdb|4AW1|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric
Compound Ps210 Bound To The Pif-Pocket
Length = 311
Score = 68.6 bits (166), Expect = 2e-11, Method: Composition-based stats.
Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 9/197 (4%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRN 737
F +LG GSF V A LA A+K+ ++ ++ + E +VM R+ H
Sbjct: 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+K+ + + + Y G L K++ R ++ SALEYLH
Sbjct: 94 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 149
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-LATIGYMAPEYGSEG 856
IIH DLKP N+LL++DM + DFG AK+L + + T Y++PE +E
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 857 IVSISGDVYSFGILMME 873
S D+++ G ++ +
Sbjct: 210 SACKSSDLWALGCIIYQ 226
>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In
Complex With Compound 9
Length = 311
Score = 68.6 bits (166), Expect = 2e-11, Method: Composition-based stats.
Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 9/197 (4%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRN 737
F +LG GSF V A LA A+K+ ++ ++ + E +VM R+ H
Sbjct: 34 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 93
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+K+ + + + Y G L K++ R ++ SALEYLH
Sbjct: 94 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 149
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-LATIGYMAPEYGSEG 856
IIH DLKP N+LL++DM + DFG AK+L + + T Y++PE +E
Sbjct: 150 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 209
Query: 857 IVSISGDVYSFGILMME 873
S D+++ G ++ +
Sbjct: 210 SACKSSDLWALGCIIYQ 226
>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-3
Length = 286
Score = 68.6 bits (166), Expect = 2e-11, Method: Composition-based stats.
Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 9/197 (4%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRN 737
F +LG GSF V A LA A+K+ ++ ++ + E +VM R+ H
Sbjct: 11 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 70
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+K+ + + + Y G L K++ R ++ SALEYLH
Sbjct: 71 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 126
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-LATIGYMAPEYGSEG 856
IIH DLKP N+LL++DM + DFG AK+L + + T Y++PE +E
Sbjct: 127 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 186
Query: 857 IVSISGDVYSFGILMME 873
S D+++ G ++ +
Sbjct: 187 SACKSSDLWALGCIIYQ 203
>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1
Catalytic Domain
pdb|1UVR|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With
Bim-8
Length = 289
Score = 68.6 bits (166), Expect = 2e-11, Method: Composition-based stats.
Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 9/197 (4%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRN 737
F +LG GSF V A LA A+K+ ++ ++ + E +VM R+ H
Sbjct: 12 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 71
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+K+ + + + Y G L K++ R ++ SALEYLH
Sbjct: 72 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 127
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-LATIGYMAPEYGSEG 856
IIH DLKP N+LL++DM + DFG AK+L + + T Y++PE +E
Sbjct: 128 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 187
Query: 857 IVSISGDVYSFGILMME 873
S D+++ G ++ +
Sbjct: 188 SACKSSDLWALGCIIYQ 204
>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead
Compound
Length = 292
Score = 68.6 bits (166), Expect = 2e-11, Method: Composition-based stats.
Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 9/197 (4%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRN 737
F +LG GSF V A LA A+K+ ++ ++ + E +VM R+ H
Sbjct: 16 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 75
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+K+ + + + Y G L K++ R ++ SALEYLH
Sbjct: 76 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 131
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-LATIGYMAPEYGSEG 856
IIH DLKP N+LL++DM + DFG AK+L + + T Y++PE +E
Sbjct: 132 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 191
Query: 857 IVSISGDVYSFGILMME 873
S D+++ G ++ +
Sbjct: 192 SACKSSDLWALGCIIYQ 208
>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8
pdb|3NUU|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment11
pdb|3NUY|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment17
Length = 286
Score = 68.6 bits (166), Expect = 2e-11, Method: Composition-based stats.
Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 9/197 (4%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRN 737
F +LG GSF V A LA A+K+ ++ ++ + E +VM R+ H
Sbjct: 10 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 69
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+K+ + + + Y G L K++ R ++ SALEYLH
Sbjct: 70 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 125
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-LATIGYMAPEYGSEG 856
IIH DLKP N+LL++DM + DFG AK+L + + T Y++PE +E
Sbjct: 126 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 185
Query: 857 IVSISGDVYSFGILMME 873
S D+++ G ++ +
Sbjct: 186 SACKSSDLWALGCIIYQ 202
>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6
pdb|3NAY|B Chain B, Pdk1 In Complex With Inhibitor Mp6
Length = 311
Score = 68.6 bits (166), Expect = 2e-11, Method: Composition-based stats.
Identities = 56/197 (28%), Positives = 91/197 (46%), Gaps = 9/197 (4%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRN 737
F +LG GSF V A LA A+K+ ++ ++ + E +VM R+ H
Sbjct: 31 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 90
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+K+ + + + Y G L K++ R ++ SALEYLH
Sbjct: 91 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 146
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-LATIGYMAPEYGSEG 856
IIH DLKP N+LL++DM + DFG AK+L + + T Y++PE +E
Sbjct: 147 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 206
Query: 857 IVSISGDVYSFGILMME 873
S D+++ G ++ +
Sbjct: 207 SACKSSDLWALGCIIYQ 223
>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A
Benzoimidazol Inhibitor
Length = 372
Score = 68.6 bits (166), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 68/230 (29%), Positives = 115/230 (50%), Gaps = 34/230 (14%)
Query: 682 FGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
+ ++ ++G+GSF VY+A L + G VA+K + +D+ K + E ++MR++ H N+++
Sbjct: 35 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 90
Query: 741 IVSSCSNPGFKA------LIMQYMPQGSLEKWLYSHNYSLTIRQRLDI------MIDVAS 788
+ + G K L++ Y+P+ + + +YS +Q L + M +
Sbjct: 91 LRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRA-KQTLPVIYVKLYMYQLFR 146
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
+L Y+H S I H D+KP N+LLD D V L DFG AK L +P + + Y
Sbjct: 147 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYY 201
Query: 848 MAPE--YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWV 895
APE +G+ S S DV+S G ++ E +F G+ + Q V
Sbjct: 202 RAPELIFGATDYTS-SIDVWSAGCVLAELLL----GQPIFPGDSGVDQLV 246
>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACC|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACD|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACD|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACG|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACG|B Chain B, Gsk3b In Complex With Inhibitor
pdb|4ACH|A Chain A, Gsk3b In Complex With Inhibitor
pdb|4ACH|B Chain B, Gsk3b In Complex With Inhibitor
Length = 465
Score = 68.6 bits (166), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 64/208 (30%), Positives = 108/208 (51%), Gaps = 30/208 (14%)
Query: 682 FGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
+ ++ ++G+GSF VY+A L + G VA+K + +D+ K + E ++MR++ H N+++
Sbjct: 101 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQDKRFK--NRELQIMRKLDHCNIVR 156
Query: 741 IVSSCSNPGFKA------LIMQYMPQGSLEKWLYSHNYSLTIRQRLDI------MIDVAS 788
+ + G K L++ Y+P+ + + +YS +Q L + M +
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRA-KQTLPVIYVKLYMYQLFR 212
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
+L Y+H S I H D+KP N+LLD D V L DFG AK L +P + + Y
Sbjct: 213 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYY 267
Query: 848 MAPE--YGSEGIVSISGDVYSFGILMME 873
APE +G+ S S DV+S G ++ E
Sbjct: 268 RAPELIFGATDYTS-SIDVWSAGCVLAE 294
>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2
With A [1, 3]thiazolo[5,4-B]pyridine Derivative
Length = 318
Score = 68.6 bits (166), Expect = 2e-11, Method: Composition-based stats.
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 34/217 (15%)
Query: 688 LGSGSFDNVYKA------TLANGVSVAVKVF----NLQEDRALKSFDTECEVMRRI-RHR 736
LG G+F V +A A +VAVK+ E RAL S E +++ I H
Sbjct: 37 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS---ELKILIHIGHHL 93
Query: 737 NLIKIVSSCSNPGFKAL-IMQYMPQGSLEKWLYSHNYS---------------LTIRQRL 780
N++ ++ +C+ PG + I+++ G+L +L S LT+ +
Sbjct: 94 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEAPEDLYKDFLTLEHLI 153
Query: 781 DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQT 839
VA +E+L S IH DL N+LL + V + DFG+A+ + D V +
Sbjct: 154 CYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 210
Query: 840 MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + +I DV+SFG+L+ E F+
Sbjct: 211 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 247
>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy)
Quinolin-4-Yloxy)benzofuran-3-Carboxamide)
pdb|4AG8|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With Axitinib (Ag-013736)
(N-Methyl-2-(3-((E)-2-Pyridin-2-
Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)-Benzamide)
Length = 316
Score = 68.6 bits (166), Expect = 2e-11, Method: Composition-based stats.
Identities = 62/217 (28%), Positives = 101/217 (46%), Gaps = 34/217 (15%)
Query: 688 LGSGSFDNVYKA------TLANGVSVAVKVF----NLQEDRALKSFDTECEVMRRI-RHR 736
LG G+F V +A A +VAVK+ E RAL S E +++ I H
Sbjct: 35 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS---ELKILIHIGHHL 91
Query: 737 NLIKIVSSCSNPGFKAL-IMQYMPQGSLEKWLYSHNYS---------------LTIRQRL 780
N++ ++ +C+ PG + I+++ G+L +L S LT+ +
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 781 DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQT 839
VA +E+L S IH DL N+LL + V + DFG+A+ + D V +
Sbjct: 152 CYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 208
Query: 840 MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + +I DV+SFG+L+ E F+
Sbjct: 209 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 245
>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors
Length = 283
Score = 68.6 bits (166), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 74/247 (29%), Positives = 112/247 (45%), Gaps = 19/247 (7%)
Query: 676 QQATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKV-FNLQEDRA--LKSFDTECEVMR 731
Q A F LG G F NVY A + A+KV F Q ++A E E+
Sbjct: 7 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 732 RIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI-DVASAL 790
+RH N++++ + LI++Y P G++ + L S QR I ++A+AL
Sbjct: 67 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 124
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMA 849
Y H S +IH D+KP N+LL + DFG + P ++ L T+ Y+
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRAALCGTLDYLP 177
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ--WVAESLPGAVTEVV 907
PE + D++S G+L E F KP E T + + K+ V + P VTE
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 908 DANLLSR 914
+L+SR
Sbjct: 237 -RDLISR 242
>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk
Length = 476
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 54/191 (28%), Positives = 93/191 (48%), Gaps = 11/191 (5%)
Query: 686 NLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALK---SFDTECEVMRRIRHRNLIKI 741
+ LG G+F V G VAVK+ N Q+ R+L E + ++ RH ++IK+
Sbjct: 22 DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKL 81
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
S P ++M+Y+ G L ++ N L ++ + + S ++Y H +
Sbjct: 82 YQVISTPSDIFMVMEYVSGGELFDYI-CKNGRLDEKESRRLFQQILSGVDYCHRHM---V 137
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVS-I 860
+H DLKP NVLLD M A + DFG++ ++ D + + Y APE S + +
Sbjct: 138 VHRDLKPENVLLDAHMNAKIADFGLSNMMS--DGEFLRXSCGSPNYAAPEVISGRLYAGP 195
Query: 861 SGDVYSFGILM 871
D++S G+++
Sbjct: 196 EVDIWSSGVIL 206
>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyrazolone Inhibitor
Length = 314
Score = 68.2 bits (165), Expect = 2e-11, Method: Composition-based stats.
Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 34/217 (15%)
Query: 688 LGSGSFDNVYKA------TLANGVSVAVKVF----NLQEDRALKSFDTECEVMRRI-RHR 736
LG G+F V +A A +VAVK+ E RAL S E +++ I H
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS---ELKILIHIGHHL 82
Query: 737 NLIKIVSSCSNPGFKALIM-QYMPQGSLEKWLYSHNYS---------------LTIRQRL 780
N++ ++ +C+ PG +++ ++ G+L +L S LT+ +
Sbjct: 83 NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 781 DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQT 839
VA +E+L S IH DL N+LL + V + DFG+A+ + D V +
Sbjct: 143 CYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 840 MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + +I DV+SFG+L+ E F+
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236
>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Pyridyl-Pyrimidine Benzimidazole Inhibitor
Length = 314
Score = 68.2 bits (165), Expect = 2e-11, Method: Composition-based stats.
Identities = 61/217 (28%), Positives = 101/217 (46%), Gaps = 34/217 (15%)
Query: 688 LGSGSFDNVYKA------TLANGVSVAVKVF----NLQEDRALKSFDTECEVMRRI-RHR 736
LG G+F V +A A +VAVK+ E RAL S E +++ I H
Sbjct: 26 LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMS---ELKILIHIGHHL 82
Query: 737 NLIKIVSSCSNPGFKALIM-QYMPQGSLEKWLYSHNYS---------------LTIRQRL 780
N++ ++ +C+ PG +++ ++ G+L +L S LT+ +
Sbjct: 83 NVVNLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 142
Query: 781 DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQT 839
VA +E+L S IH DL N+LL + V + DFG+A+ + D V +
Sbjct: 143 CYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKG 199
Query: 840 MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
+ +MAPE + + +I DV+SFG+L+ E F+
Sbjct: 200 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 236
>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
pdb|4I21|B Chain B, Crystal Structure Of L858r + T790m Egfr Kinase Domain In
Complex With Mig6 Peptide
Length = 329
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 64/239 (26%), Positives = 105/239 (43%), Gaps = 12/239 (5%)
Query: 682 FGESNLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH 735
F + +LGSG+F VYK V + V + L+E +A K E VM + +
Sbjct: 19 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LIMQ MP G L ++ H ++ + L+ + +A + YL
Sbjct: 79 PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 136
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGS 854
++H DL NVL+ + DFG AKLL + I +MA E
Sbjct: 137 --DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 855 EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912
I + DV+S+G+ + E T KP + + E+S E LP +D ++
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 253
>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With
6-Bromoindirubin-3'-Oxime
Length = 350
Score = 68.2 bits (165), Expect = 2e-11, Method: Compositional matrix adjust.
Identities = 68/230 (29%), Positives = 115/230 (50%), Gaps = 34/230 (14%)
Query: 682 FGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
+ ++ ++G+GSF VY+A L + G VA+K + + +A K + E ++MR++ H N+++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFK--NRELQIMRKLDHCNIVR 77
Query: 741 IVSSCSNPGFKA------LIMQYMPQGSLEKWLYSHNYSLTIRQRLDI------MIDVAS 788
+ + G K L++ Y+P+ + + +YS +Q L + M +
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRA-KQTLPVIYVKLYMYQLFR 133
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
+L Y+H S I H D+KP N+LLD D V L DFG AK L +P + + Y
Sbjct: 134 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYY 188
Query: 848 MAPE--YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWV 895
APE +G+ S S DV+S G ++ E +F G+ + Q V
Sbjct: 189 RAPELIFGATDYTS-SIDVWSAGCVLAELLL----GQPIFPGDSGVDQLV 233
>pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
pdb|3ETA|B Chain B, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo
Pyridine Inhibitor
Length = 317
Score = 68.2 bits (165), Expect = 2e-11, Method: Composition-based stats.
Identities = 54/224 (24%), Positives = 103/224 (45%), Gaps = 24/224 (10%)
Query: 688 LGSGSFDNVYKATLANGVS------VAVKVFNLQEDRALKS---FDTECEVMRRIRHRNL 738
LG GSF VY+ + + VAVK N E +L+ F E VM+ ++
Sbjct: 24 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 81
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSL---------TIRQRLDIMIDVASA 789
++++ S ++M+ M G L+ +L S T+++ + + ++A
Sbjct: 82 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 141
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT-MTLATIGYM 848
+ YL+ + +H DL N ++ D +GDFG+ + + D + L + +M
Sbjct: 142 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 198
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892
APE +G+ + S D++SFG+++ E + + + + E LK
Sbjct: 199 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 242
>pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The
Human Insulin Receptor
Length = 306
Score = 68.2 bits (165), Expect = 2e-11, Method: Composition-based stats.
Identities = 54/224 (24%), Positives = 103/224 (45%), Gaps = 24/224 (10%)
Query: 688 LGSGSFDNVYKATLANGVS------VAVKVFNLQEDRALKS---FDTECEVMRRIRHRNL 738
LG GSF VY+ + + VAVK N E +L+ F E VM+ ++
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 82
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSL---------TIRQRLDIMIDVASA 789
++++ S ++M+ M G L+ +L S T+++ + + ++A
Sbjct: 83 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT-MTLATIGYM 848
+ YL+ + +H DL N ++ D +GDFG+ + + D + L + +M
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 199
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892
APE +G+ + S D++SFG+++ E + + + + E LK
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243
>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1
Receptor Kinase In Complex With Pqip
Length = 301
Score = 67.8 bits (164), Expect = 3e-11, Method: Composition-based stats.
Identities = 61/237 (25%), Positives = 105/237 (44%), Gaps = 22/237 (9%)
Query: 674 ELQQATNGFGESNLLGSGSFDNVYKATLANGV-------SVAVKVFNLQED-RALKSFDT 725
E + A S LG GSF VY+ +A GV VA+K N R F
Sbjct: 6 EWEVAREKITMSRELGQGSFGMVYEG-VAKGVVKDEPETRVAIKTVNEAASMRERIEFLN 64
Query: 726 ECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYS-----HNYSLTIRQRL 780
E VM+ ++++++ S +IM+ M +G L+ +L S N + L
Sbjct: 65 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVLAPPSL 124
Query: 781 DIMI----DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836
MI ++A + YL+ + +H DL N + +D +GDFG+ + + D
Sbjct: 125 SKMIQMAGEIADGMAYLN---ANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYY 181
Query: 837 TQT-MTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892
+ L + +M+PE +G+ + DV+SFG+++ E T + + + E L+
Sbjct: 182 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLR 238
>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form)
Length = 285
Score = 67.8 bits (164), Expect = 3e-11, Method: Composition-based stats.
Identities = 76/247 (30%), Positives = 113/247 (45%), Gaps = 19/247 (7%)
Query: 676 QQATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKV-FNLQEDRA--LKSFDTECEVMR 731
Q A F LG G F NVY A + A+KV F Q ++A E E+
Sbjct: 9 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 732 RIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI-DVASAL 790
+RH N++++ + LI++Y P+G + K L S QR I ++A+AL
Sbjct: 69 HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL--QKLSKFDEQRTATYITELANAL 126
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMA 849
Y H S +IH D+KP N+LL + DFG + P ++ TL T+ Y+
Sbjct: 127 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTTLCGTLDYLP 179
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLPGAVTEVV 907
PE + D++S G+L E F KP E T + + K+ V + P VTE
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 908 DANLLSR 914
+L+SR
Sbjct: 239 -RDLISR 244
>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta.
pdb|1H8F|B Chain B, Glycogen Synthase Kinase 3 Beta
Length = 352
Score = 67.8 bits (164), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 68/230 (29%), Positives = 115/230 (50%), Gaps = 34/230 (14%)
Query: 682 FGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
+ ++ ++G+GSF VY+A L + G VA+K + + +A K + E ++MR++ H N+++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFK--NRELQIMRKLDHCNIVR 77
Query: 741 IVSSCSNPGFKA------LIMQYMPQGSLEKWLYSHNYSLTIRQRLDI------MIDVAS 788
+ + G K L++ Y+P+ + + +YS +Q L + M +
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPETV---YRVARHYSRA-KQTLPVIYVKLYMYQLFR 133
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
+L Y+H S I H D+KP N+LLD D V L DFG AK L +P + + Y
Sbjct: 134 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSYICSRYY 188
Query: 848 MAPE--YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWV 895
APE +G+ S S DV+S G ++ E +F G+ + Q V
Sbjct: 189 RAPELIFGATDYTS-SIDVWSAGCVLAELLL----GQPIFPGDSGVDQLV 233
>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And
Kinase Domains
Length = 361
Score = 67.8 bits (164), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 63/239 (26%), Positives = 105/239 (43%), Gaps = 12/239 (5%)
Query: 682 FGESNLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH 735
F + +LGSG+F VYK V + V + L+E +A K E VM + +
Sbjct: 51 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANKEILDEAYVMASVDN 110
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LI Q MP G L ++ H ++ + L+ + +A + YL
Sbjct: 111 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 168
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGS 854
++H DL NVL+ + DFG+AKLL + I +MA E
Sbjct: 169 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 226
Query: 855 EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912
I + DV+S+G+ + E T KP + + E+S E LP +D ++
Sbjct: 227 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 285
>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285
pdb|3W2P|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 2
pdb|3W2Q|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Hki-272
pdb|3W2R|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Compound 4
Length = 331
Score = 67.8 bits (164), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 64/239 (26%), Positives = 105/239 (43%), Gaps = 12/239 (5%)
Query: 682 FGESNLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH 735
F + +LGSG+F VYK V + V + L+E +A K E VM + +
Sbjct: 21 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 80
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LIMQ MP G L ++ H ++ + L+ + +A + YL
Sbjct: 81 PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 138
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGS 854
++H DL NVL+ + DFG AKLL + I +MA E
Sbjct: 139 --DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 196
Query: 855 EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912
I + DV+S+G+ + E T KP + + E+S E LP +D ++
Sbjct: 197 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 255
>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains.
pdb|2J0K|B Chain B, Crystal Structure Of A Fragment Of Focal Adhesion Kinase
Containing The Ferm And Kinase Domains
Length = 656
Score = 67.8 bits (164), Expect = 3e-11, Method: Compositional matrix adjust.
Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 13/207 (6%)
Query: 673 HELQQATNGFGESNLLGSGSFDNVYKATLAN----GVSVAVKVF-NLQEDRALKSFDTEC 727
+E+Q+ G +G G F +V++ + ++VA+K N D + F E
Sbjct: 385 YEIQRERIELG--RCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEA 442
Query: 728 EVMRRIRHRNLIKIVSSCS-NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDV 786
MR+ H +++K++ + NP + +IM+ G L +L +SL + + +
Sbjct: 443 LTMRQFDHPHIVKLIGVITENPVW--IIMELCTLGELRSFLQVRKFSLDLASLILYAYQL 500
Query: 787 ASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG 846
++AL YL S +H D+ NVL+ LGDFG+++ ++ + I
Sbjct: 501 STALAYLE---SKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIK 557
Query: 847 YMAPEYGSEGIVSISGDVYSFGILMME 873
+MAPE + + + DV+ FG+ M E
Sbjct: 558 WMAPESINFRRFTSASDVWMFGVCMWE 584
>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|E Chain E, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|F Chain F, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|G Chain G, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORX|H Chain H, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Inhibitor 1f8
pdb|3ORZ|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|B Chain B, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|C Chain C, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3ORZ|D Chain D, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator 2a2
pdb|3OTU|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment
Activator Js30
Length = 316
Score = 67.8 bits (164), Expect = 3e-11, Method: Composition-based stats.
Identities = 56/197 (28%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRN 737
F +LG GSF V A LA A+K+ ++ ++ + E +VM R+ H
Sbjct: 39 FKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 98
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+K+ + + Y G L K++ R ++ SALEYLH
Sbjct: 99 FVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 154
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-LATIGYMAPEYGSEG 856
IIH DLKP N+LL++DM + DFG AK+L + + T Y++PE +E
Sbjct: 155 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 214
Query: 857 IVSISGDVYSFGILMME 873
S D+++ G ++ +
Sbjct: 215 SACKSSDLWALGCIIYQ 231
>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic
Mutant L858r Egfr Kinase Domain
Length = 329
Score = 67.4 bits (163), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 64/242 (26%), Positives = 106/242 (43%), Gaps = 12/242 (4%)
Query: 682 FGESNLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH 735
F + +LGSG+F VYK V + V + L+E +A K E VM + +
Sbjct: 19 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LI Q MP G L ++ H ++ + L+ + +A + YL
Sbjct: 79 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 136
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGS 854
++H DL NVL+ + DFG AKLL + I +MA E
Sbjct: 137 --DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 855 EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLLS 913
I + DV+S+G+ + E T KP + + E+S E LP +D ++
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMIM 254
Query: 914 RE 915
R+
Sbjct: 255 RK 256
>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In
Complex With Dacomitinib (soaked)
Length = 329
Score = 67.4 bits (163), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 63/239 (26%), Positives = 105/239 (43%), Gaps = 12/239 (5%)
Query: 682 FGESNLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH 735
F + +LGSG+F VYK V + V + L+E +A K E VM + +
Sbjct: 19 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 78
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LI Q MP G L ++ H ++ + L+ + +A + YL
Sbjct: 79 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 136
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGS 854
++H DL NVL+ + DFG+AKLL + I +MA E
Sbjct: 137 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 194
Query: 855 EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912
I + DV+S+G+ + E T KP + + E+S E LP +D ++
Sbjct: 195 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 253
>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 309
Score = 67.0 bits (162), Expect = 4e-11, Method: Composition-based stats.
Identities = 55/197 (27%), Positives = 90/197 (45%), Gaps = 9/197 (4%)
Query: 682 FGESNLLGSGSFDN-VYKATLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRN 737
F +LG GSF V LA A+K+ ++ ++ + E +VM R+ H
Sbjct: 32 FKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPF 91
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+K+ + + + Y G L K++ R ++ SALEYLH
Sbjct: 92 FVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRF-YTAEIVSALEYLH--- 147
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-LATIGYMAPEYGSEG 856
IIH DLKP N+LL++DM + DFG AK+L + + T Y++PE +E
Sbjct: 148 GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEK 207
Query: 857 IVSISGDVYSFGILMME 873
S D+++ G ++ +
Sbjct: 208 SACKSSDLWALGCIIYQ 224
>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin
Peptide
Length = 350
Score = 67.0 bits (162), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 68/230 (29%), Positives = 114/230 (49%), Gaps = 34/230 (14%)
Query: 682 FGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
+ ++ ++G+GSF VY+A L + G VA+K + + +A K + E ++MR++ H N+++
Sbjct: 22 YTDTKVIGNGSFGVVYQAKLCDSGELVAIK--KVLQGKAFK--NRELQIMRKLDHCNIVR 77
Query: 741 IVSSCSNPGFKA------LIMQYMPQGSLEKWLYSHNYSLTIRQRLDI------MIDVAS 788
+ + G K L++ Y+P + + +YS +Q L + M +
Sbjct: 78 LRYFFYSSGEKKDEVYLNLVLDYVPATV---YRVARHYSRA-KQTLPVIYVKLYMYQLFR 133
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
+L Y+H S I H D+KP N+LLD D V L DFG AK L +P + + Y
Sbjct: 134 SLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP--NVSXICSRYY 188
Query: 848 MAPE--YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWV 895
APE +G+ S S DV+S G ++ E +F G+ + Q V
Sbjct: 189 RAPELIFGATDYTS-SIDVWSAGCVLAELLL----GQPIFPGDSGVDQLV 233
>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992
Length = 330
Score = 67.0 bits (162), Expect = 4e-11, Method: Compositional matrix adjust.
Identities = 63/239 (26%), Positives = 105/239 (43%), Gaps = 12/239 (5%)
Query: 682 FGESNLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH 735
F + +LGSG+F VYK V + V + L+E +A K E VM + +
Sbjct: 20 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LI Q MP G L ++ H ++ + L+ + +A + YL
Sbjct: 80 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 137
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGS 854
++H DL NVL+ + DFG+AKLL + I +MA E
Sbjct: 138 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 855 EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912
I + DV+S+G+ + E T KP + + E+S E LP +D ++
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 254
>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In
Complex With Amppnp
Length = 334
Score = 67.0 bits (162), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 63/239 (26%), Positives = 105/239 (43%), Gaps = 12/239 (5%)
Query: 682 FGESNLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH 735
F + +LGSG+F VYK V + V + L+E +A K E VM + +
Sbjct: 24 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LI Q MP G L ++ H ++ + L+ + +A + YL
Sbjct: 84 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 141
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGS 854
++H DL NVL+ + DFG+AKLL + I +MA E
Sbjct: 142 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 855 EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912
I + DV+S+G+ + E T KP + + E+S E LP +D ++
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 258
>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor
Receptor
pdb|1M17|A Chain A, Epidermal Growth Factor Receptor Tyrosine Kinase Domain
With 4-Anilinoquinazoline Inhibitor Erlotinib
Length = 333
Score = 67.0 bits (162), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 63/239 (26%), Positives = 105/239 (43%), Gaps = 12/239 (5%)
Query: 682 FGESNLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH 735
F + +LGSG+F VYK V + V + L+E +A K E VM + +
Sbjct: 23 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 82
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LI Q MP G L ++ H ++ + L+ + +A + YL
Sbjct: 83 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 140
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGS 854
++H DL NVL+ + DFG+AKLL + I +MA E
Sbjct: 141 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 198
Query: 855 EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912
I + DV+S+G+ + E T KP + + E+S E LP +D ++
Sbjct: 199 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 257
>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 34-Jab
pdb|2ITW|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Afn941
pdb|2ITX|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Amp- Pnp
pdb|2ITY|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Iressa
pdb|2J6M|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With
Aee788
pdb|3POZ|A Chain A, Egfr Kinase Domain Complexed With Tak-285
Length = 327
Score = 67.0 bits (162), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 63/239 (26%), Positives = 105/239 (43%), Gaps = 12/239 (5%)
Query: 682 FGESNLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH 735
F + +LGSG+F VYK V + V + L+E +A K E VM + +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LI Q MP G L ++ H ++ + L+ + +A + YL
Sbjct: 77 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 134
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGS 854
++H DL NVL+ + DFG+AKLL + I +MA E
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 855 EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912
I + DV+S+G+ + E T KP + + E+S E LP +D ++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 251
>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN The Apo Form
pdb|3UG2|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Gefitinib
pdb|3VJN|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain
(G719sT790M) IN Complex With Amppnp
Length = 334
Score = 67.0 bits (162), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 63/239 (26%), Positives = 105/239 (43%), Gaps = 12/239 (5%)
Query: 682 FGESNLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH 735
F + +L SG+F VYK V + V + L+E +A K E VM + +
Sbjct: 24 FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LIMQ MP G L ++ H ++ + L+ + +A + YL
Sbjct: 84 PHVCRLLGICLTSTVQ-LIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 141
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGS 854
++H DL NVL+ + DFG+AKLL + I +MA E
Sbjct: 142 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 855 EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912
I + DV+S+G+ + E T KP + + E+S E LP +D ++
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 258
>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain
pdb|2GS6|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain In
Complex With An Atp Analog-Peptide Conjugate
pdb|2RF9|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RF9|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|3W2S|A Chain A, Egfr Kinase Domain With Compound4
Length = 330
Score = 67.0 bits (162), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 63/239 (26%), Positives = 105/239 (43%), Gaps = 12/239 (5%)
Query: 682 FGESNLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH 735
F + +LGSG+F VYK V + V + L+E +A K E VM + +
Sbjct: 20 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 79
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LI Q MP G L ++ H ++ + L+ + +A + YL
Sbjct: 80 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 137
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGS 854
++H DL NVL+ + DFG+AKLL + I +MA E
Sbjct: 138 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 195
Query: 855 EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912
I + DV+S+G+ + E T KP + + E+S E LP +D ++
Sbjct: 196 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 254
>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|B Chain B, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|C Chain C, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
pdb|2HEN|D Chain D, Crystal Structure Of The Ephb2 Receptor Kinase Domain In
Complex With Adp
Length = 286
Score = 67.0 bits (162), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 51/202 (25%), Positives = 97/202 (48%), Gaps = 14/202 (6%)
Query: 685 SNLLGSGSFDNVYKATLA----NGVSVAVKVFNL-QEDRALKSFDTECEVMRRIRHRNLI 739
++G+G F V L + VA+K ++ + F +E +M + H N+I
Sbjct: 12 EQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVI 71
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
+ + +I ++M GSL+ +L ++ T+ Q + ++ +A+ ++YL
Sbjct: 72 HLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLA---DM 128
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLA---TIGYMAPEYGS 854
+H L N+L++ ++V + DFG+++ L D DP T T L I + APE
Sbjct: 129 NYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDP-TYTSALGGKIPIRWTAPEAIQ 187
Query: 855 EGIVSISGDVYSFGILMMETFT 876
+ + DV+S+GI+M E +
Sbjct: 188 YRKFTSASDVWSYGIVMWEVMS 209
>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An
Irreversible Inhibitor 13-Jab
Length = 327
Score = 67.0 bits (162), Expect = 5e-11, Method: Compositional matrix adjust.
Identities = 63/239 (26%), Positives = 105/239 (43%), Gaps = 12/239 (5%)
Query: 682 FGESNLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH 735
F + +LGSG+F VYK V + V + L+E +A K E VM + +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LI Q MP G L ++ H ++ + L+ + +A + YL
Sbjct: 77 PHVCRLLGICLTSTVQ-LITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 134
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGS 854
++H DL NVL+ + DFG+AKLL + I +MA E
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 855 EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912
I + DV+S+G+ + E T KP + + E+S E LP +D ++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 251
>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor-
Gw572016
Length = 352
Score = 66.6 bits (161), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 63/239 (26%), Positives = 105/239 (43%), Gaps = 12/239 (5%)
Query: 682 FGESNLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH 735
F + +LGSG+F VYK V + V + L+E +A K E VM + +
Sbjct: 42 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 101
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LI Q MP G L ++ H ++ + L+ + +A + YL
Sbjct: 102 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 159
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGS 854
++H DL NVL+ + DFG+AKLL + I +MA E
Sbjct: 160 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 217
Query: 855 EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912
I + DV+S+G+ + E T KP + + E+S E LP +D ++
Sbjct: 218 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 276
>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 635
Score = 66.6 bits (161), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 69/254 (27%), Positives = 112/254 (44%), Gaps = 17/254 (6%)
Query: 684 ESNLLGSGSFDNV----YKATLANGVSVAVKVFNLQEDRALK-SFDTECEVMRRIRHRNL 738
E LGSG+F V Y+ + N D ALK E VM+++ + +
Sbjct: 373 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 432
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
++++ C + L+M+ G L K+L N + + ++++ V+ ++YL
Sbjct: 433 VRMIGICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE---E 487
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV--TQTMTLATIGYMAPEYGSEG 856
+ +H DL NVLL A + DFG++K L + QT + + APE +
Sbjct: 488 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 547
Query: 857 IVSISGDVYSFGILMMETFTR-RKPTNEMFTGEMSLKQWVAESL---PGAVTEVVD-ANL 911
S DV+SFG+LM E F+ +KP M E++ E + G E+ D NL
Sbjct: 548 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 607
Query: 912 LSREDEEDADDFAT 925
D E+ FA
Sbjct: 608 CWTYDVENRPGFAA 621
>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
Length = 636
Score = 66.6 bits (161), Expect = 6e-11, Method: Compositional matrix adjust.
Identities = 69/254 (27%), Positives = 112/254 (44%), Gaps = 17/254 (6%)
Query: 684 ESNLLGSGSFDNV----YKATLANGVSVAVKVFNLQEDRALK-SFDTECEVMRRIRHRNL 738
E LGSG+F V Y+ + N D ALK E VM+++ + +
Sbjct: 374 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 433
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
++++ C + L+M+ G L K+L N + + ++++ V+ ++YL
Sbjct: 434 VRMIGICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLE---E 488
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV--TQTMTLATIGYMAPEYGSEG 856
+ +H DL NVLL A + DFG++K L + QT + + APE +
Sbjct: 489 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 548
Query: 857 IVSISGDVYSFGILMMETFTR-RKPTNEMFTGEMSLKQWVAESL---PGAVTEVVD-ANL 911
S DV+SFG+LM E F+ +KP M E++ E + G E+ D NL
Sbjct: 549 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 608
Query: 912 LSREDEEDADDFAT 925
D E+ FA
Sbjct: 609 CWTYDVENRPGFAA 622
>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
pdb|3COH|B Chain B, Crystal Structure Of Aurora-A In Complex With A
Pentacyclic Inhibitor
Length = 268
Score = 66.6 bits (161), Expect = 7e-11, Method: Composition-based stats.
Identities = 75/247 (30%), Positives = 113/247 (45%), Gaps = 19/247 (7%)
Query: 676 QQATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKV-FNLQEDRA--LKSFDTECEVMR 731
Q A F LG G F NVY A N + A+KV F Q ++A E E+
Sbjct: 4 QWALEDFEIGRPLGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 732 RIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI-DVASAL 790
+RH N++++ + LI++Y P G++ + L S QR I ++A+AL
Sbjct: 64 HLRHPNILRLYGYFHDSTRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 121
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMA 849
Y H S +IH D+KP N+LL + DFG + P ++ L T+ Y+
Sbjct: 122 SYCH---SKKVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRAALCGTLDYLP 174
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLPGAVTEVV 907
PE + D++S G+L E F KP E T + + K+ V + P VTE
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQDTYKRISRVEFTFPDFVTEGA 233
Query: 908 DANLLSR 914
+L+SR
Sbjct: 234 -RDLISR 239
>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|B Chain B, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|C Chain C, Structure Of Human Phosphorylase Kinase, Gamma 2
pdb|2Y7J|D Chain D, Structure Of Human Phosphorylase Kinase, Gamma 2
Length = 365
Score = 66.6 bits (161), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 49/180 (27%), Positives = 89/180 (49%), Gaps = 16/180 (8%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDR--------ALKSFDTECEVMRR 732
+ +++G G V + A G AVK+ + +R ++ E ++R+
Sbjct: 96 YDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQ 155
Query: 733 IR-HRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALE 791
+ H ++I ++ S + F L+ M +G L +L + +L+ ++ IM + A+
Sbjct: 156 VAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYL-TEKVALSEKETRSIMRSLLEAVS 214
Query: 792 YLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE 851
+LH + I+H DLKP N+LLDD+M L DFG + L+ + + + T GY+APE
Sbjct: 215 FLH---ANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRE--LCGTPGYLAPE 269
>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In
Complex With Crizotinib
Length = 327
Score = 66.2 bits (160), Expect = 7e-11, Method: Compositional matrix adjust.
Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 688 LGSGSFDNVYKATLA------NGVSVAVKVF-NLQEDRALKSFDTECEVMRRIRHRNLIK 740
LG G+F VY+ ++ + + VAVK + ++ F E ++ + H+N+++
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 741 I--VSSCSNPGFKALIMQYMPQGSLEKWLY------SHNYSLTIRQRLDIMIDVASALEY 792
VS S P F ++M+ M G L+ +L S SL + L + D+A +Y
Sbjct: 98 CIGVSLQSLPRF--ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 793 LHHGYSTPIIHCDLKPNNVLLD---DDMVAHLGDFGIAKLLDGVDPVTQT-MTLATIGYM 848
L + IH D+ N LL VA +GDFG+A+ + + + + +M
Sbjct: 156 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFT 876
PE EGI + D +SFG+L+ E F+
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|B Chain B, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|C Chain C, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORI|D Chain D, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 1)
pdb|3ORK|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 2)
pdb|3ORL|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 3)
pdb|3ORO|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 4)
pdb|3ORP|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 5)
pdb|3ORT|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant
(Crystal Form 6)
Length = 311
Score = 66.2 bits (160), Expect = 8e-11, Method: Composition-based stats.
Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 687 LLGSGSFDNVYKA-TLANGVSVAVKVF--NLQEDRALK-SFDTECEVMRRIRHRNLIKIV 742
+LG G V+ A L + VAVKV +L D + F E + + H ++ +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 743 SS--CSNPG--FKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
+ P ++M+Y+ +L +++ +T ++ ++++ D AL + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQ--- 134
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQT-MTLATIGYMAPEYGSEG 856
IIH D+KP N+++ + DFGIA+ + D + VTQT + T Y++PE
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGE 888
V DVYS G ++ E T P FTG+
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPP----FTGD 222
>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb
Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP
Length = 311
Score = 66.2 bits (160), Expect = 8e-11, Method: Composition-based stats.
Identities = 58/212 (27%), Positives = 99/212 (46%), Gaps = 18/212 (8%)
Query: 687 LLGSGSFDNVYKA-TLANGVSVAVKVF--NLQEDRALK-SFDTECEVMRRIRHRNLIKIV 742
+LG G V+ A L + VAVKV +L D + F E + + H ++ +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 743 SS--CSNPG--FKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
+ P ++M+Y+ +L +++ +T ++ ++++ D AL + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQ--- 134
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQT-MTLATIGYMAPEYGSEG 856
IIH D+KP N+++ + DFGIA+ + D + VTQT + T Y++PE
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGE 888
V DVYS G ++ E T P FTG+
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPP----FTGD 222
>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk-1 Bound To Amp-Pcp
pdb|2Z7R|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Staurosporine
pdb|2Z7S|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human
Rsk1 Bound To Purvalnol A
Length = 321
Score = 66.2 bits (160), Expect = 8e-11, Method: Composition-based stats.
Identities = 61/201 (30%), Positives = 97/201 (48%), Gaps = 13/201 (6%)
Query: 687 LLGSGSFDNVY---KATLAN-GVSVAVKVFNLQEDRALKSFDTECE--VMRRIRHRNLIK 740
+LG GSF V+ K T + G A+KV + T+ E ++ + H ++K
Sbjct: 35 VLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVNHPFVVK 94
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ + G LI+ ++ G L L S T + ++A L++LH S
Sbjct: 95 LHYAFQTEGKLYLILDFLRGGDLFTRL-SKEVMFTEEDVKFYLAELALGLDHLH---SLG 150
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGSEGIVS 859
II+ DLKP N+LLD++ L DFG++K + +D + + T+ YMAPE + S
Sbjct: 151 IIYRDLKPENILLDEEGHIKLTDFGLSK--EAIDHEKKAYSFCGTVEYMAPEVVNRQGHS 208
Query: 860 ISGDVYSFGILMMETFTRRKP 880
S D +S+G+LM E T P
Sbjct: 209 HSADWWSYGVLMFEMLTGSLP 229
>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PK9|C Chain C, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The
Phosphate-responsive Signal Transduction Pathway
pdb|2PMI|A Chain A, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
pdb|2PMI|C Chain C, Structure Of The Pho85-Pho80 Cdk-Cyclin Complex Of The
Phosphate- Responsive Signal Transduction Pathway With
Bound Atp-Gamma-S
Length = 317
Score = 66.2 bits (160), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 55/208 (26%), Positives = 100/208 (48%), Gaps = 15/208 (7%)
Query: 678 ATNGFGESNLLGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALKSFD-TECEVMRRIRH 735
+++ F + LG+G++ VYK GV VA+K L + S E +M+ ++H
Sbjct: 3 SSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELKH 62
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEY--- 792
N++++ L+ ++M L+K++ S T R + +++ ++
Sbjct: 63 ENIVRLYDVIHTENKLTLVFEFM-DNDLKKYMDSRTVGNTPR---GLELNLVKYFQWQLL 118
Query: 793 --LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
L + I+H DLKP N+L++ LGDFG+A+ G+ T + + T+ Y AP
Sbjct: 119 QGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF-GIPVNTFSSEVVTLWYRAP 177
Query: 851 E--YGSEGIVSISGDVYSFGILMMETFT 876
+ GS S S D++S G ++ E T
Sbjct: 178 DVLMGSR-TYSTSIDIWSCGCILAEMIT 204
>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1F3M|D Chain D, Crystal Structure Of Human SerineTHREONINE KINASE PAK1
pdb|1YHW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With One Point
Mutations (K299r)
Length = 297
Score = 66.2 bits (160), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 57/199 (28%), Positives = 89/199 (44%), Gaps = 17/199 (8%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
+G G+ VY A +A G VA++ NLQ+ + E VMR ++ N++ + S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 747 NPGFKALIMQYMPQGSL-----EKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
++M+Y+ GSL E + + R+ L ALE+LH S +
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-------QALEFLH---SNQV 137
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSIS 861
IH D+K +N+LL D L DFG + TM + T +MAPE +
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPK 196
Query: 862 GDVYSFGILMMETFTRRKP 880
D++S GI+ +E P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215
>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A
Diaminopyrimidine
Length = 281
Score = 66.2 bits (160), Expect = 8e-11, Method: Composition-based stats.
Identities = 75/247 (30%), Positives = 114/247 (46%), Gaps = 19/247 (7%)
Query: 676 QQATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKV-FNLQEDRA--LKSFDTECEVMR 731
Q A F LG G F NVY A + A+KV F Q ++A E E+
Sbjct: 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 732 RIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI-DVASAL 790
+RH N++++ + LI++Y P G++ + L S QR I ++A+AL
Sbjct: 65 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 122
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMA 849
Y H S +IH D+KP N+LL + DFG + P ++ TL+ T+ Y+
Sbjct: 123 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSCHA----PSSRRTTLSGTLDYLP 175
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLPGAVTEVV 907
PE + D++S G+L E F KP E T + + K+ V + P VTE
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 234
Query: 908 DANLLSR 914
+L+SR
Sbjct: 235 -RDLISR 240
>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 66.2 bits (160), Expect = 8e-11, Method: Compositional matrix adjust.
Identities = 58/208 (27%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 688 LGSGSFDNVYKATLA------NGVSVAVKVF-NLQEDRALKSFDTECEVMRRIRHRNLIK 740
LG G+F VY+ ++ + + VAVK + ++ F E ++ + H+N+++
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 112
Query: 741 I--VSSCSNPGFKALIMQYMPQGSLEKWLY------SHNYSLTIRQRLDIMIDVASALEY 792
VS S P F ++M+ M G L+ +L S SL + L + D+A +Y
Sbjct: 113 CIGVSLQSLPRF--ILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 793 LHHGYSTPIIHCDLKPNNVLLD---DDMVAHLGDFGIAKLLDGVDPVTQT-MTLATIGYM 848
L + IH D+ N LL VA +GDFG+A+ + + + + +M
Sbjct: 171 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 227
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFT 876
PE EGI + D +SFG+L+ E F+
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 255
>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase
pdb|2NP8|A Chain A, Structural Basis For The Inhibition Of Aurora A Kinase By
A Novel Class Of High Affinity Disubstituted Pyrimidine
Inhibitors
pdb|2X81|A Chain A, Structure Of Aurora A In Complex With Mln8054
pdb|3MYG|A Chain A, Aurora A Kinase Complexed With Sch 1473759
pdb|3VAP|A Chain A, Synthesis And Sar Studies Of Imidazo-[1,2-A]-Pyrazine
Aurora Kinase Inhibitors With Improved Off Target Kinase
Selectivity
Length = 272
Score = 66.2 bits (160), Expect = 9e-11, Method: Composition-based stats.
Identities = 75/247 (30%), Positives = 113/247 (45%), Gaps = 19/247 (7%)
Query: 676 QQATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKV-FNLQEDRA--LKSFDTECEVMR 731
Q A F LG G F NVY A + A+KV F Q ++A E E+
Sbjct: 8 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 67
Query: 732 RIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI-DVASAL 790
+RH N++++ + LI++Y P G++ + L S QR I ++A+AL
Sbjct: 68 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 125
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMA 849
Y H S +IH D+KP N+LL + DFG + P ++ TL T+ Y+
Sbjct: 126 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTTLCGTLDYLP 178
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLPGAVTEVV 907
PE + D++S G+L E F KP E T + + K+ V + P VTE
Sbjct: 179 PEMIEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 237
Query: 908 DANLLSR 914
+L+SR
Sbjct: 238 -RDLISR 243
>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine-
Threonine Kinase
Length = 297
Score = 66.2 bits (160), Expect = 9e-11, Method: Composition-based stats.
Identities = 75/247 (30%), Positives = 113/247 (45%), Gaps = 19/247 (7%)
Query: 676 QQATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKV-FNLQEDRA--LKSFDTECEVMR 731
Q A F LG G F NVY A + A+KV F Q ++A E E+
Sbjct: 21 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 80
Query: 732 RIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI-DVASAL 790
+RH N++++ + LI++Y P G++ + L S QR I ++A+AL
Sbjct: 81 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 138
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMA 849
Y H S +IH D+KP N+LL + DFG + P ++ TL T+ Y+
Sbjct: 139 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTTLCGTLDYLP 191
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLPGAVTEVV 907
PE + D++S G+L E F KP E T + + K+ V + P VTE
Sbjct: 192 PEMIEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 250
Query: 908 DANLLSR 914
+L+SR
Sbjct: 251 -RDLISR 256
>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine
Inhibitor
Length = 283
Score = 66.2 bits (160), Expect = 9e-11, Method: Composition-based stats.
Identities = 75/247 (30%), Positives = 113/247 (45%), Gaps = 19/247 (7%)
Query: 676 QQATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKV-FNLQEDRA--LKSFDTECEVMR 731
Q A F LG G F NVY A + A+KV F Q ++A E E+
Sbjct: 7 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 732 RIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI-DVASAL 790
+RH N++++ + LI++Y P G++ + L S QR I ++A+AL
Sbjct: 67 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 124
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMA 849
Y H S +IH D+KP N+LL + DFG + P ++ TL T+ Y+
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTTLCGTLDYLP 177
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLPGAVTEVV 907
PE + D++S G+L E F KP E T + + K+ V + P VTE
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 908 DANLLSR 914
+L+SR
Sbjct: 237 -RDLISR 242
>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O50|B Chain B, Crystal Structure Of Benzamide 9 Bound To Auroraa
pdb|3O51|A Chain A, Crystal Structure Of Anthranilamide 10 Bound To Auroraa
pdb|3EFW|A Chain A, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
pdb|3EFW|B Chain B, Structure Of Auroraa With Pyridyl-Pyrimidine Urea
Inhibitor
Length = 267
Score = 66.2 bits (160), Expect = 9e-11, Method: Composition-based stats.
Identities = 75/247 (30%), Positives = 113/247 (45%), Gaps = 19/247 (7%)
Query: 676 QQATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKV-FNLQEDRA--LKSFDTECEVMR 731
Q A F LG G F NVY A + A+KV F Q ++A E E+
Sbjct: 3 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 62
Query: 732 RIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI-DVASAL 790
+RH N++++ + LI++Y P G++ + L S QR I ++A+AL
Sbjct: 63 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 120
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMA 849
Y H S +IH D+KP N+LL + DFG + P ++ TL T+ Y+
Sbjct: 121 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTTLCGTLDYLP 173
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLPGAVTEVV 907
PE + D++S G+L E F KP E T + + K+ V + P VTE
Sbjct: 174 PEMIEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 232
Query: 908 DANLLSR 914
+L+SR
Sbjct: 233 -RDLISR 238
>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor
pdb|2X6E|A Chain A, Aurora-A Bound To An Inhibitor
Length = 285
Score = 66.2 bits (160), Expect = 9e-11, Method: Composition-based stats.
Identities = 75/247 (30%), Positives = 113/247 (45%), Gaps = 19/247 (7%)
Query: 676 QQATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKV-FNLQEDRA--LKSFDTECEVMR 731
Q A F LG G F NVY A + A+KV F Q ++A E E+
Sbjct: 9 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 732 RIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI-DVASAL 790
+RH N++++ + LI++Y P G++ + L S QR I ++A+AL
Sbjct: 69 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 126
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMA 849
Y H S +IH D+KP N+LL + DFG + P ++ TL T+ Y+
Sbjct: 127 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTTLCGTLDYLP 179
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLPGAVTEVV 907
PE + D++S G+L E F KP E T + + K+ V + P VTE
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 908 DANLLSR 914
+L+SR
Sbjct: 239 -RDLISR 244
>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1E|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1F|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 66.2 bits (160), Expect = 9e-11, Method: Composition-based stats.
Identities = 75/247 (30%), Positives = 113/247 (45%), Gaps = 19/247 (7%)
Query: 676 QQATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKV-FNLQEDRA--LKSFDTECEVMR 731
Q A F LG G F NVY A + A+KV F Q ++A E E+
Sbjct: 7 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 732 RIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI-DVASAL 790
+RH N++++ + LI++Y P G++ + L S QR I ++A+AL
Sbjct: 67 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 124
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMA 849
Y H S +IH D+KP N+LL + DFG + P ++ TL T+ Y+
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTTLCGTLDYLP 177
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLPGAVTEVV 907
PE + D++S G+L E F KP E T + + K+ V + P VTE
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 908 DANLLSR 914
+L+SR
Sbjct: 237 -RDLISR 242
>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine
Length = 353
Score = 66.2 bits (160), Expect = 9e-11, Method: Compositional matrix adjust.
Identities = 69/246 (28%), Positives = 107/246 (43%), Gaps = 25/246 (10%)
Query: 686 NLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVM-RRI-----RHRNL 738
+LG GSF V A + G AVKV L++D L+ D EC + +RI H L
Sbjct: 29 RVLGKGSFGKVMLARVKETGDLYAVKV--LKKDVILQDDDVECTMTEKRILSLARNHPFL 86
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
++ P +M+++ G L + R R ++ SAL +LH
Sbjct: 87 TQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF-YAAEIISALMFLH---D 142
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV-DPVTQTMTLATIGYMAPEYGSEGI 857
II+ DLK +NVLLD + L DFG+ K +G+ + VT T Y+APE E +
Sbjct: 143 KGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGICNGVTTATFCGTPDYIAPEILQEML 200
Query: 858 VSISGDVYSFGILMMETFTRRKP-----TNEMFTG----EMSLKQWVAESLPGAVTEVVD 908
+ D ++ G+L+ E P +++F E+ W+ E G + +
Sbjct: 201 YGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMT 260
Query: 909 ANLLSR 914
N R
Sbjct: 261 KNPTMR 266
>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Pp1
Length = 314
Score = 65.9 bits (159), Expect = 1e-10, Method: Composition-based stats.
Identities = 63/249 (25%), Positives = 112/249 (44%), Gaps = 43/249 (17%)
Query: 666 TLSRISYHELQQATNGFGESNL-----LGSGSFDNVYKATL------ANGVSVAVKVFNL 714
+LS ++ L+ F NL LG G F V KAT A +VAVK+ L
Sbjct: 4 SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM--L 61
Query: 715 QEDRA---LKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWL---- 767
+E+ + L+ +E V++++ H ++IK+ +CS G LI++Y GSL +L
Sbjct: 62 KENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESR 121
Query: 768 -------------------YSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKP 808
+ +LT+ + ++ ++YL ++H DL
Sbjct: 122 KVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MSLVHRDLAA 178
Query: 809 NNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQTMTLATIGYMAPEYGSEGIVSISGDVYSF 867
N+L+ + + DFG+++ + D V ++ + +MA E + I + DV+SF
Sbjct: 179 RNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSF 238
Query: 868 GILMMETFT 876
G+L+ E T
Sbjct: 239 GVLLWEIVT 247
>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FG9|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-320 In Complex With Atp
pdb|4FGB|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I Apo Form
Length = 320
Score = 65.9 bits (159), Expect = 1e-10, Method: Composition-based stats.
Identities = 60/196 (30%), Positives = 95/196 (48%), Gaps = 23/196 (11%)
Query: 686 NLLGSGSFDNVYKATLANGVS-VAVKVFNLQEDRALK-SFDTECEVMRRIRHRNLIKIVS 743
++LG+G+F V A VA+K + + S + E V+ +I+H N++ +
Sbjct: 24 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 744 SCSNPGFKALIMQYMPQGSL-----EKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
+ G LIMQ + G L EK Y T R ++ V A++YLH
Sbjct: 84 IYESGGHLYLIMQLVSGGELFDRIVEKGFY------TERDASRLIFQVLDAVKYLH---D 134
Query: 799 TPIIHCDLKPNNVL---LDDDMVAHLGDFGIAKLLDGVDPVTQTMT-LATIGYMAPEYGS 854
I+H DLKP N+L LD+D + DFG++K+ DP + T T GY+APE +
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLA 191
Query: 855 EGIVSISGDVYSFGIL 870
+ S + D +S G++
Sbjct: 192 QKPYSKAVDCWSIGVI 207
>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
pdb|4FG8|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-315 In Complex With Atp
Length = 315
Score = 65.9 bits (159), Expect = 1e-10, Method: Composition-based stats.
Identities = 60/196 (30%), Positives = 95/196 (48%), Gaps = 23/196 (11%)
Query: 686 NLLGSGSFDNVYKATLANGVS-VAVKVFNLQEDRALK-SFDTECEVMRRIRHRNLIKIVS 743
++LG+G+F V A VA+K + + S + E V+ +I+H N++ +
Sbjct: 24 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 744 SCSNPGFKALIMQYMPQGSL-----EKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
+ G LIMQ + G L EK Y T R ++ V A++YLH
Sbjct: 84 IYESGGHLYLIMQLVSGGELFDRIVEKGFY------TERDASRLIFQVLDAVKYLH---D 134
Query: 799 TPIIHCDLKPNNVL---LDDDMVAHLGDFGIAKLLDGVDPVTQTMT-LATIGYMAPEYGS 854
I+H DLKP N+L LD+D + DFG++K+ DP + T T GY+APE +
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLA 191
Query: 855 EGIVSISGDVYSFGIL 870
+ S + D +S G++
Sbjct: 192 QKPYSKAVDCWSIGVI 207
>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase I 1-293 In Complex With Atp
Length = 293
Score = 65.9 bits (159), Expect = 1e-10, Method: Composition-based stats.
Identities = 60/196 (30%), Positives = 95/196 (48%), Gaps = 23/196 (11%)
Query: 686 NLLGSGSFDNVYKATLANGVS-VAVKVFNLQEDRALK-SFDTECEVMRRIRHRNLIKIVS 743
++LG+G+F V A VA+K + + S + E V+ +I+H N++ +
Sbjct: 24 DVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVLHKIKHPNIVALDD 83
Query: 744 SCSNPGFKALIMQYMPQGSL-----EKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
+ G LIMQ + G L EK Y T R ++ V A++YLH
Sbjct: 84 IYESGGHLYLIMQLVSGGELFDRIVEKGFY------TERDASRLIFQVLDAVKYLH---D 134
Query: 799 TPIIHCDLKPNNVL---LDDDMVAHLGDFGIAKLLDGVDPVTQTMT-LATIGYMAPEYGS 854
I+H DLKP N+L LD+D + DFG++K+ DP + T T GY+APE +
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLA 191
Query: 855 EGIVSISGDVYSFGIL 870
+ S + D +S G++
Sbjct: 192 QKPYSKAVDCWSIGVI 207
>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
pdb|3LMG|B Chain B, Crystal Structure Of The Erbb3 Kinase Domain In Complex
With Amp-Pnp
Length = 344
Score = 65.9 bits (159), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKV-FNLQEDRA-LKSFDTECEVMRRI---RHRNLI 739
+LGSG F V+K + G S+ + V + ED++ +SF + M I H +++
Sbjct: 37 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 96
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYS 798
+++ C + L+ QY+P GSL + H +L + L+ + +A + YL HG
Sbjct: 97 RLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG-- 153
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQTMTLATIGYMAPEYGSEGI 857
++H +L NVLL + DFG+A LL D + + I +MA E G
Sbjct: 154 --MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 211
Query: 858 VSISGDVYSFGILMMETFT 876
+ DV+S+G+ + E T
Sbjct: 212 YTHQSDVWSYGVTVWELMT 230
>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|B Chain B, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|C Chain C, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|D Chain D, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|E Chain E, Aurora-2 T287d T288d Complexed With Pha-680632
pdb|2BMC|F Chain F, Aurora-2 T287d T288d Complexed With Pha-680632
Length = 306
Score = 65.9 bits (159), Expect = 1e-10, Method: Composition-based stats.
Identities = 80/270 (29%), Positives = 122/270 (45%), Gaps = 20/270 (7%)
Query: 654 SLPEENNSLNLATLSRISYHELQQ-ATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKV 711
S PE N LA+ + + +Q A F LG G F NVY A + A+KV
Sbjct: 7 SAPENNPEEELASKQKNEESKKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKV 66
Query: 712 -FNLQEDRA--LKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLY 768
F Q ++A E E+ +RH N++++ + LI++Y P G++ + L
Sbjct: 67 LFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL- 125
Query: 769 SHNYSLTIRQRLDIMI-DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIA 827
S QR I ++A+AL Y H S +IH D+KP N+LL + DFG +
Sbjct: 126 -QKLSKFDEQRTATYITELANALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWS 181
Query: 828 KLLDGVDPVTQTMTL-ATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFT 886
P ++ L T+ Y+ PE + D++S G+L E F KP E T
Sbjct: 182 VHA----PSSRRDDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANT 236
Query: 887 GEMSLKQW--VAESLPGAVTEVVDANLLSR 914
+ + K+ V + P VTE +L+SR
Sbjct: 237 YQETYKRISRVEFTFPDFVTEGA-RDLISR 265
>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
pdb|2IVS|B Chain B, Crystal Structure Of Non-Phosphorylated Ret Tyrosine
Kinase Domain
Length = 314
Score = 65.9 bits (159), Expect = 1e-10, Method: Composition-based stats.
Identities = 63/249 (25%), Positives = 112/249 (44%), Gaps = 43/249 (17%)
Query: 666 TLSRISYHELQQATNGFGESNL-----LGSGSFDNVYKATL------ANGVSVAVKVFNL 714
+LS ++ L+ F NL LG G F V KAT A +VAVK+ L
Sbjct: 4 SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM--L 61
Query: 715 QEDRA---LKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWL---- 767
+E+ + L+ +E V++++ H ++IK+ +CS G LI++Y GSL +L
Sbjct: 62 KENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESR 121
Query: 768 -------------------YSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKP 808
+ +LT+ + ++ ++YL ++H DL
Sbjct: 122 KVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAA 178
Query: 809 NNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQTMTLATIGYMAPEYGSEGIVSISGDVYSF 867
N+L+ + + DFG+++ + D V ++ + +MA E + I + DV+SF
Sbjct: 179 RNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSF 238
Query: 868 GILMMETFT 876
G+L+ E T
Sbjct: 239 GVLLWEIVT 247
>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain
pdb|2IVU|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain Complexed With The Inhibitor Zd6474
pdb|2X2K|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2L|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
pdb|2X2M|B Chain B, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase
Domain With Inhibitor
Length = 314
Score = 65.9 bits (159), Expect = 1e-10, Method: Composition-based stats.
Identities = 63/249 (25%), Positives = 112/249 (44%), Gaps = 43/249 (17%)
Query: 666 TLSRISYHELQQATNGFGESNL-----LGSGSFDNVYKATL------ANGVSVAVKVFNL 714
+LS ++ L+ F NL LG G F V KAT A +VAVK+ L
Sbjct: 4 SLSVDAFKILEDPKWEFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKM--L 61
Query: 715 QEDRA---LKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWL---- 767
+E+ + L+ +E V++++ H ++IK+ +CS G LI++Y GSL +L
Sbjct: 62 KENASPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESR 121
Query: 768 -------------------YSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKP 808
+ +LT+ + ++ ++YL ++H DL
Sbjct: 122 KVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAA 178
Query: 809 NNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQTMTLATIGYMAPEYGSEGIVSISGDVYSF 867
N+L+ + + DFG+++ + D V ++ + +MA E + I + DV+SF
Sbjct: 179 RNILVAEGRKMKISDFGLSRDVYEEDSXVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSF 238
Query: 868 GILMMETFT 876
G+L+ E T
Sbjct: 239 GVLLWEIVT 247
>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4APC|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
pdb|4B9D|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor.
pdb|4B9D|B Chain B, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1)
With Inhibitor
Length = 350
Score = 65.9 bits (159), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 52/207 (25%), Positives = 92/207 (44%), Gaps = 14/207 (6%)
Query: 677 QATNGFGESNLLGSGSFDN-VYKATLANGVSVAVKVFNLQE--DRALKSFDTECEVMRRI 733
Q+ + +G GSF + + +G +K N+ + + E V+ +
Sbjct: 21 QSMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANM 80
Query: 734 RHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIR-QRLDIMIDVASALEY 792
+H N+++ S G ++M Y G L K + + L Q LD + + AL++
Sbjct: 81 KHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKH 140
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG---YMA 849
+H I+H D+K N+ L D LGDFGIA++L+ T + A IG Y++
Sbjct: 141 VH---DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNS----TVELARACIGTPYYLS 193
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFT 876
PE + D+++ G ++ E T
Sbjct: 194 PEICENKPYNNKSDIWALGCVLYELCT 220
>pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The
Insulin Receptor Tyrosine Kinase
Length = 306
Score = 65.9 bits (159), Expect = 1e-10, Method: Composition-based stats.
Identities = 53/224 (23%), Positives = 103/224 (45%), Gaps = 24/224 (10%)
Query: 688 LGSGSFDNVYKATLANGVS------VAVKVFNLQEDRALKS---FDTECEVMRRIRHRNL 738
LG GSF VY+ + + VAVK N E +L+ F E VM+ ++
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 82
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSL---------TIRQRLDIMIDVASA 789
++++ S ++M+ M G L+ +L S T+++ + + ++A
Sbjct: 83 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT-MTLATIGYM 848
+ YL+ + +H +L N ++ D +GDFG+ + + D + L + +M
Sbjct: 143 MAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 199
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892
APE +G+ + S D++SFG+++ E + + + + E LK
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243
>pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
pdb|3EKN|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor
Length = 307
Score = 65.9 bits (159), Expect = 1e-10, Method: Composition-based stats.
Identities = 53/224 (23%), Positives = 103/224 (45%), Gaps = 24/224 (10%)
Query: 688 LGSGSFDNVYKATLANGVS------VAVKVFNLQEDRALKS---FDTECEVMRRIRHRNL 738
LG GSF VY+ + + VAVK N E +L+ F E VM+ ++
Sbjct: 26 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 83
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSL---------TIRQRLDIMIDVASA 789
++++ S ++M+ M G L+ +L S T+++ + + ++A
Sbjct: 84 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 143
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT-MTLATIGYM 848
+ YL+ + +H +L N ++ D +GDFG+ + + D + L + +M
Sbjct: 144 MAYLN---AKKFVHRNLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWM 200
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892
APE +G+ + S D++SFG+++ E + + + + E LK
Sbjct: 201 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 244
>pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of
The Insulin Receptor Tyrosine Kinase
Length = 306
Score = 65.9 bits (159), Expect = 1e-10, Method: Composition-based stats.
Identities = 53/224 (23%), Positives = 102/224 (45%), Gaps = 24/224 (10%)
Query: 688 LGSGSFDNVYKATLANGVS------VAVKVFNLQEDRALKS---FDTECEVMRRIRHRNL 738
LG GSF VY+ + + VAVK N E +L+ F E VM+ ++
Sbjct: 25 LGQGSFGMVYEGNARDIIKGEAETRVAVKTVN--ESASLRERIEFLNEASVMKGFTCHHV 82
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSL---------TIRQRLDIMIDVASA 789
++++ S ++M+ M G L+ +L S T+++ + + ++A
Sbjct: 83 VRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADG 142
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQTMTLATIGYM 848
+ YL+ + +H DL N ++ D +GDFG+ + + + L + +M
Sbjct: 143 MAYLN---AKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETAYYRKGGKGLLPVRWM 199
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLK 892
APE +G+ + S D++SFG+++ E + + + + E LK
Sbjct: 200 APESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLK 243
>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
pdb|3KEX|B Chain B, Crystal Structure Of The Catalytically Inactive Kinase
Domain Of The Human Epidermal Growth Factor Receptor 3
(Her3)
Length = 325
Score = 65.9 bits (159), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 57/199 (28%), Positives = 96/199 (48%), Gaps = 13/199 (6%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKV-FNLQEDRA-LKSFDTECEVMRRI---RHRNLI 739
+LGSG F V+K + G S+ + V + ED++ +SF + M I H +++
Sbjct: 19 KVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHIV 78
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYS 798
+++ C + L+ QY+P GSL + H +L + L+ + +A + YL HG
Sbjct: 79 RLLGLCPGSSLQ-LVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHG-- 135
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQTMTLATIGYMAPEYGSEGI 857
++H +L NVLL + DFG+A LL D + + I +MA E G
Sbjct: 136 --MVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGK 193
Query: 858 VSISGDVYSFGILMMETFT 876
+ DV+S+G+ + E T
Sbjct: 194 YTHQSDVWSYGVTVWELMT 212
>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure
pdb|2WTV|B Chain B, Aurora-A Inhibitor Structure
pdb|2WTV|C Chain C, Aurora-A Inhibitor Structure
pdb|2WTV|D Chain D, Aurora-A Inhibitor Structure
Length = 285
Score = 65.5 bits (158), Expect = 1e-10, Method: Composition-based stats.
Identities = 75/247 (30%), Positives = 112/247 (45%), Gaps = 19/247 (7%)
Query: 676 QQATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKV-FNLQEDRA--LKSFDTECEVMR 731
Q A F LG G F NVY A + A+KV F Q ++A E E+
Sbjct: 9 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 732 RIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI-DVASAL 790
+RH N++++ + LI++Y P+G + K L S QR I ++A+AL
Sbjct: 69 HLRHPNILRLYGYFHDATRVYLILEYAPRGEVYKEL--QKLSKFDEQRTATYITELANAL 126
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMA 849
Y H S +IH D+KP N+LL + DFG + P ++ L T+ Y+
Sbjct: 127 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRXXLXGTLDYLP 179
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLPGAVTEVV 907
PE + D++S G+L E F KP E T + + K+ V + P VTE
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 908 DANLLSR 914
+L+SR
Sbjct: 239 -RDLISR 244
>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant
Length = 262
Score = 65.5 bits (158), Expect = 1e-10, Method: Composition-based stats.
Identities = 75/247 (30%), Positives = 113/247 (45%), Gaps = 19/247 (7%)
Query: 676 QQATNGFGESNLLGSGSFDNVYKA-TLANGVSVAVKV-FNLQEDRA--LKSFDTECEVMR 731
Q A F LG G F NVY A +A+KV F Q ++A E E+
Sbjct: 1 QWALEDFEIGRPLGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQS 60
Query: 732 RIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI-DVASAL 790
+RH N++++ + LI++Y P G++ + L S QR I ++A+AL
Sbjct: 61 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 118
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMA 849
Y H S +IH D+KP N+LL + DFG + P ++ TL T+ Y+
Sbjct: 119 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTTLCGTLDYLP 171
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLPGAVTEVV 907
PE + D++S G+L E F KP E T + + K+ V + P VTE
Sbjct: 172 PEMIEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 230
Query: 908 DANLLSR 914
+L+SR
Sbjct: 231 -RDLISR 236
>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium
Tuberculosis
pdb|2FUM|A Chain A, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|B Chain B, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|C Chain C, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
pdb|2FUM|D Chain D, Catalytic Domain Of Protein Kinase Pknb From Mycobacterium
Tuberculosis In Complex With Mitoxantrone
Length = 299
Score = 65.5 bits (158), Expect = 1e-10, Method: Composition-based stats.
Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 18/212 (8%)
Query: 687 LLGSGSFDNVYKAT---LANGVSVAVKVFNLQEDRALK-SFDTECEVMRRIRHRNLIKIV 742
+LG G V+ A L V+V V +L D + F E + + H ++ +
Sbjct: 36 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 95
Query: 743 SS--CSNPG--FKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
+ P ++M+Y+ +L +++ +T ++ ++++ D AL + H
Sbjct: 96 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQ--- 151
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQT-MTLATIGYMAPEYGSEG 856
IIH D+KP N+++ + DFGIA+ + D + VTQT + T Y++PE
Sbjct: 152 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 211
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGE 888
V DVYS G ++ E T P FTG+
Sbjct: 212 SVDARSDVYSLGCVLYEVLTGEPP----FTGD 239
>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFD|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|B Chain B, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|C Chain C, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
pdb|2RFE|D Chain D, Crystal Structure Of The Complex Between The Egfr Kinase
Domain And A Mig6 Peptide
Length = 324
Score = 65.5 bits (158), Expect = 1e-10, Method: Composition-based stats.
Identities = 63/239 (26%), Positives = 105/239 (43%), Gaps = 12/239 (5%)
Query: 682 FGESNLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH 735
F + +LGSG+F VYK V + V + L+E +A K E VM + +
Sbjct: 14 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 73
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LI Q MP G L ++ H ++ + L+ + +A + YL
Sbjct: 74 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAEGMNYLE- 131
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGS 854
++H DL NVL+ + DFG+AKLL + I +MA E
Sbjct: 132 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 189
Query: 855 EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912
I + DV+S+G+ + E T KP + + E+S E LP +D ++
Sbjct: 190 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 248
>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 65.5 bits (158), Expect = 1e-10, Method: Compositional matrix adjust.
Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 688 LGSGSFDNVYKATLA------NGVSVAVKVF-NLQEDRALKSFDTECEVMRRIRHRNLIK 740
LG G+F VY+ ++ + + VAVK + ++ F E ++ ++ H+N+++
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 112
Query: 741 I--VSSCSNPGFKALIMQYMPQGSLEKWLY------SHNYSLTIRQRLDIMIDVASALEY 792
VS S P F ++++ M G L+ +L S SL + L + D+A +Y
Sbjct: 113 CIGVSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 793 LHHGYSTPIIHCDLKPNNVLLD---DDMVAHLGDFGIAKLLDGVDPVTQT-MTLATIGYM 848
L + IH D+ N LL VA +GDFG+A+ + + + + +M
Sbjct: 171 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 227
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFT 876
PE EGI + D +SFG+L+ E F+
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 255
>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor
pdb|2RGP|A Chain A, Structure Of Egfr In Complex With Hydrazone, A Potent Dual
Inhibitor
Length = 315
Score = 65.5 bits (158), Expect = 1e-10, Method: Composition-based stats.
Identities = 63/239 (26%), Positives = 105/239 (43%), Gaps = 12/239 (5%)
Query: 682 FGESNLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH 735
F + +LGSG+F VYK V + V + L+E +A K E VM + +
Sbjct: 11 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 70
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LI Q MP G L ++ H ++ + L+ + +A + YL
Sbjct: 71 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 128
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGS 854
++H DL NVL+ + DFG+AKLL + I +MA E
Sbjct: 129 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186
Query: 855 EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912
I + DV+S+G+ + E T KP + + E+S E LP +D ++
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 245
>pdb|3ZGW|A Chain A, Crystal Structure Of Maternal Embryonic Leucine Zipper
Kinase (melk) In Complex With Amp-pnp
Length = 347
Score = 65.5 bits (158), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 55/208 (26%), Positives = 95/208 (45%), Gaps = 22/208 (10%)
Query: 670 ISYHELQQATNGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFN---LQEDRALKSFDT 725
+ Y+EL + +G+G F V A + G VA+K+ + L D L T
Sbjct: 9 LKYYELHET---------IGTGGFAKVKLACHILTGEMVAIKIMDKNTLGSD--LPRIKT 57
Query: 726 ECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMID 785
E E ++ +RH+++ ++ ++++Y P G L ++ S + L+ + +
Sbjct: 58 EIEALKNLRHQHICQLYHVLETANKIFMVLEYCPGGELFDYIISQD-RLSEEETRVVFRQ 116
Query: 786 VASALEYLH-HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLAT 844
+ SA+ Y+H GY+ H DLKP N+L D+ L DFG+ G +
Sbjct: 117 IVSAVAYVHSQGYA----HRDLKPENLLFDEYHKLKLIDFGLCAKPKGNKDYHLQTCCGS 172
Query: 845 IGYMAPEY-GSEGIVSISGDVYSFGILM 871
+ Y APE + + DV+S GIL+
Sbjct: 173 LAYAAPELIQGKSYLGSEADVWSMGILL 200
>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma
Kinase Catalytic Domain
Length = 327
Score = 65.5 bits (158), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 57/208 (27%), Positives = 99/208 (47%), Gaps = 24/208 (11%)
Query: 688 LGSGSFDNVYKATLA------NGVSVAVKVF-NLQEDRALKSFDTECEVMRRIRHRNLIK 740
LG G+F VY+ ++ + + VAVK + ++ F E ++ ++ H+N+++
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLNHQNIVR 98
Query: 741 I--VSSCSNPGFKALIMQYMPQGSLEKWLY------SHNYSLTIRQRLDIMIDVASALEY 792
VS S P F ++++ M G L+ +L S SL + L + D+A +Y
Sbjct: 99 CIGVSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 793 LHHGYSTPIIHCDLKPNNVLLD---DDMVAHLGDFGIAKLLDGVDPVTQT-MTLATIGYM 848
L + IH D+ N LL VA +GDFG+A+ + + + + +M
Sbjct: 157 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 213
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFT 876
PE EGI + D +SFG+L+ E F+
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 241
>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In
Complex With Amppnp
Length = 334
Score = 65.5 bits (158), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 63/239 (26%), Positives = 104/239 (43%), Gaps = 12/239 (5%)
Query: 682 FGESNLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH 735
F + +LGSG+F VYK V + V + L+E +A K E VM + +
Sbjct: 24 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LI Q MP G L ++ H ++ + L+ + +A + YL
Sbjct: 84 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 141
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGS 854
++H DL NVL+ + DFG AKLL + I +MA E
Sbjct: 142 --DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 855 EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912
I + DV+S+G+ + E T KP + + E+S E LP +D ++
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 258
>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Aee788
pdb|2ITU|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Afn941
pdb|2ITV|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Amp-pnp
pdb|2ITZ|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In
Complex With Iressa
Length = 327
Score = 65.5 bits (158), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 63/239 (26%), Positives = 104/239 (43%), Gaps = 12/239 (5%)
Query: 682 FGESNLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH 735
F + +LGSG+F VYK V + V + L+E +A K E VM + +
Sbjct: 17 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LI Q MP G L ++ H ++ + L+ + +A + YL
Sbjct: 77 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 134
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGS 854
++H DL NVL+ + DFG AKLL + I +MA E
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 855 EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912
I + DV+S+G+ + E T KP + + E+S E LP +D ++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 251
>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat
Length = 332
Score = 65.1 bits (157), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 59/194 (30%), Positives = 96/194 (49%), Gaps = 19/194 (9%)
Query: 686 NLLGSGSFDNVYKATLANGVS-VAVKVFNLQEDRALK----SFDTECEVMRRIRHRNLIK 740
++LG+G+F V A VA+K +AL+ S + E V+ +I+H N++
Sbjct: 24 DVLGTGAFSEVILAEDKRTQKLVAIKCIA---KKALEGKEGSMENEIAVLHKIKHPNIVA 80
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ + G LIMQ + G L + + T R ++ V A++YLH
Sbjct: 81 LDDIYESGGHLYLIMQLVSGGELFDRIVEKGF-YTERDASRLIFQVLDAVKYLH---DLG 136
Query: 801 IIHCDLKPNNVL---LDDDMVAHLGDFGIAKLLDGVDPVTQTMT-LATIGYMAPEYGSEG 856
I+H DLKP N+L LD+D + DFG++K+ DP + T T GY+APE ++
Sbjct: 137 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKM---EDPGSVLSTACGTPGYVAPEVLAQK 193
Query: 857 IVSISGDVYSFGIL 870
S + D +S G++
Sbjct: 194 PYSKAVDCWSIGVI 207
>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase
Length = 342
Score = 65.1 bits (157), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 688 LGSGSFDNVYKATLA------NGVSVAVKVF-NLQEDRALKSFDTECEVMRRIRHRNLIK 740
LG G+F VY+ ++ + + VAVK + ++ F E ++ + H+N+++
Sbjct: 53 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFNHQNIVR 112
Query: 741 I--VSSCSNPGFKALIMQYMPQGSLEKWLY------SHNYSLTIRQRLDIMIDVASALEY 792
VS S P F ++++ M G L+ +L S SL + L + D+A +Y
Sbjct: 113 CIGVSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 170
Query: 793 LHHGYSTPIIHCDLKPNNVLLD---DDMVAHLGDFGIAKLLDGVDPVTQT-MTLATIGYM 848
L + IH D+ N LL VA +GDFG+A+ + + + + +M
Sbjct: 171 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 227
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFT 876
PE EGI + D +SFG+L+ E F+
Sbjct: 228 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 255
>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679
pdb|3UNZ|B Chain B, Aurora A In Complex With Rpm1679
pdb|3UO4|A Chain A, Aurora A In Complex With Rpm1680
pdb|3UO5|A Chain A, Aurora A In Complex With Yl1-038-31
pdb|3UO6|A Chain A, Aurora A In Complex With Yl5-083
pdb|3UO6|B Chain B, Aurora A In Complex With Yl5-083
pdb|3UOD|A Chain A, Aurora A In Complex With Rpm1693
pdb|3UOH|A Chain A, Aurora A In Complex With Rpm1722
pdb|3UOH|B Chain B, Aurora A In Complex With Rpm1722
pdb|3UOJ|A Chain A, Aurora A In Complex With Rpm1715
pdb|3UOJ|B Chain B, Aurora A In Complex With Rpm1715
pdb|3UOK|A Chain A, Aurora A In Complex With Yl5-81-1
pdb|3UOK|B Chain B, Aurora A In Complex With Yl5-81-1
pdb|3UOL|A Chain A, Aurora A In Complex With So2-162
pdb|3UOL|B Chain B, Aurora A In Complex With So2-162
pdb|3UP2|A Chain A, Aurora A In Complex With Rpm1686
pdb|3UP7|A Chain A, Aurora A In Complex With Yl1-038-09
pdb|4DEA|A Chain A, Aurora A In Complex With Yl1-038-18
pdb|4DEB|A Chain A, Aurora A In Complex With Rk2-17-01
pdb|4DED|A Chain A, Aurora A In Complex With Yl1-038-21
pdb|4DEE|A Chain A, Aurora A In Complex With Adp
Length = 279
Score = 65.1 bits (157), Expect = 2e-10, Method: Composition-based stats.
Identities = 75/247 (30%), Positives = 113/247 (45%), Gaps = 19/247 (7%)
Query: 676 QQATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKV-FNLQEDRA--LKSFDTECEVMR 731
Q A F LG G F NVY A + A+KV F Q ++A E E+
Sbjct: 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 732 RIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI-DVASAL 790
+RH N++++ + LI++Y P G++ + L S QR I ++A+AL
Sbjct: 65 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 122
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMA 849
Y H S +IH D+KP N+LL + DFG + P ++ TL T+ Y+
Sbjct: 123 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRDTLCGTLDYLP 175
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLPGAVTEVV 907
PE + D++S G+L E F KP E T + + K+ V + P VTE
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 234
Query: 908 DANLLSR 914
+L+SR
Sbjct: 235 -RDLISR 240
>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant
Length = 311
Score = 65.1 bits (157), Expect = 2e-10, Method: Composition-based stats.
Identities = 56/212 (26%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 687 LLGSGSFDNVYKAT---LANGVSVAVKVFNLQEDRALK-SFDTECEVMRRIRHRNLIKIV 742
+LG G V+ A L V+V V +L D + F E + + H ++ +
Sbjct: 19 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 743 SS--CSNPG--FKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
++ P ++M+Y+ +L +++ +T ++ ++++ D AL + H
Sbjct: 79 ATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQ--- 134
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQT-MTLATIGYMAPEYGSEG 856
IIH D+KP N+++ + DFGIA+ + D + VTQT + T Y++PE
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGE 888
V DVYS G ++ E T P FTG+
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPP----FTGD 222
>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In
A Putative Auto-Inhibition State
Length = 340
Score = 65.1 bits (157), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 45/123 (36%), Positives = 64/123 (52%), Gaps = 8/123 (6%)
Query: 782 IMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT 841
I + + ALE+LH S +IH D+KP+NVL++ + DFGI+ L VD V +T+
Sbjct: 158 IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL--VDSVAKTID 213
Query: 842 LATIGYMAPEYGSEGI----VSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAE 897
YMAPE + + S+ D++S GI M+E R P + T LKQ V E
Sbjct: 214 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE 273
Query: 898 SLP 900
P
Sbjct: 274 PSP 276
>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp
Length = 285
Score = 65.1 bits (157), Expect = 2e-10, Method: Composition-based stats.
Identities = 75/247 (30%), Positives = 112/247 (45%), Gaps = 19/247 (7%)
Query: 676 QQATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKV-FNLQEDRA--LKSFDTECEVMR 731
Q A F LG G F NVY A + A+KV F Q ++A E E+
Sbjct: 9 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 732 RIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI-DVASAL 790
+RH N++++ + LI++Y P G++ + L S QR I ++A+AL
Sbjct: 69 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 126
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMA 849
Y H S +IH D+KP N+LL + DFG + P ++ TL T+ Y+
Sbjct: 127 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTTLCGTLDYLP 179
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLPGAVTEVV 907
PE D++S G+L E F KP E T + + K+ V + P VTE
Sbjct: 180 PEXIEGRXHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 908 DANLLSR 914
+L+SR
Sbjct: 239 -RDLISR 244
>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In
Complex With Crizotinib (Pf-02341066)
Length = 327
Score = 65.1 bits (157), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 688 LGSGSFDNVYKATLA------NGVSVAVKVF-NLQEDRALKSFDTECEVMRRIRHRNLIK 740
LG G+F VY+ ++ + + VAVK + ++ F E ++ + H+N+++
Sbjct: 38 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 97
Query: 741 I--VSSCSNPGFKALIMQYMPQGSLEKWLY------SHNYSLTIRQRLDIMIDVASALEY 792
VS S P F ++++ M G L+ +L S SL + L + D+A +Y
Sbjct: 98 CIGVSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 155
Query: 793 LHHGYSTPIIHCDLKPNNVLLD---DDMVAHLGDFGIAKLLDGVDPVTQT-MTLATIGYM 848
L + IH D+ N LL VA +GDFG+A+ + + + + +M
Sbjct: 156 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 212
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFT 876
PE EGI + D +SFG+L+ E F+
Sbjct: 213 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 240
>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Nvp- Tae684
pdb|2XBA|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex
With Pha-E429
Length = 315
Score = 65.1 bits (157), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 688 LGSGSFDNVYKATLA------NGVSVAVKVF-NLQEDRALKSFDTECEVMRRIRHRNLIK 740
LG G+F VY+ ++ + + VAVK + ++ F E ++ + H+N+++
Sbjct: 30 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 89
Query: 741 I--VSSCSNPGFKALIMQYMPQGSLEKWLY------SHNYSLTIRQRLDIMIDVASALEY 792
VS S P F ++++ M G L+ +L S SL + L + D+A +Y
Sbjct: 90 CIGVSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 147
Query: 793 LHHGYSTPIIHCDLKPNNVLLD---DDMVAHLGDFGIAKLLDGVDPVTQT-MTLATIGYM 848
L + IH D+ N LL VA +GDFG+A+ + + + + +M
Sbjct: 148 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 204
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFT 876
PE EGI + D +SFG+L+ E F+
Sbjct: 205 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 232
>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (
Diphosphorylated Form) Bound To 5- Amino-3-((4-(
Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide
Length = 325
Score = 65.1 bits (157), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 14/220 (6%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G+F VYKA V A KV + + + L+ + E +++ H N++K++ +
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
+++++ G+++ + LT Q + AL YLH IIH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 807 KPNNVLLDDDMVAHLGDFGI-AKLLDGVDPVTQTMTLATIGYMAPEY-----GSEGIVSI 860
K N+L D L DFG+ AK + + + T +MAPE +
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAKNTRXIQ--RRDXFIGTPYWMAPEVVMCETSKDRPYDY 219
Query: 861 SGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP 900
DV+S GI ++E P +E+ + LK +A+S P
Sbjct: 220 KADVWSLGITLIEMAEIEPPHHELNPMRVLLK--IAKSEP 257
>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4DCE|B Chain B, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With A Piperidine-Carboxamide Inhibitor
pdb|4FOD|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 36
Length = 333
Score = 65.1 bits (157), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 688 LGSGSFDNVYKATLA------NGVSVAVKVF-NLQEDRALKSFDTECEVMRRIRHRNLIK 740
LG G+F VY+ ++ + + VAVK + ++ F E ++ + H+N+++
Sbjct: 45 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 104
Query: 741 I--VSSCSNPGFKALIMQYMPQGSLEKWLY------SHNYSLTIRQRLDIMIDVASALEY 792
VS S P F ++++ M G L+ +L S SL + L + D+A +Y
Sbjct: 105 CIGVSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 162
Query: 793 LHHGYSTPIIHCDLKPNNVLLD---DDMVAHLGDFGIAKLLDGVDPVTQT-MTLATIGYM 848
L + IH D+ N LL VA +GDFG+A+ + + + + +M
Sbjct: 163 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 219
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFT 876
PE EGI + D +SFG+L+ E F+
Sbjct: 220 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 247
>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5Q|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
pdb|1U5R|B Chain B, Crystal Structure Of The Tao2 Kinase Domain: Activation
And Specifity Of A Ste20p Map3k
Length = 348
Score = 64.7 bits (156), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 91/206 (44%), Gaps = 16/206 (7%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNL---QEDRALKSFDTECEVMRRIRHRN 737
F + +G GSF VY A + N VA+K + Q + + E ++++RH N
Sbjct: 56 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 115
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
I+ L+M+Y GS L H L Q ++I AL+ L + +
Sbjct: 116 TIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPL---QEVEIAAVTHGALQGLAYLH 171
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEY---GS 854
S +IH D+K N+LL + + LGDFG A ++ + T +MAPE
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANXFVGTPYWMAPEVILAMD 226
Query: 855 EGIVSISGDVYSFGILMMETFTRRKP 880
EG DV+S GI +E R+ P
Sbjct: 227 EGQYDGKVDVWSLGITCIELAERKPP 252
>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
pdb|3F69|B Chain B, Crystal Structure Of The Mycobacterium Tuberculosis Pknb
Mutant Kinase Domain In Complex With Kt5720
Length = 311
Score = 64.7 bits (156), Expect = 2e-10, Method: Composition-based stats.
Identities = 58/212 (27%), Positives = 98/212 (46%), Gaps = 18/212 (8%)
Query: 687 LLGSGSFDNVYKA-TLANGVSVAVKVF--NLQEDRALK-SFDTECEVMRRIRHRNLIKIV 742
+LG G V+ A L + VAVKV +L D + F E + + H ++ +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 743 SS--CSNPG--FKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
+ P ++M+Y+ +L +++ +T ++ ++++ D AL + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQ--- 134
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQT-MTLATIGYMAPEYGSEG 856
IIH D+KP N+L+ + DFGIA+ + D + V QT + T Y++PE
Sbjct: 135 NGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVIGTAQYLSPEQARGD 194
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGE 888
V DVYS G ++ E T P FTG+
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPP----FTGD 222
>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5-
Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6-
Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide
Length = 325
Score = 64.7 bits (156), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 59/224 (26%), Positives = 99/224 (44%), Gaps = 22/224 (9%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G+F VYKA V A KV + + + L+ + E +++ H N++K++ +
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
+++++ G+++ + LT Q + AL YLH IIH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-----LATIGYMAPEY-----GSEG 856
K N+L D L DFG++ T+T+ + T +MAPE +
Sbjct: 162 KAGNILFTLDGDIKLADFGVSA------KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDR 215
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP 900
DV+S GI ++E P +E+ + LK +A+S P
Sbjct: 216 PYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK--IAKSEP 257
>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Piperidine-Carboxamide Inhibitor 2
Length = 327
Score = 64.7 bits (156), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 688 LGSGSFDNVYKATLA------NGVSVAVKVF-NLQEDRALKSFDTECEVMRRIRHRNLIK 740
LG G+F VY+ ++ + + VAVK + ++ F E ++ + H+N+++
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 741 I--VSSCSNPGFKALIMQYMPQGSLEKWLY------SHNYSLTIRQRLDIMIDVASALEY 792
VS S P F ++++ M G L+ +L S SL + L + D+A +Y
Sbjct: 99 CIGVSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 793 LHHGYSTPIIHCDLKPNNVLLD---DDMVAHLGDFGIAKLLDGVDPVTQT-MTLATIGYM 848
L + IH D+ N LL VA +GDFG+A+ + + + + +M
Sbjct: 157 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 213
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFT 876
PE EGI + D +SFG+L+ E F+
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 241
>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Lambda-Fl172
pdb|3FY0|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium
Complex Dw1
pdb|4DAW|A Chain A, Crystal Structure Of Pak1 Kinase Domain With The Ruthenium
Phthalimide Complex
Length = 297
Score = 64.7 bits (156), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 17/199 (8%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
+G G+ VY A +A G VA++ NLQ+ + E VMR ++ N++ + S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 747 NPGFKALIMQYMPQGSL-----EKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
++M+Y+ GSL E + + R+ L ALE+LH S +
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-------QALEFLH---SNQV 137
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSIS 861
IH D+K +N+LL D L DFG + + ++ + T +MAPE +
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSXMVGTPYWMAPEVVTRKAYGPK 196
Query: 862 GDVYSFGILMMETFTRRKP 880
D++S GI+ +E P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215
>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma
Kinase In Complex With Ch5424802
Length = 344
Score = 64.7 bits (156), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 688 LGSGSFDNVYKATLA------NGVSVAVKVF-NLQEDRALKSFDTECEVMRRIRHRNLIK 740
LG G+F VY+ ++ + + VAVK + ++ F E ++ + H+N+++
Sbjct: 55 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 114
Query: 741 I--VSSCSNPGFKALIMQYMPQGSLEKWLY------SHNYSLTIRQRLDIMIDVASALEY 792
VS S P F ++++ M G L+ +L S SL + L + D+A +Y
Sbjct: 115 CIGVSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 172
Query: 793 LHHGYSTPIIHCDLKPNNVLLD---DDMVAHLGDFGIAKLLDGVDPVTQT-MTLATIGYM 848
L + IH D+ N LL VA +GDFG+A+ + + + + +M
Sbjct: 173 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 229
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFT 876
PE EGI + D +SFG+L+ E F+
Sbjct: 230 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 257
>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And
Tpx2
Length = 268
Score = 64.7 bits (156), Expect = 2e-10, Method: Composition-based stats.
Identities = 73/246 (29%), Positives = 110/246 (44%), Gaps = 17/246 (6%)
Query: 676 QQATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKV-FNLQEDRA--LKSFDTECEVMR 731
Q A F LG G F NVY A + A+KV F Q ++A E E+
Sbjct: 4 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 732 RIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI-DVASAL 790
+RH N++++ + LI++Y P G++ + L S QR I ++A+AL
Sbjct: 64 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 121
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
Y H S +IH D+KP N+LL + DFG + +T T+ Y+ P
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTXLCGTLDYLPP 175
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLPGAVTEVVD 908
E + D++S G+L E F KP E T + + K+ V + P VTE
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA- 233
Query: 909 ANLLSR 914
+L+SR
Sbjct: 234 RDLISR 239
>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 367
Score = 64.7 bits (156), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 688 LGSGSFDNVYKATLA------NGVSVAVKVF-NLQEDRALKSFDTECEVMRRIRHRNLIK 740
LG G+F VY+ ++ + + VAVK + ++ F E ++ + H+N+++
Sbjct: 79 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 138
Query: 741 I--VSSCSNPGFKALIMQYMPQGSLEKWLY------SHNYSLTIRQRLDIMIDVASALEY 792
VS S P F ++++ M G L+ +L S SL + L + D+A +Y
Sbjct: 139 CIGVSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 793 LHHGYSTPIIHCDLKPNNVLLD---DDMVAHLGDFGIAKLLDGVDPVTQT-MTLATIGYM 848
L + IH D+ N LL VA +GDFG+A+ + + + + +M
Sbjct: 197 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 253
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFT 876
PE EGI + D +SFG+L+ E F+
Sbjct: 254 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 281
>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
pdb|3LCS|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase
Catalytic Domain
Length = 344
Score = 64.7 bits (156), Expect = 2e-10, Method: Compositional matrix adjust.
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 688 LGSGSFDNVYKATLA------NGVSVAVKVF-NLQEDRALKSFDTECEVMRRIRHRNLIK 740
LG G+F VY+ ++ + + VAVK + ++ F E ++ + H+N+++
Sbjct: 56 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 115
Query: 741 I--VSSCSNPGFKALIMQYMPQGSLEKWLY------SHNYSLTIRQRLDIMIDVASALEY 792
VS S P F ++++ M G L+ +L S SL + L + D+A +Y
Sbjct: 116 CIGVSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 173
Query: 793 LHHGYSTPIIHCDLKPNNVLLD---DDMVAHLGDFGIAKLLDGVDPVTQT-MTLATIGYM 848
L + IH D+ N LL VA +GDFG+A+ + + + + +M
Sbjct: 174 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWM 230
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFT 876
PE EGI + D +SFG+L+ E F+
Sbjct: 231 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 258
>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded
Form)
Length = 325
Score = 64.7 bits (156), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 59/220 (26%), Positives = 98/220 (44%), Gaps = 14/220 (6%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG G+F VYKA V A KV + + + L+ + E +++ H N++K++ +
Sbjct: 45 LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFY 104
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
+++++ G+++ + LT Q + AL YLH IIH DL
Sbjct: 105 YENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDL 161
Query: 807 KPNNVLLDDDMVAHLGDFGI-AKLLDGVDPVTQTMTLATIGYMAPEY-----GSEGIVSI 860
K N+L D L DFG+ AK + + + T +MAPE +
Sbjct: 162 KAGNILFTLDGDIKLADFGVSAKNTRXIQ--RRDSFIGTPYWMAPEVVMCETSKDRPYDY 219
Query: 861 SGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP 900
DV+S GI ++E P +E+ + LK +A+S P
Sbjct: 220 KADVWSLGITLIEMAEIEPPHHELNPMRVLLK--IAKSEP 257
>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain
pdb|3Q53|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain In Complex
With Atp
Length = 306
Score = 64.7 bits (156), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 17/199 (8%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
+G G+ VY A +A G VA++ NLQ+ + E VMR ++ N++ + S
Sbjct: 29 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 747 NPGFKALIMQYMPQGSL-----EKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
++M+Y+ GSL E + + R+ L ALE+LH S +
Sbjct: 89 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-------QALEFLH---SNQV 138
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSIS 861
IH D+K +N+LL D L DFG + + ++ + T +MAPE +
Sbjct: 139 IHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSXMVGTPYWMAPEVVTRKAYGPK 197
Query: 862 GDVYSFGILMMETFTRRKP 880
D++S GI+ +E P
Sbjct: 198 VDIWSLGIMAIEMIEGEPP 216
>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb.
pdb|1MRU|B Chain B, Intracellular SerTHR PROTEIN KINASE DOMAIN OF
Mycobacterium Tuberculosis Pknb
Length = 311
Score = 64.7 bits (156), Expect = 3e-10, Method: Composition-based stats.
Identities = 56/212 (26%), Positives = 97/212 (45%), Gaps = 18/212 (8%)
Query: 687 LLGSGSFDNVYKAT---LANGVSVAVKVFNLQEDRALK-SFDTECEVMRRIRHRNLIKIV 742
+LG G V+ A L V+V V +L D + F E + + H ++ +
Sbjct: 19 ILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 743 SS--CSNPG--FKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
+ P ++M+Y+ +L +++ +T ++ ++++ D AL + H
Sbjct: 79 DTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEG-PMTPKRAIEVIADACQALNFSHQ--- 134
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDGVDPVTQT-MTLATIGYMAPEYGSEG 856
IIH D+KP N+++ + DFGIA+ + D + VTQT + T Y++PE
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGE 888
V DVYS G ++ E T P FTG+
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEPP----FTGD 222
>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s)
Length = 334
Score = 64.7 bits (156), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 62/239 (25%), Positives = 104/239 (43%), Gaps = 12/239 (5%)
Query: 682 FGESNLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH 735
F + +L SG+F VYK V + V + L+E +A K E VM + +
Sbjct: 24 FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 83
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LI Q MP G L ++ H ++ + L+ + +A + YL
Sbjct: 84 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 141
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGS 854
++H DL NVL+ + DFG+AKLL + I +MA E
Sbjct: 142 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 199
Query: 855 EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912
I + DV+S+G+ + E T KP + + E+S E LP +D ++
Sbjct: 200 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 258
>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 64.3 bits (155), Expect = 3e-10, Method: Composition-based stats.
Identities = 70/253 (27%), Positives = 112/253 (44%), Gaps = 17/253 (6%)
Query: 684 ESNLLGSGSFDNV----YKATLANGVSVAVKVFNLQEDRALK-SFDTECEVMRRIRHRNL 738
E LGSG+F V Y+ + N D ALK E VM+++ + +
Sbjct: 15 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
++++ C + L+M+ G L K+L N + + ++++ V+ ++YL
Sbjct: 75 VRMIGICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE--- 129
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAPEYGSEG 856
+ +H DL NVLL A + DFG++K L D QT + + APE +
Sbjct: 130 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVKWYAPECINYY 189
Query: 857 IVSISGDVYSFGILMMETFTR-RKPTNEMFTGEMSLKQWVAESL---PGAVTEVVD-ANL 911
S DV+SFG+LM E F+ +KP M E++ E + G E+ D NL
Sbjct: 190 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 249
Query: 912 LSREDEEDADDFA 924
D E+ FA
Sbjct: 250 CWTYDVENRPGFA 262
>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 1
pdb|4FOC|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In
Complex With Acyliminobenzimidazole Inhibitor 2
Length = 353
Score = 64.3 bits (155), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 688 LGSGSFDNVYKATLA------NGVSVAVKVF-NLQEDRALKSFDTECEVMRRIRHRNLIK 740
LG G+F VY+ ++ + + VAVK + ++ F E ++ + H+N+++
Sbjct: 65 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 124
Query: 741 I--VSSCSNPGFKALIMQYMPQGSLEKWLY------SHNYSLTIRQRLDIMIDVASALEY 792
VS S P F ++++ M G L+ +L S SL + L + D+A +Y
Sbjct: 125 CIGVSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 182
Query: 793 LHHGYSTPIIHCDLKPNNVLLD---DDMVAHLGDFGIAKLLDGVDPVTQT-MTLATIGYM 848
L + IH D+ N LL VA +GDFG+A+ + + + + +M
Sbjct: 183 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWM 239
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFT 876
PE EGI + D +SFG+L+ E F+
Sbjct: 240 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 267
>pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain
pdb|4GT4|B Chain B, Structure Of Unliganded, Inactive Ror2 Kinase Domain
Length = 308
Score = 64.3 bits (155), Expect = 3e-10, Method: Composition-based stats.
Identities = 65/286 (22%), Positives = 120/286 (41%), Gaps = 53/286 (18%)
Query: 688 LGSGSFDNVYKATL------ANGVSVAVKVFNLQEDRALKS-FDTECEVMRRIRHRNLIK 740
LG F VYK L +VA+K + + L+ F E + R++H N++
Sbjct: 34 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 93
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLY---------SHNYSLTIRQRLD------IMID 785
++ + ++I Y G L ++L S + T++ L+ ++
Sbjct: 94 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 153
Query: 786 VASALEYL--HHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT-MTL 842
+A+ +EYL HH ++H DL NVL+ D + + D G+ + + D +L
Sbjct: 154 IAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 208
Query: 843 ATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGA 902
I +MAPE G SI D++S+G+++ E F+ L+ + S
Sbjct: 209 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS------------YGLQPYCGYSNQDV 256
Query: 903 VTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEER 948
V + + +L D+ C +++ +L ++C E P R
Sbjct: 257 VEMIRNRQVLPCPDD-----------CPAWVYALMIECWNEFPSRR 291
>pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2
pdb|3ZZW|B Chain B, Crystal Structure Of The Kinase Domain Of Ror2
Length = 289
Score = 64.3 bits (155), Expect = 3e-10, Method: Composition-based stats.
Identities = 65/286 (22%), Positives = 120/286 (41%), Gaps = 53/286 (18%)
Query: 688 LGSGSFDNVYKATL------ANGVSVAVKVFNLQEDRALKS-FDTECEVMRRIRHRNLIK 740
LG F VYK L +VA+K + + L+ F E + R++H N++
Sbjct: 17 LGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPNVVC 76
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLY---------SHNYSLTIRQRLD------IMID 785
++ + ++I Y G L ++L S + T++ L+ ++
Sbjct: 77 LLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQ 136
Query: 786 VASALEYL--HHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT-MTL 842
+A+ +EYL HH ++H DL NVL+ D + + D G+ + + D +L
Sbjct: 137 IAAGMEYLSSHH-----VVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSL 191
Query: 843 ATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGA 902
I +MAPE G SI D++S+G+++ E F+ L+ + S
Sbjct: 192 LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFS------------YGLQPYCGYSNQDV 239
Query: 903 VTEVVDANLLSREDEEDADDFATKKTCISYIMSLALKCSAEIPEER 948
V + + +L D+ C +++ +L ++C E P R
Sbjct: 240 VEMIRNRQVLPCPDD-----------CPAWVYALMIECWNEFPSRR 274
>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Amp-Pnp
pdb|2ITO|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Iressa
pdb|2ITP|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Aee788
pdb|2ITQ|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In
Complex With Afn941
Length = 327
Score = 64.3 bits (155), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 62/239 (25%), Positives = 104/239 (43%), Gaps = 12/239 (5%)
Query: 682 FGESNLLGSGSFDNVYKATL---ANGVSVAVKVFNLQE---DRALKSFDTECEVMRRIRH 735
F + +L SG+F VYK V + V + L+E +A K E VM + +
Sbjct: 17 FKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 76
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
++ +++ C + LI Q MP G L ++ H ++ + L+ + +A + YL
Sbjct: 77 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLE- 134
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGS 854
++H DL NVL+ + DFG+AKLL + I +MA E
Sbjct: 135 --DRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 192
Query: 855 EGIVSISGDVYSFGILMMETFT-RRKPTNEMFTGEMSLKQWVAESLPGAVTEVVDANLL 912
I + DV+S+G+ + E T KP + + E+S E LP +D ++
Sbjct: 193 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQPPICTIDVYMI 251
>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma
Kinase Catalytic Domain
pdb|4FNY|A Chain A, Crystal Structure Of The R1275q Anaplastic Lymphoma Kinase
Catalytic Domain In Complex With A Benzoxazole Inhibitor
Length = 327
Score = 64.3 bits (155), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 57/208 (27%), Positives = 98/208 (47%), Gaps = 24/208 (11%)
Query: 688 LGSGSFDNVYKATLA------NGVSVAVKVF-NLQEDRALKSFDTECEVMRRIRHRNLIK 740
LG G+F VY+ ++ + + VAVK + ++ F E ++ + H+N+++
Sbjct: 39 LGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQNIVR 98
Query: 741 I--VSSCSNPGFKALIMQYMPQGSLEKWLY------SHNYSLTIRQRLDIMIDVASALEY 792
VS S P F ++++ M G L+ +L S SL + L + D+A +Y
Sbjct: 99 CIGVSLQSLPRF--ILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQY 156
Query: 793 LHHGYSTPIIHCDLKPNNVLLD---DDMVAHLGDFGIAKLLDGVDPVTQT-MTLATIGYM 848
L + IH D+ N LL VA +GDFG+A+ + + + + +M
Sbjct: 157 LEENH---FIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKWM 213
Query: 849 APEYGSEGIVSISGDVYSFGILMMETFT 876
PE EGI + D +SFG+L+ E F+
Sbjct: 214 PPEAFMEGIFTSKTDTWSFGVLLWEIFS 241
>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a
Length = 282
Score = 64.3 bits (155), Expect = 3e-10, Method: Composition-based stats.
Identities = 74/247 (29%), Positives = 113/247 (45%), Gaps = 19/247 (7%)
Query: 676 QQATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKV-FNLQEDRA--LKSFDTECEVMR 731
Q A F LG G F NVY A + A+KV F Q ++A E E+
Sbjct: 6 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 732 RIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI-DVASAL 790
+RH N++++ + LI++Y P G++ + L S QR I ++A+AL
Sbjct: 66 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 123
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMA 849
Y H S +IH D+KP N+LL + +FG + P ++ TL T+ Y+
Sbjct: 124 SYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHA----PSSRRTTLCGTLDYLP 176
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLPGAVTEVV 907
PE + D++S G+L E F KP E T + + K+ V + P VTE
Sbjct: 177 PEMIEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 235
Query: 908 DANLLSR 914
+L+SR
Sbjct: 236 -RDLISR 241
>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine
Inhibitor
Length = 272
Score = 64.3 bits (155), Expect = 3e-10, Method: Composition-based stats.
Identities = 74/247 (29%), Positives = 113/247 (45%), Gaps = 19/247 (7%)
Query: 676 QQATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKV-FNLQEDRA--LKSFDTECEVMR 731
Q A F LG G F NVY A + A+KV F Q ++A E E+
Sbjct: 7 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 732 RIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI-DVASAL 790
+RH N++++ + LI++Y P G++ + L S QR I ++A+AL
Sbjct: 67 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 124
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMA 849
Y H S +IH D+KP N+LL + +FG + P ++ TL T+ Y+
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIANFGWSVHA----PSSRRTTLCGTLDYLP 177
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLPGAVTEVV 907
PE + D++S G+L E F KP E T + + K+ V + P VTE
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 908 DANLLSR 914
+L+SR
Sbjct: 237 -RDLISR 242
>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836
Length = 273
Score = 64.3 bits (155), Expect = 3e-10, Method: Composition-based stats.
Identities = 69/253 (27%), Positives = 112/253 (44%), Gaps = 17/253 (6%)
Query: 684 ESNLLGSGSFDNV----YKATLANGVSVAVKVFNLQEDRALK-SFDTECEVMRRIRHRNL 738
E LGSG+F V Y+ + N D ALK E VM+++ + +
Sbjct: 9 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 68
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
++++ C + L+M+ G L K+L N + + ++++ V+ ++YL
Sbjct: 69 VRMIGICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE--- 123
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV--TQTMTLATIGYMAPEYGSEG 856
+ +H DL NVLL A + DFG++K L + QT + + APE +
Sbjct: 124 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 183
Query: 857 IVSISGDVYSFGILMMETFTR-RKPTNEMFTGEMSLKQWVAESL---PGAVTEVVD-ANL 911
S DV+SFG+LM E F+ +KP M E++ E + G E+ D NL
Sbjct: 184 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 243
Query: 912 LSREDEEDADDFA 924
D E+ FA
Sbjct: 244 CWTYDVENRPGFA 256
>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point
Mutations (K299r, T423e)
pdb|2HY8|1 Chain 1, Pak1 Complex With St2001
Length = 297
Score = 64.3 bits (155), Expect = 3e-10, Method: Compositional matrix adjust.
Identities = 55/199 (27%), Positives = 90/199 (45%), Gaps = 17/199 (8%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
+G G+ VY A +A G VA++ NLQ+ + E VMR ++ N++ + S
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 747 NPGFKALIMQYMPQGSL-----EKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
++M+Y+ GSL E + + R+ L ALE+LH S +
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-------QALEFLH---SNQV 137
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSIS 861
IH D+K +N+LL D L DFG + + ++ + T +MAPE +
Sbjct: 138 IHRDIKSDNILLGMDGSVKLTDFGFCAQITP-EQSKRSEMVGTPYWMAPEVVTRKAYGPK 196
Query: 862 GDVYSFGILMMETFTRRKP 880
D++S GI+ +E P
Sbjct: 197 VDIWSLGIMAIEMIEGEPP 215
>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly,
Lys240->arg, Met302- >leu) In Complex With
1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]-
Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea
pdb|3DJ5|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 290.
pdb|3DJ6|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 823.
pdb|3DJ7|A Chain A, Crystal Structure Of The Mouse Aurora-A Catalytic Domain
(Asn186->gly, Lys240->arg, Met302->leu) In Complex With
Compound 130.
pdb|3D15|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
1-(3-Chloro-Phenyl)-3-
{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)-
Ethyl]-Thiazol-2- Yl}-Urea [sns-314]
pdb|3D2I|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With 1-{5-[2-(1-Methyl-1h-
Pyrazolo[4,
3-D]pyrimidin-7-Ylamino)-Ethyl]-Thiazol-2-Yl}-3-
(3-Trifluoromethyl-Phenyl)-Urea
pdb|3D2K|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240-
>arg, Met302->leu) In Complex With
[7-(2-{2-[3-(3-Chloro-
Phenyl)-Ureido]-Thiazol-5-Yl}-Ethylamino)-Pyrazolo[4,3-
D]pyrimidin-1-Yl]-Acetic Acid
Length = 272
Score = 64.3 bits (155), Expect = 3e-10, Method: Composition-based stats.
Identities = 70/235 (29%), Positives = 111/235 (47%), Gaps = 19/235 (8%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKV-FNLQEDRA--LKSFDTECEVMRRIRHRNLIKIVS 743
LG G F NVY A + +A+KV F Q ++A E E+ +RH N++++
Sbjct: 20 LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI-DVASALEYLHHGYSTPII 802
+ LI++Y P G++ + L S QR I ++A+AL Y H S +I
Sbjct: 80 YFHDATRVYLILEYAPLGTVYREL--QKLSRFDEQRTATYITELANALSYCH---SKRVI 134
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGSEGIVSIS 861
H D+KP N+LL + + DFG + P ++ TL T+ Y+ PE +
Sbjct: 135 HRDIKPENLLLGSNGELKIADFGWSVHA----PSSRRTTLCGTLDYLPPEMIEGRMHDEK 190
Query: 862 GDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLPGAVTEVVDANLLSR 914
D++S G+L E F P E T + + ++ V + P VTE +L+SR
Sbjct: 191 VDLWSLGVLCYE-FLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGA-RDLISR 243
>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain
pdb|1XBB|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Gleevec
pdb|1XBC|A Chain A, Crystal Structure Of The Syk Tyrosine Kinase Domain With
Staurosporin
pdb|3FQE|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
Ym193306
pdb|3FQH|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQH|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A 2-Substituted 7-Azaindole
pdb|3FQS|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
R406
pdb|4FL1|A Chain A, Structural And Biophysical Characterization Of The Syk
Activation Switch
pdb|4FYN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
3-(8-{4-
[ethyl-(2-hydroxy-ethyl)-amino]-phenylamino}-imidazo[1,
2-a]pyrazin-5- Yl)-phenol
pdb|4FYO|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
N-{(s)-1-
[7-(3,4-dimethoxy-phenylamino)-thiazolo[5,
4-d]pyrimidin-5-yl]- Pyrrolidin-3-yl}-terephthalamic
Acid
pdb|4FZ6|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
[6-((s)-2-
Methyl-pyrrolidin-1-yl)-pyridin-2-yl]-(6-phenyl-
imidazo[1,2- B]pyridazin-8-yl)-amine
Length = 291
Score = 64.3 bits (155), Expect = 3e-10, Method: Composition-based stats.
Identities = 69/253 (27%), Positives = 112/253 (44%), Gaps = 17/253 (6%)
Query: 684 ESNLLGSGSFDNV----YKATLANGVSVAVKVFNLQEDRALK-SFDTECEVMRRIRHRNL 738
E LGSG+F V Y+ + N D ALK E VM+++ + +
Sbjct: 21 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 80
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
++++ C + L+M+ G L K+L N + + ++++ V+ ++YL
Sbjct: 81 VRMIGICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE--- 135
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV--TQTMTLATIGYMAPEYGSEG 856
+ +H DL NVLL A + DFG++K L + QT + + APE +
Sbjct: 136 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 195
Query: 857 IVSISGDVYSFGILMMETFTR-RKPTNEMFTGEMSLKQWVAESL---PGAVTEVVD-ANL 911
S DV+SFG+LM E F+ +KP M E++ E + G E+ D NL
Sbjct: 196 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 255
Query: 912 LSREDEEDADDFA 924
D E+ FA
Sbjct: 256 CWTYDVENRPGFA 268
>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
A Sulfonamidopyrazine Piperidine Inhibitor
pdb|4DFN|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With
An Adamantylpyrazine Inhibitor
Length = 274
Score = 64.3 bits (155), Expect = 3e-10, Method: Composition-based stats.
Identities = 69/253 (27%), Positives = 112/253 (44%), Gaps = 17/253 (6%)
Query: 684 ESNLLGSGSFDNV----YKATLANGVSVAVKVFNLQEDRALK-SFDTECEVMRRIRHRNL 738
E LGSG+F V Y+ + N D ALK E VM+++ + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
++++ C + L+M+ G L K+L N + + ++++ V+ ++YL
Sbjct: 71 VRMIGICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE--- 125
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV--TQTMTLATIGYMAPEYGSEG 856
+ +H DL NVLL A + DFG++K L + QT + + APE +
Sbjct: 126 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 185
Query: 857 IVSISGDVYSFGILMMETFTR-RKPTNEMFTGEMSLKQWVAESL---PGAVTEVVD-ANL 911
S DV+SFG+LM E F+ +KP M E++ E + G E+ D NL
Sbjct: 186 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 245
Query: 912 LSREDEEDADDFA 924
D E+ FA
Sbjct: 246 CWTYDVENRPGFA 258
>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In
Complex With A Diaminopyrimidine Carboxamide Inhibitor
Length = 277
Score = 64.3 bits (155), Expect = 3e-10, Method: Composition-based stats.
Identities = 69/253 (27%), Positives = 112/253 (44%), Gaps = 17/253 (6%)
Query: 684 ESNLLGSGSFDNV----YKATLANGVSVAVKVFNLQEDRALK-SFDTECEVMRRIRHRNL 738
E LGSG+F V Y+ + N D ALK E VM+++ + +
Sbjct: 15 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 74
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
++++ C + L+M+ G L K+L N + + ++++ V+ ++YL
Sbjct: 75 VRMIGICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE--- 129
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV--TQTMTLATIGYMAPEYGSEG 856
+ +H DL NVLL A + DFG++K L + QT + + APE +
Sbjct: 130 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 189
Query: 857 IVSISGDVYSFGILMMETFTR-RKPTNEMFTGEMSLKQWVAESL---PGAVTEVVD-ANL 911
S DV+SFG+LM E F+ +KP M E++ E + G E+ D NL
Sbjct: 190 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 249
Query: 912 LSREDEEDADDFA 924
D E+ FA
Sbjct: 250 CWTYDVENRPGFA 262
>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2-
Phenylcyclopropyl)urea
Length = 293
Score = 64.3 bits (155), Expect = 3e-10, Method: Composition-based stats.
Identities = 69/253 (27%), Positives = 112/253 (44%), Gaps = 17/253 (6%)
Query: 684 ESNLLGSGSFDNV----YKATLANGVSVAVKVFNLQEDRALK-SFDTECEVMRRIRHRNL 738
E LGSG+F V Y+ + N D ALK E VM+++ + +
Sbjct: 31 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
++++ C + L+M+ G L K+L N + + ++++ V+ ++YL
Sbjct: 91 VRMIGICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE--- 145
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV--TQTMTLATIGYMAPEYGSEG 856
+ +H DL NVLL A + DFG++K L + QT + + APE +
Sbjct: 146 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 205
Query: 857 IVSISGDVYSFGILMMETFTR-RKPTNEMFTGEMSLKQWVAESL---PGAVTEVVD-ANL 911
S DV+SFG+LM E F+ +KP M E++ E + G E+ D NL
Sbjct: 206 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 265
Query: 912 LSREDEEDADDFA 924
D E+ FA
Sbjct: 266 CWTYDVENRPGFA 278
>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Pyrazolylbenzimidazole Inhibitor 416
pdb|3VF9|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic
Domain With Thienopyrazolylindole Inhibitor 027
pdb|3TUC|A Chain A, Crystal Structure Of Syk Kinase Domain With
1-Benzyl-N-(5-(6,7-
Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-2-Oxo-1,
2-Dihydropyridine-3- Carboxamide
pdb|3TUD|A Chain A, Crystal Structure Of Syk Kinase Domain With
N-(4-Methyl-3-(8-Methyl-7-
Oxo-2-(Phenylamino)-7,8-Dihydropyrido[2,
3-D]pyrimidin-6-Yl)phenyl)-3- (Trifluoromethyl)benzamide
Length = 299
Score = 64.3 bits (155), Expect = 3e-10, Method: Composition-based stats.
Identities = 69/253 (27%), Positives = 112/253 (44%), Gaps = 17/253 (6%)
Query: 684 ESNLLGSGSFDNV----YKATLANGVSVAVKVFNLQEDRALK-SFDTECEVMRRIRHRNL 738
E LGSG+F V Y+ + N D ALK E VM+++ + +
Sbjct: 31 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 90
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
++++ C + L+M+ G L K+L N + + ++++ V+ ++YL
Sbjct: 91 VRMIGICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE--- 145
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV--TQTMTLATIGYMAPEYGSEG 856
+ +H DL NVLL A + DFG++K L + QT + + APE +
Sbjct: 146 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 205
Query: 857 IVSISGDVYSFGILMMETFTR-RKPTNEMFTGEMSLKQWVAESL---PGAVTEVVD-ANL 911
S DV+SFG+LM E F+ +KP M E++ E + G E+ D NL
Sbjct: 206 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 265
Query: 912 LSREDEEDADDFA 924
D E+ FA
Sbjct: 266 CWTYDVENRPGFA 278
>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2-
Phenylaminopyrimidines As Potent Inhibitors Of Spleen
Tyrosine Kinase (Syk)
Length = 291
Score = 64.3 bits (155), Expect = 3e-10, Method: Composition-based stats.
Identities = 69/253 (27%), Positives = 112/253 (44%), Gaps = 17/253 (6%)
Query: 684 ESNLLGSGSFDNV----YKATLANGVSVAVKVFNLQEDRALK-SFDTECEVMRRIRHRNL 738
E LGSG+F V Y+ + N D ALK E VM+++ + +
Sbjct: 29 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 88
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
++++ C + L+M+ G L K+L N + + ++++ V+ ++YL
Sbjct: 89 VRMIGICEAESW-MLVMEMAELGPLNKYL-QQNRHVKDKNIIELVHQVSMGMKYLEE--- 143
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV--TQTMTLATIGYMAPEYGSEG 856
+ +H DL NVLL A + DFG++K L + QT + + APE +
Sbjct: 144 SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYY 203
Query: 857 IVSISGDVYSFGILMMETFTR-RKPTNEMFTGEMSLKQWVAESL---PGAVTEVVD-ANL 911
S DV+SFG+LM E F+ +KP M E++ E + G E+ D NL
Sbjct: 204 KFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMGCPAGCPREMYDLMNL 263
Query: 912 LSREDEEDADDFA 924
D E+ FA
Sbjct: 264 CWTYDVENRPGFA 276
>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300
Length = 280
Score = 64.3 bits (155), Expect = 3e-10, Method: Composition-based stats.
Identities = 73/246 (29%), Positives = 110/246 (44%), Gaps = 17/246 (6%)
Query: 676 QQATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKV-FNLQEDRA--LKSFDTECEVMR 731
Q A F LG G F NVY A + A+KV F Q ++A E E+
Sbjct: 4 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 732 RIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI-DVASAL 790
+RH N++++ + LI++Y P G++ + L S QR I ++A+AL
Sbjct: 64 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 121
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
Y H S +IH D+KP N+LL + DFG + +T T+ Y+ P
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV---HAPSSRRTELCGTLDYLPP 175
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLPGAVTEVVD 908
E + D++S G+L E F KP E T + + K+ V + P VTE
Sbjct: 176 EMIEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA- 233
Query: 909 ANLLSR 914
+L+SR
Sbjct: 234 RDLISR 239
>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|B Chain B, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H0Z|C Chain C, Aurora A In Complex With A Bisanilinopyrimidine
pdb|3H10|A Chain A, Aurora A Inhibitor Complex
pdb|3H10|B Chain B, Aurora A Inhibitor Complex
pdb|3H10|D Chain D, Aurora A Inhibitor Complex
pdb|3P9J|A Chain A, Aurora A Kinase Domain With Phthalazinone Pyrazole
Inhibitor
Length = 268
Score = 63.9 bits (154), Expect = 4e-10, Method: Composition-based stats.
Identities = 74/247 (29%), Positives = 112/247 (45%), Gaps = 19/247 (7%)
Query: 676 QQATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKV-FNLQEDRA--LKSFDTECEVMR 731
Q A F LG G F NVY A + A+KV F Q ++A E E+
Sbjct: 4 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 732 RIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI-DVASAL 790
+RH N++++ + LI++Y P G++ + L S QR I ++A+AL
Sbjct: 64 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 121
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMA 849
Y H S +IH D+KP N+LL + DFG + P ++ L T+ Y+
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRAALCGTLDYLP 174
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLPGAVTEVV 907
PE + D++S G+L E F KP E T + + K+ V + P VTE
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 908 DANLLSR 914
+L+SR
Sbjct: 234 -RDLISR 239
>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain
pdb|3Q4Z|B Chain B, Structure Of Unphosphorylated Pak1 Kinase Domain
Length = 306
Score = 63.9 bits (154), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 56/199 (28%), Positives = 89/199 (44%), Gaps = 17/199 (8%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
+G G+ VY A +A G VA++ NLQ+ + E VMR ++ N++ + S
Sbjct: 29 IGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYL 88
Query: 747 NPGFKALIMQYMPQGSL-----EKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
++M+Y+ GSL E + + R+ L ALE+LH S +
Sbjct: 89 VGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL-------QALEFLH---SNQV 138
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSIS 861
IH ++K +N+LL D L DFG + TM + T +MAPE +
Sbjct: 139 IHRNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM-VGTPYWMAPEVVTRKAYGPK 197
Query: 862 GDVYSFGILMMETFTRRKP 880
D++S GI+ +E P
Sbjct: 198 VDIWSLGIMAIEMIEGEPP 216
>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain
pdb|4BBM|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
pdb|4BBM|B Chain B, Crystal Structure Of The Human Cdkl2 Kinase Domain With
Bound Tcs 2312
Length = 331
Score = 63.9 bits (154), Expect = 4e-10, Method: Compositional matrix adjust.
Identities = 59/228 (25%), Positives = 103/228 (45%), Gaps = 27/228 (11%)
Query: 677 QATNGFGESNLLGSGSFDNVYKATLAN-GVSVAVKVF-NLQEDRALKSFDT-ECEVMRRI 733
Q+ + L+G GS+ V K + G VA+K F +D+ +K E ++++++
Sbjct: 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQL 81
Query: 734 RHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKW-LYSHNYSLTIRQRLDIMIDVASALEY 792
RH NL+ ++ C L+ +++ L+ L+ + + Q+ + + + + +
Sbjct: 82 RHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKY--LFQIINGIGF 139
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE- 851
H S IIH D+KP N+L+ V L DFG A+ L V +AT Y APE
Sbjct: 140 CH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDD-EVATRWYRAPEL 195
Query: 852 ------YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
YG + DV++ G L+ E F +F G+ + Q
Sbjct: 196 LVGDVKYGK------AVDVWAIGCLVTEMFM----GEPLFPGDSDIDQ 233
>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
pdb|2W1G|A Chain A, Structure Determination Of Aurora Kinase In Complex With
Inhibitor
Length = 275
Score = 63.9 bits (154), Expect = 4e-10, Method: Composition-based stats.
Identities = 74/247 (29%), Positives = 112/247 (45%), Gaps = 19/247 (7%)
Query: 676 QQATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKV-FNLQEDRA--LKSFDTECEVMR 731
Q A F LG G F NVY A + A+KV F Q ++A E E+
Sbjct: 7 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 732 RIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI-DVASAL 790
+RH N++++ + LI++Y P G++ + L S QR I ++A+AL
Sbjct: 67 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 124
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMA 849
Y H S +IH D+KP N+LL + DFG + P ++ L T+ Y+
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRXXLCGTLDYLP 177
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLPGAVTEVV 907
PE + D++S G+L E F KP E T + + K+ V + P VTE
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 908 DANLLSR 914
+L+SR
Sbjct: 237 -RDLISR 242
>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287,
Thr288 And Bound To Tpx2 1-43
pdb|1OL7|A Chain A, Structure Of Human Aurora-A 122-403 Phosphorylated On
Thr287, Thr288
Length = 282
Score = 63.9 bits (154), Expect = 4e-10, Method: Composition-based stats.
Identities = 74/247 (29%), Positives = 112/247 (45%), Gaps = 19/247 (7%)
Query: 676 QQATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKV-FNLQEDRA--LKSFDTECEVMR 731
Q A F LG G F NVY A + A+KV F Q ++A E E+
Sbjct: 6 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 65
Query: 732 RIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI-DVASAL 790
+RH N++++ + LI++Y P G++ + L S QR I ++A+AL
Sbjct: 66 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 123
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMA 849
Y H S +IH D+KP N+LL + DFG + P ++ L T+ Y+
Sbjct: 124 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRXXLCGTLDYLP 176
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLPGAVTEVV 907
PE + D++S G+L E F KP E T + + K+ V + P VTE
Sbjct: 177 PEMIEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 235
Query: 908 DANLLSR 914
+L+SR
Sbjct: 236 -RDLISR 241
>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And
Compound 10
Length = 268
Score = 63.9 bits (154), Expect = 4e-10, Method: Composition-based stats.
Identities = 74/247 (29%), Positives = 112/247 (45%), Gaps = 19/247 (7%)
Query: 676 QQATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKV-FNLQEDRA--LKSFDTECEVMR 731
Q A F LG G F NVY A + A+KV F Q ++A E E+
Sbjct: 4 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 732 RIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI-DVASAL 790
+RH N++++ + LI++Y P G++ + L S QR I ++A+AL
Sbjct: 64 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 121
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMA 849
Y H S +IH D+KP N+LL + DFG + P ++ L T+ Y+
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRXXLCGTLDYLP 174
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLPGAVTEVV 907
PE + D++S G+L E F KP E T + + K+ V + P VTE
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 908 DANLLSR 914
+L+SR
Sbjct: 234 -RDLISR 239
>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure
pdb|2GCD|B Chain B, Tao2 Kinase Domain-Staurosporine Structure
Length = 309
Score = 63.9 bits (154), Expect = 4e-10, Method: Composition-based stats.
Identities = 61/210 (29%), Positives = 92/210 (43%), Gaps = 16/210 (7%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVFNL---QEDRALKSFDTECEVMRRIRHRN 737
F + +G GSF VY A + N VA+K + Q + + E ++++RH N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
I+ L+M+Y GS L H L Q ++I AL+ L + +
Sbjct: 77 TIQYRGCYLREHTAWLVMEYC-LGSASDLLEVHKKPL---QEVEIAAVTHGALQGLAYLH 132
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEY---GS 854
S +IH D+K N+LL + + LGDFG A ++ + T +MAPE
Sbjct: 133 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM-----APANXFVGTPYWMAPEVILAMD 187
Query: 855 EGIVSISGDVYSFGILMMETFTRRKPTNEM 884
EG DV+S GI +E R+ P M
Sbjct: 188 EGQYDGKVDVWSLGITCIELAERKPPLFNM 217
>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|B Chain B, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|C Chain C, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|D Chain D, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|E Chain E, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
pdb|3IS5|F Chain F, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma
Gondii, Tgme49_018720
Length = 285
Score = 63.9 bits (154), Expect = 4e-10, Method: Composition-based stats.
Identities = 60/210 (28%), Positives = 100/210 (47%), Gaps = 22/210 (10%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRA---LKSFDTECEVMRRIRHRNLIKIVS 743
LGSG+F +V+ ++G+ +K N +DR+ ++ + E EV++ + H N+IKI
Sbjct: 30 LGSGAFGDVHLVEERSSGLERVIKTIN--KDRSQVPMEQIEAEIEVLKSLDHPNIIKIFE 87
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYS---HNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ ++M+ G L + + S +L+ ++M + +AL Y H S
Sbjct: 88 VFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFH---SQH 144
Query: 801 IIHCDLKPNNVLLDDD---MVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGI 857
++H DLKP N+L D + DFG+A+L + T A YMAPE
Sbjct: 145 VVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTAL--YMAPEVFKRD- 201
Query: 858 VSISGDVYSFGILMMETFTRRKPTNEMFTG 887
V+ D++S G++M T P FTG
Sbjct: 202 VTFKCDIWSAGVVMYFLLTGCLP----FTG 227
>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
pdb|2C6E|B Chain B, Aurora A Kinase Activated Mutant (T287d) In Complex With A
5-Aminopyrimidinyl Quinazoline Inhibitor
Length = 283
Score = 63.9 bits (154), Expect = 4e-10, Method: Composition-based stats.
Identities = 74/247 (29%), Positives = 112/247 (45%), Gaps = 19/247 (7%)
Query: 676 QQATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKV-FNLQEDRA--LKSFDTECEVMR 731
Q A F LG G F NVY A + A+KV F Q ++A E E+
Sbjct: 9 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 68
Query: 732 RIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI-DVASAL 790
+RH N++++ + LI++Y P G++ + L S QR I ++A+AL
Sbjct: 69 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 126
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMA 849
Y H S +IH D+KP N+LL + DFG + P ++ L T+ Y+
Sbjct: 127 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTDLCGTLDYLP 179
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLPGAVTEVV 907
PE + D++S G+L E F KP E T + + K+ V + P VTE
Sbjct: 180 PEMIEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 238
Query: 908 DANLLSR 914
+L+SR
Sbjct: 239 -RDLISR 244
>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With
Adpnp
Length = 275
Score = 63.9 bits (154), Expect = 4e-10, Method: Composition-based stats.
Identities = 74/247 (29%), Positives = 112/247 (45%), Gaps = 19/247 (7%)
Query: 676 QQATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKV-FNLQEDRA--LKSFDTECEVMR 731
Q A F LG G F NVY A + A+KV F Q ++A E E+
Sbjct: 4 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 732 RIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI-DVASAL 790
+RH N++++ + LI++Y P G++ + L S QR I ++A+AL
Sbjct: 64 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 121
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMA 849
Y H S +IH D+KP N+LL + DFG + P ++ L T+ Y+
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTDLCGTLDYLP 174
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLPGAVTEVV 907
PE + D++S G+L E F KP E T + + K+ V + P VTE
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 908 DANLLSR 914
+L+SR
Sbjct: 234 -RDLISR 239
>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A
Gsk3beta Inhibitor
Length = 287
Score = 63.9 bits (154), Expect = 4e-10, Method: Composition-based stats.
Identities = 74/247 (29%), Positives = 112/247 (45%), Gaps = 19/247 (7%)
Query: 676 QQATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKV-FNLQEDRA--LKSFDTECEVMR 731
Q A F LG G F NVY A + A+KV F Q ++A E E+
Sbjct: 4 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 63
Query: 732 RIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI-DVASAL 790
+RH N++++ + LI++Y P G++ + L S QR I ++A+AL
Sbjct: 64 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 121
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMA 849
Y H S +IH D+KP N+LL + DFG + P ++ L T+ Y+
Sbjct: 122 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTDLCGTLDYLP 174
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLPGAVTEVV 907
PE + D++S G+L E F KP E T + + K+ V + P VTE
Sbjct: 175 PEMIEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 233
Query: 908 DANLLSR 914
+L+SR
Sbjct: 234 -RDLISR 239
>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A
Inhibitors: Structure Basis For Potency And Specificity
pdb|3K5U|A Chain A, Identification, Sar Studies And X-Ray Cocrystal Analysis
Of A Novel Furano-Pyrimidine Aurora Kinase A Inhibitor
pdb|3M11|A Chain A, Crystal Structure Of Aurora A Kinase Complexed With
Inhibitor
Length = 279
Score = 63.9 bits (154), Expect = 4e-10, Method: Composition-based stats.
Identities = 74/247 (29%), Positives = 112/247 (45%), Gaps = 19/247 (7%)
Query: 676 QQATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKV-FNLQEDRA--LKSFDTECEVMR 731
Q A F LG G F NVY A + A+KV F Q ++A E E+
Sbjct: 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 64
Query: 732 RIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI-DVASAL 790
+RH N++++ + LI++Y P G++ + L S QR I ++A+AL
Sbjct: 65 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 122
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMA 849
Y H S +IH D+KP N+LL + DFG + P ++ L T+ Y+
Sbjct: 123 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRTDLCGTLDYLP 175
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLPGAVTEVV 907
PE + D++S G+L E F KP E T + + K+ V + P VTE
Sbjct: 176 PEMIEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 234
Query: 908 DANLLSR 914
+L+SR
Sbjct: 235 -RDLISR 240
>pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mgatp)
pdb|3REP|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Mnatp)
Length = 271
Score = 63.5 bits (153), Expect = 6e-10, Method: Composition-based stats.
Identities = 51/196 (26%), Positives = 92/196 (46%), Gaps = 13/196 (6%)
Query: 704 GVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNP--GFKALIMQYMP 759
G + VKV +++ R + F+ EC +R H N++ ++ +C +P LI +MP
Sbjct: 33 GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMP 92
Query: 760 QGSLEKWLYS-HNYSLTIRQRLDIMIDVASALEYLHHGYSTPII--HCDLKPNNVLLDDD 816
GSL L+ N+ + Q + +D+A + +LH P+I H L +V++D+D
Sbjct: 93 YGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLH--TLEPLIPRHA-LNSRSVMIDED 149
Query: 817 MVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
M A + +A + + A + A + E S D++SF +L+ E T
Sbjct: 150 MTARI---SMADVKFSFQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVT 206
Query: 877 RRKPTNEMFTGEMSLK 892
R P ++ E+ +K
Sbjct: 207 REVPFADLSNMEIGMK 222
>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
pdb|2JAM|B Chain B, Crystal Structure Of Human Calmodulin-Dependent Protein
Kinase I G
Length = 304
Score = 63.5 bits (153), Expect = 6e-10, Method: Compositional matrix adjust.
Identities = 57/197 (28%), Positives = 98/197 (49%), Gaps = 27/197 (13%)
Query: 686 NLLGSGSFDNVY--KATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVS 743
+LGSG+F V+ K L G A+K S + E V+++I+H N++ +
Sbjct: 15 EVLGSGAFSEVFLVKQRL-TGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHENIVTLED 73
Query: 744 SCSNPGFKALIMQYMPQGS-----LEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGY 797
+ L+MQ + G LE+ +Y+ + SL I+Q V SA++YLH
Sbjct: 74 IYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQ-------VLSAVKYLH--- 123
Query: 798 STPIIHCDLKPNNVLL---DDDMVAHLGDFGIAKL-LDGVDPVTQTMTLATIGYMAPEYG 853
I+H DLKP N+L +++ + DFG++K+ +G+ + T GY+APE
Sbjct: 124 ENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGI----MSTACGTPGYVAPEVL 179
Query: 854 SEGIVSISGDVYSFGIL 870
++ S + D +S G++
Sbjct: 180 AQKPYSKAVDCWSIGVI 196
>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d)
Length = 290
Score = 63.5 bits (153), Expect = 6e-10, Method: Composition-based stats.
Identities = 44/123 (35%), Positives = 63/123 (51%), Gaps = 8/123 (6%)
Query: 782 IMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT 841
I + + ALE+LH S +IH D+KP+NVL++ + DFGI+ L VD V + +
Sbjct: 114 IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKMCDFGISGYL--VDDVAKDID 169
Query: 842 LATIGYMAPEYGSEGI----VSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAE 897
YMAPE + + S+ D++S GI M+E R P + T LKQ V E
Sbjct: 170 AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEE 229
Query: 898 SLP 900
P
Sbjct: 230 PSP 232
>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A19|C Chain C, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex.
pdb|2A1A|B Chain B, Pkr Kinase Domain-Eif2alpha Complex
Length = 284
Score = 63.2 bits (152), Expect = 6e-10, Method: Composition-based stats.
Identities = 54/212 (25%), Positives = 96/212 (45%), Gaps = 31/212 (14%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
F E L+GSG F V+KA +G + +K ++A + E + + ++ H N++
Sbjct: 13 FKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKA----EREVKALAKLDHVNIVH 68
Query: 741 I--------------VSSCSNPGFKALI--MQYMPQGSLEKWLYSHN-YSLTIRQRLDIM 783
+ S K L M++ +G+LE+W+ L L++
Sbjct: 69 YNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128
Query: 784 IDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMT 841
+ ++Y+H S +I+ DLKP+N+ L D +GDFG+ L DG + +
Sbjct: 129 EQITKGVDYIH---SKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG----KRXRS 181
Query: 842 LATIGYMAPEYGSEGIVSISGDVYSFGILMME 873
T+ YM+PE S D+Y+ G+++ E
Sbjct: 182 KGTLRYMSPEQISSQDYGKEVDLYALGLILAE 213
>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor
Discovered Through Site-Directed Dynamic Tethering
Length = 272
Score = 63.2 bits (152), Expect = 7e-10, Method: Composition-based stats.
Identities = 70/235 (29%), Positives = 111/235 (47%), Gaps = 19/235 (8%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKV-FNLQEDRA--LKSFDTECEVMRRIRHRNLIKIVS 743
LG G F NVY A + +A+KV F Q ++A E E+ +RH N++++
Sbjct: 20 LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 79
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI-DVASALEYLHHGYSTPII 802
+ LI++Y P G++ + L S QR I ++A+AL Y H S +I
Sbjct: 80 YFHDATRVYLILEYAPLGTVYREL--QKLSRFDEQRTATYITELANALSYCH---SKRVI 134
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGSEGIVSIS 861
H D+KP N+LL + + DFG + P ++ TL T+ Y+ PE +
Sbjct: 135 HRDIKPENLLLGSNGELKIADFGWSVHA----PSSRRDTLCGTLDYLPPEMIEGRMHDEK 190
Query: 862 GDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLPGAVTEVVDANLLSR 914
D++S G+L E F P E T + + ++ V + P VTE +L+SR
Sbjct: 191 VDLWSLGVLCYE-FLVGMPPFEAHTYQETYRRISRVEFTFPDFVTEGA-RDLISR 243
>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|C Chain C, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|D Chain D, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|E Chain E, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|F Chain F, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|G Chain G, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
pdb|2HAK|H Chain H, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1
Length = 328
Score = 63.2 bits (152), Expect = 7e-10, Method: Compositional matrix adjust.
Identities = 53/192 (27%), Positives = 86/192 (44%), Gaps = 18/192 (9%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSS 744
+G G+F V A + G VAVK+ + + +L+ E +M+ + H N++K+
Sbjct: 23 IGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
L+M+Y G + +L +H R + SA++Y H Y I+H
Sbjct: 83 IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKY---IVHR 138
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATI----GYMAPE-YGSEGIVS 859
DLK N+LLD DM + DFG + + T L T Y APE + +
Sbjct: 139 DLKAENLLLDGDMNIKIADFGFS------NEFTVGNKLDTFCGSPPYAAPELFQGKKYDG 192
Query: 860 ISGDVYSFGILM 871
DV+S G+++
Sbjct: 193 PEVDVWSLGVIL 204
>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain
pdb|3UIU|B Chain B, Crystal Structure Of Apo-Pkr Kinase Domain
Length = 306
Score = 63.2 bits (152), Expect = 8e-10, Method: Composition-based stats.
Identities = 57/225 (25%), Positives = 100/225 (44%), Gaps = 44/225 (19%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLI- 739
F E L+GSG F V+KA +G + ++ ++A + E + + ++ H N++
Sbjct: 14 FKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKA----EREVKALAKLDHVNIVH 69
Query: 740 -----------------KIVSSCSNP---------GFKALI--MQYMPQGSLEKWLYSHN 771
+ SS +P K L M++ +G+LE+W+
Sbjct: 70 YNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRR 129
Query: 772 -YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830
L L++ + ++Y+H S +IH DLKP+N+ L D +GDFG+ L
Sbjct: 130 GEKLDKVLALELFEQITKGVDYIH---SKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSL 186
Query: 831 --DGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMME 873
DG +T + T+ YM+PE S D+Y+ G+++ E
Sbjct: 187 KNDG----KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAE 227
>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN-
Dependent Protein Kinase Ii Delta In Complex With
Calmodulin
Length = 327
Score = 62.8 bits (151), Expect = 8e-10, Method: Compositional matrix adjust.
Identities = 49/190 (25%), Positives = 86/190 (45%), Gaps = 11/190 (5%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSS 744
LG G+F V + + G A K+ N ++ R + + E + R ++H N++++ S
Sbjct: 12 LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
S GF L+ + G L + + + Y D + LE ++H + I+H
Sbjct: 72 ISEEGFHYLVFDLVTGGELFEDIVAREYY----SEADASHCIQQILESVNHCHLNGIVHR 127
Query: 805 DLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSIS 861
DLKP N+LL L DFG+A + G D T GY++PE +
Sbjct: 128 DLKPENLLLASKSKGAAVKLADFGLAIEVQG-DQQAWFGFAGTPGYLSPEVLRKDPYGKP 186
Query: 862 GDVYSFGILM 871
D+++ G+++
Sbjct: 187 VDMWACGVIL 196
>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|B Chain B, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|C Chain C, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
pdb|3IEC|D Chain D, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES
BY Mimicking Host Substrates
Length = 319
Score = 62.8 bits (151), Expect = 8e-10, Method: Composition-based stats.
Identities = 41/143 (28%), Positives = 69/143 (48%), Gaps = 7/143 (4%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSS 744
+G G+F V A + G VAVK+ + + +L+ E +M+ + H N++K+
Sbjct: 15 IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 74
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
L+M+Y G + +L +H + R + SA++Y H + I+H
Sbjct: 75 IETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 130
Query: 805 DLKPNNVLLDDDMVAHLGDFGIA 827
DLK N+LLD DM + DFG +
Sbjct: 131 DLKAENLLLDADMNIKIADFGFS 153
>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|3R22|A Chain A, Design, Synthesis, And Biological Evaluation Of
Pyrazolopyridine- Sulfonamides As Potent
Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I)
pdb|4DHF|A Chain A, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
pdb|4DHF|B Chain B, Structure Of Aurora A Mutant Bound To Biogenidec Cpd 15
Length = 271
Score = 62.8 bits (151), Expect = 9e-10, Method: Composition-based stats.
Identities = 74/247 (29%), Positives = 112/247 (45%), Gaps = 19/247 (7%)
Query: 676 QQATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKV-FNLQEDRA--LKSFDTECEVMR 731
Q A F LG G F NVY A + A+KV F Q ++A E E+
Sbjct: 7 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS 66
Query: 732 RIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI-DVASAL 790
+RH N++++ + LI++Y P G++ + L S QR I ++A+AL
Sbjct: 67 HLRHPNILRLYGYFHDATRVYLILEYAPLGTVYREL--QKLSKFDEQRTATYITELANAL 124
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMA 849
Y H S +IH D+KP N+LL + DFG + P ++ L T+ Y+
Sbjct: 125 SYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSVHA----PSSRRDDLCGTLDYLP 177
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW--VAESLPGAVTEVV 907
PE + D++S G+L E F KP E T + + K+ V + P VTE
Sbjct: 178 PEMIEGRMHDEKVDLWSLGVLCYE-FLVGKPPFEANTYQETYKRISRVEFTFPDFVTEGA 236
Query: 908 DANLLSR 914
+L+SR
Sbjct: 237 -RDLISR 242
>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
pdb|1ZMU|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Wild Type
Length = 327
Score = 62.8 bits (151), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 41/143 (28%), Positives = 68/143 (47%), Gaps = 7/143 (4%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSS 744
+G G+F V A + G VAVK+ + + +L+ E +M+ + H N++K+
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
L+M+Y G + +L +H R + SA++Y H + I+H
Sbjct: 82 IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 805 DLKPNNVLLDDDMVAHLGDFGIA 827
DLK N+LLD DM + DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160
>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
pdb|2R0I|B Chain B, Crystal Structure Of A Kinase Mark2PAR-1 Mutant
Length = 327
Score = 62.8 bits (151), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 41/143 (28%), Positives = 68/143 (47%), Gaps = 7/143 (4%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSS 744
+G G+F V A + G VAVK+ + + +L+ E +M+ + H N++K+
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
L+M+Y G + +L +H R + SA++Y H + I+H
Sbjct: 82 IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 805 DLKPNNVLLDDDMVAHLGDFGIA 827
DLK N+LLD DM + DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160
>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|D Chain D, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|F Chain F, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1B6C|H Chain H, Crystal Structure Of The Cytoplasmic Domain Of The Type I
Tgf-Beta Receptor In Complex With Fkbp12
pdb|1IAS|A Chain A, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|B Chain B, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|C Chain C, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|D Chain D, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|1IAS|E Chain E, Cytoplasmic Domain Of Unphosphorylated Type I Tgf-Beta
Receptor Crystallized Without Fkbp12
pdb|3FAA|A Chain A, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|B Chain B, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|C Chain C, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|D Chain D, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3FAA|E Chain E, Crystal Structure Of Tgfbri Complexed With A 2-
Aminoimidazole Inhibitor
pdb|3KCF|A Chain A, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|B Chain B, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|C Chain C, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|D Chain D, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|3KCF|E Chain E, Crystal Structure Of Tgfbri Complexed With A Pyrazolone
Inhibitor
pdb|2X7O|A Chain A, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|B Chain B, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|C Chain C, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|D Chain D, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
pdb|2X7O|E Chain E, Crystal Structure Of Tgfbri Complexed With An Indolinone
Inhibitor
Length = 342
Score = 62.8 bits (151), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 32/213 (15%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRI--RHRNLIKIVSSC 745
+G G F V++ G VAVK+F+ +E+R S+ E E+ + + RH N++ +++
Sbjct: 50 IGKGRFGEVWRGKW-RGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAAD 105
Query: 746 SNPGFKA----LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY---- 797
+ L+ Y GSL +L + Y++T+ + + + AS L +LH
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 163
Query: 798 -STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA------TIGYMAP 850
I H DLK N+L+ + + D G+A D T T+ +A T YMAP
Sbjct: 164 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS---ATDTIDIAPNHRVGTKRYMAP 220
Query: 851 EYGSEGI------VSISGDVYSFGILMMETFTR 877
E + I D+Y+ G++ E R
Sbjct: 221 EVLDDSINMKHFESFKRADIYAMGLVFWEIARR 253
>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5
pdb|2F57|B Chain B, Crystal Structure Of The Human P21-activated Kinase 5
Length = 317
Score = 62.4 bits (150), Expect = 1e-09, Method: Composition-based stats.
Identities = 61/231 (26%), Positives = 107/231 (46%), Gaps = 17/231 (7%)
Query: 661 SLNLATLSRISYHELQQA-----TNGFGESNL-----LGSGSFDNVYKATLAN-GVSVAV 709
+L ++SR+S+ + + A + G L +G GS V AT + G VAV
Sbjct: 16 NLYFQSMSRVSHEQFRAALQLVVSPGDPREYLANFIKIGEGSTGIVCIATEKHTGKQVAV 75
Query: 710 KVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYS 769
K +L++ + + E +MR H N++ + SS ++M+++ G+L + +
Sbjct: 76 KKMDLRKQQRRELLFNEVVIMRDYHHDNVVDMYSSYLVGDELWVVMEFLEGGALTD-IVT 134
Query: 770 HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829
H + Q + + V AL YLH + +IH D+K +++LL D L DFG
Sbjct: 135 HT-RMNEEQIATVCLSVLRALSYLH---NQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQ 190
Query: 830 LDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKP 880
+ P + + + T +MAPE S D++S GI+++E P
Sbjct: 191 VSKEVPKRKXL-VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 240
>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase
Catalytic Subunit From Saccharomyces Cerevisiae
Length = 318
Score = 62.4 bits (150), Expect = 1e-09, Method: Composition-based stats.
Identities = 67/212 (31%), Positives = 97/212 (45%), Gaps = 17/212 (8%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRHRNLIKIVS 743
LG+GSF V+ + NG A+KV + LK + E ++ + H +I++
Sbjct: 14 LGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWG 73
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLY-SHNYSLTIRQRLDIMIDVASALEYLHHGYSTPII 802
+ + +IM Y+ G L L S + + + +V ALEYLH S II
Sbjct: 74 TFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY--AAEVCLALEYLH---SKDII 128
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISG 862
+ DLKP N+LLD + + DFG AK + P T Y+APE S + S
Sbjct: 129 YRDLKPENILLDKNGHIKITDFGFAKYV----PDVTYXLCGTPDYIAPEVVSTKPYNKSI 184
Query: 863 DVYSFGILMMETFTRRKP---TNEMFTGEMSL 891
D +SFGIL+ E P +N M T E L
Sbjct: 185 DWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL 216
>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
pdb|1ZMW|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
T208aS212A INACTIVE DOUBLE MUTANT
Length = 327
Score = 62.4 bits (150), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 41/143 (28%), Positives = 68/143 (47%), Gaps = 7/143 (4%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSS 744
+G G+F V A + G VAVK+ + + +L+ E +M+ + H N++K+
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
L+M+Y G + +L +H R + SA++Y H + I+H
Sbjct: 82 IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 805 DLKPNNVLLDDDMVAHLGDFGIA 827
DLK N+LLD DM + DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160
>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With
Inhibitor
Length = 326
Score = 62.4 bits (150), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 57/213 (26%), Positives = 96/213 (45%), Gaps = 32/213 (15%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRI--RHRNLIKIVSSC 745
+G G F V++ G VAVK+F+ +E+R S+ E E+ + + RH N++ +++
Sbjct: 37 IGKGRFGEVWRGKW-RGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAAD 92
Query: 746 SNPGFKA----LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY---- 797
+ L+ Y GSL +L + Y++T+ + + + AS L +LH
Sbjct: 93 NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 150
Query: 798 -STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA------TIGYMAP 850
I H DLK N+L+ + + D G+A D T T+ +A T YMAP
Sbjct: 151 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDS---ATDTIDIAPNHRVGTKRYMAP 207
Query: 851 EYGSEGI------VSISGDVYSFGILMMETFTR 877
E + I D+Y+ G++ E R
Sbjct: 208 EVLDDSINMKHFESFKRADIYAMGLVFWEIARR 240
>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXQ|A Chain A, Cdk2 In Complex With 3 Molecules Of
8-Anilino-1-Naphthalene Sulfonate
pdb|3PXR|A Chain A, Apo Cdk2 Crystallized From Jeffamine
pdb|3PXY|A Chain A, Cdk2 In Complex With Inhibitor Jws648
pdb|3PXZ|A Chain A, Cdk2 Ternary Complex With Jws648 And Ans
pdb|3PY0|A Chain A, Cdk2 In Complex With Inhibitor Su9516
pdb|3PY1|A Chain A, Cdk2 Ternary Complex With Su9516 And Ans
pdb|3QL8|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-260
pdb|3QQF|A Chain A, Cdk2 In Complex With Inhibitor L1
pdb|3QQG|A Chain A, Cdk2 In Complex With Inhibitor L2-5
pdb|3QQH|A Chain A, Cdk2 In Complex With Inhibitor L2-2
pdb|3QQJ|A Chain A, Cdk2 In Complex With Inhibitor L2
pdb|3QQL|A Chain A, Cdk2 In Complex With Inhibitor L3
pdb|3QRT|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc2-55
pdb|3QRU|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-12
pdb|3QWJ|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-142
pdb|3QWK|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-150
pdb|3QX2|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-190
pdb|3QX4|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-78
pdb|3QXO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-84
pdb|3QZF|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-52
pdb|3QZG|A Chain A, Cdk2 In Complex With Inhibitor Jws-6-76
pdb|3QZH|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-124
pdb|3QZI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-126
pdb|3R1Q|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-102
pdb|3R1S|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-127
pdb|3R1Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-134
pdb|3R28|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-140
pdb|3R6X|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-158
pdb|3R71|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-162
pdb|3R73|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-164
pdb|3R7E|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-67
pdb|3R7I|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-74
pdb|3R7U|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-75
pdb|3R7V|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-9
pdb|3R7Y|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-88
pdb|3R83|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-92
pdb|3R8L|A Chain A, Cdk2 In Complex With Inhibitor L3-4
pdb|3R8M|A Chain A, Cdk2 In Complex With Inhibitor L3-3
pdb|3R8P|A Chain A, Cdk2 In Complex With Inhibitor Nsk-Mc1-6
pdb|3RAI|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-160
pdb|3RM6|A Chain A, Cdk2 In Complex With Inhibitor Kvr-2-80
pdb|3RM7|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-91
pdb|3ROY|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-154
pdb|3RPO|A Chain A, Cdk2 In Complex With Inhibitor Kvr-1-156
pdb|4EZ3|A Chain A, Cdk2 In Complex With Nsc 134199
pdb|4EZ7|A Chain A, Cdk2 In Complex With Staurosporine And 2 Molecules Of
8-Anilino-1- Naphthalene Sulfonic Acid
pdb|3QQK|A Chain A, Cdk2 In Complex With Inhibitor L4
pdb|3QTQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-137
pdb|3QTR|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-148
pdb|3QTS|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-12
pdb|3QTU|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-132
pdb|3QTW|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-13
pdb|3QTX|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-35
pdb|3QTZ|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-36
pdb|3QU0|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-38
pdb|3QXP|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
pdb|3R8U|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-132
pdb|3R8V|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-135
pdb|3R8Z|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-136
pdb|3R9D|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-135
pdb|3R9H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-142
pdb|3R9N|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-21
pdb|3R9O|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-143
pdb|3RAH|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-22
pdb|3RAK|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-32
pdb|3RAL|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-34
pdb|3RJC|A Chain A, Cdk2 In Complex With Inhibitor L4-12
pdb|3RK5|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-72
pdb|3RK7|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-71
pdb|3RK9|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-74
pdb|3RKB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-73
pdb|3RMF|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-33
pdb|3RNI|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-86
pdb|3RPR|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-49
pdb|3RPV|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-88
pdb|3RPY|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-40
pdb|3RZB|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-23
pdb|3S00|A Chain A, Cdk2 In Complex With Inhibitor L4-14
pdb|3S0O|A Chain A, Cdk2 In Complex With Inhibitor Rc-1-138
pdb|3S1H|A Chain A, Cdk2 In Complex With Inhibitor Rc-2-39
pdb|3SQQ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-96
pdb|4GCJ|A Chain A, Cdk2 In Complex With Inhibitor Rc-3-89
Length = 306
Score = 62.4 bits (150), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 12 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ Q L+K++ + + + + + + L + H
Sbjct: 72 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 127
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T T + T+ Y APE G +
Sbjct: 128 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCK 186
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 187 -YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 219
>pdb|2UV2|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To
4-(4-(
5-Cyclopropyl-1h-Pyrazol-3-Ylamino)-Quinazolin-2-
Ylamino)- Phenyl)-Acetonitrile
Length = 287
Score = 62.4 bits (150), Expect = 1e-09, Method: Composition-based stats.
Identities = 55/221 (24%), Positives = 95/221 (42%), Gaps = 11/221 (4%)
Query: 691 GSFDNVYKA-TLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPG 749
G F VYKA V A KV + + + L+ + E +++ H N++K++ +
Sbjct: 21 GDFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYEN 80
Query: 750 FKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPN 809
+++++ G+++ + LT Q + AL YLH IIH DLK
Sbjct: 81 NLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLH---DNKIIHRDLKAG 137
Query: 810 NVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEY-----GSEGIVSISGDV 864
N+L D L DFG++ + + T +MAPE + DV
Sbjct: 138 NILFTLDGDIKLADFGVSAKNTRTXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADV 197
Query: 865 YSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTE 905
+S GI ++E P +E+ + LK +A+S P + +
Sbjct: 198 WSLGITLIEMAEIEPPHHELNPMRVLLK--IAKSEPPTLAQ 236
>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2F2U|B Chain B, Crystal Structure Of The Rho-Kinase Kinase Domain
pdb|2H9V|A Chain A, Structural Basis For Induced-Fit Binding Of Rho-Kinase To
The Inhibitor Y27632
Length = 402
Score = 62.4 bits (150), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 61/267 (22%), Positives = 111/267 (41%), Gaps = 29/267 (10%)
Query: 650 KRNKSLPEENNSLNLATLSRISYHELQQATNGFGESNLLGSGSFDNV----YKATLANGV 705
++NK++ +N LN LQ + ++G G+F V +KA+
Sbjct: 48 RKNKNI---DNFLNRYEKIVKKIRGLQMKAEDYDVVKVIGRGAFGEVQLVRHKASQKVYA 104
Query: 706 SVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEK 765
+ F + + F E ++M ++++ + + + ++M+YMP G L
Sbjct: 105 MKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVN 164
Query: 766 WLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFG 825
+ NY + + +V AL+ +H S +IH D+KP+N+LLD L DFG
Sbjct: 165 LM--SNYDVPEKWAKFYTAEVVLALDAIH---SMGLIHRDVKPDNMLLDKHGHLKLADFG 219
Query: 826 IAKLLDGVDPVTQTMTLATIGYMAPEY----GSEGIVSISGDVYSFGILMMETFTRRKPT 881
+D V + T Y++PE G +G D +S G+ + E P
Sbjct: 220 TCMKMDETGMVHCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTP- 278
Query: 882 NEMFTGEMSLKQWVAESLPGAVTEVVD 908
+ A+SL G ++++D
Sbjct: 279 ------------FYADSLVGTYSKIMD 293
>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site
pdb|3EZV|A Chain A, Cdk-2 With Indazole Inhibitor 9 Bound At Its Active Site
Length = 300
Score = 62.4 bits (150), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ Q L+K++ + + + + + + L + H
Sbjct: 66 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 121
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T T + T+ Y APE G +
Sbjct: 122 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCK 180
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 181 -YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 213
>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
pdb|3HYH|B Chain B, Crystal Structure Of The Protein Kinase Domain Of Yeast
Amp-Activated Protein Kinase Snf1
Length = 275
Score = 62.4 bits (150), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 59/241 (24%), Positives = 107/241 (44%), Gaps = 21/241 (8%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIVS 743
LG GSF V A G VA+K+ N L + + E +R +RH ++IK+
Sbjct: 21 LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 80
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
+ ++++Y + + S +R + SA+EY H I+H
Sbjct: 81 VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYCH---RHKIVH 135
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVS-ISG 862
DLKP N+LLD+ + + DFG++ ++ D + + Y APE S + +
Sbjct: 136 RDLKPENLLLDEHLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVISGKLYAGPEV 193
Query: 863 DVYSFGILMMETFTRRKPTNE---------MFTGEMSLKQWVAESLPGAVTEVVDANLLS 913
DV+S G+++ RR P ++ + G +L ++++ G + ++ N L+
Sbjct: 194 DVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLN 253
Query: 914 R 914
R
Sbjct: 254 R 254
>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-dependent Kinase Inhibitors Identified Through
Structure-based Hybridisation
Length = 299
Score = 62.4 bits (150), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ Q L+K++ + + + + + + L + H
Sbjct: 65 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLSFCH--- 120
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T T + T+ Y APE G +
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 180 -YYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQ 212
>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3Q4T|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dorsomorphin
pdb|3SOC|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|3SOC|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With A Quinazolin
pdb|4ASX|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
pdb|4ASX|B Chain B, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a)
Kinase Domain In Complex With Dihydro-Bauerine C
Length = 322
Score = 62.4 bits (150), Expect = 1e-09, Method: Composition-based stats.
Identities = 61/208 (29%), Positives = 99/208 (47%), Gaps = 29/208 (13%)
Query: 691 GSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEV--MRRIRHRNLIKIVSSCSNP 748
G F V+KA L N VAVK+F +Q+ +S+ E EV + ++H N+++ + +
Sbjct: 35 GRFGCVWKAQLLNEY-VAVKIFPIQDK---QSWQNEYEVYSLPGMKHENILQFIGA-EKR 89
Query: 749 GFKA-----LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH-------G 796
G LI + +GSL +L ++ S + I +A L YLH G
Sbjct: 90 GTSVDVDLWLITAFHEKGSLSDFLKANVVSWN--ELCHIAETMARGLAYLHEDIPGLKDG 147
Query: 797 YSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM-TLATIGYMAPEYGSE 855
+ I H D+K NVLL +++ A + DFG+A + T + T YMAPE E
Sbjct: 148 HKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEV-LE 206
Query: 856 GIVSISG------DVYSFGILMMETFTR 877
G ++ D+Y+ G+++ E +R
Sbjct: 207 GAINFQRDAFLRIDMYAMGLVLWELASR 234
>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY4|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant In Apo Form.
pdb|1ZY5|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp.
pdb|1ZY5|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g
Hyperactivating Mutant Complexed With Amppnp
Length = 303
Score = 62.4 bits (150), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 60/220 (27%), Positives = 97/220 (44%), Gaps = 32/220 (14%)
Query: 682 FGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRH----- 735
F E +LG G+F V KA A + A+K E++ L + +E ++ + H
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVR 66
Query: 736 --------RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVA 787
RN +K +++ + M+Y G+L ++S N + + + +
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 788 SALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK----LLDGVDPVTQ----- 838
AL Y+H S IIH DLKP N+ +D+ +GDFG+AK LD + +Q
Sbjct: 127 EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 839 ----TMTLATIGYMAPEY-GSEGIVSISGDVYSFGILMME 873
T + T Y+A E G + D+YS GI+ E
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
pdb|3DAE|B Chain B, Crystal Structure Of Phosphorylated Snf1 Kinase Domain
Length = 283
Score = 62.0 bits (149), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 59/241 (24%), Positives = 107/241 (44%), Gaps = 21/241 (8%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIVS 743
LG GSF V A G VA+K+ N L + + E +R +RH ++IK+
Sbjct: 22 LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 81
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
+ ++++Y + + S +R + SA+EY H I+H
Sbjct: 82 VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYCH---RHKIVH 136
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVS-ISG 862
DLKP N+LLD+ + + DFG++ ++ D + + Y APE S + +
Sbjct: 137 RDLKPENLLLDEHLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVISGKLYAGPEV 194
Query: 863 DVYSFGILMMETFTRRKPTNE---------MFTGEMSLKQWVAESLPGAVTEVVDANLLS 913
DV+S G+++ RR P ++ + G +L ++++ G + ++ N L+
Sbjct: 195 DVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLN 254
Query: 914 R 914
R
Sbjct: 255 R 255
>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast
Snf1
Length = 274
Score = 62.0 bits (149), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 59/241 (24%), Positives = 107/241 (44%), Gaps = 21/241 (8%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIVS 743
LG GSF V A G VA+K+ N L + + E +R +RH ++IK+
Sbjct: 16 LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 75
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
+ ++++Y + + S +R + SA+EY H I+H
Sbjct: 76 VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYCH---RHKIVH 130
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVS-ISG 862
DLKP N+LLD+ + + DFG++ ++ D + + Y APE S + +
Sbjct: 131 RDLKPENLLLDEHLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVISGKLYAGPEV 188
Query: 863 DVYSFGILMMETFTRRKPTNE---------MFTGEMSLKQWVAESLPGAVTEVVDANLLS 913
DV+S G+++ RR P ++ + G +L ++++ G + ++ N L+
Sbjct: 189 DVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLN 248
Query: 914 R 914
R
Sbjct: 249 R 249
>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine
Length = 306
Score = 62.0 bits (149), Expect = 1e-09, Method: Composition-based stats.
Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 12 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 71
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ Q L+K++ + + + + + + L + H
Sbjct: 72 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 127
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T T + T+ Y APE G +
Sbjct: 128 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGXK 186
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 187 -YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 219
>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine
pdb|2R3Q|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3M|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3I|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3N|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3O|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3P|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3K|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3J|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3L|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|1W8C|A Chain A, Co-crystal Structure Of
6-cyclohexylmethoxy-8-isopropyl-9h- Purin-2-ylamine And
Monomeric Cdk2
Length = 299
Score = 62.0 bits (149), Expect = 1e-09, Method: Composition-based stats.
Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ Q L+K++ + + + + + + L + H
Sbjct: 65 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 120
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T T + T+ Y APE G +
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGXK 179
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 180 -YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 212
>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of
The Saccharomyces Cerevisiae Ampk Homolog Snf1
Length = 271
Score = 62.0 bits (149), Expect = 1e-09, Method: Compositional matrix adjust.
Identities = 59/241 (24%), Positives = 107/241 (44%), Gaps = 21/241 (8%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIVS 743
LG GSF V A G VA+K+ N L + + E +R +RH ++IK+
Sbjct: 12 LGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYD 71
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
+ ++++Y + + S +R + SA+EY H I+H
Sbjct: 72 VIKSKDEIIMVIEYAGNELFDYIVQRDKMSEQEARRF--FQQIISAVEYCH---RHKIVH 126
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVS-ISG 862
DLKP N+LLD+ + + DFG++ ++ D + + Y APE S + +
Sbjct: 127 RDLKPENLLLDEHLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVISGKLYAGPEV 184
Query: 863 DVYSFGILMMETFTRRKPTNE---------MFTGEMSLKQWVAESLPGAVTEVVDANLLS 913
DV+S G+++ RR P ++ + G +L ++++ G + ++ N L+
Sbjct: 185 DVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLPKFLSPGAAGLIKRMLIVNPLN 244
Query: 914 R 914
R
Sbjct: 245 R 245
>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide,
Compound (S)-8b
pdb|3IG7|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efp With Cdk-2
pdb|3IGG|A Chain A, Novel Cdk-5 Inhibitors - Crystal Structure Of Inhibitor
Efq With Cdk-2
pdb|1B38|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1B39|A Chain A, Human Cyclin-Dependent Kinase 2 Phosphorylated On Thr 160
pdb|1E1V|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu2058
pdb|1E1X|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Nu6027
pdb|1H00|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H07|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1H08|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|2R3R|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|4ACM|A Chain A, Cdk2 In Complex With
3-Amino-6-(4-{[2-(Dimethylamino)ethyl]
Sulfamoyl}-Phenyl)-N-Pyridin-3-Ylpyrazine-2-Carboxamide
pdb|3SW4|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|3SW7|A Chain A, Crystal Structure Of The Cdk2 In Complex With
Thiazolylpyrimidine Inhibitor
pdb|1OIQ|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
pdb|1V1K|A Chain A, Cdk2 In Complex With A Disubstituted 4, 6-Bis Anilino
Pyrimidine Cdk4 Inhibitor
pdb|1URW|A Chain A, Cdk2 In Complex With An Imidazo[1,2-B]pyridazine
pdb|2VV9|A Chain A, Cdk2 In Complex With An Imidazole Piperazine
pdb|2W06|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5c
pdb|2R3G|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3H|A Chain A, Crystal Structure Of Cyclin-Dependent Kinase 2 With
Inhibitor
pdb|2R3F|A Chain A, Crystal Structure Of Cyclin-dependent Kinase 2 With
Inhibitor
Length = 299
Score = 62.0 bits (149), Expect = 2e-09, Method: Composition-based stats.
Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ Q L+K++ + + + + + + L + H
Sbjct: 65 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 120
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T T + T+ Y APE G +
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 180 -YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 212
>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|1VYW|C Chain C, Structure Of Cdk2CYCLIN A WITH PNU-292137
pdb|2C4G|A Chain A, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2C4G|C Chain C, Structure Of Cdk2-Cyclin A With Pha-533514
pdb|2BPM|A Chain A, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BPM|C Chain C, Structure Of Cdk2-Cyclin A With Pha-630529
pdb|2BKZ|A Chain A, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2BKZ|C Chain C, Structure Of Cdk2-Cyclin A With Pha-404611
pdb|2WIH|A Chain A, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIH|C Chain C, Structure Of Cdk2-Cyclin A With Pha-848125
pdb|2WIP|A Chain A, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WIP|C Chain C, Structure Of Cdk2-Cyclin A Complexed With 8-Anilino-1-
Methyl-4,5-Dihydro-1h-Pyrazolo[4,3-H] Quinazoline-3-
Carboxylic Acid
pdb|2WPA|A Chain A, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WPA|C Chain C, Optimisation Of 6,6-Dimethyl Pyrrolo 3,4-C Pyrazoles:
Identification Of Pha-793887, A Potent Cdk Inhibitor
Suitable For Intravenous Dosing
pdb|2WXV|A Chain A, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
pdb|2WXV|C Chain C, Structure Of Cdk2-Cyclin A With A Pyrazolo(4,3-H)
Quinazoline-3-Carboxamide Inhibitor
Length = 309
Score = 62.0 bits (149), Expect = 2e-09, Method: Composition-based stats.
Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 9 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ Q L+K++ + + + + + + L + H
Sbjct: 69 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 124
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T T + T+ Y APE G +
Sbjct: 125 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCK 183
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 184 -YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 216
>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2
Complexed With A Nucleoside Inhibitor
Length = 298
Score = 62.0 bits (149), Expect = 2e-09, Method: Composition-based stats.
Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ Q L+K++ + + + + + + L + H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 119
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T T + T+ Y APE G +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 179 -YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 211
>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A
Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine
Length = 299
Score = 62.0 bits (149), Expect = 2e-09, Method: Composition-based stats.
Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ Q L+K++ + + + + + + L + H
Sbjct: 65 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 120
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T T + T+ Y APE G +
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 180 -YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 212
>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1FIN|C Chain C, Cyclin A-Cyclin-Dependent Kinase 2 Complex
pdb|1CKP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Purvalanol B
pdb|1BUH|A Chain A, Crystal Structure Of The Human Cdk2 Kinase Complex With
Cell Cycle-Regulatory Protein Ckshs1
pdb|1DM2|A Chain A, Human Cyclin-Dependent Kinase 2 Complexed With The
Inhibitor Hymenialdisine
pdb|1DI8|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With
4-[3-Hydroxyanilino]-6,7-Dimethoxyquinazoline
pdb|1F5Q|A Chain A, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1F5Q|C Chain C, Crystal Structure Of Murine Gamma Herpesvirus Cyclin
Complexed To Human Cyclin Dependent Kinase 2
pdb|1FVT|A Chain A, The Structure Of Cyclin-Dependent Kinase 2 (Cdk2) In
Complex With An Oxindole Inhibitor
pdb|1FVV|A Chain A, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1FVV|C Chain C, The Structure Of Cdk2CYCLIN A IN COMPLEX WITH AN OXINDOLE
Inhibitor
pdb|1JSV|A Chain A, The Structure Of Cyclin-dependent Kinase 2 (cdk2) In
Complex With 4-[(6-amino-4-pyrimidinyl)
Amino]benzenesulfonamide
pdb|1G5S|A Chain A, Crystal Structure Of Human Cyclin Dependent Kinase 2
(Cdk2) In Complex With The Inhibitor H717
pdb|1JVP|P Chain P, Crystal Structure Of Human Cdk2 (Unphosphorylated) In
Complex With Pkf049-365
pdb|1GIH|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1KE5|A Chain A, Cdk2 Complexed With N-methyl-4-{[(2-oxo-1,2-dihydro-3h-
Indol-3-ylidene)methyl]amino}benzenesulfonamide
pdb|1KE6|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
N-Methyl-{4-
[2-(7-Oxo-6,7-Dihydro-8h-[1,3]thiazolo[5,4-E]indol-8-
Ylidene)hydrazino]phenyl}methanesulfonamide
pdb|1KE7|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[(2,2-
Dioxido-1,
3-Dihydro-2-Benzothien-5-Yl)amino]methylene}-5-
(1,3-Oxazol-5-Yl)-1,3-Dihydro-2h-Indol-2-One
pdb|1KE8|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With
4-{[(2-Oxo-
1,2-Dihydro-3h-Indol-3-Ylidene)methyl]amino}-N-(1,3-
Thiazol-2-Yl)benzenesulfonamide
pdb|1KE9|A Chain A, Cyclin-Dependent Kinase 2 (Cdk2) Complexed With 3-{[4-
({[amino(Imino)methyl]aminosulfonyl)anilino]methylene}-
2- Oxo-2,3-Dihydro-1h-Indole
pdb|1H0V|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor
2-Amino-6-[(R)-Pyrrolidino-5'-Yl]methoxypurine
pdb|1H0W|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 2-Amino-6-[cyclohex-3-Enyl]methoxypurine
pdb|1P2A|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Trisubstituted Naphthostyril Inhibitor
pdb|1OKV|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKV|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Ile-Phe-Nh2
pdb|1OKW|A Chain A, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OKW|C Chain C, Cyclin A Binding Groove Inhibitor
Ac-Arg-Arg-Leu-Asn-(M-Cl-Phe)-Nh2
pdb|1OL1|A Chain A, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL1|C Chain C, Cyclin A Binding Groove Inhibitor
H-Cit-Cit-Leu-Ile-(P-F-Phe)-Nh2
pdb|1OL2|A Chain A, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1OL2|C Chain C, Cyclin A Binding Groove Inhibitor
H-Arg-Arg-Leu-Asn-(P-F-Phe)-Nh2
pdb|1PW2|A Chain A, Apo Structure Of Human Cyclin-Dependent Kinase 2
pdb|1PXI|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-(2,5-dichloro-thiophen-3-yl)-pyrimidin-2-
Ylamine
pdb|1PXJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Ylamine
pdb|1PXK|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-dimethyl-thiazol-5-yl)pyrimidin-2-yl]-
N'-hydroxyiminoformamide
pdb|1PXL|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2,4-dimethyl-thiazol-5-yl)-pyrimidin-2-yl]-
(4-trifluoromethyl-phenyl)-amine
pdb|1R78|A Chain A, Cdk2 Complex With A 4-alkynyl Oxindole Inhibitor
pdb|1PXM|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 3-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-
Ylamino]-Phenol
pdb|1PXN|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor 4-[4-(4-Methyl-2-Methylamino-Thiazol-5-Yl)-
Pyrimidin-2-Ylamino]-Phenol
pdb|1PXO|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
[4-(2-Amino-4-Methyl-Thiazol-5-Yl)-Pyrimidin-2-
Yl]-(3-Nitro-Phenyl)-Amine
pdb|1PXP|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor
N-[4-(2,4-Dimethyl-Thiazol-5-Yl)-Pyrimidin-2-Yl]-
N',N'-Dimethyl-Benzene-1,4-Diamine
pdb|1VYZ|A Chain A, Structure Of Cdk2 Complexed With Pnu-181227
pdb|1PYE|A Chain A, Crystal Structure Of Cdk2 With Inhibitor
pdb|1URC|A Chain A, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1URC|C Chain C, Cyclin A Binding Groove Inhibitor Ace-Arg-Lys-Leu- Phe-Gly
pdb|1W0X|C Chain C, Crystals Structure Of Human Cdk2 In Complex With The
Inhibitor Olomoucine.
pdb|1WCC|A Chain A, Screening For Fragment Binding By X-Ray Crystallography
pdb|1Y8Y|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|1Y91|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Pyrazolo[1, 5-A]pyrimidine Inhibitor
pdb|2BHE|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 5-Bromo-Indirubine
pdb|2BHH|A Chain A, Human Cyclin Dependent Protein Kinase 2 In Complex With
The Inhibitor 4-Hydroxypiperindinesulfonyl-Indirubine
pdb|2B52|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Dph-
042562
pdb|2B53|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With Din-
234325
pdb|2B54|A Chain A, Human Cyclin Dependent Kinase 2 (Ckd2)complexed With Din-
232305
pdb|2B55|A Chain A, Human Cyclin Dependent Kinase 2 (Cdk2) Complexed With
Indenopyraxole Din-101312
pdb|2BTR|A Chain A, Structure Of Cdk2 Complexed With Pnu-198873
pdb|2BTS|A Chain A, Structure Of Cdk2 Complexed With Pnu-230032
pdb|2C68|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C69|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6I|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6K|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6L|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6M|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6O|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2EXM|A Chain A, Human Cdk2 In Complex With Isopentenyladenine
pdb|1YKR|A Chain A, Crystal Structure Of Cdk2 With An Aminoimidazo Pyridine
Inhibitor
pdb|2A0C|X Chain X, Human Cdk2 In Complex With Olomoucine Ii, A Novel 2,6,9-
Trisubstituted Purine Cyclin-Dependent Kinase Inhibitor
pdb|2C5N|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5N|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5O|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5V|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5X|C Chain C, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2C5Y|A Chain A, Differential Binding Of Inhibitors To Active And Inactive
Cdk2 Provides Insights For Drug Design
pdb|2A4L|A Chain A, Human Cyclin-Dependent Kinase 2 In Complex With
Roscovitine
pdb|2FVD|A Chain A, Cyclin Dependent Kinase 2 (Cdk2) With Diaminopyrimidine
Inhibitor
pdb|2I40|A Chain A, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2I40|C Chain C, Cdk2CYCLIN A COMPLEXED WITH A THIOPHENE CARBOXAMIDE
INHIBITOR
pdb|2CLX|A Chain A, 4-Arylazo-3,5-Diamino-1h-Pyrazole Cdk Inhibitors: Sar
Study, Crystal Structure In Complex With Cdk2,
Selectivity, And Cellular Effects
pdb|2DUV|A Chain A, Structure Of Cdk2 With A 3-Hydroxychromones
pdb|2UUE|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UUE|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2UZN|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZO|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2V0D|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|1AQ1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The
Inhibitor Staurosporine
pdb|1HCK|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|1HCL|A Chain A, Human Cyclin-Dependent Kinase 2
pdb|2J9M|A Chain A, Crystal Structure Of Cdk2 In Complex With Macrocyclic
Aminopyrimidine
pdb|2V22|A Chain A, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2V22|C Chain C, Replace: A Strategy For Iterative Design Of Cyclin Binding
Groove Inhibitors
pdb|2VTA|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTH|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design
pdb|2VTI|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTJ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTL|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTM|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTN|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTO|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTP|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTQ|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTR|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTS|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VTT|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2VU3|A Chain A, Identification Of N-(4-Piperidinyl)-4-(2,6-
Dichlorobenzoylamino)-1h-Pyrazole-3-Carboxamide
(At7519), A Novel Cyclin Dependent Kinase Inhibitor
Using Fragment- Based X-Ray Crystallography And
Structure Based Drug Design.
pdb|2R64|A Chain A, Crystal Structure Of A 3-Aminoindazole Compound With Cdk2
pdb|2W05|A Chain A, Structure Of Cdk2 In Complex With An Imidazolyl
Pyrimidine, Compound 5b
pdb|3EID|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EID|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|A Chain A, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EJ1|C Chain C, Cdk2CYCLINA COMPLEXED WITH A PYRAZOLOPYRIDAZINE INHIBITOR
pdb|3EOC|A Chain A, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|3EOC|C Chain C, Cdk2/cyclina Complexed With A Imidazo Triazin-2-amine
pdb|2W1H|A Chain A, Fragment-Based Discovery Of The Pyrazol-4-Yl Urea
(At9283), A Multi-Targeted Kinase Inhibitor With Potent
Aurora Kinase Activity
pdb|3F5X|A Chain A, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3F5X|C Chain C, Cdk-2-Cyclin Complex With Indazole Inhibitor 9 Bound At
Its Active Site
pdb|3FZ1|A Chain A, Crystal Structure Of A Benzthiophene Inhibitor Bound To
Human Cyclin-Dependent Kinase-2 (Cdk-2)
pdb|2WEV|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WEV|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WFY|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2WHB|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|A Chain A, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|2X1N|C Chain C, Truncation And Optimisation Of Peptide Inhibitors Of Cdk2,
Cyclin A Through Structure Guided Design
pdb|3LFN|A Chain A, Crystal Structure Of Cdk2 With Sar57, An Aminoindazole
Type Inhibitor
pdb|3LFQ|A Chain A, Crystal Structure Of Cdk2 With Sar60, An Aminoindazole
Type Inhibitor
pdb|3LFS|A Chain A, Crystal Structure Of Cdk2 With Sar37, An Aminoindazole
Type Inhibitor
pdb|2XMY|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|2XNB|A Chain A, Discovery And Characterisation Of
2-Anilino-4-(Thiazol-5-Yl) Pyrimidine Transcriptional
Cdk Inhibitors As Anticancer Agents
pdb|3LE6|A Chain A, The Structure Of Cyclin Dependent Kinase 2 (Ckd2) With A
Pyrazolobenzodiazepine Inhibitor
pdb|3NS9|A Chain A, Crystal Structure Of Cdk2 In Complex With Inhibitor Bs-194
pdb|3S2P|A Chain A, Crystal Structure Of Cdk2 With A 2-Aminopyrimidine
Compound
pdb|3UNJ|A Chain A, Cdk2 In Complex With Inhibitor Yl1-038-31
pdb|3UNK|A Chain A, Cdk2 In Complex With Inhibitor Yl5-083
pdb|3TI1|A Chain A, Cdk2 In Complex With Sunitinib
pdb|3TIY|A Chain A, Cdk2 In Complex With Nsc 35676
pdb|3TIZ|A Chain A, Cdk2 In Complex With Nsc 111848
Length = 298
Score = 62.0 bits (149), Expect = 2e-09, Method: Composition-based stats.
Identities = 58/218 (26%), Positives = 104/218 (47%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ Q L+K++ + + + + + + L + H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 119
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T T + T+ Y APE G +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 179 -YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 211
>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol
pdb|4FUY|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek2
pdb|4FV0|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek3
Length = 360
Score = 62.0 bits (149), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 21/209 (10%)
Query: 692 SFDNVYKATLANGVSVAVKVFN-LQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGF 750
++DNV N V VA+K + + + E +++ R RH N+I I P
Sbjct: 42 AYDNV------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 95
Query: 751 KALIMQYMPQGSLEKWLYS--HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKP 808
+ + Y+ Q +E LY L+ + + L+Y+H S ++H DLKP
Sbjct: 96 EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKP 152
Query: 809 NNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE--YGSEGIVSISGDV 864
+N+LL+ + DFG+A++ D T +T +AT Y APE S+G S D+
Sbjct: 153 SNLLLNTTXDLKIXDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK-SIDI 211
Query: 865 YSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
+S G ++ E + R +F G+ L Q
Sbjct: 212 WSVGCILAEMLSNRP----IFPGKHYLDQ 236
>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75
pdb|4FV1|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek4
pdb|4FV2|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek5
pdb|4FV3|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek6
pdb|4FV4|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek7
pdb|4FV5|A Chain A, Crystal Structure Of The Erk2 Complexed With Ek9
pdb|4FV8|A Chain A, Crystal Structure Of The Erk2 Complexed With E63
pdb|4FV9|A Chain A, Crystal Structure Of The Erk2 Complexed With E71
pdb|4G6N|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 62.0 bits (149), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 21/209 (10%)
Query: 692 SFDNVYKATLANGVSVAVKVFN-LQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGF 750
++DNV N V VA+K + + + E +++ R RH N+I I P
Sbjct: 42 AYDNV------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 95
Query: 751 KALIMQYMPQGSLEKWLYS--HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKP 808
+ + Y+ Q +E LY L+ + + L+Y+H S ++H DLKP
Sbjct: 96 EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKP 152
Query: 809 NNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE--YGSEGIVSISGDV 864
+N+LL+ + DFG+A++ D T +T +AT Y APE S+G S D+
Sbjct: 153 SNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK-SIDI 211
Query: 865 YSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
+S G ++ E + R +F G+ L Q
Sbjct: 212 WSVGCILAEMLSNRP----IFPGKHYLDQ 236
>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4FMQ|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 62.0 bits (149), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 21/209 (10%)
Query: 692 SFDNVYKATLANGVSVAVKVFN-LQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGF 750
++DNV N V VA+K + + + E +++ R RH N+I I P
Sbjct: 44 AYDNV------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 97
Query: 751 KALIMQYMPQGSLEKWLYS--HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKP 808
+ + Y+ Q +E LY L+ + + L+Y+H S ++H DLKP
Sbjct: 98 EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKP 154
Query: 809 NNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE--YGSEGIVSISGDV 864
+N+LL+ + DFG+A++ D T +T +AT Y APE S+G S D+
Sbjct: 155 SNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK-SIDI 213
Query: 865 YSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
+S G ++ E + R +F G+ L Q
Sbjct: 214 WSVGCILAEMLSNRP----IFPGKHYLDQ 238
>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57
Length = 360
Score = 62.0 bits (149), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/210 (28%), Positives = 97/210 (46%), Gaps = 21/210 (10%)
Query: 691 GSFDNVYKATLANGVSVAVKVFN-LQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPG 749
++DNV N V VA+K + + + E +++ R RH N+I I P
Sbjct: 41 SAYDNV------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPT 94
Query: 750 FKALIMQYMPQGSLEKWLYS--HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLK 807
+ + Y+ Q +E LY L+ + + L+Y+H S ++H DLK
Sbjct: 95 IEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLK 151
Query: 808 PNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE--YGSEGIVSISGD 863
P+N+LL+ + DFG+A++ D T +T +AT Y APE S+G S D
Sbjct: 152 PSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK-SID 210
Query: 864 VYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
++S G ++ E + R +F G+ L Q
Sbjct: 211 IWSVGCILAEMLSNRP----IFPGKHYLDQ 236
>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A
Pyrazolopyridazine Derivative
pdb|3W55|A Chain A, The Structure Of Erk2 In Complex With Fr148083
Length = 368
Score = 61.6 bits (148), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 21/209 (10%)
Query: 692 SFDNVYKATLANGVSVAVKVFN-LQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGF 750
++DNV N V VA+K + + + E +++ R RH N+I I P
Sbjct: 50 AYDNV------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 103
Query: 751 KALIMQYMPQGSLEKWLYS--HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKP 808
+ + Y+ Q +E LY L+ + + L+Y+H S ++H DLKP
Sbjct: 104 EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKP 160
Query: 809 NNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE--YGSEGIVSISGDV 864
+N+LL+ + DFG+A++ D T +T +AT Y APE S+G S D+
Sbjct: 161 SNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK-SIDI 219
Query: 865 YSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
+S G ++ E + R +F G+ L Q
Sbjct: 220 WSVGCILAEMLSNRP----IFPGKHYLDQ 244
>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule
Inhibitor
Length = 368
Score = 61.6 bits (148), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 21/209 (10%)
Query: 692 SFDNVYKATLANGVSVAVKVFN-LQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGF 750
++DNV N V VA+K + + + E +++ R RH N+I I P
Sbjct: 42 AYDNV------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 95
Query: 751 KALIMQYMPQGSLEKWLYS--HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKP 808
+ + Y+ Q +E LY L+ + + L+Y+H S ++H DLKP
Sbjct: 96 EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKP 152
Query: 809 NNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE--YGSEGIVSISGDV 864
+N+LL+ + DFG+A++ D T +T +AT Y APE S+G S D+
Sbjct: 153 SNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK-SIDI 211
Query: 865 YSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
+S G ++ E + R +F G+ L Q
Sbjct: 212 WSVGCILAEMLSNRP----IFPGKHYLDQ 236
>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5
pdb|1OB3|B Chain B, Structure Of P. Falciparum Pfpk5
pdb|1V0P|A Chain A, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
pdb|1V0P|B Chain B, Structure Of P. Falciparum Pfpk5-Purvalanol B Ligand
Complex
Length = 288
Score = 61.6 bits (148), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 49/190 (25%), Positives = 92/190 (48%), Gaps = 10/190 (5%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQ-EDRALKSFD-TECEVMRRIRHRNLIKIVSSC 745
+G G++ VYKA G + A+K L+ ED + S E +++ ++H N++K+
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
L+ +++ Q L+K L L ++ + + + Y H ++H D
Sbjct: 70 HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSEGIVSISGD 863
LKP N+L++ + + DFG+A+ G+ T + T+ Y AP+ GS+ S + D
Sbjct: 126 LKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEIVTLWYRAPDVLMGSKK-YSTTID 183
Query: 864 VYSFGILMME 873
++S G + E
Sbjct: 184 IWSVGCIFAE 193
>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|B Chain B, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|C Chain C, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|D Chain D, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|E Chain E, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
pdb|2WZJ|F Chain F, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r,
T208e Double Mutant
Length = 327
Score = 61.6 bits (148), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 48/188 (25%), Positives = 86/188 (45%), Gaps = 10/188 (5%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSS 744
+G G+F V A + G VAV++ + + +L+ E +M+ + H N++K+
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
L+M+Y G + +L +H R + SA++Y H + I+H
Sbjct: 82 IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE-YGSEGIVSISGD 863
DLK N+LLD DM + DFG + + + + + Y APE + + D
Sbjct: 138 DLKAENLLLDADMNIKIADFGFSNEFTFGNKLDE--FCGSPPYAAPELFQGKKYDGPEVD 195
Query: 864 VYSFGILM 871
V+S G+++
Sbjct: 196 VWSLGVIL 203
>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94
pdb|4G6O|A Chain A, Crystal Structure Of The Erk2
Length = 360
Score = 61.6 bits (148), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 21/209 (10%)
Query: 692 SFDNVYKATLANGVSVAVKVFN-LQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGF 750
++DNV N V VA+K + + + E +++ R RH N+I I P
Sbjct: 42 AYDNV------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 95
Query: 751 KALIMQYMPQGSLEKWLYS--HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKP 808
+ + Y+ Q +E LY L+ + + L+Y+H S ++H DLKP
Sbjct: 96 EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKP 152
Query: 809 NNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE--YGSEGIVSISGDV 864
+N+LL+ + DFG+A++ D T +T +AT Y APE S+G S D+
Sbjct: 153 SNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK-SIDI 211
Query: 865 YSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
+S G ++ E + R +F G+ L Q
Sbjct: 212 WSVGCILAEMLSNRP----IFPGKHYLDQ 236
>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 61.6 bits (148), Expect = 2e-09, Method: Composition-based stats.
Identities = 64/232 (27%), Positives = 108/232 (46%), Gaps = 30/232 (12%)
Query: 678 ATNGFGESNLLGSGSFDNVYKATLA-NGVSVA---VKVFNLQEDRALKSFDTECEVMRRI 733
AT+ + +G G++ VYKA +G VA V+V N +E + + E ++RR+
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTV-REVALLRRL 60
Query: 734 R---HRNLIKIVSSCSNPGFK-----ALIMQYMPQGSLEKWL-YSHNYSLTIRQRLDIMI 784
H N+++++ C+ L+ +++ Q L +L + L D+M
Sbjct: 61 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMR 119
Query: 785 DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD---GVDPVTQTMT 841
L++LH + I+H DLKP N+L+ L DFG+A++ +DPV
Sbjct: 120 QFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPV----- 171
Query: 842 LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
+ T+ Y APE + + D++S G + E F RRKP +F G Q
Sbjct: 172 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP---LFCGNSEADQ 219
>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With
N,n-dimethyl-4-(4-
Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide
pdb|2OJI|A Chain A, Crystal Structure Of Erk2 In Complex With
N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2OJJ|A Chain A, Crystal Structure Of Erk2 In Complex With (S)-N-(1-(3-
Chloro-4-Fluorophenyl)-2-Hydroxyethyl)-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|3I5Z|A Chain A, Crystal Structure Of Erk2 Bound To
(S)-N-(2-Hydroxy-1-Phenylethyl)-4-
(5-Methyl-2-(Phenylamino)pyrimidin-4-Yl)-1h-Pyrrole-2-
Carboxamide
pdb|3I60|A Chain A, Crystal Structure Of Erk2 Bound To
(s)-4-(2-(2-chlorophenylamino)-5-
Methylpyrimidin-4-yl)-n-(2-hydroxy-1-phenylethyl)-1h-
pyrrole-2- Carboxamide
Length = 380
Score = 61.6 bits (148), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 21/209 (10%)
Query: 692 SFDNVYKATLANGVSVAVKVFN-LQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGF 750
++DNV N V VA+K + + + E +++ R RH N+I I P
Sbjct: 62 AYDNV------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 115
Query: 751 KALIMQYMPQGSLEKWLYS--HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKP 808
+ + Y+ Q +E LY L+ + + L+Y+H S ++H DLKP
Sbjct: 116 EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKP 172
Query: 809 NNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE--YGSEGIVSISGDV 864
+N+LL+ + DFG+A++ D T +T +AT Y APE S+G S D+
Sbjct: 173 SNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK-SIDI 231
Query: 865 YSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
+S G ++ E + R +F G+ L Q
Sbjct: 232 WSVGCILAEMLSNRP----IFPGKHYLDQ 256
>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
pdb|1ZMV|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
K82r Mutant
Length = 327
Score = 61.6 bits (148), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 40/143 (27%), Positives = 68/143 (47%), Gaps = 7/143 (4%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSS 744
+G G+F V A + G VAV++ + + +L+ E +M+ + H N++K+
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLNHPNIVKLFEV 81
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
L+M+Y G + +L +H R + SA++Y H + I+H
Sbjct: 82 IETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 805 DLKPNNVLLDDDMVAHLGDFGIA 827
DLK N+LLD DM + DFG +
Sbjct: 138 DLKAENLLLDADMNIKIADFGFS 160
>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2
Length = 364
Score = 61.6 bits (148), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 61/214 (28%), Positives = 99/214 (46%), Gaps = 16/214 (7%)
Query: 688 LGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFD-TECEVMRRIRHRNLIKIVSSC 745
+G G++ V A N V VA+K + E + E +++ R RH N+I I
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENIIGINDII 94
Query: 746 SNPGFKALIMQYMPQGSLEKWLYS--HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
P + + Y+ Q +E LY L+ + + L+Y+H S ++H
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE--YGSEGIVS 859
DLKP+N+LL+ + DFG+A++ D T +T +AT Y APE S+G
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 860 ISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S D++S G ++ E + R +F G+ L Q
Sbjct: 212 -SIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 240
>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
pdb|1V0O|B Chain B, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate
Ligand Complex
Length = 288
Score = 61.2 bits (147), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 49/190 (25%), Positives = 92/190 (48%), Gaps = 10/190 (5%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQ-EDRALKSFD-TECEVMRRIRHRNLIKIVSSC 745
+G G++ VYKA G + A+K L+ ED + S E +++ ++H N++K+
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
L+ +++ Q L+K L L ++ + + + Y H ++H D
Sbjct: 70 HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSEGIVSISGD 863
LKP N+L++ + + DFG+A+ G+ T + T+ Y AP+ GS+ S + D
Sbjct: 126 LKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEVVTLWYRAPDVLMGSKK-YSTTID 183
Query: 864 VYSFGILMME 873
++S G + E
Sbjct: 184 IWSVGCIFAE 193
>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5
pdb|1V0B|B Chain B, Crystal Structure Of The T198a Mutant Of Pfpk5
Length = 288
Score = 61.2 bits (147), Expect = 2e-09, Method: Compositional matrix adjust.
Identities = 49/190 (25%), Positives = 92/190 (48%), Gaps = 10/190 (5%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQ-EDRALKSFD-TECEVMRRIRHRNLIKIVSSC 745
+G G++ VYKA G + A+K L+ ED + S E +++ ++H N++K+
Sbjct: 10 IGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVI 69
Query: 746 SNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
L+ +++ Q L+K L L ++ + + + Y H ++H D
Sbjct: 70 HTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCH---DRRVLHRD 125
Query: 806 LKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSEGIVSISGD 863
LKP N+L++ + + DFG+A+ G+ T + T+ Y AP+ GS+ S + D
Sbjct: 126 LKPQNLLINREGELKIADFGLARAF-GIPVRKYTHEVVTLWYRAPDVLMGSKK-YSTTID 183
Query: 864 VYSFGILMME 873
++S G + E
Sbjct: 184 IWSVGCIFAE 193
>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase,
Kinase: An Active Protein Kinase Complexed With
Nucleotide, Substrate-Analogue And Product
Length = 298
Score = 61.2 bits (147), Expect = 2e-09, Method: Composition-based stats.
Identities = 50/171 (29%), Positives = 81/171 (47%), Gaps = 31/171 (18%)
Query: 726 ECEVMRRIR-HRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIM- 783
E +++R++ H N+I++ + F L+ M +G L +L + +L+ ++ IM
Sbjct: 73 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMR 131
Query: 784 --IDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT 841
++V AL L+ I+H DLKP N+LLDDDM L DFG + LD + + +
Sbjct: 132 ALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE--V 183
Query: 842 LATIGYMAPE------------YGSEGIVSISGDVYSFGILMMETFTRRKP 880
T Y+APE YG E D++S G++M P
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIMYTLLAGSPP 228
>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide
Substrate Complex: Kinase Substrate Recognition
Length = 277
Score = 61.2 bits (147), Expect = 2e-09, Method: Composition-based stats.
Identities = 50/171 (29%), Positives = 81/171 (47%), Gaps = 31/171 (18%)
Query: 726 ECEVMRRIR-HRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIM- 783
E +++R++ H N+I++ + F L+ M +G L +L + +L+ ++ IM
Sbjct: 60 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMR 118
Query: 784 --IDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT 841
++V AL L+ I+H DLKP N+LLDDDM L DFG + LD + + +
Sbjct: 119 ALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRE--V 170
Query: 842 LATIGYMAPE------------YGSEGIVSISGDVYSFGILMMETFTRRKP 880
T Y+APE YG E D++S G++M P
Sbjct: 171 CGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIMYTLLAGSPP 215
>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|3QYZ|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor
pdb|4GT3|A Chain A, Atp-Bound Form Of The Erk2 Kinase
pdb|4GVA|A Chain A, Adp-Bound Form Of The Erk2 Kinase
Length = 364
Score = 61.2 bits (147), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 16/214 (7%)
Query: 688 LGSGSFDNVYKATL-ANGVSVAVKVFN-LQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
+G G++ V A N V VA+K + + + E +++ R RH N+I I
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 746 SNPGFKALIMQYMPQGSLEKWLYS--HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
P + + Y+ Q +E LY L+ + + L+Y+H S ++H
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE--YGSEGIVS 859
DLKP+N+LL+ + DFG+A++ D T +T +AT Y APE S+G
Sbjct: 152 RDLKPSNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 860 ISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S D++S G ++ E + R +F G+ L Q
Sbjct: 212 -SIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 240
>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase
Domain Phosphorylated On Ser172
pdb|4EUU|B Chain B, Structure Of Bx-795 Complexed With Human Tbk1 Kinase
Domain Phosphorylated On Ser172
Length = 319
Score = 61.2 bits (147), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 59/226 (26%), Positives = 103/226 (45%), Gaps = 27/226 (11%)
Query: 685 SNLLGSGSFDNVYKATLAN-GVSVAVKVFN-LQEDRALKSFDTECEVMRRIRHRNLIKI- 741
S++LG G+ NV++ G A+KVFN + R + E EV++++ H+N++K+
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 742 -VSSCSNPGFKALIMQYMPQGSLEKWLY--SHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
+ + K LIM++ P GSL L S+ Y L + L ++ DV + +L
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---E 130
Query: 799 TPIIHCDLKPNNVLL----DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGS 854
I+H ++KP N++ D V L DFG A+ L+ D T Y+ P
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE--DDEQFVXLYGTEEYLHP---- 184
Query: 855 EGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLP 900
D+Y +L + + T ++++ ++ SLP
Sbjct: 185 --------DMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222
>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment
pdb|3H4J|A Chain A, Crystal Structure Of Pombe Ampk Kdaid Fragment
Length = 336
Score = 61.2 bits (147), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 18/206 (8%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRI------RHRNLIK 740
LG GSF V AT VA+K + Q LK D V R I RH ++IK
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQ---LLKKSDMHMRVEREISYLKLLRHPHIIK 73
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ + P ++++Y G L ++ +T + + A+EY H
Sbjct: 74 LYDVITTPTDIVMVIEY-AGGELFDYIVEKK-RMTEDEGRRFFQQIICAIEYCH---RHK 128
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVS- 859
I+H DLKP N+LLDD++ + DFG++ ++ D + + Y APE + + +
Sbjct: 129 IVHRDLKPENLLLDDNLNVKIADFGLSNIM--TDGNFLKTSCGSPNYAAPEVINGKLYAG 186
Query: 860 ISGDVYSFGILMMETFTRRKPTNEMF 885
DV+S GI++ R P ++ F
Sbjct: 187 PEVDVWSCGIVLYVMLVGRLPFDDEF 212
>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex
With Staurosporine
Length = 287
Score = 61.2 bits (147), Expect = 3e-09, Method: Composition-based stats.
Identities = 52/205 (25%), Positives = 95/205 (46%), Gaps = 13/205 (6%)
Query: 688 LGSGSFDNVYKATL---ANGVSVAVKVFNLQEDRA-LKSFDTECEVMRRIRHRNLIKIVS 743
LG G+F +V + + VA+KV ++A + E ++M ++ + +++++
Sbjct: 18 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
C L+M+ G L K+L + + +++ V+ ++YL +H
Sbjct: 78 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVH 133
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA---TIGYMAPEYGSEGIVSI 860
DL NVLL + A + DFG++K L G D T A + + APE + S
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKAL-GADDSYYTARSAGKWPLKWYAPECINFRKFSS 192
Query: 861 SGDVYSFGILMMETFTR-RKPTNEM 884
DV+S+G+ M E + +KP +M
Sbjct: 193 RSDVWSYGVTMWEALSYGQKPYKKM 217
>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e)
Length = 358
Score = 61.2 bits (147), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 16/214 (7%)
Query: 688 LGSGSFDNVYKATL-ANGVSVAVKVFN-LQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
+G G++ V A N V VA+K + + + E +++ R RH N+I I
Sbjct: 29 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 746 SNPGFKALIMQYMPQGSLEKWLYS--HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
P + + Y+ Q +E LY L+ + + L+Y+H S ++H
Sbjct: 89 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 145
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE--YGSEGIVS 859
DLKP+N+LL+ + DFG+A++ D T +T +AT Y APE S+G
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 860 ISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S D++S G ++ E + R +F G+ L Q
Sbjct: 206 -SIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 234
>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Map Kinase Erk2
Length = 365
Score = 61.2 bits (147), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 16/214 (7%)
Query: 688 LGSGSFDNVYKATL-ANGVSVAVKVFN-LQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
+G G++ V A N V VA+K + + + E +++ R RH N+I I
Sbjct: 36 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 746 SNPGFKALIMQYMPQGSLEKWLYS--HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
P + + Y+ Q +E LY L+ + + L+Y+H S ++H
Sbjct: 96 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 152
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE--YGSEGIVS 859
DLKP+N+LL+ + DFG+A++ D T +T +AT Y APE S+G
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 212
Query: 860 ISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S D++S G ++ E + R +F G+ L Q
Sbjct: 213 -SIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 241
>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In
Complex With
(4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin
2-Yl]amino}phenyl)acetic Acid
Length = 366
Score = 61.2 bits (147), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 16/214 (7%)
Query: 688 LGSGSFDNVYKATL-ANGVSVAVKVFN-LQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
+G G++ V A N V VA+K + + + E +++ R RH N+I I
Sbjct: 37 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 96
Query: 746 SNPGFKALIMQYMPQGSLEKWLYS--HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
P + + Y+ Q +E LY L+ + + L+Y+H S ++H
Sbjct: 97 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 153
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE--YGSEGIVS 859
DLKP+N+LL+ + DFG+A++ D T +T +AT Y APE S+G
Sbjct: 154 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 213
Query: 860 ISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S D++S G ++ E + R +F G+ L Q
Sbjct: 214 -SIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 242
>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
pdb|3C9W|B Chain B, Crystal Structure Of Erk-2 With Hypothemycin Covalently
Bound
Length = 357
Score = 61.2 bits (147), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 16/214 (7%)
Query: 688 LGSGSFDNVYKATL-ANGVSVAVKVFN-LQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
+G G++ V A N V VA+K + + + E +++ R RH N+I I
Sbjct: 28 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 87
Query: 746 SNPGFKALIMQYMPQGSLEKWLYS--HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
P + + Y+ Q +E LY L+ + + L+Y+H S ++H
Sbjct: 88 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 144
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE--YGSEGIVS 859
DLKP+N+LL+ + DFG+A++ D T +T +AT Y APE S+G
Sbjct: 145 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 204
Query: 860 ISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S D++S G ++ E + R +F G+ L Q
Sbjct: 205 -SIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 233
>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|2FYS|A Chain A, Crystal Structure Of Erk2 Complex With Kim Peptide Derived
From Mkp3
pdb|1ERK|A Chain A, Structure Of Signal-Regulated Kinase
pdb|3ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2SB220025
pdb|4ERK|A Chain A, The Complex Structure Of The Map Kinase Erk2OLOMOUCINE
pdb|3QYI|A Chain A, Map Kinase Erk2 Complexed With
1,1-Dioxo-2,3-Dihydrothiophen-3-Yl Benzenesulfonate
Length = 364
Score = 61.2 bits (147), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 16/214 (7%)
Query: 688 LGSGSFDNVYKATL-ANGVSVAVKVFN-LQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
+G G++ V A N V VA+K + + + E +++ R RH N+I I
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 746 SNPGFKALIMQYMPQGSLEKWLYS--HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
P + + Y+ Q +E LY L+ + + L+Y+H S ++H
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE--YGSEGIVS 859
DLKP+N+LL+ + DFG+A++ D T +T +AT Y APE S+G
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 860 ISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S D++S G ++ E + R +F G+ L Q
Sbjct: 212 -SIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 240
>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX
Length = 358
Score = 60.8 bits (146), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 16/214 (7%)
Query: 688 LGSGSFDNVYKATL-ANGVSVAVKVFN-LQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
+G G++ V A N V VA+K + + + E +++ R RH N+I I
Sbjct: 29 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 88
Query: 746 SNPGFKALIMQYMPQGSLEKWLYS--HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
P + + Y+ Q +E LY L+ + + L+Y+H S ++H
Sbjct: 89 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 145
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE--YGSEGIVS 859
DLKP+N+LL+ + DFG+A++ D T +T +AT Y APE S+G
Sbjct: 146 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 205
Query: 860 ISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S D++S G ++ E + R +F G+ L Q
Sbjct: 206 -SIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 234
>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia
pdb|3GC0|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia In
Complex With Amp
Length = 329
Score = 60.8 bits (146), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 61/218 (27%), Positives = 108/218 (49%), Gaps = 25/218 (11%)
Query: 688 LGSGSFDNVYKA--TLANGVSVAVKVFNLQ--EDRALKSFDTECEVMRRIRHRNLIKIVS 743
LG G++ VYKA T+ N +VA+K L+ E+ + E +++ ++HRN+I++ S
Sbjct: 42 LGEGTYGEVYKAIDTVTNE-TVAIKRIRLEHEEEGVPGTAIREVSLLKELQHRNIIELKS 100
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
+ LI +Y + L+K++ N +++R + + + + + H S +H
Sbjct: 101 VIHHNHRLHLIFEYA-ENDLKKYM-DKNPDVSMRVIKSFLYQLINGVNFCH---SRRCLH 155
Query: 804 CDLKPNNVLL-----DDDMVAHLGDFGIAKLLDGVDPVTQ-TMTLATIGYMAPE--YGSE 855
DLKP N+LL + V +GDFG+A+ G+ P+ Q T + T+ Y PE GS
Sbjct: 156 RDLKPQNLLLSVSDASETPVLKIGDFGLARAF-GI-PIRQFTHEIITLWYRPPEILLGSR 213
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S S D++S + E + +F G+ + Q
Sbjct: 214 H-YSTSVDIWSIACIWAEMLMK----TPLFPGDSEIDQ 246
>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine
Mutation At Position 52
Length = 364
Score = 60.8 bits (146), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 16/214 (7%)
Query: 688 LGSGSFDNVYKATL-ANGVSVAV-KVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
+G G++ V A N V VA+ K+ + + E +++ R RH N+I I
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 746 SNPGFKALIMQYMPQGSLEKWLYS--HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
P + + Y+ Q +E LY L+ + + L+Y+H S ++H
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE--YGSEGIVS 859
DLKP+N+LL+ + DFG+A++ D T +T +AT Y APE S+G
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 860 ISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S D++S G ++ E + R +F G+ L Q
Sbjct: 212 -SIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 240
>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|B Chain B, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|C Chain C, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
pdb|3BHH|D Chain D, Crystal Structure Of Human Calcium/calmodulin-dependent
Protein Kinase Iib Isoform 1 (camk2b)
Length = 295
Score = 60.8 bits (146), Expect = 3e-09, Method: Composition-based stats.
Identities = 48/190 (25%), Positives = 85/190 (44%), Gaps = 11/190 (5%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSS 744
+G G+F V + L G A K+ N ++ R + + E + R ++H N++++ S
Sbjct: 12 IGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLKHSNIVRLHDS 71
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
S GF L+ + G L + + + Y D + LE + H + ++H
Sbjct: 72 ISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILEAVLHCHQMGVVHR 127
Query: 805 DLKPNNVLLDDD---MVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSIS 861
DLKP N+LL L DFG+A + G D T GY++PE +
Sbjct: 128 DLKPENLLLASKCKGAAVKLADFGLAIEVQG-DQQAWFGFAGTPGYLSPEVLRKEAYGKP 186
Query: 862 GDVYSFGILM 871
D+++ G+++
Sbjct: 187 VDIWACGVIL 196
>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E87|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E88|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3E8D|B Chain B, Crystal Structures Of The Kinase Domain Of Akt2 In Complex
With Atp- Competitive Inhibitors
pdb|3D0E|A Chain A, Crystal Structure Of Human Akt2 In Complex With Gsk690693
pdb|3D0E|B Chain B, Crystal Structure Of Human Akt2 In Complex With Gsk690693
Length = 335
Score = 60.8 bits (146), Expect = 3e-09, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 88/207 (42%), Gaps = 13/207 (6%)
Query: 680 NGFGESNLLGSGSFDNVYKA-TLANGVSVAVKVFN----LQEDRALKSFDTECEVMRRIR 734
N F LLG G+F V A G A+K+ + +D + TE V++ R
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVLQNTR 63
Query: 735 HRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH 794
H L + + +M+Y G L L R R ++ SALEYLH
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH 122
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV-DPVTQTMTLATIGYMAPEYG 853
S +++ D+K N++LD D + DFG+ K +G+ D T T Y+APE
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVL 177
Query: 854 SEGIVSISGDVYSFGILMMETFTRRKP 880
+ + D + G++M E R P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204
>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
pdb|3FE3|B Chain B, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a
Double Mutant
Length = 328
Score = 60.8 bits (146), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 51/196 (26%), Positives = 84/196 (42%), Gaps = 26/196 (13%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSS 744
+G G+F V A + G VA+K+ + + +L+ E +M+ + H N++K+
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
LIM+Y G + +L +H + ++ + SA++Y H I+H
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQ---KRIVHR 138
Query: 805 DLKPNNVLLDDDMVAHLGDFG------IAKLLD---GVDPVTQTMTLATIGYMAPEYGSE 855
DLK N+LLD DM + DFG + LD G P Y PE
Sbjct: 139 DLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEV--- 195
Query: 856 GIVSISGDVYSFGILM 871
DV+S G+++
Sbjct: 196 -------DVWSLGVIL 204
>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI8|C Chain C, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structures Cdk6-P19ink4d Inhibitor Complex
pdb|1BI7|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From
The Structure Of The Cdk6-P16ink4a Tumor Suppressor
Complex
pdb|1BLX|A Chain A, P19ink4dCDK6 COMPLEX
pdb|1G3N|A Chain A, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
pdb|1G3N|E Chain E, Structure Of A P18(Ink4c)-Cdk6-K-Cyclin Ternary Complex
Length = 326
Score = 60.8 bits (146), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 62/221 (28%), Positives = 104/221 (47%), Gaps = 27/221 (12%)
Query: 688 LGSGSFDNVYKAT-LANGVS-VAVKVFNLQ--EDRALKSFDTECEVMRRIR---HRNLIK 740
+G G++ V+KA L NG VA+K +Q E+ S E V+R + H N+++
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 741 IVSSCS-----NPGFKALIMQYMPQG---SLEKWLYSHNYSLTIRQRLDIMIDVASALEY 792
+ C+ L+ +++ Q L+K + TI+ D+M + L++
Sbjct: 79 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK---DMMFQLLRGLDF 135
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEY 852
LH S ++H DLKP N+L+ L DFG+A++ + T + T+ Y APE
Sbjct: 136 LH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPEV 190
Query: 853 GSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
+ + D++S G + E F RRKP +F G + Q
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEMF-RRKP---LFRGSSDVDQ 227
>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
pdb|1MRY|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain
Length = 339
Score = 60.8 bits (146), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 88/207 (42%), Gaps = 13/207 (6%)
Query: 680 NGFGESNLLGSGSFDNVYKA-TLANGVSVAVKVFN----LQEDRALKSFDTECEVMRRIR 734
N F LLG G+F V A G A+K+ + +D + TE V++ R
Sbjct: 8 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVLQNTR 66
Query: 735 HRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH 794
H L + + +M+Y G L L R R ++ SALEYLH
Sbjct: 67 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH 125
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV-DPVTQTMTLATIGYMAPEYG 853
S +++ D+K N++LD D + DFG+ K +G+ D T T Y+APE
Sbjct: 126 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVL 180
Query: 854 SEGIVSISGDVYSFGILMMETFTRRKP 880
+ + D + G++M E R P
Sbjct: 181 EDNDYGRAVDWWGLGVVMYEMMCGRLP 207
>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain
Length = 335
Score = 60.8 bits (146), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 88/207 (42%), Gaps = 13/207 (6%)
Query: 680 NGFGESNLLGSGSFDNVYKA-TLANGVSVAVKVFN----LQEDRALKSFDTECEVMRRIR 734
N F LLG G+F V A G A+K+ + +D + TE V++ R
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVLQNTR 63
Query: 735 HRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH 794
H L + + +M+Y G L L R R ++ SALEYLH
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH 122
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV-DPVTQTMTLATIGYMAPEYG 853
S +++ D+K N++LD D + DFG+ K +G+ D T T Y+APE
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVL 177
Query: 854 SEGIVSISGDVYSFGILMMETFTRRKP 880
+ + D + G++M E R P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204
>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
pdb|2VN9|B Chain B, Crystal Structure Of Human Calcium Calmodulin Dependent
Protein Kinase Ii Delta Isoform 1, Camkd
Length = 301
Score = 60.8 bits (146), Expect = 4e-09, Method: Composition-based stats.
Identities = 49/190 (25%), Positives = 86/190 (45%), Gaps = 11/190 (5%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSS 744
LG G+F V + + G A K+ N ++ R + + E + R ++H N++++ S
Sbjct: 12 LGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 71
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
S GF L+ + G L + + + Y D + LE ++H + I+H
Sbjct: 72 ISEEGFHYLVFDLVTGGELFEDIVAREY----YSEADASHCIQQILESVNHCHLNGIVHR 127
Query: 805 DLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSIS 861
DLKP N+LL L DFG+A + G D T GY++PE +
Sbjct: 128 DLKPENLLLASKSKGAAVKLADFGLAIEVQG-DQQAWFGFAGTPGYLSPEVLRKDPYGKP 186
Query: 862 GDVYSFGILM 871
D+++ G+++
Sbjct: 187 VDMWACGVIL 196
>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B
(pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3
Peptide
Length = 337
Score = 60.8 bits (146), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 88/207 (42%), Gaps = 13/207 (6%)
Query: 680 NGFGESNLLGSGSFDNVYKA-TLANGVSVAVKVFN----LQEDRALKSFDTECEVMRRIR 734
N F LLG G+F V A G A+K+ + +D + TE V++ R
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVLQNTR 63
Query: 735 HRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH 794
H L + + +M+Y G L L R R ++ SALEYLH
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH 122
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV-DPVTQTMTLATIGYMAPEYG 853
S +++ D+K N++LD D + DFG+ K +G+ D T T Y+APE
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVL 177
Query: 854 SEGIVSISGDVYSFGILMMETFTRRKP 880
+ + D + G++M E R P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204
>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d
With Gsk3 Peptide And Amp-Pnp
Length = 336
Score = 60.8 bits (146), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 88/207 (42%), Gaps = 13/207 (6%)
Query: 680 NGFGESNLLGSGSFDNVYKA-TLANGVSVAVKVFN----LQEDRALKSFDTECEVMRRIR 734
N F LLG G+F V A G A+K+ + +D + TE V++ R
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVLQNTR 63
Query: 735 HRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH 794
H L + + +M+Y G L L R R ++ SALEYLH
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH 122
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV-DPVTQTMTLATIGYMAPEYG 853
S +++ D+K N++LD D + DFG+ K +G+ D T T Y+APE
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVL 177
Query: 854 SEGIVSISGDVYSFGILMMETFTRRKP 880
+ + D + G++M E R P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204
>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
pdb|2QNJ|B Chain B, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1
Length = 328
Score = 60.5 bits (145), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 51/192 (26%), Positives = 87/192 (45%), Gaps = 18/192 (9%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSS 744
+G G+F V A + G VA+K+ + + +L+ E +M+ + H N++K+
Sbjct: 20 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 79
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
LIM+Y G + +L +H + ++ + SA++Y H I+H
Sbjct: 80 IETEKTLYLIMEYASGGEVFDYLVAHG-RMKEKEARSKFRQIVSAVQYCHQ---KRIVHR 135
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATI----GYMAPE-YGSEGIVS 859
DLK N+LLD DM + DFG + + T L T Y APE + +
Sbjct: 136 DLKAENLLLDADMNIKIADFGFS------NEFTVGGKLDTFCGSPPYAAPELFQGKKYDG 189
Query: 860 ISGDVYSFGILM 871
DV+S G+++
Sbjct: 190 PEVDVWSLGVIL 201
>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1P|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu2058
pdb|1H1Q|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1Q|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6094
pdb|1H1R|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1R|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6086
pdb|1H1S|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H1S|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With The Inhibitor Nu6102
pdb|1H24|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H24|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH A 9 RESIDUE RECRUITMENT
Peptide From E2f
pdb|1H25|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H25|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From Retinoblastoma-Associated Protein
pdb|1H26|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H26|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P53
pdb|1H27|A Chain A, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H27|C Chain C, Cdk2CYCLIN A IN COMPLEX WITH AN 11-Residue Recruitment
Peptide From P27
pdb|1H28|A Chain A, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|1H28|C Chain C, Cdk2/cyclin A In Complex With An 11-residue Recruitment
Peptide From P107
pdb|2WMA|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMA|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|A Chain A, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
pdb|2WMB|C Chain C, Structural And Thermodynamic Consequences Of Cyclization
Of Peptide Ligands For The Recruitment Site Of Cyclin A
Length = 303
Score = 60.5 bits (145), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 9 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 68
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ Q L+K++ + + + + + + L + H
Sbjct: 69 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 124
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T + T+ Y APE G +
Sbjct: 125 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCK 183
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 184 -YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 216
>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human
Tbk1 Kinase- Uld Domain
pdb|4EUT|B Chain B, Structure Of Bx-795 Complexed With Unphosphorylated Human
Tbk1 Kinase- Uld Domain
Length = 396
Score = 60.5 bits (145), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 48/157 (30%), Positives = 81/157 (51%), Gaps = 13/157 (8%)
Query: 685 SNLLGSGSFDNVYKATLAN-GVSVAVKVFN-LQEDRALKSFDTECEVMRRIRHRNLIKI- 741
S++LG G+ NV++ G A+KVFN + R + E EV++++ H+N++K+
Sbjct: 14 SDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLNHKNIVKLF 73
Query: 742 -VSSCSNPGFKALIMQYMPQGSLEKWLY--SHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
+ + K LIM++ P GSL L S+ Y L + L ++ DV + +L
Sbjct: 74 AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR---E 130
Query: 799 TPIIHCDLKPNNVLL----DDDMVAHLGDFGIAKLLD 831
I+H ++KP N++ D V L DFG A+ L+
Sbjct: 131 NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE 167
>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By
Mutational Studies
Length = 298
Score = 60.5 bits (145), Expect = 4e-09, Method: Composition-based stats.
Identities = 50/171 (29%), Positives = 80/171 (46%), Gaps = 31/171 (18%)
Query: 726 ECEVMRRIR-HRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIM- 783
E +++R++ H N+I++ + F L+ M +G L +L + +L+ ++ IM
Sbjct: 73 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL-TEKVTLSEKETRKIMR 131
Query: 784 --IDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT 841
++V AL L+ I+H DLKP N+LLDDDM L DFG + LD + +
Sbjct: 132 ALLEVICALHKLN------IVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRS--V 183
Query: 842 LATIGYMAPE------------YGSEGIVSISGDVYSFGILMMETFTRRKP 880
T Y+APE YG E D++S G++M P
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKE------VDMWSTGVIMYTLLAGSPP 228
>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDR|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With The Inhibitor
A- 443654
pdb|2UW9|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|2X39|A Chain A, Structure Of
4-Amino-N-(4-Chlorobenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidine-4-Carboxamide Bound To Pkb
pdb|2XH5|A Chain A, Structure Of 4-(4-Tert-Butylbenzyl)-1-(7h-Pyrrolo(2,3-D)
Pyrimidin-4-Yl)piperidin-4-Amine Bound To Pkb
Length = 342
Score = 60.5 bits (145), Expect = 4e-09, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 88/207 (42%), Gaps = 13/207 (6%)
Query: 680 NGFGESNLLGSGSFDNVYKA-TLANGVSVAVKVFN----LQEDRALKSFDTECEVMRRIR 734
N F LLG G+F V A G A+K+ + +D + TE V++ R
Sbjct: 10 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVLQNTR 68
Query: 735 HRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH 794
H L + + +M+Y G L L R R ++ SALEYLH
Sbjct: 69 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH 127
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV-DPVTQTMTLATIGYMAPEYG 853
S +++ D+K N++LD D + DFG+ K +G+ D T T Y+APE
Sbjct: 128 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKXFCGTPEYLAPEVL 182
Query: 854 SEGIVSISGDVYSFGILMMETFTRRKP 880
+ + D + G++M E R P
Sbjct: 183 EDNDYGRAVDWWGLGVVMYEMMCGRLP 209
>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1E9H|C Chain C, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With
The Inhibitor Indirubin-5-Sulphonate Bound
pdb|1PKD|A Chain A, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
pdb|1PKD|C Chain C, The Crystal Structure Of Ucn-01 In Complex With Phospho-
Cdk2CYCLIN A
Length = 297
Score = 60.5 bits (145), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ Q L+K++ + + + + + + L + H
Sbjct: 65 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 120
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T + T+ Y APE G +
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 180 -YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 212
>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
pdb|4EOS|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Ro3306
Length = 300
Score = 60.5 bits (145), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ Q L+K++ + + + + + + L + H
Sbjct: 67 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 122
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T + T+ Y APE G +
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 182 -YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 214
>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OGU|C Chain C, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed
With A
2-arylamino-4-cyclohexylmethyl-5-nitroso-6-
aminopyrimidine Inhibitor
pdb|1OI9|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OI9|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIU|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
pdb|1OIY|C Chain C, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED
With A 6-Cyclohexylmethyloxy-2-Anilino-Purine Inhibitor
Length = 302
Score = 60.5 bits (145), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ Q L+K++ + + + + + + L + H
Sbjct: 68 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 123
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T + T+ Y APE G +
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 183 -YYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQ 215
>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
pdb|4EOQ|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With Atp
Length = 301
Score = 60.5 bits (145), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ Q L+K++ + + + + + + L + H
Sbjct: 68 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 123
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T + T+ Y APE G +
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 183 -YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 215
>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCQ|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 301
Score = 60.5 bits (145), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ Q L+K++ + + + + + + L + H
Sbjct: 67 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 122
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T + T+ Y APE G +
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 182 -YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 214
>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2
Length = 364
Score = 60.5 bits (145), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 60/214 (28%), Positives = 99/214 (46%), Gaps = 16/214 (7%)
Query: 688 LGSGSFDNVYKATL-ANGVSVAVKVFN-LQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
+G G++ V A N V VA+K + + + E +++ R RH N+I I
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 746 SNPGFKALIMQYMPQGSLEKWLYS--HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
P + + Y+ Q +E LY L+ + + L+Y+H S ++H
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLLKCQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE--YGSEGIVS 859
DLKP+N+LL+ + DFG+A++ D T +T +AT Y APE S+G
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK 211
Query: 860 ISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S D++S G ++ E + R +F G+ L Q
Sbjct: 212 -SIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 240
>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E
pdb|4EOR|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
pdb|4EOR|C Chain C, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex
With The Inhibitor Nu6102
Length = 298
Score = 60.5 bits (145), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ Q L+K++ + + + + + + L + H
Sbjct: 65 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 120
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T + T+ Y APE G +
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 180 -YYSTAVDIWSLGCIFAEMVTRR----ALFPGDSEIDQ 212
>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6
Length = 321
Score = 60.5 bits (145), Expect = 5e-09, Method: Composition-based stats.
Identities = 47/178 (26%), Positives = 86/178 (48%), Gaps = 6/178 (3%)
Query: 703 NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGS 762
+G VAVK+ +L++ + + E +MR +H N++++ S ++M+++ G+
Sbjct: 69 SGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGA 128
Query: 763 LEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLG 822
L + L Q + V AL YLH + +IH D+K +++LL D L
Sbjct: 129 LTDIV--SQVRLNEEQIATVCEAVLQALAYLH---AQGVIHRDIKSDSILLTLDGRVKLS 183
Query: 823 DFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKP 880
DFG + P + + + T +MAPE S + + D++S GI+++E P
Sbjct: 184 DFGFCAQISKDVPKRKXL-VGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPP 240
>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1QMZ|C Chain C, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex
pdb|1GY3|A Chain A, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1GY3|C Chain C, Pcdk2CYCLIN A IN COMPLEX WITH MGADP, NITRATE AND PEPTIDE
SUBSTRATE
pdb|1P5E|A Chain A, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|1P5E|C Chain C, The Strucure Of Phospho-Cdk2CYCLIN A IN COMPLEX WITH THE
Inhibitor 4,5,6,7-Tetrabromobenzotriazole (Tbs)
pdb|2CCH|A Chain A, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCH|C Chain C, The Crystal Structure Of Cdk2 Cyclin A In Complex With A
Substrate Peptide Derived From Cdc Modified With A
Gamma- Linked Atp Analogue
pdb|2CCI|A Chain A, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2CCI|C Chain C, Crystal Structure Of Phospho-Cdk2 Cyclin A In Complex With
A Peptide Containing Both The Substrate And Recruitment
Sites Of Cdc6
pdb|2G9X|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|2G9X|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
COMPLEX WITH THE Inhibitor Nu6271
pdb|3DDP|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDP|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Cr8
pdb|3DDQ|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DDQ|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Roscovitine
pdb|3DOG|A Chain A, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
pdb|3DOG|C Chain C, Structure Of Thr 160 Phosphorylated Cdk2CYCLIN A IN
Complex With The Inhibitor N-&-N1
Length = 299
Score = 60.1 bits (144), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ Q L+K++ + + + + + + L + H
Sbjct: 65 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 120
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T + T+ Y APE G +
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 180 -YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 212
>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHT|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 3
pdb|3BHU|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHU|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
WITH THE Inhibitor Meriolin 5
pdb|3BHV|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3BHV|C Chain C, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX
With The Inhibitor Variolin B
pdb|3MY5|A Chain A, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3MY5|C Chain C, Cdk2CYCLINA IN COMPLEX WITH DRB
pdb|3TNW|A Chain A, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|3TNW|C Chain C, Structure Of Cdk2CYCLIN A IN COMPLEX WITH CAN508
pdb|4BCO|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCO|C Chain C, Structure Of Cdk2 In Complex With Cyclin A And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 300
Score = 60.1 bits (144), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ Q L+K++ + + + + + + L + H
Sbjct: 66 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 121
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T + T+ Y APE G +
Sbjct: 122 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 181 -YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 213
>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of
Cyclin-Dependent Kinase Inhibitors Identified Through
Structure-Based Hybridisation
Length = 299
Score = 60.1 bits (144), Expect = 5e-09, Method: Composition-based stats.
Identities = 56/218 (25%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKA--TLANGVSVAVKVFNLQEDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA L V K+ E + S E +++ + H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ Q L+K++ + + + + + + L + H
Sbjct: 65 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 120
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T T + T+ Y APE G +
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCK 179
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 180 -YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 212
>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino
Pyrimidine Cdk4 Inhibitor
Length = 298
Score = 60.1 bits (144), Expect = 5e-09, Method: Composition-based stats.
Identities = 56/218 (25%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKA--TLANGVSVAVKVFNLQEDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA L V K+ E + S E +++ + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ Q L+K++ + + + + + + L + H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 119
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T T + T+ Y APE G +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 179 -YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 211
>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B
Length = 289
Score = 60.1 bits (144), Expect = 5e-09, Method: Compositional matrix adjust.
Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ Q L+K++ + + + + + + L + H
Sbjct: 65 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 120
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T + T+ Y APE G +
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCK 179
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 180 -YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 212
>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
pdb|4EOO|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With Atp
Length = 299
Score = 60.1 bits (144), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ Q L+K++ + + + + + + L + H
Sbjct: 66 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 121
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T + T+ Y APE G +
Sbjct: 122 SHRVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 181 -YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 213
>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182
Length = 353
Score = 60.1 bits (144), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDT--ECEVMRRIRH 735
++ F +LLG G++ V AT G VA+K D+ L + T E ++++ +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKILKHFKH 68
Query: 736 RNLIKIVSSCSNPGFK----ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALE 791
N+I I + F+ I+Q + Q L + + + S Q + A++
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF--IYQTLRAVK 126
Query: 792 YLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL-----DGVDPVTQ----TMTL 842
LH + +IH DLKP+N+L++ + + DFG+A+++ D +P Q T +
Sbjct: 127 VLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEXV 183
Query: 843 ATIGYMAPEYG-SEGIVSISGDVYSFGILMMETFTRR 878
AT Y APE + S + DV+S G ++ E F RR
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A60|B Chain B, Crystal Structure Of Unphosphorylated P70s6k1 (Form I)
pdb|3A61|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form Ii)
Length = 327
Score = 60.1 bits (144), Expect = 6e-09, Method: Compositional matrix adjust.
Identities = 61/213 (28%), Positives = 96/213 (45%), Gaps = 21/213 (9%)
Query: 686 NLLGSGSFDNVY---KATLAN-GVSVAVKVFN----LQEDRALKSFDTECEVMRRIRHRN 737
+LG G + V+ K T AN G A+KV ++ + E ++ ++H
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
++ ++ + G LI++Y+ G L L + + +++ AL +LH
Sbjct: 83 IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHLH--- 138
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAK--LLDGVDPVTQTMTLATIGYMAPEYGSE 855
II+ DLKP N++L+ L DFG+ K + DG VT T TI YMAPE
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFC-GTIEYMAPEILMR 195
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGE 888
+ + D +S G LM + T P FTGE
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPP----FTGE 224
>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70
Length = 613
Score = 60.1 bits (144), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 51/205 (24%), Positives = 95/205 (46%), Gaps = 13/205 (6%)
Query: 688 LGSGSFDNVYKATL---ANGVSVAVKVFNLQEDRA-LKSFDTECEVMRRIRHRNLIKIVS 743
LG G+F +V + + VA+KV ++A + E ++M ++ + +++++
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
C L+M+ G L K+L + + +++ V+ ++YL +H
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVH 459
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA---TIGYMAPEYGSEGIVSI 860
+L NVLL + A + DFG++K L G D T A + + APE + S
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKAL-GADDSYYTARSAGKWPLKWYAPECINFRKFSS 518
Query: 861 SGDVYSFGILMMETFTR-RKPTNEM 884
DV+S+G+ M E + +KP +M
Sbjct: 519 RSDVWSYGVTMWEALSYGQKPYKKM 543
>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
pdb|4I3Z|C Chain C, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM
IONS
Length = 296
Score = 59.7 bits (143), Expect = 7e-09, Method: Composition-based stats.
Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ Q L+K++ + + + + + + L + H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 119
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T + T+ Y APE G +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCK 178
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 179 -YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 211
>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JST|C Chain C, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A
pdb|1JSU|A Chain A, P27(Kip1)CYCLIN ACDK2 COMPLEX
pdb|1FQ1|B Chain B, Crystal Structure Of Kinase Associated Phosphatase (Kap)
In Complex With Phospho-Cdk2
pdb|2C6T|A Chain A, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2C6T|C Chain C, Crystal Structure Of The Human Cdk2 Complexed With The
Triazolopyrimidine Inhibitor
pdb|2CJM|A Chain A, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2CJM|C Chain C, Mechanism Of Cdk Inhibition By Active Site
Phosphorylation: Cdk2 Y15p T160p In Complex With Cyclin
A Structure
pdb|2UZB|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZB|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZD|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZE|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|A Chain A, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|2UZL|C Chain C, Crystal Structure Of Human Cdk2 Complexed With A
Thiazolidinone Inhibitor
pdb|4II5|A Chain A, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
pdb|4II5|C Chain C, Structure Of Pcdk2/cyclina Bound To Adp And 1 Magnesium
Ion
Length = 298
Score = 59.7 bits (143), Expect = 7e-09, Method: Composition-based stats.
Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ Q L+K++ + + + + + + L + H
Sbjct: 64 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 119
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T + T+ Y APE G +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCK 178
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 179 -YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 211
>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHR|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
pdb|3QHW|C Chain C, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic
Length = 298
Score = 59.7 bits (143), Expect = 7e-09, Method: Composition-based stats.
Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ Q L+K++ + + + + + + L + H
Sbjct: 66 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 121
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T + T+ Y APE G +
Sbjct: 122 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 181 -YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 213
>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral
Cyclin
pdb|1XO2|B Chain B, Crystal Structure Of A Human Cyclin-Dependent Kinase 6
Complex With A Flavonol Inhibitor, Fisetin
pdb|2EUF|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclin In Complex With The
Inhibitor Pd0332991
pdb|2F2C|B Chain B, X-Ray Structure Of Human Cdk6-Vcyclinwith The Inhibitor
Aminopurvalanol
Length = 308
Score = 59.7 bits (143), Expect = 7e-09, Method: Composition-based stats.
Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 27/221 (12%)
Query: 688 LGSGSFDNVYKA-TLANGVS-VAVKVFNLQEDRALKSFDT--ECEVMRRIR---HRNLIK 740
+G G++ V+KA L NG VA+K +Q T E V+R + H N+++
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 741 IVSSCS-----NPGFKALIMQYMPQG---SLEKWLYSHNYSLTIRQRLDIMIDVASALEY 792
+ C+ L+ +++ Q L+K + TI+ D+M + L++
Sbjct: 79 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK---DMMFQLLRGLDF 135
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEY 852
LH S ++H DLKP N+L+ L DFG+A++ + T + T+ Y APE
Sbjct: 136 LH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPEV 190
Query: 853 GSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
+ + D++S G + E F RRKP +F G + Q
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEMF-RRKP---LFRGSSDVDQ 227
>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|3NUX|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor
pdb|4AUA|A Chain A, Liganded X-ray Crystal Structure Of Cyclin Dependent
Kinase 6 (cdk6)
pdb|4EZ5|A Chain A, Cdk6 (monomeric) In Complex With Inhibitor
Length = 307
Score = 59.7 bits (143), Expect = 7e-09, Method: Composition-based stats.
Identities = 61/221 (27%), Positives = 102/221 (46%), Gaps = 27/221 (12%)
Query: 688 LGSGSFDNVYKA-TLANGVS-VAVKVFNLQEDRALKSFDT--ECEVMRRIR---HRNLIK 740
+G G++ V+KA L NG VA+K +Q T E V+R + H N+++
Sbjct: 19 IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 741 IVSSCS-----NPGFKALIMQYMPQG---SLEKWLYSHNYSLTIRQRLDIMIDVASALEY 792
+ C+ L+ +++ Q L+K + TI+ D+M + L++
Sbjct: 79 LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK---DMMFQLLRGLDF 135
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEY 852
LH S ++H DLKP N+L+ L DFG+A++ + T + T+ Y APE
Sbjct: 136 LH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSF--QMALTSVVVTLWYRAPEV 190
Query: 853 GSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
+ + D++S G + E F RRKP +F G + Q
Sbjct: 191 LLQSSYATPVDLWSVGCIFAEMF-RRKP---LFRGSSDVDQ 227
>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp
Site Inhibitor
Length = 301
Score = 59.7 bits (143), Expect = 7e-09, Method: Composition-based stats.
Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 28/211 (13%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRI--RHRNLIKIVSSC 745
+G G F V++ G VAVK+F+ +E+R S+ E E+ + + RH N++ +++
Sbjct: 12 IGKGRFGEVWRGKW-RGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAAD 67
Query: 746 SNPGFKA----LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY---- 797
+ L+ Y GSL +L + Y++T+ + + + AS L +LH
Sbjct: 68 NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 125
Query: 798 -STPIIHCDLKPNNVLLDDDMVAHLGDFGIA----KLLDGVDPVTQTMTLATIGYMAPEY 852
I H DLK N+L+ + + D G+A D +D + + T YMAPE
Sbjct: 126 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID-IAPNHRVGTKRYMAPEV 184
Query: 853 GSEGI------VSISGDVYSFGILMMETFTR 877
+ I D+Y+ G++ E R
Sbjct: 185 LDDSINMKHFESFKRADIYAMGLVFWEIARR 215
>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human
Tgf- Beta Type I Receptor
pdb|3GXL|A Chain A, Alk-5 Kinase Complex With Gw857175
pdb|3HMM|A Chain A, Structure Of Alk5 + Gw855857
Length = 303
Score = 59.7 bits (143), Expect = 7e-09, Method: Composition-based stats.
Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 28/211 (13%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRI--RHRNLIKIVSSC 745
+G G F V++ G VAVK+F+ +E+R S+ E E+ + + RH N++ +++
Sbjct: 11 IGKGRFGEVWRGKW-RGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAAD 66
Query: 746 SNPGFKA----LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY---- 797
+ L+ Y GSL +L + Y++T+ + + + AS L +LH
Sbjct: 67 NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 798 -STPIIHCDLKPNNVLLDDDMVAHLGDFGIA----KLLDGVDPVTQTMTLATIGYMAPEY 852
I H DLK N+L+ + + D G+A D +D + + T YMAPE
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID-IAPNHRVGTKRYMAPEV 183
Query: 853 GSEGI------VSISGDVYSFGILMMETFTR 877
+ I D+Y+ G++ E R
Sbjct: 184 LDDSINMKHFESFKRADIYAMGLVFWEIARR 214
>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542
Length = 309
Score = 59.7 bits (143), Expect = 7e-09, Method: Composition-based stats.
Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 28/211 (13%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRI--RHRNLIKIVSSC 745
+G G F V++ G VAVK+F+ +E+R S+ E E+ + + RH N++ +++
Sbjct: 17 IGKGRFGEVWRGKW-RGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAAD 72
Query: 746 SNPGFKA----LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY---- 797
+ L+ Y GSL +L + Y++T+ + + + AS L +LH
Sbjct: 73 NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 130
Query: 798 -STPIIHCDLKPNNVLLDDDMVAHLGDFGIA----KLLDGVDPVTQTMTLATIGYMAPEY 852
I H DLK N+L+ + + D G+A D +D + + T YMAPE
Sbjct: 131 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID-IAPNHRVGTKRYMAPEV 189
Query: 853 GSEGI------VSISGDVYSFGILMMETFTR 877
+ I D+Y+ G++ E R
Sbjct: 190 LDDSINMKHFESFKRADIYAMGLVFWEIARR 220
>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3-
Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine
pdb|2WOU|A Chain A, Alk5 In Complex With
4-((4-((2,6-Dimethyl-3-Pyridyl)oxy)-2-
Pyridyl)amino)benzenesulfonamide
Length = 306
Score = 59.7 bits (143), Expect = 7e-09, Method: Composition-based stats.
Identities = 55/211 (26%), Positives = 95/211 (45%), Gaps = 28/211 (13%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRI--RHRNLIKIVSSC 745
+G G F V++ G VAVK+F+ +E+R S+ E E+ + + RH N++ +++
Sbjct: 14 IGKGRFGEVWRGKW-RGEEVAVKIFSSREER---SWFREAEIYQTVMLRHENILGFIAAD 69
Query: 746 SNPGFKA----LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY---- 797
+ L+ Y GSL +L + Y++T+ + + + AS L +LH
Sbjct: 70 NKDNGTWTQLWLVSDYHEHGSLFDYL--NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 127
Query: 798 -STPIIHCDLKPNNVLLDDDMVAHLGDFGIA----KLLDGVDPVTQTMTLATIGYMAPEY 852
I H DLK N+L+ + + D G+A D +D + + T YMAPE
Sbjct: 128 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTID-IAPNHRVGTKRYMAPEV 186
Query: 853 GSEGI------VSISGDVYSFGILMMETFTR 877
+ I D+Y+ G++ E R
Sbjct: 187 LDDSINMKHFESFKRADIYAMGLVFWEIARR 217
>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YA9|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
pdb|2YAA|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAA|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Atp
pdb|2YAB|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
pdb|2YAB|B Chain B, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2
In Complex With Amp
Length = 361
Score = 59.7 bits (143), Expect = 7e-09, Method: Compositional matrix adjust.
Identities = 56/209 (26%), Positives = 94/209 (44%), Gaps = 22/209 (10%)
Query: 676 QQATNGF---GESNLLGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALK------SFDT 725
QQ F GE LGSG F V K + G+ A K ++ RA + +
Sbjct: 7 QQKVEDFYDIGEE--LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIER 64
Query: 726 ECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMID 785
E ++R++ H N+I + N LI++ + G L +L + SL+ + +
Sbjct: 65 EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQ 123
Query: 786 VASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVA----HLGDFGIAKLLDGVDPVTQTMT 841
+ + YLH + I H DLKP N++L D + L DFG+A ++ D V
Sbjct: 124 ILDGVNYLH---TKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEFKNI 178
Query: 842 LATIGYMAPEYGSEGIVSISGDVYSFGIL 870
T ++APE + + + D++S G++
Sbjct: 179 FGTPEFVAPEIVNYEPLGLEADMWSIGVI 207
>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOP|C Chain C, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 300
Score = 59.7 bits (143), Expect = 7e-09, Method: Composition-based stats.
Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ Q L+K++ + + + + + + L + H
Sbjct: 67 VKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 122
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T + T+ Y APE G +
Sbjct: 123 SHRVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCK 181
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 182 -YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 214
>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
pdb|1KOB|B Chain B, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein
Kinase Domain
Length = 387
Score = 59.7 bits (143), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 47/186 (25%), Positives = 86/186 (46%), Gaps = 8/186 (4%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LGSG+F V++ A G K N + E +M ++ H LI + +
Sbjct: 59 LGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFE 118
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
+ LI++++ G L + + +Y ++ + ++ M A E L H + I+H D+
Sbjct: 119 DKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYM---RQACEGLKHMHEHSIVHLDI 175
Query: 807 KPNNVLLDDDMVAHLG--DFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDV 864
KP N++ + + + DFG+A L+ + V +T AT + APE V D+
Sbjct: 176 KPENIMCETKKASSVKIIDFGLATKLNPDEIV--KVTTATAEFAAPEIVDREPVGFYTDM 233
Query: 865 YSFGIL 870
++ G+L
Sbjct: 234 WAIGVL 239
>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3
Length = 353
Score = 59.7 bits (143), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 61/217 (28%), Positives = 104/217 (47%), Gaps = 23/217 (10%)
Query: 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDT--ECEVMRRIRH 735
++ F +LLG G++ V AT G VA+K D+ L + T E ++++ +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKILKHFKH 68
Query: 736 RNLIKIVSSCSNPGFK----ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALE 791
N+I I + F+ I+Q + Q L + + + S Q + A++
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF--IYQTLRAVK 126
Query: 792 YLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL-----DGVDPVTQ----TMTL 842
LH + +IH DLKP+N+L++ + + DFG+A+++ D +P Q T +
Sbjct: 127 VLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYV 183
Query: 843 ATIGYMAPEYG-SEGIVSISGDVYSFGILMMETFTRR 878
AT Y APE + S + DV+S G ++ E F RR
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.28 A Resolution
pdb|4G34|A Chain A, Crystal Structure Of Gsk6924 Bound To Perk (R587-R1092,
Delete A660- T867) At 2.70 A Resolution
Length = 299
Score = 59.7 bits (143), Expect = 8e-09, Method: Composition-based stats.
Identities = 55/216 (25%), Positives = 97/216 (44%), Gaps = 36/216 (16%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNL-QEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
LG G F V++A + + A+K L + A + E + + ++ H +++ ++
Sbjct: 13 LGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPGIVRYFNAW 72
Query: 746 -----------SNPGFKALI-MQYMPQGSLEKWLYSHNYSLTIRQR-----LDIMIDVAS 788
S+P I MQ + +L+ W+ N TI +R L I + +A
Sbjct: 73 LEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWM---NGRCTIEERERSVCLHIFLQIAE 129
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT------- 841
A+E+LH S ++H DLKP+N+ D V +GDFG+ +D + +T
Sbjct: 130 AVEFLH---SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAR 186
Query: 842 ----LATIGYMAPEYGSEGIVSISGDVYSFGILMME 873
+ T YM+PE S D++S G+++ E
Sbjct: 187 HTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFE 222
>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
pdb|3UTO|B Chain B, Twitchin Kinase Region From C.Elegans
(Fn31-Nl-Kin-Crd-Ig26)
Length = 573
Score = 59.7 bits (143), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 50/187 (26%), Positives = 83/187 (44%), Gaps = 10/187 (5%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG+G+F V++ T A G + A K + ++ E + M +RH L+ + +
Sbjct: 165 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 224
Query: 747 NPGFKALIMQYMPQGSL-EKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
+ +I ++M G L EK HN ++ + ++ M V L ++H +H D
Sbjct: 225 DDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMH---ENNYVHLD 280
Query: 806 LKPNNVLLDDDMVAHLG--DFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGD 863
LKP N++ L DFG+ LD V +T T + APE V D
Sbjct: 281 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--KVTTGTAEFAAPEVAEGKPVGYYTD 338
Query: 864 VYSFGIL 870
++S G+L
Sbjct: 339 MWSVGVL 345
>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
pdb|2IW8|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v-
H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor
Length = 302
Score = 59.7 bits (143), Expect = 8e-09, Method: Compositional matrix adjust.
Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ Q L+K++ + + + + + + L + H
Sbjct: 68 VKLLDVIHTENKLYLVFEHVDQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 123
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T + T+ Y APE G +
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 183 -YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 215
>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|E Chain E, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|C Chain C, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|B Chain B, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|F Chain F, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|D Chain D, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|H Chain H, Human Death-Associated Kinase Drp-1, Mutant S308d D40
pdb|1WMK|G Chain G, Human Death-Associated Kinase Drp-1, Mutant S308d D40
Length = 321
Score = 59.3 bits (142), Expect = 9e-09, Method: Composition-based stats.
Identities = 51/194 (26%), Positives = 89/194 (45%), Gaps = 17/194 (8%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALK------SFDTECEVMRRIRHRNLIK 740
LGSG F V K + G+ A K ++ RA + + E ++R++ H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ N LI++ + G L +L + SL+ + + + + YLH +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 801 IIHCDLKPNNVLLDDDMVA----HLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG 856
I H DLKP N++L D + L DFG+A ++ D V T ++APE +
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEFKNIFGTPEFVAPEIVNYE 193
Query: 857 IVSISGDVYSFGIL 870
+ + D++S G++
Sbjct: 194 PLGLEADMWSIGVI 207
>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|B Chain B, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|C Chain C, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|D Chain D, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|E Chain E, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|F Chain F, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|G Chain G, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
pdb|1ZWS|H Chain H, Crystal Structure Of The Catalytic Domain Of Human Drp-1
Kinase
Length = 288
Score = 59.3 bits (142), Expect = 9e-09, Method: Composition-based stats.
Identities = 51/194 (26%), Positives = 89/194 (45%), Gaps = 17/194 (8%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALK------SFDTECEVMRRIRHRNLIK 740
LGSG F V K + G+ A K ++ RA + + E ++R++ H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ N LI++ + G L +L + SL+ + + + + YLH +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 801 IIHCDLKPNNVLLDDDMVA----HLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG 856
I H DLKP N++L D + L DFG+A ++ D V T ++APE +
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEFKNIFGTPEFVAPEIVNYE 193
Query: 857 IVSISGDVYSFGIL 870
+ + D++S G++
Sbjct: 194 PLGLEADMWSIGVI 207
>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|B Chain B, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|C Chain C, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2A2A|D Chain D, High-resolution Crystallographic Analysis Of The
Autoinhibited Conformation Of A Human Death-associated
Protein Kinase
pdb|2CKE|A Chain A, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|B Chain B, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|C Chain C, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
pdb|2CKE|D Chain D, Human Death-Associated Drp-1 Kinase In Complex With
Inhibitor
Length = 321
Score = 59.3 bits (142), Expect = 9e-09, Method: Composition-based stats.
Identities = 51/194 (26%), Positives = 89/194 (45%), Gaps = 17/194 (8%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALK------SFDTECEVMRRIRHRNLIK 740
LGSG F V K + G+ A K ++ RA + + E ++R++ H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ N LI++ + G L +L + SL+ + + + + YLH +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 801 IIHCDLKPNNVLLDDDMVA----HLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG 856
I H DLKP N++L D + L DFG+A ++ D V T ++APE +
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEFKNIFGTPEFVAPEIVNYE 193
Query: 857 IVSISGDVYSFGIL 870
+ + D++S G++
Sbjct: 194 PLGLEADMWSIGVI 207
>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
pdb|1Z9X|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 3 Monomers In The Asymmetric Unit
Length = 321
Score = 59.3 bits (142), Expect = 9e-09, Method: Composition-based stats.
Identities = 51/194 (26%), Positives = 89/194 (45%), Gaps = 17/194 (8%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALK------SFDTECEVMRRIRHRNLIK 740
LGSG F V K + G+ A K ++ RA + + E ++R++ H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ N LI++ + G L +L + SL+ + + + + YLH +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 801 IIHCDLKPNNVLLDDDMVA----HLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG 856
I H DLKP N++L D + L DFG+A ++ D V T ++APE +
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEFKNIFGTPEFVAPEIVNYE 193
Query: 857 IVSISGDVYSFGIL 870
+ + D++S G++
Sbjct: 194 PLGLEADMWSIGVI 207
>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|B Chain B, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|C Chain C, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|D Chain D, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|E Chain E, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|F Chain F, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|G Chain G, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
pdb|2A27|H Chain H, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form
With 8 Monomers In The Asymmetric Unit
Length = 321
Score = 59.3 bits (142), Expect = 9e-09, Method: Composition-based stats.
Identities = 51/194 (26%), Positives = 89/194 (45%), Gaps = 17/194 (8%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALK------SFDTECEVMRRIRHRNLIK 740
LGSG F V K + G+ A K ++ RA + + E ++R++ H N+I
Sbjct: 20 LGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVIT 79
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ N LI++ + G L +L + SL+ + + + + YLH +
Sbjct: 80 LHDVYENRTDVVLILELVSGGELFDFL-AQKESLSEEEATSFIKQILDGVNYLH---TKK 135
Query: 801 IIHCDLKPNNVLLDDDMVA----HLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG 856
I H DLKP N++L D + L DFG+A ++ D V T ++APE +
Sbjct: 136 IAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE--DGVEFKNIFGTPEFVAPEIVNYE 193
Query: 857 IVSISGDVYSFGIL 870
+ + D++S G++
Sbjct: 194 PLGLEADMWSIGVI 207
>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYC|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type In Apo Form.
pdb|1ZYD|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp.
pdb|1ZYD|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild-
Type Complexed With Atp
Length = 303
Score = 59.3 bits (142), Expect = 9e-09, Method: Compositional matrix adjust.
Identities = 59/220 (26%), Positives = 96/220 (43%), Gaps = 32/220 (14%)
Query: 682 FGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRH----- 735
F E +LG G+F V KA A + A+K E++ L + +E ++ + H
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQYVVR 66
Query: 736 --------RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVA 787
RN +K +++ + M+Y +L ++S N + + + +
Sbjct: 67 YYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 788 SALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK----LLDGVDPVTQ----- 838
AL Y+H S IIH DLKP N+ +D+ +GDFG+AK LD + +Q
Sbjct: 127 EALSYIH---SQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 839 ----TMTLATIGYMAPEY-GSEGIVSISGDVYSFGILMME 873
T + T Y+A E G + D+YS GI+ E
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFE 223
>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated
Protein Kinase And Immunoglobulin Domains
Length = 491
Score = 59.3 bits (142), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 50/187 (26%), Positives = 83/187 (44%), Gaps = 10/187 (5%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
LG+G+F V++ T A G + A K + ++ E + M +RH L+ + +
Sbjct: 59 LGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFE 118
Query: 747 NPGFKALIMQYMPQGSL-EKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCD 805
+ +I ++M G L EK HN ++ + ++ M V L ++H +H D
Sbjct: 119 DDNEMVMIYEFMSGGELFEKVADEHN-KMSEDEAVEYMRQVCKGLCHMH---ENNYVHLD 174
Query: 806 LKPNNVLLDDDMVAHLG--DFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGD 863
LKP N++ L DFG+ LD V +T T + APE V D
Sbjct: 175 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV--KVTTGTAEFAAPEVAEGKPVGYYTD 232
Query: 864 VYSFGIL 870
++S G+L
Sbjct: 233 MWSVGVL 239
>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Cgp74514a
pdb|2J0I|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 303
Score = 59.3 bits (142), Expect = 1e-08, Method: Composition-based stats.
Identities = 52/194 (26%), Positives = 95/194 (48%), Gaps = 7/194 (3%)
Query: 688 LGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
+G GS V AT+ ++G VAVK +L++ + + E +MR +H N++++ +S
Sbjct: 39 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 98
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++M+++ G+L + +H + Q + + V AL LH + +IH D+
Sbjct: 99 VGDELWVVMEFLEGGALTD-IVTHT-RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 153
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
K +++LL D L DFG + P + + + T +MAPE S D++S
Sbjct: 154 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL-VGTPYWMAPELISRLPYGPEVDIWS 212
Query: 867 FGILMMETFTRRKP 880
GI+++E P
Sbjct: 213 LGIMVIEMVDGEPP 226
>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4
pdb|2BVA|B Chain B, Crystal Structure Of The Human P21-Activated Kinase 4
Length = 292
Score = 59.3 bits (142), Expect = 1e-08, Method: Composition-based stats.
Identities = 52/194 (26%), Positives = 95/194 (48%), Gaps = 7/194 (3%)
Query: 688 LGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
+G GS V AT+ ++G VAVK +L++ + + E +MR +H N++++ +S
Sbjct: 28 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 87
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++M+++ G+L + +H + Q + + V AL LH + +IH D+
Sbjct: 88 VGDELWVVMEFLEGGALTD-IVTHT-RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 142
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
K +++LL D L DFG + P + + + T +MAPE S D++S
Sbjct: 143 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL-VGTPYWMAPELISRLPYGPEVDIWS 201
Query: 867 FGILMMETFTRRKP 880
GI+++E P
Sbjct: 202 LGIMVIEMVDGEPP 215
>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With Pf-03758309
pdb|4APP|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In
Complex With (S)-N-(5-(3-Benzyl-1-Methylpiperazine-4-
Carbonyl)-6,6-Dimethyl-1,4,5,6-Tetrahydropyrrolo(3,4-C)
Pyrazol-3-Yl)-3-Phenoxybenzamide
Length = 296
Score = 59.3 bits (142), Expect = 1e-08, Method: Composition-based stats.
Identities = 52/194 (26%), Positives = 95/194 (48%), Gaps = 7/194 (3%)
Query: 688 LGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
+G GS V AT+ ++G VAVK +L++ + + E +MR +H N++++ +S
Sbjct: 32 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 91
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++M+++ G+L + +H + Q + + V AL LH + +IH D+
Sbjct: 92 VGDELWVVMEFLEGGALTD-IVTHT-RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 146
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
K +++LL D L DFG + P + + + T +MAPE S D++S
Sbjct: 147 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL-VGTPYWMAPELISRLPYGPEVDIWS 205
Query: 867 FGILMMETFTRRKP 880
GI+++E P
Sbjct: 206 LGIMVIEMVDGEPP 219
>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In
Complex With A Consensus Peptide
Length = 301
Score = 59.3 bits (142), Expect = 1e-08, Method: Composition-based stats.
Identities = 52/194 (26%), Positives = 95/194 (48%), Gaps = 7/194 (3%)
Query: 688 LGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
+G GS V AT+ ++G VAVK +L++ + + E +MR +H N++++ +S
Sbjct: 37 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 96
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++M+++ G+L + +H + Q + + V AL LH + +IH D+
Sbjct: 97 VGDELWVVMEFLEGGALTD-IVTHT-RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 151
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
K +++LL D L DFG + P + + + T +MAPE S D++S
Sbjct: 152 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL-VGTPYWMAPELISRLPYGPEVDIWS 210
Query: 867 FGILMMETFTRRKP 880
GI+++E P
Sbjct: 211 LGIMVIEMVDGEPP 224
>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|C Chain C, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|D Chain D, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|E Chain E, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
pdb|4FR4|F Chain F, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
32a (Yank1)
Length = 384
Score = 59.3 bits (142), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 19/203 (9%)
Query: 688 LGSGSFDNVYKATLANGVSV-AVKVFNLQ---EDRALKSFDTECEVMRRIRHRNLIKIVS 743
+G GSF V + + A+K N Q E +++ E ++M+ + H L+ +
Sbjct: 23 IGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWY 82
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYS--HNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
S + +++ + G L L H T++ + ++ AL+YL + I
Sbjct: 83 SFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKL---FICELVMALDYLQ---NQRI 136
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPEYGSE---GI 857
IH D+KP+N+LLD+ H+ DF IA +L TQ T+A T YMAPE S
Sbjct: 137 IHRDMKPDNILLDEHGHVHITDFNIAAMLPR---ETQITTMAGTKPYMAPEMFSSRKGAG 193
Query: 858 VSISGDVYSFGILMMETFTRRKP 880
S + D +S G+ E R+P
Sbjct: 194 YSFAVDWWSLGVTAYELLRGRRP 216
>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
pdb|3ZUV|C Chain C, Crystal Structure Of A Designed Selected Ankyrin Repeat
Protein In Complex With The Phosphorylated Map Kinase
Erk2
Length = 364
Score = 58.9 bits (141), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 16/214 (7%)
Query: 688 LGSGSFDNVYKATL-ANGVSVAVKVFN-LQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
+G G++ V A N V VA+K + + + E +++ R RH N+I I
Sbjct: 35 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 94
Query: 746 SNPGFKALIMQYMPQGSLEKWLYS--HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
P + + Y+ Q +E LY L+ + + L+Y+H S ++H
Sbjct: 95 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 151
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM--TLATIGYMAPE--YGSEGIVS 859
DLKP+N+LL+ + DFG+A++ D T + +AT Y APE S+G
Sbjct: 152 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 211
Query: 860 ISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S D++S G ++ E + R +F G+ L Q
Sbjct: 212 -SIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 240
>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2
Length = 365
Score = 58.9 bits (141), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 16/214 (7%)
Query: 688 LGSGSFDNVYKATL-ANGVSVAVKVFN-LQEDRALKSFDTECEVMRRIRHRNLIKIVSSC 745
+G G++ V A N V VA+K + + + E +++ R RH N+I I
Sbjct: 36 IGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDII 95
Query: 746 SNPGFKALIMQYMPQGSLEKWLYS--HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
P + + Y+ Q +E LY L+ + + L+Y+H S ++H
Sbjct: 96 RAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLH 152
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTM--TLATIGYMAPE--YGSEGIVS 859
DLKP+N+LL+ + DFG+A++ D T + +AT Y APE S+G
Sbjct: 153 RDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLXEXVATRWYRAPEIMLNSKGYTK 212
Query: 860 ISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S D++S G ++ E + R +F G+ L Q
Sbjct: 213 -SIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 241
>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
pdb|2BDW|B Chain B, Crystal Structure Of The Auto-Inhibited Kinase Domain Of
CalciumCALMODULIN ACTIVATED KINASE II
Length = 362
Score = 58.9 bits (141), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 48/191 (25%), Positives = 86/191 (45%), Gaps = 14/191 (7%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSS 744
LG G+F V + G+ A K+ N ++ R + + E + R+++H N++++ S
Sbjct: 37 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 96
Query: 745 CSNPGFKALIMQYMPQGSL-EKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
F L+ + G L E + YS D + LE + + +S I+H
Sbjct: 97 IQEESFHYLVFDLVTGGELFEDIVAREFYS-----EADASHCIQQILESIAYCHSNGIVH 151
Query: 804 CDLKPNNVLLDDD---MVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSI 860
+LKP N+LL L DFG+A ++ D T GY++PE + S
Sbjct: 152 RNLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSK 209
Query: 861 SGDVYSFGILM 871
D+++ G+++
Sbjct: 210 PVDIWACGVIL 220
>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
pdb|4H3P|D Chain D, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 58.9 bits (141), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 21/209 (10%)
Query: 692 SFDNVYKATLANGVSVAVKVFN-LQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGF 750
++DNV N V VA+K + + + E +++ RH N+I I P
Sbjct: 44 AYDNV------NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDIIRAPTI 97
Query: 751 KALIMQYMPQGSLEKWLYS--HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKP 808
+ + Y+ Q +E LY L+ + + L+Y+H S ++H DLKP
Sbjct: 98 EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKP 154
Query: 809 NNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE--YGSEGIVSISGDV 864
+N+LL+ + DFG+A++ D T +T +AT Y APE S+G S D+
Sbjct: 155 SNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK-SIDI 213
Query: 865 YSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
+S G ++ E + R +F G+ L Q
Sbjct: 214 WSVGCILAEMLSNRP----IFPGKHYLDQ 238
>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent
Protein Kinase Ii Gamma
Length = 336
Score = 58.9 bits (141), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 47/190 (24%), Positives = 83/190 (43%), Gaps = 11/190 (5%)
Query: 688 LGSGSFDNVYKATLANGV-SVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSS 744
LG G+F V + A K+ N ++ R + + E + R ++H N++++ S
Sbjct: 39 LGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 98
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
S GF L+ + G L + + + Y D + LE ++H + I+H
Sbjct: 99 ISEEGFHYLVFDLVTGGELFEDIVAREYY----SEADASHCIHQILESVNHIHQHDIVHR 154
Query: 805 DLKPNNVLLDDD---MVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSIS 861
DLKP N+LL L DFG+A + G T GY++PE +
Sbjct: 155 DLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWFGFA-GTPGYLSPEVLRKDPYGKP 213
Query: 862 GDVYSFGILM 871
D+++ G+++
Sbjct: 214 VDIWACGVIL 223
>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
pdb|4EOI|C Chain C, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3
Complex With The Inhibitor Ro3306
Length = 299
Score = 58.9 bits (141), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 56/217 (25%), Positives = 98/217 (45%), Gaps = 14/217 (6%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 5 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 64
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
+K++ L+ +++ Q + S + + + + L + H S
Sbjct: 65 VKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCH---S 121
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSEG 856
++H DLKP N+L++ + L DFG+A+ GV T + T+ Y APE G +
Sbjct: 122 HRVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCK- 179
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 180 YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 212
>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIF|B Chain B, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIG|A Chain A, Catalytic Domain Of Human Pak4
pdb|4FIG|B Chain B, Catalytic Domain Of Human Pak4
pdb|4FIH|A Chain A, Catalytic Domain Of Human Pak4 With Qkftglprqw Peptide
pdb|4FII|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide
pdb|4FIJ|A Chain A, Catalytic Domain Of Human Pak4
Length = 346
Score = 58.9 bits (141), Expect = 1e-08, Method: Compositional matrix adjust.
Identities = 52/194 (26%), Positives = 95/194 (48%), Gaps = 7/194 (3%)
Query: 688 LGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
+G GS V AT+ ++G VAVK +L++ + + E +MR +H N++++ +S
Sbjct: 82 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 141
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++M+++ G+L + +H + Q + + V AL LH + +IH D+
Sbjct: 142 VGDELWVVMEFLEGGALTD-IVTHT-RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 196
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
K +++LL D L DFG + P + + + T +MAPE S D++S
Sbjct: 197 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL-VGTPYWMAPELISRLPYGPEVDIWS 255
Query: 867 FGILMMETFTRRKP 880
GI+++E P
Sbjct: 256 LGIMVIEMVDGEPP 269
>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|1GIJ|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
pdb|2DS1|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4
Inhibitor
Length = 298
Score = 58.9 bits (141), Expect = 1e-08, Method: Composition-based stats.
Identities = 57/218 (26%), Positives = 103/218 (47%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 4 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 63
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ Q L+ ++ + + + + + + L + H
Sbjct: 64 VKLLDVIHTENKLYLVFEHVHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 119
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T T + T+ Y APE G +
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYTHEVVTLWYRAPEILLGCK 178
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 179 -YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 211
>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B
Akt By Hydrophobic Motif Phosphorylation
pdb|1GZO|A Chain A, Structure Of Protein Kinase B Unphosphorylated
Length = 315
Score = 58.5 bits (140), Expect = 2e-08, Method: Composition-based stats.
Identities = 58/207 (28%), Positives = 88/207 (42%), Gaps = 13/207 (6%)
Query: 680 NGFGESNLLGSGSFDNVYKA-TLANGVSVAVKVFN----LQEDRALKSFDTECEVMRRIR 734
N F LLG G+F V A G A+K+ + +D + TE V++ R
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTV-TESRVLQNTR 63
Query: 735 HRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH 794
H L + + +M+Y G L L R R ++ SALEYLH
Sbjct: 64 HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARF-YGAEIVSALEYLH 122
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV-DPVTQTMTLATIGYMAPEYG 853
S +++ D+K N++LD D + DFG+ K +G+ D T T Y+APE
Sbjct: 123 ---SRDVVYRDIKLENLMLDKDGHIKITDFGLCK--EGISDGATMKTFCGTPEYLAPEVL 177
Query: 854 SEGIVSISGDVYSFGILMMETFTRRKP 880
+ + D + G++M E R P
Sbjct: 178 EDNDYGRAVDWWGLGVVMYEMMCGRLP 204
>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid-
Regulated Kinase 1 In Complex With Amp-Pnp
pdb|3HDM|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 1
pdb|3HDN|A Chain A, Crystal Structure Of Serum And Glucocorticoid-Regulated
Kinase 1 In Complex With Compound 2
Length = 373
Score = 58.5 bits (140), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 64/213 (30%), Positives = 92/213 (43%), Gaps = 18/213 (8%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVM-------RRIRHRN 737
++G GSF V A A V AVKV LQ+ LK E +M + ++H
Sbjct: 44 KVIGKGSFGKVLLARHKAEEVFYAVKV--LQKKAILKK-KEEKHIMSERNVLLKNVKHPF 100
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
L+ + S ++ Y+ G L L L R R ++ASAL YLH
Sbjct: 101 LVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARF-YAAEIASALGYLH--- 156
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGSEG 856
S I++ DLKP N+LLD L DFG+ K + ++ + T T T Y+APE +
Sbjct: 157 SLNIVYRDLKPENILLDSQGHIVLTDFGLCK--ENIEHNSTTSTFCGTPEYLAPEVLHKQ 214
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGEM 889
+ D + G ++ E P T EM
Sbjct: 215 PYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 247
>pdb|4FIE|A Chain A, Full-Length Human Pak4
pdb|4FIE|B Chain B, Full-Length Human Pak4
Length = 423
Score = 58.5 bits (140), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 51/187 (27%), Positives = 94/187 (50%), Gaps = 7/187 (3%)
Query: 688 LGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCS 746
+G GS V AT+ ++G VAVK +L++ + + E +MR +H N++++ +S
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYL 218
Query: 747 NPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDL 806
++M+++ G+L + +H + Q + + V AL LH + +IH D+
Sbjct: 219 VGDELWVVMEFLEGGALTD-IVTHT-RMNEEQIAAVCLAVLQALSVLH---AQGVIHRDI 273
Query: 807 KPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYS 866
K +++LL D L DFG + P + + + T +MAPE S D++S
Sbjct: 274 KSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKXL-VGTPYWMAPELISRLPYGPEVDIWS 332
Query: 867 FGILMME 873
GI+++E
Sbjct: 333 LGIMVIE 339
>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino(
Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6-
Difluoro-Phenyl)-Amide)
Length = 349
Score = 58.5 bits (140), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 57/202 (28%), Positives = 89/202 (44%), Gaps = 24/202 (11%)
Query: 679 TNGFGESNLLGSGSFDNVYKATLANGVS-VAVKVFNLQEDRALKSFDTECEVMRRIRHRN 737
++ F + LG G+ VY+ A+KV D+ K TE V+ R+ H N
Sbjct: 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPN 109
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
+IK+ P +L+++ + G L + Y + R D + + A+ YLH
Sbjct: 110 IIKLKEIFETPTEISLVLELVTGGELFDRIVEKGY-YSERDAADAVKQILEAVAYLHE-- 166
Query: 798 STPIIHCDLKPNNVLLDD---DMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--- 851
I+H DLKP N+L D + DFG++K+++ V T GY APE
Sbjct: 167 -NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVE--HQVLMKTVCGTPGYCAPEILR 223
Query: 852 ---YGSEGIVSISGDVYSFGIL 870
YG E D++S GI+
Sbjct: 224 GCAYGPE------VDMWSVGII 239
>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
pdb|2ZOQ|B Chain B, Structural Dissection Of Human Mitogen-Activated Kinase
Erk1
Length = 382
Score = 58.5 bits (140), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 61/229 (26%), Positives = 105/229 (45%), Gaps = 24/229 (10%)
Query: 672 YHELQQATNG-FGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVM 730
Y +LQ G +G + S ++D+V K +A K+ + + E +++
Sbjct: 45 YTQLQYIGEGAYG----MVSSAYDHVRKTRVA-----IKKISPFEHQTYCQRTLREIQIL 95
Query: 731 RRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYS--HNYSLTIRQRLDIMIDVAS 788
R RH N+I I +A+ Y+ Q +E LY + L+ + +
Sbjct: 96 LRFRHENVIGIRDILRASTLEAMRDVYIVQDLMETDLYKLLKSQQLSNDHICYFLYQILR 155
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIG 846
L+Y+H S ++H DLKP+N+L++ + DFG+A++ D T +T +AT
Sbjct: 156 GLKYIH---SANVLHRDLKPSNLLINTTCDLKICDFGLARIADPEHDHTGFLTEXVATRW 212
Query: 847 YMAPE--YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
Y APE S+G S D++S G ++ E + R +F G+ L Q
Sbjct: 213 YRAPEIMLNSKGYTK-SIDIWSVGCILAEMLSNRP----IFPGKHYLDQ 256
>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
pdb|2W9Z|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 58.5 bits (140), Expect = 2e-08, Method: Composition-based stats.
Identities = 63/232 (27%), Positives = 107/232 (46%), Gaps = 30/232 (12%)
Query: 678 ATNGFGESNLLGSGSFDNVYKATLA-NGVSVA---VKVFNLQEDRALKSFDTECEVMRRI 733
AT+ + +G G++ VYKA +G VA V+V N +E + + E ++RR+
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTV-REVALLRRL 60
Query: 734 R---HRNLIKIVSSCSNPGFK-----ALIMQYMPQGSLEKWL-YSHNYSLTIRQRLDIMI 784
H N+++++ C+ L+ +++ Q L +L + L D+M
Sbjct: 61 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMR 119
Query: 785 DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD---GVDPVTQTMT 841
L++LH + I+H DLKP N+L+ L DFG+A++ + PV
Sbjct: 120 QFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPV----- 171
Query: 842 LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
+ T+ Y APE + + D++S G + E F RRKP +F G Q
Sbjct: 172 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP---LFCGNSEADQ 219
>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk
Docking Peptide
Length = 362
Score = 58.5 bits (140), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 58/209 (27%), Positives = 96/209 (45%), Gaps = 21/209 (10%)
Query: 692 SFDNVYKATLANGVSVAVKVFN-LQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGF 750
++DNV N V VA+K + + + E +++ RH N+I I P
Sbjct: 44 AYDNV------NKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENIIGINDIIRAPTI 97
Query: 751 KALIMQYMPQGSLEKWLYS--HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKP 808
+ + Y+ Q +E LY L+ + + L+Y+H S ++H DLKP
Sbjct: 98 EQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKP 154
Query: 809 NNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE--YGSEGIVSISGDV 864
+N+LL+ + DFG+A++ D T +T +AT Y APE S+G S D+
Sbjct: 155 SNLLLNTTSDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK-SIDI 213
Query: 865 YSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
+S G ++ E + R +F G+ L Q
Sbjct: 214 WSVGCILAEMLSNRP----IFPGKHYLDQ 238
>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound
pdb|2WQO|A Chain A, Structure Of Nek2 Bound To The Aminopyridine Cct241950
pdb|2XK3|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 35
pdb|2XK4|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 17
pdb|2XK6|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 36
pdb|2XK7|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 23
pdb|2XK8|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 15
pdb|2XKC|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 14
pdb|2XKD|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 12
pdb|2XKF|A Chain A, Structure Of Nek2 Bound To Aminopyrazine Compound 2
pdb|2XKE|A Chain A, Structure Of Nek2 Bound To Aminipyrazine Compound 5
pdb|2XNM|A Chain A, Structure Of Nek2 Bound To Cct
pdb|2XNN|A Chain A, Structure Of Nek2 Bound To Cct242430
pdb|2XNO|A Chain A, Structure Of Nek2 Bound To Cct243779
pdb|2XNP|A Chain A, Structure Of Nek2 Bound To Cct244858
pdb|4AFE|A Chain A, Nek2 Bound To Hybrid Compound 21
Length = 279
Score = 58.5 bits (140), Expect = 2e-08, Method: Composition-based stats.
Identities = 48/182 (26%), Positives = 84/182 (46%), Gaps = 22/182 (12%)
Query: 725 TECEVMRRIRHRNLIK----IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRL 780
+E ++R ++H N+++ I+ + + ++M+Y G L + RQ L
Sbjct: 54 SEVNLLRELKHPNIVRYYDRIIDRTNTTLY--IVMEYCEGGDLASVITKGTKE---RQYL 108
Query: 781 D------IMIDVASALEYLHH----GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830
D +M + AL+ H G++ ++H DLKP NV LD LGDFG+A++L
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHT--VLHRDLKPANVFLDGKQNVKLGDFGLARIL 166
Query: 831 DGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMS 890
+ +T + T YM+PE + + D++S G L+ E P E++
Sbjct: 167 NHDTSFAKTF-VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA 225
Query: 891 LK 892
K
Sbjct: 226 GK 227
>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With A Beta-Carboline Ligand
pdb|3BQR|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase
3 (Dapk3) In Complex With An Imidazo-Pyridazine Ligand
Length = 283
Score = 58.5 bits (140), Expect = 2e-08, Method: Composition-based stats.
Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 21/212 (9%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN---LQEDR---ALKSFDTECEVMRRIRHRNLIK 740
LGSG F V K G A K L R + + + E ++R IRH N+I
Sbjct: 13 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 72
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ N LI++ + G L +L + SLT + + + + YLH S
Sbjct: 73 LHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEATQFLKQILDGVHYLH---SKR 128
Query: 801 IIHCDLKPNNVLLDDDMVAH----LGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG 856
I H DLKP N++L D V + L DFGIA ++ + T ++APE +
Sbjct: 129 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTPEFVAPEIVNYE 186
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGE 888
+ + D++S G++ + P F GE
Sbjct: 187 PLGLEADMWSIGVITYILLSGASP----FLGE 214
>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
pdb|1YRP|B Chain B, Catalytic Domain Of Human Zip Kinase Phosphorylated At
Thr265
Length = 278
Score = 58.5 bits (140), Expect = 2e-08, Method: Composition-based stats.
Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 21/212 (9%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN---LQEDR---ALKSFDTECEVMRRIRHRNLIK 740
LGSG F V K G A K L R + + + E ++R IRH N+I
Sbjct: 20 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIIT 79
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ N LI++ + G L +L + SLT + + + + YLH S
Sbjct: 80 LHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEATQFLKQILDGVHYLH---SKR 135
Query: 801 IIHCDLKPNNVLLDDDMVAH----LGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG 856
I H DLKP N++L D V + L DFGIA ++ + T ++APE +
Sbjct: 136 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTPEFVAPEIVNYE 193
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGE 888
+ + D++S G++ + P F GE
Sbjct: 194 PLGLEADMWSIGVITYILLSGASP----FLGE 221
>pdb|2F7E|E Chain E, Pka Complexed With
(S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6-
Yl-Pyridin-3-Yloxymethyl-Etylamine
pdb|2F7X|E Chain E, Protein Kinase A Bound To
(s)-2-(1h-indol-3-yl)-1-[5-((e)-2-
Pyridin-4-yl-vinyl)-pyridin-3-yloxymethyl]-ethylamine
pdb|2F7Z|E Chain E, Protein Kinase A Bound To
(R)-1-(1h-Indol-3-Ylmethyl)-2-(2-
Pyridin-4-Yl-[1,7]naphtyridin-5-Yloxy)-Ehylamine
pdb|2OH0|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
pdb|2OJF|E Chain E, Crystal Structure Of Protein Kinase A In Complex With
Pyridine-Pyrazolopyridine Based Inhibitors
Length = 351
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 20/202 (9%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V + G A+K+ + Q+ LK + E +++ +
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---ALEY 792
L+K+ S + ++M+Y+P G + +SH + A EY
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
LH S +I+ DLKP N+L+D + DFG AK + G +T TL T Y+APE
Sbjct: 158 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEYLAPE 209
Query: 852 YGSEGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 210 IILSKGYNKAVDWWALGVLIYE 231
>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent
Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In
Complex With Sto-609
Length = 298
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 44/151 (29%), Positives = 76/151 (50%), Gaps = 11/151 (7%)
Query: 726 ECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY--MPQGSLEKWLYSHNYSLTIRQRLDIM 783
E +++++ H N++K+V +P L M + + QG + + L+ Q
Sbjct: 86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME--VPTLKPLSEDQARFYF 143
Query: 784 IDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA 843
D+ +EYLH+ IIH D+KP+N+L+ +D + DFG++ G D + T+
Sbjct: 144 QDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSN-TVG 199
Query: 844 TIGYMAPEYGSEGIVSISG---DVYSFGILM 871
T +MAPE SE SG DV++ G+ +
Sbjct: 200 TPAFMAPESLSETRKIFSGKALDVWAMGVTL 230
>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors
pdb|2UZU|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
pdb|2UZV|A Chain A, Pka Structures Of Indazole-pyridine Series Of Akt
Inhibitors
pdb|2UZW|E Chain E, Pka Structures Of Indazole-Pyridine Series Of Akt
Inhibitors
Length = 336
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 55/202 (27%), Positives = 91/202 (45%), Gaps = 20/202 (9%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V + G A+K+ + Q+ LK + E +++ +
Sbjct: 27 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 86
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---ALEY 792
L+K+ S + ++M+Y+P G + +SH + A EY
Sbjct: 87 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 142
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
LH S +I+ DLKP N+L+D + DFG AK + G +T TL T Y+APE
Sbjct: 143 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWTLCGTPEYLAPE 194
Query: 852 YGSEGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 195 IILSKGYNKAVDWWALGVLIYE 216
>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
pdb|2J90|B Chain B, Crystal Structure Of Human Zip Kinase In Complex With A
Tetracyclic Pyridone Inhibitor (pyridone 6)
Length = 304
Score = 58.2 bits (139), Expect = 2e-08, Method: Composition-based stats.
Identities = 59/212 (27%), Positives = 91/212 (42%), Gaps = 21/212 (9%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN---LQEDR---ALKSFDTECEVMRRIRHRNLIK 740
LGSG F V K G A K L R + + + E ++R IRH N+I
Sbjct: 34 LGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNILREIRHPNIIT 93
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ N LI++ + G L +L + SLT + + + + YLH S
Sbjct: 94 LHDIFENKTDVVLILELVSGGELFDFL-AEKESLTEDEATQFLKQILDGVHYLH---SKR 149
Query: 801 IIHCDLKPNNVLLDDDMVAH----LGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG 856
I H DLKP N++L D V + L DFGIA ++ + T ++APE +
Sbjct: 150 IAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKN--IFGTPEFVAPEIVNYE 207
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGE 888
+ + D++S G++ + P F GE
Sbjct: 208 PLGLEADMWSIGVITYILLSGASP----FLGE 235
>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW6|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
pdb|2IW9|C Chain C, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed
With A Bisanilinopyrimidine Inhibitor
Length = 302
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 56/218 (25%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ Q L+ ++ + + + + + + L + H
Sbjct: 68 VKLLDVIHTENKLYLVFEFLHQ-DLKTFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 123
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T + T+ Y APE G +
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 183 -YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 215
>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90
Ribosomal S6 Kinase 2 (rsk2)
pdb|4D9U|A Chain A, Rsk2 C-Terminal Kinase Domain, (E)-Tert-Butyl
3-(4-Amino-7-(3-
Hydroxypropyl)-5-P-Tolyl-7h-Pyrrolo[2,
3-D]pyrimidin-6-Yl)-2- Cyanoacrylate
pdb|4D9T|A Chain A, Rsk2 C-Terminal Kinase Domain With Inhibitor (E)-Methyl
3-(4-Amino-7-
(3-Hydroxypropyl)-5-P-Tolyl-7h-Pyrrolo[2,
3-D]pyrimidin-6-Yl)-2- Cyanoacrylate
Length = 342
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 52/213 (24%), Positives = 97/213 (45%), Gaps = 21/213 (9%)
Query: 677 QATNGFGESNLLGSGSFD----NVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRR 732
Q T+G+ +G GS+ ++KAT + AVK+ D++ + E E++ R
Sbjct: 19 QFTDGYEVKEDIGVGSYSVCKRCIHKAT---NMEFAVKII----DKSKRDPTEEIEILLR 71
Query: 733 I-RHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALE 791
+H N+I + + + ++ + M G L + + + R+ ++ + +E
Sbjct: 72 YGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKF-FSEREASAVLFTITKTVE 130
Query: 792 YLHHGYSTPIIHCDLKPNNVLLDDD----MVAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
YLH + ++H DLKP+N+L D+ + DFG AK L + + T T +
Sbjct: 131 YLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT-PCYTANF 186
Query: 848 MAPEYGSEGIVSISGDVYSFGILMMETFTRRKP 880
+APE + D++S G+L+ T P
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219
>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights
Into Receptor Autoregulation
Length = 343
Score = 58.2 bits (139), Expect = 2e-08, Method: Compositional matrix adjust.
Identities = 53/221 (23%), Positives = 97/221 (43%), Gaps = 36/221 (16%)
Query: 688 LGSGSFDNVYKATLANGV-------SVAVKVFNLQEDRALKS-FDTECEVMRRIRHRNLI 739
+G G+F V++A A G+ VAVK+ + +++ F E +M + N++
Sbjct: 55 IGEGAFGRVFQAR-APGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIV 113
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYS---HNYS--------------------LTI 776
K++ C+ L+ +YM G L ++L S H L+
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSC 173
Query: 777 RQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPV 836
++L I VA+ + YL +H DL N L+ ++MV + DFG+++ + D
Sbjct: 174 AEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230
Query: 837 TQTMTLAT-IGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
A I +M PE + DV+++G+++ E F+
Sbjct: 231 KADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 271
>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin.
pdb|2BFY|B Chain B, Complex Of Aurora-B With Incenp And Hesperidin
Length = 284
Score = 58.2 bits (139), Expect = 2e-08, Method: Composition-based stats.
Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 11/197 (5%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRNLIKIVS 743
LG G F NVY A N +A+KV L+++ E E+ +RH N++++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
+ L++++ P+G L K L H ++ M ++A AL Y H +IH
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHE---RKVIH 137
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGD 863
D+KP N+L+ + DFG + + + T+ Y+ PE D
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVD 194
Query: 864 VYSFGILMMETFTRRKP 880
++ G+L E P
Sbjct: 195 LWCAGVLCYEFLVGMPP 211
>pdb|2BFX|A Chain A, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2BFX|B Chain B, Mechanism Of Aurora-B Activation By Incenp And Inhibition
By Hesperidin.
pdb|2VGP|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGP|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With A
Aminothiazole Inhibitor
pdb|2VGO|A Chain A, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|2VGO|B Chain B, Crystal Structure Of Aurora B Kinase In Complex With
Reversine Inhibitor
pdb|3ZTX|A Chain A, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen.
pdb|3ZTX|B Chain B, Aurora Kinase Selective Inhibitors Identified Using A
Taxol- Induced Checkpoint Sensitivity Screen
Length = 284
Score = 58.2 bits (139), Expect = 2e-08, Method: Composition-based stats.
Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 11/197 (5%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRNLIKIVS 743
LG G F NVY A N +A+KV L+++ E E+ +RH N++++ +
Sbjct: 22 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 81
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
+ L++++ P+G L K L H ++ M ++A AL Y H +IH
Sbjct: 82 YFHDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHE---RKVIH 137
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGD 863
D+KP N+L+ + DFG + + + T+ Y+ PE D
Sbjct: 138 RDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVD 194
Query: 864 VYSFGILMMETFTRRKP 880
++ G+L E P
Sbjct: 195 LWCAGVLCYEFLVGMPP 211
>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer
Length = 319
Score = 58.2 bits (139), Expect = 2e-08, Method: Composition-based stats.
Identities = 46/178 (25%), Positives = 78/178 (43%), Gaps = 19/178 (10%)
Query: 662 LNLATLSRISYHELQQATNGFGES-----------NLLGSGSFDNVYKATLANGVSVAVK 710
+NL+ LS S+ T+ F + L+G G F VY VA++
Sbjct: 4 MNLSLLSARSFPRKASQTSIFLQEWDIPFEQLEIGELIGKGRFGQVYHGRWHG--EVAIR 61
Query: 711 VFNLQEDR--ALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLY 768
+ +++ D LK+F E R+ RH N++ + +C +P A+I +L +
Sbjct: 62 LIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR 121
Query: 769 SHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGI 826
L + + I ++ + YLH + I+H DLK NV D+ V + DFG+
Sbjct: 122 DAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNGKVV-ITDFGL 175
>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439
pdb|2VRX|B Chain B, Structure Of Aurora B Kinase In Complex With Zm447439
Length = 285
Score = 58.2 bits (139), Expect = 2e-08, Method: Composition-based stats.
Identities = 50/197 (25%), Positives = 85/197 (43%), Gaps = 11/197 (5%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRNLIKIVS 743
LG G F NVY A N +A+KV L+++ E E+ +RH N++++ +
Sbjct: 23 LGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYN 82
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
+ L++++ P+G L K L H ++ M ++A AL Y H +IH
Sbjct: 83 YFHDRKRIYLMLEFAPRGELYKELQKHG-RFDEQRSATFMEELADALHYCHE---RKVIH 138
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGD 863
D+KP N+L+ + DFG + + + T+ Y+ PE D
Sbjct: 139 RDIKPENLLMGYKGELKIADFGWSV---HAPSLRRRXMCGTLDYLPPEMIEGKTHDEKVD 195
Query: 864 VYSFGILMMETFTRRKP 880
++ G+L E P
Sbjct: 196 LWCAGVLCYEFLVGMPP 212
>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1
Length = 327
Score = 58.2 bits (139), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 60/213 (28%), Positives = 95/213 (44%), Gaps = 21/213 (9%)
Query: 686 NLLGSGSFDNVY---KATLAN-GVSVAVKVFN----LQEDRALKSFDTECEVMRRIRHRN 737
+LG G + V+ K T AN G A+KV ++ + E ++ ++H
Sbjct: 23 RVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPF 82
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGY 797
++ ++ + G LI++Y+ G L L + + +++ AL +LH
Sbjct: 83 IVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACF-YLAEISMALGHLH--- 138
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAK--LLDGVDPVTQTMTLATIGYMAPEYGSE 855
II+ DLKP N++L+ L DFG+ K + DG VT TI YMAPE
Sbjct: 139 QKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHXFC-GTIEYMAPEILMR 195
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGE 888
+ + D +S G LM + T P FTGE
Sbjct: 196 SGHNRAVDWWSLGALMYDMLTGAPP----FTGE 224
>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
pdb|4EOM|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With Atp
Length = 301
Score = 57.8 bits (138), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 56/218 (25%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ L+K++ + + + + + + L + H
Sbjct: 68 VKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 123
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T + T+ Y APE G +
Sbjct: 124 SHRVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCK 182
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 183 -YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 215
>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EON|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 57.8 bits (138), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 56/218 (25%), Positives = 102/218 (46%), Gaps = 16/218 (7%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 6 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 65
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYS-LTIRQRLDIMIDVASALEYLHHGY 797
+K++ L+ +++ L+K++ + + + + + + L + H
Sbjct: 66 VKLLDVIHTENKLYLVFEFLSM-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCH--- 121
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
S ++H DLKP N+L++ + L DFG+A+ GV T + T+ Y APE G +
Sbjct: 122 SHRVLHRDLKPENLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCK 180
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 181 -YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 213
>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1
pdb|3FPQ|B Chain B, Crystal Structure Of The Kinase Domain Of Wnk1
Length = 290
Score = 57.8 bits (138), Expect = 3e-08, Method: Composition-based stats.
Identities = 59/208 (28%), Positives = 93/208 (44%), Gaps = 22/208 (10%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKS----FDTECEVMRRIRHRNLIKIVS 743
+G GSF VYK L +V V LQ+ + KS F E E ++ ++H N+++
Sbjct: 34 IGRGSFKTVYKG-LDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQHPNIVRFYD 92
Query: 744 SCSN--PGFKALIM--QYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
S + G K +++ + G+L+ +L I+ + L++LH +
Sbjct: 93 SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVX-KIKVLRSWCRQILKGLQFLH-TRTP 150
Query: 800 PIIHCDLKPNNVLLDDDM-VAHLGDFGIAKLLDGVDPVTQTMTLATIG---YMAPEYGSE 855
PIIH DLK +N+ + +GD G+A L + A IG + APE E
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA------SFAKAVIGTPEFXAPEXYEE 204
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNE 883
S DVY+FG +E T P +E
Sbjct: 205 KYDE-SVDVYAFGXCXLEXATSEYPYSE 231
>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin
Length = 306
Score = 57.8 bits (138), Expect = 3e-08, Method: Composition-based stats.
Identities = 63/232 (27%), Positives = 107/232 (46%), Gaps = 30/232 (12%)
Query: 678 ATNGFGESNLLGSGSFDNVYKATLA-NGVSVA---VKVFNLQEDRALKSFDTECEVMRRI 733
AT+ + +G G++ VYKA +G VA V+V N +E + + E ++RR+
Sbjct: 2 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTV-REVALLRRL 60
Query: 734 R---HRNLIKIVSSCSNPGFK-----ALIMQYMPQGSLEKWL-YSHNYSLTIRQRLDIMI 784
H N+++++ C+ L+ +++ Q L +L + L D+M
Sbjct: 61 EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDLMR 119
Query: 785 DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD---GVDPVTQTMT 841
L++LH + I+H DLKP N+L+ L DFG+A++ + PV
Sbjct: 120 QFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPV----- 171
Query: 842 LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
+ T+ Y APE + + D++S G + E F RRKP +F G Q
Sbjct: 172 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP---LFCGNSEADQ 219
>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|B Chain B, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|C Chain C, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
pdb|3QC9|D Chain D, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C
DOUBLE MUTANT Complexed With Adp And Mg
Length = 543
Score = 57.8 bits (138), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 16/231 (6%)
Query: 660 NSLNLATLSRISYHELQ-QATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED 717
+SL + + E Q + F + +LG G F V+ + A G A K N +
Sbjct: 164 DSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL 223
Query: 718 RALKSFD---TECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLY---SHN 771
+ K + E +++ ++ R ++ + + L+M M G + +Y N
Sbjct: 224 KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN 283
Query: 772 YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831
+ + + S LE+LH II+ DLKP NVLLDDD + D G+A L
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340
Query: 832 GVDPVTQTMTLATIGYMAPE--YGSEGIVSISGDVYSFGILMMETFTRRKP 880
T+ T G+MAPE G E S+ D ++ G+ + E R P
Sbjct: 341 AGQTKTKGYA-GTPGFMAPELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388
>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4X|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.9a
pdb|3C4Y|A Chain A, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Y|B Chain B, Crystal Structure Of Apo Form Of G Protein Coupled
Receptor Kinase 1 At 7.51a
pdb|3C4Z|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 1.84a
pdb|3C50|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C50|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 2.6a
pdb|3C51|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
pdb|3C51|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Adp And Magnesium Chloride At 3.55a
Length = 543
Score = 57.8 bits (138), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 16/231 (6%)
Query: 660 NSLNLATLSRISYHELQ-QATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED 717
+SL + + E Q + F + +LG G F V+ + A G A K N +
Sbjct: 164 DSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL 223
Query: 718 RALKSFD---TECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLY---SHN 771
+ K + E +++ ++ R ++ + + L+M M G + +Y N
Sbjct: 224 KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN 283
Query: 772 YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831
+ + + S LE+LH II+ DLKP NVLLDDD + D G+A L
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340
Query: 832 GVDPVTQTMTLATIGYMAPE--YGSEGIVSISGDVYSFGILMMETFTRRKP 880
T+ T G+MAPE G E S+ D ++ G+ + E R P
Sbjct: 341 AGQTKTKGYA-GTPGFMAPELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388
>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7
pdb|2B9I|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Msg5
pdb|2B9J|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Far1
pdb|2F49|A Chain A, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2F49|B Chain B, Crystal Structure Of Fus3 In Complex With A Ste5 Peptide
pdb|2FA2|A Chain A, Crystal Structure Of Fus3 Without A Peptide From Ste5
pdb|2FA2|B Chain B, Crystal Structure Of Fus3 Without A Peptide From Ste5
Length = 353
Score = 57.8 bits (138), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 60/217 (27%), Positives = 103/217 (47%), Gaps = 23/217 (10%)
Query: 679 TNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDT--ECEVMRRIRH 735
++ F +LLG G++ V AT G VA+K D+ L + T E ++++ +H
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIE-PFDKPLFALRTLREIKILKHFKH 68
Query: 736 RNLIKIVSSCSNPGFK----ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALE 791
N+I I + F+ I+Q + Q L + + + S Q + A++
Sbjct: 69 ENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYF--IYQTLRAVK 126
Query: 792 YLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL-----DGVDPVTQTMTL---- 842
LH + +IH DLKP+N+L++ + + DFG+A+++ D +P Q +
Sbjct: 127 VLH---GSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFV 183
Query: 843 ATIGYMAPEYG-SEGIVSISGDVYSFGILMMETFTRR 878
AT Y APE + S + DV+S G ++ E F RR
Sbjct: 184 ATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRR 220
>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
pdb|3C4W|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 1
Bound To Atp And Magnesium Chloride At 2.7a
Length = 543
Score = 57.8 bits (138), Expect = 3e-08, Method: Compositional matrix adjust.
Identities = 61/231 (26%), Positives = 98/231 (42%), Gaps = 16/231 (6%)
Query: 660 NSLNLATLSRISYHELQ-QATNGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQED 717
+SL + + E Q + F + +LG G F V+ + A G A K N +
Sbjct: 164 DSLYFLRFLQWKWLEAQPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRL 223
Query: 718 RALKSFD---TECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLY---SHN 771
+ K + E +++ ++ R ++ + + L+M M G + +Y N
Sbjct: 224 KKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDN 283
Query: 772 YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831
+ + + S LE+LH II+ DLKP NVLLDDD + D G+A L
Sbjct: 284 PGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELK 340
Query: 832 GVDPVTQTMTLATIGYMAPE--YGSEGIVSISGDVYSFGILMMETFTRRKP 880
T+ T G+MAPE G E S+ D ++ G+ + E R P
Sbjct: 341 AGQTKTKGYA-GTPGFMAPELLLGEEYDFSV--DYFALGVTLYEMIAARGP 388
>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution
Length = 543
Score = 57.4 bits (137), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 91/210 (43%), Gaps = 15/210 (7%)
Query: 680 NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F + +LG G F V+ + A G A K N + + K + E +++ ++
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLY---SHNYSLTIRQRLDIMIDVASALEY 792
R ++ + + L+M M G + +Y N + + + S LE+
Sbjct: 245 RFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEH 304
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE- 851
LH II+ DLKP NVLLDDD + D G+A L T+ T G+MAPE
Sbjct: 305 LHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYA-GTPGFMAPEL 360
Query: 852 -YGSEGIVSISGDVYSFGILMMETFTRRKP 880
G E S+ D ++ G+ + E R P
Sbjct: 361 LLGEEYDFSV--DYFALGVTLYEMIAARGP 388
>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase
1)
Length = 294
Score = 57.4 bits (137), Expect = 4e-08, Method: Composition-based stats.
Identities = 62/233 (26%), Positives = 94/233 (40%), Gaps = 42/233 (18%)
Query: 668 SRISYHELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTEC 727
SR+ EL F + + +G GSF VYK G+ K E A+K D E
Sbjct: 13 SRVDPEEL------FTKLDRIGKGSFGEVYK-----GIDNHTK-----EVVAIKIIDLEE 56
Query: 728 EVMRRIRHRNLIKIVSSCSNPGFKA------------LIMQYMPQGS----LEKWLYSHN 771
+ I ++S C +P +IM+Y+ GS L+
Sbjct: 57 AEDEIEDIQQEITVLSQCDSPYITRYFGSYLKSTKLWIIMEYLGGGSALDLLKPGPLEET 116
Query: 772 YSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831
Y TI + ++ L+YLH S IH D+K NVLL + L DFG+A L
Sbjct: 117 YIATI------LREILKGLDYLH---SERKIHRDIKAANVLLSEQGDVKLADFGVAGQLT 167
Query: 832 GVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEM 884
+ + + T +MAPE + D++S GI +E P +++
Sbjct: 168 DTQ-IKRNXFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 219
>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With
Y- 27632
Length = 350
Score = 57.4 bits (137), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F +G+GSF V + G A+K+ + Q+ LK + E +++ +
Sbjct: 41 DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---ALEY 792
L+K+ S + ++M+YMP G + +SH + A EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
LH S +I+ DLKP N+L+D + DFG AK + G +T L T Y+APE
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 852 YGSEGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230
>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase
pdb|2GNH|A Chain A, Pka Five Fold Mutant Model Of Rho-Kinase With H1152p
pdb|2GNI|A Chain A, Pka Fivefold Mutant Model Of Rho-Kinase With Inhibitor
Fasudil (Ha1077)
Length = 350
Score = 57.4 bits (137), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F +G+GSF V + G A+K+ + Q+ LK + E +++ +
Sbjct: 41 DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---ALEY 792
L+K+ S + ++M+YMP G + +SH + A EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYMPGGDM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
LH S +I+ DLKP N+L+D + DFG AK + G +T L T Y+APE
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 852 YGSEGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230
>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
pdb|4EOJ|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With Atp
Length = 302
Score = 57.0 bits (136), Expect = 4e-08, Method: Compositional matrix adjust.
Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 14/217 (6%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 8 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 67
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
+K++ L+ +++ S++ + +LT I + L+ L +S
Sbjct: 68 VKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 124
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSEG 856
++H DLKP N+L++ + L DFG+A+ GV T + T+ Y APE G +
Sbjct: 125 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCK- 182
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 183 YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 215
>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ESM|B Chain B, Crystal Structure Of Rock 1 Bound To Fasudil
pdb|2ETK|A Chain A, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETK|B Chain B, Crystal Structure Of Rock 1 Bound To Hydroxyfasudil
pdb|2ETR|A Chain A, Crystal Structure Of Rock I Bound To Y-27632
pdb|2ETR|B Chain B, Crystal Structure Of Rock I Bound To Y-27632
pdb|3D9V|A Chain A, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3D9V|B Chain B, Crystal Structure Of Rock I Bound To H-1152p A Di-
Methylated Variant Of Fasudil
pdb|3NCZ|A Chain A, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|B Chain B, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|C Chain C, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NCZ|D Chain D, X-Ray Co-Structure Of Rho-Associated Protein Kinase
(Rock1) With A Potent 2h-Isoquinolin-1-One Inhibitor
pdb|3NDM|A Chain A, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|B Chain B, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|C Chain C, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
pdb|3NDM|D Chain D, Crystal Structure Of Rho-Associated Protein Kinase (Rock1)
With A Potent Isoquinolone Derivative
Length = 415
Score = 57.0 bits (136), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 61/254 (24%), Positives = 104/254 (40%), Gaps = 30/254 (11%)
Query: 681 GFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
FGE L+ S VY L + + + D A F E ++M +++
Sbjct: 86 AFGEVQLVRHKSTRKVYAMKLLSKFEMIKR-----SDSAF--FWEERDIMAFANSPWVVQ 138
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ + + + ++M+YMP G L + NY + + +V AL+ +H S
Sbjct: 139 LFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVLALDAIH---SMG 193
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE----YGSEG 856
IH D+KP+N+LLD L DFG ++ V + T Y++PE G +G
Sbjct: 194 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 253
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVD-ANLLSRE 915
D +S G+ + E P + A+SL G +++++ N L+
Sbjct: 254 YYGRECDWWSVGVFLYEMLVGDTP-------------FYADSLVGTYSKIMNHKNSLTFP 300
Query: 916 DEEDADDFATKKTC 929
D+ D A C
Sbjct: 301 DDNDISKEAKNLIC 314
>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOK|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Nu6102
pdb|4EOL|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
pdb|4EOL|C Chain C, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human
Cyclin A3 Complex With The Inhibitor Ro3306
Length = 300
Score = 57.0 bits (136), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 14/217 (6%)
Query: 682 FGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQ-EDRALKSFDT-ECEVMRRIRHRNL 738
F + +G G++ VYKA G VA+K L E + S E +++ + H N+
Sbjct: 7 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNI 66
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
+K++ L+ +++ S++ + +LT I + L+ L +S
Sbjct: 67 VKLLDVIHTENKLYLVFEFL---SMDLKDFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 123
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSEG 856
++H DLKP N+L++ + L DFG+A+ GV T + T+ Y APE G +
Sbjct: 124 HRVLHRDLKPQNLLINTEGAIKLADFGLARAF-GVPVRTYXHEVVTLWYRAPEILLGCK- 181
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
S + D++S G + E TRR +F G+ + Q
Sbjct: 182 YYSTAVDIWSLGCIFAEMVTRRA----LFPGDSEIDQ 214
>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C-kit Tyrosine Kinase
Length = 313
Score = 57.0 bits (136), Expect = 5e-08, Method: Compositional matrix adjust.
Identities = 57/233 (24%), Positives = 100/233 (42%), Gaps = 35/233 (15%)
Query: 673 HELQQATNGFGESNLLGSGSFDNVYKATLAN------GVSVAVKVF----NLQEDRALKS 722
H+ + N LG+G+F V +AT ++VAVK+ +L E AL S
Sbjct: 16 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 75
Query: 723 FDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLD 781
E +V+ + H N++ ++ +C+ G +I +Y G L +L S +
Sbjct: 76 ---ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 132
Query: 782 IMI-----------------DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDF 824
++ VA + +L S IH DL N+LL + + DF
Sbjct: 133 AIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDF 189
Query: 825 GIAK-LLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
G+A+ + + + V + + +MAPE + + DV+S+GI + E F+
Sbjct: 190 GLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 242
>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand
pdb|2W5B|A Chain A, Human Nek2 Kinase Atpgammas-bound
pdb|2W5H|A Chain A, Human Nek2 Kinase Apo
Length = 279
Score = 57.0 bits (136), Expect = 5e-08, Method: Composition-based stats.
Identities = 48/182 (26%), Positives = 83/182 (45%), Gaps = 22/182 (12%)
Query: 725 TECEVMRRIRHRNLIK----IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRL 780
+E ++R ++H N+++ I+ + + ++M+Y G L + RQ L
Sbjct: 54 SEVNLLRELKHPNIVRYYDRIIDRTNTTLY--IVMEYCEGGDLASVITKGTKE---RQYL 108
Query: 781 D------IMIDVASALEYLHH----GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830
D +M + AL+ H G++ ++H DLKP NV LD LGDFG+A++L
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHT--VLHRDLKPANVFLDGKQNVKLGDFGLARIL 166
Query: 831 DGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMS 890
+ D + T YM+PE + + D++S G L+ E P E++
Sbjct: 167 NH-DTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA 225
Query: 891 LK 892
K
Sbjct: 226 GK 227
>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662
Length = 279
Score = 57.0 bits (136), Expect = 5e-08, Method: Composition-based stats.
Identities = 47/182 (25%), Positives = 84/182 (46%), Gaps = 22/182 (12%)
Query: 725 TECEVMRRIRHRNLIK----IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRL 780
+E ++R ++H N+++ I+ + + ++M+Y G L + RQ L
Sbjct: 54 SEVNLLRELKHPNIVRYYDRIIDRTNTTLY--IVMEYCEGGDLASVITKGTKE---RQYL 108
Query: 781 D------IMIDVASALEYLHH----GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL 830
D +M + AL+ H G++ ++H DLKP NV LD LGDFG+A++L
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHT--VLHRDLKPANVFLDGKQNVKLGDFGLARIL 166
Query: 831 DGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMS 890
+ + + + T YM+PE + + D++S G L+ E P E++
Sbjct: 167 NHDEDFAKEF-VGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELA 225
Query: 891 LK 892
K
Sbjct: 226 GK 227
>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|B Chain B, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|C Chain C, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3V8S|D Chain D, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex
With Indazole Derivative (Compound 18)
pdb|3TV7|A Chain A, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|B Chain B, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|C Chain C, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TV7|D Chain D, Human Rho-associated Protein Kinase 1 (rock 1) In Complex
With Rki1342
pdb|3TWJ|A Chain A, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|B Chain B, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|C Chain C, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
pdb|3TWJ|D Chain D, Rho-Associated Protein Kinase 1 (Rock 1) In Complex With
Rki1447
Length = 410
Score = 57.0 bits (136), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 62/254 (24%), Positives = 105/254 (41%), Gaps = 30/254 (11%)
Query: 681 GFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
FGE L+ S VY L + + + D A F E ++M +++
Sbjct: 81 AFGEVQLVRHKSTRKVYAMKLLSKFEMIKR-----SDSAF--FWEERDIMAFANSPWVVQ 133
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ + + + ++M+YMP G L + NY + + +V AL+ +H S
Sbjct: 134 LFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVLALDAIH---SMG 188
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE----YGSEG 856
IH D+KP+N+LLD L DFG ++ V + T Y++PE G +G
Sbjct: 189 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 248
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVD-ANLLSRE 915
D +S G+ + EM G+ A+SL G +++++ N L+
Sbjct: 249 YYGRECDWWSVGVFLY----------EMLVGDTPF---YADSLVGTYSKIMNHKNSLTFP 295
Query: 916 DEEDADDFATKKTC 929
D+ D A C
Sbjct: 296 DDNDISKEAKNLIC 309
>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|B Chain B, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|C Chain C, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
pdb|3ENM|D Chain D, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory
Dimer
Length = 316
Score = 56.6 bits (135), Expect = 6e-08, Method: Composition-based stats.
Identities = 42/123 (34%), Positives = 60/123 (48%), Gaps = 8/123 (6%)
Query: 782 IMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT 841
I + + ALE+LH S +IH D+KP+NVL++ DFGI+ L VD V + +
Sbjct: 141 IAVSIVKALEHLHSKLS--VIHRDVKPSNVLINALGQVKXCDFGISGYL--VDDVAKDID 196
Query: 842 LATIGYMAPEYGSEGI----VSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAE 897
Y APE + + S+ D++S GI +E R P + T LKQ V E
Sbjct: 197 AGCKPYXAPERINPELNQKGYSVKSDIWSLGITXIELAILRFPYDSWGTPFQQLKQVVEE 256
Query: 898 SLP 900
P
Sbjct: 257 PSP 259
>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex
pdb|1PKG|B Chain B, Structure Of A C-kit Kinase Product Complex
Length = 329
Score = 56.6 bits (135), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 57/233 (24%), Positives = 100/233 (42%), Gaps = 35/233 (15%)
Query: 673 HELQQATNGFGESNLLGSGSFDNVYKATLAN------GVSVAVKVF----NLQEDRALKS 722
H+ + N LG+G+F V +AT ++VAVK+ +L E AL S
Sbjct: 32 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 91
Query: 723 FDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLD 781
E +V+ + H N++ ++ +C+ G +I +Y G L +L S +
Sbjct: 92 ---ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 148
Query: 782 IMI-----------------DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDF 824
++ VA + +L S IH DL N+LL + + DF
Sbjct: 149 AIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDF 205
Query: 825 GIAK-LLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
G+A+ + + + V + + +MAPE + + DV+S+GI + E F+
Sbjct: 206 GLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 258
>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant
Length = 334
Score = 56.6 bits (135), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 17/194 (8%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALK------SFDTECEVMRRIRHRNLIK 740
LGSG F V K + G+ A K + ++ + + E +++ I+H N+I
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ N LI++ + G L +L + SLT + + + + + + YLH S
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH---SLQ 134
Query: 801 IIHCDLKPNNVLLDDDMVA----HLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG 856
I H DLKP N++L D V + DFG+A +D + T ++APE +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPAFVAPEIVNYE 192
Query: 857 IVSISGDVYSFGIL 870
+ + D++S G++
Sbjct: 193 PLGLEADMWSIGVI 206
>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 56.6 bits (135), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 14/199 (7%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V + G A+K+ + Q+ LK + E +++ +
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
L+K+ S + ++M+Y+P G + L R + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGS 854
S +I+ DLKP N+L+D + DFG AK + G +T L T Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIIL 211
Query: 855 EGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230
>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex
pdb|3KL8|C Chain C, Camkiintide Inhibitor Complex
pdb|3KL8|E Chain E, Camkiintide Inhibitor Complex
pdb|3KL8|G Chain G, Camkiintide Inhibitor Complex
pdb|3KL8|I Chain I, Camkiintide Inhibitor Complex
Length = 269
Score = 56.6 bits (135), Expect = 6e-08, Method: Composition-based stats.
Identities = 45/190 (23%), Positives = 86/190 (45%), Gaps = 12/190 (6%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSS 744
LG G+F V + G+ A K+ N ++ R + + E + R+++H N++++ S
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
F L+ + G L + + + + D + LE + + +S I+H
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIAYCHSNGIVHR 129
Query: 805 DLKPNNVLLDDD---MVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSIS 861
+LKP N+LL L DFG+A ++ D T GY++PE + S
Sbjct: 130 NLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKP 187
Query: 862 GDVYSFGILM 871
D+++ G+++
Sbjct: 188 VDIWACGVIL 197
>pdb|3KK9|A Chain A, Camkii Substrate Complex B
Length = 282
Score = 56.6 bits (135), Expect = 6e-08, Method: Composition-based stats.
Identities = 45/190 (23%), Positives = 86/190 (45%), Gaps = 12/190 (6%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSS 744
LG G+F V + G+ A K+ N ++ R + + E + R+++H N++++ S
Sbjct: 13 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 72
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
F L+ + G L + + + + D + LE + + +S I+H
Sbjct: 73 IQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIAYCHSNGIVHR 128
Query: 805 DLKPNNVLLDDD---MVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSIS 861
+LKP N+LL L DFG+A ++ D T GY++PE + S
Sbjct: 129 NLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKP 186
Query: 862 GDVYSFGILM 871
D+++ G+++
Sbjct: 187 VDIWACGVIL 196
>pdb|3KK8|A Chain A, Camkii Substrate Complex A
Length = 284
Score = 56.6 bits (135), Expect = 6e-08, Method: Composition-based stats.
Identities = 45/190 (23%), Positives = 86/190 (45%), Gaps = 12/190 (6%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSS 744
LG G+F V + G+ A K+ N ++ R + + E + R+++H N++++ S
Sbjct: 14 LGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDS 73
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
F L+ + G L + + + + D + LE + + +S I+H
Sbjct: 74 IQEESFHYLVFDLVTGGELFEDIVAREF----YSEADASHCIQQILESIAYCHSNGIVHR 129
Query: 805 DLKPNNVLLDDD---MVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSIS 861
+LKP N+LL L DFG+A ++ D T GY++PE + S
Sbjct: 130 NLKPENLLLASKAKGAAVKLADFGLA--IEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKP 187
Query: 862 GDVYSFGILM 871
D+++ G+++
Sbjct: 188 VDIWACGVIL 197
>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex
With N-(4-
(5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h-
Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide
Length = 446
Score = 56.6 bits (135), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 12/207 (5%)
Query: 680 NGFGESNLLGSGSFDNV-YKATLANGVSVAVKVFNLQ----EDRALKSFDTECEVMRRIR 734
N F LLG G+F V A G A+K+ + +D + TE V++ R
Sbjct: 148 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL-TENRVLQNSR 206
Query: 735 HRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH 794
H L + S +M+Y G L L R R ++ SAL+YLH
Sbjct: 207 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH 265
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV-DPVTQTMTLATIGYMAPEYG 853
+++ DLK N++LD D + DFG+ K +G+ D T T Y+APE
Sbjct: 266 S--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVL 321
Query: 854 SEGIVSISGDVYSFGILMMETFTRRKP 880
+ + D + G++M E R P
Sbjct: 322 EDNDYGRAVDWWGLGVVMYEMMCGRLP 348
>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric
Inhibitor
Length = 446
Score = 56.6 bits (135), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 12/207 (5%)
Query: 680 NGFGESNLLGSGSFDNV-YKATLANGVSVAVKVFNLQ----EDRALKSFDTECEVMRRIR 734
N F LLG G+F V A G A+K+ + +D + TE V++ R
Sbjct: 151 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL-TENRVLQNSR 209
Query: 735 HRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH 794
H L + S +M+Y G L L R R ++ SAL+YLH
Sbjct: 210 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH 268
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV-DPVTQTMTLATIGYMAPEYG 853
+++ DLK N++LD D + DFG+ K +G+ D T T Y+APE
Sbjct: 269 S--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKTFCGTPEYLAPEVL 324
Query: 854 SEGIVSISGDVYSFGILMMETFTRRKP 880
+ + D + G++M E R P
Sbjct: 325 EDNDYGRAVDWWGLGVVMYEMMCGRLP 351
>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077)
pdb|1XH4|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|3BWJ|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Lead Compound Arc-1034
pdb|3KKV|A Chain A, Structure Of Pka With A Protein Kinase B-Selective
Inhibitor
Length = 350
Score = 56.6 bits (135), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 14/199 (7%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V + G A+K+ + Q+ LK + E +++ +
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
L+K+ S + ++M+Y+P G + L R + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGS 854
S +I+ DLKP N+L+D + DFG AK + G +T L T Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIIL 211
Query: 855 EGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230
>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
A- 443654
Length = 351
Score = 56.6 bits (135), Expect = 6e-08, Method: Compositional matrix adjust.
Identities = 53/199 (26%), Positives = 88/199 (44%), Gaps = 14/199 (7%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V + G A+K+ + Q+ LK + E +++ +
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
L+K+ S + ++M+Y+P G + L R + EYLH
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGS 854
S +I+ DLKP N+L+D + DFG AK + G +T L T Y+APE
Sbjct: 160 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIIL 212
Query: 855 EGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 213 SKGYNKAVDWWALGVLIYE 231
>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363
Length = 340
Score = 56.6 bits (135), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 12/207 (5%)
Query: 680 NGFGESNLLGSGSFDNV-YKATLANGVSVAVKVFNLQ----EDRALKSFDTECEVMRRIR 734
N F LLG G+F V A G A+K+ + +D + TE V++ R
Sbjct: 8 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL-TENRVLQNSR 66
Query: 735 HRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH 794
H L + S +M+Y G L L R R ++ SAL+YLH
Sbjct: 67 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH 125
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV-DPVTQTMTLATIGYMAPEYG 853
+++ DLK N++LD D + DFG+ K +G+ D T T Y+APE
Sbjct: 126 S--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVL 181
Query: 854 SEGIVSISGDVYSFGILMMETFTRRKP 880
+ + D + G++M E R P
Sbjct: 182 EDNDYGRAVDWWGLGVVMYEMMCGRLP 208
>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3
pdb|3G33|C Chain C, Crystal Structure Of Cdk4CYCLIN D3
Length = 308
Score = 56.6 bits (135), Expect = 7e-08, Method: Composition-based stats.
Identities = 62/231 (26%), Positives = 103/231 (44%), Gaps = 25/231 (10%)
Query: 678 ATNGFGESNLLGSGSFDNVYKATLA-NGVSVA---VKVFNLQEDRALKSFDT--ECEVMR 731
AT+ + +G G++ VYKA +G VA V+V N T E ++R
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 732 RIR---HRNLIKIVSSCSNPGFK-----ALIMQYMPQGSLEKWL-YSHNYSLTIRQRLDI 782
R+ H N+++++ C+ L+ +++ Q L +L + L D+
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIKDL 125
Query: 783 MIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL 842
M L++LH + I+H DLKP N+L+ L DFG+A++ + T +
Sbjct: 126 MRQFLRGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSY--QMALTPVV 180
Query: 843 ATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
T+ Y APE + + D++S G + E F RRKP +F G Q
Sbjct: 181 VTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMF-RRKP---LFCGNSEADQ 227
>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With
N-(4-chlorophenyl)-2-
((pyridin-4-ylmethyl)amino)benzamide
Length = 360
Score = 56.6 bits (135), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 34/104 (32%), Positives = 55/104 (52%), Gaps = 4/104 (3%)
Query: 774 LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDG 832
+T+ + VA +E+L S IH DL N+LL ++ V + DFG+A+ +
Sbjct: 196 ITMEDLISYSFQVARGMEFLS---SRKCIHRDLAARNILLSENNVVKICDFGLARDIYKN 252
Query: 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
D V + T + +MAPE + I S DV+S+G+L+ E F+
Sbjct: 253 PDYVRKGDTRLPLKWMAPESIFDKIYSTKSDVWSYGVLLWEIFS 296
>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
pdb|2VZ6|B Chain B, Structure Of Human Calcium Calmodulin Dependent Protein
Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin
E804
Length = 313
Score = 56.6 bits (135), Expect = 7e-08, Method: Composition-based stats.
Identities = 47/190 (24%), Positives = 85/190 (44%), Gaps = 11/190 (5%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSS 744
LG G+F V + + G A K+ N ++ R + + E + R ++H N++++ S
Sbjct: 30 LGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 89
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
S G LI + G L + + + Y D + LE + H + ++H
Sbjct: 90 ISEEGHHYLIFDLVTGGELFEDIVAREY----YSEADASHCIQQILEAVLHCHQMGVVHR 145
Query: 805 DLKPNNVLLDDDM---VAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSIS 861
DLKP N+LL + L DFG+A ++G T GY++PE +
Sbjct: 146 DLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVLRKDPYGKP 204
Query: 862 GDVYSFGILM 871
D+++ G+++
Sbjct: 205 VDLWACGVIL 214
>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571
Inhibition Of C- Kit Tyrosine Kinase
Length = 331
Score = 56.6 bits (135), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 57/233 (24%), Positives = 100/233 (42%), Gaps = 35/233 (15%)
Query: 673 HELQQATNGFGESNLLGSGSFDNVYKATLAN------GVSVAVKVF----NLQEDRALKS 722
H+ + N LG+G+F V +AT ++VAVK+ +L E AL S
Sbjct: 34 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 93
Query: 723 FDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLD 781
E +V+ + H N++ ++ +C+ G +I +Y G L +L S +
Sbjct: 94 ---ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 150
Query: 782 IMI-----------------DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDF 824
++ VA + +L S IH DL N+LL + + DF
Sbjct: 151 AIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDF 207
Query: 825 GIAK-LLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
G+A+ + + + V + + +MAPE + + DV+S+GI + E F+
Sbjct: 208 GLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 260
>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OCB|B Chain B, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor
pdb|3OW4|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3OW4|B Chain B, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|3QKK|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKL|A Chain A, Spirochromane Akt Inhibitors
pdb|3QKM|A Chain A, Spirocyclic Sulfonamides As Akt Inhibitors
pdb|4EKK|A Chain A, Akt1 With Amp-Pnp
pdb|4EKK|B Chain B, Akt1 With Amp-Pnp
pdb|4EKL|A Chain A, Akt1 With Gdc0068
Length = 341
Score = 56.6 bits (135), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 12/207 (5%)
Query: 680 NGFGESNLLGSGSFDNV-YKATLANGVSVAVKVFNLQ----EDRALKSFDTECEVMRRIR 734
N F LLG G+F V A G A+K+ + +D + TE V++ R
Sbjct: 9 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL-TENRVLQNSR 67
Query: 735 HRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH 794
H L + S +M+Y G L L R R ++ SAL+YLH
Sbjct: 68 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH 126
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV-DPVTQTMTLATIGYMAPEYG 853
+++ DLK N++LD D + DFG+ K +G+ D T T Y+APE
Sbjct: 127 S--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVL 182
Query: 854 SEGIVSISGDVYSFGILMMETFTRRKP 880
+ + D + G++M E R P
Sbjct: 183 EDNDYGRAVDWWGLGVVMYEMMCGRLP 209
>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
pdb|2V55|C Chain C, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe
Complex Structure
Length = 406
Score = 56.6 bits (135), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 61/254 (24%), Positives = 104/254 (40%), Gaps = 30/254 (11%)
Query: 681 GFGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
FGE L+ S VY L + + + D A F E ++M +++
Sbjct: 86 AFGEVQLVRHKSTRKVYAMKLLSKFEMIKR-----SDSAF--FWEERDIMAFANSPWVVQ 138
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ + + + ++M+YMP G L + NY + + +V AL+ +H S
Sbjct: 139 LFYAFQDDRYLYMVMEYMPGGDLVNLM--SNYDVPEKWARFYTAEVVLALDAIH---SMG 193
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEY----GSEG 856
IH D+KP+N+LLD L DFG ++ V + T Y++PE G +G
Sbjct: 194 FIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDG 253
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPGAVTEVVD-ANLLSRE 915
D +S G+ + E P + A+SL G +++++ N L+
Sbjct: 254 YYGRECDWWSVGVFLYEMLVGDTP-------------FYADSLVGTYSKIMNHKNSLTFP 300
Query: 916 DEEDADDFATKKTC 929
D+ D A C
Sbjct: 301 DDNDISKEAKNLIC 314
>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed
With A Specific Inhibitor Of Human P38 Map Kinase
Length = 380
Score = 56.6 bits (135), Expect = 7e-08, Method: Compositional matrix adjust.
Identities = 57/209 (27%), Positives = 95/209 (45%), Gaps = 21/209 (10%)
Query: 692 SFDNVYKATLANGVSVAVKVFN-LQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGF 750
++DNV N V VA+K + + + E +++ R RH N+I I P
Sbjct: 62 AYDNV------NKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTI 115
Query: 751 KALIMQYMPQGSLEKWLYS--HNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKP 808
+ + Y+ + LY L+ + + L+Y+H S ++H DLKP
Sbjct: 116 EQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIH---SANVLHRDLKP 172
Query: 809 NNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE--YGSEGIVSISGDV 864
+N+LL+ + DFG+A++ D T +T +AT Y APE S+G S D+
Sbjct: 173 SNLLLNTTXDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTK-SIDI 231
Query: 865 YSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
+S G ++ E + R +F G+ L Q
Sbjct: 232 WSVGCILAEMLSNRP----IFPGKHYLDQ 256
>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
pdb|3G0F|B Chain B, Kit Kinase Domain Mutant D816h In Complex With Sunitinib
Length = 336
Score = 56.2 bits (134), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 57/233 (24%), Positives = 100/233 (42%), Gaps = 35/233 (15%)
Query: 673 HELQQATNGFGESNLLGSGSFDNVYKATLAN------GVSVAVKVF----NLQEDRALKS 722
H+ + N LG+G+F V +AT ++VAVK+ +L E AL S
Sbjct: 39 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 98
Query: 723 FDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLD 781
E +V+ + H N++ ++ +C+ G +I +Y G L +L S +
Sbjct: 99 ---ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 155
Query: 782 IMI-----------------DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDF 824
++ VA + +L S IH DL N+LL + + DF
Sbjct: 156 AIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDF 212
Query: 825 GIAK-LLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
G+A+ + + + V + + +MAPE + + DV+S+GI + E F+
Sbjct: 213 GLARHIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265
>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib
Length = 336
Score = 56.2 bits (134), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 57/233 (24%), Positives = 100/233 (42%), Gaps = 35/233 (15%)
Query: 673 HELQQATNGFGESNLLGSGSFDNVYKATLAN------GVSVAVKVF----NLQEDRALKS 722
H+ + N LG+G+F V +AT ++VAVK+ +L E AL S
Sbjct: 39 HKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMS 98
Query: 723 FDTECEVMRRI-RHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLD 781
E +V+ + H N++ ++ +C+ G +I +Y G L +L S +
Sbjct: 99 ---ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSP 155
Query: 782 IMI-----------------DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDF 824
++ VA + +L S IH DL N+LL + + DF
Sbjct: 156 AIMEDDELALDLEDLLSFSYQVAKGMAFLA---SKNCIHRDLAARNILLTHGRITKICDF 212
Query: 825 GIAK-LLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
G+A+ + + + V + + +MAPE + + DV+S+GI + E F+
Sbjct: 213 GLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFS 265
>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3CQW|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate
Peptide And Inhibitor
pdb|3MV5|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
pdb|3MVH|A Chain A, Crystal Structure Of Akt-1-Inhibitor Complexes
Length = 342
Score = 56.2 bits (134), Expect = 8e-08, Method: Compositional matrix adjust.
Identities = 58/207 (28%), Positives = 87/207 (42%), Gaps = 12/207 (5%)
Query: 680 NGFGESNLLGSGSFDNV-YKATLANGVSVAVKVFNLQ----EDRALKSFDTECEVMRRIR 734
N F LLG G+F V A G A+K+ + +D + TE V++ R
Sbjct: 10 NEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTL-TENRVLQNSR 68
Query: 735 HRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH 794
H L + S +M+Y G L L R R ++ SAL+YLH
Sbjct: 69 HPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARF-YGAEIVSALDYLH 127
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV-DPVTQTMTLATIGYMAPEYG 853
+++ DLK N++LD D + DFG+ K +G+ D T T Y+APE
Sbjct: 128 S--EKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXFCGTPEYLAPEVL 183
Query: 854 SEGIVSISGDVYSFGILMMETFTRRKP 880
+ + D + G++M E R P
Sbjct: 184 EDNDYGRAVDWWGLGVVMYEMMCGRLP 210
>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution.
pdb|2JED|B Chain B, The Crystal Structure Of The Kinase Domain Of The Protein
Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a
Resolution
Length = 352
Score = 56.2 bits (134), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 59/215 (27%), Positives = 94/215 (43%), Gaps = 16/215 (7%)
Query: 674 ELQQATNGFGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECE-VMR 731
+++ F +LG GSF V+ A A+K L++D L D EC V +
Sbjct: 12 QIKLKIEDFELHKMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEK 69
Query: 732 RI-----RHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYS-HNYSLTIRQRLDIMID 785
R+ H L + + +M+Y+ G L + S H + L+ + +
Sbjct: 70 RVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS--RATFYAAE 127
Query: 786 VASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATI 845
+ L++LH S I++ DLK +N+LLD D + DFG+ K D T T
Sbjct: 128 IILGLQFLH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFC-GTP 183
Query: 846 GYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKP 880
Y+APE + S D +SFG+L+ E + P
Sbjct: 184 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSP 218
>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|2OWB|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like
Kinase 1
pdb|3FC2|A Chain A, Plk1 In Complex With Bi6727
Length = 335
Score = 56.2 bits (134), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 57/238 (23%), Positives = 106/238 (44%), Gaps = 11/238 (4%)
Query: 687 LLGSGSFDNVYKATLANGVSV-AVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G F ++ + A+ V A K+ L + + E + R + H++++
Sbjct: 48 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 107
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPII 802
+ F ++++ + SL + L+ +LT + + + +YLH +I
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 163
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISG 862
H DLK N+ L++D+ +GDFG+A ++ D + + T Y+APE S+ S
Sbjct: 164 HRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKVLCGTPNYIAPEVLSKKGHSFEV 222
Query: 863 DVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAE-SLPGAVTEVVDANLLSREDEED 919
DV+S G +M + P E L+ E S+P + V A+L+ + + D
Sbjct: 223 DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA-ASLIQKMLQTD 279
>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
pdb|4AE9|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2
Length = 343
Score = 56.2 bits (134), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 55/202 (27%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 680 NGFGESNLLGSGSFDNV----YKATLANGVSVAVKVFNLQEDRALKSFD---TECEVMRR 732
+ F LG+GSF V +K T G A+K+ + Q+ LK + E +++
Sbjct: 34 DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 733 IRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEY 792
+ L+K+ S + ++M+Y+P G + L R + EY
Sbjct: 91 VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEY 149
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
LH S +I+ DLKP N+L+D + DFG AK + G +T L T Y+APE
Sbjct: 150 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 201
Query: 852 YGSEGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 202 IILSKGYNKAVDWWALGVLIYE 223
>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 8
pdb|1XH5|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH6|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|1XH8|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
pdb|2GFC|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 56.2 bits (134), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V + G A+K+ + Q+ LK + E +++ +
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---ALEY 792
L+K+ S + ++M+Y+P G + +SH + A EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
LH S +I+ DLKP N+L+D + DFG AK + G +T L T Y+APE
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 852 YGSEGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230
>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl)amide
pdb|2C1B|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With
(4r,2s)-5'-(4-(4-Chlorobenzyloxy)pyrrolidin-2-
Ylmethanesulfonyl)isoquinoline
pdb|2VO7|A Chain A, Structure Of Pka Complexed With 4-(4-Chlorobenzyl)-1-(7h-
Pyrrolo(2,3-D)pyrimidin-4-Yl)piperidin-4-Ylamine
pdb|3AG9|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
pdb|3AG9|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1012
Length = 351
Score = 56.2 bits (134), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V + G A+K+ + Q+ LK + E +++ +
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---ALEY 792
L+K+ S + ++M+Y+P G + +SH + A EY
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
LH S +I+ DLKP N+L+D + DFG AK + G +T L T Y+APE
Sbjct: 158 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 209
Query: 852 YGSEGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 210 IILSKGYNKAVDWWALGVLIYE 231
>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304
Length = 326
Score = 56.2 bits (134), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 17/194 (8%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALK------SFDTECEVMRRIRHRNLIK 740
LGSG F V K + G+ A K + ++ + + E +++ I+H N+I
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ N LI++ + G L +L + SLT + + + + + + YLH S
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH---SLQ 134
Query: 801 IIHCDLKPNNVLLDDDMVA----HLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG 856
I H DLKP N++L D V + DFG+A +D + T ++APE +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYE 192
Query: 857 IVSISGDVYSFGIL 870
+ + D++S G++
Sbjct: 193 PLGLEADMWSIGVI 206
>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In
Complex With Staurosporine
pdb|1Q8T|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase
(Pka) In Complex With Rho-Kinase Inhibitor Y-27632
pdb|1Q8U|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In
Complex With Rho-Kinase Inhibitor H-1152p
pdb|1SVE|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 1
pdb|1SVG|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 4
pdb|1VEB|A Chain A, Crystal Structure Of Protein Kinase A In Complex With
Azepane Derivative 5
pdb|3E8C|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|C Chain C, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|D Chain D, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8C|F Chain F, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp- Competitive Inhibitors
pdb|3E8E|A Chain A, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|B Chain B, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|E Chain E, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|I Chain I, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|L Chain L, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
pdb|3E8E|P Chain P, Crystal Structures Of The Kinase Domain Of Pka In Complex
With Atp-Competitive Inhibitors
Length = 350
Score = 56.2 bits (134), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V + G A+K+ + Q+ LK + E +++ +
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---ALEY 792
L+K+ S + ++M+Y+P G + +SH + A EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
LH S +I+ DLKP N+L+D + DFG AK + G +T L T Y+APE
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 852 YGSEGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230
>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of
Camp-Dependent Protein Kinase And An Inhibitor Peptide
Displays An Open Conformation
Length = 350
Score = 56.2 bits (134), Expect = 9e-08, Method: Compositional matrix adjust.
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 26/205 (12%)
Query: 680 NGFGESNLLGSGSFDNV----YKATLANGVSVAVKVFNLQEDRALKSFD---TECEVMRR 732
+ F LG+GSF V +K T G A+K+ + Q+ LK + E +++
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHKET---GNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 733 IRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---A 789
+ L+K+ S + ++M+Y+P G + +SH + A
Sbjct: 98 VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYM 848
EYLH S +I+ DLKP N+L+D + DFG AK + G +T L T Y+
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYL 205
Query: 849 APEYGSEGIVSISGDVYSFGILMME 873
APE + + D ++ G+L+ E
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYE 230
>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain
Length = 332
Score = 55.8 bits (133), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 40/133 (30%), Positives = 65/133 (48%), Gaps = 18/133 (13%)
Query: 755 MQYMPQGSLEKWLYSHNYSLTIRQR---LDIMIDVASALEYLHHGYSTPIIHCDLKPNNV 811
MQ + +L+ W+ + SL R+ L I I +A A+E+LH S ++H DLKP+N+
Sbjct: 140 MQLCRKENLKDWM-NRRCSLEDREHGVCLHIFIQIAEAVEFLH---SKGLMHRDLKPSNI 195
Query: 812 LLDDDMVAHLGDFGIAKLLDGVDPVTQTMT-----------LATIGYMAPEYGSEGIVSI 860
D V +GDFG+ +D + +T + T YM+PE S
Sbjct: 196 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSH 255
Query: 861 SGDVYSFGILMME 873
D++S G+++ E
Sbjct: 256 KVDIFSLGLILFE 268
>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex
Length = 334
Score = 55.8 bits (133), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 17/194 (8%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALK------SFDTECEVMRRIRHRNLIK 740
LGSG F V K + G+ A K + ++ + + E +++ I+H N+I
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ N LI++ + G L +L + SLT + + + + + + YLH S
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH---SLQ 134
Query: 801 IIHCDLKPNNVLLDDDMVA----HLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG 856
I H DLKP N++L D V + DFG+A +D + T ++APE +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYE 192
Query: 857 IVSISGDVYSFGIL 870
+ + D++S G++
Sbjct: 193 PLGLEADMWSIGVI 206
>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A
Benzolactam-Derived Inhibitor
Length = 333
Score = 55.8 bits (133), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 57/238 (23%), Positives = 106/238 (44%), Gaps = 11/238 (4%)
Query: 687 LLGSGSFDNVYKATLANGVSV-AVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G F ++ + A+ V A K+ L + + E + R + H++++
Sbjct: 46 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 105
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPII 802
+ F ++++ + SL + L+ +LT + + + +YLH +I
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 161
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISG 862
H DLK N+ L++D+ +GDFG+A ++ D + + T Y+APE S+ S
Sbjct: 162 HRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKVLCGTPNYIAPEVLSKKGHSFEV 220
Query: 863 DVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAE-SLPGAVTEVVDANLLSREDEED 919
DV+S G +M + P E L+ E S+P + V A+L+ + + D
Sbjct: 221 DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA-ASLIQKMLQTD 277
>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta
pdb|3ZHP|D Chain D, Human Mst3 (stk24) In Complex With Mo25beta
Length = 294
Score = 55.8 bits (133), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 57/215 (26%), Positives = 86/215 (40%), Gaps = 28/215 (13%)
Query: 682 FGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKI 741
F + +G GSF V+K + N V A+K D E + I +
Sbjct: 29 FTKLEKIGKGSFGEVFKG-IDNRTQKVV---------AIKIIDLEEAEDEIEDIQQEITV 78
Query: 742 VSSCSNPGFKA------------LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASA 789
+S C +P +IM+Y+ GS L T Q I+ ++
Sbjct: 79 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDET--QIATILREILKG 136
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+YLH S IH D+K NVLL + L DFG+A L + + + T +MA
Sbjct: 137 LDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMA 192
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEM 884
PE + D++S GI +E P +E+
Sbjct: 193 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 227
>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
pdb|1CDK|B Chain B, Camp-Dependent Protein Kinase Catalytic Subunit
(E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein
Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24)
Isoelectric Variant Ca) And Mn2+ Adenylyl
Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c
Length = 350
Score = 55.8 bits (133), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 26/205 (12%)
Query: 680 NGFGESNLLGSGSFDNV----YKATLANGVSVAVKVFNLQEDRALKSFD---TECEVMRR 732
+ F LG+GSF V +K T G A+K+ + Q+ LK + E +++
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHKET---GNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 733 IRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---A 789
+ L+K+ S + ++M+Y+P G + +SH + A
Sbjct: 98 VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYM 848
EYLH S +I+ DLKP N+L+D + DFG AK + G +T L T Y+
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYL 205
Query: 849 APEYGSEGIVSISGDVYSFGILMME 873
APE + + D ++ G+L+ E
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYE 230
>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
pdb|3DNE|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With
Pki-5-24
Length = 350
Score = 55.8 bits (133), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V + G A+K+ + Q+ LK + E +++ +
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---ALEY 792
L+K+ S + ++M+Y+P G + +SH + A EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
LH S +I+ DLKP N+L+D + DFG AK + G +T L T Y+APE
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 852 YGSEGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230
>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit
Of Camp- Dependent Protein Kinase Reveal Open And Closed
Conformations
Length = 350
Score = 55.8 bits (133), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 26/205 (12%)
Query: 680 NGFGESNLLGSGSFDNV----YKATLANGVSVAVKVFNLQEDRALKSFD---TECEVMRR 732
+ F LG+GSF V +K T G A+K+ + Q+ LK + E +++
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHKET---GNHFAMKILDKQKVVKLKQIEHTLNEKRILQA 97
Query: 733 IRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---A 789
+ L+K+ S + ++M+Y+P G + +SH + A
Sbjct: 98 VNFPFLVKLEYSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 153
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYM 848
EYLH S +I+ DLKP N+L+D + DFG AK + G +T L T Y+
Sbjct: 154 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYL 205
Query: 849 APEYGSEGIVSISGDVYSFGILMME 873
APE + + D ++ G+L+ E
Sbjct: 206 APEIILSKGYNKAVDWWALGVLIYE 230
>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer
Length = 395
Score = 55.8 bits (133), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 53/216 (24%), Positives = 105/216 (48%), Gaps = 12/216 (5%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALK-SFDTECEVMRRIRHRN 737
+ F + + LG+G+ V+K + +G+ +A K+ +L+ A++ E +V+
Sbjct: 68 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 127
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRL--DIMIDVASALEYLHH 795
++ + + G ++ M++M GSL++ L I +++ + I V L YL
Sbjct: 128 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE 184
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSE 855
+ I+H D+KP+N+L++ L DFG++ L +D + + + T YM+PE
Sbjct: 185 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF-VGTRSYMSPERLQG 239
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSL 891
S+ D++S G+ ++E R P E+ L
Sbjct: 240 THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 275
>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
pdb|1Y8G|B Chain B, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1:
Inactive Double Mutant With Selenomethionine
Length = 327
Score = 55.8 bits (133), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 49/196 (25%), Positives = 80/196 (40%), Gaps = 26/196 (13%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSS 744
+G G+F V A + G VAVK+ + + +L+ E + + + H N++K+
Sbjct: 22 IGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLNHPNIVKLFEV 81
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
L+ +Y G + +L +H R + SA++Y H + I+H
Sbjct: 82 IETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFR-QIVSAVQYCHQKF---IVHR 137
Query: 805 DLKPNNVLLDDDMVAHLGDFGIA------KLLD---GVDPVTQTMTLATIGYMAPEYGSE 855
DLK N+LLD D + DFG + LD G P Y PE
Sbjct: 138 DLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPEV--- 194
Query: 856 GIVSISGDVYSFGILM 871
DV+S G+++
Sbjct: 195 -------DVWSLGVIL 203
>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With
Staurosporine At 2a Resolution
Length = 345
Score = 55.8 bits (133), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 58/203 (28%), Positives = 90/203 (44%), Gaps = 16/203 (7%)
Query: 686 NLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECE-VMRRI-----RHRNL 738
+LG GSF V+ A A+K L++D L D EC V +R+ H L
Sbjct: 23 KMLGKGSFGKVFLAEFKKTNQFFAIKA--LKKDVVLMDDDVECTMVEKRVLSLAWEHPFL 80
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYS-HNYSLTIRQRLDIMIDVASALEYLHHGY 797
+ + +M+Y+ G L + S H + L+ + ++ L++LH
Sbjct: 81 THMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLS--RATFYAAEIILGLQFLH--- 135
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGI 857
S I++ DLK +N+LLD D + DFG+ K D T T Y+APE
Sbjct: 136 SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFC-GTPDYIAPEILLGQK 194
Query: 858 VSISGDVYSFGILMMETFTRRKP 880
+ S D +SFG+L+ E + P
Sbjct: 195 YNHSVDWWSFGVLLYEMLIGQSP 217
>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A
Novel Pyrrolopyrimidine Inhibitor
Length = 359
Score = 55.8 bits (133), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 34/104 (32%), Positives = 54/104 (51%), Gaps = 4/104 (3%)
Query: 774 LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDG 832
LT+ + VA +E+L S IH DL N+LL + V + DFG+A+ +
Sbjct: 190 LTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 246
Query: 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
D V + + +MAPE + + +I DV+SFG+L+ E F+
Sbjct: 247 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 290
>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With
Compound A
Length = 356
Score = 55.8 bits (133), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 34/104 (32%), Positives = 54/104 (51%), Gaps = 4/104 (3%)
Query: 774 LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDG 832
LT+ + VA +E+L S IH DL N+LL + V + DFG+A+ +
Sbjct: 188 LTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 244
Query: 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
D V + + +MAPE + + +I DV+SFG+L+ E F+
Sbjct: 245 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 288
>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632
pdb|2GNL|A Chain A, Pka Threefold Mutant Model Of Rho-Kinase With Inhibitor H-
1152p
Length = 350
Score = 55.5 bits (132), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F +G+GSF V + G A+K+ + Q+ LK + E +++ +
Sbjct: 41 DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---ALEY 792
L+K+ S + ++M+Y+P G + +SH + A EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
LH S +I+ DLKP N+L+D + DFG AK + G +T L T Y+APE
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 852 YGSEGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230
>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN3|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4AN9|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs.
pdb|4ANB|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based
Allosteric Inhibitor Xl518 (Gdc-0973), Or Related
Analogs
Length = 301
Score = 55.5 bits (132), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 53/214 (24%), Positives = 104/214 (48%), Gaps = 12/214 (5%)
Query: 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALK-SFDTECEVMRRIRHRN 737
+ F + + LG+G+ V+K + +G+ +A K+ +L+ A++ E +V+
Sbjct: 9 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 68
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRL--DIMIDVASALEYLHH 795
++ + + G ++ M++M GSL++ L I +++ + I V L YL
Sbjct: 69 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE 125
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSE 855
+ I+H D+KP+N+L++ L DFG++ L +D + + T YM+PE
Sbjct: 126 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDEMANEF-VGTRSYMSPERLQG 180
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEM 889
S+ D++S G+ ++E R P M E+
Sbjct: 181 THYSVQSDIWSMGLSLVEMAVGRYPRPPMAIFEL 214
>pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|B Chain B, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|C Chain C, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|D Chain D, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|E Chain E, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|F Chain F, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|G Chain G, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|H Chain H, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|I Chain I, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|J Chain J, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|K Chain K, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|L Chain L, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|M Chain M, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|N Chain N, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|O Chain O, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|P Chain P, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|Q Chain Q, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|R Chain R, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|S Chain S, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|T Chain T, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|U Chain U, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|V Chain V, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|W Chain W, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
pdb|3MY0|X Chain X, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound
To Ldn- 193189
Length = 305
Score = 55.5 bits (132), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 58/211 (27%), Positives = 99/211 (46%), Gaps = 28/211 (13%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRI--RHRNLIKIVSS- 744
+G G + V++ L +G SVAVK+F+ +++ +S+ E E+ + RH N++ ++S
Sbjct: 16 VGKGRYGEVWRG-LWHGESVAVKIFSSRDE---QSWFRETEIYNTVLLRHDNILGFIASD 71
Query: 745 --CSNPGFK-ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYST- 799
N + LI Y GSL +L +L L + + A L +LH + T
Sbjct: 72 MTSRNSSTQLWLITHYHEHGSLYDFL--QRQTLEPHLALRLAVSAACGLAHLHVEIFGTQ 129
Query: 800 ---PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL----DGVDPVTQTMTLATIGYMAPEY 852
I H D K NVL+ ++ + D G+A + D +D + + T YMAPE
Sbjct: 130 GKPAIAHRDFKSRNVLVKSNLQCCIADLGLAVMHSQGSDYLD-IGNNPRVGTKRYMAPEV 188
Query: 853 GSEGIVSIS------GDVYSFGILMMETFTR 877
E I + D+++FG+++ E R
Sbjct: 189 LDEQIRTDCFESYKWTDIWAFGLVLWEIARR 219
>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
pdb|2V5Q|B Chain B, Crystal Structure Of Wild-type Plk-1 Kinase Domain In
Complex With A Selective Darpin
Length = 315
Score = 55.5 bits (132), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 57/238 (23%), Positives = 105/238 (44%), Gaps = 11/238 (4%)
Query: 687 LLGSGSFDNVYKATLANGVSV-AVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G F ++ + A+ V A K+ L + + E + R + H++++
Sbjct: 28 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 87
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPII 802
+ F ++++ + SL + L+ +LT + + + +YLH +I
Sbjct: 88 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 143
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISG 862
H DLK N+ L++D+ +GDFG+A ++ D + T Y+APE S+ S
Sbjct: 144 HRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKTLCGTPNYIAPEVLSKKGHSFEV 202
Query: 863 DVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAE-SLPGAVTEVVDANLLSREDEED 919
DV+S G +M + P E L+ E S+P + V A+L+ + + D
Sbjct: 203 DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA-ASLIQKMLQTD 259
>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3EQB|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
Length = 333
Score = 55.5 bits (132), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 53/221 (23%), Positives = 107/221 (48%), Gaps = 12/221 (5%)
Query: 675 LQQATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALK-SFDTECEVMRR 732
++ + F + + LG+G+ V+K + +G+ +A K+ +L+ A++ E +V+
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 733 IRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRL--DIMIDVASAL 790
++ + + G ++ M++M GSL++ L I +++ + I V L
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGL 117
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
YL + I+H D+KP+N+L++ L DFG++ L +D + + + T YM+P
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF-VGTRSYMSP 172
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSL 891
E S+ D++S G+ ++E R P E+ L
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELEL 213
>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
Pyrazoloquinazoline Inhibitor
Length = 311
Score = 55.5 bits (132), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 57/238 (23%), Positives = 105/238 (44%), Gaps = 11/238 (4%)
Query: 687 LLGSGSFDNVYKATLANGVSV-AVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G F ++ + A+ V A K+ L + + E + R + H++++
Sbjct: 24 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPII 802
+ F ++++ + SL + L+ +LT + + + +YLH +I
Sbjct: 84 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 139
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISG 862
H DLK N+ L++D+ +GDFG+A ++ D + T Y+APE S+ S
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKTLCGTPNYIAPEVLSKKGHSFEV 198
Query: 863 DVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAE-SLPGAVTEVVDANLLSREDEED 919
DV+S G +M + P E L+ E S+P + V A+L+ + + D
Sbjct: 199 DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA-ASLIQKMLQTD 255
>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4987655 And Mgamp-Pnp
pdb|3OS3|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In
Complex With Ch4858061 And Mgatp
Length = 307
Score = 55.5 bits (132), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 51/210 (24%), Positives = 104/210 (49%), Gaps = 12/210 (5%)
Query: 675 LQQATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALK-SFDTECEVMRR 732
++ + F + + LG+G+ V+K + +G+ +A K+ +L+ A++ E +V+
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 733 IRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRL--DIMIDVASAL 790
++ + + G ++ M++M GSL++ L I +++ + I V L
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGL 117
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
YL + I+H D+KP+N+L++ L DFG++ L +D + + + T YM+P
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF-VGTRSYMSP 172
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKP 880
E S+ D++S G+ ++E R P
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90
Ribosomal S6 Kinase 2: Se-Met Derivative
Length = 342
Score = 55.5 bits (132), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 51/213 (23%), Positives = 95/213 (44%), Gaps = 21/213 (9%)
Query: 677 QATNGFGESNLLGSGSFD----NVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRR 732
Q T+G+ +G GS+ ++KAT AVK+ D++ + E E++ R
Sbjct: 19 QFTDGYEVKEDIGVGSYSVCKRCIHKAT---NXEFAVKII----DKSKRDPTEEIEILLR 71
Query: 733 I-RHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALE 791
+H N+I + + + ++ + G L + + + R+ ++ + +E
Sbjct: 72 YGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKF-FSEREASAVLFTITKTVE 130
Query: 792 YLHHGYSTPIIHCDLKPNNVLLDDD----MVAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
YLH + ++H DLKP+N+L D+ + DFG AK L + + T T +
Sbjct: 131 YLH---AQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLXTPCY-TANF 186
Query: 848 MAPEYGSEGIVSISGDVYSFGILMMETFTRRKP 880
+APE + D++S G+L+ T P
Sbjct: 187 VAPEVLERQGYDAACDIWSLGVLLYTXLTGYTP 219
>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With
Nms-P937
pdb|4A4L|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
5-(2-Amino-Pyrimidin-4-Yl)-1h-Pyrrole Inhibitor
pdb|4A4O|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A
2-
(2-Amino-Pyrimidin-4-Yl)-1,5,6,
7-Tetrahydro-Pyrrolopyridin- 4-One Inhibitor
Length = 311
Score = 55.5 bits (132), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 57/238 (23%), Positives = 105/238 (44%), Gaps = 11/238 (4%)
Query: 687 LLGSGSFDNVYKATLANGVSV-AVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G F ++ + A+ V A K+ L + + E + R + H++++
Sbjct: 24 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 83
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPII 802
+ F ++++ + SL + L+ +LT + + + +YLH +I
Sbjct: 84 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 139
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISG 862
H DLK N+ L++D+ +GDFG+A ++ D + T Y+APE S+ S
Sbjct: 140 HRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKTLCGTPNYIAPEVLSKKGHSFEV 198
Query: 863 DVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAE-SLPGAVTEVVDANLLSREDEED 919
DV+S G +M + P E L+ E S+P + V A+L+ + + D
Sbjct: 199 DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA-ASLIQKMLQTD 255
>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-670
pdb|3L9L|A Chain A, Crystal Structure Of Pka With Compound 36
pdb|3L9L|B Chain B, Crystal Structure Of Pka With Compound 36
pdb|3OOG|A Chain A, Human Camp-Dependent Protein Kinase In Complex With A
Small Fragment
pdb|3OVV|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OWP|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3OXT|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3P0M|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
pdb|3POO|A Chain A, Human Camp-Dependent Protein Kinase In Complex With An
Inhibitor
Length = 351
Score = 55.5 bits (132), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 26/205 (12%)
Query: 680 NGFGESNLLGSGSFDNV----YKATLANGVSVAVKVFNLQEDRALKSFD---TECEVMRR 732
+ F LG+GSF V +K T G A+K+ + Q+ LK + E +++
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 733 IRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---A 789
+ L+K+ S + ++M+Y+P G + +SH + A
Sbjct: 99 VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 154
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYM 848
EYLH S +I+ DLKP N+L+D + DFG AK + G +T L T Y+
Sbjct: 155 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYL 206
Query: 849 APEYGSEGIVSISGDVYSFGILMME 873
APE + + D ++ G+L+ E
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYE 231
>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3DY7|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Complex With Ligand And
Mgatp
pdb|3E8N|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) Complexed With A Potent Inhibitor
Rdea119 And Mgatp
pdb|3V01|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions.
pdb|3V04|A Chain A, Discovery Of Novel Allosteric Mek Inhibitors Possessing
Classical And Non-Classical Bidentate Ser212
Interactions
Length = 341
Score = 55.5 bits (132), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 51/210 (24%), Positives = 104/210 (49%), Gaps = 12/210 (5%)
Query: 675 LQQATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALK-SFDTECEVMRR 732
++ + F + + LG+G+ V+K + +G+ +A K+ +L+ A++ E +V+
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 733 IRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRL--DIMIDVASAL 790
++ + + G ++ M++M GSL++ L I +++ + I V L
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGL 117
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
YL + I+H D+KP+N+L++ L DFG++ L +D + + + T YM+P
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF-VGTRSYMSP 172
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKP 880
E S+ D++S G+ ++E R P
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
pdb|4AE6|B Chain B, Structure And Function Of The Human Sperm-specific Isoform
Of Protein Kinase A (pka) Catalytic Subunit Calpha 2
Length = 343
Score = 55.5 bits (132), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 26/205 (12%)
Query: 680 NGFGESNLLGSGSFDNV----YKATLANGVSVAVKVFNLQEDRALKSFD---TECEVMRR 732
+ F LG+GSF V +K T G A+K+ + Q+ LK + E +++
Sbjct: 34 DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 90
Query: 733 IRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---A 789
+ L+K+ S + ++M+Y+P G + +SH + A
Sbjct: 91 VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 146
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYM 848
EYLH S +I+ DLKP N+L+D + DFG AK + G +T L T Y+
Sbjct: 147 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYL 198
Query: 849 APEYGSEGIVSISGDVYSFGILMME 873
APE + + D ++ G+L+ E
Sbjct: 199 APEIILSKGYNKAVDWWALGVLIYE 223
>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
pdb|3GGF|B Chain B, Crystal Structure Of Human SerineTHREONINE-Protein Kinase
Mst4 In Complex With An Quinazolin
Length = 301
Score = 55.5 bits (132), Expect = 1e-07, Method: Compositional matrix adjust.
Identities = 55/206 (26%), Positives = 89/206 (43%), Gaps = 10/206 (4%)
Query: 682 FGESNLLGSGSFDNVYKATLANGVS--VAVKVFNLQEDRALKSF-DTECEVMRRIRHRNL 738
F + +G GSF V+K + N VA+K+ +L+E E V+ + +
Sbjct: 25 FTKLERIGKGSFGEVFKG-IDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSSYV 83
Query: 739 IKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
K S +IM+Y+ GS L + + Q ++ ++ L+YLH S
Sbjct: 84 TKYYGSYLKGSKLWIIMEYLGGGSALDLLRAGPFDEF--QIATMLKEILKGLDYLH---S 138
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIV 858
IH D+K NVLL + L DFG+A L + + + T +MAPE +
Sbjct: 139 EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMAPEVIQQSAY 197
Query: 859 SISGDVYSFGILMMETFTRRKPTNEM 884
D++S GI +E P ++M
Sbjct: 198 DSKADIWSLGITAIELAKGEPPNSDM 223
>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3AGL|B Chain B, Complex Of Pka With The Bisubstrate Protein Kinase
Inhibitor Arc-1039
pdb|3VQH|A Chain A, Bromine Sad Partially Resolves Multiple Binding Modes For
Pka Inhibitor H-89
Length = 351
Score = 55.5 bits (132), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 26/205 (12%)
Query: 680 NGFGESNLLGSGSFDNV----YKATLANGVSVAVKVFNLQEDRALKSFD---TECEVMRR 732
+ F LG+GSF V +K T G A+K+ + Q+ LK + E +++
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 733 IRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---A 789
+ L+K+ S + ++M+Y+P G + +SH + A
Sbjct: 99 VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 154
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYM 848
EYLH S +I+ DLKP N+L+D + DFG AK + G +T L T Y+
Sbjct: 155 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYL 206
Query: 849 APEYGSEGIVSISGDVYSFGILMME 873
APE + + D ++ G+L+ E
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYE 231
>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp
pdb|3PP1|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgatp
Length = 328
Score = 55.5 bits (132), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 51/210 (24%), Positives = 104/210 (49%), Gaps = 12/210 (5%)
Query: 675 LQQATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALK-SFDTECEVMRR 732
++ + F + + LG+G+ V+K + +G+ +A K+ +L+ A++ E +V+
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 733 IRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRL--DIMIDVASAL 790
++ + + G ++ M++M GSL++ L I +++ + I V L
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGL 117
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
YL + I+H D+KP+N+L++ L DFG++ L +D + + + T YM+P
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF-VGTRSYMSP 172
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKP 880
E S+ D++S G+ ++E R P
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound
Length = 322
Score = 55.5 bits (132), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 51/210 (24%), Positives = 104/210 (49%), Gaps = 12/210 (5%)
Query: 675 LQQATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALK-SFDTECEVMRR 732
++ + F + + LG+G+ V+K + +G+ +A K+ +L+ A++ E +V+
Sbjct: 1 MELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHE 60
Query: 733 IRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRL--DIMIDVASAL 790
++ + + G ++ M++M GSL++ L I +++ + I V L
Sbjct: 61 CNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGL 117
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
YL + I+H D+KP+N+L++ L DFG++ L +D + + + T YM+P
Sbjct: 118 TYLREKHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF-VGTRSYMSP 172
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKP 880
E S+ D++S G+ ++E R P
Sbjct: 173 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYP 202
>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With
Bound Inhibitor Fragment
Length = 293
Score = 55.5 bits (132), Expect = 2e-07, Method: Composition-based stats.
Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 17/194 (8%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALK------SFDTECEVMRRIRHRNLIK 740
LGSG F V K + G+ A K + ++ + + E +++ I+H N+I
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ N LI++ + G L +L + SLT + + + + + + YLH S
Sbjct: 78 LHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH---SLQ 133
Query: 801 IIHCDLKPNNVLLDDDMVA----HLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG 856
I H DLKP N++L D V + DFG+A +D + T ++APE +
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYE 191
Query: 857 IVSISGDVYSFGIL 870
+ + D++S G++
Sbjct: 192 PLGLEADMWSIGVI 205
>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mn.
pdb|1JKL|A Chain A, 1.6a X-Ray Structure Of Binary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue
pdb|1JKS|A Chain A, 1.5a X-Ray Structure Of Apo Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|A Chain A, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKT|B Chain B, Tetragonal Crystal Form Of A Catalytic Domain Of
Death-Associated Protein Kinase
pdb|1JKK|A Chain A, 2.4a X-Ray Structure Of Ternary Complex Of A Catalytic
Domain Of Death-Associated Protein Kinase With Atp
Analogue And Mg.
pdb|3F5G|A Chain A, Crystal Structure Of Death Associated Protein Kinase In
Complex With Adp And Mg2+
pdb|3EH9|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Adp
pdb|3EHA|A Chain A, Crystal Structure Of Death Associated Protein Kinase
Complexed With Amppnp
Length = 294
Score = 55.5 bits (132), Expect = 2e-07, Method: Composition-based stats.
Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 17/194 (8%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALK------SFDTECEVMRRIRHRNLIK 740
LGSG F V K + G+ A K + ++ + + E +++ I+H N+I
Sbjct: 18 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 77
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ N LI++ + G L +L + SLT + + + + + + YLH S
Sbjct: 78 LHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH---SLQ 133
Query: 801 IIHCDLKPNNVLLDDDMVA----HLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG 856
I H DLKP N++L D V + DFG+A +D + T ++APE +
Sbjct: 134 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYE 191
Query: 857 IVSISGDVYSFGIL 870
+ + D++S G++
Sbjct: 192 PLGLEADMWSIGVI 205
>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312
pdb|2XZS|B Chain B, Death Associated Protein Kinase 1 Residues 1-312
Length = 312
Score = 55.5 bits (132), Expect = 2e-07, Method: Composition-based stats.
Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 17/194 (8%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALK------SFDTECEVMRRIRHRNLIK 740
LGSG F V K + G+ A K + ++ + + E +++ I+H N+I
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ N LI++ + G L +L + SLT + + + + + + YLH S
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH---SLQ 134
Query: 801 IIHCDLKPNNVLLDDDMVA----HLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG 856
I H DLKP N++L D V + DFG+A +D + T ++APE +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYE 192
Query: 857 IVSISGDVYSFGIL 870
+ + D++S G++
Sbjct: 193 PLGLEADMWSIGVI 206
>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In
Complex With A Ruthenium Octasporine Ligand (Osv)
pdb|2Y4P|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|2Y4P|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain
pdb|3ZXT|A Chain A, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|B Chain B, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|C Chain C, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
pdb|3ZXT|D Chain D, Dimeric Structure Of Dapk-1 Catalytic Domain In Complex
With Amppcp-Mg
Length = 285
Score = 55.5 bits (132), Expect = 2e-07, Method: Composition-based stats.
Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 17/194 (8%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALK------SFDTECEVMRRIRHRNLIK 740
LGSG F V K + G+ A K + ++ + + E +++ I+H N+I
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ N LI++ + G L +L + SLT + + + + + + YLH S
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH---SLQ 134
Query: 801 IIHCDLKPNNVLLDDDMVA----HLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG 856
I H DLKP N++L D V + DFG+A +D + T ++APE +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYE 192
Query: 857 IVSISGDVYSFGIL 870
+ + D++S G++
Sbjct: 193 PLGLEADMWSIGVI 206
>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302
Length = 302
Score = 55.5 bits (132), Expect = 2e-07, Method: Composition-based stats.
Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 17/194 (8%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALK------SFDTECEVMRRIRHRNLIK 740
LGSG F V K + G+ A K + ++ + + E +++ I+H N+I
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ N LI++ + G L +L + SLT + + + + + + YLH S
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH---SLQ 134
Query: 801 IIHCDLKPNNVLLDDDMVA----HLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG 856
I H DLKP N++L D V + DFG+A +D + T ++APE +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYE 192
Query: 857 IVSISGDVYSFGIL 870
+ + D++S G++
Sbjct: 193 PLGLEADMWSIGVI 206
>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277
Length = 277
Score = 55.5 bits (132), Expect = 2e-07, Method: Composition-based stats.
Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 17/194 (8%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALK------SFDTECEVMRRIRHRNLIK 740
LGSG F V K + G+ A K + ++ + + E +++ I+H N+I
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ N LI++ + G L +L + SLT + + + + + + YLH S
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH---SLQ 134
Query: 801 IIHCDLKPNNVLLDDDMVA----HLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG 856
I H DLKP N++L D V + DFG+A +D + T ++APE +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYE 192
Query: 857 IVSISGDVYSFGIL 870
+ + D++S G++
Sbjct: 193 PLGLEADMWSIGVI 206
>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase
In Complex With Amppnp And Mg2+
Length = 295
Score = 55.5 bits (132), Expect = 2e-07, Method: Composition-based stats.
Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 17/194 (8%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALK------SFDTECEVMRRIRHRNLIK 740
LGSG F V K + G+ A K + ++ + + E +++ I+H N+I
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ N LI++ + G L +L + SLT + + + + + + YLH S
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH---SLQ 134
Query: 801 IIHCDLKPNNVLLDDDMVA----HLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG 856
I H DLKP N++L D V + DFG+A +D + T ++APE +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYE 192
Query: 857 IVSISGDVYSFGIL 870
+ + D++S G++
Sbjct: 193 PLGLEADMWSIGVI 206
>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVX|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
pdb|1WVY|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In
Complex With Small Molecular Inhibitors
Length = 278
Score = 55.5 bits (132), Expect = 2e-07, Method: Composition-based stats.
Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 17/194 (8%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALK------SFDTECEVMRRIRHRNLIK 740
LGSG F V K + G+ A K + ++ + + E +++ I+H N+I
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ N LI++ + G L +L + SLT + + + + + + YLH S
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH---SLQ 134
Query: 801 IIHCDLKPNNVLLDDDMVA----HLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG 856
I H DLKP N++L D V + DFG+A +D + T ++APE +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYE 192
Query: 857 IVSISGDVYSFGIL 870
+ + D++S G++
Sbjct: 193 PLGLEADMWSIGVI 206
>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
pdb|1Y6B|A Chain A, Crystal Structure Of Vegfr2 In Complex With A
2-Anilino-5-Aryl-Oxazole Inhibitor
Length = 366
Score = 55.5 bits (132), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 34/104 (32%), Positives = 54/104 (51%), Gaps = 4/104 (3%)
Query: 774 LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDG 832
LT+ + VA +E+L S IH DL N+LL + V + DFG+A+ +
Sbjct: 195 LTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 251
Query: 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
D V + + +MAPE + + +I DV+SFG+L+ E F+
Sbjct: 252 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 295
>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex
With A Back Pocket Binder
Length = 368
Score = 55.5 bits (132), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 34/104 (32%), Positives = 54/104 (51%), Gaps = 4/104 (3%)
Query: 774 LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK-LLDG 832
LT+ + VA +E+L S IH DL N+LL + V + DFG+A+ +
Sbjct: 197 LTLEHLICYSFQVAKGMEFLA---SRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKD 253
Query: 833 VDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
D V + + +MAPE + + +I DV+SFG+L+ E F+
Sbjct: 254 PDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFS 297
>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol
Length = 351
Score = 55.5 bits (132), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 26/205 (12%)
Query: 680 NGFGESNLLGSGSFDNV----YKATLANGVSVAVKVFNLQEDRALKSFD---TECEVMRR 732
+ F LG+GSF V +K T G A+K+ + Q+ LK + E +++
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 733 IRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---A 789
+ L+K+ S + ++M+Y+P G + +SH + A
Sbjct: 99 VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 154
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYM 848
EYLH S +I+ DLKP N+L+D + DFG AK + G +T L T Y+
Sbjct: 155 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYL 206
Query: 849 APEYGSEGIVSISGDVYSFGILMME 873
APE + + D ++ G+L+ E
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYE 231
>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain With
Amppnp
pdb|3DGK|A Chain A, Crystal Structure Of A Glycine-Rich Loop Mutant Of The
Death Associated Protein Kinase Catalytic Domain
Length = 295
Score = 55.5 bits (132), Expect = 2e-07, Method: Composition-based stats.
Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 17/194 (8%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALK------SFDTECEVMRRIRHRNLIK 740
LGSG F V K + G+ A K + ++ + + E +++ I+H N+I
Sbjct: 19 LGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ N LI++ + G L +L + SLT + + + + + + YLH S
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH---SLQ 134
Query: 801 IIHCDLKPNNVLLDDDMVA----HLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG 856
I H DLKP N++L D V + DFG+A +D + T ++APE +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYE 192
Query: 857 IVSISGDVYSFGIL 870
+ + D++S G++
Sbjct: 193 PLGLEADMWSIGVI 206
>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|B Chain B, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
pdb|3MVJ|E Chain E, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor
Complex
Length = 371
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 26/205 (12%)
Query: 680 NGFGESNLLGSGSFDNV----YKATLANGVSVAVKVFNLQEDRALKSFD---TECEVMRR 732
+ F LG+GSF V +K T G A+K+ + Q+ LK + E +++
Sbjct: 62 DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 118
Query: 733 IRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---A 789
+ L+K+ S + ++M+Y+P G + +SH + A
Sbjct: 119 VNFPFLVKLEFSFKDNSNLYMVMEYVPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 174
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYM 848
EYLH S +I+ DLKP N+L+D + DFG AK + G +T L T Y+
Sbjct: 175 FEYLH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYL 226
Query: 849 APEYGSEGIVSISGDVYSFGILMME 873
APE + + D ++ G+L+ E
Sbjct: 227 APEIILSKGYNKAVDWWALGVLIYE 251
>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered
N- Terminal Helix
pdb|1XHA|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V + G A+K+ + Q+ LK + E +++ +
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---ALEY 792
L+K+ S + ++M+Y P G + +SH + A EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
LH S +I+ DLKP N+++D + DFG+AK + G +T L T Y+APE
Sbjct: 157 LH---SLDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 852 YGSEGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230
>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik)
pdb|4DN5|B Chain B, Crystal Structure Of Nf-kb-inducing Kinase (nik)
Length = 356
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 71/252 (28%), Positives = 102/252 (40%), Gaps = 18/252 (7%)
Query: 649 RKRNKSLPEENNSLNLAT--LSRISYHELQQATNGFGESNLLGSGSFDNVYK-ATLANGV 705
R R S E+N L T L + Y E ++ + LG GSF V++ G
Sbjct: 42 RSREPSPKTEDNEGVLLTEKLKPVDY-EYREEVHWATHQLRLGRGSFGEVHRMEDKQTGF 100
Query: 706 SVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEK 765
AVK L+ RA + C + R ++ + + + + M+ + GSL +
Sbjct: 101 QCAVKKVRLEVFRAEELM--ACAGLTSPR---IVPLYGAVREGPWVNIFMELLEGGSLGQ 155
Query: 766 WLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMV-AHLGDF 824
L L + L + LEYLH S I+H D+K +NVLL D A L DF
Sbjct: 156 -LVKEQGCLPEDRALYYLGQALEGLEYLH---SRRILHGDVKADNVLLSSDGSHAALCDF 211
Query: 825 GIAKLLD----GVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKP 880
G A L G D +T T +MAPE DV+S +M+ P
Sbjct: 212 GHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 271
Query: 881 TNEMFTGEMSLK 892
+ F G + LK
Sbjct: 272 WTQFFRGPLCLK 283
>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain
pdb|3RNY|B Chain B, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain
Length = 346
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 21/202 (10%)
Query: 679 TNGFGESNLLGSGSFDN----VYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRI- 733
++G+ +G GS+ V+KAT + AVKV D++ + E E++ R
Sbjct: 26 SDGYVVKETIGVGSYSECKRCVHKAT---NMEYAVKVI----DKSKRDPSEEIEILLRYG 78
Query: 734 RHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYL 793
+H N+I + + L+ + M G L + + + R+ ++ + +EYL
Sbjct: 79 QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF-FSEREASFVLHTIGKTVEYL 137
Query: 794 HHGYSTPIIHCDLKPNNVLLDDD----MVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
H S ++H DLKP+N+L D+ + DFG AK L + + T T ++A
Sbjct: 138 H---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMT-PCYTANFVA 193
Query: 850 PEYGSEGIVSISGDVYSFGILM 871
PE D++S GIL+
Sbjct: 194 PEVLKRQGYDEGCDIWSLGILL 215
>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With
Compound 1, Atp-Gs And Mg2p
pdb|3EQD|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Atp-Gs
And Mg2p
pdb|3EQF|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With K252a
And Mg2p
pdb|3EQG|A Chain A, X-ray Structure Of The Human Mitogen-activated Protein
Kinase Kinase 1 (mek1) In A Ternary Complex With Pd, Adp
And Mg2p
pdb|3EQH|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Ternary Complex With U0126,
Adp And Mg2p
pdb|3EQI|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 1 (Mek1) In A Binary Complex With Adp And
Mg2p
Length = 360
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 51/205 (24%), Positives = 102/205 (49%), Gaps = 12/205 (5%)
Query: 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALK-SFDTECEVMRRIRHRN 737
+ F + + LG+G+ V+K + +G+ +A K+ +L+ A++ E +V+
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRL--DIMIDVASALEYLHH 795
++ + + G ++ M++M GSL++ L I +++ + I V L YL
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE 149
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSE 855
+ I+H D+KP+N+L++ L DFG++ L +D + + + T YM+PE
Sbjct: 150 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF-VGTRSYMSPERLQG 204
Query: 856 GIVSISGDVYSFGILMMETFTRRKP 880
S+ D++S G+ ++E R P
Sbjct: 205 THYSVQSDIWSMGLSLVEMAVGRYP 229
>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680
Length = 292
Score = 55.1 bits (131), Expect = 2e-07, Method: Composition-based stats.
Identities = 53/198 (26%), Positives = 89/198 (44%), Gaps = 13/198 (6%)
Query: 688 LGSGSFDNVYKATLANG-VSVAVKVF---NLQEDRALKSFDTECEVMRRIRHRNLIKIVS 743
LG G F NVY A VA+KV ++++ E E+ + H N++++ +
Sbjct: 31 LGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLHHPNILRLYN 90
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
+ LI++Y P+G L K L + + ++ IM ++A AL Y H +IH
Sbjct: 91 YFYDRRRIYLILEYAPRGELYKEL-QKSCTFDEQRTATIMEELADALMYCH---GKKVIH 146
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGSEGIVSISG 862
D+KP N+LL + DFG + P + T+ T+ Y+ PE + +
Sbjct: 147 RDIKPENLLLGLKGELKIADFGWSVHA----PSLRRKTMCGTLDYLPPEMIEGRMHNEKV 202
Query: 863 DVYSFGILMMETFTRRKP 880
D++ G+L E P
Sbjct: 203 DLWCIGVLCYELLVGNPP 220
>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
pdb|2ACX|B Chain B, Crystal Structure Of G Protein Coupled Receptor Kinase 6
Bound To Amppnp
Length = 576
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 64/258 (24%), Positives = 107/258 (41%), Gaps = 26/258 (10%)
Query: 660 NSLNLATLSRISYHELQQAT-NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ-- 715
+S+ + + E Q T N F + +LG G F V + A G A K +
Sbjct: 163 DSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI 222
Query: 716 -----EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSH 770
E AL E +++ ++ R ++ + + L++ M G L+ +Y
Sbjct: 223 KKRKGEAMAL----NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM 278
Query: 771 NYSLTIRQR-LDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829
+ R + ++ LE LH I++ DLKP N+LLDD + D G+A
Sbjct: 279 GQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVH 335
Query: 830 LDGVDPVTQTMT--LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTG 887
+ P QT+ + T+GYMAPE + S D ++ G L+ E + P +
Sbjct: 336 V----PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR--- 388
Query: 888 EMSLKQWVAESLPGAVTE 905
+ +K+ E L V E
Sbjct: 389 KKKIKREEVERLVKEVPE 406
>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
pdb|1SZM|B Chain B, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein
Kinase A (Pka)
Length = 350
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 52/199 (26%), Positives = 87/199 (43%), Gaps = 14/199 (7%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V + G A+K+ + Q+ LK + E +++ +
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
L+K+ S + ++M+Y P G + L R + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGS 854
S +I+ DLKP N+++D + DFG AK + G +T L T Y+APE
Sbjct: 159 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIIL 211
Query: 855 EGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230
>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYN|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Sangivamycin
pdb|3NYO|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
pdb|3NYO|B Chain B, Crystal Structure Of G Protein-Coupled Receptor Kinase 6
In Complex With Amp
Length = 576
Score = 55.1 bits (131), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 64/258 (24%), Positives = 107/258 (41%), Gaps = 26/258 (10%)
Query: 660 NSLNLATLSRISYHELQQAT-NGFGESNLLGSGSFDNVYKATL-ANGVSVAVKVFNLQ-- 715
+S+ + + E Q T N F + +LG G F V + A G A K +
Sbjct: 163 DSIYFNRFLQWKWLERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRI 222
Query: 716 -----EDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSH 770
E AL E +++ ++ R ++ + + L++ M G L+ +Y
Sbjct: 223 KKRKGEAMAL----NEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHM 278
Query: 771 NYSLTIRQR-LDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKL 829
+ R + ++ LE LH I++ DLKP N+LLDD + D G+A
Sbjct: 279 GQAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVH 335
Query: 830 LDGVDPVTQTMT--LATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTG 887
+ P QT+ + T+GYMAPE + S D ++ G L+ E + P +
Sbjct: 336 V----PEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR--- 388
Query: 888 EMSLKQWVAESLPGAVTE 905
+ +K+ E L V E
Sbjct: 389 KKKIKREEVERLVKEVPE 406
>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
pdb|3SLS|B Chain B, Crystal Structure Of Human Mek-1 Kinase In Complex With
Ucb1353770 And Amppnp
Length = 304
Score = 54.7 bits (130), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 51/205 (24%), Positives = 102/205 (49%), Gaps = 12/205 (5%)
Query: 680 NGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALK-SFDTECEVMRRIRHRN 737
+ F + + LG+G+ V+K + +G+ +A K+ +L+ A++ E +V+
Sbjct: 25 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 84
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRL--DIMIDVASALEYLHH 795
++ + + G ++ M++M GSL++ L I +++ + I V L YL
Sbjct: 85 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG---RIPEQILGKVSIAVIKGLTYLRE 141
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSE 855
+ I+H D+KP+N+L++ L DFG++ L +D + + + T YM+PE
Sbjct: 142 KHK--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF-VGTRSYMSPERLQG 196
Query: 856 GIVSISGDVYSFGILMMETFTRRKP 880
S+ D++S G+ ++E R P
Sbjct: 197 THYSVQSDIWSMGLSLVEMAVGRYP 221
>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24)
Length = 304
Score = 54.7 bits (130), Expect = 2e-07, Method: Composition-based stats.
Identities = 57/215 (26%), Positives = 86/215 (40%), Gaps = 28/215 (13%)
Query: 682 FGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKI 741
F + +G GSF V+K + N V A+K D E + I +
Sbjct: 9 FTKLEKIGKGSFGEVFKG-IDNRTQKVV---------AIKIIDLEEAEDEIEDIQQEITV 58
Query: 742 VSSCSNPGFKA------------LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASA 789
+S C +P +IM+Y+ GS L T Q I+ ++
Sbjct: 59 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDET--QIATILREILKG 116
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+YLH S IH D+K NVLL + L DFG+A L + + + T +MA
Sbjct: 117 LDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNTFVGTPFWMA 172
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEM 884
PE + D++S GI +E P +E+
Sbjct: 173 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207
>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3,
Stk24) In Complex With Staurosporine
Length = 304
Score = 54.7 bits (130), Expect = 2e-07, Method: Composition-based stats.
Identities = 57/215 (26%), Positives = 86/215 (40%), Gaps = 28/215 (13%)
Query: 682 FGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKI 741
F + +G GSF V+K + N V A+K D E + I +
Sbjct: 9 FTKLEKIGKGSFGEVFKG-IDNRTQKVV---------AIKIIDLEEAEDEIEDIQQEITV 58
Query: 742 VSSCSNPGFKA------------LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASA 789
+S C +P +IM+Y+ GS L T Q I+ ++
Sbjct: 59 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDET--QIATILREILKG 116
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+YLH S IH D+K NVLL + L DFG+A L + + + T +MA
Sbjct: 117 LDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNXFVGTPFWMA 172
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEM 884
PE + D++S GI +E P +E+
Sbjct: 173 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 207
>pdb|3A7F|A Chain A, Human Mst3 Kinase
pdb|3A7G|A Chain A, Human Mst3 Kinase
pdb|3A7G|B Chain B, Human Mst3 Kinase
pdb|3A7H|A Chain A, Human Mst3 Kinase In Complex With Atp
pdb|3A7H|B Chain B, Human Mst3 Kinase In Complex With Atp
pdb|3A7I|A Chain A, Human Mst3 Kinase In Complex With Adenine
pdb|3A7J|A Chain A, Human Mst3 Kinase In Complex With Mnadp
Length = 303
Score = 54.7 bits (130), Expect = 2e-07, Method: Composition-based stats.
Identities = 57/215 (26%), Positives = 86/215 (40%), Gaps = 28/215 (13%)
Query: 682 FGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKI 741
F + +G GSF V+K + N V A+K D E + I +
Sbjct: 24 FTKLEKIGKGSFGEVFKG-IDNRTQKVV---------AIKIIDLEEAEDEIEDIQQEITV 73
Query: 742 VSSCSNPGFKA------------LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASA 789
+S C +P +IM+Y+ GS L T Q I+ ++
Sbjct: 74 LSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGPLDET--QIATILREILKG 131
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+YLH S IH D+K NVLL + L DFG+A L + + + T +MA
Sbjct: 132 LDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ-IKRNXFVGTPFWMA 187
Query: 850 PEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEM 884
PE + D++S GI +E P +E+
Sbjct: 188 PEVIKQSAYDSKADIWSLGITAIELARGEPPHSEL 222
>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective
Inhibitors In Complex With Protein Kinase A And Mutants
Length = 350
Score = 54.7 bits (130), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V + G A+K+ + Q+ LK + E +++ +
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVNF 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---ALEY 792
L+K+ S + ++M+Y P G + +SH + A EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
LH S +I+ DLKP N+++D + DFG+AK + G +T L T Y+APE
Sbjct: 157 LH---SLDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 852 YGSEGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230
>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp
pdb|1Q62|A Chain A, Pka Double Mutant Model Of Pkb
Length = 350
Score = 54.7 bits (130), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V + G A+K+ + Q+ LK + E +++ +
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---ALEY 792
L+K+ S + ++M+Y P G + +SH + A EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
LH S +I+ DLKP N+++D + DFG AK + G +T L T Y+APE
Sbjct: 157 LH---SLDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 852 YGSEGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230
>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase
pdb|2WNT|B Chain B, Crystal Structure Of The Human Ribosomal Protein S6 Kinase
Length = 330
Score = 54.7 bits (130), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 53/202 (26%), Positives = 92/202 (45%), Gaps = 21/202 (10%)
Query: 679 TNGFGESNLLGSGSFDN----VYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRI- 733
++G+ +G GS+ V+KAT + AVKV D++ + E E++ R
Sbjct: 26 SDGYVVKETIGVGSYSECKRCVHKAT---NMEYAVKVI----DKSKRDPSEEIEILLRYG 78
Query: 734 RHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYL 793
+H N+I + + L+ + M G L + + + R+ ++ + +EYL
Sbjct: 79 QHPNIITLKDVYDDGKHVYLVTELMRGGELLDKILRQKF-FSEREASFVLHTIGKTVEYL 137
Query: 794 HHGYSTPIIHCDLKPNNVLLDDD----MVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
H S ++H DLKP+N+L D+ + DFG AK L + + T T ++A
Sbjct: 138 H---SQGVVHRDLKPSNILYVDESGNPECLRICDFGFAKQLRAENGLLMT-PCYTANFVA 193
Query: 850 PEYGSEGIVSISGDVYSFGILM 871
PE D++S GIL+
Sbjct: 194 PEVLKRQGYDEGCDIWSLGILL 215
>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3PP0|B Chain B, Crystal Structure Of The Kinase Domain Of Human Her2
(Erbb2).
pdb|3RCD|A Chain A, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|B Chain B, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|C Chain C, Her2 Kinase Domain Complexed With Tak-285
pdb|3RCD|D Chain D, Her2 Kinase Domain Complexed With Tak-285
Length = 338
Score = 54.7 bits (130), Expect = 2e-07, Method: Compositional matrix adjust.
Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 19/202 (9%)
Query: 686 NLLGSGSFDNVYKATL---ANGVSVAVKVFNLQED---RALKSFDTECEVMRRIRHRNLI 739
+LGSG+F VYK V + V + L+E+ +A K E VM + +
Sbjct: 23 KVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVS 82
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
+++ C + L+ Q MP G L + + L + L+ + +A + YL
Sbjct: 83 RLLGICLTSTVQ-LVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQIAKGMSYLE---DV 138
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLAT-----IGYMAPEYGS 854
++H DL NVL+ + DFG+A+LLD + +T A I +MA E
Sbjct: 139 RLVHRDLAARNVLVKSPNHVKITDFGLARLLD----IDETEYHADGGKVPIKWMALESIL 194
Query: 855 EGIVSISGDVYSFGILMMETFT 876
+ DV+S+G+ + E T
Sbjct: 195 RRRFTHQSDVWSYGVTVWELMT 216
>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp
pdb|3GU5|A Chain A, Crystal Structure Of Dapkq23v-Amppnp-Mg2+
pdb|3GU6|A Chain A, Crystal Structure Of Dapkq23v-Adp
pdb|3GU7|A Chain A, Crystal Structure Of Dapkq23v-Adp-Mg2+
Length = 295
Score = 54.7 bits (130), Expect = 2e-07, Method: Composition-based stats.
Identities = 50/194 (25%), Positives = 89/194 (45%), Gaps = 17/194 (8%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALK------SFDTECEVMRRIRHRNLIK 740
LGSG F V K + G+ A K + ++ + + E +++ I+H N+I
Sbjct: 19 LGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ N LI++ + G L +L + SLT + + + + + + YLH S
Sbjct: 79 LHEVYENKTDVILILELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH---SLQ 134
Query: 801 IIHCDLKPNNVLLDDDMVA----HLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG 856
I H DLKP N++L D V + DFG+A +D + T ++APE +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYE 192
Query: 857 IVSISGDVYSFGIL 870
+ + D++S G++
Sbjct: 193 PLGLEADMWSIGVI 206
>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin
Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin
Length = 330
Score = 54.7 bits (130), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 36/215 (16%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRI--RHRNLIKIVSSC 745
+G G + V++ + G +VAVK+F+ +++ KS+ E E+ + RH N++ ++S
Sbjct: 45 VGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASD 100
Query: 746 SNPGFKA----LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYST- 799
+ LI Y GSL +L +L L I++ +AS L +LH + T
Sbjct: 101 MTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 158
Query: 800 ---PIIHCDLKPNNVLLDDDMVAHLGDFGIAKL-------LD-GVDPVTQTMTLATIGYM 848
I H DLK N+L+ + + D G+A + LD G +P + T YM
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP-----RVGTKRYM 213
Query: 849 APEYGSEGIV------SISGDVYSFGILMMETFTR 877
APE E I D+++FG+++ E R
Sbjct: 214 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 248
>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb
Length = 350
Score = 54.3 bits (129), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V + G A+K+ + Q+ LK + E +++ +
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---ALEY 792
L+K+ S + ++M+Y P G + +SH + A EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
LH S +I+ DLKP N+++D + DFG AK + G +T L T Y+APE
Sbjct: 157 LH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 852 YGSEGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230
>pdb|3SOA|A Chain A, Full-Length Human Camkii
Length = 444
Score = 54.3 bits (129), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 45/190 (23%), Positives = 84/190 (44%), Gaps = 11/190 (5%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSS 744
LG G+F V + + G A + N ++ R + + E + R ++H N++++ S
Sbjct: 19 LGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLKHPNIVRLHDS 78
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
S G LI + G L + + + Y D + LE + H + ++H
Sbjct: 79 ISEEGHHYLIFDLVTGGELFEDIVAREYY----SEADASHCIQQILEAVLHCHQMGVVHR 134
Query: 805 DLKPNNVLLDDDM---VAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSIS 861
+LKP N+LL + L DFG+A ++G T GY++PE +
Sbjct: 135 NLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFA-GTPGYLSPEVLRKDPYGKP 193
Query: 862 GDVYSFGILM 871
D+++ G+++
Sbjct: 194 VDLWACGVIL 203
>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1
Reveals A Novel Autoinhibitory Conformation For A Dual
Kinase Protein
Length = 355
Score = 54.3 bits (129), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 56/209 (26%), Positives = 93/209 (44%), Gaps = 21/209 (10%)
Query: 686 NLLGSGSFDNVYKATLANGVSV----AVKVFN----LQEDRALKSFDTECEVMRRIRHRN 737
+LG+G++ V+ +G A+KV +Q+ + + TE +V+ IR
Sbjct: 60 KVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSP 119
Query: 738 LIKIVSSCSNPGFK-ALIMQYMPQGSLEKWLYSHNYSLTIRQRL---DIMIDVASALEYL 793
+ + K LI+ Y+ G L ++H L+ R+R ++ I V + L
Sbjct: 120 FLVTLHYAFQTETKLHLILDYINGGEL----FTH---LSQRERFTEHEVQIYVGEIVLAL 172
Query: 794 HHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE-- 851
H + II+ D+K N+LLD + L DFG++K + TI YMAP+
Sbjct: 173 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIV 232
Query: 852 YGSEGIVSISGDVYSFGILMMETFTRRKP 880
G + + D +S G+LM E T P
Sbjct: 233 RGGDSGHDKAVDWWSLGVLMYELLTGASP 261
>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
pdb|1H4L|B Chain B, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex
Length = 292
Score = 54.3 bits (129), Expect = 3e-07, Method: Compositional matrix adjust.
Identities = 48/198 (24%), Positives = 94/198 (47%), Gaps = 11/198 (5%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDR--ALKSFDTECEVMRRIRHRNLIKIVSS 744
+G G++ V+KA VA+K L +D S E +++ ++H+N++++
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
+ L+ ++ Q L+K+ S N L + + L + H S ++H
Sbjct: 70 LHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHR 125
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSEGIVSISG 862
DLKP N+L++ + L DFG+A+ G+ + + T+ Y P+ +G++ + S S
Sbjct: 126 DLKPQNLLINRNGELKLADFGLARAF-GIPVRCYSAEVVTLWYRPPDVLFGAK-LYSTSI 183
Query: 863 DVYSFGILMMETFTRRKP 880
D++S G + E +P
Sbjct: 184 DMWSAGCIFAELANAARP 201
>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3MTF|B Chain B, Crystal Structure Of The Acvr1 Kinase In Complex With A 2-
Aminopyridine Inhibitor
pdb|3OOM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00507
pdb|3Q4U|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|B Chain B, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|C Chain C, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
pdb|3Q4U|D Chain D, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With Ldn- 193189
Length = 301
Score = 54.3 bits (129), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 36/215 (16%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRI--RHRNLIKIVSSC 745
+G G + V++ + G +VAVK+F+ +++ KS+ E E+ + RH N++ ++S
Sbjct: 16 VGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASD 71
Query: 746 SNPGFKA----LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYST- 799
+ LI Y GSL +L +L L I++ +AS L +LH + T
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 800 ---PIIHCDLKPNNVLLDDDMVAHLGDFGIAKL-------LD-GVDPVTQTMTLATIGYM 848
I H DLK N+L+ + + D G+A + LD G +P + T YM
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP-----RVGTKRYM 184
Query: 849 APEYGSEGIV------SISGDVYSFGILMMETFTR 877
APE E I D+++FG+++ E R
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex
With The Imidazo[1,2-B]pyridazine Inhibitor K00135
Length = 301
Score = 54.3 bits (129), Expect = 4e-07, Method: Compositional matrix adjust.
Identities = 60/215 (27%), Positives = 100/215 (46%), Gaps = 36/215 (16%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRI--RHRNLIKIVSSC 745
+G G + V++ + G +VAVK+F+ +++ KS+ E E+ + RH N++ ++S
Sbjct: 16 VGKGRYGEVWRGSW-QGENVAVKIFSSRDE---KSWFRETELYNTVMLRHENILGFIASD 71
Query: 746 SNPGFKA----LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYST- 799
+ LI Y GSL +L +L L I++ +AS L +LH + T
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYL--QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQ 129
Query: 800 ---PIIHCDLKPNNVLLDDDMVAHLGDFGIAKL-------LD-GVDPVTQTMTLATIGYM 848
I H DLK N+L+ + + D G+A + LD G +P + T YM
Sbjct: 130 GKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNP-----RVGTKRYM 184
Query: 849 APEYGSEGIV------SISGDVYSFGILMMETFTR 877
APE E I D+++FG+++ E R
Sbjct: 185 APEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219
>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|B Chain B, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|C Chain C, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|D Chain D, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|E Chain E, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
pdb|1ZXE|F Chain F, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n
Inactivating Mutant In Apo Form
Length = 303
Score = 53.9 bits (128), Expect = 4e-07, Method: Composition-based stats.
Identities = 57/220 (25%), Positives = 93/220 (42%), Gaps = 32/220 (14%)
Query: 682 FGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALKSFDTECEVMRRIRH----- 735
F E +LG G+F V KA A + A+K E++ L + +E ++ + H
Sbjct: 8 FEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVXLLASLNHQYVVR 66
Query: 736 --------RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVA 787
RN +K ++ + +Y +L ++S N + + + +
Sbjct: 67 YYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIHSENLNQQRDEYWRLFRQIL 126
Query: 788 SALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK----LLDGVDPVTQ----- 838
AL Y+H S IIH +LKP N+ +D+ +GDFG+AK LD + +Q
Sbjct: 127 EALSYIH---SQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 839 ----TMTLATIGYMAPE-YGSEGIVSISGDVYSFGILMME 873
T + T Y+A E G + D YS GI+ E
Sbjct: 184 SDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223
>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|B Chain B, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|C Chain C, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|D Chain D, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|E Chain E, Crystal Structure Of Human Pas Kinase Bound To Adp
pdb|3DLS|F Chain F, Crystal Structure Of Human Pas Kinase Bound To Adp
Length = 335
Score = 53.9 bits (128), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 55/180 (30%), Positives = 77/180 (42%), Gaps = 28/180 (15%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQ--------EDRALKSFDTECEVMRRIRHRNL 738
LGSG+F V+ A V VK + ED L E ++ R+ H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 739 IKIVSSCSNPGFKALIMQYMPQG-SLEKWLYSHNYSLTIRQRLD------IMIDVASALE 791
IK++ N GF L+M+ G L ++ H RLD I + SA+
Sbjct: 92 IKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRH-------PRLDEPLASYIFRQLVSAVG 144
Query: 792 YLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE 851
YL IIH D+K N+++ +D L DFG A L+ + T TI Y APE
Sbjct: 145 YLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLER-GKLFYTFC-GTIEYCAPE 199
>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9M|B Chain B, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 18
pdb|3L9N|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a,
L173m, Q181k) With Compound 27
Length = 351
Score = 53.5 bits (127), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 55/205 (26%), Positives = 91/205 (44%), Gaps = 26/205 (12%)
Query: 680 NGFGESNLLGSGSFDNV----YKATLANGVSVAVKVFNLQEDRALKSFD---TECEVMRR 732
+ F LG+GSF V +K T G A+K+ + Q+ LK + E +++
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRILQA 98
Query: 733 IRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---A 789
+ L+K+ S + ++M+Y P G + +SH + A
Sbjct: 99 VNFPFLVKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 154
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYM 848
EYLH S +I+ DLKP N+++D + DFG AK + G +T L T Y+
Sbjct: 155 FEYLH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYL 206
Query: 849 APEYGSEGIVSISGDVYSFGILMME 873
APE + + D ++ G+L+ E
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYE 231
>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h-
Purin-6-yl)-benzyl)-amine
pdb|2UVZ|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
C-Phenyl-C-(4-( 9h-Purin-6-Yl)-Phenyl)-Methylamine
pdb|2UW0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 6-(4-(4-(4-
Chloro-Phenyl)-Piperidin-4-Yl)-Phenyl)-9h-Purine
pdb|2UW3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 5-Methyl-4-
Phenyl-1h-Pyrazole
pdb|2UW5|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (R)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With (S)-2-(4-
Chloro-Phenyl)-2-(4-1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW8|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 2-(4-Chloro-
Phenyl)-2-Phenyl-Ethylamine
pdb|2VNW|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)methanamine
pdb|2VNY|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
(1-(9h-Purin-6- Yl)piperidin-4-Yl)amine
pdb|2VO3|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
pdb|2VO6|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-
Chlorobenzyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Ylamine
Length = 351
Score = 53.5 bits (127), Expect = 5e-07, Method: Compositional matrix adjust.
Identities = 52/199 (26%), Positives = 86/199 (43%), Gaps = 14/199 (7%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V + G A+K+ + Q+ LK + E +++ +
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
L K+ S + ++M+Y P G + L R + EYLH
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 159
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGS 854
S +I+ DLKP N+++D + DFG AK + G +T L T Y+APE
Sbjct: 160 --SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIIL 212
Query: 855 EGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 213 SKGYNKAVDWWALGVLIYE 231
>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine
pdb|3GUB|A Chain A, Crystal Structure Of Dapkl93g Complexed With N6-(2-
Phenylethyl)adenosine
Length = 295
Score = 53.5 bits (127), Expect = 6e-07, Method: Composition-based stats.
Identities = 50/194 (25%), Positives = 88/194 (45%), Gaps = 17/194 (8%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALK------SFDTECEVMRRIRHRNLIK 740
LGSG F V K + G+ A K + ++ + + E +++ I+H N+I
Sbjct: 19 LGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVIT 78
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ N LI + + G L +L + SLT + + + + + + YLH S
Sbjct: 79 LHEVYENKTDVILIGELVAGGELFDFL-AEKESLTEEEATEFLKQILNGVYYLH---SLQ 134
Query: 801 IIHCDLKPNNVLLDDDMVA----HLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG 856
I H DLKP N++L D V + DFG+A +D + T ++APE +
Sbjct: 135 IAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKN--IFGTPEFVAPEIVNYE 192
Query: 857 IVSISGDVYSFGIL 870
+ + D++S G++
Sbjct: 193 PLGLEADMWSIGVI 206
>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536
Length = 294
Score = 53.5 bits (127), Expect = 6e-07, Method: Composition-based stats.
Identities = 62/264 (23%), Positives = 116/264 (43%), Gaps = 15/264 (5%)
Query: 687 LLGSGSFDNVYKATLANGVSV-AVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G F ++ + A+ V A K+ L + + E + R + H++++
Sbjct: 22 FLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFH 81
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPII 802
+ F ++++ + SL + L+ +LT + + + +YLH +I
Sbjct: 82 GFFEDNDFVFVVLELCRRRSLLE-LHKRRKALTEPEARYYLRQIVLGCQYLHRNR---VI 137
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISG 862
H DLK N+ L++D+ +GDFG+A ++ D + + T Y+APE S+ S
Sbjct: 138 HRDLKLGNLFLNEDLEVKIGDFGLATKVE-YDGERKKVLCGTPNYIAPEVLSKKGHSFEV 196
Query: 863 DVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAE-SLPGAVTEVVDANLLSREDEEDAD 921
DV+S G +M + P E L+ E S+P + V A+L+ + + D
Sbjct: 197 DVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVA-ASLIQKMLQTD-- 253
Query: 922 DFATKKTCISYIMSLALKCSAEIP 945
T + I+ +++ S IP
Sbjct: 254 --PTARPTINELLNDEFFTSGYIP 275
>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And
Regulatory (Ri{alpha}) Subunits Of Pka
Length = 350
Score = 53.1 bits (126), Expect = 6e-07, Method: Compositional matrix adjust.
Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V +G A+K+ + Q+ LK + E +++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---ALEY 792
L+K+ S + ++M+Y+ G + +SH + A EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLA-TIGYMAPE 851
LH S +I+ DLKP N+L+D + DFG AK + G +T LA T Y+APE
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLAGTPEYLAPE 208
Query: 852 YGSEGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230
>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
pdb|3MDY|C Chain C, Crystal Structure Of The Cytoplasmic Domain Of The Bone
Morp Protein Receptor Type-1b (Bmpr1b) In Complex With
Fkbp12 An 193189
Length = 337
Score = 53.1 bits (126), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 61/210 (29%), Positives = 91/210 (43%), Gaps = 26/210 (12%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRI--RHRNLIK-IVSS 744
+G G + V+ G VAVKVF E+ S+ E E+ + + RH N++ I +
Sbjct: 45 IGKGRYGEVWMGKW-RGEKVAVKVFFTTEE---ASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 745 CSNPGFKA---LIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHG-YST- 799
G LI Y GSL +L S +L + L + S L +LH +ST
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSGLCHLHTEIFSTQ 158
Query: 800 ---PIIHCDLKPNNVLLDDDMVAHLGDFGIA-KLLDGVDPVT--QTMTLATIGYMAPEYG 853
I H DLK N+L+ + + D G+A K + + V + T YM PE
Sbjct: 159 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVL 218
Query: 854 SEGI------VSISGDVYSFGILMMETFTR 877
E + I D+YSFG+++ E R
Sbjct: 219 DESLNRNHFQSYIMADMYSFGLILWEVARR 248
>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent
Protein Kinase With Unphosphorylated Activation Loop
pdb|4DFY|E Chain E, Crystal Structure Of R194a Mutant Of Camp-Dependent
Protein Kinase With Unphosphorylated Activation Loop
Length = 371
Score = 53.1 bits (126), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 54/202 (26%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V +G A+K+ + Q+ LK + E +++ +
Sbjct: 62 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---ALEY 792
L+K+ S + ++M+Y+ G + +SH + A EY
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 177
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
LH S +I+ DLKP N+L+D + DFG AK + G T TL T Y+APE
Sbjct: 178 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGA-----TWTLCGTPEYLAPE 229
Query: 852 YGSEGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 230 IILSKGYNKAVDWWALGVLIYE 251
>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|B Chain B, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|C Chain C, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
pdb|3DAK|D Chain D, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain
Length = 290
Score = 53.1 bits (126), Expect = 7e-07, Method: Composition-based stats.
Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 17/208 (8%)
Query: 687 LLGSGSFDNVYKATLA-NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSS 744
++GSG+ V A A VA+K NL++ ++ E + M + H N++ +S
Sbjct: 17 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 76
Query: 745 CSNPGFKALIMQYMPQGSLEKWLY------SHNYSLTIRQRL-DIMIDVASALEYLHHGY 797
L+M+ + GS+ + H + + I+ +V LEYLH
Sbjct: 77 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG 136
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT----LATIGYMAPEYG 853
IH D+K N+LL +D + DFG++ L +T+ + T +MAPE
Sbjct: 137 Q---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 193
Query: 854 SE-GIVSISGDVYSFGILMMETFTRRKP 880
+ D++SFGI +E T P
Sbjct: 194 EQVRGYDFKADIWSFGITAIELATGAAP 221
>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|B Chain B, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|C Chain C, Structure Of The Osr1 Kinase, A Hypertension Drug Target
pdb|2VWI|D Chain D, Structure Of The Osr1 Kinase, A Hypertension Drug Target
Length = 303
Score = 53.1 bits (126), Expect = 7e-07, Method: Composition-based stats.
Identities = 54/208 (25%), Positives = 90/208 (43%), Gaps = 17/208 (8%)
Query: 687 LLGSGSFDNVYKATLA-NGVSVAVKVFNLQE-DRALKSFDTECEVMRRIRHRNLIKIVSS 744
++GSG+ V A A VA+K NL++ ++ E + M + H N++ +S
Sbjct: 22 VIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPNIVSYYTS 81
Query: 745 CSNPGFKALIMQYMPQGSLEKWLY------SHNYSLTIRQRL-DIMIDVASALEYLHHGY 797
L+M+ + GS+ + H + + I+ +V LEYLH
Sbjct: 82 FVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNG 141
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT----LATIGYMAPEYG 853
IH D+K N+LL +D + DFG++ L +T+ + T +MAPE
Sbjct: 142 Q---IHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVM 198
Query: 854 SE-GIVSISGDVYSFGILMMETFTRRKP 880
+ D++SFGI +E T P
Sbjct: 199 EQVRGYDFKADIWSFGITAIELATGAAP 226
>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
pdb|1S9I|B Chain B, X-Ray Structure Of The Human Mitogen-Activated Protein
Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp
Length = 354
Score = 53.1 bits (126), Expect = 7e-07, Method: Compositional matrix adjust.
Identities = 52/205 (25%), Positives = 99/205 (48%), Gaps = 12/205 (5%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALK-SFDTECEVMRRIRHRN 737
+ F + LG+G+ V K +G+ +A K+ +L+ A++ E +V+
Sbjct: 16 DDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 75
Query: 738 LIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRL--DIMIDVASALEYLHH 795
++ + + G ++ M++M GSL++ L + I + + + I V L YL
Sbjct: 76 IVGFYGAFYSDGEISICMEHMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLRE 132
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSE 855
+ I+H D+KP+N+L++ L DFG++ L +D + + + T YMAPE
Sbjct: 133 KHQ--IMHRDVKPSNILVNSRGEIKLCDFGVSGQL--IDSMANSF-VGTRSYMAPERLQG 187
Query: 856 GIVSISGDVYSFGILMMETFTRRKP 880
S+ D++S G+ ++E R P
Sbjct: 188 THYSVQSDIWSMGLSLVELAVGRYP 212
>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv976
Length = 323
Score = 53.1 bits (126), Expect = 7e-07, Method: Composition-based stats.
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 29/205 (14%)
Query: 715 QEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSL------EKWLY 768
+ D AL + +TE E+++++ H +IKI + + ++++ M G L K L
Sbjct: 55 EADPAL-NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLK 112
Query: 769 SHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL---DDDMVAHLGDFG 825
L Q L A++YLH IIH DLKP NVLL ++D + + DFG
Sbjct: 113 EATCKLYFYQML-------LAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFG 162
Query: 826 IAKLLDGVDPVTQTMTLATIGYMAPE----YGSEGIVSISGDVYSFGILMMETFTRRKPT 881
+K+L G + +T+ T Y+APE G+ G + + D +S G+++ + P
Sbjct: 163 HSKIL-GETSLMRTLC-GTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPF 219
Query: 882 NEMFTGEMSLKQWVAESLPGAVTEV 906
+E T ++SLK + + EV
Sbjct: 220 SEHRT-QVSLKDQITSGKYNFIPEV 243
>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1531
Length = 322
Score = 53.1 bits (126), Expect = 7e-07, Method: Composition-based stats.
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 29/205 (14%)
Query: 715 QEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSL------EKWLY 768
+ D AL + +TE E+++++ H +IKI + + ++++ M G L K L
Sbjct: 55 EADPAL-NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLK 112
Query: 769 SHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL---DDDMVAHLGDFG 825
L Q L A++YLH IIH DLKP NVLL ++D + + DFG
Sbjct: 113 EATCKLYFYQML-------LAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFG 162
Query: 826 IAKLLDGVDPVTQTMTLATIGYMAPE----YGSEGIVSISGDVYSFGILMMETFTRRKPT 881
+K+L G + +T+ T Y+APE G+ G + + D +S G+++ + P
Sbjct: 163 HSKIL-GETSLMRTLC-GTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPF 219
Query: 882 NEMFTGEMSLKQWVAESLPGAVTEV 906
+E T ++SLK + + EV
Sbjct: 220 SEHRT-QVSLKDQITSGKYNFIPEV 243
>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In
Complex With Inhibitor Pv1533
Length = 322
Score = 53.1 bits (126), Expect = 7e-07, Method: Composition-based stats.
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 29/205 (14%)
Query: 715 QEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSL------EKWLY 768
+ D AL + +TE E+++++ H +IKI + + ++++ M G L K L
Sbjct: 54 EADPAL-NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLK 111
Query: 769 SHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL---DDDMVAHLGDFG 825
L Q L A++YLH IIH DLKP NVLL ++D + + DFG
Sbjct: 112 EATCKLYFYQML-------LAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFG 161
Query: 826 IAKLLDGVDPVTQTMTLATIGYMAPE----YGSEGIVSISGDVYSFGILMMETFTRRKPT 881
+K+L G + +T+ T Y+APE G+ G + + D +S G+++ + P
Sbjct: 162 HSKIL-GETSLMRTLC-GTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPF 218
Query: 882 NEMFTGEMSLKQWVAESLPGAVTEV 906
+E T ++SLK + + EV
Sbjct: 219 SEHRT-QVSLKDQITSGKYNFIPEV 242
>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A
Specific Inhibitor
pdb|2W7X|A Chain A, Cellular Inhibition Of Checkpoint Kinase 2 And
Potentiation Of Cytotoxic Drugs By Novel Chk2 Inhibitor
Pv1019
pdb|2YIQ|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1322
pdb|2YIR|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1352
pdb|2YIT|A Chain A, Structural Analysis Of Checkpoint Kinase 2 In Complex With
Pv1162, A Novel Inhibitor
pdb|2YCQ|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Inhibitor Pv1115
pdb|2YCS|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With
Pv788
Length = 323
Score = 53.1 bits (126), Expect = 7e-07, Method: Composition-based stats.
Identities = 59/205 (28%), Positives = 99/205 (48%), Gaps = 29/205 (14%)
Query: 715 QEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSL------EKWLY 768
+ D AL + +TE E+++++ H +IKI + + ++++ M G L K L
Sbjct: 55 EADPAL-NVETEIEILKKLNHPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLK 112
Query: 769 SHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLL---DDDMVAHLGDFG 825
L Q L A++YLH IIH DLKP NVLL ++D + + DFG
Sbjct: 113 EATCKLYFYQML-------LAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFG 162
Query: 826 IAKLLDGVDPVTQTMTLATIGYMAPE----YGSEGIVSISGDVYSFGILMMETFTRRKPT 881
+K+L G + +T+ T Y+APE G+ G + + D +S G+++ + P
Sbjct: 163 HSKIL-GETSLMRTLC-GTPTYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPF 219
Query: 882 NEMFTGEMSLKQWVAESLPGAVTEV 906
+E T ++SLK + + EV
Sbjct: 220 SEHRT-QVSLKDQITSGKYNFIPEV 243
>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain
pdb|2HW6|B Chain B, Crystal Structure Of Mnk1 Catalytic Domain
Length = 307
Score = 53.1 bits (126), Expect = 8e-07, Method: Composition-based stats.
Identities = 49/178 (27%), Positives = 87/178 (48%), Gaps = 15/178 (8%)
Query: 685 SNLLGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIR-HRNLIKIV 742
S LLG G++ V A +L NG AVK+ Q + E E + + + ++N+++++
Sbjct: 18 SELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELI 77
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPII 802
+ L+ + + GS+ + + R+ ++ DVA+AL++LH + I
Sbjct: 78 EFFEDDTRFYLVFEKLQGGSILAHIQKQKH-FNEREASRVVRDVAAALDFLH---TKGIA 133
Query: 803 HCDLKPNNVLLDD-DMVA--HLGDFGIA---KLLDGVDPVTQ---TMTLATIGYMAPE 851
H DLKP N+L + + V+ + DF + KL + P+T T + YMAPE
Sbjct: 134 HRDLKPENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPE 191
>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4-
Chlorophenyl)-1-(7h-Pyrrolo(2,
3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine
Length = 351
Score = 53.1 bits (126), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 20/202 (9%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V + G A+K+ + Q+ LK + E +++ +
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---ALEY 792
L K+ S + ++M+Y P G + +SH + A EY
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
LH S +I+ DLKP N+++D + DFG AK + G +T L T Y+APE
Sbjct: 158 LH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 209
Query: 852 YGSEGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 210 IILSKGYNKAVDWWALGVLIYE 231
>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy)
Ethylamino)ethyl) Amide
pdb|2JDV|A Chain A, Structure Of Pka-Pkb Chimera Complexed With A-443654
pdb|2UVX|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 7-Azaindole
pdb|2UW4|A Chain A, Structure Of Pka-Pkb Chimera Complexed With
2-(4-(5-Methyl- 1h-Pyrazol-4-Yl)-Phenyl)-Ethylamine
pdb|2UW7|A Chain A, Structure Of Pka-Pkb Chimera Complexed With 4-(4-Chloro-
Phenyl)-4-(4-(1h-Pyrazol-4-Yl)-Phenyl)-Piperidine
pdb|4AXA|A Chain A, Structure Of Pka-pkb Chimera Complexed With
(1s)-2-amino-1-(
4-chlorophenyl)-1-(4-(1h-pyrazol-4-yl)phenyl)ethan-1-ol
Length = 351
Score = 53.1 bits (126), Expect = 8e-07, Method: Compositional matrix adjust.
Identities = 53/202 (26%), Positives = 88/202 (43%), Gaps = 20/202 (9%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V + G A+K+ + Q+ LK + E +++ +
Sbjct: 42 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---ALEY 792
L K+ S + ++M+Y P G + +SH + A EY
Sbjct: 102 PFLTKLEFSFKDNSNLYMVMEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
LH S +I+ DLKP N+++D + DFG AK + G +T L T Y+APE
Sbjct: 158 LH---SLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 209
Query: 852 YGSEGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 210 IILSKGYNKAVDWWALGVLIYE 231
>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With
Inhibitor Jnj- 7706621
pdb|3AMB|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With
Inhibitor Vx- 680
Length = 351
Score = 52.8 bits (125), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 55/205 (26%), Positives = 90/205 (43%), Gaps = 26/205 (12%)
Query: 680 NGFGESNLLGSGSFDNV----YKATLANGVSVAVKVFNLQEDRALKSFD---TECEVMRR 732
+ F LG+GSF V +K T G A+K+ + Q+ LK + E + +
Sbjct: 42 DQFERIRTLGTGSFGRVMLVKHKET---GNHYAMKILDKQKVVKLKQIEHTLNEKRIQQA 98
Query: 733 IRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---A 789
+ L+K+ S + ++++Y P G + +SH + A
Sbjct: 99 VNFPFLVKLEFSFKDNSNLYMVLEYAPGGEM----FSHLRRIGRFSEPHARFYAAQIVLT 154
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYM 848
EYLH S +I+ DLKP N+L+D + DFG AK + G +T L T Y+
Sbjct: 155 FEYLH---SLDLIYRDLKPENLLIDQQGYIKVADFGFAKRVKG-----RTWXLCGTPEYL 206
Query: 849 APEYGSEGIVSISGDVYSFGILMME 873
APE + + D ++ G+L+ E
Sbjct: 207 APEIILSKGYNKAVDWWALGVLIYE 231
>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|B Chain B, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALN|C Chain C, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Complexed With Amp-Pnp
pdb|3ALO|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase
Domain Ternary Complex With Amp-Pnp And P38 Peptide
pdb|3VUT|A Chain A, Crystal Structures Of Non-Phosphorylated Map2k4
pdb|3VUT|B Chain B, Crystal Structures Of Non-Phosphorylated Map2k4
Length = 327
Score = 52.8 bits (125), Expect = 9e-07, Method: Compositional matrix adjust.
Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 20/206 (9%)
Query: 688 LGSGSFDNVYKATLA-NGVSVAVK-----VFNLQEDRALKSFDTECEVMRRIRHRNLIKI 741
+G G++ +V K +G +AVK V ++ + L D VMR +++
Sbjct: 30 IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDV---VMRSSDCPYIVQF 86
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSL---TIRQRLDIMIDVASALEYLHHGYS 798
+ G + M+ M S +K+ Y + YS+ I + + I +A+ H +
Sbjct: 87 YGALFREGDCWICMELM-STSFDKF-YKYVYSVLDDVIPEEILGKITLATVKALNHLKEN 144
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEY----GS 854
IIH D+KP+N+LLD L DFGI+ L VD + +T YMAPE S
Sbjct: 145 LKIIHRDIKPSNILLDRSGNIKLCDFGISGQL--VDSIAKTRDAGCRPYMAPERIDPSAS 202
Query: 855 EGIVSISGDVYSFGILMMETFTRRKP 880
+ DV+S GI + E T R P
Sbjct: 203 RQGYDVRSDVWSLGITLYELATGRFP 228
>pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
pdb|2BUJ|B Chain B, Crystal Structure Of The Human Serine-Threonine Kinase 16
In Complex With Staurosporine
Length = 317
Score = 52.8 bits (125), Expect = 9e-07, Method: Composition-based stats.
Identities = 61/219 (27%), Positives = 98/219 (44%), Gaps = 26/219 (11%)
Query: 688 LGSGSFDNV-YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSC- 745
LG G F V L +G A+K E + + E ++ R H N++++V+ C
Sbjct: 37 LGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 746 SNPGFKA---LIMQYMPQGSL----EKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGY 797
G K L++ + +G+L E+ N+ LT Q L +++ + LE +H GY
Sbjct: 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNF-LTEDQILWLLLGICRGLEAIHAKGY 155
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFG-IAKLLDGVDPVTQTMTL-------ATIGYMA 849
+ H DLKP N+LL D+ L D G + + V+ Q +TL TI Y A
Sbjct: 156 A----HRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRA 211
Query: 850 PEY---GSEGIVSISGDVYSFGILMMETFTRRKPTNEMF 885
PE S ++ DV+S G ++ P + +F
Sbjct: 212 PELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250
>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|B Chain B, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|D Chain D, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
pdb|4G3D|E Chain E, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik)
Length = 371
Score = 52.8 bits (125), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 71/252 (28%), Positives = 103/252 (40%), Gaps = 18/252 (7%)
Query: 649 RKRNKSLPEENNSLNLAT--LSRISYHELQQATNGFGESNLLGSGSFDNVYK-ATLANGV 705
R R S E+N L T L + Y E ++ + LG GSF V++ G
Sbjct: 61 RSREPSPKTEDNEGVLLTEKLKPVDY-EYREEVHWATHQLRLGRGSFGEVHRMEDKQTGF 119
Query: 706 SVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEK 765
AVK L+ RA + C + R ++ + + + + M+ + GSL +
Sbjct: 120 QCAVKKVRLEVFRAEELM--ACAGLTSPR---IVPLYGAVREGPWVNIFMELLEGGSLGQ 174
Query: 766 WLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMV-AHLGDF 824
L L + L + LEYLH S I+H D+K +NVLL D A L DF
Sbjct: 175 -LVKEQGCLPEDRALYYLGQALEGLEYLH---SRRILHGDVKADNVLLSSDGSHAALCDF 230
Query: 825 GIAKLL--DGVDP--VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKP 880
G A L DG+ +T T +MAPE DV+S +M+ P
Sbjct: 231 GHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWSSCCMMLHMLNGCHP 290
Query: 881 TNEMFTGEMSLK 892
+ F G + LK
Sbjct: 291 WTQFFRGPLCLK 302
>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp
pdb|2CN8|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Debromohymenialdisine
pdb|2WTC|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTD|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTI|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2WTJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XBJ|A Chain A, Crystal Structure Of Chk2 In Complex With An Inhibitor
pdb|2XM8|A Chain A, Co-Crystal Structure Of A Small Molecule Inhibitor Bound
To The Kinase Domain Of Chk2
pdb|2XM9|A Chain A, Structure Of A Small Molecule Inhibitor With The Kinase
Domain Of Chk2
pdb|4A9R|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9S|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9T|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
pdb|4A9U|A Chain A, Crystal Structure Of Human Chk2 In Complex With
Benzimidazole Carboxamide Inhibitor
Length = 329
Score = 52.8 bits (125), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 69/245 (28%), Positives = 114/245 (46%), Gaps = 39/245 (15%)
Query: 685 SNLLGSGSFDNVYKA-TLANGVSVAVKVFNLQE---------DRALKSFDTECEVMRRIR 734
S LGSG+ V A VA+K+ + ++ D AL + +TE E+++++
Sbjct: 21 SKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPAL-NVETEIEILKKLN 79
Query: 735 HRNLIKIVSSCSNPGFKALIMQYMPQGSL------EKWLYSHNYSLTIRQRLDIMIDVAS 788
H +IKI + + ++++ M G L K L L Q L
Sbjct: 80 HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML-------L 131
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATI 845
A++YLH IIH DLKP NVLL ++D + + DFG +K+L G + +T+ T
Sbjct: 132 AVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLC-GTP 186
Query: 846 GYMAPE----YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPG 901
Y+APE G+ G + + D +S G+++ + P +E T ++SLK +
Sbjct: 187 TYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRT-QVSLKDQITSGKYN 244
Query: 902 AVTEV 906
+ EV
Sbjct: 245 FIPEV 249
>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And
Potent Inhibitors For Akt: Synthesis And Sar Studies
Length = 337
Score = 52.8 bits (125), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 20/202 (9%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V +G A+K+ + Q+ LK + E +++ +
Sbjct: 28 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 87
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---ALEY 792
L+K+ S + ++M+Y+ G + +SH + A EY
Sbjct: 88 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 143
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
LH S +I+ DLKP N+L+D+ + DFG AK + G +T L T Y+APE
Sbjct: 144 LH---SLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 195
Query: 852 YGSEGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 196 IILSKGYNKAVDWWALGVLIYE 217
>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H89 Protein
Kinase Inhibitor N-[2-
(4-Bromocinnamylamino)ethyl]-5-Isoquinoline
pdb|1YDR|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H7 Protein
Kinase Inhibitor 1-(5-
Isoquinolinesulfonyl)-2-Methylpiperazine
pdb|1YDS|E Chain E, Structure Of Camp-Dependent Protein Kinase,
Alpha-Catalytic Subunit In Complex With H8 Protein
Kinase Inhibitor [n-(2-Methylamino)ethyl]-5-
Isoquinolinesulfonamide
Length = 350
Score = 52.4 bits (124), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V + G A+K+ + Q+ LK + E +++ +
Sbjct: 41 DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---ALEY 792
L+K+ S + ++M+Y+ G + +SH + A EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
LH S +I+ DLKP N+L+D + DFG AK + G +T L T Y+APE
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 852 YGSEGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230
>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|B Chain B, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|C Chain C, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|D Chain D, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
pdb|2X7F|E Chain E, Crystal Structure Of The Kinase Domain Of Human Traf2- And
Nck-Interacting Kinase With Wee1chk1 Inhibitor
Length = 326
Score = 52.4 bits (124), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 56/221 (25%), Positives = 95/221 (42%), Gaps = 17/221 (7%)
Query: 666 TLSRISYHELQQATNGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD 724
+L I L+ F L+G+G++ VYK + G A+KV ++ D +
Sbjct: 10 SLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEE-EEIK 68
Query: 725 TECEVMRRI-RHRNLIKIVSSC---SNPGFKA---LIMQYMPQGSLEKWLYSHNYSLTIR 777
E ++++ HRN+ + + PG L+M++ GS+ L + T++
Sbjct: 69 QEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD-LIKNTKGNTLK 127
Query: 778 QRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVT 837
+ I L L H + +IH D+K NVLL ++ L DFG++ LD
Sbjct: 128 EEW-IAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR 186
Query: 838 QTMTLATIGYMAPEY-----GSEGIVSISGDVYSFGILMME 873
T + T +MAPE + D++S GI +E
Sbjct: 187 NTF-IGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Soak)
pdb|3KRX|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol
(Co-Crystal)
Length = 688
Score = 52.4 bits (124), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 54/223 (24%), Positives = 93/223 (41%), Gaps = 27/223 (12%)
Query: 680 NGFGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNL 738
N F ++G G F VY A+ G A+K + + + +K +T + R +
Sbjct: 188 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK-MKQGETLA-----LNERIM 241
Query: 739 IKIVSS-------CSNPGFK-----ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDV 786
+ +VS+ C + F + I+ M G L L H + D+
Sbjct: 242 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYA 297
Query: 787 ASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG 846
A + L H ++ +++ DLKP N+LLD+ + D G+A P ++ T G
Sbjct: 298 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHG 354
Query: 847 YMAPEYGSEGIV-SISGDVYSFGILMMETFTRRKPTNEMFTGE 888
YMAPE +G+ S D +S G ++ + P + T +
Sbjct: 355 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 397
>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits
pdb|3V5W|A Chain A, Human G Protein-Coupled Receptor Kinase 2 In Complex With
Soluble Gbetagamma Subunits And Paroxetine
Length = 689
Score = 52.0 bits (123), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 54/223 (24%), Positives = 93/223 (41%), Gaps = 27/223 (12%)
Query: 680 NGFGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNL 738
N F ++G G F VY A+ G A+K + + + +K +T + R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK-MKQGETLA-----LNERIM 242
Query: 739 IKIVSS-------CSNPGFK-----ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDV 786
+ +VS+ C + F + I+ M G L L H + D+
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYA 298
Query: 787 ASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG 846
A + L H ++ +++ DLKP N+LLD+ + D G+A P ++ T G
Sbjct: 299 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHG 355
Query: 847 YMAPEYGSEGIV-SISGDVYSFGILMMETFTRRKPTNEMFTGE 888
YMAPE +G+ S D +S G ++ + P + T +
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 398
>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory
Subunit Of Protein Kinase A That Represents The
Inhibited State
pdb|2CPK|E Chain E, Crystal Structure Of The Catalytic Subunit Of Cyclic
Adenosine Monophosphate-Dependent Protein Kinase
pdb|4DG0|E Chain E, Crystal Structure Of Myristoylated Wt Catalytic Subunit Of
Camp- Dependent Protein Kinase In Complex With Sp20 And
Amp-Pnp
pdb|4DG2|E Chain E, Crystal Structure Of Myristoylated Wt Catalytic Subunit Of
Camp- Dependent Protein Kinase In Complex With Sp20
pdb|4DH1|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With Low Mg2+, Atp And Ip20
pdb|4DH3|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Atp And Ip20
pdb|4DH5|A Chain A, Room Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Adp,
Phosphate, And Ip20
pdb|4DH7|A Chain A, Low Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Amp-pnp And
Ip20'
pdb|4DH8|A Chain A, Room Temperature X-ray Structure Of Camp Dependent Protein
Kinase A Catalytic Subunit With High Mg2+, Amp-pnp And
Ip20
Length = 350
Score = 52.0 bits (123), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 52/199 (26%), Positives = 87/199 (43%), Gaps = 14/199 (7%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V +G A+K+ + Q+ LK + E +++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
L+K+ S + ++M+Y+ G + L R + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGS 854
S +I+ DLKP N+L+D + DFG AK + G +T L T Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIIL 211
Query: 855 EGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230
>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent
Protein Kinase With Unphosphorylated Turn Motif
Length = 371
Score = 52.0 bits (123), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 52/199 (26%), Positives = 87/199 (43%), Gaps = 14/199 (7%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V +G A+K+ + Q+ LK + E +++ +
Sbjct: 62 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 121
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
L+K+ S + ++M+Y+ G + L R + EYLH
Sbjct: 122 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 179
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGS 854
S +I+ DLKP N+L+D + DFG AK + G +T L T Y+APE
Sbjct: 180 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIIL 232
Query: 855 EGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 233 SKGYNKAVDWWALGVLIYE 251
>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of
Camp-Dependent Protein Kinase
Length = 345
Score = 52.0 bits (123), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 52/199 (26%), Positives = 87/199 (43%), Gaps = 14/199 (7%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V +G A+K+ + Q+ LK + E +++ +
Sbjct: 36 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 95
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
L+K+ S + ++M+Y+ G + L R + EYLH
Sbjct: 96 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 153
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGS 854
S +I+ DLKP N+L+D + DFG AK + G +T L T Y+APE
Sbjct: 154 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIIL 206
Query: 855 EGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 207 SKGYNKAVDWWALGVLIYE 225
>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit
Of Camp- Dependent Protein Kinase In Complex With Sp20
And Amp-Pnp
pdb|4DFZ|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit
Of Camp- Dependent Protein Kinase In Complex With Sp20
Length = 350
Score = 52.0 bits (123), Expect = 1e-06, Method: Compositional matrix adjust.
Identities = 52/199 (26%), Positives = 87/199 (43%), Gaps = 14/199 (7%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V +G A+K+ + Q+ LK + E +++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
L+K+ S + ++M+Y+ G + L R + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGS 854
S +I+ DLKP N+L+D + DFG AK + G +T L T Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIIL 211
Query: 855 EGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230
>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map
Kinase Jnk1
Length = 370
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 92/211 (43%), Gaps = 30/211 (14%)
Query: 702 ANGVSVAVKVFNLQEDRALKS----FDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQY 757
A G+ VA L+ + A+K F + R R L+K+V+ + G L+ +
Sbjct: 36 AQGIVVAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNIIG---LLNVF 92
Query: 758 MPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASALEYLHHGYSTPIIH 803
PQ SLE++ L N S I+ LD ++ + +++LH S IIH
Sbjct: 93 TPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGIKHLH---SAGIIH 149
Query: 804 CDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGD 863
DLKP+N+++ D + DFG+A+ T + T Y APE + D
Sbjct: 150 RDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRYYRAPEVILGMGYKENVD 207
Query: 864 VYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
++S G++M E +F G + QW
Sbjct: 208 IWSVGVIMGEMIK----GGVLFPGTDHIDQW 234
>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The
Catalytic Subunit Of Camp-Dependent Protein Kinase
pdb|3TNP|C Chain C, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
pdb|3TNP|F Chain F, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
pdb|3TNQ|B Chain B, Structure And Allostery Of The Pka Riib Tetrameric
Holoenzyme
Length = 350
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 52/199 (26%), Positives = 87/199 (43%), Gaps = 14/199 (7%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V +G A+K+ + Q+ LK + E +++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
L+K+ S + ++M+Y+ G + L R + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARF-YAAQIVLTFEYLH- 158
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGS 854
S +I+ DLKP N+L+D + DFG AK + G +T L T Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIIL 211
Query: 855 EGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230
>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled
Receptor Kinase 2 And Heterotrimeric G Protein Beta 1
And Gamma 2 Subunits
pdb|1YM7|A Chain A, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|B Chain B, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|C Chain C, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|1YM7|D Chain D, G Protein-Coupled Receptor Kinase 2 (Grk2)
pdb|2BCJ|A Chain A, Crystal Structure Of G Protein-coupled Receptor Kinase 2
In Complex With Galpha-q And Gbetagamma Subunits
pdb|3UZS|A Chain A, Structure Of The C13.28 Rna Aptamer Bound To The G
Protein-Coupled Receptor Kinase 2-Heterotrimeric G
Protein Beta 1 And Gamma 2 Subunit Complex
pdb|3UZT|A Chain A, Structure Of The C13.18 Rna Aptamer In Complex With G
Protein-Coupled Receptor Kinase 2
Length = 689
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 54/223 (24%), Positives = 93/223 (41%), Gaps = 27/223 (12%)
Query: 680 NGFGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNL 738
N F ++G G F VY A+ G A+K + + + +K +T + R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK-MKQGETLA-----LNERIM 242
Query: 739 IKIVSS-------CSNPGFK-----ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDV 786
+ +VS+ C + F + I+ M G L L H + D+
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYA 298
Query: 787 ASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG 846
A + L H ++ +++ DLKP N+LLD+ + D G+A P ++ T G
Sbjct: 299 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHG 355
Query: 847 YMAPEYGSEGIV-SISGDVYSFGILMMETFTRRKPTNEMFTGE 888
YMAPE +G+ S D +S G ++ + P + T +
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 398
>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits
pdb|3PVU|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd101)
pdb|3PVW|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits And A
Selective Kinase Inhibitor (Cmpd103a)
Length = 695
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 54/223 (24%), Positives = 93/223 (41%), Gaps = 27/223 (12%)
Query: 680 NGFGESNLLGSGSFDNVYKATLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNL 738
N F ++G G F VY A+ G A+K + + + +K +T + R +
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIK-MKQGETLA-----LNERIM 242
Query: 739 IKIVSS-------CSNPGFK-----ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDV 786
+ +VS+ C + F + I+ M G L L H + D+
Sbjct: 243 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHG----VFSEADMRFYA 298
Query: 787 ASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIG 846
A + L H ++ +++ DLKP N+LLD+ + D G+A P ++ T G
Sbjct: 299 AEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP---HASVGTHG 355
Query: 847 YMAPEYGSEGIV-SISGDVYSFGILMMETFTRRKPTNEMFTGE 888
YMAPE +G+ S D +S G ++ + P + T +
Sbjct: 356 YMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKD 398
>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From
Toxoplasma Gondii, Tgme49.101440
Length = 507
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 18/202 (8%)
Query: 679 TNGFGESNLLGSGSFDNVY--KATLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRI 733
++ + +LG GSF V K + G AVKV +++ +S E ++++++
Sbjct: 48 SDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 106
Query: 734 RHRNLIKIVSSCSNPGFKALIMQYMPQGSL-EKWLYSHNYSLTIRQRLDIMIDVASALEY 792
H N++K+ + G+ L+ + G L ++ + +S R I+ V S + Y
Sbjct: 107 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIRQVLSGITY 164
Query: 793 LHHGYSTPIIHCDLKPNNVLLD---DDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
+H I+H DLKP N+LL+ D + DFG++ + + + T Y+A
Sbjct: 165 MH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIA 219
Query: 850 PEYGSEGIVSISGDVYSFGILM 871
PE G DV+S G+++
Sbjct: 220 PEV-LHGTYDEKCDVWSTGVIL 240
>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha
pdb|3OHT|B Chain B, Crystal Structure Of Salmo Salar P38alpha
Length = 389
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 55/210 (26%), Positives = 100/210 (47%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V + + +G+ +AVK + Q K E +++ ++H N+I
Sbjct: 59 VGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 113
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 114 -------GLLDVFTPATSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 166
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 167 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 219
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + +++ D++S G +M E T R
Sbjct: 220 PEIMLNWMHYNMTVDIWSVGCIMAELLTGR 249
>pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex
(Apo)
Length = 271
Score = 52.0 bits (123), Expect = 2e-06, Method: Composition-based stats.
Identities = 49/196 (25%), Positives = 84/196 (42%), Gaps = 13/196 (6%)
Query: 704 GVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSCSNP--GFKALIMQYMP 759
G + VKV +++ R + F+ EC +R H N++ ++ +C +P LI + P
Sbjct: 33 GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWXP 92
Query: 760 QGSLEKWLYS-HNYSLTIRQRLDIMIDVASALEYLHHGYSTPII--HCDLKPNNVLLDDD 816
GSL L+ N+ + Q + +D A +LH P+I H L +V +D+D
Sbjct: 93 YGSLYNVLHEGTNFVVDQSQAVKFALDXARGXAFLH--TLEPLIPRHA-LNSRSVXIDED 149
Query: 817 MVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFT 876
A + A + + A + A + E S D +SF +L+ E T
Sbjct: 150 XTARISX---ADVKFSFQSPGRXYAPAWVAPEALQKKPEDTNRRSADXWSFAVLLWELVT 206
Query: 877 RRKPTNEMFTGEMSLK 892
R P ++ E+ K
Sbjct: 207 REVPFADLSNXEIGXK 222
>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic
Subunit Of Camp-Dependent Protein Kinase Complexed With
A Peptide Inhibitor And Detergent
Length = 350
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 52/199 (26%), Positives = 87/199 (43%), Gaps = 14/199 (7%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V +G A+K+ + Q+ LK + E +++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHH 795
L+K+ S + ++M+Y+ G + L R + EYLH
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARF-YAAQIVLTFEYLH- 158
Query: 796 GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPEYGS 854
S +I+ DLKP N+L+D + DFG AK + G +T L T Y+APE
Sbjct: 159 --SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPEIIL 211
Query: 855 EGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 212 SKGYNKAVDWWALGVLIYE 230
>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|C Chain C, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|D Chain D, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|E Chain E, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|F Chain F, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|G Chain G, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6W|H Chain H, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 443
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 68/245 (27%), Positives = 114/245 (46%), Gaps = 39/245 (15%)
Query: 685 SNLLGSGSFDNVYKA-TLANGVSVAVKVFNLQE---------DRALKSFDTECEVMRRIR 734
S LGSG+ V A VA+++ + ++ D AL + +TE E+++++
Sbjct: 154 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPAL-NVETEIEILKKLN 212
Query: 735 HRNLIKIVSSCSNPGFKALIMQYMPQGSL------EKWLYSHNYSLTIRQRLDIMIDVAS 788
H +IKI + + ++++ M G L K L L Q L
Sbjct: 213 HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML-------L 264
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATI 845
A++YLH IIH DLKP NVLL ++D + + DFG +K+L G + +T+ T
Sbjct: 265 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLC-GTP 319
Query: 846 GYMAPE----YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPG 901
Y+APE G+ G + + D +S G+++ + P +E T ++SLK +
Sbjct: 320 TYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRT-QVSLKDQITSGKYN 377
Query: 902 AVTEV 906
+ EV
Sbjct: 378 FIPEV 382
>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii,
Tgme49_101440, In Presence Of Calcium
Length = 508
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 51/202 (25%), Positives = 94/202 (46%), Gaps = 18/202 (8%)
Query: 679 TNGFGESNLLGSGSFDNVY--KATLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRI 733
++ + +LG GSF V K + G AVKV +++ +S E ++++++
Sbjct: 49 SDRYKGQRVLGKGSFGEVILCKDKI-TGQECAVKVISKRQVKQKTDKESLLREVQLLKQL 107
Query: 734 RHRNLIKIVSSCSNPGFKALIMQYMPQGSL-EKWLYSHNYSLTIRQRLDIMIDVASALEY 792
H N++K+ + G+ L+ + G L ++ + +S R I+ V S + Y
Sbjct: 108 DHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIRQVLSGITY 165
Query: 793 LHHGYSTPIIHCDLKPNNVLLD---DDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
+H I+H DLKP N+LL+ D + DFG++ + + + T Y+A
Sbjct: 166 MH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIA 220
Query: 850 PEYGSEGIVSISGDVYSFGILM 871
PE G DV+S G+++
Sbjct: 221 PEV-LHGTYDEKCDVWSTGVIL 241
>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNG|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNH|B Chain B, Structural Mechanism For The Inhibition Of Cdk5-P25 By
Roscovitine, Aloisine And Indirubin.
pdb|1UNL|A Chain A, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|1UNL|B Chain B, Structural Mechanism For The Inhibition Of Cd5-P25 From
The Roscovitine, Aloisine And Indirubin.
pdb|3O0G|A Chain A, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
pdb|3O0G|B Chain B, Crystal Structure Of Cdk5:p25 In Complex With An Atp
Analogue
Length = 292
Score = 52.0 bits (123), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 47/198 (23%), Positives = 94/198 (47%), Gaps = 11/198 (5%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDR--ALKSFDTECEVMRRIRHRNLIKIVSS 744
+G G++ V+KA VA+K L +D S E +++ ++H+N++++
Sbjct: 10 IGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDV 69
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
+ L+ ++ Q L+K+ S N L + + L + H S ++H
Sbjct: 70 LHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCH---SRNVLHR 125
Query: 805 DLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSEGIVSISG 862
DLKP N+L++ + L +FG+A+ G+ + + T+ Y P+ +G++ + S S
Sbjct: 126 DLKPQNLLINRNGELKLANFGLARAF-GIPVRCYSAEVVTLWYRPPDVLFGAK-LYSTSI 183
Query: 863 DVYSFGILMMETFTRRKP 880
D++S G + E +P
Sbjct: 184 DMWSAGCIFAELANAGRP 201
>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
pdb|3I6U|B Chain B, Structure And Activation Mechanism Of The Chk2 Dna-Damage
Checkpoint Kinase
Length = 419
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 68/245 (27%), Positives = 114/245 (46%), Gaps = 39/245 (15%)
Query: 685 SNLLGSGSFDNVYKA-TLANGVSVAVKVFNLQE---------DRALKSFDTECEVMRRIR 734
S LGSG+ V A VA+++ + ++ D AL + +TE E+++++
Sbjct: 140 SKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPAL-NVETEIEILKKLN 198
Query: 735 HRNLIKIVSSCSNPGFKALIMQYMPQGSL------EKWLYSHNYSLTIRQRLDIMIDVAS 788
H +IKI + + ++++ M G L K L L Q L
Sbjct: 199 HPCIIKIKNFFDAEDY-YIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML-------L 250
Query: 789 ALEYLHHGYSTPIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATI 845
A++YLH IIH DLKP NVLL ++D + + DFG +K+L G + +T+ T
Sbjct: 251 AVQYLHEN---GIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-GETSLMRTLC-GTP 305
Query: 846 GYMAPE----YGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVAESLPG 901
Y+APE G+ G + + D +S G+++ + P +E T ++SLK +
Sbjct: 306 TYLAPEVLVSVGTAG-YNRAVDCWSLGVILFICLSGYPPFSEHRT-QVSLKDQITSGKYN 363
Query: 902 AVTEV 906
+ EV
Sbjct: 364 FIPEV 368
>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1)
pdb|3I7B|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Nm-Pp1
pdb|3N51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor
Rm-1-95
pdb|3SX9|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-132
pdb|3SXF|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-89
pdb|3T3U|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-130
pdb|3T3V|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor,
Rm-1-87
pdb|3UPX|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1300
pdb|3UPZ|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumpless Bki Analog Uw1243
pdb|3V51|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Rm-1-176
pdb|3V5P|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1288
pdb|3V5T|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Inhibitor Uw1299
Length = 484
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 50/201 (24%), Positives = 92/201 (45%), Gaps = 16/201 (7%)
Query: 679 TNGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVF---NLQEDRALKSFDTECEVMRRIR 734
++ + +LG GSF V G AVKV +++ +S E ++++++
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 735 HRNLIKIVSSCSNPGFKALIMQYMPQGSL-EKWLYSHNYSLTIRQRLDIMIDVASALEYL 793
H N++K+ + G+ L+ + G L ++ + +S R I+ V S + Y+
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIRQVLSGITYM 142
Query: 794 HHGYSTPIIHCDLKPNNVLLD---DDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
H I+H DLKP N+LL+ D + DFG++ + + + T Y+AP
Sbjct: 143 H---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIAP 197
Query: 851 EYGSEGIVSISGDVYSFGILM 871
E G DV+S G+++
Sbjct: 198 EV-LHGTYDEKCDVWSTGVIL 217
>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase
Length = 360
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 84
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 85 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 190
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 191 PEIMLNAMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent
Protein Kinase
Length = 350
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V +G A+K+ + Q+ LK + E +++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---ALEY 792
L+K+ S + ++M+Y+ G + +SH + A EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
LH S +I+ DLKP N+L+D + DFG AK + G +T L T Y+APE
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 852 YGSEGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230
>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant
Catalytic Subunit Of Camp-Dependent Protein Kinase
Complexed With The Peptide Inhibitor Pki(5-24) And
Adenosine
pdb|1JLU|E Chain E, Crystal Structure Of The Catalytic Subunit Of
Camp-dependent Protein Kinase Complexed With A
Phosphorylated Substrate Peptide And Detergent
pdb|1RE8|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 2
pdb|1REJ|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 1
pdb|1REK|A Chain A, Crystal Structure Of Camp-Dependent Protein Kinase
Complexed With Balanol Analog 8
pdb|2QVS|E Chain E, Crystal Structure Of Type Iia Holoenzyme Of Camp-Dependent
Protein Kinase
pdb|3FJQ|E Chain E, Crystal Structure Of Camp-Dependent Protein Kinase
Catalytic Subunit Alpha In Complex With Peptide
Inhibitor Pki Alpha (6-25)
pdb|3IDB|A Chain A, Crystal Structure Of (108-268)riib:c Holoenzyme Of Camp-
Dependent Protein Kinase
pdb|3IDC|A Chain A, Crystal Structure Of (102-265)riib:c Holoenzyme Of Camp-
Dependent Protein Kinase
pdb|3O7L|D Chain D, Crystal Structure Of Phospholamban (1-19):pka
C-Subunit:amp-Pnp:mg2+ Complex
pdb|3OW3|A Chain A, Discovery Of Dihydrothieno- And Dihydrofuropyrimidines As
Potent Pan Akt Inhibitors
pdb|1ATP|E Chain E, 2.2 Angstrom Refined Crystal Structure Of The Catalytic
Subunit Of Camp-Dependent Protein Kinase Complexed With
Mnatp And A Peptide Inhibitor
pdb|4DIN|A Chain A, Novel Localization And Quaternary Structure Of The Pka Ri
Beta Holoenzyme
Length = 350
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V +G A+K+ + Q+ LK + E +++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---ALEY 792
L+K+ S + ++M+Y+ G + +SH + A EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
LH S +I+ DLKP N+L+D + DFG AK + G +T L T Y+APE
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 852 YGSEGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230
>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein
Kinase Catalytic Subunit
pdb|1J3H|B Chain B, Crystal Structure Of Apoenzyme Camp-Dependent Protein
Kinase Catalytic Subunit
Length = 350
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V +G A+K+ + Q+ LK + E +++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---ALEY 792
L+K+ S + ++M+Y+ G + +SH + A EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
LH S +I+ DLKP N+L+D + DFG AK + G +T L T Y+APE
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLXGTPEYLAPE 208
Query: 852 YGSEGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230
>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit
Of Camp- Dependent Protein Kinase
Length = 350
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V +G A+K+ + Q+ LK + E +++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---ALEY 792
L+K+ S + ++M+Y+ G + +SH + A EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
LH S +I+ DLKP N+L+D + DFG AK + G +T L T Y+APE
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 852 YGSEGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230
>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To
Hydroxyfasudil
Length = 351
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V +G A+K+ + Q+ LK + E +++ +
Sbjct: 42 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 101
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---ALEY 792
L+K+ S + ++M+Y+ G + +SH + A EY
Sbjct: 102 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 157
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
LH S +I+ DLKP N+L+D + DFG AK + G +T L T Y+APE
Sbjct: 158 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 209
Query: 852 YGSEGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 210 IILSKGYNKAVDWWALGVLIYE 231
>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated
Protein Kinase-Activated Protein Kinase 3
(Mk3)-Inhibitor Complex
pdb|3FXW|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated
Protein Kinase- Activated Protein Kinase 3INHIBITOR 2
COMPLEX
Length = 336
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 41/123 (33%), Positives = 62/123 (50%), Gaps = 10/123 (8%)
Query: 753 LIMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNV 811
+IM+ M G L + + + T R+ +IM D+ +A+++LH S I H D+KP N+
Sbjct: 103 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENL 159
Query: 812 LL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFG 868
L + D V L DFG AK + QT T Y+APE S D++S G
Sbjct: 160 LYTSKEKDAVLKLTDFGFAK--ETTQNALQT-PCYTPYYVAPEVLGPEKYDKSCDMWSLG 216
Query: 869 ILM 871
++M
Sbjct: 217 VIM 219
>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex
With Dp802
Length = 354
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 84
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 85 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGXVATRWYRA 190
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
pdb|3IPH|A Chain A, Crystal Structure Of P38 In Complex With A Biphenylamide
Inhibitor
Length = 360
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 84
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH-----------NYSLTIRQRLDIMIDVASA 789
L+ + P SLE+ +L +H LT ++ +
Sbjct: 85 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRG 137
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD----EMTGYVATRWYRA 190
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195
Length = 365
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 35 IGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 89
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 90 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 143 LKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD----EMTGYVATRWYRA 195
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of
Camp-Dependent Protein Kinase And Adenosine Further
Defines Conformational Flexibility
pdb|1BX6|A Chain A, Crystal Structure Of The Potent Natural Product Inhibitor
Balanol In Complex With The Catalytic Subunit Of Camp-
Dependent Protein Kinase
Length = 350
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V +G A+K+ + Q+ LK + E +++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---ALEY 792
L+K+ S + ++M+Y+ G + +SH + A EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
LH S +I+ DLKP N+L+D + DFG AK + G +T L T Y+APE
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 852 YGSEGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230
>pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX
Length = 462
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 76/266 (28%), Positives = 118/266 (44%), Gaps = 44/266 (16%)
Query: 67 NLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVS 126
NL+ L L +S N+ D + L + L+ ++FSSN ++ P + N T LE D+S
Sbjct: 127 NLTNLNRLELSSNTISDI--SALSGLTSLQQLNFSSNQVTDLKP--LAN-LTTLERLDIS 181
Query: 127 SNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLV----QLRLLG-----N 177
SNK++ S + +++L+S+ NN +S P + T L L QL+ +G
Sbjct: 182 SNKVSD--ISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLT 239
Query: 178 NITG-RIPNREIPN--EIGNLHNLKILDLGGNNIAGLIP--------------------S 214
N+T + N +I N + L L L LG N I+ + P S
Sbjct: 240 NLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDIS 299
Query: 215 MIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILEL 274
I N N+ + LY N++S P S L L+ LF + N +S + S+ N + L
Sbjct: 300 PISNLKNLTYLTLYFNNISDISPVS-SLTKLQRLFFYNNKVSDV--SSLANLTNINWLSA 356
Query: 275 SSNLFSGLVPNTFGNCRQLQILSLGD 300
N S L P N ++ L L D
Sbjct: 357 GHNQISDLTP--LANLTRITQLGLND 380
Score = 37.4 bits (85), Expect = 0.036, Method: Compositional matrix adjust.
Identities = 43/147 (29%), Positives = 63/147 (42%), Gaps = 10/147 (6%)
Query: 437 TCLANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFXXXXXXXXXXXXXXXXEALGGL 496
+ L+ LTSL+ L+F SN + P +L + +D L L
Sbjct: 145 SALSGLTSLQQLNFSSNQVTDLKP--LANLTTLERLDISSNKVSDISVLAKLTN--LESL 200
Query: 497 NLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIP 556
T NQ+S P +G L NLD L+L N + + SL +L LDL+ N IS P
Sbjct: 201 IATNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP 256
Query: 557 KSLEKLSRLVDFNVSFNGLEGEIPSGG 583
L L++L + + N + P G
Sbjct: 257 --LSGLTKLTELKLGANQISNISPLAG 281
>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955
Length = 350
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 28 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 82
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 83 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 135
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 136 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 188
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 189 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 218
>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp-
Dependent Protein Kinase Complexed With A Substrate
Peptide, Adp And Detergent
Length = 350
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 53/202 (26%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V +G A+K+ + Q+ LK + E +++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---ALEY 792
L+K+ S + ++M+Y+ G + +SH + A EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
LH S +I+ DLKP N+L+D + DFG AK + G +T L T Y+APE
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 852 YGSEGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230
>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine
pdb|4AA5|A Chain A, P38alpha Map Kinase Bound To Cmpd 33
Length = 365
Score = 51.6 bits (122), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 35 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 89
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 90 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 143 LKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD----EMTGYVATRWYRA 195
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|3HEC|A Chain A, P38 In Complex With Imatinib
pdb|3HEG|A Chain A, P38 In Complex With Sorafenib
Length = 348
Score = 51.2 bits (121), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 26 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 80
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 81 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 133
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 134 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 186
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl
Amide Inhibitor
Length = 360
Score = 51.2 bits (121), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 94/210 (44%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 84
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH-----------NYSLTIRQRLDIMIDVASA 789
L+ + P SLE+ +L +H LT ++ +
Sbjct: 85 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKXQKLTDDHVQFLIYQILRG 137
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 190
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
Length = 349
Score = 51.2 bits (121), Expect = 2e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 27 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 81
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 82 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 134
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 135 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 187
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217
>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
pdb|2I6L|B Chain B, Crystal Structure Of Human Mitogen Activated Protein
Kinase 6 (Mapk6)
Length = 320
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 60/225 (26%), Positives = 103/225 (45%), Gaps = 27/225 (12%)
Query: 707 VAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPG---------FKALIMQY 757
VA+K L + +++K E +++RR+ H N++K+ G L Y
Sbjct: 39 VAIKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVY 98
Query: 758 MPQGSLEKWL---YSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLD 814
+ Q +E L L RL M + L+Y+H S ++H DLKP N+ ++
Sbjct: 99 IVQEYMETDLANVLEQGPLLEEHARL-FMYQLLRGLKYIH---SANVLHRDLKPANLFIN 154
Query: 815 -DDMVAHLGDFGIAKLLDGVDPVTQTMT--LATIGYMAPE-YGSEGIVSISGDVYSFGIL 870
+D+V +GDFG+A+++D ++ L T Y +P S + + D+++ G +
Sbjct: 155 TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCI 214
Query: 871 MMETFTRRKPTNEMFTG--EMSLKQWVAESLPGAVTEVVDANLLS 913
E T + +F G E+ Q + ES+P V E LLS
Sbjct: 215 FAEMLTGKT----LFAGAHELEQMQLILESIP-VVHEEDRQELLS 254
>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase
Length = 362
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 32 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 86
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 87 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 140 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 192
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
pdb|3E93|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl
Amide Inhibitor
Length = 371
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 41 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 95
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 96 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 148
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 149 LKYIH---SADIIHRDLKPSNLAVNEDXELKILDFGLARHTDD----EMTGYVATRWYRA 201
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231
>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48
pdb|3GCU|B Chain B, Human P38 Map Kinase In Complex With Rl48
pdb|3HV4|A Chain A, Human P38 Map Kinase In Complex With Rl51
pdb|3HV4|B Chain B, Human P38 Map Kinase In Complex With Rl51
pdb|3HV5|A Chain A, Human P38 Map Kinase In Complex With Rl24
pdb|3HV5|B Chain B, Human P38 Map Kinase In Complex With Rl24
pdb|3HV6|A Chain A, Human P38 Map Kinase In Complex With Rl39
pdb|3HV7|A Chain A, Human P38 Map Kinase In Complex With Rl38
pdb|3HUC|A Chain A, Human P38 Map Kinase In Complex With Rl40
pdb|3LFA|A Chain A, Human P38 Map Kinase In Complex With Dasatinib
pdb|3QUE|A Chain A, Human P38 Map Kinase In Complex With Skepinone-L
pdb|3QUD|A Chain A, Human P38 Map Kinase In Complex With
2-Amino-Phenylamino-Benzophenone
pdb|3UVP|A Chain A, Human P38 Map Kinase In Complex With A Benzamide
Substituted Benzosuberone
pdb|3UVQ|A Chain A, Human P38 Map Kinase In Complex With A Dibenzosuberone
Derivative
pdb|4EH2|A Chain A, Human P38 Map Kinase In Complex With Np-F1 And Rl87
pdb|4EH3|A Chain A, Human P38 Map Kinase In Complex With Np-F2 And Rl87
pdb|4EH4|A Chain A, Human P38 Map Kinase In Complex With Np-F3 And Rl87
pdb|4EH5|A Chain A, Human P38 Map Kinase In Complex With Np-F4 And Rl87
pdb|4EH6|A Chain A, Human P38 Map Kinase In Complex With Np-F5 And Rl87
pdb|4EH7|A Chain A, Human P38 Map Kinase In Complex With Np-F6 And Rl87
pdb|4EH8|A Chain A, Human P38 Map Kinase In Complex With Np-F7 And Rl87
pdb|4EH9|A Chain A, Human P38 Map Kinase In Complex With Np-F11 And Rl87
pdb|4EHV|A Chain A, Human P38 Map Kinase In Complex With Np-F10 And Rl87
pdb|3UVR|A Chain A, Human P38 Map Kinase In Complex With Km064
pdb|4DLI|A Chain A, Human P38 Map Kinase In Complex With Rl87
pdb|4DLJ|A Chain A, Human P38 Map Kinase In Complex With Rl163
Length = 360
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 84
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 85 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 190
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant
Length = 360
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 84
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 85 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 190
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499
pdb|3FKO|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3668
pdb|3FLN|C Chain C, P38 Kinase Crystal Structure In Complex With R1487
Length = 372
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 42 VGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHMKHENVI----- 96
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 97 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 149
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 150 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 202
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232
>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole
Inhibitor
Length = 372
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 42 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 96
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 97 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 149
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 150 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 202
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232
>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195
pdb|3FKL|A Chain A, P38 Kinase Crystal Structure In Complex With Ro9552
pdb|3FKN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro7125
pdb|3FL4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro5634
pdb|3FLQ|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((S)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin
pdb|3FLS|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-((R)-2-Methanesulfonyl-1-Methyl-
Ethylamino)-8-Methyl-8h-Pyrido[2,3-D]pyrimidin-7-One
pdb|3FLW|A Chain A, P38 Kinase Crystal Structure In Complex With Pamapimod
pdb|3FLY|A Chain A, P38 Kinase Crystal Structure In Complex With 6-(2,4-
Difluoro-Phenoxy)-2-Isopropylamino-8-Methyl-8h-Pyrido[2,
3- D]pyrimidin-7-One
pdb|3FLZ|A Chain A, P38 Kinase Crystal Structure In Complex With
8-Methyl-6-Phenoxy-2-
(Tetrahydro-Pyran-4-Ylamino)-8h-Pyrido[2,
3-D]pyrimidin-7-One
pdb|3FMH|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((R)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FMJ|A Chain A, P38 Kinase Crystal Structure In Complex With
4-(5-Methyl-3-Phenyl- Isoxazol-4-Yl)-Pyrimidin-2-Ylamine
pdb|3FMK|A Chain A, P38 Kinase Crystal Structure In Complex With
6-(2,4-Difluoro-Phenoxy)-
8-Methyl-2-((S)-1-Methyl-2-Tetrazol-2-Yl-Ethylamino)-8h-
Pyrido[2,3- D]pyrimidin-7-One
pdb|3FML|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6224
pdb|3FMM|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6226
pdb|3FMN|A Chain A, P38 Kinase Crystal Structure In Complex With Ro2530
pdb|3FSF|A Chain A, P38 Kinase Crystal Structure In Complex With 3-(2,6-
Dichloro-Phenyl)-7-[4-(2-Diethylamino-Ethoxy)-
Phenylamino]-
1-Methyl-3,4-Dihydro-1h-Pyrimido[4,5-D]pyrimidin-2-One
pdb|3FSK|A Chain A, P38 Kinase Crystal Structure In Complex With Ro6257
Length = 372
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 42 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 96
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 97 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 149
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 150 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 202
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 203 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 232
>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1-
Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3-
Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide
Length = 380
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 50 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 104
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 105 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 157
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 158 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 210
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240
>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine
pdb|2YIX|A Chain A, Triazolopyridine Inhibitors Of P38
Length = 351
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 27 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 81
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 82 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 134
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 135 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 187
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 188 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 217
>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant
Length = 360
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 84
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 85 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 190
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121
Length = 362
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 32 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 86
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 87 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 140 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 192
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715
pdb|3ZSH|A Chain A, X-Ray Structure Of P38alpha Bound To Scio-469
pdb|3ZSI|A Chain A, X-Ray Structure Of P38alpha Bound To Vx-745
pdb|3ZS5|A Chain A, Structural Basis For Kinase Selectivity Of Three Clinical
P38alpha Inhibitors
Length = 362
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 32 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 86
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 87 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 140 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 192
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant
Length = 360
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 84
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 85 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 190
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995
pdb|1BL7|A Chain A, The Complex Structure Of The Map Kinase P38SB220025
pdb|2EWA|A Chain A, Dual Binding Mode Of Pyridinylimidazole To Map Kinase P38
pdb|1A9U|A Chain A, The Complex Structure Of The Map Kinase P38SB203580
pdb|3HA8|A Chain A, The Complex Structure Of The Map Kinase P38COMPOUND 14B
Length = 379
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 49 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 103
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 104 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 156
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 157 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 209
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239
>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea
pdb|2BAK|A Chain A, P38alpha Map Kinase Bound To Mpaq
pdb|4A9Y|A Chain A, P38alpha Map Kinase Bound To Cmpd 8
pdb|4AA0|A Chain A, P38alpha Map Kinase Bound To Cmpd 2
pdb|4AA4|A Chain A, P38alpha Map Kinase Bound To Cmpd 22
pdb|4AAC|A Chain A, P38alpha Map Kinase Bound To Cmpd 29
Length = 365
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 35 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 89
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 90 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 143 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 195
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|3MW1|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|2YIS|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase.
pdb|2YIW|A Chain A, Triazolopyridine Inhibitors Of P38 Kinase
Length = 359
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 29 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 83
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 84 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 136
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 137 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 189
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 190 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 219
>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A
Pyrrole-2- Carboxamide Inhibitor
Length = 371
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 41 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 95
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 96 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 148
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 149 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 201
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 202 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 231
>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A
Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE
COMPLEX IN Solution
Length = 359
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 35 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 89
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 90 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 142
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 143 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 195
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 196 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 225
>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376
pdb|3NNV|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp437
pdb|3NNW|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp802
Length = 354
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 84
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 85 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 190
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor
Length = 383
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 53 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 107
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 108 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 160
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 161 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 213
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243
>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b
pdb|3SHE|A Chain A, Novel Atp-Competitive Mk2 Inhibitors With Potent
Biochemical And Cell- Based Activity Throughout The
Series
Length = 317
Score = 51.2 bits (121), Expect = 3e-06, Method: Composition-based stats.
Identities = 41/123 (33%), Positives = 62/123 (50%), Gaps = 10/123 (8%)
Query: 753 LIMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNV 811
+IM+ M G L + + + T R+ +IM D+ +A+++LH S I H D+KP N+
Sbjct: 84 IIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLH---SHNIAHRDVKPENL 140
Query: 812 LL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFG 868
L + D V L DFG AK + QT T Y+APE S D++S G
Sbjct: 141 LYTSKEKDAVLKLTDFGFAK--ETTQNALQT-PCYTPYYVAPEVLGPEKYDKSCDMWSLG 197
Query: 869 ILM 871
++M
Sbjct: 198 VIM 200
>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map
Kinase
Length = 360
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 84
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 85 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 190
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase
Length = 367
Score = 51.2 bits (121), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 91
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 92 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 145 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 197
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A
Dihydroquinazolinone Inhibitor
pdb|1OUK|A Chain A, The Structure Of P38 Alpha In Complex With A
Pyridinylimidazole Inhibitor
pdb|1OUY|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydropyrido- Pyrimidine Inhibitor
pdb|1R39|A Chain A, The Structure Of P38alpha
pdb|1YQJ|A Chain A, Crystal Structure Of P38 Alpha In Complex With A Selective
Pyridazine Inhibitor
pdb|2OKR|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2OKR|D Chain D, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|A Chain A, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|B Chain B, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|1WFC|A Chain A, Structure Of Apo, Unphosphorylated, P38 Mitogen Activated
Protein Kinase P38 (P38 Map Kinase) The Mammalian
Homologue Of The Yeast Hog1 Protein
pdb|3DS6|A Chain A, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|B Chain B, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|C Chain C, P38 Complex With A Phthalazine Inhibitor
pdb|3DS6|D Chain D, P38 Complex With A Phthalazine Inhibitor
pdb|3FC1|X Chain X, Crystal Structure Of P38 Kinase Bound To
Pyrimido-Pyridazinone Inhibitor
pdb|3GFE|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor
pdb|3ITZ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridazine Inhibitor
pdb|3LHJ|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Pyrazolopyridinone Inhibitor.
pdb|3ZYA|A Chain A, Human P38 Map Kinase In Complex With 2-Amino-Phenylamino-
Dibenzosuberone
pdb|3U8W|A Chain A, Crystal Structure Of P38a Mitogen-Activated Protein Kinase
In Complex With A Triazolopyridazinone Inhibitor
Length = 366
Score = 50.8 bits (120), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 36 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 90
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 91 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 143
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 144 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 196
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In
Complex With 4-[3-Methylsulfanylanilino]-6,7-
Dimethoxyquinazoline
pdb|1KV1|A Chain A, P38 Map Kinase In Complex With Inhibitor 1
pdb|1KV2|A Chain A, Human P38 Map Kinase In Complex With Birb 796
pdb|1WBO|A Chain A, Fragment Based P38 Inhibitors
pdb|1W7H|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W82|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W83|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1W84|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|1ZZ2|A Chain A, Two Classes Of P38alpha Map Kinase Inhibitors Having A
Common Diphenylether Core But Exhibiting Divergent
Binding Modes
pdb|1WBN|A Chain A, Fragment Based P38 Inhibitors
pdb|1WBS|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBT|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-based Lead Generation.
pdb|1WBV|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1WBW|A Chain A, Identification Of Novel P38 Alpha Map Kinase Inhibitors
Using Fragment-Based Lead Generation.
pdb|1ZYJ|A Chain A, Human P38 Map Kinase In Complex With Inhibitor 1a
pdb|2ZAZ|A Chain A, Crystal Structure Of P38 In Complex With 4-Anilino
Quinoline Inhibitor
pdb|2ZB0|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|2ZB1|A Chain A, Crystal Structure Of P38 In Complex With Biphenyl Amide
Inhibitor
pdb|3HL7|A Chain A, Crystal Structure Of Human P38alpha Complexed With Sd-0006
pdb|3HLL|A Chain A, Crystal Structure Of Human P38alpha Complexed With
Ph-797804
pdb|3HP2|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyridinone Compound
pdb|3HP5|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Pyrimidopyridazinone Compound
pdb|3KF7|A Chain A, Crystal Structure Of Human P38alpha Complexed With A
Triazolopyrimidine Compound
pdb|3MGY|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3ROC|A Chain A, Crystal Structure Of Human P38 Alpha Complexed With A
Pyrimidinone Compound
pdb|3RIN|A Chain A, P38 Kinase Crystal Structure In Complex With Small
Molecule Inhibitor
pdb|4E5B|A Chain A, Structure Of P38a Map Kinase Without Bog
pdb|4E6A|A Chain A, P38a-Pia23 Complex
pdb|4E6C|A Chain A, P38a-perifosine Complex
pdb|4E8A|A Chain A, The Crystal Structure Of P38a Map Kinase In Complex With
Pia24
Length = 360
Score = 50.8 bits (120), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 84
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 85 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 190
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka
C-Subunit:amp-Pnp:mg2+ Complex
Length = 350
Score = 50.8 bits (120), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V +G A+K+ + Q+ LK + E +++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---ALEY 792
L+K+ S + ++M+Y+ G + +SH + A EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
LH S +I+ DLKP N+++D + DFG AK + G +T L T Y+APE
Sbjct: 157 LH---SLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 852 YGSEGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 209 IIISKGYNKAVDWWALGVLIYE 230
>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
pdb|3MA6|B Chain B, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence
Of 3brb-Pp1
Length = 298
Score = 50.8 bits (120), Expect = 3e-06, Method: Composition-based stats.
Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 16/204 (7%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIV 742
+LG GSF V G AVKV + +++ +S E ++++++ H N++K+
Sbjct: 39 VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLY 98
Query: 743 SSCSNPGFKALIMQYMPQGSL-EKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
+ G+ L+ + G L ++ + +S R I+ V S + Y+H I
Sbjct: 99 EFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIRQVLSGITYMH---KNKI 153
Query: 802 IHCDLKPNNVLLDD---DMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIV 858
+H DLKP N+LL+ D + DFG++ + + + T Y+APE G
Sbjct: 154 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKD--KIGTAYYIAPEV-LHGTY 210
Query: 859 SISGDVYSFGILMMETFTRRKPTN 882
DV+S G+++ + P N
Sbjct: 211 DEKCDVWSTGVILYILLSGCPPFN 234
>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1)
Catalytic Domain
Length = 317
Score = 50.8 bits (120), Expect = 3e-06, Method: Composition-based stats.
Identities = 48/198 (24%), Positives = 88/198 (44%), Gaps = 9/198 (4%)
Query: 687 LLGSGSFDNVYKATLANGVSV-AVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G F Y+ T + V A KV L + + TE + + + + +++
Sbjct: 49 FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPII 802
+ F ++++ + SL + L+ ++T + M ++YLH+ +I
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQYLHNNR---VI 164
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISG 862
H DLK N+ L+DDM +GDFG+A ++ D + T Y+APE + S
Sbjct: 165 HRDLKLGNLFLNDDMDVKIGDFGLATKIE-FDGERKKTLCGTPNYIAPEVLCKKGHSFEV 223
Query: 863 DVYSFGILMMETFTRRKP 880
D++S G ++ + P
Sbjct: 224 DIWSLGCILYTLLVGKPP 241
>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk
Docking Peptide
Length = 362
Score = 50.8 bits (120), Expect = 3e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 32 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 86
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 87 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 139
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 140 LKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDD----EMTGYVATRWYRA 192
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 193 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 222
>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1
(Plk1) Catalytic Domain In Complex With Adp
Length = 317
Score = 50.8 bits (120), Expect = 3e-06, Method: Composition-based stats.
Identities = 48/198 (24%), Positives = 88/198 (44%), Gaps = 9/198 (4%)
Query: 687 LLGSGSFDNVYKATLANGVSV-AVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G F Y+ T + V A KV L + + TE + + + + +++
Sbjct: 49 FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPII 802
+ F ++++ + SL + L+ ++T + M ++YLH+ +I
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQYLHNNR---VI 164
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISG 862
H DLK N+ L+DDM +GDFG+A ++ D + T Y+APE + S
Sbjct: 165 HRDLKLGNLFLNDDMDVKIGDFGLATKIE-FDGERKKXLCGTPNYIAPEVLCKKGHSFEV 223
Query: 863 DVYSFGILMMETFTRRKP 880
D++S G ++ + P
Sbjct: 224 DIWSLGCILYTLLVGKPP 241
>pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX
Length = 462
Score = 50.8 bits (120), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 76/266 (28%), Positives = 117/266 (43%), Gaps = 44/266 (16%)
Query: 67 NLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVS 126
NL+ L L +S N+ D + L + L+ + FSSN ++ P + N T LE D+S
Sbjct: 127 NLTNLNRLELSSNTISDI--SALSGLTSLQQLSFSSNQVTDLKP--LAN-LTTLERLDIS 181
Query: 127 SNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLV----QLRLLG-----N 177
SNK++ S + +++L+S+ NN +S P + T L L QL+ +G
Sbjct: 182 SNKVSD--ISVLAKLTNLESLIATNNQISDITPLGILTNLDELSLNGNQLKDIGTLASLT 239
Query: 178 NITG-RIPNREIPN--EIGNLHNLKILDLGGNNIAGLIP--------------------S 214
N+T + N +I N + L L L LG N I+ + P S
Sbjct: 240 NLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPLAGLTALTNLELNENQLEDIS 299
Query: 215 MIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILEL 274
I N N+ + LY N++S P S L L+ LF + N +S + S+ N + L
Sbjct: 300 PISNLKNLTYLTLYFNNISDISPVS-SLTKLQRLFFYNNKVSDV--SSLANLTNINWLSA 356
Query: 275 SSNLFSGLVPNTFGNCRQLQILSLGD 300
N S L P N ++ L L D
Sbjct: 357 GHNQISDLTP--LANLTRITQLGLND 380
>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein
Kinase Kinase 7 Activated Mutant (S287d, T291d)
Length = 318
Score = 50.8 bits (120), Expect = 4e-06, Method: Composition-based stats.
Identities = 39/124 (31%), Positives = 59/124 (47%), Gaps = 9/124 (7%)
Query: 782 IMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMT 841
+ + + AL YL + +IH D+KP+N+LLD+ L DFGI+ L VD + +
Sbjct: 129 MTVAIVKALYYLKEKHG--VIHRDVKPSNILLDERGQIKLCDFGISGRL--VDDKAKDRS 184
Query: 842 LATIGYMAPEY-----GSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWVA 896
YMAPE ++ I DV+S GI ++E T + P T L + +
Sbjct: 185 AGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQ 244
Query: 897 ESLP 900
E P
Sbjct: 245 EEPP 248
>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And
Drb
pdb|4EC9|A Chain A, Crystal Structure Of Full-Length Cdk9 In Complex With
Cyclin T
Length = 373
Score = 50.8 bits (120), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 27/209 (12%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDR------ALKSFDTECEVMRRIRHRNLIK 740
+G G+F V+KA G VA+K ++ ++ AL+ E ++++ ++H N++
Sbjct: 26 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKILQLLKHENVVN 81
Query: 741 IVSSCSNP--------GFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEY 792
++ C G L+ + + L L + T+ + +M + + L Y
Sbjct: 82 LIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK---LLDGVDPVTQTMTLATIGYMA 849
+H I+H D+K NVL+ D V L DFG+A+ L P + T+ Y
Sbjct: 141 IHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 850 PE-YGSEGIVSISGDVYSFGILMMETFTR 877
PE E D++ G +M E +TR
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEMWTR 226
>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 50.8 bits (120), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 58/224 (25%), Positives = 93/224 (41%), Gaps = 38/224 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNII----- 86
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
L+ + PQ SLE++ L N S I+ LD ++ + +
Sbjct: 87 -------GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGI 139
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ T + T Y AP
Sbjct: 140 KHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRYYRAP 194
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E + D++S G++M E +F G + QW
Sbjct: 195 EVILGMGYKENVDIWSVGVIMGEMIK----GGVLFPGTDHIDQW 234
>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|B Chain B, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
pdb|2QG5|D Chain D, Cryptosporidium Parvum Calcium Dependent Protein Kinase
Cgd7_1840
Length = 294
Score = 50.8 bits (120), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 54/194 (27%), Positives = 85/194 (43%), Gaps = 17/194 (8%)
Query: 685 SNLLGSGSFDNVYKATLANGVSV--AVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIV 742
N +G GS+ V K + G + A K + F E E+M+ + H N+I++
Sbjct: 31 ENTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLY 89
Query: 743 SSCSNPGFKALIMQYMPQGSL-EKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
+ + L+M+ G L E+ ++ + + R IM DV SA+ Y H +
Sbjct: 90 ETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR--IMKDVLSAVAYCH---KLNV 144
Query: 802 IHCDLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMT-LATIGYMAPEYGSEGI 857
H DLKP N L D L DFG+A P T + T Y++P+ EG+
Sbjct: 145 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARF---KPGKMMRTKVGTPYYVSPQV-LEGL 200
Query: 858 VSISGDVYSFGILM 871
D +S G++M
Sbjct: 201 YGPECDEWSAGVMM 214
>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From
Par-3
Length = 396
Score = 50.8 bits (120), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 36/97 (37%), Positives = 50/97 (51%), Gaps = 6/97 (6%)
Query: 785 DVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-A 843
+++ AL YLH II+ DLK +NVLLD + L D+G+ K +G+ P T T
Sbjct: 161 EISLALNYLH---ERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSTFCG 215
Query: 844 TIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKP 880
T Y+APE S D ++ G+LM E R P
Sbjct: 216 TPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSP 252
>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex
pdb|2QD9|A Chain A, P38 Alpha Map Kinase Inhibitor Based On Heterobicyclic
Scaffolds
pdb|2RG5|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11b
pdb|2RG6|A Chain A, Phenylalanine Pyrrolotriazine P38 Alpha Map Kinase
Inhibitor Compound 11j
pdb|3C5U|A Chain A, P38 Alpha Map Kinase Complexed With A Benzothiazole Based
Inhibitor
pdb|3BV2|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 30
pdb|3BV3|A Chain A, Morpholino Pyrrolotriazine P38 Alpha Map Kinase Inhibitor
Compound 2
pdb|3BX5|A Chain A, P38 Alpha Map Kinase Complexed With Bms-640994
pdb|3L8X|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Pyrimidine
Based Inhibitor
pdb|3NWW|A Chain A, P38 Alpha Kinase Complexed With A
2-Aminothiazol-5-Yl-Pyrimidine Based Inhibitor
pdb|3MVL|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVL|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7k
pdb|3MVM|A Chain A, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3MVM|B Chain B, P38 Alpha Map Kinase Complexed With Pyrrolotriazine
Inhibitor 7v
pdb|3OCG|A Chain A, P38 Alpha Kinase Complexed With A 5-Amino-Pyrazole Based
Inhibitor
pdb|3S4Q|A Chain A, P38 Alpha Kinase Complexed With A Pyrazolo-Triazine Based
Inhibitor
Length = 366
Score = 50.4 bits (119), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 36 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 90
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 91 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 143
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 144 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 196
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A
Dihydroquinolinone
pdb|1R3C|A Chain A, The Structure Of P38alpha C162s Mutant
pdb|2I0H|A Chain A, The Structure Of P38alpha In Complex With An
Arylpyridazinone
pdb|3GC7|A Chain A, The Structure Of P38alpha In Complex With A
Dihydroquinazolinone
pdb|3NEW|A Chain A, P38-Alpha Complexed With Compound 10
Length = 366
Score = 50.4 bits (119), Expect = 4e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 36 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 90
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 91 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 143
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 144 LKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLARHTDD----EMTGYVATRWYRA 196
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1
pdb|3BLQ|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
ATP
pdb|3BLR|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 IN COMPLEX WITH
Flavopiridol
pdb|3MY1|A Chain A, Structure Of Cdk9CYCLINT1 IN COMPLEX WITH DRB
pdb|3LQ5|A Chain A, Structure Of Cdk9CYCLINT IN COMPLEX WITH S-Cr8
pdb|3TN8|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNH|A Chain A, Cdk9CYCLIN T IN COMPLEX WITH CAN508
pdb|3TNI|A Chain A, Structure Of Cdk9CYCLIN T F241L
pdb|4BCH|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCI|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
pdb|4BCJ|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 50.4 bits (119), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 27/209 (12%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDR------ALKSFDTECEVMRRIRHRNLIK 740
+G G+F V+KA G VA+K ++ ++ AL+ E ++++ ++H N++
Sbjct: 26 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKILQLLKHENVVN 81
Query: 741 IVSSCSNP--------GFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEY 792
++ C G L+ + + L L + T+ + +M + + L Y
Sbjct: 82 LIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 140
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK---LLDGVDPVTQTMTLATIGYMA 849
+H I+H D+K NVL+ D V L DFG+A+ L P + T+ Y
Sbjct: 141 IHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 197
Query: 850 PE-YGSEGIVSISGDVYSFGILMMETFTR 877
PE E D++ G +M E +TR
Sbjct: 198 PELLLGERDYGPPIDLWGAGCIMAEMWTR 226
>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent
Protein Kinase Reveals Unexpected Apoenzyme Conformation
pdb|1SYK|B Chain B, Crystal Structure Of E230q Mutant Of Camp-Dependent
Protein Kinase Reveals Unexpected Apoenzyme Conformation
Length = 350
Score = 50.4 bits (119), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 52/202 (25%), Positives = 89/202 (44%), Gaps = 20/202 (9%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V +G A+K+ + Q+ LK + E +++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---ALEY 792
L+K+ S + ++M+Y+ G + +SH + A EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
LH S +I+ DLKP N+L+D + DFG AK + G +T L T Y+APE
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEYLAPE 208
Query: 852 YGSEGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ +
Sbjct: 209 IILSKGYNKAVDWWALGVLIYQ 230
>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC7|D Chain D, Crystal Structure Of The Erk5 Kinase Domain In Complex
With An Mkk5 Binding Fragment
pdb|4IC8|A Chain A, Crystal Structure Of The Apo Erk5 Kinase Domain
pdb|4IC8|B Chain B, Crystal Structure Of The Apo Erk5 Kinase Domain
Length = 442
Score = 50.4 bits (119), Expect = 5e-06, Method: Compositional matrix adjust.
Identities = 63/244 (25%), Positives = 113/244 (46%), Gaps = 22/244 (9%)
Query: 663 NLATLSRISYHELQQATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALK 721
NLA L S+ + + +G+G++ V A G VA+K D
Sbjct: 38 NLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTN 97
Query: 722 SFDT--ECEVMRRIRHRNLIKIVS----SCSNPGFKAL--IMQYMPQGSLEKWLYSHNYS 773
+ T E ++++ +H N+I I + FK++ ++ M + L + ++S +
Sbjct: 98 AKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHS-SQP 155
Query: 774 LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833
LT+ + + L+Y+H S +IH DLKP+N+L++++ +GDFG+A+ L
Sbjct: 156 LTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 212
Query: 834 DPVTQ---TMTLATIGYMAPEYG-SEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEM 889
Q T +AT Y APE S + + D++S G + E RR ++F G+
Sbjct: 213 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR----QLFPGKN 268
Query: 890 SLKQ 893
+ Q
Sbjct: 269 YVHQ 272
>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit
Of Camp- Dependent Protein Kinase
Length = 350
Score = 50.1 bits (118), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 28/206 (13%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V +G A+K+ + Q+ LK + E +++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---ALEY 792
L+K+ S + ++M+Y+ G + +SH + A EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEY 852
LH S +I+ DLKP N+L+D + DFG AK + G +T L PEY
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCG----TPEY 204
Query: 853 GSEGIVSISG-----DVYSFGILMME 873
+ I+ G D ++ G+L+ E
Sbjct: 205 LAPAIILSKGYNKAVDWWALGVLIYE 230
>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580
pdb|3GCQ|A Chain A, Human P38 Map Kinase In Complex With Rl45
pdb|3GCS|A Chain A, Human P38 Map Kinase In Complex With Sorafenib
pdb|3GCV|A Chain A, Human P38 Map Kinase In Complex With Rl62
pdb|3HV3|A Chain A, Human P38 Map Kinase In Complex With Rl49
pdb|3IW5|A Chain A, Human P38 Map Kinase In Complex With An Indole Derivative
pdb|3IW6|A Chain A, Human P38 Map Kinase In Complex With A Benzylpiperazin-
Pyrrol
pdb|3IW7|A Chain A, Human P38 Map Kinase In Complex With An Imidazo-Pyridine
pdb|3IW8|A Chain A, Structure Of Inactive Human P38 Map Kinase In Complex With
A Thiazole-Urea
pdb|3HUB|A Chain A, Human P38 Map Kinase In Complex With Scios-469
pdb|3L8S|A Chain A, Human P38 Map Kinase In Complex With Cp-547632
pdb|3LFB|A Chain A, Human P38 Map Kinase In Complex With Rl98
pdb|3LFC|A Chain A, Human P38 Map Kinase In Complex With Rl99
pdb|3LFD|A Chain A, Human P38 Map Kinase In Complex With Rl113
pdb|3LFE|A Chain A, Human P38 Map Kinase In Complex With Rl116
pdb|3LFF|A Chain A, Human P38 Map Kinase In Complex With Rl166
pdb|3PG3|A Chain A, Human P38 Map Kinase In Complex With Rl182
Length = 360
Score = 50.1 bits (118), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 94/210 (44%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 84
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH-----------NYSLTIRQRLDIMIDVASA 789
L+ + P SLE+ +L +H + LT ++ +
Sbjct: 85 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKSQKLTDDHVQFLIYQILRG 137
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+ + D T +AT Y A
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDD----EMTGYVATRWYRA 190
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb
pdb|3MIA|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Atp-Bound
Human P-Tefb
Length = 351
Score = 50.1 bits (118), Expect = 6e-06, Method: Compositional matrix adjust.
Identities = 52/209 (24%), Positives = 92/209 (44%), Gaps = 27/209 (12%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDR------ALKSFDTECEVMRRIRHRNLIK 740
+G G+F V+KA G VA+K ++ ++ AL+ E ++++ ++H N++
Sbjct: 25 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKILQLLKHENVVN 80
Query: 741 IVSSCSNP--------GFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEY 792
++ C G L+ + + L L + T+ + +M + + L Y
Sbjct: 81 LIEICRTKASPYNRCKGSIYLVFDFC-EHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYY 139
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK---LLDGVDPVTQTMTLATIGYMA 849
+H I+H D+K NVL+ D V L DFG+A+ L P + T+ Y
Sbjct: 140 IHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRP 196
Query: 850 PE-YGSEGIVSISGDVYSFGILMMETFTR 877
PE E D++ G +M E +TR
Sbjct: 197 PELLLGERDYGPPIDLWGAGCIMAEMWTR 225
>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
pdb|2WTK|F Chain F, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha
Complex
Length = 305
Score = 50.1 bits (118), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 51/198 (25%), Positives = 88/198 (44%), Gaps = 17/198 (8%)
Query: 686 NLLGSGSFDNVYKA----TLAN-GVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIK 740
+LLG GS+ V + TL V + K + + E +++RR+RH+N+I+
Sbjct: 11 DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQ 70
Query: 741 IVSSCSNPGFKAL--IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
+V N + + +M+Y G E + Q + LEYLH S
Sbjct: 71 LVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH---S 127
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD--GVDPVTQTMTLATIGYMAPEYGSEG 856
I+H D+KP N+LL + G+A+ L D +T + + + PE + G
Sbjct: 128 QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRT-SQGSPAFQPPEI-ANG 185
Query: 857 IVSISG---DVYSFGILM 871
+ + SG D++S G+ +
Sbjct: 186 LDTFSGFKVDIWSAGVTL 203
>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With
Inhibitor Pg-892579
pdb|2GTN|A Chain A, Mutated Map Kinase P38 (mus Musculus) In Complex With
Inhbitor Pg-951717
Length = 348
Score = 50.1 bits (118), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G VAVK + Q K E +++ ++H N+I
Sbjct: 26 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 80
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 81 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 133
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 134 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 186
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain.
pdb|3DB8|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 041
pdb|3DBC|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 257
pdb|3DBD|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 094
Length = 317
Score = 50.1 bits (118), Expect = 7e-06, Method: Composition-based stats.
Identities = 48/198 (24%), Positives = 88/198 (44%), Gaps = 9/198 (4%)
Query: 687 LLGSGSFDNVYKATLANGVSV-AVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G F Y+ T + V A KV L + + TE + + + + +++
Sbjct: 49 FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 108
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPII 802
+ F ++++ + SL + L+ ++T + M ++YLH+ +I
Sbjct: 109 GFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQYLHNNR---VI 164
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISG 862
H DLK N+ L+DDM +GDFG+A ++ D + T Y+APE + S
Sbjct: 165 HRDLKLGNLFLNDDMDVKIGDFGLATKIE-FDGERKKDLCGTPNYIAPEVLCKKGHSFEV 223
Query: 863 DVYSFGILMMETFTRRKP 880
D++S G ++ + P
Sbjct: 224 DIWSLGCILYTLLVGKPP 241
>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 902
pdb|3D5X|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Wortmannin.
pdb|3DBE|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 557
pdb|3DBF|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like
Kinase 1 (Plk1) Catalytic Domain In Complex With
Compound 562
Length = 301
Score = 50.1 bits (118), Expect = 7e-06, Method: Composition-based stats.
Identities = 48/198 (24%), Positives = 88/198 (44%), Gaps = 9/198 (4%)
Query: 687 LLGSGSFDNVYKATLANGVSV-AVKVFN---LQEDRALKSFDTECEVMRRIRHRNLIKIV 742
LG G F Y+ T + V A KV L + + TE + + + + +++
Sbjct: 33 FLGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLDNPHVVGFH 92
Query: 743 SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPII 802
+ F ++++ + SL + L+ ++T + M ++YLH+ +I
Sbjct: 93 GFFEDDDFVYVVLEICRRRSLLE-LHKRRKAVTEPEARYFMRQTIQGVQYLHNNR---VI 148
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISG 862
H DLK N+ L+DDM +GDFG+A ++ D + T Y+APE + S
Sbjct: 149 HRDLKLGNLFLNDDMDVKIGDFGLATKIE-FDGERKKDLCGTPNYIAPEVLCKKGHSFEV 207
Query: 863 DVYSFGILMMETFTRRKP 880
D++S G ++ + P
Sbjct: 208 DIWSLGCILYTLLVGKPP 225
>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A
2-amino-4- Heteroaryl-pyrimidine Inhibitor
Length = 331
Score = 50.1 bits (118), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 52/208 (25%), Positives = 94/208 (45%), Gaps = 25/208 (12%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDR------ALKSFDTECEVMRRIRHRNLIK 740
+G G+F V+KA G VA+K ++ ++ AL+ E ++++ ++H N++
Sbjct: 26 IGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALR----EIKILQLLKHENVVN 81
Query: 741 IVSSC---SNPGFKALIMQYMP----QGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYL 793
++ C ++P + Y+ + L L + T+ + +M + + L Y+
Sbjct: 82 LIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYI 141
Query: 794 HHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAK---LLDGVDPVTQTMTLATIGYMAP 850
H I+H D+K NVL+ D V L DFG+A+ L P + T+ Y P
Sbjct: 142 HR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWYRPP 198
Query: 851 E-YGSEGIVSISGDVYSFGILMMETFTR 877
E E D++ G +M E +TR
Sbjct: 199 ELLLGERDYGPPIDLWGAGCIMAEMWTR 226
>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|B Chain B, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
pdb|3IW4|C Chain C, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071
Length = 360
Score = 49.7 bits (117), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 57/211 (27%), Positives = 95/211 (45%), Gaps = 22/211 (10%)
Query: 687 LLGSGSFDNVYKATLANGVSV-AVKVFNLQEDRALKSFDTECE-VMRRI-----RHRNLI 739
+LG GSF V A + A+K+ L++D ++ D EC V +R+ + L
Sbjct: 26 VLGKGSFGKVMLADRKGTEELYAIKI--LKKDVVIQDDDVECTMVEKRVLALLDKPPFLT 83
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
++ S +M+Y+ G L + Q + +++ L +LH
Sbjct: 84 QLHSCFQTVDRLYFVMEYVNGGDL-MYHIQQVGKFKEPQAVFYAAEISIGLFFLH---KR 139
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAK--LLDGVDPVTQTMTLATIGYMAPEYGSEGI 857
II+ DLK +NV+LD + + DFG+ K ++DG VT T Y+APE +
Sbjct: 140 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDG---VTTREFCGTPDYIAPEIIAYQP 196
Query: 858 VSISGDVYSFGILMMETFTRRKPTNEMFTGE 888
S D +++G+L+ E + P F GE
Sbjct: 197 YGKSVDWWAYGVLLYEMLAGQPP----FDGE 223
>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8U|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 49.7 bits (117), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 97/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 84
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 85 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + D+G+A+ D T +AT Y A
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDYGLARHTDD----EMTGYVATRWYRA 190
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655
pdb|1P38|A Chain A, The Structure Of The Map Kinase P38 At 2.1 Angstoms
Resolution
Length = 379
Score = 49.7 bits (117), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G VAVK + Q K E +++ ++H N+I
Sbjct: 49 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 103
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 104 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 156
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 157 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 209
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 210 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 239
>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1,
Cgd3_920
pdb|3MWU|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Rm-1-95
pdb|3NCG|A Chain A, Activated Calcium-Dependent Protein Kinase 1 From
Cryptosporidium Parvum (Cpcdpk1) In Complex With Bumped
Kinase Inhibitor Nm-Pp1
Length = 486
Score = 49.7 bits (117), Expect = 7e-06, Method: Compositional matrix adjust.
Identities = 53/200 (26%), Positives = 86/200 (43%), Gaps = 31/200 (15%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDT-----ECEVMRRIRHRNLIK 740
+LG GSF V K AVKV N + K+ DT E E+++++ H N++K
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVIN---KASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 741 IVSSCSNPGFKALIMQYMPQGSL------EKWLYSHNYSLTIRQRLDIMIDVASALEYLH 794
+ + ++ + G L K H+ + I+Q V S + Y+H
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQ-------VFSGITYMH 138
Query: 795 HGYSTPIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE 851
I+H DLKP N+LL + D + DFG++ + + T Y+APE
Sbjct: 139 ---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPE 193
Query: 852 YGSEGIVSISGDVYSFGILM 871
G DV+S G+++
Sbjct: 194 V-LRGTYDEKCDVWSAGVIL 212
>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In
Phosphorylated P38a And In Solution
Length = 370
Score = 49.7 bits (117), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G VAVK + Q K E +++ ++H N+I
Sbjct: 40 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 94
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 95 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 147
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 148 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 200
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 201 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 230
>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk
Docking Partner
Length = 380
Score = 49.7 bits (117), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G VAVK + Q K E +++ ++H N+I
Sbjct: 50 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 104
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 105 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 157
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 158 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 210
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240
>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Nuclear Substrate Mef2a
pdb|1LEZ|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The
Docking Site On Its Activator Mkk3b
Length = 360
Score = 49.7 bits (117), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G VAVK + Q K E +++ ++H N+I
Sbjct: 30 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 84
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 85 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 190
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein
Kinase C Beta Ii
Length = 674
Score = 49.7 bits (117), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 687 LLGSGSFDNVYKATLANGVSV-AVKVFNLQEDRALKSFDTECE-VMRRI-----RHRNLI 739
+LG GSF V + + AVK+ L++D ++ D EC V +R+ + L
Sbjct: 348 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 405
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI--DVASALEYLHHGY 797
++ S +M+Y+ G L +Y ++ + ++A L +L
Sbjct: 406 QLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ--- 459
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAK--LLDGVDPVTQTMTLATIGYMAPEYGSE 855
S II+ DLK +NV+LD + + DFG+ K + DG VT T Y+APE +
Sbjct: 460 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG---VTTKXFCGTPDYIAPEIIAY 516
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGE 888
S D ++FG+L+ E + P F GE
Sbjct: 517 QPYGKSVDWWAFGVLLYEMLAGQAP----FEGE 545
>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 49.7 bits (117), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 58/224 (25%), Positives = 92/224 (41%), Gaps = 38/224 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNII----- 86
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
L+ + PQ SLE++ L N S I+ LD ++ + +
Sbjct: 87 -------GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ T + T Y AP
Sbjct: 140 KHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRYYRAP 194
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E + D++S G +M E +F G + QW
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQW 234
>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor
Length = 398
Score = 49.7 bits (117), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 63/244 (25%), Positives = 113/244 (46%), Gaps = 22/244 (9%)
Query: 663 NLATLSRISYHELQQATNGFGESNLLGSGSFDNVYKATLA-NGVSVAVKVFNLQEDRALK 721
NLA L S+ + + +G+G++ V A G VA+K D
Sbjct: 37 NLALLKARSFDVTFDVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTN 96
Query: 722 SFDT--ECEVMRRIRHRNLIKIVS----SCSNPGFKAL--IMQYMPQGSLEKWLYSHNYS 773
+ T E ++++ +H N+I I + FK++ ++ M + L + ++S +
Sbjct: 97 AKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLM-ESDLHQIIHS-SQP 154
Query: 774 LTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGV 833
LT+ + + L+Y+H S +IH DLKP+N+L++++ +GDFG+A+ L
Sbjct: 155 LTLEHVRYFLYQLLRGLKYMH---SAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTS 211
Query: 834 DPVTQ---TMTLATIGYMAPEYG-SEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEM 889
Q T +AT Y APE S + + D++S G + E RR ++F G+
Sbjct: 212 PAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARR----QLFPGKN 267
Query: 890 SLKQ 893
+ Q
Sbjct: 268 YVHQ 271
>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor,
Sr- 3451
Length = 353
Score = 49.7 bits (117), Expect = 8e-06, Method: Compositional matrix adjust.
Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 38/224 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 32 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNII----- 86
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
+L+ + PQ +LE++ L N I+ LD ++ + +
Sbjct: 87 -------SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ T + T Y AP
Sbjct: 140 KHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVTRYYRAP 194
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E + D++S G +M E + +F G + QW
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234
>pdb|4EXU|A Chain A, Mapk13, Inactive Form
pdb|4EYJ|A Chain A, Mapk13 Complex With Inhibitor
pdb|4EYM|A Chain A, Mapk13 Complex With Inhibitor
Length = 371
Score = 49.7 bits (117), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 25/216 (11%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIV-- 742
+GSG++ +V A +G VA+K + Q + K E +++ ++H N+I ++
Sbjct: 50 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 109
Query: 743 ----SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
SS N L+M +M Q L+K + +S Q L + + L+Y+H S
Sbjct: 110 FTPASSLRNFYDFYLVMPFM-QTDLQK-IMGMEFSEEKIQYL--VYQMLKGLKYIH---S 162
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGI- 857
++H DLKP N+ +++D + DFG+A+ D T + T Y APE +
Sbjct: 163 AGVVHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYVVTRWYRAPEVILSWMH 218
Query: 858 VSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
+ + D++S G +M E T + +F G+ L Q
Sbjct: 219 YNQTVDIWSVGCIMAEMLTGKT----LFKGKDYLDQ 250
>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774
Length = 355
Score = 49.7 bits (117), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 38/224 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 32 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNII----- 86
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
+L+ + PQ +LE++ L N I+ LD ++ + +
Sbjct: 87 -------SLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLCGI 139
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ T + T Y AP
Sbjct: 140 KHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVTRYYRAP 194
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E + D++S G +M E + +F G + QW
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234
>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk
Inhibitor For The Prevention Of Ischemia-Reperfusion
Injury
pdb|3TTI|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-930, An Orally
Active Anti-Fibrotic Jnk Inhibitor
Length = 464
Score = 49.3 bits (116), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 38/224 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII----- 124
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
+L+ + PQ +LE++ L N I+ LD ++ + +
Sbjct: 125 -------SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 177
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ T + T Y AP
Sbjct: 178 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAP 232
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E + D++S G +M E + +F G + QW
Sbjct: 233 EVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 272
>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737
Length = 364
Score = 49.3 bits (116), Expect = 9e-06, Method: Compositional matrix adjust.
Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 38/224 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 32 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVNHKNII----- 86
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
+L+ + PQ +LE++ L N I+ LD ++ + +
Sbjct: 87 -------SLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGI 139
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ T + T Y AP
Sbjct: 140 KHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVTRYYRAP 194
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E + D++S G +M E + +F G + QW
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234
>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis
SerineTHREONINE Kinase, Pkne
pdb|2H34|B Chain B, Apoenzyme Crystal Structure Of The Tuberculosis
SerineTHREONINE Kinase, Pkne
Length = 309
Score = 49.3 bits (116), Expect = 1e-05, Method: Composition-based stats.
Identities = 27/78 (34%), Positives = 38/78 (48%)
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISG 862
H D+KP N+L+ D A+L DFGIA T+ T+ Y APE SE +
Sbjct: 157 HRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYRA 216
Query: 863 DVYSFGILMMETFTRRKP 880
D+Y+ ++ E T P
Sbjct: 217 DIYALTCVLYECLTGSPP 234
>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2
pdb|3NYV|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii
(Tgcdpk1) In Complex With Non-Specific Inhibitor
Whi-P180
Length = 484
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 51/202 (25%), Positives = 91/202 (45%), Gaps = 18/202 (8%)
Query: 679 TNGFGESNLLGSGSFDNVY--KATLANGVSVAVKVF---NLQEDRALKSFDTECEVMRRI 733
++ + +LG GSF V K + G AVKV +++ +S E ++++++
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKIT-GQECAVKVISKRQVKQKTDKESLLREVQLLKQL 83
Query: 734 RHRNLIKIVSSCSNPGFKALIMQYMPQGSL-EKWLYSHNYSLTIRQRLDIMIDVASALEY 792
H N+ K+ + G+ L+ + G L ++ + +S R I+ V S + Y
Sbjct: 84 DHPNIXKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAAR--IIRQVLSGITY 141
Query: 793 LHHGYSTPIIHCDLKPNNVLLD---DDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
H I+H DLKP N+LL+ D + DFG++ + + T Y+A
Sbjct: 142 XH---KNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKD--KIGTAYYIA 196
Query: 850 PEYGSEGIVSISGDVYSFGILM 871
PE G DV+S G+++
Sbjct: 197 PEV-LHGTYDEKCDVWSTGVIL 217
>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P-
Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl-
Pyridin-3-Yl)naphthalen-1-Yl]urea
pdb|3CTQ|A Chain A, Structure Of Map Kinase P38 In Complex With A
1-O-Tolyl-1,2, 3-Triazole-4-Carboxamide
Length = 348
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 93/210 (44%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G VAVK + Q K E +++ ++H N+I
Sbjct: 26 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 80
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH-----------NYSLTIRQRLDIMIDVASA 789
L+ + P SLE+ +L +H LT ++ +
Sbjct: 81 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCAKLTDDHVQFLIYQILRG 133
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 134 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 186
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map
Kinase Jnk1
Length = 370
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 58/224 (25%), Positives = 92/224 (41%), Gaps = 38/224 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII----- 86
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
L+ + PQ SLE++ L N S I+ LD ++ + +
Sbjct: 87 -------GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ T + T Y AP
Sbjct: 140 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAP 194
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E + D++S G +M E +F G + QW
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQW 234
>pdb|2OZA|B Chain B, Structure Of P38alpha Complex
pdb|3P78|A Chain A, P38 Inhibitor-Bound
pdb|3P79|A Chain A, P38 Inhibitor-Bound
pdb|3P7A|A Chain A, P38 Inhibitor-Bound
pdb|3P7B|A Chain A, P38 Inhibitor-Bound
pdb|3P7C|A Chain A, P38 Inhibitor-Bound
pdb|3P5K|A Chain A, P38 Inhibitor-Bound
Length = 366
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 96/210 (45%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G VAVK + Q K E +++ ++H N+I
Sbjct: 36 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 90
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 91 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 143
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D T +AT Y A
Sbjct: 144 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMTGYVATRWYRA 196
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 197 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 226
>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map
Kinase Jnk1
Length = 370
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 58/224 (25%), Positives = 92/224 (41%), Gaps = 38/224 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII----- 86
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
L+ + PQ SLE++ L N S I+ LD ++ + +
Sbjct: 87 -------GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLCGI 139
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ T + T Y AP
Sbjct: 140 KHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRYYRAP 194
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E + D++S G +M E +F G + QW
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQW 234
>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C
Beta Ii Complexed With A Bisindolylmaleimide Inhibitor
pdb|2I0E|B Chain B, Structure Of Catalytic Domain Of Human Protein Kinase C
Beta Ii Complexed With A Bisindolylmaleimide Inhibitor
Length = 353
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 59/213 (27%), Positives = 96/213 (45%), Gaps = 26/213 (12%)
Query: 687 LLGSGSFDNVYKATLANGVSV-AVKVFNLQEDRALKSFDTECE-VMRRI-----RHRNLI 739
+LG GSF V + + AVK+ L++D ++ D EC V +R+ + L
Sbjct: 27 VLGKGSFGKVMLSERKGTDELYAVKI--LKKDVVIQDDDVECTMVEKRVLALPGKPPFLT 84
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMI--DVASALEYLHHGY 797
++ S +M+Y+ G L +Y ++ + ++A L +L
Sbjct: 85 QLHSCFQTMDRLYFVMEYVNGGDL---MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQ--- 138
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAK--LLDGVDPVTQTMTLATIGYMAPEYGSE 855
S II+ DLK +NV+LD + + DFG+ K + DG VT T Y+APE +
Sbjct: 139 SKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG---VTTKXFCGTPDYIAPEIIAY 195
Query: 856 GIVSISGDVYSFGILMMETFTRRKPTNEMFTGE 888
S D ++FG+L+ E + P F GE
Sbjct: 196 QPYGKSVDWWAFGVLLYEMLAGQAP----FEGE 224
>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based
Inhibitor
Length = 383
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 53 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 107
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 108 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 160
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D +AT Y A
Sbjct: 161 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMXGYVATRWYRA 213
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 214 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 243
>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native
pdb|3MFS|A Chain A, Cask-4m Cam Kinase Domain, Amppnp
pdb|3MFT|A Chain A, Cask-4m Cam Kinase Domain, Mn2+
pdb|3MFU|A Chain A, Cask-4m Cam Kinase Domain, Amppnp-Mn2+
Length = 351
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 47/205 (22%), Positives = 87/205 (42%), Gaps = 28/205 (13%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFNLQE-----DRALKSFDTECEVMRRIRHRNLI 739
++G G+F V + G AVK+ ++ + + + E + ++H +++
Sbjct: 30 EVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASA---------L 790
+++ + S+ G ++ ++M L I +R D + A L
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADL---------CFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 791 EYLHHGYSTPIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
E L + + IIH D+KP NVLL ++ LGDFG+A L G + + T +
Sbjct: 141 EALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQL-GESGLVAGGRVGTPHF 199
Query: 848 MAPEYGSEGIVSISGDVYSFGILMM 872
MAPE DV+ G+++
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILF 224
>pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex
Length = 462
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 74/242 (30%), Positives = 116/242 (47%), Gaps = 24/242 (9%)
Query: 67 NLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVS 126
NL+ L L +S N+ D + L + L+ + FSSN ++ P + N T LE D+S
Sbjct: 127 NLTNLNRLELSSNTISDI--SALSGLTSLQQLSFSSNQVTDLKP--LAN-LTTLERLDIS 181
Query: 127 SNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNR 186
SNK++ S + +++L+S+ NN +S P + T L +L L GN + +
Sbjct: 182 SNKVSD--ISVLAKLTNLESLIATNNQISDITPLGILTNLD---ELSLNGNQL------K 230
Query: 187 EIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLE 246
+I + +L NL LDL N I+ L P + + + + L N +S P + L L
Sbjct: 231 DI-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLA-GLTALT 286
Query: 247 NLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTG 306
NL L +N L I P I N T L L N S + P + +LQ L +N+++
Sbjct: 287 NLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFSNNKVSDV 342
Query: 307 SS 308
SS
Sbjct: 343 SS 344
>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical
Protein Kinase C-Iota
Length = 364
Score = 49.3 bits (116), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 53/203 (26%), Positives = 87/203 (42%), Gaps = 12/203 (5%)
Query: 686 NLLGSGSFDNVYKATLANGVSV-AVKVFNLQ---EDRALKSFDTECEVMRRIRHRNLIKI 741
++G GS+ V L + A+KV + +D + TE V + + +
Sbjct: 26 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 85
Query: 742 VSSCSNPGFKAL-IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ SC + +++Y+ G L + L +++ AL YLH
Sbjct: 86 LHSCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFYSAEISLALNYLH---ERG 141
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQTMTLATIGYMAPEYGSEGIVS 859
II+ DLK +NVLLD + L D+G+ K +G+ P T + T Y+APE
Sbjct: 142 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYG 199
Query: 860 ISGDVYSFGILMMETFTRRKPTN 882
S D ++ G+LM E R P +
Sbjct: 200 FSVDWWALGVLMFEMMAGRSPFD 222
>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase
Length = 353
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 59/216 (27%), Positives = 103/216 (47%), Gaps = 25/216 (11%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIV-- 742
+GSG++ +V A +G VA+K + Q + K E +++ ++H N+I ++
Sbjct: 32 VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDV 91
Query: 743 ----SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
SS N L+M +M Q L+K + +S Q L + + L+Y+H S
Sbjct: 92 FTPASSLRNFYDFYLVMPFM-QTDLQK-IMGLKFSEEKIQYL--VYQMLKGLKYIH---S 144
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGI- 857
++H DLKP N+ +++D + DFG+A+ D T + T Y APE +
Sbjct: 145 AGVVHRDLKPGNLAVNEDCELKILDFGLARHADA----EMTGYVVTRWYRAPEVILSWMH 200
Query: 858 VSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
+ + D++S G +M E T + +F G+ L Q
Sbjct: 201 YNQTVDIWSVGCIMAEMLTGKT----LFKGKDYLDQ 232
>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map
Kinase Jnk1
Length = 370
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 58/224 (25%), Positives = 92/224 (41%), Gaps = 38/224 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKVVNHKNII----- 86
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
L+ + PQ SLE++ L N S I+ LD ++ + +
Sbjct: 87 -------GLLNVFTPQKSLEEFQDVYIVMELMDANLSQVIQMELDHERMSYLLYQMLVGI 139
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ T + T Y AP
Sbjct: 140 KHLH---SAGIIHRDLKPSNIVVKSDATLKILDFGLART--AGTSFMMTPYVVTRYYRAP 194
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E + D++S G +M E +F G + QW
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQW 234
>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|B Chain B, A Novel Small Molecule Apkc Inhibitor
pdb|3ZH8|C Chain C, A Novel Small Molecule Apkc Inhibitor
Length = 349
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 53/203 (26%), Positives = 87/203 (42%), Gaps = 12/203 (5%)
Query: 686 NLLGSGSFDNVYKATLANGVSV-AVKVFNLQ---EDRALKSFDTECEVMRRIRHRNLIKI 741
++G GS+ V L + A+KV + +D + TE V + + +
Sbjct: 11 RVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 70
Query: 742 VSSCSNPGFKAL-IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ SC + +++Y+ G L + L +++ AL YLH
Sbjct: 71 LHSCFQTESRLFFVIEYVNGGDL-MFHMQRQRKLPEEHARFYSAEISLALNYLH---ERG 126
Query: 801 IIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQTMTLATIGYMAPEYGSEGIVS 859
II+ DLK +NVLLD + L D+G+ K +G+ P T + T Y+APE
Sbjct: 127 IIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYG 184
Query: 860 ISGDVYSFGILMMETFTRRKPTN 882
S D ++ G+LM E R P +
Sbjct: 185 FSVDWWALGVLMFEMMAGRSPFD 207
>pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo
Form)
pdb|4FVQ|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain
(Mg-Atp-Bound Form)
Length = 289
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 45/214 (21%), Positives = 96/214 (44%), Gaps = 17/214 (7%)
Query: 672 YHELQQATNGFGESNLLGSGSFDNVYKATLA--------NGVSVAVKVFNLQEDRALKSF 723
+H+++ F ES LG G+F ++K + V +KV + +SF
Sbjct: 2 FHKIRNEDLIFNES--LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF 59
Query: 724 DTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIM 783
+M ++ H++L+ C L+ +++ GSL+ +L + + I +L++
Sbjct: 60 FEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVA 119
Query: 784 IDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD---GVDPVTQTM 840
+A+A+ +L +IH ++ N+LL + G+ KL D + + + +
Sbjct: 120 KQLAAAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI 176
Query: 841 TLATIGYMAPE-YGSEGIVSISGDVYSFGILMME 873
I ++ PE + ++++ D +SFG + E
Sbjct: 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWE 210
>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8W|B Chain B, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|A Chain A, Crystal Structure Of Pkciota Kinase Domain
pdb|3A8X|B Chain B, Crystal Structure Of Pkciota Kinase Domain
Length = 345
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 53/202 (26%), Positives = 87/202 (43%), Gaps = 12/202 (5%)
Query: 687 LLGSGSFDNVYKATLANGVSV-AVKVFNLQ---EDRALKSFDTECEVMRRIRHRNLIKIV 742
++G GS+ V L + A+KV + +D + TE V + + + +
Sbjct: 16 VIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 75
Query: 743 SSCSNPGFKAL-IMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
SC + +++Y+ G L + R +++ AL YLH I
Sbjct: 76 HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARF-YSAEISLALNYLH---ERGI 131
Query: 802 IHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDP-VTQTMTLATIGYMAPEYGSEGIVSI 860
I+ DLK +NVLLD + L D+G+ K +G+ P T + T Y+APE
Sbjct: 132 IYRDLKLDNVLLDSEGHIKLTDYGMCK--EGLRPGDTTSXFCGTPNYIAPEILRGEDYGF 189
Query: 861 SGDVYSFGILMMETFTRRKPTN 882
S D ++ G+LM E R P +
Sbjct: 190 SVDWWALGVLMFEMMAGRSPFD 211
>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420
Length = 504
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 53/202 (26%), Positives = 90/202 (44%), Gaps = 26/202 (12%)
Query: 688 LGSGSFDNVYKATLANGVS-VAVKVFNL-QEDRALKSFDT------------ECEVMRRI 733
LGSG++ V NG S A+KV Q D+ S D E +++ +
Sbjct: 44 LGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSL 103
Query: 734 RHRNLIKIVSSCSNPGFKALIMQYMPQGSL-EKWLYSHNYSLTIRQRLDIMIDVASALEY 792
H N+IK+ + + L+ ++ G L E+ + H + +IM + S + Y
Sbjct: 104 DHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDEC--DAANIMKQILSGICY 161
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDD---MVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
LH I+H D+KP N+LL++ + + DFG++ + L T Y+A
Sbjct: 162 LH---KHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRD--RLGTAYYIA 216
Query: 850 PEYGSEGIVSISGDVYSFGILM 871
PE + + DV+S G++M
Sbjct: 217 PEVLKKK-YNEKCDVWSCGVIM 237
>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine
Inhibitor
Length = 369
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 57/224 (25%), Positives = 92/224 (41%), Gaps = 38/224 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 37 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII----- 91
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
L+ + PQ SLE++ L N I+ LD ++ + +
Sbjct: 92 -------GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 144
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ T + T Y AP
Sbjct: 145 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAP 199
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E + D++S G +M E + +F G + QW
Sbjct: 200 EVILGMGYKENVDLWSVGCIMGEMVCHKI----LFPGRDYIDQW 239
>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With
Mgamp-Pnp
Length = 423
Score = 48.9 bits (115), Expect = 1e-05, Method: Compositional matrix adjust.
Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 38/224 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 70 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII----- 124
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
+L+ + PQ +LE++ L N I+ LD ++ + +
Sbjct: 125 -------SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 177
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ T + T Y AP
Sbjct: 178 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAP 232
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E + D++S G +M E + +F G + QW
Sbjct: 233 EVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 272
>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3)
Length = 350
Score = 48.9 bits (115), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 62/247 (25%), Positives = 98/247 (39%), Gaps = 25/247 (10%)
Query: 657 EENNSLNLATLSRISYHELQQATNGFGESNLLGSGSFDNVYKAT-LANGVSVAVK----- 710
E+N + L + +E ++ + LG GSF V++ G AVK
Sbjct: 49 EDNEGVLLTEKLKPVDYEYREEVHWMTHQPRLGRGSFGEVHRMKDKQTGFQCAVKKVRLE 108
Query: 711 VFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSH 770
VF ++E A + ++ + + + + M+ + GSL + L
Sbjct: 109 VFRVEELVACAGLSSP----------RIVPLYGAVREGPWVNIFMELLEGGSLGQ-LIKQ 157
Query: 771 NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD-MVAHLGDFGIAKL 829
L + L + LEYLH + I+H D+K +NVLL D A L DFG A
Sbjct: 158 MGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALC 214
Query: 830 L--DGVDP--VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMF 885
L DG+ +T T +MAPE D++S +M+ P + F
Sbjct: 215 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 274
Query: 886 TGEMSLK 892
G + LK
Sbjct: 275 RGPLCLK 281
>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide
pdb|4H39|A Chain A, Crystal Structure Of Jnk3 In Complex With Jip1 Peptide
pdb|4H3B|A Chain A, Crystal Structure Of Jnk3 In Complex With Sab Peptide
pdb|4H3B|C Chain C, Crystal Structure Of Jnk3 In Complex With Sab Peptide
Length = 356
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 38/224 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 26 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII----- 80
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
+L+ + PQ +LE++ L N I+ LD ++ + +
Sbjct: 81 -------SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 133
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ T + T Y AP
Sbjct: 134 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAP 188
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E + D++S G +M E + +F G + QW
Sbjct: 189 EVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 228
>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3
Length = 355
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 38/224 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII----- 79
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
+L+ + PQ +LE++ L N I+ LD ++ + +
Sbjct: 80 -------SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 132
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ T + T Y AP
Sbjct: 133 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAP 187
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E + D++S G +M E + +F G + QW
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 227
>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A
Natural Jnk1 Inhibitor
Length = 379
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 57/224 (25%), Positives = 91/224 (40%), Gaps = 38/224 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII----- 86
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
L+ + PQ SLE++ L N I+ LD ++ + +
Sbjct: 87 -------GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ T + T Y AP
Sbjct: 140 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPEVVTRYYRAP 194
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E + D++S G +M E +F G + QW
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQW 234
>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And
Thiazole Based Inhibitors Of Jnk For The Treatment Of
Neurodegenerative Diseases
pdb|3OY1|A Chain A, Highly Selective C-Jun N-Terminal Kinase (Jnk) 2 And 3
Inhibitors With In Vitro Cns-Like Pharmacokinetic
Properties
Length = 362
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 38/224 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 31 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII----- 85
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
+L+ + PQ +LE++ L N I+ LD ++ + +
Sbjct: 86 -------SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 138
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ T + T Y AP
Sbjct: 139 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAP 193
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E + D++S G +M E + +F G + QW
Sbjct: 194 EVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 233
>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor
Length = 358
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 57/224 (25%), Positives = 92/224 (41%), Gaps = 38/224 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 26 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII----- 80
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
L+ + PQ SLE++ L N I+ LD ++ + +
Sbjct: 81 -------GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 133
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ T + T Y AP
Sbjct: 134 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAP 188
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E + D++S G +M E + +F G + QW
Sbjct: 189 EVILGMGYKENVDLWSVGCIMGEMVCHKI----LFPGRDYIDQW 228
>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious
Tri-Substituted Thiophene Based Jnk Inhibitor
Length = 363
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 38/224 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 32 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII----- 86
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
+L+ + PQ +LE++ L N I+ LD ++ + +
Sbjct: 87 -------SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ T + T Y AP
Sbjct: 140 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAP 194
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E + D++S G +M E + +F G + QW
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234
>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a)
Activating Mutant
Length = 367
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 91
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 92 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D +T +AT Y A
Sbjct: 145 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTG--YVATRWYRA 197
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l)
Activating Mutant
Length = 367
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 91
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 92 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D +T +AT Y A
Sbjct: 145 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTG--YVATRWYRA 197
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
pdb|2R9S|B Chain B, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline
Inhibitor
Length = 356
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 38/224 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 25 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII----- 79
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
+L+ + PQ +LE++ L N I+ LD ++ + +
Sbjct: 80 -------SLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGI 132
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ T + T Y AP
Sbjct: 133 KHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVTRYYRAP 187
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E + D++S G +M E + +F G + QW
Sbjct: 188 EVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 227
>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-A
pdb|2FSM|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s)
Activating Mutant Form-B
Length = 367
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 57/210 (27%), Positives = 98/210 (46%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 37 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 91
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 92 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 144
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D +T +AT Y A
Sbjct: 145 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLAR--HTADEMTG--YVATRWYRA 197
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 198 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3
Length = 356
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 38/224 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 26 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII----- 80
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
+L+ + PQ +LE++ L N I+ LD ++ + +
Sbjct: 81 -------SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 133
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ T + T Y AP
Sbjct: 134 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAP 188
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E + D++S G +M E + +F G + QW
Sbjct: 189 EVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 228
>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3-
Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide
pdb|2P33|A Chain A, Synthesis And Sar Of Aminopyrimidines As Novel C-Jun N-
Terminal Kinase (Jnk) Inhibitors
pdb|3CGF|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3CGO|A Chain A, Irak-4 Inhibitors (Part Ii)- A Structure Based Assessment
Of Imidazo[1,2 A]pyridine Binding
pdb|3G90|X Chain X, Jnk-3 Bound To
(Z)-5-Fluoro-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)
Methyl)-3-(Hydroxyimino)indolin-2-One
pdb|3G9N|A Chain A, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Phenylindolin-2-One
pdb|3G9L|X Chain X, Jnk3 Bound To
(Z)-1-((6-Fluoro-4h-Benzo[d][1,3]dioxin-8-Yl)methyl)-3-
(Hydroxyimino)-4-Styrylindolin-2-One
Length = 365
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 38/224 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 33 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII----- 87
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
+L+ + PQ +LE++ L N I+ LD ++ + +
Sbjct: 88 -------SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 140
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ T + T Y AP
Sbjct: 141 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAP 195
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E + D++S G +M E + +F G + QW
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 235
>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMQ|A Chain A, The Structure Of Jnk3 In Complex With An Imidazole-
Pyrimidine Inhibitor
pdb|1PMU|A Chain A, The Crystal Structure Of Jnk3 In Complex With A
Phenantroline Inhibitor
pdb|1PMV|A Chain A, The Structure Of Jnk3 In Complex With A
Dihydroanthrapyrazole Inhibitor
Length = 364
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 38/224 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 33 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII----- 87
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
+L+ + PQ +LE++ L N I+ LD ++ + +
Sbjct: 88 -------SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 140
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ T + T Y AP
Sbjct: 141 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAP 195
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E + D++S G +M E + +F G + QW
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 235
>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562
Length = 364
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 38/224 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 32 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII----- 86
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
+L+ + PQ +LE++ L N I+ LD ++ + +
Sbjct: 87 -------SLLNVFTPQKTLEEFQDVYLVMELMDANLXQVIQMELDHERMSYLLYQMLXGI 139
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ T + T Y AP
Sbjct: 140 KHLH---SAGIIHRDLKPSNIVVKSDXTLKILDFGLART--AGTSFMMTPYVVTRYYRAP 194
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E + D++S G +M E + +F G + QW
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234
>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-{3-Cyano-6-[3-(1-
Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2,
3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide
pdb|2O2U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Cyano-4,5,6,7-
Tetrahydro-1-Benzothien-2-Yl)-2-Fluorobenzamide
pdb|2ZDT|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|2ZDU|A Chain A, Crystal Structure Of Human Jnk3 Complexed With An
Isoquinolone Inhibitor
pdb|3DA6|A Chain A, Crystal Structure Of Human Jnk3 Complexed With
N-(3-Methyl-
4-(3-(2-(Methylamino)pyrimidin-4-Yl)pyridin-2-Yloxy)
Naphthalen-1-Yl)-1h-Benzo[d]imidazol-2-Amine
pdb|2WAJ|A Chain A, Crystal Structure Of Human Jnk3 Complexed With A
1-Aryl-3,4- Dihydroisoquinoline Inhibitor
pdb|3V6R|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6R|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|A Chain A, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
pdb|3V6S|B Chain B, Discovery Of Potent And Selective Covalent Inhibitors Of
Jnk
Length = 364
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 56/224 (25%), Positives = 93/224 (41%), Gaps = 38/224 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 32 IGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII----- 86
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
+L+ + PQ +LE++ L N I+ LD ++ + +
Sbjct: 87 -------SLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ T + T Y AP
Sbjct: 140 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAP 194
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E + D++S G +M E + +F G + QW
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMVRHKI----LFPGRDYIDQW 234
>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O17|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform
pdb|3O2M|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
pdb|3O2M|B Chain B, Crystal Structure Of Jnk1-Alpha1 Isoform Complex With A
Biaryl Tetrazol (A-82118)
Length = 370
Score = 48.5 bits (114), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 57/224 (25%), Positives = 94/224 (41%), Gaps = 38/224 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII----- 86
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
L+ + PQ SLE++ L N I+ LD ++ + +
Sbjct: 87 -------GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ G + + + T Y AP
Sbjct: 140 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMEP-EVVTRYYRAP 194
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E + D++S G +M E + +F G + QW
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMVCHKI----LFPGRDYIDQW 234
>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain
Length = 343
Score = 48.1 bits (113), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSC 745
+GSG V++ A+K NL+E ++ L S+ E + +++ + KI+
Sbjct: 17 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRLY 75
Query: 746 SNPGFKALIMQYMPQGSLE--KWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPII 802
I M G+++ WL S+ +R ++ A+ +H HG I+
Sbjct: 76 DYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG----IV 130
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIA-KLLDGVDPVTQTMTLATIGYMAPE 851
H DLKP N L+ D M+ L DFGIA ++ V + + T+ YM PE
Sbjct: 131 HSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 179
>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of
Camp-Dependent Protein Kinase
Length = 350
Score = 48.1 bits (113), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 52/202 (25%), Positives = 88/202 (43%), Gaps = 20/202 (9%)
Query: 680 NGFGESNLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFD---TECEVMRRIRH 735
+ F LG+GSF V +G A+K+ + Q+ LK + E +++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVAS---ALEY 792
L+K+ S + ++M+Y+ G + +SH + A EY
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEM----FSHLRRIGRFSEPHARFYAAQIVLTFEY 156
Query: 793 LHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTL-ATIGYMAPE 851
LH S +I+ DLKP N+L+D + DFG AK + G +T L T +APE
Sbjct: 157 LH---SLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKG-----RTWXLCGTPEALAPE 208
Query: 852 YGSEGIVSISGDVYSFGILMME 873
+ + D ++ G+L+ E
Sbjct: 209 IILSKGYNKAVDWWALGVLIYE 230
>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase
Length = 380
Score = 48.1 bits (113), Expect = 2e-05, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G VAVK + Q K E +++ ++H N+I
Sbjct: 50 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 104
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 105 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 157
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D +AT Y A
Sbjct: 158 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMXGXVATRWYRA 210
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 211 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 240
>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 371
Score = 48.1 bits (113), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 57/224 (25%), Positives = 91/224 (40%), Gaps = 38/224 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 33 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII----- 87
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
L+ + PQ SLE++ L N I+ LD ++ + +
Sbjct: 88 -------GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 140
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ T + T Y AP
Sbjct: 141 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAP 195
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E + D++S G +M E +F G + QW
Sbjct: 196 EVILGMGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQW 235
>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
pdb|3MPA|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 47.8 bits (112), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 84
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 85 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + FG+A+ D T +AT Y A
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILGFGLARHTDD----EMTGYVATRWYRA 190
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
pdb|1UKI|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By
The Scaffolding Protein Jip1 And Sp600125
Length = 369
Score = 47.8 bits (112), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 57/224 (25%), Positives = 91/224 (40%), Gaps = 38/224 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII----- 86
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
L+ + PQ SLE++ L N I+ LD ++ + +
Sbjct: 87 -------GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ T + T Y AP
Sbjct: 140 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAP 194
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E + D++S G +M E +F G + QW
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQW 234
>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With
Inhibitor Pg-874743
pdb|2GHM|A Chain A, Mutated Map Kinase P38 (Mus Musculus) In Complex With
Inhbitor Pg-895449
Length = 348
Score = 47.8 bits (112), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G VAVK + Q K E +++ ++H N+I
Sbjct: 26 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 80
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 81 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 133
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D +AT Y A
Sbjct: 134 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMAGFVATRWYRA 186
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 187 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
>pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant
V617f (Mg- Atp-Bound Form)
Length = 289
Score = 47.8 bits (112), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 45/214 (21%), Positives = 95/214 (44%), Gaps = 17/214 (7%)
Query: 672 YHELQQATNGFGESNLLGSGSFDNVYKATLA--------NGVSVAVKVFNLQEDRALKSF 723
+H+++ F ES LG G+F ++K + V +KV + +SF
Sbjct: 2 FHKIRNEDLIFNES--LGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF 59
Query: 724 DTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIM 783
+M ++ H++L+ C L+ +++ GSL+ +L + + I +L++
Sbjct: 60 FEAASMMSKLSHKHLVLNYGVCFCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVA 119
Query: 784 IDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD---GVDPVTQTM 840
+A A+ +L +IH ++ N+LL + G+ KL D + + + +
Sbjct: 120 KQLAWAMHFLE---ENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKDI 176
Query: 841 TLATIGYMAPE-YGSEGIVSISGDVYSFGILMME 873
I ++ PE + ++++ D +SFG + E
Sbjct: 177 LQERIPWVPPECIENPKNLNLATDKWSFGTTLWE 210
>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 2-(aminothiazoly)phenol (cmp2)
Length = 336
Score = 47.8 bits (112), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 61/247 (24%), Positives = 98/247 (39%), Gaps = 25/247 (10%)
Query: 657 EENNSLNLATLSRISYHELQQATNGFGESNLLGSGSFDNVYKAT-LANGVSVAVK----- 710
E+N + L + +E ++ + +G GSF V++ G AVK
Sbjct: 35 EDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE 94
Query: 711 VFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSH 770
VF ++E A + ++ + + + + M+ + GSL + L
Sbjct: 95 VFRVEELVACAGLSSP----------RIVPLYGAVREGPWVNIFMELLEGGSLGQ-LIKQ 143
Query: 771 NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD-MVAHLGDFGIAKL 829
L + L + LEYLH + I+H D+K +NVLL D A L DFG A
Sbjct: 144 MGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALC 200
Query: 830 L--DGVDP--VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMF 885
L DG+ +T T +MAPE D++S +M+ P + F
Sbjct: 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 260
Query: 886 TGEMSLK 892
G + LK
Sbjct: 261 RGPLCLK 267
>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1
Catalytic Domain Apo Form
Length = 390
Score = 47.8 bits (112), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSC 745
+GSG V++ A+K NL+E ++ L S+ E + +++ + KI+
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRLY 122
Query: 746 SNPGFKALIMQYMPQGSLE--KWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPII 802
I M G+++ WL S+ +R ++ A+ +H HG I+
Sbjct: 123 DYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG----IV 177
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIA-KLLDGVDPVTQTMTLATIGYMAPE 851
H DLKP N L+ D M+ L DFGIA ++ V + + T+ YM PE
Sbjct: 178 HSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 226
>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38)
Length = 360
Score = 47.8 bits (112), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G VAVK + Q K E +++ ++H N+I
Sbjct: 30 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 84
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 85 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D +AT Y A
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMAGFVATRWYRA 190
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map
Kinase Jnk1
Length = 370
Score = 47.8 bits (112), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 57/224 (25%), Positives = 91/224 (40%), Gaps = 38/224 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII----- 86
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
L+ + PQ SLE++ L N I+ LD ++ + +
Sbjct: 87 -------GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ T + T Y AP
Sbjct: 140 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMTPYVVTRYYRAP 194
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E + D++S G +M E +F G + QW
Sbjct: 195 EVILGMGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQW 234
>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium
Dependent Protein Kinase Cgd7_1840 In Presence Of
Indirubin E804
Length = 277
Score = 47.8 bits (112), Expect = 3e-05, Method: Composition-based stats.
Identities = 56/197 (28%), Positives = 86/197 (43%), Gaps = 25/197 (12%)
Query: 686 NLLGSGSFDNVYKATLANGVSV------AVKVFNLQEDRALKSFDTECEVMRRIRHRNLI 739
N +G GS+ V K + G + K F DR F E E+M+ + H N+I
Sbjct: 15 NTIGRGSWGEV-KIAVQKGTRIRRAAKKIPKYFVEDVDR----FKQEIEIMKSLDHPNII 69
Query: 740 KIVSSCSNPGFKALIMQYMPQGSL-EKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
++ + + L+M+ G L E+ ++ + + R IM DV SA+ Y H
Sbjct: 70 RLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAAR--IMKDVLSAVAYCH---K 124
Query: 799 TPIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMT-LATIGYMAPEYGS 854
+ H DLKP N L D L DFG+A P T + T Y++P+
Sbjct: 125 LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF---KPGKMMRTKVGTPYYVSPQV-L 180
Query: 855 EGIVSISGDVYSFGILM 871
EG+ D +S G++M
Sbjct: 181 EGLYGPECDEWSAGVMM 197
>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain
In Complex With A Monocyclic Pyrazolone Inhibitor
Length = 360
Score = 47.8 bits (112), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G VAVK + Q K E +++ ++H N+I
Sbjct: 30 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 84
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 85 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DFG+A+ D +AT Y A
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD----EMAGFVATRWYRA 190
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform
Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo
Sapiens
Length = 350
Score = 47.8 bits (112), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 18/164 (10%)
Query: 737 NLIKIVSSCSNPGFK--ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH 794
N+IK++ + +P K AL+ +Y+ K LY IR M ++ AL+Y H
Sbjct: 94 NIIKLIDTVKDPVSKTPALVFEYINNTDF-KQLYQILTDFDIRF---YMYELLKALDYCH 149
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVA-HLGDFGIAKLLDGVDPVTQ-TMTLATIGYMAPEY 852
S I+H D+KP+NV++D L D+G+A+ P + + +A+ + PE
Sbjct: 150 ---SKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEF---YHPAQEYNVRVASRYFKGPEL 203
Query: 853 GSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWV 895
+ + S D++S G ++ RR+P F G+ + Q V
Sbjct: 204 LVDYQMYDYSLDMWSLGCMLASMIFRREP---FFHGQDNYDQLV 244
>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3O8T|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg-Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 47.8 bits (112), Expect = 3e-05, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 84
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 85 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + D G+A+ D T +AT Y A
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDAGLARHTDD----EMTGYVATRWYRA 190
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2-
Yl)amino]benzamide
Length = 320
Score = 47.4 bits (111), Expect = 3e-05, Method: Composition-based stats.
Identities = 45/170 (26%), Positives = 79/170 (46%), Gaps = 13/170 (7%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRN--LIKIVS 743
+GSG V++ A+K NL+E ++ L S+ E + +++ + +I++
Sbjct: 16 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 75
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPII 802
+ ++M+ L WL S+ +R ++ A+ +H HG I+
Sbjct: 76 YEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG----IV 129
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIA-KLLDGVDPVTQTMTLATIGYMAPE 851
H DLKP N L+ D M+ L DFGIA ++ V + + T+ YM PE
Sbjct: 130 HSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 178
>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBJ|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
Length = 360
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 84
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 85 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + D G+A+ D T +AT Y A
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDRGLARHTDD----EMTGYVATRWYRA 190
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium
Parvum Calcium Dependent Protein Kinase In Complex With
3- Mb-Pp1
Length = 287
Score = 47.4 bits (111), Expect = 4e-05, Method: Composition-based stats.
Identities = 53/200 (26%), Positives = 86/200 (43%), Gaps = 31/200 (15%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDT-----ECEVMRRIRHRNLIK 740
+LG GSF V K AVKV N + K+ DT E E+++++ H N++K
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVIN---KASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 741 IVSSCSNPGFKALIMQYMPQGSL------EKWLYSHNYSLTIRQRLDIMIDVASALEYLH 794
+ + ++ + G L K H+ + I+Q V S + Y+H
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQ-------VFSGITYMH 138
Query: 795 HGYSTPIIHCDLKPNNVLLDD---DMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE 851
I+H DLKP N+LL+ D + DFG++ + + T Y+APE
Sbjct: 139 ---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPE 193
Query: 852 YGSEGIVSISGDVYSFGILM 871
G DV+S G+++
Sbjct: 194 V-LRGTYDEKCDVWSAGVIL 212
>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent
Protein Kinase Cgd3_920 From Cryptosporidium Parvum
Length = 286
Score = 47.4 bits (111), Expect = 4e-05, Method: Composition-based stats.
Identities = 53/200 (26%), Positives = 86/200 (43%), Gaps = 31/200 (15%)
Query: 687 LLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDT-----ECEVMRRIRHRNLIK 740
+LG GSF V K AVKV N + K+ DT E E+++++ H N++K
Sbjct: 29 MLGKGSFGEVLKCKDRITQQEYAVKVIN---KASAKNKDTSTILREVELLKKLDHPNIMK 85
Query: 741 IVSSCSNPGFKALIMQYMPQGSL------EKWLYSHNYSLTIRQRLDIMIDVASALEYLH 794
+ + ++ + G L K H+ + I+Q V S + Y+H
Sbjct: 86 LFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQ-------VFSGITYMH 138
Query: 795 HGYSTPIIHCDLKPNNVLLDD---DMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE 851
I+H DLKP N+LL+ D + DFG++ + + T Y+APE
Sbjct: 139 ---KHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKD--RIGTAYYIAPE 193
Query: 852 YGSEGIVSISGDVYSFGILM 871
G DV+S G+++
Sbjct: 194 V-LRGTYDEKCDVWSAGVIL 212
>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase
(nik)
pdb|4G3C|B Chain B, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase
(nik)
pdb|4G3E|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 6-alkynylindoline (cmp1)
pdb|4G3E|B Chain B, Crystal Structure Of Murine Nf-kappab Inducing Kinase
(nik) Bound To A 6-alkynylindoline (cmp1)
Length = 352
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 61/247 (24%), Positives = 98/247 (39%), Gaps = 25/247 (10%)
Query: 657 EENNSLNLATLSRISYHELQQATNGFGESNLLGSGSFDNVYKAT-LANGVSVAVK----- 710
E+N + L + +E ++ + +G GSF V++ G AVK
Sbjct: 51 EDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLE 110
Query: 711 VFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSH 770
VF ++E A + ++ + + + + M+ + GSL + L
Sbjct: 111 VFRVEELVACAGLSSP----------RIVPLYGAVREGPWVNIFMELLEGGSLGQ-LIKQ 159
Query: 771 NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDD-MVAHLGDFGIAKL 829
L + L + LEYLH + I+H D+K +NVLL D A L DFG A
Sbjct: 160 MGCLPEDRALYYLGQALEGLEYLH---TRRILHGDVKADNVLLSSDGSRAALCDFGHALC 216
Query: 830 L--DGVDP--VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMF 885
L DG+ +T T +MAPE D++S +M+ P + F
Sbjct: 217 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYF 276
Query: 886 TGEMSLK 892
G + LK
Sbjct: 277 RGPLCLK 283
>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase
(ttk)
pdb|3GFW|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase
(Ttk) In Complex With A Pyrolo-Pyridin Ligand
Length = 313
Score = 47.4 bits (111), Expect = 4e-05, Method: Composition-based stats.
Identities = 45/170 (26%), Positives = 79/170 (46%), Gaps = 13/170 (7%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRN--LIKIVS 743
+GSG V++ A+K NL+E ++ L S+ E + +++ + +I++
Sbjct: 36 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPII 802
+ ++M+ L WL S+ +R ++ A+ +H HG I+
Sbjct: 96 YEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG----IV 149
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIA-KLLDGVDPVTQTMTLATIGYMAPE 851
H DLKP N L+ D M+ L DFGIA ++ V + + T+ YM PE
Sbjct: 150 HSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 198
>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor
6-(5-(2-Aminopyrimidin-4-Ylamino)-2-
Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide
Length = 320
Score = 47.4 bits (111), Expect = 4e-05, Method: Composition-based stats.
Identities = 59/197 (29%), Positives = 92/197 (46%), Gaps = 28/197 (14%)
Query: 697 YKAT---LANGVSVAV-KVFN--LQEDRALKSFDTECEVMRR---IRHR-----NLIKIV 742
YK T L G++ V ++FN QE ALK +C RR + R ++++IV
Sbjct: 17 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVELHWRASQCPHIVRIV 75
Query: 743 SSCSN--PGFKAL--IMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGY 797
N G K L +M+ + G L + + + T R+ +IM + A++YLH
Sbjct: 76 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--- 132
Query: 798 STPIIHCDLKPNNVLLDD---DMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGS 854
S I H D+KP N+L + + L DFG AK + +T+ T Y+APE
Sbjct: 133 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCY--TPYYVAPEVLG 190
Query: 855 EGIVSISGDVYSFGILM 871
S D++S G++M
Sbjct: 191 PEKYDKSCDMWSLGVIM 207
>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2G01|B Chain B, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors
pdb|2GMX|A Chain A, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2GMX|B Chain B, Selective Aminopyridine-Based C-Jun N-Terminal Kinase
Inhibitors With Cellular Activity
pdb|2H96|A Chain A, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2H96|B Chain B, Discovery Of Potent, Highly Selective, And Orally
Bioavailable Pyridine Carboxamide C-Jun Nh2-Terminal
Kinase Inhibitors
pdb|2NO3|A Chain A, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
pdb|2NO3|B Chain B, Novel 4-Anilinopyrimidines As Potent Jnk1 Inhibitors
Length = 370
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 57/224 (25%), Positives = 94/224 (41%), Gaps = 38/224 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 32 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII----- 86
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
L+ + PQ SLE++ L N I+ LD ++ + +
Sbjct: 87 -------GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 139
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ G + + + T Y AP
Sbjct: 140 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA-GTSFMMEP-EVVTRYYRAP 194
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E + D++S G +M E + +F G + QW
Sbjct: 195 EVILGMGYKENVDLWSVGCIMGEMVCHKI----LFPGRDYIDQW 234
>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With Atp
pdb|3HMO|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With The Inhibitor Staurosporine
pdb|3HMP|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In
Complex With A Quinazolin Ligand Compound 4
Length = 342
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 47/170 (27%), Positives = 78/170 (45%), Gaps = 13/170 (7%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSC 745
+GSG V++ A+K NL+E ++ L S+ E + +++ + KI+
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRLY 122
Query: 746 SNPGFKALIMQYMPQGSLE--KWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPII 802
I M G+++ WL S+ +R ++ A+ +H HG I+
Sbjct: 123 DYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG----IV 177
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIA-KLLDGVDPVTQTMTLATIGYMAPE 851
H DLKP N L+ D M+ L DFGIA ++ V + + T+ YM PE
Sbjct: 178 HSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 226
>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein
Kinase Ck2alpha Prime With A Potent Indazole-Derivative
Inhibitor
Length = 339
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 45/164 (27%), Positives = 80/164 (48%), Gaps = 18/164 (10%)
Query: 737 NLIKIVSSCSNPGFK--ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH 794
N+IK++ + +P K AL+ +Y+ ++ LY IR M ++ AL+Y H
Sbjct: 99 NIIKLIDTVKDPVSKTPALVFEYINNTDFKQ-LYQILTDFDIRF---YMYELLKALDYCH 154
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVA-HLGDFGIAKLLDGVDPVTQ-TMTLATIGYMAPEY 852
S I+H D+KP+NV++D L D+G+A+ P + + +A+ + PE
Sbjct: 155 ---SKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEF---YHPAQEYNVRVASRYFKGPEL 208
Query: 853 GSE-GIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWV 895
+ + S D++S G ++ RR+P F G+ + Q V
Sbjct: 209 LVDYQMYDYSLDMWSLGCMLASMIFRREP---FFHGQDNYDQLV 249
>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha
(Mrck Alpha)
Length = 437
Score = 47.4 bits (111), Expect = 4e-05, Method: Compositional matrix adjust.
Identities = 50/206 (24%), Positives = 85/206 (41%), Gaps = 16/206 (7%)
Query: 686 NLLGSGSFDNVYKATLANGVSV-AVKVFNLQEDRALKSFDTEC-----EVMRRIRHRNLI 739
++G G+F V L N V A+K+ N E LK +T C +V+ + +
Sbjct: 80 KVIGRGAFGEVAVVKLKNADKVFAMKILNKWE--MLKRAETACFREERDVLVNGDSKWIT 137
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYST 799
+ + + L+M Y G L L L + ++ A++ +H +
Sbjct: 138 TLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLH-- 195
Query: 800 PIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEY-----GS 854
+H D+KP+N+L+D + L DFG L V ++ + T Y++PE G
Sbjct: 196 -YVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGG 254
Query: 855 EGIVSISGDVYSFGILMMETFTRRKP 880
+G D +S G+ M E P
Sbjct: 255 KGRYGPECDWWSLGVCMYEMLYGETP 280
>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715
Length = 317
Score = 47.4 bits (111), Expect = 4e-05, Method: Composition-based stats.
Identities = 45/170 (26%), Positives = 79/170 (46%), Gaps = 13/170 (7%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRN--LIKIVS 743
+GSG V++ A+K NL+E ++ L S+ E + +++ + +I++
Sbjct: 20 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 79
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPII 802
+ ++M+ L WL S+ +R ++ A+ +H HG I+
Sbjct: 80 YEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG----IV 133
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIA-KLLDGVDPVTQTMTLATIGYMAPE 851
H DLKP N L+ D M+ L DFGIA ++ V + + T+ YM PE
Sbjct: 134 HSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPE 182
>pdb|3FXI|A Chain A, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps
Ra Complex
pdb|3FXI|B Chain B, Crystal Structure Of The Human Tlr4-Human Md-2-E.Coli Lps
Ra Complex
Length = 605
Score = 47.0 bits (110), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 43/161 (26%), Positives = 68/161 (42%), Gaps = 9/161 (5%)
Query: 442 LTSLRHLDFRSNSLNSTIP-STFWSLKYILAVDFXXXXXXXXXXXXXXXXEALGGLNLTG 500
L L HLDF+ ++L S F SL+ ++ +D +L L + G
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454
Query: 501 NQLS-GYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSL 559
N ++P L+NL +L L++ + P +F SL SLQ L++S NN
Sbjct: 455 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPY 514
Query: 560 EKLSRLVDFNVSFNGLE-------GEIPSGGPFVNFTADSF 593
+ L+ L + S N + PS F+N T + F
Sbjct: 515 KCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 555
Score = 34.3 bits (77), Expect = 0.38, Method: Compositional matrix adjust.
Identities = 21/56 (37%), Positives = 30/56 (53%), Gaps = 1/56 (1%)
Query: 511 IGNLKNLDWLALARNAFQG-PIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRL 565
IG+LK L L +A N Q +P+ F +L +L+ LDLS N I L L ++
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM 175
Score = 32.7 bits (73), Expect = 0.90, Method: Compositional matrix adjust.
Identities = 40/170 (23%), Positives = 72/170 (42%), Gaps = 14/170 (8%)
Query: 84 TLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISS 143
T+ + + +L+ +DF ++L + S L D+S F +SS
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446
Query: 144 LKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDL 203
L+ +++ NS +F D+ T L +L L L + + P +L +L++L++
Sbjct: 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL-----EQLSPTAFNSLSSLQVLNM 501
Query: 204 GGNNIAGLIPSMIFNNSNMVAILLYG-NHLS-------GHLPSSIYLPNL 245
NN L + + N + +L Y NH+ H PSS+ NL
Sbjct: 502 SHNNFFSL-DTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 550
>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of
Phe169 In Function And Structural Dynamics And Reveals A
Novel Dfg-Out State
pdb|3OBG|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Mutants In
Response To Inhibitor Binding
pdb|3OC1|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif
Mutants In Response To Inhibitor Binding
Length = 360
Score = 47.0 bits (110), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 96/210 (45%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G+ VAVK + Q K E +++ ++H N+I
Sbjct: 30 VGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 84
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 85 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + D G+A+ D T +AT Y A
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDGGLARHTDD----EMTGYVATRWYRA 190
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands
pdb|3GOK|B Chain B, Binding Site Mapping Of Protein Ligands
pdb|3GOK|C Chain C, Binding Site Mapping Of Protein Ligands
pdb|3GOK|D Chain D, Binding Site Mapping Of Protein Ligands
pdb|3GOK|E Chain E, Binding Site Mapping Of Protein Ligands
pdb|3GOK|F Chain F, Binding Site Mapping Of Protein Ligands
pdb|3GOK|G Chain G, Binding Site Mapping Of Protein Ligands
pdb|3GOK|H Chain H, Binding Site Mapping Of Protein Ligands
pdb|3GOK|I Chain I, Binding Site Mapping Of Protein Ligands
pdb|3GOK|J Chain J, Binding Site Mapping Of Protein Ligands
pdb|3GOK|K Chain K, Binding Site Mapping Of Protein Ligands
pdb|3GOK|L Chain L, Binding Site Mapping Of Protein Ligands
Length = 334
Score = 47.0 bits (110), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 59/197 (29%), Positives = 91/197 (46%), Gaps = 28/197 (14%)
Query: 697 YKAT---LANGVSVAV-KVFN--LQEDRALKSFDTECEVMRR---IRHR-----NLIKIV 742
YK T L G++ V ++FN QE ALK +C RR + R ++++IV
Sbjct: 33 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVELHWRASQCPHIVRIV 91
Query: 743 SSCSN--PGFKAL--IMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGY 797
N G K L +M+ + G L + + + T R+ +IM + A++YLH
Sbjct: 92 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--- 148
Query: 798 STPIIHCDLKPNNVLLDD---DMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGS 854
S I H D+KP N+L + + L DFG AK + + T T Y+APE
Sbjct: 149 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLG 206
Query: 855 EGIVSISGDVYSFGILM 871
S D++S G++M
Sbjct: 207 PEKYDKSCDMWSLGVIM 223
>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal
Form-1, Soaking)
pdb|2JBP|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|B Chain B, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|C Chain C, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|D Chain D, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|E Chain E, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|F Chain F, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|G Chain G, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|H Chain H, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|I Chain I, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|J Chain J, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|K Chain K, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
pdb|2JBP|L Chain L, Protein Kinase Mk2 In Complex With An Inhibitor (crystal
Form-2, Co-crystallization)
Length = 326
Score = 47.0 bits (110), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 59/197 (29%), Positives = 91/197 (46%), Gaps = 28/197 (14%)
Query: 697 YKAT---LANGVSVAV-KVFN--LQEDRALKSFDTECEVMRR---IRHR-----NLIKIV 742
YK T L G++ V ++FN QE ALK +C RR + R ++++IV
Sbjct: 25 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVELHWRASQCPHIVRIV 83
Query: 743 SSCSN--PGFKAL--IMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGY 797
N G K L +M+ + G L + + + T R+ +IM + A++YLH
Sbjct: 84 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--- 140
Query: 798 STPIIHCDLKPNNVLLDD---DMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGS 854
S I H D+KP N+L + + L DFG AK + + T T Y+APE
Sbjct: 141 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLG 198
Query: 855 EGIVSISGDVYSFGILM 871
S D++S G++M
Sbjct: 199 PEKYDKSCDMWSLGVIM 215
>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2
pdb|1KWP|B Chain B, Crystal Structure Of Mapkap2
pdb|1NY3|A Chain A, Crystal Structure Of Adp Bound To Map Kap Kinase 2
Length = 400
Score = 47.0 bits (110), Expect = 5e-05, Method: Compositional matrix adjust.
Identities = 53/182 (29%), Positives = 84/182 (46%), Gaps = 24/182 (13%)
Query: 708 AVKVFN--LQEDRALKSFDTECEVMRR---IRHR-----NLIKIVSSCSN--PGFKAL-- 753
+++FN QE ALK +C RR + R ++++IV N G K L
Sbjct: 78 VLQIFNKRTQEKFALKMLQ-DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 136
Query: 754 IMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVL 812
+M+ + G L + + + T R+ +IM + A++YLH S I H D+KP N+L
Sbjct: 137 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLL 193
Query: 813 LDD---DMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGI 869
+ + L DFG AK + + T T Y+APE S D++S G+
Sbjct: 194 YTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 251
Query: 870 LM 871
+M
Sbjct: 252 IM 253
>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap
Kinase-2
Length = 325
Score = 47.0 bits (110), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 53/182 (29%), Positives = 84/182 (46%), Gaps = 24/182 (13%)
Query: 708 AVKVFN--LQEDRALKSFDTECEVMRR---IRHR-----NLIKIVSSCSN--PGFKAL-- 753
+++FN QE ALK +C RR + R ++++IV N G K L
Sbjct: 39 VLQIFNKRTQEKFALKMLQ-DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 97
Query: 754 IMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVL 812
+M+ + G L + + + T R+ +IM + A++YLH S I H D+KP N+L
Sbjct: 98 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLL 154
Query: 813 LDD---DMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGI 869
+ + L DFG AK + + T T Y+APE S D++S G+
Sbjct: 155 YTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 212
Query: 870 LM 871
+M
Sbjct: 213 IM 214
>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
pdb|2ONL|D Chain D, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer
Length = 406
Score = 47.0 bits (110), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 59/197 (29%), Positives = 91/197 (46%), Gaps = 28/197 (14%)
Query: 697 YKAT---LANGVSVAV-KVFN--LQEDRALKSFDTECEVMRR---IRHR-----NLIKIV 742
YK T L G++ V ++FN QE ALK +C RR + R ++++IV
Sbjct: 69 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVELHWRASQCPHIVRIV 127
Query: 743 SSCSN--PGFKAL--IMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGY 797
N G K L +M+ + G L + + + T R+ +IM + A++YLH
Sbjct: 128 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--- 184
Query: 798 STPIIHCDLKPNNVLLDD---DMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGS 854
S I H D+KP N+L + + L DFG AK + + T T Y+APE
Sbjct: 185 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLG 242
Query: 855 EGIVSISGDVYSFGILM 871
S D++S G++M
Sbjct: 243 PEKYDKSCDMWSLGVIM 259
>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase
(Ttk) In Complex With A Pyrimido-Diazepin Ligand
Length = 313
Score = 47.0 bits (110), Expect = 6e-05, Method: Composition-based stats.
Identities = 45/170 (26%), Positives = 79/170 (46%), Gaps = 13/170 (7%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRN--LIKIVS 743
+GSG V++ A+K NL+E ++ L S+ E + +++ + +I++
Sbjct: 36 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPII 802
+ ++M+ L WL S+ +R ++ A+ +H HG I+
Sbjct: 96 YEITDQYIYMVME-CGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG----IV 149
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIA-KLLDGVDPVTQTMTLATIGYMAPE 851
H DLKP N L+ D M+ L DFGIA ++ V + + T+ YM PE
Sbjct: 150 HSDLKPANFLIVDGML-KLIDFGIANQMQPDXXXVVKDSQVGTVNYMPPE 198
>pdb|2Z66|A Chain A, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And
Hagfish Vlrb.61
pdb|2Z66|B Chain B, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And
Hagfish Vlrb.61
pdb|2Z66|C Chain C, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And
Hagfish Vlrb.61
pdb|2Z66|D Chain D, Crystal Structure Of The Vt3 Hybrid Of Human Tlr4 And
Hagfish Vlrb.61
Length = 306
Score = 47.0 bits (110), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 43/161 (26%), Positives = 68/161 (42%), Gaps = 9/161 (5%)
Query: 442 LTSLRHLDFRSNSLNSTIP-STFWSLKYILAVDFXXXXXXXXXXXXXXXXEALGGLNLTG 500
L L HLDF+ ++L S F SL+ ++ +D +L L + G
Sbjct: 100 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 159
Query: 501 NQLS-GYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSL 559
N ++P L+NL +L L++ + P +F SL SLQ L++S NN
Sbjct: 160 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPY 219
Query: 560 EKLSRLVDFNVSFNGLE-------GEIPSGGPFVNFTADSF 593
+ L+ L + S N + PS F+N T + F
Sbjct: 220 KCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 260
Score = 32.3 bits (72), Expect = 1.4, Method: Compositional matrix adjust.
Identities = 40/170 (23%), Positives = 72/170 (42%), Gaps = 14/170 (8%)
Query: 84 TLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISS 143
T+ + + +L+ +DF ++L + S L D+S F +SS
Sbjct: 92 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 151
Query: 144 LKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDL 203
L+ +++ NS +F D+ T L +L L L + + P +L +L++L++
Sbjct: 152 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL-----EQLSPTAFNSLSSLQVLNM 206
Query: 204 GGNNIAGLIPSMIFNNSNMVAILLYG-NHLS-------GHLPSSIYLPNL 245
NN L + + N + +L Y NH+ H PSS+ NL
Sbjct: 207 SHNNFFSL-DTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 255
>pdb|4G8A|A Chain A, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g
And T399i In Complex With Md-2 And Lps
pdb|4G8A|B Chain B, Crystal Structure Of Human Tlr4 Polymorphic Variant D299g
And T399i In Complex With Md-2 And Lps
Length = 635
Score = 46.6 bits (109), Expect = 6e-05, Method: Compositional matrix adjust.
Identities = 43/161 (26%), Positives = 68/161 (42%), Gaps = 9/161 (5%)
Query: 442 LTSLRHLDFRSNSLNSTIP-STFWSLKYILAVDFXXXXXXXXXXXXXXXXEALGGLNLTG 500
L L HLDF+ ++L S F SL+ ++ +D +L L + G
Sbjct: 419 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 478
Query: 501 NQLS-GYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSL 559
N ++P L+NL +L L++ + P +F SL SLQ L++S NN
Sbjct: 479 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPY 538
Query: 560 EKLSRLVDFNVSFNGLE-------GEIPSGGPFVNFTADSF 593
+ L+ L + S N + PS F+N T + F
Sbjct: 539 KCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDF 579
Score = 33.9 bits (76), Expect = 0.45, Method: Compositional matrix adjust.
Identities = 21/56 (37%), Positives = 30/56 (53%), Gaps = 1/56 (1%)
Query: 511 IGNLKNLDWLALARNAFQG-PIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRL 565
IG+LK L L +A N Q +P+ F +L +L+ LDLS N I L L ++
Sbjct: 144 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQM 199
Score = 33.1 bits (74), Expect = 0.80, Method: Compositional matrix adjust.
Identities = 40/170 (23%), Positives = 72/170 (42%), Gaps = 14/170 (8%)
Query: 84 TLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISS 143
T+ + + +L+ +DF ++L + S L D+S F +SS
Sbjct: 411 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 470
Query: 144 LKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDL 203
L+ +++ NS +F D+ T L +L L L + + P +L +L++L++
Sbjct: 471 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL-----EQLSPTAFNSLSSLQVLNM 525
Query: 204 GGNNIAGLIPSMIFNNSNMVAILLYG-NHLS-------GHLPSSIYLPNL 245
NN L + + N + +L Y NH+ H PSS+ NL
Sbjct: 526 SHNNFFSL-DTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNL 574
>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1
pdb|3R30|A Chain A, Mk2 Kinase Bound To Compound 2
Length = 319
Score = 46.6 bits (109), Expect = 6e-05, Method: Composition-based stats.
Identities = 59/197 (29%), Positives = 91/197 (46%), Gaps = 28/197 (14%)
Query: 697 YKAT---LANGVSVAV-KVFN--LQEDRALKSFDTECEVMRR---IRHR-----NLIKIV 742
YK T L G++ V ++FN QE ALK +C RR + R ++++IV
Sbjct: 18 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVELHWRASQCPHIVRIV 76
Query: 743 SSCSN--PGFKAL--IMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGY 797
N G K L +M+ + G L + + + T R+ +IM + A++YLH
Sbjct: 77 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--- 133
Query: 798 STPIIHCDLKPNNVLLDD---DMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGS 854
S I H D+KP N+L + + L DFG AK + + T T Y+APE
Sbjct: 134 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLG 191
Query: 855 EGIVSISGDVYSFGILM 871
S D++S G++M
Sbjct: 192 PEKYDKSCDMWSLGVIM 208
>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|B Chain B, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|C Chain C, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|D Chain D, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|E Chain E, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|F Chain F, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|G Chain G, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|H Chain H, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|I Chain I, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|J Chain J, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|K Chain K, Mk2 Kinase Bound To Compound 5b
pdb|3R2B|L Chain L, Mk2 Kinase Bound To Compound 5b
Length = 318
Score = 46.6 bits (109), Expect = 6e-05, Method: Composition-based stats.
Identities = 59/197 (29%), Positives = 91/197 (46%), Gaps = 28/197 (14%)
Query: 697 YKAT---LANGVSVAV-KVFN--LQEDRALKSFDTECEVMRR---IRHR-----NLIKIV 742
YK T L G++ V ++FN QE ALK +C RR + R ++++IV
Sbjct: 17 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVELHWRASQCPHIVRIV 75
Query: 743 SSCSN--PGFKAL--IMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGY 797
N G K L +M+ + G L + + + T R+ +IM + A++YLH
Sbjct: 76 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--- 132
Query: 798 STPIIHCDLKPNNVLLDD---DMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGS 854
S I H D+KP N+L + + L DFG AK + + T T Y+APE
Sbjct: 133 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLG 190
Query: 855 EGIVSISGDVYSFGILM 871
S D++S G++M
Sbjct: 191 PEKYDKSCDMWSLGVIM 207
>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76
pdb|2PZY|B Chain B, Structure Of Mk2 Complexed With Compound 76
pdb|2PZY|C Chain C, Structure Of Mk2 Complexed With Compound 76
pdb|2PZY|D Chain D, Structure Of Mk2 Complexed With Compound 76
pdb|3KC3|A Chain A, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|B Chain B, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|C Chain C, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|D Chain D, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|E Chain E, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|F Chain F, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|G Chain G, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|H Chain H, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|I Chain I, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|J Chain J, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|K Chain K, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3KC3|L Chain L, Mk2 Complexed To Inhibitor
N4-(7-(Benzofuran-2-Yl)-1h-Indazol-5-Yl)
Pyrimidine-2,4-Diamine
pdb|3A2C|A Chain A, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|B Chain B, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|C Chain C, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|D Chain D, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|E Chain E, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|F Chain F, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|G Chain G, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|H Chain H, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|I Chain I, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|J Chain J, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|K Chain K, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
pdb|3A2C|L Chain L, Crystal Structure Of A Pyrazolopyrimidine Inhibitor
Complex Mapkap Kinase-2 (Mk2)
Length = 324
Score = 46.6 bits (109), Expect = 6e-05, Method: Composition-based stats.
Identities = 59/197 (29%), Positives = 91/197 (46%), Gaps = 28/197 (14%)
Query: 697 YKAT---LANGVSVAV-KVFN--LQEDRALKSFDTECEVMRR---IRHR-----NLIKIV 742
YK T L G++ V ++FN QE ALK +C RR + R ++++IV
Sbjct: 23 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVELHWRASQCPHIVRIV 81
Query: 743 SSCSN--PGFKAL--IMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGY 797
N G K L +M+ + G L + + + T R+ +IM + A++YLH
Sbjct: 82 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--- 138
Query: 798 STPIIHCDLKPNNVLLDD---DMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGS 854
S I H D+KP N+L + + L DFG AK + + T T Y+APE
Sbjct: 139 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLG 196
Query: 855 EGIVSISGDVYSFGILM 871
S D++S G++M
Sbjct: 197 PEKYDKSCDMWSLGVIM 213
>pdb|2OZA|A Chain A, Structure Of P38alpha Complex
Length = 356
Score = 46.6 bits (109), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 53/182 (29%), Positives = 84/182 (46%), Gaps = 24/182 (13%)
Query: 708 AVKVFN--LQEDRALKSFDTECEVMRR---IRHR-----NLIKIVSSCSN--PGFKAL-- 753
+++FN QE ALK +C RR + R ++++IV N G K L
Sbjct: 34 VLQIFNKRTQEKFALKMLQ-DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 92
Query: 754 IMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVL 812
+M+ + G L + + + T R+ +IM + A++YLH S I H D+KP N+L
Sbjct: 93 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLL 149
Query: 813 LDD---DMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGI 869
+ + L DFG AK + + T T Y+APE S D++S G+
Sbjct: 150 YTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 207
Query: 870 LM 871
+M
Sbjct: 208 IM 209
>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To
Mapkap Kinase-2
pdb|3FYJ|X Chain X, Crystal Structure Of An Optimzied Benzothiophene Inhibitor
Bound To Mapkap Kinase-2 (Mk-2)
pdb|3FYK|X Chain X, Crystal Structure Of A Benzthiophene Lead Bound To Mapkap
Kinase-2 (Mk-2)
Length = 327
Score = 46.6 bits (109), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 53/182 (29%), Positives = 84/182 (46%), Gaps = 24/182 (13%)
Query: 708 AVKVFN--LQEDRALKSFDTECEVMRR---IRHR-----NLIKIVSSCSN--PGFKAL-- 753
+++FN QE ALK +C RR + R ++++IV N G K L
Sbjct: 34 VLQIFNKRTQEKFALKMLQ-DCPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLI 92
Query: 754 IMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVL 812
+M+ + G L + + + T R+ +IM + A++YLH S I H D+KP N+L
Sbjct: 93 VMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH---SINIAHRDVKPENLL 149
Query: 813 LDD---DMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGI 869
+ + L DFG AK + + T T Y+APE S D++S G+
Sbjct: 150 YTSKRPNAILKLTDFGFAK--ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGV 207
Query: 870 LM 871
+M
Sbjct: 208 IM 209
>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein
Kinase 11 (p38 Beta) In Complex With Nilotinib
Length = 348
Score = 46.6 bits (109), Expect = 7e-05, Method: Compositional matrix adjust.
Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 42/207 (20%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V Y A L V+V Q + E +++ ++H N+I
Sbjct: 28 VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVI----- 82
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDI-----------------MIDVA 787
L+ + P S+E +S Y +T D+ + +
Sbjct: 83 -------GLLDVFTPATSIED--FSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLL 133
Query: 788 SALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
L+Y+H S IIH DLKP+NV +++D + DFG+A+ D T +AT Y
Sbjct: 134 RGLKYIH---SAGIIHRDLKPSNVAVNEDCELRILDFGLARQADE----EMTGYVATRWY 186
Query: 848 MAPEYGSEGI-VSISGDVYSFGILMME 873
APE + + + D++S G +M E
Sbjct: 187 RAPEIMLNWMHYNQTVDIWSVGCIMAE 213
>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin
Antagonistically Control The Nuclear Shuttling Of Nfat4
Length = 386
Score = 46.2 bits (108), Expect = 8e-05, Method: Compositional matrix adjust.
Identities = 56/224 (25%), Positives = 90/224 (40%), Gaps = 38/224 (16%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG+ V Y A L V++ Q K E +M+ + H+N+I
Sbjct: 34 IGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNII----- 88
Query: 745 CSNPGFKALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASAL 790
L+ + PQ SLE++ L N I+ LD ++ + +
Sbjct: 89 -------GLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 141
Query: 791 EYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAP 850
++LH S IIH DLKP+N+++ D + DFG+A+ + T Y AP
Sbjct: 142 KHLH---SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGTSFMMVPFVVTRYYRAP 196
Query: 851 EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E + D++S G +M E +F G + QW
Sbjct: 197 EVILGMGYKENVDIWSVGCIMGEMIK----GGVLFPGTDHIDQW 236
>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
pdb|3GC9|B Chain B, The Structure Of P38beta C119s, C162s In Complex With A
Dihydroquinazolinone Inhibitor
Length = 370
Score = 46.2 bits (108), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 42/207 (20%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V Y A L V+V Q + E +++ ++H N+I
Sbjct: 36 VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVI----- 90
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDI-----------------MIDVA 787
L+ + P S+E +S Y +T D+ + +
Sbjct: 91 -------GLLDVFTPATSIED--FSEVYLVTTLMGADLNNIVKSQALSDEHVQFLVYQLL 141
Query: 788 SALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
L+Y+H S IIH DLKP+NV +++D + DFG+A+ D T +AT Y
Sbjct: 142 RGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADE----EMTGYVATRWY 194
Query: 848 MAPEYGSEGI-VSISGDVYSFGILMME 873
APE + + + D++S G +M E
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAE 221
>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With
Ind E804
Length = 324
Score = 46.2 bits (108), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 52/203 (25%), Positives = 92/203 (45%), Gaps = 26/203 (12%)
Query: 688 LGSGSFDNVYK--ATLANGVSVAVKVFNLQ-EDRALKSFDTECEVMRRIRHRNLIKIVSS 744
LG G++ VYK + L + + VA+K L+ E+ A + E +++ ++H N++ +
Sbjct: 10 LGEGTYATVYKGKSKLTDNL-VALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDI 68
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYS-------HNYSLTIRQRLDIMIDVASALEYLHHGY 797
L+ +Y+ + L+++L HN L + Q L L Y H
Sbjct: 69 IHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQLL-------RGLAYCH--- 117
Query: 798 STPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE--YGSE 855
++H DLKP N+L+++ L DFG+A+ + T + T+ Y P+ GS
Sbjct: 118 RQKVLHRDLKPQNLLINERGELKLADFGLAR-AKSIPTKTYDNEVVTLWYRPPDILLGST 176
Query: 856 GIVSISGDVYSFGILMMETFTRR 878
S D++ G + E T R
Sbjct: 177 D-YSTQIDMWGVGCIFYEMATGR 198
>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle
Protein Titin
pdb|1TKI|B Chain B, Autoinhibited Serine Kinase Domain Of The Giant Muscle
Protein Titin
Length = 321
Score = 46.2 bits (108), Expect = 9e-05, Method: Composition-based stats.
Identities = 36/148 (24%), Positives = 69/148 (46%), Gaps = 7/148 (4%)
Query: 726 ECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMID 785
E ++ RHRN++ + S + +I +++ + + + + + L R+ + +
Sbjct: 51 EISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ 110
Query: 786 VASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLG--DFGIAKLLDGVDPVTQTMTLA 843
V AL++LH S I H D++P N++ + + +FG A+ L D T
Sbjct: 111 VCEALQFLH---SHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAP 167
Query: 844 TIGYMAPEYGSEGIVSISGDVYSFGILM 871
Y APE +VS + D++S G L+
Sbjct: 168 E--YYAPEVHQHDVVSTATDMWSLGTLV 193
>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In
Complex With P38 Map Kinase
Length = 360
Score = 46.2 bits (108), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 56/210 (26%), Positives = 95/210 (45%), Gaps = 38/210 (18%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V A G VAVK + Q K E +++ ++H N+I
Sbjct: 30 VGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVI----- 84
Query: 745 CSNPGFKALIMQYMPQGSLEK----WLYSH------NYSLTIRQRLD-----IMIDVASA 789
L+ + P SLE+ +L +H N + ++ D ++ +
Sbjct: 85 -------GLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 137
Query: 790 LEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMA 849
L+Y+H S IIH DLKP+N+ +++D + DF +A+ D T +AT Y A
Sbjct: 138 LKYIH---SADIIHRDLKPSNLAVNEDCELKILDFYLARHTDD----EMTGYVATRWYRA 190
Query: 850 PEYGSEGI-VSISGDVYSFGILMMETFTRR 878
PE + + + D++S G +M E T R
Sbjct: 191 PEIMLNWMHYNQTVDIWSVGCIMAELLTGR 220
>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
pdb|3GC8|B Chain B, The Structure Of P38beta C162s In Complex With A
Dihydroquinazolinone
Length = 370
Score = 46.2 bits (108), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 53/207 (25%), Positives = 89/207 (42%), Gaps = 42/207 (20%)
Query: 688 LGSGSFDNV---YKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSS 744
+GSG++ +V Y A L V+V Q + E +++ ++H N+I
Sbjct: 36 VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLKHENVI----- 90
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDI-----------------MIDVA 787
L+ + P S+E +S Y +T D+ + +
Sbjct: 91 -------GLLDVFTPATSIED--FSEVYLVTTLMGADLNNIVKCQALSDEHVQFLVYQLL 141
Query: 788 SALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
L+Y+H S IIH DLKP+NV +++D + DFG+A+ D T +AT Y
Sbjct: 142 RGLKYIH---SAGIIHRDLKPSNVAVNEDSELRILDFGLARQADE----EMTGYVATRWY 194
Query: 848 MAPEYGSEGI-VSISGDVYSFGILMME 873
APE + + + D++S G +M E
Sbjct: 195 RAPEIMLNWMHYNQTVDIWSVGCIMAE 221
>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796
pdb|3NPC|B Chain B, Crystal Structure Of Jnk2 Complexed With Birb796
Length = 364
Score = 46.2 bits (108), Expect = 9e-05, Method: Compositional matrix adjust.
Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 39/218 (17%)
Query: 691 GSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGF 750
+FD V G++VAVK + + F + R R L+K V+ +
Sbjct: 42 AAFDTVL------GINVAVKKLS-------RPFQNQTHAKRAYRELVLLKCVN---HKNI 85
Query: 751 KALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASALEYLHHG 796
+L+ + PQ +LE++ L N I LD ++ + +++LH
Sbjct: 86 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH-- 143
Query: 797 YSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG 856
S IIH DLKP+N+++ D + DFG+A+ T + T Y APE
Sbjct: 144 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--ACTNFMMTPYVVTRYYRAPEVILGM 200
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
+ + D++S G +M E +F G + QW
Sbjct: 201 GYAANVDIWSVGCIMGELVK----GCVIFQGTDHIDQW 234
>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|B Chain B, Crystal Structure Of The Human Cdkl1 Kinase Domain
pdb|4AGU|C Chain C, Crystal Structure Of The Human Cdkl1 Kinase Domain
Length = 311
Score = 45.8 bits (107), Expect = 1e-04, Method: Composition-based stats.
Identities = 46/169 (27%), Positives = 73/169 (43%), Gaps = 12/169 (7%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRAL--KSFDTECEVMRRIRHRNLIKIVSS 744
+G GS+ V+K G VA+K F ED + K E ++++++H NL+ ++
Sbjct: 11 IGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLKHPNLVNLLEV 70
Query: 745 CSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRL--DIMIDVASALEYLHHGYSTPII 802
L+ +Y L + Y + + L I A+ + H I
Sbjct: 71 FRRKRRLHLVFEYCDHTVLHEL---DRYQRGVPEHLVKSITWQTLQAVNFCH---KHNCI 124
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPE 851
H D+KP N+L+ V L DFG A+LL G +AT Y +PE
Sbjct: 125 HRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDD-EVATRWYRSPE 172
>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil
pdb|3TKU|B Chain B, Mrck Beta In Complex With Fasudil
Length = 433
Score = 45.8 bits (107), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 57/232 (24%), Positives = 89/232 (38%), Gaps = 44/232 (18%)
Query: 674 ELQQATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKVFNLQEDRALKSFDTECEVMRR 732
E+Q F ++G G+F V + N + A+K+ N E LK +T C
Sbjct: 84 EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWE--MLKRAETAC----- 136
Query: 733 IRHRNLIKIVSSCS-----NPGFK-----ALIMQYMPQGSLEKWLYSHNYSL---TIRQR 779
R + + C + F+ L+M Y G L L L R
Sbjct: 137 FREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFY 196
Query: 780 LDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT 839
+ M+ ++ LH+ +H D+KP+NVLLD + L DFG ++ V +
Sbjct: 197 IGEMVLAIDSIHQLHY------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSS 250
Query: 840 MTLATIGYMAPE-----------YGSEGIVSISGDVYSFGILMMETFTRRKP 880
+ + T Y++PE YG E D +S G+ M E P
Sbjct: 251 VAVGTPDYISPEILQAMEDGMGKYGPE------CDWWSLGVCMYEMLYGETP 296
>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii,
25.M01780 Or Tgme49_007820
Length = 458
Score = 45.8 bits (107), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 44/165 (26%), Positives = 76/165 (46%), Gaps = 9/165 (5%)
Query: 673 HELQQATNGFGESNLLGSGSFDNVYKA--TLANGVSVAVKVFNLQEDRA-LKSFDTECEV 729
H Q + + +L+G+GS+ +V +A L V K+ + ED K E +
Sbjct: 46 HSDWQIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAI 105
Query: 730 MRRIRHRNLIK---IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDV 786
+ R+ H +++K IV F L + S K L+ LT ++ ++
Sbjct: 106 LNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNL 165
Query: 787 ASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD 831
++Y+H S I+H DLKP N L++ D + DFG+A+ +D
Sbjct: 166 LVGVKYVH---SAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD 207
>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a
Mutant In Complex With Sp600125 Inhibitor
Length = 390
Score = 45.8 bits (107), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 46/170 (27%), Positives = 77/170 (45%), Gaps = 13/170 (7%)
Query: 688 LGSGSFDNVYKATLANGVSVAVKVFNLQE--DRALKSFDTECEVMRRIRHRNLIKIVSSC 745
+GSG V++ A+K NL+E ++ L S+ E + +++ + KI+
Sbjct: 64 IGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHS-DKIIRLY 122
Query: 746 SNPGFKALIMQYMPQGSLE--KWLYSHNYSLTIRQRLDIMIDVASALEYLH-HGYSTPII 802
I M G+++ WL S+ +R ++ A+ +H HG I+
Sbjct: 123 DYEITDQYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVHTIHQHG----IV 177
Query: 803 HCDLKPNNVLLDDDMVAHLGDFGIA-KLLDGVDPVTQTMTLATIGYMAPE 851
H DLKP N L+ D M+ L DFGIA ++ V + + + YM PE
Sbjct: 178 HSDLKPANFLIVDGMLK-LIDFGIANQMQPDTTSVVKDSQVGAVNYMPPE 226
>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1
pdb|3QFV|B Chain B, Mrck Beta In Complex With Tpca-1
Length = 415
Score = 45.8 bits (107), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 57/232 (24%), Positives = 89/232 (38%), Gaps = 44/232 (18%)
Query: 674 ELQQATNGFGESNLLGSGSFDNVYKATLANGVSV-AVKVFNLQEDRALKSFDTECEVMRR 732
E+Q F ++G G+F V + N + A+K+ N E LK +T C
Sbjct: 68 EMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWE--MLKRAETAC----- 120
Query: 733 IRHRNLIKIVSSCS-----NPGFK-----ALIMQYMPQGSLEKWLYSHNYSL---TIRQR 779
R + + C + F+ L+M Y G L L L R
Sbjct: 121 FREERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFY 180
Query: 780 LDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQT 839
+ M+ ++ LH+ +H D+KP+NVLLD + L DFG ++ V +
Sbjct: 181 IGEMVLAIDSIHQLHY------VHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSS 234
Query: 840 MTLATIGYMAPE-----------YGSEGIVSISGDVYSFGILMMETFTRRKP 880
+ + T Y++PE YG E D +S G+ M E P
Sbjct: 235 VAVGTPDYISPEILQAMEDGMGKYGPE------CDWWSLGVCMYEMLYGETP 280
>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
In With Amp-Pnp
pdb|3KN5|B Chain B, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
In With Amp-Pnp
pdb|3KN6|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
pdb|3KN6|B Chain B, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1
Length = 325
Score = 45.8 bits (107), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 50/199 (25%), Positives = 91/199 (45%), Gaps = 15/199 (7%)
Query: 688 LGSGSFDNVYKATLANG-VSVAVKVFNLQEDRALKSFDTECEVMRRIR-HRNLIKIVSSC 745
LG GSF K + AVK+ + R + E ++ H N++K+
Sbjct: 19 LGEGSFSICRKCVHKKSNQAFAVKIIS---KRMEANTQKEITALKLCEGHPNIVKLHEVF 75
Query: 746 SNPGFKALIMQYMPQGSL-EKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIHC 804
+ L+M+ + G L E+ ++S T + IM + SA+ ++H ++H
Sbjct: 76 HDQLHTFLVMELLNGGELFERIKKKKHFSET--EASYIMRKLVSAVSHMH---DVGVVHR 130
Query: 805 DLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGIVSIS 861
DLKP N+L +D++ + DFG A+L + +T T+ Y APE ++ S
Sbjct: 131 DLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF-TLHYAAPELLNQNGYDES 189
Query: 862 GDVYSFGILMMETFTRRKP 880
D++S G+++ + + P
Sbjct: 190 CDLWSLGVILYTMLSGQVP 208
>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With
A Potent 3-Aminopyrazole Atp Site Inhibitor
pdb|3M2W|A Chain A, Crystal Structure Of Mapkak Kinase 2 (Mk2) Complexed With
A Spiroazetidine-Tetracyclic Atp Site Inhibitor
pdb|3M42|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With
A Tetracyclic Atp Site Inhibitor
Length = 299
Score = 45.8 bits (107), Expect = 1e-04, Method: Composition-based stats.
Identities = 71/279 (25%), Positives = 115/279 (41%), Gaps = 52/279 (18%)
Query: 697 YKAT---LANGVSVAV-KVFN--LQEDRALKSFDTECEVMRR---IRHR-----NLIKIV 742
YK T L G++ V ++FN QE ALK +C RR + R ++++IV
Sbjct: 19 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQ-DCPKARREVELHWRASQCPHIVRIV 77
Query: 743 SSCSN--PGFKAL--IMQYMPQGSLEKWLYSH-NYSLTIRQRLDIMIDVASALEYLHHGY 797
N G K L +M+ + G L + + + T R+ +IM + A++YLH
Sbjct: 78 DVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH--- 134
Query: 798 STPIIHCDLKPNNVLLDD---DMVAHLGDFGIAKLLDG--VDPVTQTMTLATIGYM---- 848
S I H D+KP N+L + + L DFG AK G D +L I Y+
Sbjct: 135 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTGEKYDKSCDMWSLGVIMYILLCG 194
Query: 849 -APEYGSEGIVSISG------------------DVYSFGILMMETFTRRKPTNEMFTGEM 889
P Y + G+ G +V +++ + +PT M E
Sbjct: 195 YPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEF 254
Query: 890 SLKQWVAESLPGAVTEVVDANLLSREDEEDADDFATKKT 928
W+ +S T + + +L +ED+E +D + T
Sbjct: 255 MNHPWIMQSTKVPQTPLHTSRVL-KEDKERWEDVKEEMT 292
>pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex
Length = 461
Score = 45.8 bits (107), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 76/286 (26%), Positives = 119/286 (41%), Gaps = 59/286 (20%)
Query: 65 VGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLS----------------GS 108
+ NL+ L L + N D P L ++ L ++ SSN++S G+
Sbjct: 103 LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLNFGN 160
Query: 109 LPGDM--CNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRL 166
D+ + T LE D+SSNK++ S + +++L+S+ NN +S P + T L
Sbjct: 161 QVTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLGILTNL 218
Query: 167 PSLV----QLRLLG-----NNITG-RIPNREIPN--EIGNLHNLKILDLGGNNIAGLIP- 213
L QL+ +G N+T + N +I N + L L L LG N I+ + P
Sbjct: 219 DELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPL 278
Query: 214 -------------------SMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNN 254
S I N N+ + LY N++S P S L L+ LF + N
Sbjct: 279 AGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVS-SLTKLQRLFFYNNK 337
Query: 255 LSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGD 300
+S + S+ N + L N S L P N ++ L L D
Sbjct: 338 VSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLND 379
Score = 36.2 bits (82), Expect = 0.098, Method: Compositional matrix adjust.
Identities = 41/146 (28%), Positives = 63/146 (43%), Gaps = 34/146 (23%)
Query: 439 LANLTSLRHLDFRSNSLNS-TIPSTFWSLKYILAVDFXXXXXXXXXXXXXXXXEALGGLN 497
LANLT+L LD SN ++ ++ + +L+ ++A
Sbjct: 168 LANLTTLERLDISSNKVSDISVLAKLTNLESLIA-------------------------- 201
Query: 498 LTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPK 557
T NQ+S P +G L NLD L+L N + + SL +L LDL+ N IS P
Sbjct: 202 -TNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP- 255
Query: 558 SLEKLSRLVDFNVSFNGLEGEIPSGG 583
L L++L + + N + P G
Sbjct: 256 -LSGLTKLTELKLGANQISNISPLAG 280
>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In
Complex With The Bisindoylmaleide Inhibitor Bim Viii
pdb|2VD5|B Chain B, Structure Of Human Myotonic Dystrophy Protein Kinase In
Complex With The Bisindoylmaleide Inhibitor Bim Viii
Length = 412
Score = 45.4 bits (106), Expect = 1e-04, Method: Compositional matrix adjust.
Identities = 61/277 (22%), Positives = 111/277 (40%), Gaps = 33/277 (11%)
Query: 670 ISYHELQQATNGFGESNLLGSGSFDNVYKATLAN-GVSVAVKVFN---LQEDRALKSFDT 725
+ E++ + F ++G G+F V + G A+K+ N + + + F
Sbjct: 51 VRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFRE 110
Query: 726 ECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMID 785
E +V+ R + ++ + + + L+M+Y G L L + + +
Sbjct: 111 ERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAE 170
Query: 786 VASALEYLHH-GYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLAT 844
+ A++ +H GY +H D+KP+N+LLD L DFG L V + + T
Sbjct: 171 IVMAIDSVHRLGY----VHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGT 226
Query: 845 IGYMAPE-------YGSEGIVSISGDVYSFGILMMETFTRRKP-----TNEMFTGEMSLK 892
Y++PE G D ++ G+ E F + P T E + + K
Sbjct: 227 PDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYK 286
Query: 893 QWVAESLPGAVTEVVDANLLSREDEEDADDFATKKTC 929
+ + SLP +VD + E+A DF + C
Sbjct: 287 EHL--SLP-----LVDEGV-----PEEARDFIQRLLC 311
>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g
pdb|2HW7|A Chain A, Crystal Structure Of Mnk2-D228g In Complex With
Staurosporine
Length = 316
Score = 45.4 bits (106), Expect = 1e-04, Method: Composition-based stats.
Identities = 53/204 (25%), Positives = 94/204 (46%), Gaps = 20/204 (9%)
Query: 684 ESNLLGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIR-HRNLIKI 741
+ ++LG G+ V L AVK+ Q E E++ + + HRN++++
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
+ L+ + M GS+ ++ + + + ++ DVASAL++LH + I
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-VVQDVASALDFLH---NKGI 132
Query: 802 IHCDLKPNNVLLDD-DMVA--HLGDFGIA---KLLDGVDPVTQTMTLATIG---YMAPE- 851
H DLKP N+L + + V+ + DFG+ KL P++ L G YMAPE
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 852 ---YGSEG-IVSISGDVYSFGILM 871
+ E I D++S G+++
Sbjct: 193 VEAFSEEASIYDKRCDLWSLGVIL 216
>pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human)
Recognition Complex
pdb|1O6T|A Chain A, Internalin (Inla,Listeria Monocytogenes) - Functional
Domain, Uncomplexed
pdb|1O6V|A Chain A, Internalin (Inla,Listeria Monocytogenes) - Functional
Domain, Uncomplexed
pdb|1O6V|B Chain B, Internalin (Inla,Listeria Monocytogenes) - Functional
Domain, Uncomplexed
Length = 466
Score = 45.4 bits (106), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 76/286 (26%), Positives = 119/286 (41%), Gaps = 59/286 (20%)
Query: 65 VGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLS----------------GS 108
+ NL+ L L + N D P L ++ L ++ SSN++S G+
Sbjct: 108 LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGN 165
Query: 109 LPGDM--CNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRL 166
D+ + T LE D+SSNK++ S + +++L+S+ NN +S P + T L
Sbjct: 166 QVTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLGILTNL 223
Query: 167 PSLV----QLRLLG-----NNITG-RIPNREIPN--EIGNLHNLKILDLGGNNIAGLIP- 213
L QL+ +G N+T + N +I N + L L L LG N I+ + P
Sbjct: 224 DELSLNGNQLKDIGTLASLTNLTDLDLANNQISNLAPLSGLTKLTELKLGANQISNISPL 283
Query: 214 -------------------SMIFNNSNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKNN 254
S I N N+ + LY N++S P S L L+ LF + N
Sbjct: 284 AGLTALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPVS-SLTKLQRLFFYNNK 342
Query: 255 LSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGD 300
+S + S+ N + L N S L P N ++ L L D
Sbjct: 343 VSDV--SSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLND 384
Score = 30.8 bits (68), Expect = 3.5, Method: Compositional matrix adjust.
Identities = 53/201 (26%), Positives = 77/201 (38%), Gaps = 31/201 (15%)
Query: 402 LNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPS 461
+N+N++ P L L L L NN + P L NLT+L L+ SN+++ S
Sbjct: 97 MNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--S 150
Query: 462 TFWSLKYILAVDFXXXXXXXXXXXXXXXXEALG-------------------GLNLTGNQ 502
L + + F E L L T NQ
Sbjct: 151 ALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQ 210
Query: 503 LSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKL 562
+S P +G L NLD L+L N + + SL +L LDL+ N IS P L L
Sbjct: 211 ISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGL 264
Query: 563 SRLVDFNVSFNGLEGEIPSGG 583
++L + + N + P G
Sbjct: 265 TKLTELKLGANQISNISPLAG 285
>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2
pdb|3E7O|B Chain B, Crystal Structure Of Jnk2
Length = 360
Score = 45.4 bits (106), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 55/218 (25%), Positives = 91/218 (41%), Gaps = 39/218 (17%)
Query: 691 GSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRHRNLIKIVSSCSNPGF 750
+FD V G++VAVK + + F + R R L+K V+ +
Sbjct: 40 AAFDTVL------GINVAVKKLS-------RPFQNQTHAKRAYRELVLLKCVN---HKNI 83
Query: 751 KALIMQYMPQGSLEKW--------LYSHNYSLTIRQRLD------IMIDVASALEYLHHG 796
+L+ + PQ +LE++ L N I LD ++ + +++LH
Sbjct: 84 ISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQMLCGIKHLH-- 141
Query: 797 YSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEG 856
S IIH DLKP+N+++ D + DFG+A+ T + T Y APE
Sbjct: 142 -SAGIIHRDLKPSNIVVKSDCTLKILDFGLART--ASTNFMMTPYVVTRYYRAPEVILGM 198
Query: 857 IVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
+ D++S G +M E + +F G + QW
Sbjct: 199 GYKENVDIWSVGCIMGELVK----GSVIFQGTDHIDQW 232
>pdb|3ZYJ|A Chain A, Netring1 In Complex With Ngl1
pdb|3ZYJ|C Chain C, Netring1 In Complex With Ngl1
Length = 440
Score = 45.4 bits (106), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 62/234 (26%), Positives = 100/234 (42%), Gaps = 19/234 (8%)
Query: 74 LNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGE 133
LN+ N N H+R L+I+ S N + G N L + ++ N++T
Sbjct: 69 LNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAF-NGLANLNTLELFDNRLTTI 127
Query: 134 FPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNE-- 191
A V +S LK + L NN + S P+ R+PSL +L L G + +E
Sbjct: 128 PNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDL------GELKRLSYISEGA 180
Query: 192 IGNLHNLKILDLGGNN---IAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIY-LPNLEN 247
L NL+ L+L N I L P + + + L GNHLS P S L +L+
Sbjct: 181 FEGLSNLRYLNLAMCNLREIPNLTPLIKLDELD-----LSGNHLSAIRPGSFQGLMHLQK 235
Query: 248 LFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDN 301
L++ ++ + I ++ N + L+ N + L + F L+ + L N
Sbjct: 236 LWMIQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
Score = 31.6 bits (70), Expect = 2.4, Method: Compositional matrix adjust.
Identities = 20/60 (33%), Positives = 33/60 (55%)
Query: 493 LGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNIS 552
L L+L+GN LS P S L +L L + ++ Q +F +L SL ++L+ NN++
Sbjct: 209 LDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIERNAFDNLQSLVEINLAHNNLT 268
Score = 30.4 bits (67), Expect = 4.4, Method: Compositional matrix adjust.
Identities = 26/86 (30%), Positives = 45/86 (52%), Gaps = 1/86 (1%)
Query: 496 LNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEI 555
LNL NQ+ +S +L++L+ L L+RN + +F L +L +L+L N ++
Sbjct: 69 LNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIP 128
Query: 556 PKSLEKLSRLVDFNVSFNGLEGEIPS 581
+ LS+L + + N +E IPS
Sbjct: 129 NGAFVYLSKLKELWLRNNPIES-IPS 153
>pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte
Receptors Of Jawless Vertebrates By Module Engineering
Length = 279
Score = 45.1 bits (105), Expect = 2e-04, Method: Compositional matrix adjust.
Identities = 38/117 (32%), Positives = 57/117 (48%), Gaps = 5/117 (4%)
Query: 192 IGNLHNLKILDLGGNNIAGLIPSMIFNN-SNMVAILLYGNHLSGHLPSSIY--LPNLENL 248
+ L NL L L GN + L P+ +F+ +N+ ++L N L LP ++ L NL L
Sbjct: 81 LKELTNLTYLILTGNQLQSL-PNGVFDKLTNLKELVLVENQLQS-LPDGVFDKLTNLTYL 138
Query: 249 FLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTT 305
+L+ N L + + T L+L +N L F QL+ LSL DNQL +
Sbjct: 139 YLYHNQLQSLPKGVFDKLTNLTRLDLDNNQLQSLPEGVFDKLTQLKQLSLNDNQLKS 195
Score = 32.7 bits (73), Expect = 1.1, Method: Compositional matrix adjust.
Identities = 27/90 (30%), Positives = 38/90 (42%), Gaps = 1/90 (1%)
Query: 493 LGGLNLTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNIS 552
L L L NQL L NL +L L N Q F L +L LDL N +
Sbjct: 111 LKELVLVENQLQSLPDGVFDKLTNLTYLYLYHNQLQSLPKGVFDKLTNLTRLDLDNNQLQ 170
Query: 553 GEIPKSLEKLSRLVDFNVSFNGLEGEIPSG 582
+KL++L +++ N L+ +P G
Sbjct: 171 SLPEGVFDKLTQLKQLSLNDNQLKS-VPDG 199
Score = 30.4 bits (67), Expect = 5.0, Method: Compositional matrix adjust.
Identities = 28/86 (32%), Positives = 38/86 (44%), Gaps = 3/86 (3%)
Query: 498 LTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPK 557
LTGNQL L NL L L N Q F L +L L L N + +PK
Sbjct: 92 LTGNQLQSLPNGVFDKLTNLKELVLVENQLQSLPDGVFDKLTNLTYLYLYHNQLQS-LPK 150
Query: 558 SL-EKLSRLVDFNVSFNGLEGEIPSG 582
+ +KL+ L ++ N L+ +P G
Sbjct: 151 GVFDKLTNLTRLDLDNNQLQS-LPEG 175
>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In
Complex With Ca2+ And Amppnp
Length = 494
Score = 44.3 bits (103), Expect = 3e-04, Method: Compositional matrix adjust.
Identities = 39/150 (26%), Positives = 68/150 (45%), Gaps = 10/150 (6%)
Query: 726 ECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMID 785
E V++ + H N++K+ + L+M+ G L + H I+
Sbjct: 86 EVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEII-HRMKFNEVDAAVIIKQ 144
Query: 786 VASALEYLHHGYSTPIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTL 842
V S + YLH I+H DLKP N+LL + D + + DFG++ + + + + L
Sbjct: 145 VLSGVTYLH---KHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKE--RL 199
Query: 843 ATIGYMAPEYGSEGIVSISGDVYSFGILMM 872
T Y+APE + DV+S G+++
Sbjct: 200 GTAYYIAPEVLRKKYDE-KCDVWSIGVILF 228
>pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex
Length = 466
Score = 44.3 bits (103), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 74/262 (28%), Positives = 118/262 (45%), Gaps = 39/262 (14%)
Query: 65 VGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLS----------------GS 108
+ NL+ L L + N D P L ++ L ++ SSN++S G+
Sbjct: 107 LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGN 164
Query: 109 LPGDM--CNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRL 166
D+ + T LE D+SSNK++ S + +++L+S+ NN +S P + T L
Sbjct: 165 QVTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLGILTNL 222
Query: 167 PSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAIL 226
+L L GN + ++I + +L NL LDL N I+ L P + + + +
Sbjct: 223 D---ELSLNGNQL------KDI-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELK 270
Query: 227 LYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNT 286
L N +S P + L L NL L +N L I P I N T L L N S + P
Sbjct: 271 LGANQISNISPLA-GLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-- 325
Query: 287 FGNCRQLQILSLGDNQLTTGSS 308
+ +LQ L +N+++ SS
Sbjct: 326 VSSLTKLQRLFFANNKVSDVSS 347
Score = 30.8 bits (68), Expect = 3.6, Method: Compositional matrix adjust.
Identities = 53/201 (26%), Positives = 77/201 (38%), Gaps = 31/201 (15%)
Query: 402 LNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIPS 461
+N+N++ P L L L L NN + P L NLT+L L+ SN+++ S
Sbjct: 96 MNNNQIADITP--LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDI--S 149
Query: 462 TFWSLKYILAVDFXXXXXXXXXXXXXXXXEALG-------------------GLNLTGNQ 502
L + + F E L L T NQ
Sbjct: 150 ALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISVLAKLTNLESLIATNNQ 209
Query: 503 LSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKL 562
+S P +G L NLD L+L N + + SL +L LDL+ N IS P L L
Sbjct: 210 ISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP--LSGL 263
Query: 563 SRLVDFNVSFNGLEGEIPSGG 583
++L + + N + P G
Sbjct: 264 TKLTELKLGANQISNISPLAG 284
>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human
Protein Kinase Ck2
Length = 329
Score = 44.3 bits (103), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 53/215 (24%), Positives = 101/215 (46%), Gaps = 23/215 (10%)
Query: 688 LGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIRH-RNLIKIVSSC 745
LG G + V++A + N V VK+ + +K E +++ +R N+I +
Sbjct: 45 LGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKR---EIKILENLRGGPNIITLADIV 101
Query: 746 SNPGFK--ALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPIIH 803
+P + AL+ +++ ++ LY +LT M ++ AL+Y H S I+H
Sbjct: 102 KDPVSRTPALVFEHVNNTDFKQ-LYQ---TLTDYDIRFYMYEILKALDYCH---SMGIMH 154
Query: 804 CDLKPNNVLLDDDMVA-HLGDFGIAKLLDGVDPVTQ-TMTLATIGYMAPEYGSE-GIVSI 860
D+KP+NV++D + L D+G+A+ P + + +A+ + PE + +
Sbjct: 155 RDVKPHNVMIDHEHRKLRLIDWGLAEFY---HPGQEYNVRVASRYFKGPELLVDYQMYDY 211
Query: 861 SGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQWV 895
S D++S G ++ R++P F G + Q V
Sbjct: 212 SLDMWSLGCMLASMIFRKEP---FFHGHDNYDQLV 243
>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54
pdb|2QHM|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2a
pdb|2QHN|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1a
pdb|3TKH|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S01
pdb|3TKI|A Chain A, Crystal Structure Of Chk1 In Complex With Inhibitor S25
Length = 323
Score = 44.3 bits (103), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 52/227 (22%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRAL---KSFDTECEVMRRIRHRNLIKIVS 743
LG G++ V A +VAVK+ +++ RA+ ++ E + + + H N++K
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKFYG 72
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH--------- 794
+ L ++Y G L R DI + A + H
Sbjct: 73 HRREGNIQYLFLEYCSGGEL-----------FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 121
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAP-- 850
HG I H D+KP N+LLD+ + DFG+A + + + + M T+ Y+AP
Sbjct: 122 HGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 178
Query: 851 ----EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
E+ +E + DV+S GI++ M GE+ Q
Sbjct: 179 LKRREFHAEPV-----DVWSCGIVL----------TAMLAGELPWDQ 210
>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20
pdb|2HXL|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 1
pdb|2HXQ|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 2
pdb|2HY0|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 22
pdb|3F9N|A Chain A, Crystal Structure Of Chk1 Kinase In Complex With Inhibitor
38
Length = 322
Score = 44.3 bits (103), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 55/227 (24%), Positives = 93/227 (40%), Gaps = 52/227 (22%)
Query: 688 LGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRAL---KSFDTECEVMRRIRHRNLIKIVS 743
LG G++ V A +VAVK+ +++ RA+ ++ E + + + H N++K
Sbjct: 14 LGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKFYG 71
Query: 744 SCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH--------- 794
+ L ++Y G L R DI + A + H
Sbjct: 72 HRREGNIQYLFLEYCSGGEL-----------FDRIEPDIGMPEPDAQRFFHQLMAGVVYL 120
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAP-- 850
HG I H D+KP N+LLD+ + DFG+A + + + + M T+ Y+AP
Sbjct: 121 HGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAPEL 177
Query: 851 ----EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
E+ +E + DV+S GI++ M GE+ Q
Sbjct: 178 LKRREFHAEPV-----DVWSCGIVL----------TAMLAGELPWDQ 209
>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma
pdb|1CM8|B Chain B, Phosphorylated Map Kinase P38-Gamma
Length = 367
Score = 44.3 bits (103), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 55/216 (25%), Positives = 94/216 (43%), Gaps = 24/216 (11%)
Query: 688 LGSGSFDNVYKATLAN-GVSVAVKVFN--LQEDRALKSFDTECEVMRRIRHRNLIKIV-- 742
+GSG++ V A G VA+K Q + K E +++ +RH N+I ++
Sbjct: 33 VGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDV 92
Query: 743 ----SSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYS 798
+ + L+M +M G+ L H R + ++ + L Y+H +
Sbjct: 93 FTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQF-LVYQMLKGLRYIH---A 146
Query: 799 TPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGYMAPEYGSEGI- 857
IIH DLKP N+ +++D + DFG+A+ D + T Y APE +
Sbjct: 147 AGIIHRDLKPGNLAVNEDCELKILDFGLARQADS----EMXGXVVTRWYRAPEVILNWMR 202
Query: 858 VSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQ 893
+ + D++S G +M E T + +F G L Q
Sbjct: 203 YTQTVDIWSVGCIMAEMITGKT----LFKGSDHLDQ 234
>pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex
pdb|2OMW|A Chain A, Crystal Structure Of Inla S192n Y369s/mec1 Complex
Length = 461
Score = 44.3 bits (103), Expect = 4e-04, Method: Compositional matrix adjust.
Identities = 74/262 (28%), Positives = 118/262 (45%), Gaps = 39/262 (14%)
Query: 65 VGNLSFLVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLS----------------GS 108
+ NL+ L L + N D P L ++ L ++ SSN++S G+
Sbjct: 103 LANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLNFGN 160
Query: 109 LPGDM--CNSFTQLESFDVSSNKITGEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRL 166
D+ + T LE D+SSNK++ S + +++L+S+ NN +S P + T L
Sbjct: 161 QVTDLKPLANLTTLERLDISSNKVSD--ISVLAKLTNLESLIATNNQISDITPLGILTNL 218
Query: 167 PSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAIL 226
+L L GN + ++I + +L NL LDL N I+ L P + + + +
Sbjct: 219 D---ELSLNGNQL------KDI-GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELK 266
Query: 227 LYGNHLSGHLPSSIYLPNLENLFLWKNNLSGIIPDSICNASEATILELSSNLFSGLVPNT 286
L N +S P + L L NL L +N L I P I N T L L N S + P
Sbjct: 267 LGANQISNISPLA-GLTALTNLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP-- 321
Query: 287 FGNCRQLQILSLGDNQLTTGSS 308
+ +LQ L +N+++ SS
Sbjct: 322 VSSLTKLQRLFFSNNKVSDVSS 343
Score = 36.2 bits (82), Expect = 0.094, Method: Compositional matrix adjust.
Identities = 41/146 (28%), Positives = 63/146 (43%), Gaps = 34/146 (23%)
Query: 439 LANLTSLRHLDFRSNSLNS-TIPSTFWSLKYILAVDFXXXXXXXXXXXXXXXXEALGGLN 497
LANLT+L LD SN ++ ++ + +L+ ++A
Sbjct: 168 LANLTTLERLDISSNKVSDISVLAKLTNLESLIA-------------------------- 201
Query: 498 LTGNQLSGYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPK 557
T NQ+S P +G L NLD L+L N + + SL +L LDL+ N IS P
Sbjct: 202 -TNNQISDITP--LGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDLANNQISNLAP- 255
Query: 558 SLEKLSRLVDFNVSFNGLEGEIPSGG 583
L L++L + + N + P G
Sbjct: 256 -LSGLTKLTELKLGANQISNISPLAG 280
>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 43.5 bits (101), Expect = 5e-04, Method: Composition-based stats.
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 46/219 (21%)
Query: 688 LGSGSFDNVYKATLANGVS---VAVKVFNLQEDRAL---KSFDTECEVMRRIRHRNLIKI 741
LG G++ V A N V+ VAVK+ +++ RA+ ++ E + + + H N++K
Sbjct: 14 LGEGAYGEVQLAV--NRVTEEAVAVKIVDMK--RAVDCPENIKKEIXINKMLNHENVVKF 69
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH------- 794
+ L ++Y G L R DI + A + H
Sbjct: 70 YGHRREGNIQYLFLEYCSGGELFD-----------RIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 795 --HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAP 850
HG I H D+KP N+LLD+ + DFG+A + + + + M T+ Y+AP
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX-GTLPYVAP 175
Query: 851 ------EYGSEGIVSISGDVYSFGILMMETFTRRKPTNE 883
E+ +E + DV+S GI++ P ++
Sbjct: 176 ELLKRREFHAEPV-----DVWSCGIVLTAMLAGELPWDQ 209
>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
pdb|2YDJ|B Chain B, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 43.5 bits (101), Expect = 5e-04, Method: Composition-based stats.
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 46/219 (21%)
Query: 688 LGSGSFDNVYKATLANGVS---VAVKVFNLQEDRAL---KSFDTECEVMRRIRHRNLIKI 741
LG G++ V A N V+ VAVK+ +++ RA+ ++ E + + + H N++K
Sbjct: 15 LGEGAYGEVQLAV--NRVTEEAVAVKIVDMK--RAVDCPENIKKEIXINKMLNHENVVKF 70
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH------- 794
+ L ++Y G L R DI + A + H
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFD-----------RIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 795 --HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAP 850
HG I H D+KP N+LLD+ + DFG+A + + + + M T+ Y+AP
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX-GTLPYVAP 176
Query: 851 ------EYGSEGIVSISGDVYSFGILMMETFTRRKPTNE 883
E+ +E + DV+S GI++ P ++
Sbjct: 177 ELLKRREFHAEPV-----DVWSCGIVLTAMLAGELPWDQ 210
>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 43.5 bits (101), Expect = 5e-04, Method: Composition-based stats.
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 46/219 (21%)
Query: 688 LGSGSFDNVYKATLANGVS---VAVKVFNLQEDRAL---KSFDTECEVMRRIRHRNLIKI 741
LG G++ V A N V+ VAVK+ +++ RA+ ++ E + + + H N++K
Sbjct: 14 LGEGAYGEVQLAV--NRVTEEAVAVKIVDMK--RAVDCPENIKKEIXINKMLNHENVVKF 69
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH------- 794
+ L ++Y G L R DI + A + H
Sbjct: 70 YGHRREGNIQYLFLEYCSGGELFD-----------RIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 795 --HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAP 850
HG I H D+KP N+LLD+ + DFG+A + + + + M T+ Y+AP
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAP 175
Query: 851 ------EYGSEGIVSISGDVYSFGILMMETFTRRKPTNE 883
E+ +E + DV+S GI++ P ++
Sbjct: 176 ELLKRREFHAEPV-----DVWSCGIVLTAMLAGELPWDQ 209
>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs
Resolution)
Length = 362
Score = 43.5 bits (101), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 53/225 (23%), Positives = 94/225 (41%), Gaps = 29/225 (12%)
Query: 674 ELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVK-VFNLQEDRALKSFDTE---CE- 728
EL + + + SGS+ V + G+ VA+K VFN D + ++ C+
Sbjct: 16 ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 729 VMRRIR------HRNLI---KIVSSCSNPGFKAL-IMQYMPQGSLEKWLYSHNYSLTIRQ 778
V+R IR H N++ I P L ++ + + L + ++ ++ +
Sbjct: 76 VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH 135
Query: 779 RLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ 838
M + L LH ++H DL P N+LL D+ + DF +A+ + +
Sbjct: 136 IQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR--EDTADANK 190
Query: 839 TMTLATIGYMAPEYGSEGIVSISG-----DVYSFGILMMETFTRR 878
T + Y APE ++ G D++S G +M E F R+
Sbjct: 191 THYVTHRWYRAPEL----VMQFKGFTKLVDMWSAGCVMAEMFNRK 231
>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With
Sb203580
Length = 362
Score = 43.5 bits (101), Expect = 6e-04, Method: Compositional matrix adjust.
Identities = 54/225 (24%), Positives = 93/225 (41%), Gaps = 29/225 (12%)
Query: 674 ELQQATNGFGESNLLGSGSFDNVYKATLANGVSVAVK-VFNLQED-RALKSFDTE--CE- 728
EL + + + SGS+ V + G+ VA+K VFN D R + C+
Sbjct: 16 ELHAMQSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKR 75
Query: 729 VMRRIR------HRNLI---KIVSSCSNPGFKAL-IMQYMPQGSLEKWLYSHNYSLTIRQ 778
V+R IR H N++ I P L ++ + + L + ++ ++ +
Sbjct: 76 VLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQH 135
Query: 779 RLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVDPVTQ 838
M + L LH ++H DL P N+LL D+ + DF +A+ + +
Sbjct: 136 IQYFMYHILLGLHVLH---EAGVVHRDLHPGNILLADNNDITICDFNLAR--EDTADANK 190
Query: 839 TMTLATIGYMAPEYGSEGIVSISG-----DVYSFGILMMETFTRR 878
T + Y APE ++ G D++S G +M E F R+
Sbjct: 191 THYVTHRWYRAPEL----VMQFKGFTKLVDMWSAGCVMAEMFNRK 231
>pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte
Receptors A29
Length = 270
Score = 43.1 bits (100), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 53/173 (30%), Positives = 78/173 (45%), Gaps = 18/173 (10%)
Query: 199 KILDLGGNNIAGLIPSMIFNNSNMVAILLYGNHLSGHLPSSIY--LPNLENLFLWKNNLS 256
K LDL N ++ L PS F+ + +L ++ LP+ I+ L NLE L++ N L
Sbjct: 40 KKLDLQSNKLSSL-PSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ 98
Query: 257 GI---IPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQI 313
+ + D + N +E L L N L P F + +L LSLG N+L S +
Sbjct: 99 ALPIGVFDQLVNLAE---LRLDRNQLKSLPPRVFDSLTKLTYLSLGYNEL---QSLPKGV 152
Query: 314 FYSSLAKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVG 366
F K L+ L L N LK V + L T L+ ++QL +P G
Sbjct: 153 F----DKLTSLKELRLYNNQLKRVPEGAFDKL-TELKTLKLDNNQLK-RVPEG 199
Score = 37.0 bits (84), Expect = 0.048, Method: Compositional matrix adjust.
Identities = 48/183 (26%), Positives = 63/183 (34%), Gaps = 25/183 (13%)
Query: 401 DLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTCLANLTSLRHLDFRSNSLNSTIP 460
DL SNKL +L KL L N+N LQ L +L L N L +
Sbjct: 43 DLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQALPI 102
Query: 461 STFWSLKYILAVDFXXXXXXXXXXXXXXXXEALGGLNLTGNQLSGYIPSSIGNLKNLDWL 520
F L L L L NQL P +L L +L
Sbjct: 103 GVFDQL------------------------VNLAELRLDRNQLKSLPPRVFDSLTKLTYL 138
Query: 521 ALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSLEKLSRLVDFNVSFNGLEGEIP 580
+L N Q F L SL+ L L N + + +KL+ L + N L+ +P
Sbjct: 139 SLGYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLK-RVP 197
Query: 581 SGG 583
G
Sbjct: 198 EGA 200
Score = 35.8 bits (81), Expect = 0.12, Method: Compositional matrix adjust.
Identities = 39/167 (23%), Positives = 68/167 (40%), Gaps = 31/167 (18%)
Query: 84 TLPNELWH-MRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNIS 142
+LP++ +H + +L+++ + N L +LP + LE+ V+ NK+ +
Sbjct: 51 SLPSKAFHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQALPIGVFDQLV 109
Query: 143 SLKSIRLDNNSLSG-----------------------SFPTDLCTRLPSLVQLRLLGNNI 179
+L +RLD N L S P + +L SL +LRL N +
Sbjct: 110 NLAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQSLPKGVFDKLTSLKELRLYNNQL 169
Query: 180 TGRIPNREIPNEIGNLHNLKILDLGGNNIAGLIPSMIFNNSNMVAIL 226
R+P L LK L L N + +P F++ + +L
Sbjct: 170 K-RVPE----GAFDKLTELKTLKLDNNQLKR-VPEGAFDSLEKLKML 210
Score = 33.5 bits (75), Expect = 0.62, Method: Compositional matrix adjust.
Identities = 56/247 (22%), Positives = 89/247 (36%), Gaps = 26/247 (10%)
Query: 259 IPDSICNASEATILELSSNLFSGLVPNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSL 318
IP +I ++ L+L SN S L F +L++L L DN+L T + IF
Sbjct: 31 IPSNI--PADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAG---IF---- 81
Query: 319 AKCRYLRVLVLDTNPLKGVIPNSIGNLSTSLENFYAGSSQLSGGIPVGFGXXXXXXXXXX 378
+ + L L + N L+ +P + + +L +QL P F
Sbjct: 82 KELKNLETLWVTDNKLQA-LPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYLSL 140
Query: 379 XXXELAGAIPTVXXXXXXXXXXDLNSNKLKGFIPTDLCKLEKLNTLLSNNNALQGQIPTC 438
EL V L +N+LK KL +L TL +NN L+
Sbjct: 141 GYNELQSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGA 200
Query: 439 LANLTSLRHLDFRSNSLNSTIPSTFWSLKYILAVDFXXXXXXXXXXXXXXXXEALGGLNL 498
+L L+ L + N + T + K++ E LGG++
Sbjct: 201 FDSLEKLKMLQLQENPWDCTCNGIIYMAKWL----------------KKKADEGLGGVDT 244
Query: 499 TGNQLSG 505
G + G
Sbjct: 245 AGCEKGG 251
Score = 30.4 bits (67), Expect = 4.6, Method: Compositional matrix adjust.
Identities = 21/85 (24%), Positives = 37/85 (43%), Gaps = 1/85 (1%)
Query: 71 LVSLNISGNSFYDTLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKI 130
L L + N P + +L + N L SLP + + T L+ + +N++
Sbjct: 111 LAELRLDRNQLKSLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYNNQL 169
Query: 131 TGEFPSAIVNISSLKSIRLDNNSLS 155
A ++ LK+++LDNN L
Sbjct: 170 KRVPEGAFDKLTELKTLKLDNNQLK 194
>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX
Length = 361
Score = 43.1 bits (100), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 46/205 (22%), Positives = 85/205 (41%), Gaps = 28/205 (13%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTE-----CEVMRRIRHRNLI 739
++G G F V + G AVK+ ++ + + TE + ++H +++
Sbjct: 32 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 91
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASA---------L 790
+++ + S+ G ++ ++M L I +R D + A L
Sbjct: 92 ELLETYSSDGMLYMVFEFMDGADL---------CFEIVKRADAGFVYSEAVASHYMRQIL 142
Query: 791 EYLHHGYSTPIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
E L + + IIH D+KP+ VLL ++ LG FG+A L G + + T +
Sbjct: 143 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL-GESGLVAGGRVGTPHF 201
Query: 848 MAPEYGSEGIVSISGDVYSFGILMM 872
MAPE DV+ G+++
Sbjct: 202 MAPEVVKREPYGKPVDVWGCGVILF 226
>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3,
Tgme49_105860
Length = 467
Score = 43.1 bits (100), Expect = 7e-04, Method: Compositional matrix adjust.
Identities = 41/155 (26%), Positives = 70/155 (45%), Gaps = 22/155 (14%)
Query: 726 ECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLD---- 781
E V++++ H N++K+ + L+M+ G L + +RQ+
Sbjct: 54 EVAVLKQLDHPNIMKLYEFFEDKRNYYLVMEVYRGGELFD-------EIILRQKFSEVDA 106
Query: 782 --IMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDD---DMVAHLGDFGIAKLLDGVDPV 836
IM V S YLH I+H DLKP N+LL+ D + + DFG++ + +
Sbjct: 107 AVIMKQVLSGTTYLH---KHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKM 163
Query: 837 TQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILM 871
+ L T Y+APE + DV+S G+++
Sbjct: 164 KE--RLGTAYYIAPEVLRKKYDE-KCDVWSCGVIL 195
>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1
pdb|4GH2|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 43.1 bits (100), Expect = 8e-04, Method: Composition-based stats.
Identities = 55/230 (23%), Positives = 94/230 (40%), Gaps = 46/230 (20%)
Query: 688 LGSGSFDNVYKATLANGVS---VAVKVFNLQEDRAL---KSFDTECEVMRRIRHRNLIKI 741
LG G++ V A N V+ VAVK+ +++ RA+ ++ E + + + H N++K
Sbjct: 14 LGEGAYGEVQLAV--NRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKF 69
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH------- 794
+ L ++Y G L R DI + A + H
Sbjct: 70 YGHRREGNIQYLFLEYCSGGELFD-----------RIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 795 --HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAP 850
HG I H D+KP N+LLD+ + DFG+A + + + + M T+ Y+AP
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX-GTLPYVAP 175
Query: 851 ------EYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGEMSLKQW 894
E+ +E + DV+S GI++ P ++ W
Sbjct: 176 ELLKRREFHAEPV-----DVWSCGIVLTAMLAGELPWDQPSDSXQEYSDW 220
>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And
Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1)
Length = 311
Score = 43.1 bits (100), Expect = 8e-04, Method: Composition-based stats.
Identities = 58/201 (28%), Positives = 89/201 (44%), Gaps = 21/201 (10%)
Query: 682 FGESNLLGSGSFDNVYKA-TLANGVSVAVK----VFNLQEDRALKSFDTECEVMRRI-RH 735
F + LG GS+ V+K + +G AVK F +DRA K E ++ +H
Sbjct: 59 FQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKL--AEVGSHEKVGQH 116
Query: 736 RNLIKIVSSCSNPGFKALIMQYMPQG-SLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH 794
+++ + G L +Q G SL++ + SL Q + D AL +LH
Sbjct: 117 PCCVRLEQAWEEGGI--LYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLD--GVDPVTQTMTLATIGYMAPEY 852
S ++H D+KP N+ L LGDFG+ L G V + YMAPE
Sbjct: 175 ---SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE----GDPRYMAPEL 227
Query: 853 GSEGIVSISGDVYSFGILMME 873
+G + DV+S G+ ++E
Sbjct: 228 -LQGSYGTAADVFSLGLTILE 247
>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase
(gak)
pdb|3LL6|B Chain B, Crystal Structure Of The Human Cyclin G Associated Kinase
(gak)
Length = 337
Score = 43.1 bits (100), Expect = 8e-04, Method: Compositional matrix adjust.
Identities = 40/153 (26%), Positives = 69/153 (45%), Gaps = 12/153 (7%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFNLQEDRALKSFDTECEVMRRIR-HRNLIKIVS 743
+L G F VY+A + +G A+K E+ ++ E M+++ H N+++ S
Sbjct: 34 RVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCS 93
Query: 744 SCS-------NPGFKALIMQYMPQGSLEKWLYSHNYS--LTIRQRLDIMIDVASALEYLH 794
+ S + L++ + +G L ++L L+ L I A++++H
Sbjct: 94 AASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMH 153
Query: 795 HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIA 827
PIIH DLK N+LL + L DFG A
Sbjct: 154 R-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSA 185
>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
pdb|3C0G|B Chain B, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form
pdb|3C0H|A Chain A, Cask Cam-Kinase Domain- Amppnp Complex, P1 Form
pdb|3C0H|B Chain B, Cask Cam-Kinase Domain- Amppnp Complex, P1 Form
pdb|3C0I|A Chain A, Cask Cam-Kinase Domain- 3'-Amp Complex, P212121 Form
Length = 351
Score = 42.7 bits (99), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 45/205 (21%), Positives = 85/205 (41%), Gaps = 28/205 (13%)
Query: 686 NLLGSGSFDNVYKAT-LANGVSVAVKVFNLQE-----DRALKSFDTECEVMRRIRHRNLI 739
++G G F V + G AVK+ ++ + + + E + ++H +++
Sbjct: 30 EVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIV 89
Query: 740 KIVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASA---------L 790
+++ + S+ G ++ ++M L I +R D + A L
Sbjct: 90 ELLETYSSDGMLYMVFEFMDGADL---------CFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 791 EYLHHGYSTPIIHCDLKPNNVLL---DDDMVAHLGDFGIAKLLDGVDPVTQTMTLATIGY 847
E L + + IIH D+KP+ VLL ++ LG FG+A L G + + T +
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL-GESGLVAGGRVGTPHF 199
Query: 848 MAPEYGSEGIVSISGDVYSFGILMM 872
MAPE DV+ G+++
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILF 224
>pdb|2Z63|A Chain A, Crystal Structure Of The Tv8 Hybrid Of Human Tlr4 And
Hagfish Vlrb.61
Length = 570
Score = 42.7 bits (99), Expect = 9e-04, Method: Compositional matrix adjust.
Identities = 33/126 (26%), Positives = 57/126 (45%), Gaps = 2/126 (1%)
Query: 442 LTSLRHLDFRSNSLNSTIP-STFWSLKYILAVDFXXXXXXXXXXXXXXXXEALGGLNLTG 500
L L HLDF+ ++L S F SL+ ++ +D +L L + G
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454
Query: 501 NQLS-GYIPSSIGNLKNLDWLALARNAFQGPIPQSFGSLISLQSLDLSGNNISGEIPKSL 559
N ++P L+NL +L L++ + P +F SL SLQ L+++ N +
Sbjct: 455 NSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLKSVPDGIF 514
Query: 560 EKLSRL 565
++L+ L
Sbjct: 515 DRLTSL 520
Score = 33.5 bits (75), Expect = 0.62, Method: Compositional matrix adjust.
Identities = 19/42 (45%), Positives = 26/42 (61%), Gaps = 1/42 (2%)
Query: 511 IGNLKNLDWLALARNAFQG-PIPQSFGSLISLQSLDLSGNNI 551
IG+LK L L +A N Q +P+ F +L +L+ LDLS N I
Sbjct: 120 IGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKI 161
Score = 32.7 bits (73), Expect = 1.0, Method: Compositional matrix adjust.
Identities = 38/171 (22%), Positives = 73/171 (42%), Gaps = 13/171 (7%)
Query: 84 TLPNELWHMRRLKIIDFSSNSLSGSLPGDMCNSFTQLESFDVSSNKITGEFPSAIVNISS 143
T+ + + +L+ +DF ++L + S L D+S F +SS
Sbjct: 387 TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSS 446
Query: 144 LKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNEIGNLHNLKILDL 203
L+ +++ NS +F D+ T L +L L L + + P +L +L++L++
Sbjct: 447 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQL-----EQLSPTAFNSLSSLQVLNM 501
Query: 204 GGNNIAGLIPSMIFNN-SNMVAILLYGNHLSGHLPSSIYLPNLENLFLWKN 253
N + +P IF+ +++ I L+ N P P ++ L W N
Sbjct: 502 ASNQLKS-VPDGIFDRLTSLQKIWLHTN------PWDCSCPRIDYLSRWLN 545
Score = 30.0 bits (66), Expect = 6.0, Method: Compositional matrix adjust.
Identities = 73/266 (27%), Positives = 108/266 (40%), Gaps = 50/266 (18%)
Query: 132 GEFPSAIVNISSLKSIRLDNNSLSGSFPTDLCTRLPSLVQLRLLGNNITGRIPNREIPNE 191
G+FP+ + + SLK + +N +F LPSL L L N ++ + + ++
Sbjct: 317 GQFPT--LKLKSLKRLTFTSNKGGNAFSE---VDLPSLEFLDLSRNGLSFKGCCSQ--SD 369
Query: 192 IGNLHNLKILDLGGN-------NIAGL--IPSMIFNNSNMVAILLYGNHLSGHLPSSIYL 242
G +LK LDL N N GL + + F +SN+ + + LS L + IYL
Sbjct: 370 FGTT-SLKYLDLSFNGVITMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLS--LRNLIYL 426
Query: 243 ------------------PNLENLFLWKNNLS-GIIPDSICNASEATILELSSNLFSGLV 283
+LE L + N+ +PD T L+LS L
Sbjct: 427 DISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLS 486
Query: 284 PNTFGNCRQLQILSLGDNQLTTGSSAQGQIFYSSLAKCRYLRVLVLDTNPLKGVIPNSIG 343
P F + LQ+L++ NQL S IF + L+ + L TNP P I
Sbjct: 487 PTAFNSLSSLQVLNMASNQL---KSVPDGIF----DRLTSLQKIWLHTNPWDCSCPR-ID 538
Query: 344 NLSTSL---ENFYAGSSQLSG-GIPV 365
LS L GS++ SG G PV
Sbjct: 539 YLSRWLNKNSQKEQGSAKCSGSGKPV 564
>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|B Chain B, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|C Chain C, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
pdb|3P23|D Chain D, Crystal Structure Of The Human Kinase And Rnase Domains In
Complex With Adp
Length = 432
Score = 42.7 bits (99), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 48/201 (23%), Positives = 96/201 (47%), Gaps = 18/201 (8%)
Query: 682 FGESNLLGSGSFDNVYKATLANGVSVAVKVFNLQEDRALKSFDTECEVMRRI-RHRNLIK 740
F ++LG G+ + + + VAVK L E D E +++R H N+I+
Sbjct: 26 FCPKDVLGHGAEGTIVYRGMFDNRDVAVKRI-LPE--CFSFADREVQLLRESDEHPNVIR 82
Query: 741 IVSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTP 800
+ + F+ + ++ + +L++++ +++ + + ++ S L +LH S
Sbjct: 83 YFCTEKDRQFQYIAIE-LCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLH---SLN 138
Query: 801 IIHCDLKPNNVLL-----DDDMVAHLGDFGIAKLLD-GVDPVTQTMTL-ATIGYMAPEYG 853
I+H DLKP+N+L+ + A + DFG+ K L G ++ + T G++APE
Sbjct: 139 IVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEML 198
Query: 854 SEGIV---SISGDVYSFGILM 871
SE + + D++S G +
Sbjct: 199 SEDCKENPTYTVDIFSAGCVF 219
>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B
(STK17B)
pdb|3LM5|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B
(STK17B) IN Complex With Quercetin
Length = 327
Score = 42.7 bits (99), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 31/113 (27%), Positives = 56/113 (49%), Gaps = 13/113 (11%)
Query: 781 DIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLG-----DFGIAKLLDGVDP 835
D++ + LE +++ + I+H DLKP N+LL + LG DFG+++ +
Sbjct: 132 DVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSS--IYPLGDIKIVDFGMSRKIGHACE 189
Query: 836 VTQTMTLATIGYMAPEYGSEGIVSISGDVYSFGILMMETFTRRKPTNEMFTGE 888
+ + M T Y+APE + ++ + D+++ GI+ T P F GE
Sbjct: 190 LREIM--GTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSP----FVGE 236
>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue
pdb|2PMN|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp-Site
Inhibitor
pdb|2PMO|X Chain X, Crystal Structure Of Pfpk7 In Complex With Hymenialdisine
Length = 348
Score = 42.7 bits (99), Expect = 0.001, Method: Compositional matrix adjust.
Identities = 42/164 (25%), Positives = 78/164 (47%), Gaps = 16/164 (9%)
Query: 722 SFDTECEVMRRIRHRNLIKIVSSCSNPGFKALIMQYMPQGSLEKW-----LYSHNYS--L 774
F E +++ I++ + +N +I +YM S+ K+ + NY+ +
Sbjct: 89 DFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFI 148
Query: 775 TIRQRLDIMIDVASALEYLHHGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLLDGVD 834
I+ I+ V ++ Y+H+ I H D+KP+N+L+D + L DFG ++ + VD
Sbjct: 149 PIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYM--VD 204
Query: 835 PVTQTMTLATIGYMAPEYGSEGIVSISG---DVYSFGILMMETF 875
+ + T +M PE+ S S +G D++S GI + F
Sbjct: 205 KKIKG-SRGTYEFMPPEFFSNE-SSYNGAKVDIWSLGICLYVMF 246
>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain
Length = 316
Score = 42.7 bits (99), Expect = 0.001, Method: Composition-based stats.
Identities = 52/204 (25%), Positives = 93/204 (45%), Gaps = 20/204 (9%)
Query: 684 ESNLLGSGSFDNVYKA-TLANGVSVAVKVFNLQEDRALKSFDTECEVMRRIR-HRNLIKI 741
+ ++LG G+ V L AVK+ Q E E++ + + HRN++++
Sbjct: 17 QEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLEL 76
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLHHGYSTPI 801
+ L+ + M GS+ ++ + + + ++ DVASAL++LH + I
Sbjct: 77 IEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASV-VVQDVASALDFLH---NKGI 132
Query: 802 IHCDLKPNNVLLDD-DMVA--HLGDFGIA---KLLDGVDPVTQTMTLATIG---YMAPE- 851
H DLKP N+L + + V+ + DF + KL P++ L G YMAPE
Sbjct: 133 AHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEV 192
Query: 852 ---YGSEG-IVSISGDVYSFGILM 871
+ E I D++S G+++
Sbjct: 193 VEAFSEEASIYDKRCDLWSLGVIL 216
>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1
pdb|4FTA|A Chain A, Crystal Structure Of The Chk1
pdb|4FTC|A Chain A, Crystal Structure Of The Chk1
pdb|4FTN|A Chain A, Crystal Structure Of The Chk1
pdb|4FTQ|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 42.4 bits (98), Expect = 0.001, Method: Composition-based stats.
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 46/219 (21%)
Query: 688 LGSGSFDNVYKATLANGVS---VAVKVFNLQEDRAL---KSFDTECEVMRRIRHRNLIKI 741
LG G++ V A N V+ VAVK+ +++ RA+ ++ E + + + H N++K
Sbjct: 14 LGEGAYGEVQLAV--NRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKF 69
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH------- 794
+ L ++Y G L R DI + A + H
Sbjct: 70 YGHRREGNIQYLFLEYCSGGELFD-----------RIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 795 --HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAP 850
HG I H D+KP N+LLD+ + DFG+A + + + + M T+ Y+AP
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX-GTLPYVAP 175
Query: 851 ------EYGSEGIVSISGDVYSFGILMMETFTRRKPTNE 883
E+ +E + DV+S GI++ P ++
Sbjct: 176 ELLKRREFHAEPV-----DVWSCGIVLTAMLAGELPWDQ 209
>pdb|4FST|A Chain A, Crystal Structure Of The Chk1
Length = 269
Score = 42.4 bits (98), Expect = 0.001, Method: Composition-based stats.
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 46/219 (21%)
Query: 688 LGSGSFDNVYKATLANGVS---VAVKVFNLQEDRAL---KSFDTECEVMRRIRHRNLIKI 741
LG G++ V A N V+ VAVK+ +++ RA+ ++ E + + + H N++K
Sbjct: 14 LGEGAYGEVQLAV--NRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKF 69
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH------- 794
+ L ++Y G L R DI + A + H
Sbjct: 70 YGHRREGNIQYLFLEYCSGGELFD-----------RIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 795 --HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAP 850
HG I H D+KP N+LLD+ + DFG+A + + + + M T+ Y+AP
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMX-GTLPYVAP 175
Query: 851 ------EYGSEGIVSISGDVYSFGILMMETFTRRKPTNE 883
E+ +E + DV+S GI++ P ++
Sbjct: 176 ELLKRREFHAEPV-----DVWSCGIVLTAMLAGELPWDQ 209
>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRB|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRG|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRH|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRM|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRN|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2BRO|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights
Into Hydrogen Bonding And Protein-Ligand Affinity
pdb|2C3J|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3K|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2C3L|A Chain A, Identification Of A Buried Pocket For Potent And Selective
Inhibition Of Chk1: Prediction And Verification
pdb|2CGU|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGV|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGW|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|2CGX|A Chain A, Identification Of Chemically Diverse Chk1 Inhibitors By
Receptor-Based Virtual Screening
pdb|3NLB|A Chain A, Novel Kinase Profile Highlights The Temporal Basis Of
Context Dependent Checkpoint Pathways To Cell Death
Length = 297
Score = 42.4 bits (98), Expect = 0.001, Method: Composition-based stats.
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 46/219 (21%)
Query: 688 LGSGSFDNVYKATLANGVS---VAVKVFNLQEDRAL---KSFDTECEVMRRIRHRNLIKI 741
LG G++ V A N V+ VAVK+ +++ RA+ ++ E + + + H N++K
Sbjct: 15 LGEGAYGEVQLAV--NRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKF 70
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH------- 794
+ L ++Y G L R DI + A + H
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFD-----------RIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 795 --HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAP 850
HG I H D+KP N+LLD+ + DFG+A + + + + M T+ Y+AP
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAP 176
Query: 851 ------EYGSEGIVSISGDVYSFGILMMETFTRRKPTNE 883
E+ +E + DV+S GI++ P ++
Sbjct: 177 ELLKRREFHAEPV-----DVWSCGIVLTAMLAGELPWDQ 210
>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint
Kinase Chk1
pdb|1NVQ|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1UCN-01
pdb|1NVR|A Chain A, The Complex Structure Of Checkpoint Kinase
Chk1STAUROSPORINE
pdb|1NVS|A Chain A, The Complex Structure Of Checkpoint Kinase Chk1SB218078
pdb|2WMQ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMR|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMS|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMT|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMU|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMV|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMX|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2WMW|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEY|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XF0|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2XEZ|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2X8D|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2X8I|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YM3|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM4|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM5|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM6|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM7|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YM8|A Chain A, Crystal Structure Of Checkpoint Kinase 1 (Chk1) In Complex
With Inhibitors
pdb|2YDI|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 289
Score = 42.4 bits (98), Expect = 0.001, Method: Composition-based stats.
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 46/219 (21%)
Query: 688 LGSGSFDNVYKATLANGVS---VAVKVFNLQEDRAL---KSFDTECEVMRRIRHRNLIKI 741
LG G++ V A N V+ VAVK+ +++ RA+ ++ E + + + H N++K
Sbjct: 15 LGEGAYGEVQLAV--NRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKF 70
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH------- 794
+ L ++Y G L R DI + A + H
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFD-----------RIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 795 --HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAP 850
HG I H D+KP N+LLD+ + DFG+A + + + + M T+ Y+AP
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAP 176
Query: 851 ------EYGSEGIVSISGDVYSFGILMMETFTRRKPTNE 883
E+ +E + DV+S GI++ P ++
Sbjct: 177 ELLKRREFHAEPV-----DVWSCGIVLTAMLAGELPWDQ 210
>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1
Length = 278
Score = 42.4 bits (98), Expect = 0.001, Method: Composition-based stats.
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 46/219 (21%)
Query: 688 LGSGSFDNVYKATLANGVS---VAVKVFNLQEDRAL---KSFDTECEVMRRIRHRNLIKI 741
LG G++ V A N V+ VAVK+ +++ RA+ ++ E + + + H N++K
Sbjct: 13 LGEGAYGEVQLAV--NRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKF 68
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH------- 794
+ L ++Y G L R DI + A + H
Sbjct: 69 YGHRREGNIQYLFLEYCSGGELFD-----------RIEPDIGMPEPDAQRFFHQLMAGVV 117
Query: 795 --HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAP 850
HG I H D+KP N+LLD+ + DFG+A + + + + M T+ Y+AP
Sbjct: 118 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAP 174
Query: 851 ------EYGSEGIVSISGDVYSFGILMMETFTRRKPTNE 883
E+ +E + DV+S GI++ P ++
Sbjct: 175 ELLKRREFHAEPV-----DVWSCGIVLTAMLAGELPWDQ 208
>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1
pdb|4FSQ|A Chain A, Crystal Structure Of The Chk1
pdb|4FSR|A Chain A, Crystal Structure Of The Chk1
pdb|4FT0|A Chain A, Crystal Structure Of The Chk1
pdb|4FT5|A Chain A, Crystal Structure Of The Chk1
pdb|4FT7|A Chain A, Crystal Structure Of The Chk1
pdb|4FT9|A Chain A, Crystal Structure Of The Chk1
pdb|4FTI|A Chain A, Crystal Structure Of The Chk1
pdb|4FTJ|A Chain A, Crystal Structure Of The Chk1
pdb|4FTK|A Chain A, Crystal Structure Of The Chk1
pdb|4FTL|A Chain A, Crystal Structure Of The Chk1
pdb|4FTM|A Chain A, Crystal Structure Of The Chk1
pdb|4FTO|A Chain A, Crystal Structure Of The Chk1
pdb|4FTR|A Chain A, Crystal Structure Of The Chk1
pdb|4FTT|A Chain A, Crystal Structure Of The Chk1
pdb|4FTU|A Chain A, Crystal Structure Of The Chk1
Length = 279
Score = 42.4 bits (98), Expect = 0.001, Method: Composition-based stats.
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 46/219 (21%)
Query: 688 LGSGSFDNVYKATLANGVS---VAVKVFNLQEDRAL---KSFDTECEVMRRIRHRNLIKI 741
LG G++ V A N V+ VAVK+ +++ RA+ ++ E + + + H N++K
Sbjct: 14 LGEGAYGEVQLAV--NRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKF 69
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH------- 794
+ L ++Y G L R DI + A + H
Sbjct: 70 YGHRREGNIQYLFLEYCSGGELFD-----------RIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 795 --HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAP 850
HG I H D+KP N+LLD+ + DFG+A + + + + M T+ Y+AP
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAP 175
Query: 851 ------EYGSEGIVSISGDVYSFGILMMETFTRRKPTNE 883
E+ +E + DV+S GI++ P ++
Sbjct: 176 ELLKRREFHAEPV-----DVWSCGIVLTAMLAGELPWDQ 209
>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human
Chk1 Kinase Domain
pdb|3OT8|A Chain A, X-Ray Crystal Structure Of Compound 17r Bound To Human
Chk1 Kinase Domain
pdb|3PA3|A Chain A, X-Ray Crystal Structure Of Compound 70 Bound To Human Chk1
Kinase Domain
pdb|3PA4|A Chain A, X-Ray Crystal Structure Of Compound 2a Bound To Human Chk1
Kinase Domain
pdb|3PA5|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
pdb|3U9N|A Chain A, X-Ray Crystal Structure Of Compound 1 Bound To Human Chk1
Kinase Domain
Length = 273
Score = 42.4 bits (98), Expect = 0.001, Method: Composition-based stats.
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 46/219 (21%)
Query: 688 LGSGSFDNVYKATLANGVS---VAVKVFNLQEDRAL---KSFDTECEVMRRIRHRNLIKI 741
LG G++ V A N V+ VAVK+ +++ RA+ ++ E + + + H N++K
Sbjct: 14 LGEGAYGEVQLAV--NRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKF 69
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH------- 794
+ L ++Y G L R DI + A + H
Sbjct: 70 YGHRREGNIQYLFLEYCSGGELFD-----------RIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 795 --HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAP 850
HG I H D+KP N+LLD+ + DFG+A + + + + M T+ Y+AP
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAP 175
Query: 851 ------EYGSEGIVSISGDVYSFGILMMETFTRRKPTNE 883
E+ +E + DV+S GI++ P ++
Sbjct: 176 ELLKRREFHAEPV-----DVWSCGIVLTAMLAGELPWDQ 209
>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint
Kinase Inhibitors - Hit To Lead Exploration
pdb|2YER|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YEX|A Chain A, Synthesis And Evaluation Of Triazolones As Checkpoint
Kinase 1 Inhibitors
pdb|2YDK|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By
Structure Based Design And Optimization Of Thiophene
Carboxamide Ureas
Length = 276
Score = 42.4 bits (98), Expect = 0.001, Method: Composition-based stats.
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 46/219 (21%)
Query: 688 LGSGSFDNVYKATLANGVS---VAVKVFNLQEDRAL---KSFDTECEVMRRIRHRNLIKI 741
LG G++ V A N V+ VAVK+ +++ RA+ ++ E + + + H N++K
Sbjct: 15 LGEGAYGEVQLAV--NRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKF 70
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH------- 794
+ L ++Y G L R DI + A + H
Sbjct: 71 YGHRREGNIQYLFLEYCSGGELFD-----------RIEPDIGMPEPDAQRFFHQLMAGVV 119
Query: 795 --HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAP 850
HG I H D+KP N+LLD+ + DFG+A + + + + M T+ Y+AP
Sbjct: 120 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAP 176
Query: 851 ------EYGSEGIVSISGDVYSFGILMMETFTRRKPTNE 883
E+ +E + DV+S GI++ P ++
Sbjct: 177 ELLKRREFHAEPV-----DVWSCGIVLTAMLAGELPWDQ 210
>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
pdb|3JVS|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding
Site
Length = 271
Score = 42.4 bits (98), Expect = 0.001, Method: Composition-based stats.
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 46/219 (21%)
Query: 688 LGSGSFDNVYKATLANGVS---VAVKVFNLQEDRAL---KSFDTECEVMRRIRHRNLIKI 741
LG G++ V A N V+ VAVK+ +++ RA+ ++ E + + + H N++K
Sbjct: 14 LGEGAYGEVQLAV--NRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKF 69
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH------- 794
+ L ++Y G L R DI + A + H
Sbjct: 70 YGHRREGNIQYLFLEYCSGGELFD-----------RIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 795 --HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAP 850
HG I H D+KP N+LLD+ + DFG+A + + + + M T+ Y+AP
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAP 175
Query: 851 ------EYGSEGIVSISGDVYSFGILMMETFTRRKPTNE 883
E+ +E + DV+S GI++ P ++
Sbjct: 176 ELLKRREFHAEPV-----DVWSCGIVLTAMLAGELPWDQ 209
>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017
pdb|2E9V|B Chain B, Structure Of H-Chk1 Complexed With A859017
Length = 268
Score = 42.4 bits (98), Expect = 0.001, Method: Composition-based stats.
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 46/219 (21%)
Query: 688 LGSGSFDNVYKATLANGVS---VAVKVFNLQEDRAL---KSFDTECEVMRRIRHRNLIKI 741
LG G++ V A N V+ VAVK+ +++ RA+ ++ E + + + H N++K
Sbjct: 14 LGEGAYGEVQLAV--NRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKF 69
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH------- 794
+ L ++Y G L R DI + A + H
Sbjct: 70 YGHRREGNIQYLFLEYCSGGELFD-----------RIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 795 --HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAP 850
HG I H D+KP N+LLD+ + DFG+A + + + + M T+ Y+AP
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAP 175
Query: 851 ------EYGSEGIVSISGDVYSFGILMMETFTRRKPTNE 883
E+ +E + DV+S GI++ P ++
Sbjct: 176 ELLKRREFHAEPV-----DVWSCGIVLTAMLAGELPWDQ 209
>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994
pdb|2YWP|A Chain A, Crystal Structure Of Chk1 With A Urea Inhibitor
pdb|2E9N|A Chain A, Structure Of H-chk1 Complexed With A767085
pdb|2E9O|A Chain A, Structure Of H-Chk1 Complexed With Aa582939
pdb|2E9P|A Chain A, Structure Of H-Chk1 Complexed With A771129
pdb|2E9U|A Chain A, Structure Of H-Chk1 Complexed With A780125
Length = 269
Score = 42.4 bits (98), Expect = 0.001, Method: Composition-based stats.
Identities = 54/219 (24%), Positives = 93/219 (42%), Gaps = 46/219 (21%)
Query: 688 LGSGSFDNVYKATLANGVS---VAVKVFNLQEDRAL---KSFDTECEVMRRIRHRNLIKI 741
LG G++ V A N V+ VAVK+ +++ RA+ ++ E + + + H N++K
Sbjct: 14 LGEGAYGEVQLAV--NRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKMLNHENVVKF 69
Query: 742 VSSCSNPGFKALIMQYMPQGSLEKWLYSHNYSLTIRQRLDIMIDVASALEYLH------- 794
+ L ++Y G L R DI + A + H
Sbjct: 70 YGHRREGNIQYLFLEYCSGGELFD-----------RIEPDIGMPEPDAQRFFHQLMAGVV 118
Query: 795 --HGYSTPIIHCDLKPNNVLLDDDMVAHLGDFGIAKLL--DGVDPVTQTMTLATIGYMAP 850
HG I H D+KP N+LLD+ + DFG+A + + + + M T+ Y+AP
Sbjct: 119 YLHGIG--ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMC-GTLPYVAP 175
Query: 851 ------EYGSEGIVSISGDVYSFGILMMETFTRRKPTNE 883
E+ +E + DV+S GI++ P ++
Sbjct: 176 ELLKRREFHAEPV-----DVWSCGIVLTAMLAGELPWDQ 209
Database: pdbaa
Posted date: Mar 3, 2013 10:34 PM
Number of letters in database: 14,973,337
Number of sequences in database: 62,578
Lambda K H
0.318 0.135 0.394
Lambda K H
0.267 0.0410 0.140
Matrix: BLOSUM62
Gap Penalties: Existence: 11, Extension: 1
Number of Hits to DB: 26,345,055
Number of Sequences: 62578
Number of extensions: 1055603
Number of successful extensions: 5284
Number of sequences better than 100.0: 1000
Number of HSP's better than 100.0 without gapping: 733
Number of HSP's successfully gapped in prelim test: 427
Number of HSP's that attempted gapping in prelim test: 2689
Number of HSP's gapped (non-prelim): 1589
length of query: 973
length of database: 14,973,337
effective HSP length: 108
effective length of query: 865
effective length of database: 8,214,913
effective search space: 7105899745
effective search space used: 7105899745
T: 11
A: 40
X1: 16 ( 7.3 bits)
X2: 38 (14.6 bits)
X3: 64 (24.7 bits)
S1: 41 (21.7 bits)
S2: 56 (26.2 bits)